0000919956-14-000036.txt : 20141106 0000919956-14-000036.hdr.sgml : 20141106 20141106160722 ACCESSION NUMBER: 0000919956-14-000036 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141106 DATE AS OF CHANGE: 20141106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diversicare Healthcare Services, Inc. CENTRAL INDEX KEY: 0000919956 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 621559667 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12996 FILM NUMBER: 141200702 BUSINESS ADDRESS: STREET 1: 1621 GALLERIA BLVD. CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 6157717575 MAIL ADDRESS: STREET 1: 1621 GALLERIA BLVD. CITY: BRENTWOOD STATE: TN ZIP: 37027 FORMER COMPANY: FORMER CONFORMED NAME: ADVOCAT INC DATE OF NAME CHANGE: 19940309 10-Q 1 dvcr-20140930x10q.htm 10-Q DVCR-2014.09.30-10Q


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________ 
FORM 10-Q
________________________________ 
CHECK ONE:
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended: September 30, 2014
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             .

Commission file No.: 1-12996
________________________________ 
Diversicare Healthcare Services, Inc.
(exact name of registrant as specified in its charter)
 ________________________________
Delaware
 
62-1559667
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification No.)
1621 Galleria Boulevard, Brentwood, TN 37027
(Address of principal executive offices) (Zip Code)
(615) 771-7575
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and a “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
 
¨
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
¨
Smaller reporting Company
 
ý
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý
6,156,332
(Outstanding shares of the issuer’s common stock as of October 31, 2014)
 



Part I. FINANCIAL INFORMATION
ITEM 1 – FINANCIAL STATEMENTS
DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED BALANCE SHEETS
(in thousands)
 
 
September 30,
2014
 
December 31,
2013
 
(Unaudited)
 
 
CURRENT ASSETS:
 
 
 
Cash and cash equivalents
$
3,855

 
$
3,781

Receivables, less allowance for doubtful accounts of $5,333 and $3,879, respectively
42,067

 
32,658

Other receivables
899

 
1,118

Prepaid expenses and other current assets
2,339

 
2,442

Income tax refundable
515

 
763

Current assets of discontinued operations
390

 
2,870

Deferred income taxes
7,757

 
6,579

Total current assets
57,822

 
50,211

PROPERTY AND EQUIPMENT, at cost
97,605

 
93,572

Less accumulated depreciation and amortization
(53,288
)
 
(48,516
)
Discontinued operations, net
600

 
8,987

Property and equipment, net
44,917

 
54,043

OTHER ASSETS:
 
 
 
Deferred income taxes
12,130

 
15,912

Deferred financing and other costs, net
1,839

 
1,914

Investment in unconsolidated affiliate
399

 
487

Other noncurrent assets
6,180

 
5,698

Acquired leasehold interest, net
7,940

 
8,228

Noncurrent assets of discontinued operations
4

 
1,251

Total other assets
28,492

 
33,490

 
$
131,231

 
$
137,744

The accompanying notes are an integral part of these interim consolidated financial statements.

2


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(continued)
 
 
September 30,
2014
 
December 31,
2013
 
(Unaudited)
 
 
CURRENT LIABILITIES:
 
 
 
Current portion of long-term debt and capitalized lease obligations
$
7,208

 
$
4,549

Trade accounts payable
7,863

 
7,177

Current liabilities of discontinued operations
136

 
1,359

Accrued expenses:
 
 
 
Payroll and employee benefits
14,200

 
12,255

Self-insurance reserves, current portion
12,159

 
11,711

Other current liabilities
6,024

 
5,116

Total current liabilities
47,590

 
42,167

NONCURRENT LIABILITIES:
 
 
 
Long-term debt and capitalized lease obligations, less current portion
42,851

 
43,552

Self-insurance reserves, noncurrent portion
15,378

 
16,375

Noncurrent liabilities of discontinued operations
—

 
5,952

Other noncurrent liabilities
13,875

 
15,214

Total noncurrent liabilities
72,104

 
81,093

COMMITMENTS AND CONTINGENCIES

 

SERIES C REDEEMABLE PREFERRED STOCK
 
 
 
$.10 par value, 5,000 shares authorized and issued, and 0 and 5,000 shares outstanding, respectively
—

 
4,918

SHAREHOLDERS’ EQUITY:
 
 
 
Series A preferred stock, authorized 200,000 shares, $.10 par value, none issued and outstanding
—

 
—

Common stock, authorized 20,000,000 shares, $.01 par value, 6,388,000 and 6,307,000 shares issued, and 6,156,000 and 6,075,000 shares outstanding, respectively
64

 
63

Treasury stock at cost, 232,000 shares of common stock
(2,500
)
 
(2,500
)
Paid-in capital
19,891

 
19,570

Accumulated deficit
(5,450
)
 
(8,435
)
Accumulated other comprehensive loss
(468
)
 
(569
)
Total shareholders’ equity of Diversicare Healthcare Services, Inc.
11,537

 
8,129

Noncontrolling interest
—

 
1,437

Total shareholders’ equity
11,537

 
9,566

 
$
131,231

 
$
137,744

The accompanying notes are an integral part of these interim consolidated financial statements.

3


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts, unaudited)
 
Three Months Ended
September 30,
 
2014
 
2013
PATIENT REVENUES, net
$
90,331

 
$
64,631

EXPENSES:
 
 
 
Operating
73,006

 
54,186

Lease and rent expense
6,876

 
4,817

Professional liability
1,743

 
947

General and administrative
5,582

 
5,006

Depreciation and amortization
1,812

 
1,634

Restructuring
—

 
944

Total expenses
89,019

 
67,534

OPERATING INCOME (LOSS)
1,312

 
(2,903
)
OTHER INCOME (EXPENSE):
 
 
 
Equity in net income (loss) of unconsolidated affiliate
(30
)
 
63

Interest expense, net
(916
)
 
(855
)
Total other expense
(946
)
 
(792
)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
366

 
(3,695
)
BENEFIT (PROVISION) FOR INCOME TAXES
(147
)
 
1,374

INCOME (LOSS) FROM CONTINUING OPERATIONS
219

 
(2,321
)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
 
 
 
Operating loss, net of tax of $384 and $1,435, respectively
(585
)
 
(2,444
)
Gain on disposal, net of tax of $(3,009) and $0, respectively
4,513

 
—

Income (loss) from discontinued operations
3,928

 
(2,444
)
NET INCOME (LOSS)
4,147

 
(4,765
)
Less: (income) loss attributable to noncontrolling interests
—

 
(17
)
NET INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.
4,147

 
(4,782
)
PREFERRED STOCK DIVIDENDS
(48
)
 
(86
)
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS
$
4,099

 
$
(4,868
)
NET INCOME (LOSS) PER COMMON SHARE FOR DIVERSICARE HEALTHCARE SERVICES, INC. SHAREHOLDERS:
 
 
 
Per common share – basic
 
 
 
Continuing operations
$
0.03

 
$
(0.41
)
Discontinued operations
0.65

 
(0.42
)
 
$
0.68

 
$
(0.83
)
Per common share – diluted
 
 
 
Continuing operations
$
0.03

 
$
(0.41
)
Discontinued operations
0.63

 
(0.42
)
 
$
0.66

 
$
(0.83
)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK
$
0.055

 
$
0.055

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
 
 
 
Basic
6,020,000

 
5,892,000

Diluted
6,248,000

 
5,892,000

                              
The accompanying notes are an integral part of these interim consolidated financial statements.

4


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands and unaudited)
 
 
Three Months Ended
September 30,
 
2014
 
2013
NET INCOME (LOSS)
$
4,147

 
$
(4,765
)
OTHER COMPREHENSIVE INCOME (LOSS):
 
 
 
Change in fair value of cash flow hedge, net of tax
254

 
100

Less: reclassification adjustment for amounts recognized in net income
(128
)
 
(135
)
Total other comprehensive income (loss)
126

 
(35
)
COMPREHENSIVE INCOME (LOSS)
4,273

 
(4,800
)
Less: comprehensive (income) loss attributable to noncontrolling interest
—

 
(17
)
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.
$
4,273

 
$
(4,817
)

The accompanying notes are an integral part of these interim consolidated financial statements.

5


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts, unaudited)
 
 
Nine Months Ended
September 30,
 
2014
 
2013
PATIENT REVENUES, net
$
250,443

 
$
184,558

EXPENSES:
 
 
 
Operating
200,517

 
152,014

Lease and rent expense
19,094

 
14,398

Professional liability
5,360

 
4,212

General and administrative
16,077

 
15,769

Depreciation and amortization
5,252

 
4,572

Restructuring
—

 
944

Total expenses
246,300

 
191,909

OPERATING INCOME (LOSS)
4,143

 
(7,351
)
OTHER INCOME (EXPENSE):
 
 
 
Equity in net loss of unconsolidated affiliate
(89
)
 
(152
)
Interest expense, net
(2,757
)
 
(2,140
)
Debt retirement costs
—

 
(320
)
Total other income (expense)
(2,846
)
 
(2,612
)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
1,297

 
(9,963
)
BENEFIT (PROVISION) FOR INCOME TAXES
(538
)
 
3,947

INCOME (LOSS) FROM CONTINUING OPERATIONS
759

 
(6,016
)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
 
 
 
Operating loss, net of tax of $732 and $1,101, respectively
(1,069
)
 
(1,875
)
Gain on disposal, net of taxes of $(3,009) and $0, respectively
4,513

 
—

Income (loss) from discontinued operations
3,444

 
(1,875
)
NET INCOME (LOSS)
4,203

 
(7,891
)
Less: (income) loss attributable to noncontrolling interests
25

 
(51
)
NET INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.
4,228

 
(7,942
)
PREFERRED STOCK DIVIDENDS
(220
)
 
(258
)
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS
$
4,008

 
$
(8,200
)
NET INCOME (LOSS) PER COMMON SHARE FOR DIVERSICARE HEALTHCARE SERVICES, INC. SHAREHOLDERS:
 
 
 
Per common share – basic
 
 
 
Continuing operations
$
0.09

 
$
(1.07
)
Discontinued operations
0.57

 
(0.32
)
 
$
0.66

 
$
(1.39
)
Per common share – diluted
 
 
 
Continuing operations
$
0.09

 
$
(1.07
)
Discontinued operations
0.56

 
(0.32
)
 
$
0.65

 
$
(1.39
)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK
$
0.165

 
$
0.165

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
 
 
 
Basic
6,004,000

 
5,878,000

Diluted
6,171,000

 
5,878,000


The accompanying notes are an integral part of these interim consolidated financial statements.


6




DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands and unaudited)
 
 
Nine Months Ended
September 30,
 
2014
 
2013
NET INCOME (LOSS)
4,203

 
(7,891
)
OTHER COMPREHENSIVE INCOME (LOSS):
 
 
 
Change in fair value of cash flow hedge, net of tax
478

 
469

Less: reclassification adjustment for amounts recognized in net income
(376
)
 
(226
)
Total other comprehensive income (loss)
102

 
243

COMPREHENSIVE INCOME (LOSS)
4,305

 
(7,648
)
Less: comprehensive (income) loss attributable to noncontrolling interest
25

 
(51
)
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC.
$
4,330

 
$
(7,699
)

The accompanying notes are an integral part of these interim consolidated financial statements.



7


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands and unaudited)
 
 
Nine Months Ended
September 30,
 
2014
 
2013
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
Net income (loss)
4,203

 
(7,891
)
Discontinued operations
3,444

 
(1,875
)
Income (loss) from continuing operations
759

 
(6,016
)
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities:
 
 
 
Depreciation and amortization
5,252

 
4,572

Provision for doubtful accounts
4,235

 
2,785

Deferred income tax benefit
(467
)
 
(4,214
)
Provision for self-insured professional liability, net of cash payments
815

 
660

Stock-based compensation
441

 
809

Equity in net losses of unconsolidated affiliate, net of investment
88

 
(99
)
Debt retirement costs
—

 
320

Other
(468
)
 
(182
)
Changes in assets and liabilities affecting operating activities:
 
 
 
Receivables, net
(13,775
)
 
(5,551
)
Prepaid expenses and other assets
(323
)
 
(1,124
)
Trade accounts payable and accrued expenses
4,131

 
2,565

Net cash provided by (used in) continuing operations
688

 
(5,475
)
Discontinued operations
(600
)
 
5,117

Net cash provided by (used in) operating activities
88

 
(358
)
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
Purchases of property and equipment
(4,228
)
 
(4,109
)
Acquisition of property and equipment through business combination
—

 
(14,742
)
Change in restricted cash
33

 
(3,894
)
Proceeds from sale of discontinued operations
16,500

 
—

Deposits and other deferred balances
(64
)
 
—

Net cash provided by (used in) continuing operations
12,241

 
(22,745
)
Discontinued operations
(61
)
 
1,808

Net cash provided by (used in) investing activities
12,180

 
(20,937
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Repayment of debt obligations
(14,850
)
 
(28,757
)
Proceeds from issuance of debt
16,808

 
50,500

Financing costs
(180
)
 
(1,341
)
Issuance and redemption of employee equity awards
(30
)
 
28

Redemption of preferred stock
(4,918
)
 
—

Payment of common stock dividends
(993
)
 
(647
)
Payment of preferred stock dividends
(220
)
 
(258
)
Distributions to noncontrolling interest
(1,411
)
 
(158
)
Payment for preferred stock restructuring
(448
)
 
(434
)
Net cash provided by (used in) continuing operations
$
(6,242
)
 
$
18,933

Discontinued operations
(5,952
)
 
(150
)
Net cash provided by (used in) financing activities
(12,194
)
 
18,783


8


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands and unaudited)
(continued)
 
 
Nine Months Ended
September 30,
 
2014
 
2013
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
$
74

 
$
(2,512
)
CASH AND CASH EQUIVALENTS, beginning of period
3,781

 
5,928

CASH AND CASH EQUIVALENTS, end of period
$
3,855

 
$
3,416

SUPPLEMENTAL INFORMATION:
 
 
 
Cash payments of interest, net of amounts capitalized
$
2,496

 
$
1,854

Cash payments of income taxes
$
66

 
$
74

The accompanying notes are an integral part of these interim consolidated financial statements.

9


DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2014 AND 2013

1.
BUSINESS
Diversicare Healthcare Services, Inc. (together with its subsidiaries, “Diversicare Healthcare Services” or the “Company”) provides long-term care services to nursing center patients in nine states, primarily in the Southeast, Midwest, and Southwest. The Company’s centers provide a wide range of health care services to their patients and residents that include nursing, personal care, and social services. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company’s nursing centers also offer a variety of comprehensive rehabilitation services, as well as nutritional support services. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Missouri, Ohio, Tennessee, and Texas. The Company's operating results also include the results of certain discontinued operations that have been reclassified on the face of the financial statements to reflect the discontinued status of these operations.
As of September 30, 2014, the Company’s continuing operations consist of 51 skilled nursing and long-term care centers with 6,229 licensed beds. The Company owns 13 and leases 38 of its nursing centers.

2.
CONSOLIDATION AND BASIS OF PRESENTATION OF FINANCIAL STATEMENTS
The interim consolidated financial statements include the operations and accounts of Diversicare Healthcare Services and its subsidiaries, all wholly-owned. All significant intercompany accounts and transactions have been eliminated in consolidation. Any variable interest entities (“VIEs”) in which the Company has an interest are consolidated when the Company identifies that it is the primary beneficiary. The Company had one variable interest entity related to a nursing center in West Virginia that was dissolved in the first quarter of 2014 as a result of the asset purchase of the Rose Terrace nursing center as further described in Note 8, and is no longer consolidated into the interim consolidated financial statements of the Company. The investment in an unconsolidated affiliate (a 50 percent-owned joint venture partnership) is accounted for using the equity method and is described in Note 9.
The interim consolidated financial statements for the three and nine month periods ended September 30, 2014 and 2013, included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management of the Company, the accompanying interim consolidated financial statements reflect all normal, recurring adjustments necessary to present fairly the Company’s financial position at September 30, 2014, and the results of operations for the three month and nine month periods ended September 30, 2014 and 2013, and cash flows for the nine month periods ended September 30, 2014 and 2013. The Company’s balance sheet information at December 31, 2013, was derived from its audited consolidated financial statements as of December 31, 2013.
The results of operations for the periods ended September 30, 2014 and 2013, are not necessarily indicative of the operating results that may be expected for a full year. These interim consolidated financial statements should be read in connection with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013.

3.
RECENT ACCOUNTING GUIDANCE
In February 2013, the FASB issued Accounting Standards Update ("ASU") 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.
In April 2014, the FASB issued ASU 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity changing the criteria for reporting discontinued operations. The ASU states that only those disposed components (or components held-for-sale) representing a strategic shift that have a significant effect on operations and financial results will be reported in discontinued operations. The ASU also required expanded disclosures about discontinued operations in the financial statement notes. The ASU is effective for disposals (or classifications as held-for-sale) that occur within annual periods beginning on or after December 15, 2014 and interim periods within those annual periods. Early application is permitted, but only for those disposals that have not been reported in financial statements previously issued or available for issuance. We have chosen to

10


early adopt this ASU and have applied the new criteria in determining the accounting treatment for the nursing centers exited during 2014. The adoption of this guidance did not have a material impact on the Company's consolidated financial results.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.


4.
LONG-TERM DEBT AND INTEREST RATE SWAP
The Company has agreements with a syndicate of banks for a mortgage term loan ("Original Mortgage Loan") and the Company’s revolving credit agreement ("Original Revolver"). On May 1, 2013, the Company executed an Amended and Restated Credit Agreement (the "Credit Agreement") which modified the terms of the Original Mortgage Loan and the Original Revolver Agreements dated February 28, 2011. The Credit Agreement increases the Company's borrowing capacity to $65,000,000 allocated between a $45,000,000 Mortgage Loan ("Amended Mortgage Loan") and a $20,000,000 Revolver ("Amended Revolver"). Loan acquisition costs associated with the Amended Mortgage Loan and the Amended Revolver were capitalized in the amount of $1,341,000 and are being amortized over the five-year term of the agreements.
Under the terms of the amended agreements, the syndicate of banks provided the Amended Mortgage Loan with an original balance of $45,000,000 with a five-year maturity through April 30, 2018, and a $20,000,000 Amended Revolver through April 30, 2018. The Amended Mortgage Loan has a term of five years, with principal and interest payable monthly based on a 25-year amortization. Interest is based on LIBOR plus 4.5%. A portion of the Amended Mortgage Loan is effectively fixed at 6.87% pursuant to an interest rate swap with a notional amount of $21,847,000. As of September 30, 2014, the interest rate related to the Amended Mortgage Loan was 4.65%. The Amended Mortgage Loan is secured by thirteen owned nursing centers, related equipment and a lien on the accounts receivable of these centers. The Amended Mortgage Loan and the Amended Revolver are cross-collateralized. The Company’s Amended Revolver has an interest rate of LIBOR plus 4.5% and is secured by accounts receivable and is subject to limits on the maximum amount of loans that can be outstanding under the revolver based on borrowing base restrictions.
Effective March 31, 2014, the Company entered into the Second Amendment to the Amended and Restated Revolver ("Second Amendment"). The Second Amendment temporarily increased the Amended Revolver capacity from the $20,000,000 in the original Amended Revolver to $27,500,000 through September 30, 2014, as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process. Effective July 1, 2014, the Company entered into the Third Amendment to the Amended and Restated Revolver ("Third Amendment"). The Third Amendment makes the previously temporary increase to the Amended Revolver capacity from the $20,000,000 in the original Amended Revolver to $27,500,000, a permanent change to the borrowing capacity as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process.
As of September 30, 2014, the Company had $6,000,000 borrowings outstanding under the revolving credit facility compared to $3,000,000 outstanding as of December 31, 2013. The outstanding borrowings on the revolver primarily reflect the Company's approach to accumulated Medicaid and Medicare receivables at recently acquired facilities as these facilities proceed through the change in ownership process with CMS. Annual fees for letters of credit issued under this Revolver are 3.00% of the amount outstanding. The Company has ten letters of credit with a total value of $7,991,000 outstanding as of September 30, 2014. Considering the balance of eligible accounts receivable, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of $27,500,000, the balance available for borrowing under the revolving credit center is $12,728,000 at September 30, 2014.
Effective March 27, 2014, the Company executed its purchase option to acquire all assets associated with the Rose Terrace nursing center in Culloden, West Virginia from Milton Holdings, LLC which was considered a variable interest entity ("VIE") by the Company and consolidated prior to the date of this transaction. See Note 8 for further information on the VIE considerations. In conjunction with the purchase of the assets, the Company entered into an interest-only $8,000,000 term loan ("Rose Terrace Note") with a maturity date of March 27, 2015. The structure of the Rose Terrace Note reflected the Company's intent to sell the property and transfer operations to an unrelated third-party operator as further disclosed in Note 11. This transaction closed on July 1, 2014, at which time the Rose Terrace Note was paid in full.
The Company’s debt agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. The Company is in compliance with all such covenants at September 30, 2014.

11


Interest Rate Swap Transaction
As part of the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The Company designated its interest rate swap as a cash flow hedge and the earnings component of the hedge, net of taxes, is reflected as a component of other comprehensive income (loss). In conjunction with the amendment to the credit facility, the Company retained the previously agreed upon interest rate swap terms, and redesignated the interest rate swap as a cash flow hedge. The interest rate swap agreement requires the Company to make fixed rate payments to the bank calculated on the applicable notional amount of $21,847,000 at an annual fixed rate of 6.87% while the bank is obligated to make payments to the Company based on LIBOR on the same notional amounts.
The Company assesses the effectiveness of its interest rate swap on a quarterly basis, and at September 30, 2014, the Company determined that the interest rate swap was effective. The interest rate swap valuation model indicated a net liability of $755,000 at September 30, 2014. The fair value of the interest rate swap is included in “other noncurrent liabilities” on the Company’s interim consolidated balance sheet. The balance of accumulated other comprehensive loss at September 30, 2014 is $468,000 and reflects the liability related to the interest rate swap, net of the income tax benefit of $287,000. As the Company’s interest rate swap is not traded on a market exchange, the fair value is determined using a valuation based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy, in accordance with the FASB guidance set forth in ASC 820, Fair Value Measurement.

5.
INSURANCE MATTERS
Professional Liability and Other Liability Insurance
The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, consolidated offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”) which has issued a policy insuring claims made against all of the Company's nursing centers in Florida and Tennessee, the Company’s formerly operated Arkansas and West Virginia facilities, and several of the Company’s nursing centers in Alabama, Kentucky, Ohio, and Texas. The SHC policy provides coverage limits of either $500,000 or $1,000,000 per medical incident with a sublimit per center of $1,000,000 and total annual aggregate policy limits of $5,000,000. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers.  These policies provide coverage limits of $1,000,000 per claim and have sublimits of $3,000,000 per center, with varying aggregate policy limits. 
Reserve for Estimated Self-Insured Professional Liability Claims
Because the Company’s actual liability for existing and anticipated professional liability and general liability claims will likely exceed the Company’s limited insurance coverage, the Company has recorded total liabilities for reported and estimated future claims of $26,377,000 as of September 30, 2014. This accrual includes estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of legal costs related to these claims. All losses are projected on an undiscounted basis and are presented without regard to any potential insurance recoveries. Amounts are added to the accrual for estimates of anticipated liability for claims incurred during each period, and amounts are deducted from the accrual for settlements paid on existing claims during each period.
The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of the current portion of this reserve. Merlinos & Associates, Inc. (“Merlinos”) assisted management in the preparation of an estimate of the appropriate accrual for the current claims period and for incurred, but not reported, general and professional liability claims based on data furnished as of May 31, 2014.  The Company used this estimate from Merlinos in the preparation of its estimate of liability for incurred, but unreported professional liability claims as of September 30, 2014.
On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company’s insurers and a third-party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator’s estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company’s evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual decreases results of operations in the period and any reduction in the accrual increases results of operations during the period.

12


As of September 30, 2014, the Company is engaged in 48 professional liability lawsuits. Seven lawsuits are currently scheduled for trial or arbitration during the next twelve months, and it is expected that additional cases will be set for trial or hearing. The Company’s cash expenditures for self-insured professional liability costs from continuing operations were $3,641,000 and $3,005,000 for the nine months ended September 30, 2014 and 2013, respectively.
The Company follows current accounting guidance set forth in FASB ASU 2010-24, “Presentation of Insurance Claims and Related Insurance Recoveries,” that clarifies that a health care entity should not net insurance recoveries against a related professional liability claim, and that the amount of the claim liability should be determined without consideration of insurance recoveries. Accordingly, the Company has recorded assets and equal liabilities of $217,000 at September 30, 2014 and $440,000 at December 31, 2013, respectively.
Although the Company adjusts its accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company’s actual liability for claims incurred in any given period is a process that takes years. As a result, the Company’s actual liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company’s reported earnings and financial position for the period in which the change in accrual is made.
Other Insurance
With respect to workers’ compensation insurance, substantially all of the Company’s employees became covered under either an indemnity insurance plan or state-sponsored programs in May 1997. The Company is completely self-insured for workers’ compensation exposures prior to May 1997. The Company has been and remains a non-subscriber to the Texas workers’ compensation system and is, therefore, completely self-insured for employee injuries with respect to its Texas operations. From June 30, 2003 until June 30, 2007, the Company’s workers’ compensation insurance programs provided coverage for claims incurred with premium adjustments depending on incurred losses. For the period from July 1, 2008 through September 30, 2014, the Company is covered by a prefunded deductible policy. Under this policy, the Company is self-insured for the first $500,000 per claim, subject to an aggregate maximum of $3,000,000. The Company funds a loss fund account with the insurer to pay for claims below the deductible. The Company accounts for premium expense under this policy based on its estimate of the level of claims subject to the policy deductibles expected to be incurred. The liability for workers’ compensation claims is $261,000 at September 30, 2014. The Company has a non-current receivable for workers’ compensation policies covering previous years of $1,183,000 as of September 30, 2014. The non-current receivable is a function of payments paid to the Company’s insurance carrier in excess of the estimated level of claims expected to be incurred.
As of September 30, 2014, the Company is self-insured for health insurance benefits for certain employees and dependents for amounts up to $175,000 per individual annually. The Company provides reserves for the settlement of outstanding self-insured health claims at amounts believed to be adequate. The liability for reported claims and estimates for incurred but unreported claims is $899,000 at September 30, 2014. The differences between actual settlements and reserves are included in expense in the period finalized.

6.
STOCK-BASED COMPENSATION

Overview of Plans
In December 2005, the Compensation Committee of the Board of Directors adopted the 2005 Long-Term Incentive Plan (“2005 Plan”). The 2005 Plan allows the Company to issue stock options and other share and cash based awards. Under the 2005 Plan, 700,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted thereunder. All grants under this plan expire 10 years from the date the grants were authorized by the Board of Directors.
In June 2008, the Company adopted the Advocat Inc. 2008 Stock Purchase Plan for Key Personnel (“Stock Purchase Plan”). The Stock Purchase Plan provides for the granting of rights to purchase shares of the Company's common stock to directors and officers and 150,000 shares of the Company's common stock has been reserved for issuance under the Stock Purchase Plan. The Stock Purchase Plan allows participants to elect to utilize a specified portion of base salary, annual cash bonus, or director compensation to purchase restricted shares or restricted share units (“RSU's”) at 85% of the quoted market price of a share of the Company's common stock on the date of purchase. The restriction period under the Stock Purchase Plan is generally two years from the date of purchase and during which the shares will have the rights to receive dividends, however, the restricted share certificates will not be delivered to the shareholder and the shares cannot be sold, assigned or disposed of during the restriction period. No grants can be made under the Stock Purchase Plan after April 25, 2018.

13


In April 2010, the Compensation Committee of the Board of Directors adopted the 2010 Long-Term Incentive Plan (“2010 Plan”), followed by approval by the Company's shareholders in June 2010. The 2010 Plan allows the Company to issue stock appreciation rights, stock options and other share and cash based awards. Under the 2010 Plan, 380,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted.

Equity Grants and Valuations
During 2014 and 2013, the Compensation Committee of the Board of Directors approved grants totaling approximately 68,000 and 69,000 shares of restricted common stock to certain employees and members of the Board of Directors, respectively. The fair value of restricted shares are determined as the quoted market price of the underlying common shares at the date of the grant. The restricted shares typically vest 33% on the first, second and third anniversaries of the grant date. Unvested shares may not be sold or transferred. During the vesting period, dividends accrue on the restricted shares, but are paid in additional shares of common stock upon vesting, subject to the vesting provisions of the underlying restricted shares. The restricted shares are entitled to the same voting rights as other common shares. Upon vesting, all restrictions are removed. In addition to the shares of restricted common stock granted in 2013, the Compensation Committee of the Board of Directors also approved grants of approximately 55,000 unrestricted shares of common stock to certain employees. These shares were granted without restrictions and considered fully vested upon the date of the grant.
Summarized activity of the equity compensation plans is presented below:
 
 
 
Weighted
 
 
 
Average
 
Shares
 
Exercise Price
Outstanding, December 31, 2013
333,000

 
$
6.64

Granted
—

 
—

Exercised
(22,000
)
 
4.54

Expired or cancelled
(36,000
)
 
7.87

Outstanding, September 30, 2014
275,000

 
$
6.65

 
 
 
 
Exercisable, September 30, 2014
244,000

 
$
6.77


 
 
 
Weighted
 
 
 
Average
 
Restricted
 
Grant Date
 
Shares
 
Fair Value
Outstanding, December 31, 2013
118,000

 
$
5.41

Granted
68,000

 
5.51

Dividend Equivalents
3,000

 
7.72

Vested
(57,000
)
 
5.61

Cancelled
(2,000
)
 
5.47

Outstanding September 30, 2014
130,000

 
$
5.43


Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:

14


 
 
 
Weighted
 
 
 
Average
 
Restricted
 
Grant Date
 
Share Units
 
Fair Value
Outstanding, December 31, 2013
41,000

 
$
5.35

Granted
25,000

 
5.51

Dividend Equivalents
1,000

 
6.86

Vested
(21,000
)
 
5.70

Cancelled
—

 
—

Outstanding September 30, 2014
46,000

 
$
5.30



Prior to 2013, the Compensation Committee of the Board of Directors also approved grants of Stock Only Stock Appreciation Rights (“SOSARs”) and Stock Options at the market price of the Company's common stock on the grant date. The SOSARs and Options vest 33% on the first, second and third anniversaries of the grant date, and expire 10 years from the grant date. The SOSARs and Options were valued and recorded in the same manner, and will be settled with issuance of new stock for the difference between the market price on the date of exercise and the exercise price. The Company estimated the total recognized and unrecognized compensation using the Black-Scholes-Merton equity grant valuation model.

In computing the fair value estimates using the Black-Scholes-Merton valuation model, the Company took into consideration the exercise price of the equity grants and the market price of the Company's stock on the date of grant. The Company used an expected volatility that equals the historical volatility over the most recent period equal to the expected life of the equity grants. The risk free interest rate is based on the U.S. treasury yield curve in effect at the time of grant. The Company used the expected dividend yield at the date of grant, reflecting the level of annual cash dividends currently being paid on its common stock.

While no SOSARs or Options were granted during 2014 and 2013, previously granted SOSARs and Options remain outstanding as of September 30, 2014. The following table summarizes information regarding stock options and SOSAR grants outstanding as of September 30, 2014:
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
Intrinsic
 
 
 
Intrinsic
Range of
 
Exercise
 
Grants
 
Value-Grants
 
Grants
 
Value-Grants
Exercise Prices
 
Prices
 
Outstanding
 
Outstanding
 
Exercisable
 
Exercisable
$10.40 to $11.59
 
11.11

 
57,000

 
1,000

 
57,000

 
1,000

$2.37 to $6.21
 
5.49

 
218,000

 
1,145,000

 
187,000

 
994,000

 
 
 
 
275,000

 
 
 
244,000

 
 
Stock-based compensation expense is non-cash and is included as a component of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. The Company recorded total stock-based compensation expense of $441,000 and $809,000 in the nine month periods ended September 30, 2014 and 2013, respectively.

7.
EARNINGS (LOSS) PER COMMON SHARE
Information with respect to basic and diluted net earnings (loss) per common share is presented below in thousands, except per share:
 

15


 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
 
 
 
 
 
2014
 
2013
 
2014
 
2013
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
219

 
$
(2,321
)
 
$
759

 
$
(6,016
)
Less: income (loss) attributable to noncontrolling interests
—

 
(17
)
 
25

 
(51
)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.
219

 
(2,338
)
 
784

 
(6,067
)
Preferred stock dividends
(48
)
 
(86
)
 
(220
)
 
(258
)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders
171

 
(2,424
)
 
564

 
(6,325
)
Income (loss) from discontinued operations, net of income taxes
3,928

 
(2,444
)
 
3,444

 
(1,875
)
Net income (loss) attributable to Diversicare Healthcare Services, Inc. common shareholders
$
4,099

 
$
(4,868
)
 
$
4,008

 
$
(8,200
)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Net income (loss) per common share:
 
 
 
 
 
 
 
Per common share – basic
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
0.03

 
$
(0.41
)
 
$
0.09

 
$
(1.07
)
Income (loss) from discontinued operations
 
 
 
 
 
 
 
Operating income (loss), net of taxes
(0.10
)
 
(0.42
)
 
(0.18
)
 
(0.32
)
Gain on disposal, net of taxes
0.75

 
—

 
0.75

 
—

Discontinued operations, net of taxes
0.65

 
(0.42
)
 
0.57

 
(0.32
)
Net income (loss) per common share – basic
$
0.68

 
$
(0.83
)
 
$
0.66

 
$
(1.39
)
Per common share – diluted
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
0.03

 
$
(0.41
)
 
$
0.09

 
$
(1.07
)
Income (loss) from discontinued operations
 
 
 
 
 
 
 
Operating income (loss), net of taxes
(0.10
)
 
(0.42
)
 
(0.17
)
 
(0.32
)
Gain on disposal, net of taxes
0.73

 
—

 
0.73

 
—

Discontinued operations, net of taxes
0.63

 
(0.42
)
 
0.56

 
(0.32
)
Net income (loss) per common share - diluted
$
0.66

 
$
(0.83
)
 
$
0.65

 
$
(1.39
)
Denominator: Weighted Average Common Shares Outstanding:
 
 
 
 
 
 
 
Basic
6,020

 
5,892

 
6,004

 
5,878

Diluted
6,248

 
5,892

 
6,171

 
5,878

The effects of 228,000 SOSARs and options outstanding were excluded from the computation of diluted earnings per common share for the three-month and nine-month periods ended September 30, 2013, because these securities would have been anti-dilutive due to the net loss. The weighted average common shares for basic and diluted earnings for common shares were the same due to the year-to-date loss in these periods.

8.
VARIABLE INTEREST ENTITY

16


Accounting guidance requires that a variable interest entity (“VIE”) must be consolidated by the primary beneficiary in accordance with the provisions set forth in FASB ASC 810, Consolidation, as mentioned in Note 2 above. The primary beneficiary is the party that has both the power to direct activities of a VIE that most significantly impact the entity's economic performance and the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. We perform an ongoing qualitative analysis to determine if we are the primary beneficiary of a VIE. The Company had one variable interest entity related to a nursing center in West Virginia that was dissolved in the first quarter of 2014 as a result of the asset purchase of the Rose Terrace nursing center, and is no longer consolidated into the interim consolidated financial statements of the Company.
Rose Terrace Health and Rehabilitation Center
On December 28, 2011, the Company completed construction of Rose Terrace Health and Rehabilitation Center (“Rose Terrace”), its third health care center in West Virginia. The 90-bed skilled nursing center is located in Culloden, West Virginia, along the Huntington-Charleston corridor, and offers 24-hour skilled nursing care designed to meet the care needs of both short and long-term nursing patients. The Rose Terrace nursing center utilizes a Certificate of Need the Company obtained in June 2009, when the Company completed the acquisition of certain assets of a skilled nursing center in West Virginia.
The Company initially entered into a lease agreement with the real estate developer that constructed, furnished, and equipped Rose Terrace. The agreement included the right to purchase the center and all associated assets beginning at the end of the first year of the initial term of the lease and continuing through the fifth year for a purchase price ranging from 110% to 120% of the total project cost. On March 27, 2014, the Company exercised this purchase option and acquired the land, building, and all other assets of the Rose Terrace nursing center from the real estate developer for the contractually agreed upon price of $7,693,000.
Prior to the exercise of the purchase option, the Company had determined it was the primary beneficiary of the VIE based on the ownership of the Certificate of Need, the fixed price purchase option described above, the Company’s ability to direct the activities that most significantly impact the economic performance of the VIE, and the right to receive potentially significant benefits from the VIE. Accordingly, as the primary beneficiary, the Company consolidated the balance sheet and results of operations of the VIE for periods prior to the exercise of the purchase option. However, after the exercise of the purchase option, the previous owners paid the outstanding debt related to the entity in full. Subsequently, as further disclosed in Note 11, the Company sold the Rose Terrace facility and all assets associated with the facility. As a result of these events, the entity is no longer considered a VIE.

9. EQUITY METHOD INVESTMENT
The investment in unconsolidated affiliate reflected on the interim consolidated balance sheet relates to a pharmacy joint venture partnership in which the Company owns 50%. The joint venture was initially funded by the Company and its partner and began operations during 2012. This investment in unconsolidated affiliate is accounted for using the equity method as the Company exerts significant influence, but does not control or otherwise consolidate the entity. The investment in unconsolidated affiliate balance at September 30, 2014, was $399,000 as compared to $487,000 at December 31, 2013. Additionally, the Company's share of the net profits and losses of the unconsolidated affiliate are reported in equity in net earnings or losses of unconsolidated affiliate in our statement of operations. The Company's equity in the net losses of unconsolidated affiliate for the nine month period ended September 30, 2014, was $89,000 as compared to $152,000 for the nine month period ended September 30, 2013.

10.
BUSINESS DEVELOPMENT
Acquisitions
On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities was completed on May 1, 2013. The Company also incurred $338,000 in acquisition-related expenses associated with this transaction. The five facilities acquired under the Agreement include the following:

•
77-bed skilled nursing facility known as Chanute HealthCare Center
•
119-bed skilled nursing facility known as Haysville HealthCare Center
•
80-bed skilled nursing facility known as Larned HealthCare Center
•
62-bed skilled nursing facility known as Sedgwick HealthCare Center
•
80-bed skilled nursing facility known as Council Grove HealthCare Center


17


As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:

 
As of May 1, 2013
Purchase Price
$
15,500,000

 
 
Land
$
2,130,000

Buildings
12,127,000

Furniture, fixtures, and equipment
1,200,000

Inventory
43,000

 
 
Less: Liabilities assumed
$
758,000

 
 
Total cash paid
$
14,742,000


Lease Agreements and Assumption of Operations
On August 1, 2014, the Company completed a transaction to assume operations of two centers in Ohio. The centers included in this transaction are a 142-bed skilled nursing facility and a 42-bed assisted living center. The lease provides for an initial lease term of 10 years. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On July 1, 2014, the Company completed a transaction to enter the state of Missouri through the assumption of operations of three facilities totaling 339 skilled nursing beds. The nursing centers are owned by a real estate investment trust ("REIT"), and the lease provides for an initial 15-year lease term with a 5-year renewal option. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On June 1, 2014, the Company assumed operations at Diversicare of Nicholasville, an existing 73-bed facility in Nicholasville, Kentucky. The nursing center is owned by a real estate investment trust ("REIT"), and the lease provides for an initial 15-year lease term with a 5-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
On March 1, 2014, the Company assumed operations at Diversicare of Big Springs, an existing 135-bed facility in Huntsville, Alabama. The nursing center is owned by an unrelated third-party and the lease provides for an initial 10-year lease term with two additional 5-year renewal options. The additional skilled nursing center increases the Company's footprint in Alabama to seven centers, and the third center in the Huntsville market. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
On October 1, 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On August 1, 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT, and the lease provides for an initial 15-year lease term with a 5-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.


11.
DISCONTINUED OPERATIONS
West Virginia Disposition
Effective April 3, 2014, the Company entered into an asset purchase agreement with Rose Terrace Acq., LLC (“Purchaser”) to sell its skilled nursing facility in Culloden, West Virginia. The original asset purchase agreement was subject to a number of conditions including an amendment to the Master Lease with Omega Health Investors, Inc. ("Omega") to terminate the lease

18


only with respect to two other skilled nursing facilities in West Virginia, state licensure and regulatory approval. The Company concurrently entered into an operations transfer agreement with respect to the two other skilled nursing facilities located in Danville and Ivydale, West Virginia.
Effective July 1, 2014, the Company completed the transaction with Rose Terrace Acq., LLC to sell Rose Terrace, a 90-bed skilled nursing facility in Culloden, West Virginia for a sales price of $16,500,000. The Company also entered into the Fifteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") with Omega Health Investors, Inc. ("Omega") to terminate the lease only with respect to two other skilled nursing facilities in West Virginia, and concurrently entered into an operations transfer agreement with American Health Care Management, LLC, an affiliate of the purchaser with respect to two other skilled nursing facilities located in Danville and Ivydale, West Virginia. Upon completion of the transaction, Diversicare no longer operates any skilled nursing centers in the state of West Virginia. In conjunction with the closing of the sale, the Company paid the balance of the $8,000,000 mortgage loan outstanding on the Rose Terrace facility.
The transaction resulted in a gain on the disposition of West Virginia which, along with the results of operations for these nursing facilities, is presented within Discontinued Operations on the Interim Consolidated Statements of Operations. The pretax gain on the transaction was $7,522,000. The tax expense associated with the gain was $(3,009,000) for which the Company plans to apply net operating loss carryforwards from our deferred tax assets to substantially offset and minimize the cash outlay for this transaction.
These centers contributed revenues of $10,988,000 and $15,944,000 and net income of $165,000 and $680,000 during the nine months ended September 30, 2014 and 2013, respectively.  The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations.
Arkansas Lease Termination
Effective September 1, 2013, the Company entered into an agreement with Omega to terminate its lease with respect to eleven nursing centers and 1,181 licensed beds located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. In connection with the closing of this transaction, the Company and Omega entered into the Master Lease most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.
As a result of this transaction, the Company has reclassified the operations of these centers as discontinued operations for all periods presented in the accompanying interim consolidated financial statements. These centers contributed revenues of $0 and $40,161,000 and net loss of $935,000 and $2,432,000 during the nine months ended September 30, 2014 and 2013, respectively.  The net loss in 2014 primarily relates to professional liability expense incurred during the first three quarters of 2014. The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations.
The discontinued assets and liabilities of the disposed skilled nursing centers in Arkansas and West Virginia have been reclassified and are segregated in the interim consolidated balance sheets as assets and liabilities of discontinued operations. The current asset amounts, which are primarily composed of net accounts receivable of $390,000 and $2,870,000 at September 30, 2014 and December 31, 2013, respectively. The current liabilities are primarily composed of trade payables and various accrued expenses of $136,000 and $1,359,000 at September 30, 2014 and December 31, 2013, respectively. The Company expects to collect the balance of the accounts receivable and pay the remaining trade payables and accrued expenses in the ordinary course of business. The Company did not transfer the accounts receivable or liabilities to the new owners or operators of the facilities. Further, in accordance with Company accounting policy, the reserve for professional liability and workers' compensation will remain in the consolidated liability accounts as future payment of these liabilities will be paid through the Company's future operating cash flows.


12.
SUBSEQUENT EVENTS
Effective October 1, 2014, the Company completed a transaction to assume operations of a 62-bed skilled nursing facility in Greenville, Kentucky. This facility is expected to contribute in excess of $4.5 million in annual revenues with initial lease terms of 14 years.


19



ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
Diversicare Healthcare Services, Inc. provides long-term care services to nursing center patients in nine states, primarily in the Southeast, Midwest and Southwest. Our centers provide a range of health care services to their patients and residents that include nursing, personal care, and social services. In addition to the services usually provided in long-term care centers, we also offer a variety of comprehensive rehabilitation services as well as nutritional support services. As of September 30, 2014, the Company’s continuing operations consist of 51 skilled nursing and long-term care centers with 6,229 licensed beds. The Company owns 13 and leases 38 of its nursing centers.
The nursing center and licensed bed count includes the following recent business development activity:
•
Effective August 1, 2014, the Company completed a transaction to assume operations of two centers in Ohio. The centers included in this transaction are a 142-bed skilled nursing facility and a 42-bed assisted living center. The Medicaid and Medicare certification processes for these facilities are currently underway, and are expected to be completed in the fourth quarter of 2014.
•
Three facilities totaling 339 skilled nursing beds in Missouri for which the Company entered into a lease agreement and assumed operations effective July 1, 2014. The Medicaid and Medicare certification processes for these facilities are currently underway, and are expected to be completed in the fourth quarter of 2014.
•
The 73-bed facility in Nicholasville, Kentucky, for which the Company entered into a lease agreement and assumed operations effective June 1, 2014. The Medicaid and Medicare certification processes for this facility are currently underway, and are expected to be completed in the fourth quarter of 2014.
•
The 135-bed facility in Huntsville, Alabama, for which the Company entered into a lease agreement and assumed operations effective March 1, 2014. The Medicaid and Medicare certification processes for this facility were completed in the third quarter of 2014, and billing and collections commenced in the fourth quarter of 2014.
•
The 442 licensed nursing beds at the four recently leased skilled nursing centers, three in Ohio and one in Indiana, which we have operated since October 1, 2013. The Medicaid and Medicare certification processes were completed for these four leased facilities in the first quarter of 2014. In addition to the licensed nursing beds, these four centers also include 270 licensed assisted living beds which are not included in the licensed nursing bed count.
•
The 107-bed facility in Louisville, Kentucky, for which the Company entered into a lease agreement in August 2013. The Medicare certification process for this facility was completed in the first quarter of 2014. The Medicaid certification process was completed in the second quarter of 2014.
•
The Kansas centers acquired in May 2013, which comprise five skilled nursing centers and 418 licensed beds. The Medicaid certification process was completed for these facilities during the second quarter of 2013, and the Medicare certification process was completed for these facilities during the third quarter of 2013.
Our continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Missouri, Ohio, Tennessee, and Texas.
Discontinued Operations
Effective April 3, 2014, the Company entered into an asset purchase agreement with Rose Terrace Acq., LLC (“Purchaser”) to sell its skilled nursing facility in Culloden, West Virginia. The original asset purchase agreement was subject to a number of conditions including an amendment to the Master Lease with Omega Health Investors, Inc. ("Omega") to terminate the lease only with respect to two other skilled nursing facilities in West Virginia, state licensure and regulatory approval. The Company concurrently entered into an operations transfer agreement with respect to the two other skilled nursing facilities located in Danville and Ivydale, West Virginia. Effective July 1, 2014, the Company finalized the transaction under the terms of the purchase agreement. As a result, the three facilities with 240 licensed beds are reflected as discontinued operations for all periods in the accompanying interim financial statements.
Effective September 1, 2013, the Company finalized an agreement with Omega to terminate its lease with respect only to eleven nursing centers with 1,181 licensed beds located in Arkansas and to concurrently transfer operations to an operator selected by Omega. The completion of this transaction represents disposal of all of the Company's operations in the state of Arkansas.
The net income for the nursing centers included in discontinued operations does not reflect any allocation of regional or corporate general and administrative expense or any allocation of corporate interest expense. We considered these additional

20


costs along with the future prospects of these nursing centers when determining the contribution of the skilled nursing centers to our operations.
The assets and liabilities of the disposed skilled nursing centers have been reclassified and are segregated in the interim consolidated balance sheets as assets and liabilities of discontinued operations. The current asset amounts are primarily composed of net accounts receivable and the current liabilities consist primarily of accounts payable. The Company expects to collect the balance of the accounts receivable and pay the remaining trade payables and taxes in the ordinary course of business. The Company did not transfer the accounts receivable or liabilities to the new operators of these centers. Further, in accordance with Company accounting policy, the reserve for professional liability and workers' compensation will remain in the consolidated liability accounts as future payment of these liabilities will be paid through the Company's future operating cash flows.
Strategic Operating Initiatives
During the third quarter of 2010, we identified several key strategic objectives to increase shareholder value through improved operations and business development. These strategic operating initiatives included: improving skilled mix in our nursing centers, improving our average Medicare rate, implementing Electronic Medical Records (“EMR”), and completing strategic acquisitions. We have experienced success in these initiatives and expect to continue to build on these improvements. We describe each of these below as well as provide metrics for our most recent quarter versus the third quarter of 2010, the quarter before we embarked on our strategic operating initiatives.
Improving skilled mix and average Medicare rate:
Our strategic operating initiatives of improving our skilled mix and our average Medicare rate by accurately capturing the delivery of care required investing in nursing and clinical care to treat more acute patients along with nursing center based sales representatives to attract these patients. These initiatives developed referral and Managed Care relationships that have attracted and are expected to continue to attract patients whose stay in the centers is covered by Medicare and Managed Care. A comparison of our most recent quarter versus the third quarter of 2010, the quarter before we embarked on our strategic operating initiatives, reflects our success with these strategic operating initiatives: 
 
Three Months Ended
 
September 30, 2014
 
September 30,
2010
As a percent of total census:
 
 
 
Medicare census
12.3
%
 
12.3
%
Managed Care census
3.4
%
 
1.3
%
Total skilled mix census
15.7
%
 
13.6
%
As a percent of total revenues:
 
 
 
Medicare revenues
29.2
%
 
29.3
%
Managed Care revenues
6.6
%
 
2.8
%
Total skilled mix revenues
35.8
%
 
32.1
%
Medicare average rate per day:
$
446.75

 
$
394.23

The initiatives have developed positive results in growing our skilled patient population, increasing the Managed Care census to 3.4% of total census in the third quarter of 2014, as compared to 1.3% in the third quarter of 2010, and total skilled mix census from 13.6% to 15.7% over the same period.
Implementing Electronic Medical Records:
As another part of our strategic operating initiative, we implemented EMR to improve documentation of the delivery of care. We completed the implementation of EMR in all our nursing centers in December 2011, on time and under budget. A comparison of our most recent quarter versus the third quarter of 2010 reflects the increase in our average Medicaid rate per day:
 
Three Months Ended
 
September 30, 2014
 
September 30,
2010
Medicaid average rate per day:
$
161.43

 
$
147.93


21



Completing strategic acquisitions:
Our strategic operating initiatives include a renewed focus on completing strategic acquisitions. We continue to pursue and investigate opportunities to acquire, lease or develop new centers, focusing primarily on opportunities within our existing areas of operation. We expect to announce additional development projects in the near future. Since September 30, 2010, the Company has added four skilled nursing centers in Kentucky, five in Ohio, one in Indiana, one in Alabama, three in Missouri, and five in Kansas.
As part of our strategic efforts, we have also performed a thorough analysis on our existing centers in order to determine whether continuing operations within certain markets or regions was in line with the short-term and long-term strategy of the business. As a result, we disposed of an owned building in Arkansas in 2012, and reached an agreement to terminate our lease for eleven other facilities in Arkansas in 2013. Additionally, we reached an agreement to dispose of the owned Rose Terrace facility in West Virginia and transfer operations of the other two facilities we operated in West Virginia. This transaction was effective July 1, 2014. As a result of these transactions, we no longer operate within the states of Arkansas or West Virginia.
Basis of Financial Statements
Our patient revenues consist of the fees charged for the care of patients in the nursing centers we own and lease. Our operating expenses include the costs, other than lease, professional liability, depreciation and amortization expenses, incurred in the operation of the nursing centers we own and lease. Our general and administrative expenses consist of the costs of the corporate office and regional support functions. Our interest, depreciation and amortization expenses include all such expenses across the range of our operations.

Critical Accounting Policies and Judgments
A “critical accounting policy” is one which is both important to the understanding of our financial condition and results of operations and requires management’s most difficult, subjective or complex judgments often involving estimates of the effect of matters that are inherently uncertain. Actual results could differ from those estimates and cause our reported net income or loss to vary significantly from period to period. Our critical accounting policies are more fully described in our 2013 Annual Report on Form 10-K.

Revenue Sources
We classify our revenues from patients and residents into four major categories: Medicaid, Medicare, Managed Care, and Private Pay and other. Medicaid revenues are composed of the traditional Medicaid program established to provide benefits to those in need of financial assistance in the securing of medical services. Medicare revenues include revenues received under both Part A and Part B of the Medicare program. Managed Care revenues include payments for patients who are insured by a third-party entity, typically called a Health Maintenance Organization, often referred to as an HMO plan, or are Medicare beneficiaries who assign their Medicare benefits to a Managed Care replacement plan often referred to as Medicare replacement products. The Private Pay and other revenues are composed primarily of individuals or parties who directly pay for their services. Included in the Private Pay and other are patients who are hospice beneficiaries as well as the recipients of Veterans Administration benefits. Veterans Administration payments are made pursuant to renewable contracts negotiated with these payors.
The following table sets forth net patient and resident revenues related to our continuing operations by payor source for the periods presented (dollar amounts in thousands):
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Medicaid
$
43,866

 
48.6
%
 
$
35,268

 
54.6
%
 
$121,376
 
48.5%
 
$98,644
 
53.4%
Medicare
26,348

 
29.2

 
17,169

 
26.6

 
74,387
 
29.7
 
51,229
 
27.8
Managed Care
5,926

 
6.6

 
3,685

 
5.7

 
16,643
 
6.6
 
11,096
 
6.0
Private Pay and other
14,191

 
15.6

 
8,509

 
13.1

 
38,037
 
15.2
 
23,589
 
12.8
Total
$
90,331

 
100.0
%
 
$
64,631

 
100.0
%
 
$250,443
 
100.0%
 
$184,558
 
100.0%

22


The following table sets forth average daily skilled nursing census by payor source for our continuing operations for the periods presented: 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
2013
 
2014
 
2013
Medicaid
2,949

 
66.8
%
 
2,443

 
70.6
%
 
2,796

 
67.1
%
 
2,302

 
70.0
%
Medicare
544

 
12.3

 
374

 
10.8

 
536

 
12.9

 
380

 
11.6

Managed Care
152

 
3.4

 
100

 
2.9

 
147

 
3.5

 
100

 
3.0

Private Pay and other
769

 
17.5

 
543

 
15.7

 
687

 
16.5

 
507

 
15.4

Total
4,414

 
100.0
%
 
3,460

 
100.0
%
 
4,166

 
100.0
%
 
3,289

 
100.0
%
Consistent with the nursing home industry in general, changes in the mix of a facility’s patient population among Medicaid, Medicare, Managed Care, and Private Pay and other can significantly affect the profitability of the facility’s operations.

Health Care Industry
The health care industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not necessarily limited to, matters such as licensure, accreditation, government health care program participation requirements, reimbursement for patient services, quality of resident care and Medicare and Medicaid fraud and abuse. Over the last several years, government activity has increased with respect to investigations and allegations concerning possible violations by health care providers of fraud and abuse laws and regulations as well as laws and regulations governing quality of care issues in the skilled nursing profession in general. Violations of these laws and regulations could result in exclusion from government health care programs together with the imposition of significant fines and penalties, as well as significant repayments for patient services previously billed. Compliance with such laws and regulations is subject to ongoing government review and interpretation, as well as regulatory actions in which government agencies seek to impose fines and penalties. The Company is involved in regulatory actions of this type from time to time.
In March 2010, significant legislation concerning health care and health insurance was passed, including the “Patient Protection and Affordable Care Act,” (“Affordable Care Act”) along with the “Health Care and Education Reconciliation Act of 2010” (“Reconciliation Act”) collectively defined as the “Legislation.” We expect this Legislation to impact our Company, our employees and our patients and residents in a variety of ways. This Legislation significantly changes the future responsibility of employers with respect to providing health care coverage to employees in the United States. Two of the main provisions of the Legislation become effective in 2014 whereby most individuals will be required to either have health insurance or pay a fine and employers with 50 or more employees will either have to provide minimum essential coverage or will be subject to additional taxes. On July 2, 2013, the United States Treasury Department announced that it will delay the employer reporting mandate, which was to be effective for 2014, until 2015 to allow additional time for process improvement and system integration. We have not estimated the financial impact of the Legislation and the costs associated with complying with the increased levels of health insurance we will be required to provide our employees and their dependents in future years. We expect the Legislation will result in increased operating expenses.
We also expect for this Legislation to continue to impact our Medicaid and Medicare reimbursement as well, though the exact timing and level of that impact is currently unknown. The Legislation expands the role of home-based and community services, which may place downward pressure on our ability to maintain our population of Medicaid residents.
On June 28, 2012, the United States Supreme Court ruled that the enactment of the Affordable Care Act did not violate the Constitution of the United States. This ruling permits the implementation of most of the provisions of the Affordable Care Act to proceed. The provisions of the Affordable Care Act discussed above are only examples of federal health reform provisions that we believe may have a material impact on the long-term care industry and on our business. We anticipate that many of the provisions of the Legislation may be subject to further clarification and modification through the rule making process and could have a material adverse impact on our results of operations.
Medicare and Medicaid Reimbursement
A significant portion of our revenues are derived from government-sponsored health insurance programs. Our nursing centers derive revenues under Medicaid, Medicare, Managed Care, Private Pay and other third party sources. We employ third-party specialists in reimbursement and also use these services to monitor regulatory developments to comply with reporting requirements and to ensure that proper payments are made to our operated nursing centers. It is generally recognized that all government-funded programs have been and will continue to be under cost containment pressures, but the extent to which these pressures will affect our future reimbursement is unknown.

23


Medicare
Effective October 1, 2011, Medicare rates were reduced by a nationwide average of 11.1%, the net effect of a reduction to restore overall payments to their intended levels on a prospective basis and the application of a 2.7% market basket increase and a negative 1.0% productivity adjustment required by the Affordable Care Act. The final Centers for Medicare and Medicaid Services (“CMS”) rule also adjusts the method by which group therapy is counted for reimbursement purposes and, for patients receiving therapy, changes the timing of reassessment for purposes of determining patient RUG categories. These October 2011 Medicare reimbursement changes decreased our Medicare revenue and our Medicare rate per patient day. The new regulations also resulted in an increase in costs to provide therapy services to our patients.
The Budget Control Act of 2011 (“BCA”), enacted on August 2, 2011, increased the United States debt ceiling and linked the debt ceiling increase to corresponding deficit reductions through 2021. The BCA also established a 12 member joint committee of Congress known as the Joint Select Committee on Deficit Reduction (“Super Committee”). The Super Committee’s objective was to create proposed legislation to reduce the United States federal budget deficit by $1.5 trillion for fiscal years 2012 through 2021. Part of the BCA required this legislation to be enacted by December 23, 2011, or approximately $1.2 trillion in spending reductions would automatically begin through sequestration on January 1, 2013, split between domestic and defense spending. As no legislation was passed that would achieve the targeted savings outlined in the BCA, payments to Medicare providers have been reduced by 2% from planned levels effective April 1, 2013.
In July 2014, CMS issued Medicare payment rates, effective October 1, 2014, that increased reimbursement to skilled nursing centers by approximately 1.6% compared to the fiscal year ending September 30, 2014. The increase is the net effect of a 2.5% inflation increase as measured by the SNF market basket, offset by a 0.5% market basket update factor. The wage index budget neutrality factor resulted in an additional 0.4% downward adjustment in rates for the Company's facilities. This adjustment is further offset by the ongoing sequestration from the BCA as mentioned above. The 2% sequestration is not applied to the payment rate, but rather it is applied to Medicare claims after determining coinsurance, any applicable deductibles, and any applicable Medicare secondary payment adjustments.
Therapy Services. There are annual Medicare Part B reimbursement limits on therapy services that can be provided to an individual. The limits impose a $1,920 per patient annual ceiling on physical and speech therapy services, and a separate $1,920 per patient annual ceiling on occupational therapy services. CMS established an exception process to permit therapy services in certain situations and we provide services that are reimbursed under the exceptions process. The exceptions process has been extended several times, most recently by the Protecting Access to Medicare Act of 2014, which extended this exception process through March 31, 2015.
Related to the exceptions process discussed above, for services provided with dates of service between January 1, 2014, through March 31, 2015, providers are required to submit a request for an exception for therapy services above the threshold of $3,700 which will then be manually medically reviewed, consistent with the treatment of these services historically. Similar to the therapy cap exceptions process, the threshold process will have a $3,700 per patient threshold on physical and speech therapy services, and a separate $3,700 per patient threshold on occupational therapy services. The exception reviews were conducted by Medicare Administrative Contractors during this period.
It is unknown if any further extension of the therapy cap exceptions or the new threshold process will be included in future legislation or CMS policy decisions. If the exception process is discontinued or if the manual review process for therapy in excess of $3,700 negatively impacts our Medicare Part B reimbursement, we would likely see a reduction in our therapy revenues which would negatively impact our operating results and cash flows.
On November 2, 2010, CMS released a final proposed rule as part of the Medicare Physician Fee Schedule (“MPFS”) that was effective January 1, 2011. The policy impacts the reimbursement we receive for Medicare Part B therapy services in our facilities. The policy provides that Medicare Part B pay the full rate for the therapy unit of service that has the highest Practice Expense ("PE") component for each patient on each day they receive multiple therapy treatments. Reimbursement for the second and subsequent therapy units for each patient each day they receive multiple therapy treatments was reimbursed at a rate equal to 75% of the applicable PE component through March 31, 2013. Effective April 1, 2013, the rate at which these services are reimbursed was reduced to 50% of the applicable PE component.
Medicare Part B therapy services in our centers are determined according to MPFS. Annually since 1997, the MPFS has been subject to a Sustainable Growth Rate Adjustment (“SGR”) intended to keep spending growth in line with allowable spending. Each year since the SGR was enacted, this adjustment produced a scheduled negative update to payment for physicians, therapists and other healthcare providers paid under the MPFS. Congress has stepped in with so-called “doc fix” legislation numerous times to stop payment cuts to physicians, most recently by the Protecting Access to Medicare Act of 2014, which stopped these payment cuts through March 31, 2015.

24


The Protecting Access to Medicare Act of 2014 also extended several other elements of the Middle Class Tax Relief and Job Creation Act of 2012, including the reduction of bad debt treated as an allowable cost. Prior to this act, Medicare reimbursed providers for beneficiaries’ unpaid coinsurance and deductible amounts after reasonable collection efforts at a rate between 70 and 100 percent of beneficiary bad debt. This provision reduced bad debt reimbursement exposure for all providers to 65 percent.
Medicaid
We receive the majority of our annual Medicaid rate increases during the third quarter of each year. The rate changes received in the third quarter of 2013 and the third quarter of 2012, along with increased Medicaid acuity in our acuity based states, was the primary contributor to our 2.9% increase in average rate per day for Medicaid patients in 2014 compared to 2013. Based on the rate changes received during the third quarter of 2014, we expect a favorable impact to our rate per day for Medicaid patients as we move into 2015 due to modest rate decreases in many of the states within which we operate.
We are unable to predict what, if any, reform proposals or reimbursement limitations will be implemented in the future, or the effect such changes would have on our operations. For the nine months ended September 30, 2014, we derived 29.2% and 48.6% of our total patient revenues related to continuing operations from the Medicare and Medicaid programs, respectively. Any health care reforms that significantly limit rates of reimbursement under these programs could, therefore, have a material adverse effect on our profitability.
We will attempt to increase revenues from non-governmental sources to the extent capital is available to do so. However, private payors, including Managed Care payors, are increasingly demanding that providers accept discounted fees or assume all or a portion of the financial risk for the delivery of health care services. Such measures may include capitated payments, which can result in significant losses to health care providers if patients require expensive treatment not adequately covered by the capitated rate.
Licensure and Other Health Care Laws
All of our nursing centers must be licensed by the state in which they are located in order to accept patients, regardless of payor source. In most states, nursing centers are subject to certificate of need laws, which require us to obtain government approval for the construction of new nursing centers or the addition of new licensed beds to existing centers. Our nursing centers must comply with detailed statutory and regulatory requirements on an ongoing basis in order to qualify for licensure, as well as for certification as a provider eligible to receive payments from the Medicare and Medicaid programs. Generally, the requirements for licensure and Medicare/Medicaid certification are similar and relate to quality and adequacy of personnel, quality of medical care, record keeping, dietary services, patient rights, and the physical condition of the center and the adequacy of the equipment used therein. Each center is subject to periodic inspections, known as “surveys” by health care regulators, to determine compliance with all applicable licensure and certification standards. Such requirements are both subjective and subject to change. If the survey concludes that there are deficiencies in compliance, the center is subject to various sanctions, including, but not limited to, monetary fines and penalties, suspension of new admissions, non-payment for new admissions and loss of licensure or certification. Generally, however, once a center receives written notice of any compliance deficiencies, it may submit a written plan of correction and is given a reasonable opportunity to correct the deficiencies. There can be no assurance that, in the future, we will be able to maintain such licenses and certifications for our facilities or that we will not be required to expend significant sums in order to comply with regulatory requirements.

Contractual Obligations and Commercial Commitments
We have certain contractual obligations of continuing operations as of September 30, 2014, summarized by the period in which payment is due, as follows (dollar amounts in thousands):
Contractual Obligations
Total
 
Less than
1  year
 
1 to 3
Years
 
3 to 5
Years
 
After
5 Years
Long-term debt obligations (1)
$
60,126

 
$
9,938

 
$
8,031

 
$
42,157

 
$
—

Settlement obligations (2)
7,165

 
7,165

 
—

 
—

 
—

Elimination of Preferred Stock Conversion feature (3)
2,748

 
687

 
1,374

 
687

 
—

Operating leases (4)
590,431

 
30,579

 
61,892

 
63,955

 
434,005

Required capital expenditures under operating leases (5)
5,717

 
240

 
480

 
480

 
4,517

Total
$
666,187

 
$
48,609

 
$
71,777

 
$
107,279

 
$
438,522

 

25


(1)
Long-term debt obligations include scheduled future payments of principal and interest of long-term debt and amounts outstanding on our capital lease obligations.
(2)
Settlement obligations relate to professional liability cases that the Company is obligated to pay within the next twelve months. The professional liabilities are included in our current portion of self-insurance reserves.
(3)
Payments to Omega Health Investors ("Omega"), from which we lease 23 nursing centers, for the elimination of the preferred stock conversion feature in connection with restructuring the preferred stock and master lease agreements. Monthly payments of approximately $57,000 will be made through the end of the initial lease period that ends in September 2018.
(4)
Represents lease payments under our operating lease agreements. Assumes all renewal periods are enacted.
(5)
Includes annual expenditure requirements under operating leases.
We have employment agreements with certain members of management that provide for the payment to these members of amounts up to two times their annual salary in the event of a termination without cause, a constructive discharge (as defined therein), or upon a change of control of the Company (as defined therein). The maximum contingent liability under these agreements is approximately $1,610,000 as of September 30, 2014. The terms of such agreements are for one year and automatically renew for one year if not terminated by us or the employee. In addition, upon the occurrence of any triggering event, those certain members of management may elect to require that we purchase equity awards granted to them for a purchase price equal to the difference in the fair market value of our common stock at the date of termination versus the stated equity award exercise price. Based on the closing price of our common stock on September 30, 2014, the potential contingent liability for the repurchase of the equity grants is $496,000.

Results of Operations
The results of operations presented have been reclassified to present the effects of certain divestitures discussed in the overview to "Management's Discussion and Analysis of Financial Condition and Results of Operations."
The following tables present the unaudited interim statements of operations and related data for the three and nine month periods ended September 30, 2014 and 2013:
 
(in thousands)
Three Months Ended
September 30,
 
2014
 
2013
 
Change
 
%
PATIENT REVENUES, net
$
90,331

 
$
64,631

 
$
25,700

 
39.8
 %
EXPENSES:
 
 
 
 
 
 
 
Operating
73,006

 
54,186

 
18,820

 
34.7
 %
Lease and rent expense
6,876

 
4,817

 
2,059

 
42.7
 %
Professional liability
1,743

 
947

 
796

 
84.1
 %
General and administrative
5,582

 
5,006

 
576

 
11.5
 %
Depreciation and amortization
1,812

 
1,634

 
178

 
10.9
 %
Restructuring
—

 
944

 
(944
)
 
(100.0
)%
Total expenses
89,019

 
67,534

 
21,485

 
31.8
 %
OPERATING INCOME (LOSS)
1,312

 
(2,903
)
 
4,215

 
145.2
 %
OTHER INCOME (EXPENSE):
 
 
 
 
 
 
 
Equity in net income (loss) of unconsolidated affiliate
(30
)
 
63

 
(93
)
 
(147.6
)%
Interest expense, net
(916
)
 
(855
)
 
(61
)
 
7.1
 %
Debt retirement costs
—

 
—

 
—

 
—
 %
 
(946
)
 
(792
)
 
(154
)
 
(19.4
)%
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
366

 
(3,695
)
 
4,061

 
109.9
 %
BENEFIT (PROVISION) FOR INCOME TAXES
(147
)
 
1,374

 
(1,521
)
 
(110.7
)%
INCOME (LOSS) FROM CONTINUING OPERATIONS
$
219

 
$
(2,321
)
 
$
2,540

 
109.4
 %
 

26


(in thousands)
Nine Months Ended
September 30,
 
2014
 
2013
 
Change
 
%
PATIENT REVENUES, net
$
250,443

 
$
184,558

 
$
65,885

 
35.7
 %
EXPENSES:
 
 
 
 
 
 
 
Operating
200,517

 
152,014

 
48,503

 
31.9
 %
Lease and rent expense
19,094

 
14,398

 
4,696

 
32.6
 %
Professional liability
5,360

 
4,212

 
1,148

 
27.3
 %
General and administrative
16,077

 
15,769

 
308

 
2.0
 %
Depreciation and amortization
5,252

 
4,572

 
680

 
14.9
 %
Restructuring
—

 
944

 
(944
)
 
(100.0
)%
Total expenses
246,300

 
191,909

 
54,391

 
28.3
 %
OPERATING INCOME (LOSS)
4,143

 
(7,351
)
 
11,494

 
156.4
 %
OTHER INCOME (EXPENSE):
 
 
 
 
 
 
 
Equity in net income (loss) of unconsolidated affiliate
(89
)
 
(152
)
 
63

 
41.4
 %
Interest expense, net
(2,757
)
 
(2,140
)
 
(617
)
 
(28.8
)%
Debt retirement costs
—

 
(320
)
 
320

 
100.0
 %
 
(2,846
)
 
(2,612
)
 
(234
)
 
(9.0
)%
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
1,297

 
(9,963
)
 
11,260

 
113.0
 %
BENEFIT (PROVISION) FOR INCOME TAXES
(538
)
 
3,947

 
(4,485
)
 
(113.6
)%
INCOME (LOSS) FROM CONTINUING OPERATIONS
$
759

 
$
(6,016
)
 
$
6,775

 
112.6
 %

Percentage of Net Revenues
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
PATIENT REVENUES, net
100.0
%
 
100.0
 %
 
100.0
 %
 
100.0
 %
EXPENSES:
 
 
 
 
 
 
 
Operating
80.8

 
83.8

 
80.1

 
82.4

Lease and rent expense
7.6

 
7.5

 
7.6

 
7.8

Professional liability
1.9

 
1.5

 
2.1

 
2.3

General and administrative
6.2

 
7.7

 
6.4

 
8.5

Depreciation and amortization
2.0

 
2.5

 
2.1

 
2.5

Restructuring
—

 
1.5

 
—

 
0.5

Total expenses
98.5

 
104.5

 
98.3

 
104.0

OPERATING INCOME (LOSS)
1.5

 
(4.5
)
 
1.7

 
(4.0
)
OTHER INCOME (EXPENSE):
 
 
 
 
 
 
 
Equity in net losses of unconsolidated affiliate
—

 
0.1

 
—

 
(0.1
)
Interest expense, net
(1.0
)
 
(1.3
)
 
(1.1
)
 
(1.2
)
Debt retirement costs
—

 
—

 
—

 
(0.2
)
 
(1.0
)
 
(1.2
)
 
(1.1
)
 
(1.5
)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
0.5

 
(5.7
)
 
0.6

 
(5.5
)
BENEFIT (PROVISION) FOR INCOME TAXES
(0.2
)
 
2.1

 
(0.2
)
 
2.1

INCOME (LOSS) FROM CONTINUING OPERATIONS
0.3
%
 
(3.6
)%
 
0.4
 %
 
(3.4
)%

27


Three Months Ended September 30, 2014 Compared With Three Months Ended September 30, 2013
Patient Revenues
Patient revenues were $90.3 million for the three months ended September 30, 2014, as compared to $64.6 million in the three months ended September 30, 2013. This increase is primarily attributable to the acquisition of new facilities during the period. The following table summarizes the revenue increases attributable to our portfolio growth (in thousands):
 
Three Months Ended
September 30,
 
2014
 
2013
 
Change
Same-store revenue
$
61,709

 
$
57,514

 
$
4,195

2013 acquisition revenue
18,593

 
7,117

 
11,476

2014 acquisition revenue
10,029

 
—

 
10,029

Total revenue
$
90,331

 
$
64,631

 
$
25,700

The overall increase in revenue of $25.7 million is primarily attributable to revenue contributions from acquisition activity in 2013 of $11.5 million, as well as the $10.0 million contribution from the seven newly leased nursing centers in 2014.
The same-store revenues increased by $4.2 million in 2014 compared to the same period in 2013 primarily attributable to improved census. The largest driver for the increase in same-store revenues is the increase in Medicare census which increased 7.5% resulting in a $1.0 million increase in revenues for the three months ended September 30, 2014, as compared to the same period in 2013. Managed Care average daily census increased 18.5% resulting in a revenue increase at our same-store nursing centers of $0.6 million. Additionally, Medicaid census increased slightly in 2014 compared to the same period in 2013, resulting in an increase of $0.1 million to revenues. These increases were offset by a decline in private pay census during the period which resulted in a decrease of $0.5 million for the three months ended September 30, 2014 compared to the same period in 2013.
The average Medicare rate per patient day at same-store nursing centers for the three months ended September 30, 2014 increased 3.4% compared to the same period in 2013, resulting in an increase in revenue of $0.5 million. The average rate per day for Medicaid patients also increased during the period by 2.5% resulting in an increase in revenue of $0.8 million.
The following table summarizes key revenue and census statistics for continuing operations for each period:
 
 
Three Months Ended
September 30,
 
 
2014
 
 
 
2013
 
Skilled nursing occupancy
77.2
%
 

 
75.1
%
 
As a percent of total census:
 
 
 
 
 
 
Medicare census
12.3
%
 
 
 
10.8
%
 
Managed Care census
3.4
%
 
 
 
2.9
%
 
As a percent of total revenues:
 
 
 
 
 
 
Medicare revenues
29.2
%
 
 
 
26.6
%
 
Medicaid revenues
48.6
%
 
 
 
54.6
%
 
Managed Care revenues
6.6
%
 
 
 
5.7
%
 
Average rate per day:
 
 
 
 
 
 
Medicare
$
446.75

 
  
 
$
429.23

 
Medicaid
$
161.43

 
  
 
$
156.85

 
Managed Care
$
384.45

 
  
 
$
379.52

 
Operating Expense
Operating expense increased in the third quarter of 2014 to $73.0 million as compared to $54.2 million in the third quarter of 2013, driven primarily by the $9.1 million increase in operating costs attributable to the nursing center operations acquired in 2013, as well as $8.0 million of operating expense associated with the nursing center operations assumed in 2014. The following table summarizes the expense increases attributable to our portfolio growth (in thousands):

28


 
Three Months Ended
September 30,
 
2014
 
2013
 
Change
Same-store operating expense
$
49,372

 
$
47,645

 
$
1,727

2013 acquisition expense
15,647

 
6,541

 
9,106

2014 acquisition expense
7,987

 
—

 
7,987

Total expense
$
73,006

 
$
54,186

 
$
18,820

Operating expense decreased as a percentage of revenue at 80.8% for the third quarter of 2014 as compared to 83.8% for the third quarter of 2013. The largest component of operating expenses is wages. Considering the aforementioned addition of the new centers, we experienced an increase to $42.9 million in the third quarter of 2014 as compared to $32.0 million in the third quarter of 2013, an increase of $10.9 million, or 34.2%. While wages increased overall, wages as a percentage of revenue decreased in the third quarter of 2014 to 47.5% as compared to 49.5% in the third quarter of 2013, a decrease of 2.0%.
Lease Expense
Lease expense increased in the third quarter of 2014 to $6.9 million as compared to $4.8 million in the third quarter of 2013. The increase in lease expense was primarily attributable to $1.1 million in combined lease expense for the seven newly leased nursing centers in 2014. Additionally, the five nursing centers leased in 2013 contributed $1.0 million in expense during the period.
Professional Liability
Professional liability expense was $1.7 million in the third quarter of 2014 compared to $0.9 million in the third quarter of 2013, an increase of $0.8 million. We were engaged in 48 professional liability lawsuits as of September 30, 2014, compared to 54 as of December 31, 2013. Our quarterly cash expenditures for professional liability costs of continuing operations were $1.4 million and $0.9 million for 2014 and 2013, respectively. Professional liability expense and cash expenditures fluctuate from year to year based respectively on the results of our third-party professional liability actuarial studies and on the costs incurred in defending and settling existing claims. See “Liquidity and Capital Resources” for further discussion of the accrual for professional liability.

General and Administrative Expense
General and administrative expense was $5.6 million in the third quarter of 2014 as compared to $5.0 million in the third quarter of 2013, an increase of $0.6 million, but decreased as a percentage of revenue from 7.7% in 2013 to 6.2% in 2014. The increase in general and administrative expense is primarily attributable to expansion of regional operating teams in new operating regions as a result of acquisition and growth.
Depreciation and Amortization
Depreciation and amortization expense was approximately $1.8 million in the third quarter of 2014 as compared to $1.6 million in 2013. The increase in depreciation expense relates to fixed assets at the newly leased and acquired centers.
Interest Expense, Net
Interest expense was $0.9 million in the third quarter of 2014 and 2013. The balance remained flat as the impact of the higher debt balances as a result of the amended Mortgage Loan was factored into both the prior and current years for the full quarter.
Income (Loss) from Continuing Operations before Income Taxes; Income (Loss) from Continuing Operations per Common Share
As a result of the above, continuing operations reported income before income taxes of $0.4 million for the third quarter of 2014 as compared to a loss of $3.7 million for the third quarter of 2013. The provision for income taxes was $0.1 million in the third quarter of 2014 as compared to a benefit for income taxes of $1.4 million in the third quarter of 2013. The basic and diluted income per common share from continuing operations was $0.03 for the third quarter of 2014, as compared to a loss per common share from continuing operations of $0.41 in the third quarter of 2013.

29


Nine Months Ended September 30, 2014 Compared With Nine Months Ended September 30, 2013
Patient Revenues
Patient revenues were $250.4 million for the nine months ended September 30, 2014, as compared to $184.6 million in the nine months ended September 30, 2013. This increase is primarily attributable to the acquisition of new facilities during the period. The following table summarizes the revenue increases attributable to our portfolio growth (in thousands):
 
Nine Months Ended
September 30,
 
2014
 
2013
 
Change
Same-store revenue
$
181,296

 
$
173,546

 
$
7,750

2013 acquisition revenue
54,893

 
11,012

 
43,881

2014 acquisition revenue
14,254

 
—

 
14,254

Total revenue
$
250,443

 
$
184,558

 
$
65,885

The overall increase in revenue of $65.9 million is primarily attributable to increased revenue contributions from acquisition activity in 2013 of $43.9 million, as well as the $14.3 million contribution from the seven newly leased nursing centers in 2014.
The same-store revenues increased by $7.8 million in the nine months ended September 30, 2014 compared to the same period in 2013 primarily attributable to improved census. One driver for the increase in same-store revenues is the increase in Medicaid census which increased 1.8% resulting in a $1.7 million increase in revenues for the nine months ended September 30, 2014, as compared to the same period in 2013. Medicare census also increased by 4.9% resulting in a $2.1 million increase in revenues in 2014 as compared to 2013. Additionally, Managed Care average daily census increased 11.8% resulting in a revenue increase at our same-store nursing centers of $1.2 million. These increases were offset by a decline in private pay census during the period which resulted in a decrease of $1.6 million in 2014 compared to the same period in 2013.
The average Medicare rate per patient day at same-store nursing centers for the nine months ended September 30, 2014 increased 2.0% compared to the same period in 2013, resulting in an increase in revenue of $0.9 million. This average rate per day for Medicaid patients also increased during the period by 1.4% resulting in increased revenue of $1.4 million.
The following table summarizes key revenue and census statistics for continuing operations for each period:
 
 
Nine Months Ended
September 30,
 
 
2014
 
 
 
2013
 
Skilled nursing occupancy
77.7
%
 
 
 
75.2
%
 
As a percent of total census:
 
 
 
 
 
 
Medicare census
12.9
%
 
 
 
11.6
%
 
Managed Care census
3.5
%
 
 
 
3.0
%
 
As a percent of total revenues:
 
 
 
 
 
 
Medicare revenues
29.7
%
 
 
 
27.8
%
 
Medicaid revenues
48.5
%
 
 
 
53.4
%
 
Managed Care revenues
6.6
%
 
 
 
6.0
%
 
Average rate per day:
 
 
 
 
 
 
Medicare
$
441.05

 
  
 
$
430.67

 
Medicaid
$
159.32

 
  
 
$
156.51

 
Managed Care
$
380.35

 
  
 
$
380.62

 
Operating Expense
Operating expense increased in 2014 to $200.5 million as compared to $152.0 million in 2013, driven primarily by the $35.7 million increase in operating costs attributable to the nursing center operations acquired in 2013, as well as $10.9 million of operating expense associated with the nursing center operations assumed in 2014. The following table summarizes the expense increases attributable to our portfolio growth (in thousands):

30


 
Nine Months Ended
September 30,
 
2014
 
2013
 
Change
Same-store operating expense
$
143,787

 
$
141,970

 
$
1,817

2013 acquisition expense
45,781

 
10,044

 
35,737

2014 acquisition expense
10,949

 
—

 
10,949

Total expense
$
200,517

 
$
152,014

 
$
48,503

Operating expense decreased as a percentage of revenue at 80.1% for 2014 as compared to 82.4% for 2013. The largest component of operating expenses is wages. Considering the aforementioned addition of the new centers, we experienced an increase to $116.9 million in 2014 as compared to $90.6 million in 2013, an increase of $26.3 million, or 29.0%. While wages increased overall, wages as a percentage of revenue decreased in 2014 to 46.7% as compared to 49.1% in 2013, a decrease of 2.4%.
Lease Expense
Lease expense increased in 2014 to $19.1 million as compared to $14.4 million in 2013. The increase in lease expense was primarily attributable to $3.4 million in combined lease expense for the five newly leased nursing centers in 2013. Additionally, the seven nursing centers leased in 2014 contributed $1.5 million in expense during the period.
Professional Liability
Professional liability expense was $5.4 million in 2014 compared to $4.2 million in 2013, a increase of $1.2 million. We were engaged in 48 professional liability lawsuits as of September 30, 2014, compared to 54 as of December 31, 2013. Our cash expenditures for professional liability costs of continuing operations were $3.6 million and $3.0 million for 2014 and 2013, respectively. Professional liability expense and cash expenditures fluctuate from year to year based respectively on the results of our third-party professional liability actuarial studies and on the costs incurred in defending and settling existing claims. See “Liquidity and Capital Resources” for further discussion of the accrual for professional liability.

General and Administrative Expense
General and administrative expense was $16.1 million in 2014 as compared to $15.8 million in 2013, an increase of $0.3 million, but decreased as a percentage of revenue from 8.5% in 2013 to 6.4% in 2014. The decrease in general and administrative expense as a percent of revenues is primarily attributable to a decrease in non-recurring, acquisition-related expenses of $0.2 million in 2013 related to the acquisition of the Kansas portfolio, but also increased incremental revenue as mentioned above from new facility operations.
Depreciation and Amortization
Depreciation and amortization expense was approximately $5.3 million in 2014 as compared to $4.6 million in 2013. The increase in depreciation expense relates to fixed assets at the newly leased and acquired centers, and primarily driven by an increase of $0.3 million in depreciation expense for the Kansas portfolio.
Interest Expense, Net
Interest expense was $2.8 million in 2014 and $2.1 million in 2013, an increase of $0.7 million. The increase was primarily attributable to higher debt balances in 2014 as a result of the amended Mortgage Loan, which increased the balance of outstanding debt as a result of the acquisition of the Kansas centers, as well as the outstanding balance of the amended Revolver as a result of the on-going CHOW process at newly leased facilities.
Income (Loss) from Continuing Operations before Income Taxes; Income (Loss) from Continuing Operations per Common Share
As a result of the above, continuing operations reported income before income taxes of $1.3 million for the nine months ended September 30, 2014, as compared to a loss of $10.0 million for the same period in 2013. The provision for income taxes was $0.5 million for the nine months ended September 30, 2014, as compared to a benefit for income taxes of $3.9 million for the nine months ended September 30, 2013. The basic and diluted income per common share from continuing operations were both $0.09 for the nine months ended September 30, 2014, as compared to a loss per common share from continuing operations of $1.07 for the same period in 2013.

31


Liquidity and Capital Resources
Liquidity
Our primary source of liquidity is the net cash flow provided by the operating activities of our centers. We believe that these internally generated cash flows will be adequate to service existing debt obligations, fund required capital expenditures as well as provide cash flows for investing opportunities. In determining priorities for our cash flow, we evaluate alternatives available to us and select the ones that we believe will most benefit us over the long-term. Options for our cash include, but are not limited to, capital improvements, dividends, purchase of additional shares of our common stock, acquisitions, payment of existing debt obligations, preferred stock redemptions as well as initiatives to improve nursing center performance. We review these potential uses and align them to our cash flows with a goal of achieving long-term success.
Net cash provided by operating activities of continuing operations totaled $0.7 million in the nine months ended September 30, 2014, as compared to cash used by operating activities of $5.5 million in the same period of 2013.
Our cash expenditures related to professional liability claims of continuing operations were $3.6 million and $3.0 million for nine months ended September 30, 2014 and 2013, respectively. We will also have on-going cash expenditures related to professional liability claims remaining against our discontinued operations. Although we work diligently to limit the cash required to settle and defend professional liability claims, a significant judgment entered against us in one or more legal actions could have a material adverse impact on our cash flows and could result in our being unable to meet all of our cash needs as they become due.
Investing activities of continuing operations provided cash of $12.2 million in 2014 and used cash of $22.7 million in 2013. The cash provided in 2014 is a result of the gain on sale for West Virginia during the third quarter, while the decrease in 2013 is a result of the Kansas asset purchase that occurred in the second quarter.
Financing activities of continuing operations used cash of $6.2 million in 2014 as compared to cash provided of $18.9 million in 2013. The cash used in 2014 is primarily attributable to the redemption of preferred shares of $4.9 million, as well as normal debt repayments on the Company's revolving credit facility. The cash provided in 2013 is primarily due to the Company's debt restructuring associated with the Kansas acquisition in the second quarter from which additional proceeds were received from the restructured term loan.

Dividends
On November 5, 2014, the Board of Directors declared a quarterly dividend of $0.055 per common share payable to shareholders of record as of December 31, 2014, to be paid on January 14, 2015. While the Board of Directors intends to pay quarterly dividends, the Board will make the determination of the amount of future cash dividends, if any, to be declared and paid based on, among other things, the Company’s financial condition, funds from operations, the level of its capital expenditures and its future business prospects and opportunities.
Redeemable Preferred Stock
Effective August 14, 2014, the Company redeemed all of its outstanding shares of Series C Preferred Stock (“Preferred Stock”) from the holder, Omega Health Investors, Inc. (“Omega”). The redemption was affected as a result of Omega’s exercise of its pre-existing option to require the Company to redeem the Preferred Stock as provided in the Company’s Certificate of Designation. As previously disclosed, the Preferred Stock has been redeemable at Omega’s option since September 30, 2010 at a stated value of approximately $4.9 million plus accrued, but unpaid, dividends. The Preferred Stock was issued to Omega in 2006 and is not convertible, but has been redeemable at its stated value at Omega’s option since September 30, 2010, and since September 30, 2007 has been redeemable at its stated value at our option. Following the redemption, the Company no longer has any Series C Preferred Stock outstanding.
Professional Liability
The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”), to replace some of the expiring commercial policies. SHC covers losses up to specified limits per occurrence. On a per claim basis, coverage for losses in excess of those covered by SHC are maintained through unaffiliated commercial reinsurance carriers. All of the Company's nursing centers in Florida and Tennessee are now covered under the captive insurance policies along with most of the nursing centers in Alabama, Kentucky, Ohio, and Texas. This policy also covers claims related to our discontinued operations in West Virginia and Arkansas. The insurance coverage provided for these centers under the SHC policy include coverage limits of $0.5 million per medical incident with a sublimit per center of $1.0 million and total annual aggregate policy

32


limits of $5.0 million. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers. 
As of September 30, 2014, we have recorded total liabilities for reported and settled professional liability claims and estimates for incurred, but unreported claims of $26.4 million. Our calculation of this estimated liability is based on an assumption that the Company will not incur a severely adverse judgment with respect to any asserted claim; however, a significant judgment could be entered against us in one or more of these legal actions, and such a judgment could have a material adverse impact on our financial position and cash flows.
Capital Resources
As of September 30, 2014, we had $50.1 million of outstanding long-term debt and capital lease obligations. The $50.1 million total includes $0.4 million in capital lease obligations, and $6.0 million currently outstanding on the revolving credit facility. The balance of the long-term debt is comprised of $43.7 million owed on our mortgage loan.
On May 1, 2013, the Company executed an Amended and Restated Credit Agreement (the "Credit Agreement") which modified the terms of the Original Mortgage Loan and the Original Revolver Agreements dated February 28, 2011. The Credit Agreement increases the Company's borrowing capacity to $65.0 million allocated between a $45 million Mortgage Loan ("Amended Mortgage Loan") and a $20.0 million Revolver ("Amended Revolver"). Loan acquisition costs associated with the Amended Mortgage Loan and the Amended Revolver were capitalized in the amount of $1.3 million and are being amortized over the five-year term of the agreements. Loan acquisition costs of $320,000 associated with the Original Mortgage Loan were written off in conjunction with this restructuring and are recorded in Debt Retirement Costs in the Interim Consolidated Statement of Operations for the nine-month period ended September 30, 2013.
Under the terms of the amended agreements, the syndicate of banks provided the Amended Mortgage Loan with an original balance of $45.0 million with a five-year maturity through April 30, 2018, and a $20.0 million Amended Revolver through April 30, 2018. The Amended Mortgage Loan has a term of five years, with principal and interest payable monthly based on a 25-year amortization. Interest is based on LIBOR plus 4.5%, which was 4.65% at September 30, 2014, but a portion of the outstanding principal balance under the Amended Mortgage Loan is effectively fixed at 6.87% as a result of the interest rate swap described below. The Amended Mortgage Loan is secured by thirteen owned nursing centers, related equipment and a lien on the accounts receivable of these centers. The Amended Mortgage Loan and the Amended Revolver are cross-collateralized. The Company’s Amended Revolver has an interest rate of LIBOR plus 4.5%, which resulted in an interest rate of 4.65% as of September 30, 2014.
Effective March 31, 2014, the Company entered into the Second Amendment to the Amended and Restated Revolver ("Second Amendment"). The Second Amendment temporarily increased the Amended Revolver capacity from the $20.0 million in the original Amended Revolver to $27.5 million through September 30, 2014, as a result of the increase in receivables related to new facilities that continue to progress in the change in ownership process. The Second Amendment also provided for a permanent increase in the Amended Revolver capacity to $22.5 million beginning October 1, 2014 through the original maturity date of April 30, 2018, to reflect the expansion of the Company's business through new facility acquisitions. Effective July 1, 2014, the Company entered into the Third Amendment to the Amended and Restated Revolver ("Third Amendment"). The Third Amendment makes the previously temporary increase to the Amended Revolver capacity from the $20.0 million in the original Amended Revolver to $27.5 million as defined in the Second Amendment, a permanent change to the borrowing capacity as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process.
As of September 30, 2014, the Company had $6.0 million borrowings outstanding under the revolving credit facility. The outstanding borrowings on the revolver primarily reflect the Company's approach to accumulated Medicaid and Medicare receivables at recently acquired facilities as these facilities proceed through the change in ownership process with CMS. Annual fees for letters of credit issued under this Revolver are 3.00% of the amount outstanding. The Company has ten letters of credit with a total value of $8.0 million outstanding as of September 30, 2014. Considering the balance of eligible accounts receivable, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of $27.5 million, the balance available for borrowing under the revolving credit center is $12.7 million at September 30, 2014.
Effective March 27, 2014, the Company executed its purchase option to acquire all assets associated with the Rose Terrace nursing center in Culloden, West Virginia from Milton Holdings, LLC which was considered a variable interest entity ("VIE") by the Company and consolidated prior to the date of this transaction. See Note 8 to the Interim Consolidated Financial Statements under Item 1 above (the "Financial Statements") for further information on the VIE considerations. In conjunction with the purchase of the assets, the Company entered into an interest-only $8.0 million term loan ("Rose Terrace Note") with a maturity date of March 27, 2015. The structure of the Rose Terrace Note reflected the Company's intent to sell the property and transfer operations to an unrelated third-party operator. Effective July 1, 2014, the Company completed the transaction with Rose Terrace Acq., LLC to sell Rose Terrace, a 90-bed skilled nursing facility in Culloden, West Virginia for a sales price of

33


$16.5 million. The Company also agreed to an amendment to the Master Lease with Omega Health Investors, Inc. to terminate the lease only with respect to two other skilled nursing facilities in West Virginia, and concurrently entered into an operations transfer agreement with American Health Care Management, LLC, an affiliate of the purchaser with respect to these two other skilled nursing facilities located in Danville and Ivydale, West Virginia. Upon completion of the transaction, Diversicare no longer operates any skilled nursing centers in the state of West Virginia. In conjunction with the closing of the sale, the Company paid the balance of the $8.0 million mortgage loan outstanding on the Rose Terrace facility.
Our lending agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. We are in compliance with all such covenants at September 30, 2014.
Our calculated compliance with financial covenants is presented below:
 
 
Requirement
  
Level at
September 30, 2014
Minimum fixed charge coverage ratio
1.10:1.00
 
1.28:1.00
Minimum adjusted EBITDA
$10.00 million
 
$16.31 million
EBITDAR (mortgaged centers)
$6.150 million
 
$9.267 million
As part of the debt agreements entered into in March 2011, we entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The interest rate swap agreement has the same effective date and maturity date as the Amended Mortgage Loan, and carries a notional equivalent to half of the outstanding principal on the Amended Mortgage Loan. The interest rate swap agreement requires us to make fixed rate payments to the bank calculated on the applicable notional amount at an annual fixed rate of 6.87% while the bank is obligated to make payments to us based on LIBOR on the same notional amounts. We entered into the interest rate swap agreement to mitigate the variable interest rate risk on our outstanding mortgage borrowings.
Receivables
Our operations could be adversely affected if we experience significant delays in reimbursement from Medicare, Medicaid or other third-party revenue sources. Our future liquidity will continue to be dependent upon the relative amounts of current assets (principally cash, accounts receivable and inventories) and current liabilities (principally accounts payable and accrued expenses). In that regard, accounts receivable can have a significant impact on our liquidity. Continued efforts by governmental and third-party payors to contain or reduce the acceleration of costs by monitoring reimbursement rates, by increasing medical review of bills for services, or by negotiating reduced contract rates, as well as any delay by us in the processing of our invoices, could adversely affect our liquidity and results of operations.
Accounts receivable attributable to patient services of continuing operations totaled $47.2 million at September 30, 2014 compared to $36.6 million at December 31, 2013, representing approximately 42 days and 43 days revenue in accounts receivable, respectively. The increase in accounts receivable is due to increases in payor sources with longer payment cycles, including Managed Care payors, as well as an increase in Medicaid patients undergoing the initial qualification process.
Our accounts receivable included approximately $8.3 million and $5.1 million at September 30, 2014 and December 31, 2013, respectively of unbilled accounts, primarily attributable to newly acquired facilities.  During the change of ownership process, we were required to hold these accounts while waiting for final Medicare and Medicaid approvals.
The allowance for bad debt was $5.3 million at September 30, 2014 as compared to $3.9 million at December 31, 2013. We continually evaluate the adequacy of our bad debt reserves based on patient mix trends, aging of older balances, payment terms and delays with regard to third-party payors, collateral and deposit resources, as well as other factors. We continue to evaluate and implement additional procedures to strengthen our collection efforts and reduce the incidence of uncollectible accounts.
Off-Balance Sheet Arrangements
We have ten letters of credit outstanding with an aggregate value of approximately $8.0 million as of September 30, 2014, the first of which serves as a security deposit for our facility lease with Omega in the amount of $4.6 million. The second letter of credit serves our initial funding of insurance policies with a captive insurance company in the amount of $1.0 million. The balance of the outstanding letters of credit relate to deposits at various leased facilities where the Company opted to issue letters of credit as a deposit in lieu of cash. These letters of credit were issued under our revolving credit facility. Our accounts receivable serve as the collateral for this revolving credit facility.


34


Forward-Looking Statements
The foregoing discussion and analysis provides information deemed by management to be relevant to an assessment and understanding of our consolidated results of operations and financial condition. This discussion and analysis should be read in conjunction with our consolidated financial statements included herein. Certain statements made by or on behalf of us, including those contained in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere, are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those contemplated by the forward-looking statements made herein. In addition to any assumptions and other factors referred to specifically in connection with such statements, other factors, many of which are beyond our ability to control or predict, could cause our actual results to differ materially from the results expressed or implied in any forward-looking statements including, but not limited to, our ability to successfully operate the new nursing centers in Alabama, Kansas, Kentucky, Missouri, Ohio, and Indiana, our ability to increase census at our renovated centers, changes in governmental reimbursement, including the impact of the CMS final rule that has resulted in a reduction in Medicare reimbursement as of October 2012 and our ability to mitigate the impact of the revenue reduction, government regulation, the impact of the recently adopted federal health care reform or any future health care reform, any increases in the cost of borrowing under our credit agreements, our ability to comply with covenants contained in those credit agreements, the outcome of professional liability lawsuits and claims, our ability to control ultimate professional liability costs, the accuracy of our estimate of our anticipated professional liability expense, the impact of future licensing surveys, the outcome of proceedings alleging violations of state or Federal False Claims Acts, laws and regulations governing quality of care or other laws and regulations applicable to our business including laws governing reimbursement from government payors, impacts associated with the implementation of our electronic medical records plan, the costs of investing in our business initiatives and development, our ability to control costs, changes to our valuation of deferred tax assets, changes in occupancy rates in our centers, changing economic and competitive conditions, changes in anticipated revenue and cost growth, changes in the anticipated results of operations, the effect of changes in accounting policies as well as others. Investors also should refer to the risks identified in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as risks identified in “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013, for a discussion of various risk factors of the Company and that are inherent in the health care industry. Given these risks and uncertainties, we can give no assurances that these forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. These assumptions may not materialize to the extent assumed, and risks and uncertainties may cause actual results to be different from anticipated results. These risks and uncertainties also may result in changes to the Company’s business plans and prospects. Such cautionary statements identify important factors that could cause our actual results to materially differ from those projected in forward-looking statements. In addition, we disclaim any intent or obligation to update these forward-looking statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The chief market risk factor affecting our financial condition and operating results is interest rate risk. As of September 30, 2014, we had outstanding borrowings of approximately $49.7 million, $27.8 million of which was subject to variable interest rates. In connection with our May 2013 financing agreement, we entered into an interest rate swap with respect to one half of the Amended Mortgage Loan to mitigate the floating interest rate risk of such borrowing. In the event that interest rates were to change 1%, the impact on future pre-tax cash flows would be approximately $278,000 annually, representing the impact of increased or decreased interest expense on variable rate debt.

ITEM 4. CONTROLS AND PROCEDURES
As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), our management, including our chief executive officer and chief financial officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of September 30, 2014. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, such as this Quarterly Report on Form 10-Q, is properly recorded, processed, summarized and reported within the time periods required by the Securities and Exchange Commission’s rules and forms. Management necessarily applied its judgment in assessing the costs and benefits of such controls and procedures that, by their nature, can provide only reasonable assurance regarding management’s control objectives. Management does not expect that its disclosure controls and procedures will prevent all errors and fraud. A control system, irrespective of how well it is designed and operated, can only provide reasonable assurance, and cannot guarantee that it will succeed in its stated objectives.
Based on an evaluation of the effectiveness of the design and operation of disclosure controls and procedures, our chief executive officer and chief financial officer concluded that, as of September 30, 2014, our disclosure controls and procedures were effective in reaching a reasonable level of assurance that information required to be disclosed by us in the reports that we

35


file or submit under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the Securities and Exchange Commission’s rules and forms.

PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The provision of health care services entails an inherent risk of liability. Participants in the health care industry are subject to lawsuits alleging malpractice, product liability, violations of laws governing payments received from participation in the Medicare and Medicaid programs, and other legal theories, many of which involve large claims and significant defense costs. Like many other companies engaged in the long-term care profession in the United States, we have numerous pending liability claims, disputes and legal actions for professional liability and other related issues. It is expected that we will continue to be subject to such suits as a result of the nature of our business. Further, as with all health care providers, we are periodically subject to actions seeking fines and penalties for alleged violations of health care laws and are potentially subject to claims related to compliance with health care reimbursement and fraud and abuse laws and/or the quality of care provided to residents of our facility. As with other health care providers, in the ordinary course of our business, we are also subject to claims made by employees and other disputes and litigation arising from the conduct of our business.
As of September 30, 2014, we are engaged in 48 professional liability lawsuits. Seven lawsuits are currently scheduled for trial or arbitration during the next twelve months, and it is expected that additional cases will be set for trial or hearing. The ultimate results of any of our professional liability claims and disputes cannot be predicted with certainty. A significant judgment entered against us in one or more of these legal actions could have a material adverse impact on our financial position and cash flows.
In July 2013, the Company learned that the United States Attorney for the Middle District of Tennessee (DOJ) had commenced a civil investigation of potential violations of the False Claims Act (FCA) at two of the Company's facilities. Notice to the Company came in the form of a civil investigative demand (CID), a form of subpoena, to produce certain documents relating to our practices and policies for rehabilitation and other services since 2010 at those two facilities. The Company responded to this limited CID and has cooperated with the DOJ in connection with its investigation. In October 2014, the Company received a second CID indicating that the DOJ’s investigation now covers all of the Company’s facilities, but only directing the Company to produce material related to a total of six of the Company's facilities. The Company intends to respond to the most recent CID and to continue cooperating with the DOJ in its FCA investigation. The Company cannot predict the outcome of this investigation or any possible related proceedings, and the outcome could have a materially adverse effect on the Company, including the imposition of damages, fines, penalties and/or a corporate integrity agreement, but the Company is committed to provide caring and professional services to its patients and residents in compliance with applicable laws and regulations.
In November 2012, a purported stockholder class action complaint was filed in the Chancery Court for Williamson County, Tennessee (21st Judicial District) against the Company's Board of Directors. This action alleges that the Board of Directors breached its fiduciary duties to stockholders related to its response to certain expressions of interest in a potential strategic transaction from Covington Investments, LLC (“Covington”). The complaint asserts that the Board failed to negotiate or otherwise appropriately consider Covington's proposals. Plaintiff has filed a motion seeking to certify the action as a class action, which is not currently set for hearing. On May 23, 2014, the plaintiff and defendants entered into a memorandum of understanding outlining the terms of a settlement subject to the execution of definitive documentation and court approval. The agreement provides that the Company will adopt and maintain certain corporate governance procedures for a period of at least three years. This settlement has not yet been approved by the court.
In June 2012, a collective action complaint was filed in the U.S. District Court for the U.S. District Court for the Western District of Arkansas against us and certain of our subsidiaries.  The complaint alleges that the defendants violated the Fair Labor Standards Act (FLSA) and seeks unpaid overtime wages as well as liquidated damages.  The Court conditionally certified a nationwide class of all of the Company's hourly employees, but recently decertified the class.  The Company intends to defend the lawsuit vigorously.
In January 2009, a purported class action complaint was filed in the Circuit Court of Garland County, Arkansas against the Company and certain of its subsidiaries and Garland Nursing & Rehabilitation Center (the “Facility”). The complaint alleges that the defendants breached their statutory and contractual obligations to the patients of the Facility over the five-year period prior to the filing of the complaints. The lawsuit remains in its early stages and has not yet been certified by the court as a class action. The Company intends to defend the lawsuit vigorously.
We cannot currently predict with certainty the ultimate impact of any of the above cases on our financial condition, cash flows or results of operations. Our reserve for professional liability expenses does not include any amounts for the collective actions, the pending DOJ investigation, the purported class action against the Arkansas facilities or the lawsuit filed against our directors. An unfavorable outcome in any of these lawsuits or any of our professional liability actions, any regulatory action,

36


any investigation or lawsuit alleging violations of fraud and abuse laws or of elderly abuse laws or any state or Federal False Claims Act case could subject us to fines, penalties and damages, including exclusion from the Medicare or Medicaid programs, and could have a material adverse impact on our financial condition, cash flows or results of operations.
ITEM 1A RISK FACTORS
The risks described in our Annual Report on Form 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently believe to be immaterial also may adversely affect our business, financial condition and/or operating results. This section updates our risk factors as stated in our Annual Report in Form 10-K to reflect material developments since our Form 10-K was filed.
The U.S. Department of Justice is conducting an investigation into the Company’s provision of rehabilitation services, which could adversely affect our operations and financial condition. In July 2013, the Company learned that the United States Attorney for the Middle District of Tennessee (DOJ) had commenced a civil investigation of potential violations of the False Claims Act (FCA) at two of the Company's facilities. Notice to the Company came in the form of a civil investigative demand (CID), a form of subpoena, to produce certain documents relating to our practices and policies for rehabilitation and other services since 2010 at those two facilities. The Company responded to this limited CID and has cooperated with the DOJ in connection with its investigation. In October 2014, the Company received a second CID indicating that the DOJ’s investigation now covers all of the Company’s facilities, but only directing the Company to produce material related to a total of six of the Company's facilities. The Company intends to respond to the most recent CID and to continue cooperating with the DOJ in its FCA investigation. The Company cannot predict the outcome of this investigation or any possible related proceedings, and the outcome could have a materially adverse effect on the Company, including the imposition of damages, fines, penalties and/or a corporate integrity agreement, but the Company is committed to provide caring and professional services to its patients and residents in compliance with applicable laws and regulations.

ITEM 6. EXHIBITS
The exhibits filed as part of this report on Form 10-Q are listed in the Exhibit Index immediately following the signature page.

37


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
 
Diversicare Healthcare Services, Inc.
 
 
 
November 6, 2014
 
 
 
 
 
 
 
By:
 
/s/ Kelly J. Gill
 
 
 
Kelly J. Gill
 
 
 
President and Chief Executive Officer, Principal Executive Officer and
 
 
 
An Officer Duly Authorized to Sign on Behalf of the Registrant
 
 
 
 
By:
 
/s/ James R. McKnight, Jr.
 
 
 
James R. McKnight, Jr.
 
 
 
Executive Vice President and Chief Financial Officer and
 
 
 
An Officer Duly Authorized to Sign on Behalf of the Registrant

38


 
 
 
Exhibit
Number
  
Description of Exhibits
3.1

  
Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement No. 33-76150 on Form S-1).
 
 
3.2

  
Certificate of Designation of Registrant (incorporated by reference to Exhibit 3.5 to the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2006).
 
 
3.3

  
Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement No. 33-76150 on Form S-1).
 
 
3.4

  
Bylaw Amendment adopted November 5, 2007 (incorporated by reference to Exhibit 3.4 to the Company’s annual report on Form 10-K for the year ended December 31, 2007).
 
 
3.5

  
Amendment to Certificate of Incorporation dated March 23, 1995 (incorporated by reference to Exhibit A of Exhibit 1 to the Company’s Form 8-A filed March 30, 1995).
 
 
3.6

  
Certificate of Designation of Registrant (incorporated by reference to Exhibit 3.4 to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2001).
 
 
4.1

  
Form of Common Stock Certificate (incorporated by reference to Exhibit 4 to the Company’s Registration Statement No. 33-76150 on Form S-1).
 
 
4.2

  
Amended and Restated Rights Agreement dated as of December 7, 1998 (incorporated by reference to Exhibit 1 to Form 8-A/A filed December 7, 1998).
 
 
4.3

  
Amendment No. 1 to the Amended and Restated Rights Agreement, dated March 19, 2005, by and between the Company and SunTrust Bank, as Rights Agent (incorporated by reference to Exhibit 2 to Form 8-A/A filed on March 24, 2005).
 
 
4.4

  
Second Amendment to the Amended and Restated Rights Agreement, dated August 15, 2008, by and between the Company and ComputerShare Trust Company, N.A., as successor to SunTrust Bank (incorporated by reference to Exhibit 3 to Form 8-A/A filed on August 18, 2008).
 
 
4.5

  
Third Amendment to Amended and Restated Rights Agreement, dated August 14, 2009, between the Company and Computershare Trust Company, N.A, as successor to SunTrust Bank, (incorporated by reference to Exhibit 4 to the Company’s Registration Statement on Form 8-A/A filed on August 14, 2009).
 
 
 
4.6

  
Fourth Amendment to Amended and Restated Rights Agreement, dated May 7, 2014, between the Company and Computershare Trust Company, N.A, as successor to SunTrust Bank, as Rights Agent (incorporated by reference to Exhibit 5 to the Company's Registration Statement on Form 8-A/A filed on May 8, 2014).
 
 
 
10.1

 
Third Amendment to Amended and Restated Term Loan And Security Agreement dated as of July 1, 2014, by and among the Company and a syndicate of financial institutions and banks, including The PrivateBank as the Administering Agent (incorporated by reference to exhibit 10.1 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2014).
 
 
 
10.2

 
Third Amendment and Consent to Amended And Restated Revolving Loan and Security Agreement dated as of July 1, 2014 by and among the Company and a syndicate of financial institutions and banks, including The PrivateBank as the Administering Agent (incorporated by reference to exhibit 10.2 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2014).
 
 
 
10.3

 
Fifteenth Amendment to Consolidated Amended and Restated Master Lease dated as of June 30, 2014 by and between the Company and Sterling Acquisition Corp. (incorporated by reference to exhibit 10.3 to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2014).
 
 
 
10.4

 
Asset Purchase Agreement dated April 3, 2014 by and between Diversicare Rose Terrace, LLC, and Rose Terrace Acq., LLC. (incorporated by reference to exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2014).
 
 
 
31.1

  
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a).
 
 
31.2

  
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a).
 
 
32

  
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b).
 
 

39


101.INS

  
XBRL Instance Document
 
 
101.SCH

  
XBRL Taxonomy Extension Schema Document
 
 
101.CAL

  
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.LAB

  
XBRL Taxonomy Extension Labels Linkbase Document
 
 
101.PRE

  
XBRL Taxonomy Extension Presentation Linkbase Document
 
 


40
 EX-31.1 2 dvcr-ex311x93014certificat.htm EXHIBIT DVCR-EX31.1 - 9.30.14 Certification of CEO


Exhibit 31.1
CERTIFICATIONS PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
(i) CERTIFICATION
I, Kelly J. Gill, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Diversicare Healthcare Services, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 6, 2014
 
 
/s/ Kelly J. Gill
Kelly J. Gill
Chief Executive Officer



 EX-31.2 3 dvcr-ex312x93014certificat.htm EXHIBIT DVCR-EX31.2 - 9.30.14 Certification of CFO


Exhibit 31.2
CERTIFICATIONS PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
(ii) CERTIFICATION
I, James Reed McKnight, Jr., certify that:
1. I have reviewed this quarterly report on Form 10-Q of Diversicare Healthcare Services, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date:  November 6, 2014
 
/s/ James Reed McKnight, Jr.
James Reed McKnight, Jr.
Executive Vice President and Chief Financial Officer



 EX-32 4 dvcr-ex32x93014certificati.htm EXHIBIT DVCR-EX32 - 9.30.14 Certification


Exhibit 32
CERTIFICATION OF QUARTERLY REPORT ON FORM 10-Q
OF DIVERSICARE HEALTHCARE SERVICES, INC.
FOR THE QUARTER ENDED SEPTEMBER 30, 2014
The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the undersigned’s best knowledge and belief, the Quarterly Report on Form 10-Q for Diversicare Healthcare Services, Inc. (the “Company”) for the period ending September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”):
(a)
fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
This Certification is executed as of November 6, 2014.

 
 
/s/ Kelly J. Gill
Kelly J. Gill
Chief Executive Officer
 
/s/ James Reed McKnight, Jr.
James Reed McKnight, Jr.
Executive Vice President and Chief Financial Officer
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



 EX-101.INS 5 avca-20140930.xml XBRL INSTANCE DOCUMENT 0000919956 2013-05-01 2013-05-01 0000919956 avca:SkilledNursingCenterMember stpr:KS 2013-05-01 2013-05-01 0000919956 avca:CreditAgreementMember 2013-05-01 2013-05-01 0000919956 avca:LouisvilleKentuckyMember 2013-08-01 2013-08-01 0000919956 2013-10-01 2013-10-01 0000919956 avca:HuntsvilleAlabamaMember 2014-03-01 2014-03-01 0000919956 avca:RoseTerraceNursingCenterMember 2014-03-27 2014-03-27 0000919956 avca:NicholasvilleKentuckyMember 2014-06-01 2014-06-01 0000919956 avca:SkilledNursingCenterMember stpr:KS 2014-05-01 2014-05-01 0000919956 stpr:OH 2014-08-01 2014-08-01 0000919956 avca:RoseTerraceNoteMember avca:RoseTerraceNursingCenterMember us-gaap:LoansPayableMember 2014-07-01 2014-07-01 0000919956 stpr:MO 2014-07-01 2014-07-01 0000919956 avca:GreenvilleKentuckyMember us-gaap:SubsequentEventMember 2014-10-01 2014-10-01 0000919956 2013-07-01 2013-09-30 0000919956 2013-01-01 2013-09-30 0000919956 stpr:WV avca:RoseTerraceNursingCenterMember 2013-01-01 2013-09-30 0000919956 us-gaap:RestrictedStockMember 2013-01-01 2013-09-30 0000919956 avca:LeasedSkilledNursingCentersMember 2013-01-01 2013-09-30 0000919956 2014-07-01 2014-09-30 0000919956 2014-01-01 2014-09-30 0000919956 stpr:WV avca:RoseTerraceNursingCenterMember 2014-01-01 2014-09-30 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember 2014-01-01 2014-09-30 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember avca:StockOptionsExercisePriceRangeOneMember 2014-01-01 2014-09-30 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember avca:StockOptionsExercisePriceRangeTwoMember 2014-01-01 2014-09-30 0000919956 us-gaap:EmployeeStockMember 2014-01-01 2014-09-30 0000919956 us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0000919956 us-gaap:RestrictedStockUnitsRSUMember 2014-01-01 2014-09-30 0000919956 us-gaap:StockCompensationPlanMember 2014-01-01 2014-09-30 0000919956 avca:SHCRiskCarriersIncMember us-gaap:ProfessionalMalpracticeLiabilityMember 2014-01-01 2014-09-30 0000919956 avca:UnaffiliatedEntitiesMember us-gaap:ProfessionalMalpracticeLiabilityMember 2014-01-01 2014-09-30 0000919956 avca:CreditAgreementMember 2014-01-01 2014-09-30 0000919956 avca:LeasedSkilledNursingCentersMember 2014-01-01 2014-09-30 0000919956 avca:TwoThousandAndEightStockPurchasePlanMember 2014-01-01 2014-09-30 0000919956 avca:TwoThousandAndFiveLongTermIncentivePlanMember 2014-01-01 2014-09-30 0000919956 us-gaap:MaximumMember 2014-01-01 2014-09-30 0000919956 us-gaap:MinimumMember 2014-01-01 2014-09-30 0000919956 avca:PrefundedDeductiblePolicyMember 2014-01-01 2014-09-30 0000919956 2012-12-31 0000919956 2013-09-30 0000919956 2013-12-31 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember 2013-12-31 0000919956 us-gaap:EmployeeStockMember 2013-12-31 0000919956 us-gaap:RestrictedStockUnitsRSUMember 2013-12-31 0000919956 avca:RevolvingCreditFacilityInterestAtFourPointFivePercentAboveLiborMember us-gaap:RevolvingCreditFacilityMember 2013-12-31 0000919956 2014-09-30 0000919956 avca:TrialOrArbitrationScheduleTimeframeMember 2014-09-30 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember 2014-09-30 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember avca:StockOptionsExercisePriceRangeOneMember 2014-09-30 0000919956 avca:StockOptionsAndStockAppreciationRightsSarsMember avca:StockOptionsExercisePriceRangeTwoMember 2014-09-30 0000919956 us-gaap:EmployeeStockMember 2014-09-30 0000919956 us-gaap:RestrictedStockUnitsRSUMember 2014-09-30 0000919956 us-gaap:StockAppreciationRightsSARSMember avca:TwoThousandAndTenLongTermIncentivePlanMember 2014-09-30 0000919956 avca:LondonInterbankOfferedRateMember 2014-09-30 0000919956 us-gaap:LoansPayableMember 2014-09-30 0000919956 us-gaap:RevolvingCreditFacilityMember 2014-09-30 0000919956 us-gaap:RevolvingCreditFacilityMember us-gaap:MaximumMember 2014-09-30 0000919956 avca:RevolvingCreditFacilityInterestAtFourPointFivePercentAboveLiborMember us-gaap:LetterOfCreditMember 2014-09-30 0000919956 avca:RevolvingCreditFacilityInterestAtFourPointFivePercentAboveLiborMember us-gaap:RevolvingCreditFacilityMember 2014-09-30 0000919956 us-gaap:InterestRateSwapMember 2014-09-30 0000919956 avca:TwoThousandAndEightStockPurchasePlanMember 2014-09-30 0000919956 avca:TwoThousandAndFiveLongTermIncentivePlanMember 2014-09-30 0000919956 us-gaap:ProfessionalMalpracticeLiabilityMember 2014-09-30 0000919956 avca:OmegaHealthcareInvestorsInc.Member 2013-01-22 0000919956 avca:OmegaHealthcareInvestorsInc.Member stpr:AR 2013-01-22 0000919956 avca:ChanuteHealthcareCenterMember avca:SkilledNursingCenterMember stpr:KS 2013-05-01 0000919956 avca:CouncilGroveHealthcareCenterMember avca:SkilledNursingCenterMember stpr:KS 2013-05-01 0000919956 avca:HaysvilleHealthcareCenterMember avca:SkilledNursingCenterMember stpr:KS 2013-05-01 0000919956 avca:LarnedHealthcareCenterMember avca:SkilledNursingCenterMember stpr:KS 2013-05-01 0000919956 avca:SedgwickHealthcareCenterMember avca:SkilledNursingCenterMember stpr:KS 2013-05-01 0000919956 avca:SkilledNursingCenterMember stpr:KS 2013-05-01 0000919956 us-gaap:RevolvingCreditFacilityMember 2013-05-01 0000919956 avca:CreditAgreementMember 2013-05-01 0000919956 stpr:KS 2013-05-01 0000919956 avca:LouisvilleKentuckyMember 2013-08-01 0000919956 avca:OmegaHealthcareInvestorsInc.Member stpr:AR 2013-09-01 0000919956 avca:CullodenWestVirginiaMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2011-12-28 0000919956 avca:SkilledNursingCenterMember 2013-10-01 0000919956 avca:SkilledNursingCenterMember stpr:IN 2013-10-01 0000919956 avca:SkilledNursingCenterMember stpr:OH 2013-10-01 0000919956 avca:HuntsvilleAlabamaMember 2014-03-01 0000919956 us-gaap:RevolvingCreditFacilityMember 2014-03-30 0000919956 stpr:WV avca:RoseTerraceNursingCenterMember 2014-04-03 0000919956 avca:NicholasvilleKentuckyMember 2014-06-01 0000919956 avca:AvonPlaceMember stpr:OH 2014-08-01 0000919956 avca:OntarioCommonsMember stpr:OH 2014-08-01 0000919956 stpr:OH 2014-08-01 0000919956 avca:CullodenWestVirginiaMember avca:RoseTerraceNursingCenterMember 2014-07-01 0000919956 avca:DanvilleandIvydaleWestVirginiaMember avca:RoseTerraceNursingCenterMember 2014-07-01 0000919956 stpr:WV avca:RoseTerraceNursingCenterMember 2014-07-01 0000919956 stpr:MO 2014-07-01 0000919956 2014-10-31 0000919956 avca:GreenvilleKentuckyMember us-gaap:SubsequentEventMember 2014-10-01 avca:Bed avca:Center avca:Entity avca:Facility avca:Lawsuit avca:Letter_Of_Credit avca:Option avca:State xbrli:pure xbrli:shares iso4217:USD iso4217:USD xbrli:shares 7863000 7177000 42067000 32658000 48516000 53288000 -569000 -468000 468000 19891000 19570000 5333000 3879000 228000 326000 137744000 131231000 57822000 50211000 2870000 390000 4500000 338000 7693000 15500000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">VARIABLE INTEREST ENTITY</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting guidance requires that a variable interest entity (&#8220;VIE&#8221;) must be consolidated by the primary beneficiary in accordance with the provisions set forth in FASB ASC 810, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidation</font><font style="font-family:inherit;font-size:10pt;">, as mentioned in Note 2 above. The primary beneficiary is the party that has both the power to direct activities of a VIE that most significantly impact the entity's economic performance and the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. We perform an ongoing qualitative analysis to determine if we are the primary beneficiary of a VIE. The Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> variable interest entity related to a nursing center in West Virginia that was dissolved in the first quarter of 2014 as a result of the asset purchase of the Rose Terrace nursing center, and is no longer consolidated into the interim consolidated financial statements of the Company. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Rose Terrace Health and Rehabilitation Center</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December&#160;28, 2011, the Company completed construction of Rose Terrace Health and Rehabilitation Center (&#8220;Rose Terrace&#8221;), its third health care center in West Virginia. The </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing center is located in Culloden, West Virginia, along the Huntington-Charleston corridor, and offers 24-hour skilled nursing care designed to meet the care needs of both short and long-term nursing patients. The Rose Terrace nursing center utilizes a Certificate of Need the Company obtained in June 2009, when the Company completed the acquisition of certain assets of a skilled nursing center in West Virginia. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company initially entered into a lease agreement with the real estate developer that constructed, furnished, and equipped Rose Terrace. The agreement included the right to purchase the center and all associated assets beginning at the end of the first year of the initial term of the lease and continuing through the fifth year for a purchase price ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">110%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">120%</font><font style="font-family:inherit;font-size:10pt;"> of the total project cost. On March 27, 2014, the Company exercised this purchase option and acquired the land, building, and all other assets of the Rose Terrace nursing center from the real estate developer for the contractually agreed upon price of </font><font style="font-family:inherit;font-size:10pt;">$7,693,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the exercise of the purchase option, the Company had determined it was the primary beneficiary of the VIE based on the ownership of the Certificate of Need, the fixed price purchase option described above, the Company&#8217;s ability to direct the activities that most significantly impact the economic performance of the VIE, and the right to receive potentially significant benefits from the VIE. Accordingly, as the primary beneficiary, the Company consolidated the balance sheet and results of operations of the VIE for periods prior to the exercise of the purchase option. However, after the exercise of the purchase option, the previous owners paid the outstanding debt related to the entity in full. Subsequently, as further disclosed in Note 11, the Company sold the Rose Terrace facility and all assets associated with the facility. As a result of these events, the entity is no longer considered a VIE.</font></div></div> 12127000 1200000 43000 2130000 758000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">CONSOLIDATION AND BASIS OF PRESENTATION OF FINANCIAL STATEMENTS</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim consolidated financial statements include the operations and accounts of Diversicare Healthcare Services and its subsidiaries, all wholly-owned. All significant intercompany accounts and transactions have been eliminated in consolidation. Any variable interest entities (&#8220;VIEs&#8221;) in which the Company has an interest are consolidated when the Company identifies that it is the primary beneficiary. The Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> variable interest entity related to a nursing center in West Virginia that was dissolved in the first quarter of 2014 as a result of the asset purchase of the Rose Terrace nursing center as further described in Note 8, and is no longer consolidated into the interim consolidated financial statements of the Company. The investment in an unconsolidated affiliate (a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">50 percent</font><font style="font-family:inherit;font-size:10pt;">-owned joint venture partnership) is accounted for using the equity method and is described in Note&#160;9.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim consolidated financial statements for the three and </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management of the Company, the accompanying interim consolidated financial statements reflect all normal, recurring adjustments necessary to present fairly the Company&#8217;s financial position at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, and the results of operations for the three month and nine month periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, and cash flows for the nine month periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">. The Company&#8217;s balance sheet information at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, was derived from its audited consolidated financial statements as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The results of operations for the periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the operating results that may be expected for a full year. These interim consolidated financial statements should be read in connection with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> 3855000 3781000 5928000 3416000 74000 -2512000 -150000 -5952000 -61000 1808000 5117000 -600000 0.055 0.055 0.165 0.165 0.01 0.01 20000000 20000000 6307000 6388000 6075000 6156000 63000 64000 4273000 -4817000 4330000 -7699000 4273000 -4800000 -7648000 4305000 73006000 54186000 152014000 200517000 89019000 67534000 246300000 191909000 0.0465 12728000 1341000 1914000 1839000 -467000 -4214000 7757000 6579000 12130000 15912000 1812000 1634000 4572000 5252000 755000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">STOCK-BASED COMPENSATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Overview of Plans</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2005, the Compensation Committee of the Board of Directors adopted the 2005 Long-Term Incentive Plan (&#8220;2005 Plan&#8221;). The 2005 Plan allows the Company to issue stock options and other share and cash based awards. Under the 2005 Plan, </font><font style="font-family:inherit;font-size:10pt;">700,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted thereunder. All grants under this plan expire </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years from the date the grants were authorized by the Board of Directors.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2008, the Company adopted the Advocat Inc. 2008 Stock Purchase Plan for Key Personnel (&#8220;Stock Purchase Plan&#8221;). The Stock Purchase Plan provides for the granting of rights to purchase shares of the Company's common stock to directors and officers and </font><font style="font-family:inherit;font-size:10pt;">150,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock has been reserved for issuance under the Stock Purchase Plan. The Stock Purchase Plan allows participants to elect to utilize a specified portion of base salary, annual cash bonus, or director compensation to purchase restricted shares or restricted share units (&#8220;RSU's&#8221;) at </font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the quoted market price of a share of the Company's common stock on the date of purchase. The restriction period under the Stock Purchase Plan is generally </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> years from the date of purchase and during which the shares will have the rights to receive dividends, however, the restricted share certificates will not be delivered to the shareholder and the shares cannot be sold, assigned or disposed of during the restriction period. No grants can be made under the Stock Purchase Plan after April 25, 2018. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2010, the Compensation Committee of the Board of Directors adopted the 2010 Long-Term Incentive Plan (&#8220;2010 Plan&#8221;), followed by approval by the Company's shareholders in June 2010. The 2010 Plan allows the Company to issue stock appreciation rights, stock options and other share and cash based awards. Under the 2010 Plan, </font><font style="font-family:inherit;font-size:10pt;">380,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Grants and Valuations</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Compensation Committee of the Board of Directors approved grants totaling approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">68,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">69,000</font><font style="font-family:inherit;font-size:10pt;"> shares of restricted common stock to certain employees and members of the Board of Directors, respectively. The fair value of restricted shares are determined as the quoted market price of the underlying common shares at the date of the grant. The restricted shares typically vest </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">33%</font><font style="font-family:inherit;font-size:10pt;"> on the first, second and third anniversaries of the grant date. Unvested shares may not be sold or transferred. During the vesting period, dividends accrue on the restricted shares, but are paid in additional shares of common stock upon vesting, subject to the vesting provisions of the underlying restricted shares. The restricted shares are entitled to the same voting rights as other common shares. Upon vesting, all restrictions are removed. In addition to the shares of restricted common stock granted in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Compensation Committee of the Board of Directors also approved grants of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">55,000</font><font style="font-family:inherit;font-size:10pt;"> unrestricted shares of common stock to certain employees. These shares were granted without restrictions and considered fully vested upon the date of the grant.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized activity of the equity compensation plans is presented below: </font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:474px;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="108px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="99px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired or cancelled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.87</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable, September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:474px;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="108px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="99px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(57,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:69.7265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="23%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, the Compensation Committee of the Board of Directors also approved grants of Stock Only Stock Appreciation Rights (&#8220;SOSARs&#8221;) and Stock Options at the market price of the Company's common stock on the grant date. The SOSARs and Options vest </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">33%</font><font style="font-family:inherit;font-size:10pt;"> on the first, second and third anniversaries of the grant date, and expire </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years from the grant date. The SOSARs and Options were valued and recorded in the same manner, and will be settled with issuance of new stock for the difference between the market price on the date of exercise and the exercise price. The Company estimated the total recognized and unrecognized compensation using the Black-Scholes-Merton equity grant valuation model.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In computing the fair value estimates using the Black-Scholes-Merton valuation model, the Company took into consideration the exercise price of the equity grants and the market price of the Company's stock on the date of grant. The Company used an expected volatility that equals the historical volatility over the most recent period equal to the expected life of the equity grants. The risk free interest rate is based on the U.S. treasury yield curve in effect at the time of grant. The Company used the expected dividend yield at the date of grant, reflecting the level of annual cash dividends currently being paid on its common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While no SOSARs or Options were granted during </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, previously granted SOSARs and Options remain outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. The following table summarizes information regarding stock options and SOSAR grants outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.28125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intrinsic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intrinsic</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Range of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value-Grants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value-Grants</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$10.40 to $11.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.37 to $6.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">994,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense is non-cash and is included as a component of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. The Company recorded total stock-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$441,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$809,000</font><font style="font-family:inherit;font-size:10pt;"> in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized activity of the equity compensation plans is presented below: </font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:474px;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="108px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="99px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired or cancelled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.87</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable, September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> 7522000 4513000 0 0 4513000 0.00 0.00 0.75 0.75 0.73 0.00 0.73 0.00 -585000 -2444000 -1875000 -1069000 1435000 384000 1101000 732000 0 -3009000 -3009000 0 -3009000 16500000 1251000 4000 600000 8987000 40161000 10988000 0 15944000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">DISCONTINUED OPERATIONS</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">West Virginia Disposition</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective April 3, 2014, the Company entered into an asset purchase agreement with Rose Terrace Acq., LLC (&#8220;Purchaser&#8221;) to sell its skilled nursing facility in Culloden, West Virginia. The original asset purchase agreement was subject to a number of conditions including an amendment to the Master Lease with Omega Health Investors, Inc. ("Omega") to terminate the lease only with respect to </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other skilled nursing facilities in West Virginia, state licensure and regulatory approval. The Company concurrently entered into an operations transfer agreement with respect to the </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other skilled nursing facilities located in Danville and Ivydale, West Virginia. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective July 1, 2014, the Company completed the transaction with Rose Terrace Acq., LLC to sell Rose Terrace, a </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility in Culloden, West Virginia for a sales price of </font><font style="font-family:inherit;font-size:10pt;">$16,500,000</font><font style="font-family:inherit;font-size:10pt;">. The Company also entered into the Fifteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") with Omega Health Investors, Inc. ("Omega") to terminate the lease only with respect to </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other skilled nursing facilities in West Virginia, and concurrently entered into an operations transfer agreement with American Health Care Management, LLC, an affiliate of the purchaser with respect to </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other skilled nursing facilities located in Danville and Ivydale, West Virginia. Upon completion of the transaction, Diversicare no longer operates any skilled nursing centers in the state of West Virginia. In conjunction with the closing of the sale, the Company paid the balance of the </font><font style="font-family:inherit;font-size:10pt;">$8,000,000</font><font style="font-family:inherit;font-size:10pt;"> mortgage loan outstanding on the Rose Terrace facility. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transaction resulted in a gain on the disposition of West Virginia which, along with the results of operations for these nursing facilities, is presented within Discontinued Operations on the Interim Consolidated Statements of Operations. The pretax gain on the transaction was </font><font style="font-family:inherit;font-size:10pt;">$7,522,000</font><font style="font-family:inherit;font-size:10pt;">. The tax expense associated with the gain was </font><font style="font-family:inherit;font-size:10pt;">$(3,009,000)</font><font style="font-family:inherit;font-size:10pt;"> for which the Company plans to apply net operating loss carryforwards from our deferred tax assets to substantially offset and minimize the cash outlay for this transaction.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These centers contributed revenues of </font><font style="font-family:inherit;font-size:10pt;">$10,988,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$15,944,000</font><font style="font-family:inherit;font-size:10pt;"> and net income of </font><font style="font-family:inherit;font-size:10pt;">$165,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$680,000</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.&#160; The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Arkansas Lease Termination</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective September 1, 2013, the Company entered into an agreement with Omega to terminate its lease with respect to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">eleven</font><font style="font-family:inherit;font-size:10pt;"> nursing centers and </font><font style="font-family:inherit;font-size:10pt;">1,181</font><font style="font-family:inherit;font-size:10pt;"> licensed beds located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those </font><font style="font-family:inherit;font-size:10pt;">eleven</font><font style="font-family:inherit;font-size:10pt;"> centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. In connection with the closing of this transaction, the Company and Omega entered into the Master Lease most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the </font><font style="font-family:inherit;font-size:10pt;">eleven</font><font style="font-family:inherit;font-size:10pt;"> nursing centers in Arkansas, and only as to those </font><font style="font-family:inherit;font-size:10pt;">eleven</font><font style="font-family:inherit;font-size:10pt;"> centers, and effectively reduces the annual rent payable under the Master Lease by </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">$5,000,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of this transaction, the Company has reclassified the operations of these centers as discontinued operations for all periods presented in the accompanying interim consolidated financial statements. These centers contributed revenues of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$40,161,000</font><font style="font-family:inherit;font-size:10pt;"> and net loss of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$935,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,432,000</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.&#160; The net loss in 2014 primarily relates to professional liability expense incurred during the first three quarters of 2014. The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The discontinued assets and liabilities of the disposed skilled nursing centers in Arkansas and West Virginia have been reclassified and are segregated in the interim consolidated balance sheets as assets and liabilities of discontinued operations. The current asset amounts, which are primarily composed of net accounts receivable of </font><font style="font-family:inherit;font-size:10pt;">$390,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,870,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. The current liabilities are primarily composed of trade payables and various accrued expenses of </font><font style="font-family:inherit;font-size:10pt;">$136,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,359,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. The Company expects to collect the balance of the accounts receivable and pay the remaining trade payables and accrued expenses in the ordinary course of business. The Company did not transfer the accounts receivable or liabilities to the new owners or operators of the facilities. Further, in accordance with Company accounting policy, the reserve for professional liability and workers' compensation will remain in the consolidated liability accounts as future payment of these liabilities will be paid through the Company's future operating cash flows.</font></div></div> 48000 86000 220000 258000 0.68 -0.83 0.66 -1.39 0.66 -0.83 0.65 -1.39 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">EARNINGS (LOSS) PER COMMON SHARE</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to basic and diluted net earnings (loss) per common share is presented below in thousands, except per share:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended <br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,321</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,016</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: income (loss) attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,338</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">784</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,067</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock dividends</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,424</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">564</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,325</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,928</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Diversicare Healthcare Services, Inc. common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,099</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended <br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per common share &#8211; basic</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.07</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss), net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on disposal, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.57</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share &#8211; basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.39</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per common share &#8211; diluted</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.07</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss), net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on disposal, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.56</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share - diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.39</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator: Weighted Average Common Shares Outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,020</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,892</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,878</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,892</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,171</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,878</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effects of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">228,000</font><font style="font-family:inherit;font-size:10pt;"> SOSARs and options outstanding were excluded from the computation of diluted earnings per common share for the three-month and </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;">-month periods ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">, because these securities would have been anti-dilutive due to the net loss. The weighted average common shares for basic and diluted earnings for common shares were the same due to the year-to-date loss in these periods.</font></div></div> 12255000 14200000 0.50 487000 399000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">EQUITY METHOD INVESTMENT</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The investment in unconsolidated affiliate reflected on the interim consolidated balance sheet relates to a pharmacy joint venture partnership in which the Company owns </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">50%</font><font style="font-family:inherit;font-size:10pt;">. The joint venture was initially funded by the Company and its partner and began operations during 2012. This investment in unconsolidated affiliate is accounted for using the equity method as the Company exerts significant influence, but does not control or otherwise consolidate the entity. The investment in unconsolidated affiliate balance at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$399,000</font><font style="font-family:inherit;font-size:10pt;"> as compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$487,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">. Additionally, the Company's share of the net profits and losses of the unconsolidated affiliate are reported in equity in net earnings or losses of unconsolidated affiliate in our statement of operations. The Company's equity in the net losses of unconsolidated affiliate for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> month period ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;">$89,000</font><font style="font-family:inherit;font-size:10pt;"> as compared to </font><font style="font-family:inherit;font-size:10pt;">$152,000</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> month period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> 8000000 0 -320000 5006000 5582000 15769000 16077000 90331000 64631000 250443000 184558000 -2321000 219000 759000 -6016000 -3695000 366000 -9963000 1297000 784000 -2338000 -6067000 219000 -0.41 0.03 -1.07 0.09 0.03 -0.41 0.09 -1.07 3928000 -2444000 -1875000 3444000 165000 -2432000 -935000 680000 3444000 -1875000 3928000 -2444000 -0.42 0.65 0.57 -0.32 -0.42 0.63 -0.32 0.56 63000 -30000 -89000 -152000 -1374000 147000 -3947000 538000 74000 66000 515000 763000 2565000 4131000 1124000 323000 5551000 13775000 3894000 -33000 815000 660000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">INSURANCE MATTERS</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Professional Liability and Other Liability Insurance</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, consolidated offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (&#8220;SHC&#8221;) which has issued a policy insuring claims made against all of the Company's nursing centers in Florida and Tennessee, the Company&#8217;s formerly operated Arkansas and West Virginia facilities, and several of the Company&#8217;s nursing centers in Alabama, Kentucky, Ohio, and Texas. The SHC policy provides coverage limits of either </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$500,000</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> per medical incident with a sublimit per center of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> and total annual aggregate policy limits of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5,000,000</font><font style="font-family:inherit;font-size:10pt;">. All other centers within the Company&#8217;s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers.&#160; These policies provide coverage limits of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> per claim and have sublimits of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3,000,000</font><font style="font-family:inherit;font-size:10pt;"> per center, with varying aggregate policy limits.&#160; </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reserve for Estimated Self-Insured Professional Liability Claims</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because the Company&#8217;s actual liability for existing and anticipated professional liability and general liability claims will likely exceed the Company&#8217;s limited insurance coverage, the Company has recorded total liabilities for reported and estimated future claims of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$26,377,000</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. This accrual includes estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of legal costs related to these claims. All losses are projected on an undiscounted basis and are presented without regard to any potential insurance recoveries. Amounts are added to the accrual for estimates of anticipated liability for claims incurred during each period, and amounts are deducted from the accrual for settlements paid on existing claims during each period.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of the current portion of this reserve. Merlinos&#160;&amp; Associates, Inc. (&#8220;Merlinos&#8221;) assisted management in the preparation of an estimate of the appropriate accrual for the current claims period and for incurred, but not reported, general and professional liability claims based on data furnished as of May 31, 2014.&#160; The Company used this estimate from Merlinos in the preparation of its estimate of liability for incurred, but unreported professional liability claims as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company&#8217;s insurers and a third-party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator&#8217;s estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company&#8217;s evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual decreases results of operations in the period and any reduction in the accrual increases results of operations during the period. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company is engaged in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">48</font><font style="font-family:inherit;font-size:10pt;"> professional liability lawsuits. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Seven</font><font style="font-family:inherit;font-size:10pt;"> lawsuits are currently scheduled for trial or arbitration during the next twelve months, and it is expected that additional cases will be set for trial or hearing. The Company&#8217;s cash expenditures for self-insured professional liability costs from continuing operations were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3,641,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3,005,000</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows current accounting guidance set forth in FASB ASU 2010-24, &#8220;Presentation of Insurance Claims and Related Insurance Recoveries,&#8221; that clarifies that a health care entity should not net insurance recoveries against a related professional liability claim, and that the amount of the claim liability should be determined without consideration of insurance recoveries. Accordingly, the Company has recorded assets and equal liabilities of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$217,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$440,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although the Company adjusts its accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company&#8217;s actual liability for claims incurred in any given period is a process that takes years. As a result, the Company&#8217;s actual liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company&#8217;s reported earnings and financial position for the period in which the change in accrual is made.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Insurance</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to workers&#8217; compensation insurance, substantially all of the Company&#8217;s employees became covered under either an indemnity insurance plan or state-sponsored programs in May 1997. The Company is completely self-insured for workers&#8217; compensation exposures prior to May 1997. The Company has been and remains a non-subscriber to the Texas workers&#8217; compensation system and is, therefore, completely self-insured for employee injuries with respect to its Texas operations. From June&#160;30, 2003 until June&#160;30, 2007, the Company&#8217;s workers&#8217; compensation insurance programs provided coverage for claims incurred with premium adjustments depending on incurred losses. For the period from July&#160;1, 2008 through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company is covered by a prefunded deductible policy. Under this policy, the Company is self-insured for the first </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$500,000</font><font style="font-family:inherit;font-size:10pt;"> per claim, subject to an aggregate maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3,000,000</font><font style="font-family:inherit;font-size:10pt;">. The Company funds a loss fund account with the insurer to pay for claims below the deductible. The Company accounts for premium expense under this policy based on its estimate of the level of claims subject to the policy deductibles expected to be incurred. The liability for workers&#8217; compensation claims is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$261,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. The Company has a non-current receivable for workers&#8217; compensation policies covering previous years of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,183,000</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. The non-current receivable is a function of payments paid to the Company&#8217;s insurance carrier in excess of the estimated level of claims expected to be incurred.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company is self-insured for health insurance benefits for certain employees and dependents for amounts up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$175,000</font><font style="font-family:inherit;font-size:10pt;"> per individual annually. The Company provides reserves for the settlement of outstanding self-insured health claims at amounts believed to be adequate. The liability for reported claims and estimates for incurred but unreported claims is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$899,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. The differences between actual settlements and reserves are included in expense in the period finalized.</font></div></div> 217000 440000 855000 916000 2140000 2757000 1854000 2496000 P5Y P5Y P5Y P5Y P5Y P15Y P15Y P10Y P15Y P15Y P10Y P14Y 131231000 137744000 42167000 47590000 81093000 72104000 136000 1359000 5952000 0 899000 27500000 20000000 20000000 65000000 6000000 7991000 3000000 42851000 43552000 7208000 4549000 0.0687 0.0687 0.045 0.045 5000000 500000 1000000 500000 26377000 947000 1743000 5360000 4212000 1437000 0 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">BUSINESS</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diversicare Healthcare Services, Inc. (together with its subsidiaries, &#8220;Diversicare Healthcare Services&#8221; or the &#8220;Company&#8221;) provides long-term care services to nursing center patients in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">nine</font><font style="font-family:inherit;font-size:10pt;"> states, primarily in the Southeast, Midwest, and Southwest. The Company&#8217;s centers provide a wide range of health care services to their patients and residents that include nursing, personal care, and social services. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company&#8217;s nursing centers also offer a variety of comprehensive rehabilitation services, as well as nutritional support services. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Missouri, Ohio, Tennessee, and Texas. The Company's operating results also include the results of certain discontinued operations that have been reclassified on the face of the financial statements to reflect the discontinued status of these operations. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s continuing operations consist of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">51</font><font style="font-family:inherit;font-size:10pt;"> skilled nursing and long-term care centers with </font><font style="font-family:inherit;font-size:10pt;">6,229</font><font style="font-family:inherit;font-size:10pt;"> licensed beds. The Company owns </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">13</font><font style="font-family:inherit;font-size:10pt;"> and leases </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">38</font><font style="font-family:inherit;font-size:10pt;"> of its nursing centers.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">BUSINESS DEVELOPMENT</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisitions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland &amp; Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> facilities, all located in Kansas, for an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$15,500,000</font><font style="font-family:inherit;font-size:10pt;">. The purchase of the Kansas facilities was completed on May 1, 2013. The Company also incurred </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$338,000</font><font style="font-family:inherit;font-size:10pt;"> in acquisition-related expenses associated with this transaction. The </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> facilities acquired under the Agreement include the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">77</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility known as Chanute HealthCare Center</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">119</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility known as Haysville HealthCare Center</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">80</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility known as Larned HealthCare Center</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">62</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility known as Sedgwick HealthCare Center</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-transform:default;">80</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility known as Council Grove HealthCare Center</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of the consummation of the Agreement, the Company allocated the purchase price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$15,500,000</font><font style="font-family:inherit;font-size:10pt;"> between the assets associated with the transaction based on the fair value of the acquired net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$758,000</font><font style="font-family:inherit;font-size:10pt;"> which resulted in total cash outlay of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14,742,000</font><font style="font-family:inherit;font-size:10pt;">. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:52.34375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="35%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of May 1, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,500,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,130,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,127,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture, fixtures, and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Liabilities assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash paid</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,742,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lease Agreements and Assumption of Operations</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 1, 2014, the Company completed a transaction to assume operations of </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> centers in Ohio. The centers included in this transaction are a </font><font style="font-family:inherit;font-size:10pt;">142</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility and a </font><font style="font-family:inherit;font-size:10pt;">42</font><font style="font-family:inherit;font-size:10pt;">-bed assisted living center. The lease provides for an initial lease term of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 1, 2014, the Company completed a transaction to enter the state of Missouri through the assumption of operations of three facilities totaling </font><font style="font-family:inherit;font-size:10pt;">339</font><font style="font-family:inherit;font-size:10pt;"> skilled nursing beds. The nursing centers are owned by a real estate investment trust ("REIT"), and the lease provides for an initial </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">-year lease term with a </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">-year renewal option. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 1, 2014, the Company assumed operations at Diversicare of Nicholasville, an existing </font><font style="font-family:inherit;font-size:10pt;">73</font><font style="font-family:inherit;font-size:10pt;">-bed facility in Nicholasville, Kentucky. The nursing center is owned by a real estate investment trust ("REIT"), and the lease provides for an initial </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">-year lease term with a </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 1, 2014, the Company assumed operations at Diversicare of Big Springs, an existing </font><font style="font-family:inherit;font-size:10pt;">135</font><font style="font-family:inherit;font-size:10pt;">-bed facility in Huntsville, Alabama. The nursing center is owned by an unrelated third-party and the lease provides for an initial </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">-year lease term with </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> additional </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">-year renewal options. The additional skilled nursing center increases the Company's footprint in Alabama to </font><font style="font-family:inherit;font-size:10pt;">seven</font><font style="font-family:inherit;font-size:10pt;"> centers, and the third center in the Huntsville market. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 1, 2013, the Company assumed operations at </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> existing nursing centers, </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> in Ohio and </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">-year lease term with a </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana. All </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 1, 2013, the Company assumed operations at Seneca Place, an existing </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">107</font><font style="font-family:inherit;font-size:10pt;">-bed facility in Louisville, Kentucky.&#160; The nursing center is owned by a REIT, and the lease provides for an initial </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">15</font><font style="font-family:inherit;font-size:10pt;">-year lease term with a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5</font><font style="font-family:inherit;font-size:10pt;">-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.</font></div></div> 18783000 -12194000 18933000 -6242000 -20937000 12180000 -22745000 12241000 88000 -358000 -5475000 688000 -4782000 4147000 4228000 -7942000 17000 0 -25000 51000 4099000 -4868000 -8200000 4008000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">RECENT ACCOUNTING GUIDANCE</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2013, the FASB issued Accounting Standards Update ("ASU") 2013-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income</font><font style="font-family:inherit;font-size:10pt;">. The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements. </font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the FASB issued ASU 2014-08,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity</font><font style="font-family:inherit;font-size:10pt;">&#160;changing the criteria for reporting discontinued operations. The ASU states that only those disposed components (or components held-for-sale) representing a strategic shift that have a significant effect on operations and financial results will be reported in discontinued operations. The ASU also required expanded disclosures about discontinued operations in the financial statement notes. The ASU is effective for disposals (or classifications as held-for-sale) that occur within annual periods beginning on or after December&#160;15, 2014 and interim periods within those annual periods. Early application is permitted, but only for those disposals that have not been reported in financial statements previously issued or available for issuance. We have chosen to early adopt this ASU and have applied the new criteria in determining the accounting treatment for the nursing centers exited during 2014. The adoption of this guidance did not have a material impact on the Company's consolidated financial results.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No.&#160;2014-09,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January&#160;1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.</font></div></div> -946000 -792000 -2846000 -2612000 9 1312000 -2903000 -7351000 4143000 6876000 4817000 14398000 19094000 28492000 33490000 -35000 126000 243000 102000 135000 128000 226000 376000 254000 100000 478000 469000 6024000 5116000 15214000 13875000 468000 182000 0 64000 4918000 0 993000 647000 258000 220000 1341000 180000 434000 448000 14742000 14742000 14742000 0 4228000 4109000 1411000 158000 0.10 0.1 200000 200000 0 0 0 0 0 0 2339000 2442000 16500000 0 50500000 16808000 28000 -30000 4147000 -4765000 -7891000 4203000 97605000 93572000 44917000 54043000 2785000 4235000 899000 1118000 14850000 28757000 0 944000 0 944000 -8435000 -5450000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to basic and diluted net earnings (loss) per common share is presented below in thousands, except per share:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended <br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,321</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">759</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,016</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: income (loss) attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,338</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">784</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,067</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock dividends</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,424</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">564</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,325</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from discontinued operations, net of income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,928</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) attributable to Diversicare Healthcare Services, Inc. common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,099</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended<br clear="none"/>September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended <br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per common share &#8211; basic</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.07</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss), net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on disposal, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.57</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share &#8211; basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.39</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per common share &#8211; diluted</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.07</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from discontinued operations</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss), net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on disposal, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.63</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.56</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share - diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.66</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.39</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator: Weighted Average Common Shares Outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,020</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,892</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,878</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,892</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,171</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,878</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The allocation for the net assets acquired is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:52.34375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="35%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of May 1, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,500,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,130,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,127,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture, fixtures, and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Liabilities assumed</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cash paid</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,742,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes information regarding stock options and SOSAR grants outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.28125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intrinsic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intrinsic</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Range of</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value-Grants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Value-Grants</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercise Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Prices</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$10.40 to $11.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.37 to $6.21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">218,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">994,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:474px;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="108px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="99px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(57,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:69.7265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="23%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding, December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend Equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> 12159000 11711000 15378000 16375000 809000 441000 2000 0 5.47 0.00 68000 25000 55000 68000 69000 5.51 5.51 118000 130000 46000 41000 3000 1000 57000 21000 5.61 5.70 150000 380000 700000 2.37 10.4 11.59 6.21 8129000 11537000 11537000 9566000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective October 1, 2014, the Company completed a transaction to assume operations of a </font><font style="font-family:inherit;font-size:10pt;">62</font><font style="font-family:inherit;font-size:10pt;">-bed skilled nursing facility in Greenville, Kentucky. This facility is expected to contribute in excess of </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> in annual revenues with initial lease terms of </font><font style="font-family:inherit;font-size:10pt;">14</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div></div> 0 4918000 5000 5000 5000 5000 5000 0 232000 232000 2500000 2500000 6248000 5892000 5878000 6171000 5892000 6020000 6004000 5878000 261000 320000 0 7940000 8228000 13 P5Y 175000 564000 -2424000 171000 -6325000 -0.42 -0.18 -0.32 -0.10 -0.17 -0.10 -0.42 -0.32 -88000 99000 1.20 1.10 5000000 11 11 0.03 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">LONG-TERM DEBT AND INTEREST RATE SWAP</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has agreements with a syndicate of banks for a mortgage term loan ("Original Mortgage Loan") and the Company&#8217;s revolving credit agreement ("Original Revolver"). On May 1, 2013, the Company executed an Amended and Restated Credit Agreement (the "Credit Agreement") which modified the terms of the Original Mortgage Loan and the Original Revolver Agreements dated February 28, 2011. The Credit Agreement increases the Company's borrowing capacity to </font><font style="font-family:inherit;font-size:10pt;">$65,000,000</font><font style="font-family:inherit;font-size:10pt;"> allocated between a </font><font style="font-family:inherit;font-size:10pt;">$45,000,000</font><font style="font-family:inherit;font-size:10pt;"> Mortgage Loan ("Amended Mortgage Loan") and a </font><font style="font-family:inherit;font-size:10pt;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;"> Revolver ("Amended Revolver"). Loan acquisition costs associated with the Amended Mortgage Loan and the Amended Revolver were capitalized in the amount of </font><font style="font-family:inherit;font-size:10pt;">$1,341,000</font><font style="font-family:inherit;font-size:10pt;"> and are being amortized over the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;">-year term of the agreements.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the terms of the amended agreements, the syndicate of banks provided the Amended Mortgage Loan with an original balance of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$45,000,000</font><font style="font-family:inherit;font-size:10pt;"> with a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;">-year maturity through April 30, 2018, and a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;"> Amended Revolver through April 30, 2018. The Amended Mortgage Loan has a term of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> years, with principal and interest payable monthly based on a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">25</font><font style="font-family:inherit;font-size:10pt;">-year amortization. Interest is based on LIBOR plus </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">4.5%</font><font style="font-family:inherit;font-size:10pt;">. A portion of the Amended Mortgage Loan is effectively fixed at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">6.87%</font><font style="font-family:inherit;font-size:10pt;"> pursuant to an interest rate swap with a notional amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$21,847,000</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the interest rate related to the Amended Mortgage Loan was </font><font style="font-family:inherit;font-size:10pt;">4.65%</font><font style="font-family:inherit;font-size:10pt;">. The Amended Mortgage Loan is secured by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">thirteen</font><font style="font-family:inherit;font-size:10pt;"> owned nursing centers, related equipment and a lien on the accounts receivable of these centers. The Amended Mortgage Loan and the Amended Revolver are cross-collateralized. The Company&#8217;s Amended Revolver has an interest rate of LIBOR plus </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">4.5%</font><font style="font-family:inherit;font-size:10pt;"> and is secured by accounts receivable and is subject to limits on the maximum amount of loans that can be outstanding under the revolver based on borrowing base restrictions. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective March 31, 2014, the Company entered into the Second Amendment to the Amended and Restated Revolver ("Second Amendment"). The Second Amendment temporarily increased the Amended Revolver capacity from the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;"> in the original Amended Revolver to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$27,500,000</font><font style="font-family:inherit;font-size:10pt;"> through September 30, 2014, as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process. Effective July 1, 2014, the Company entered into the Third Amendment to the Amended and Restated Revolver ("Third Amendment"). The Third Amendment makes the previously temporary increase to the Amended Revolver capacity from the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20,000,000</font><font style="font-family:inherit;font-size:10pt;"> in the original Amended Revolver to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$27,500,000</font><font style="font-family:inherit;font-size:10pt;">, a permanent change to the borrowing capacity as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$6,000,000</font><font style="font-family:inherit;font-size:10pt;"> borrowings outstanding under the revolving credit facility compared to </font><font style="font-family:inherit;font-size:10pt;">$3,000,000</font><font style="font-family:inherit;font-size:10pt;"> outstanding as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">. The outstanding borrowings on the revolver primarily reflect the Company's approach to accumulated Medicaid and Medicare receivables at recently acquired facilities as these facilities proceed through the change in ownership process with CMS. Annual fees for letters of credit issued under this Revolver are </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3.00%</font><font style="font-family:inherit;font-size:10pt;"> of the amount outstanding. The Company has </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;"> letters of credit with a total value of </font><font style="font-family:inherit;font-size:10pt;">$7,991,000</font><font style="font-family:inherit;font-size:10pt;"> outstanding as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. Considering the balance of eligible accounts receivable, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$27,500,000</font><font style="font-family:inherit;font-size:10pt;">, the balance available for borrowing under the revolving credit center is </font><font style="font-family:inherit;font-size:10pt;">$12,728,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective March 27, 2014, the Company executed its purchase option to acquire all assets associated with the Rose Terrace nursing center in Culloden, West Virginia from Milton Holdings, LLC which was considered a variable interest entity ("VIE") by the Company and consolidated prior to the date of this transaction. See Note 8 for further information on the VIE considerations. In conjunction with the purchase of the assets, the Company entered into an interest-only </font><font style="font-family:inherit;font-size:10pt;">$8,000,000</font><font style="font-family:inherit;font-size:10pt;"> term loan ("Rose Terrace Note") with a maturity date of March 27, 2015. The structure of the Rose Terrace Note reflected the Company's intent to sell the property and transfer operations to an unrelated third-party operator as further disclosed in Note 11. This transaction closed on July 1, 2014, at which time the Rose Terrace Note was paid in full. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s debt agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. The Company is in compliance with all such covenants at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Swap Transaction</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The Company designated its interest rate swap as a cash flow hedge and the earnings component of the hedge, net of taxes, is reflected as a component of other comprehensive income (loss). In conjunction with the amendment to the credit facility, the Company retained the previously agreed upon interest rate swap terms, and redesignated the interest rate swap as a cash flow hedge. The interest rate swap agreement requires the Company to make fixed rate payments to the bank calculated on the applicable notional amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$21,847,000</font><font style="font-family:inherit;font-size:10pt;"> at an annual fixed rate of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">6.87%</font><font style="font-family:inherit;font-size:10pt;"> while the bank is obligated to make payments to the Company based on LIBOR on the same notional amounts. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assesses the effectiveness of its interest rate swap on a quarterly basis, and at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the Company determined that the interest rate swap was effective. The interest rate swap valuation model indicated a net liability of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$755,000</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">. The fair value of the interest rate swap is included in &#8220;other noncurrent liabilities&#8221; on the Company&#8217;s interim consolidated balance sheet. The balance of accumulated other comprehensive loss at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;"> is </font><font style="font-family:inherit;font-size:10pt;">$468,000</font><font style="font-family:inherit;font-size:10pt;"> and reflects the liability related to the interest rate swap, net of the income tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$287,000</font><font style="font-family:inherit;font-size:10pt;">. As the Company&#8217;s interest rate swap is not traded on a market exchange, the fair value is determined using a valuation based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy, in accordance with the FASB guidance set forth in ASC 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> P5Y 45000000 45000000 3000000 1000000 3000000 3005000 3641000 2 P25Y -287000 6229 90 135 80 142 107 77 80 119 339 62 73 42 1181 90 62 51 4 2 7 5 1 3 2 2 2 38 13 7 48 1 10 5698000 6180000 0.10 0.1 1000 994000 244000 6.77 22000 36000 7.87 0 1000 1145000 275000 333000 6.64 6.65 5.49 11.11 5.41 5.43 5.30 5.35 0.85 0.33 4.54 0.00 P10Y 244000 57000 187000 275000 57000 218000 7.72 6.86 P2Y 1183000 false --12-31 Q3 2014 2014-09-30 10-Q 0000919956 6156332 Smaller Reporting Company Diversicare Healthcare Services, Inc. 21847000 EX-101.SCH 6 avca-20140930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2101100 - Disclosure - Business link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Business (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Business Development link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Business Development (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Business Development (Schedule of Assets Acquired) (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Business Development (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Consolidation and Basis of Presentation of Financial Statements link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Consolidation and Basis of Presentation of Financial Statements (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 2411401 - Disclosure - Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Earnings (Loss) Per Common Share link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Earnings (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Earnings (Loss) Per Common Share (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Earnings (Loss) Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Equity Method Investment link:presentationLink link:calculationLink link:definitionLink 2409401 - Disclosure - Equity Method Investment (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Insurance Matters link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Insurance Matters (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Interim Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Interim Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Interim Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Interim Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Interim Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - Interim Consolidated Statements of Operations (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Long-Term Debt and Interest Rate Swap link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Long-Term Debt and Interest Rate Swap (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Recent Accounting Guidance link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Share-Based Compensation (Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable) (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Stock-Based Compensation (Restricted Stock and Restricted Stock Units Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Stock-Based Compensation (Schedule of Stock Options Outstanding and Exercisable) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Variable Interest Entity link:presentationLink link:calculationLink link:definitionLink 2408401 - Disclosure - Variable Interest Entity (Details Textual) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 avca-20140930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 avca-20140930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 avca-20140930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Accounting Changes and Error Corrections [Abstract] RECENT ACCOUNTING GUIDANCE New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Statement of Financial Position [Abstract] Allowance for doubtful accounts receivable Allowance for Doubtful Accounts Receivable, Current Redeemable preferred stock, par value (dollars per share) Redeemable Preferred Stock Par or Stated Value Per Share Redeemable preferred stock, par value. Redeemable preferred stock, shares authorized (shares) Temporary Equity, Shares Authorized Redeemable preferred stock, shares issued (shares) Temporary Equity, Shares Issued Redeemable preferred stock, shares outstanding (shares) Temporary Equity, Shares Outstanding Preferred stock, par value (dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common stock, par value (dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (shares) Common Stock, Shares Authorized Common stock, shares issued (shares) Common Stock, Shares, Issued Common stock, shares outstanding (shares) Common Stock, Shares, Outstanding Treasury stock, shares (shares) Treasury Stock, Shares Earnings Per Share [Abstract] EARNINGS (LOSS) PER COMMON SHARE Earnings Per Share [Text Block] CONSOLIDATION AND BASIS OF PRESENTATION OF FINANCIAL STATEMENTS Business Description and Basis of Presentation [Text Block] Insurance [Abstract] Schedule of Malpractice Insurance [Table] Schedule of Malpractice Insurance [Table] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] SHC Risk Carriers, Inc SHC Risk Carriers, Inc [Member] SHC Risk Carriers, Inc [Member] Unaffiliated Entities Unaffiliated Entities [Member] Unaffiliated Entities [Member] Insurance Type and Tier Identifier [Axis] Insurance Type and Tier Identifier [Axis] Type and Tier Identifier [Domain] Type and Tier Identifier [Domain] Professional malpractice liability insurance Professional Malpractice Liability Insurance [Member] Prefunded deductible policy Prefunded Deductible Policy [Member] Prefunded deductible policy. Trial or Arbitration Schedule Timeframe [Axis] Trial Or Arbitration Schedule Timeframe [Axis] Trial Or Arbitration Schedule Timeframe [Axis] Trial or Arbitration Schedule Timeframe [Domain] Scheduled For Trial Or Arbitration Over Next Twelve Months [Domain] Scheduled For Trial Or Arbitration Over Next Twelve Months Scheduled for trial or arbitration over next 12 months Trial Or Arbitration Schedule Timeframe [Member] Trial Or Arbitration Schedule Timeframe [Member] Malpractice Insurance [Line Items] Malpractice Insurance [Line Items] Insurance policy coverage limits per claim Malpractice Insurance, Maximum Coverage Per Incident Annual sublimit per center Malpractice Insurance Annual Sublimit Per Center Malpractice Insurance Annual Sublimit Per Center Maximum annual coverage Malpractice Insurance, Annual Coverage Limit Liability for reported and estimated future claims Malpractice Loss Contingency, Accrual, Undiscounted Number of professional liability lawsuits Number Of Professional Liability Lawsuits Number Of Professional Liability Lawsuits Cash expenditures for self-insured professional liability costs Malpractice Insurance Self Insured Costs Paid During Period Malpractice Insurance Self Insured Costs Paid During Period Non-current receivables for workers' compensation policy Insurance Receivable for Malpractice Other Insurance Industry Disclosures [Abstract] Other Insurance Industry Disclosures [Abstract] Professional liability insurance, annual coverage limit per facility Malpractice Insurance Annual Coverage Limit Per Facility Malpractice Insurance Annual Coverage Limit Per Facility Liability for workers compensation claims Workers' Compensation Liability Workers compensation insurance, non current receivable for excess premiums paid Workers Compensation Receivable For Excess Premiums Paid Workers Compensation Receivable For Excess Premiums Paid Health insurance, maximum self-insured annual amount per individual Employee Health Insurance Maximum Payable Per Individual Annually Employee Health Insurance Maximum Payable Per Individual Annually Liability for reported claims and estimates for incurred but unreported claims Liability for Future Policy Benefits Subsequent Events [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Earnings (Loss) Per Common Share (Textual) [Abstract] Earnings Loss Per Common Share (Textual) [Abstract] Earnings loss per common share. Antidilutive shares excluded from computation of diluted earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Stock Options and Stock Appreciation Rights (SARs) Stock Options and Stock Appreciation Rights (SARs) [Member] Stock Options and Stock Appreciation Rights (SARs) [Member] Exercise Price Range [Axis] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] $10.40 to $11.59 Stock Options Exercise Price Range One [Member] Stock Options Exercise Price Range One [Member] $2.37 to $6.21 Stock Options Exercise Price Range Two [Member] Stock Options Exercise Price Range Two [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Range of Exercise Prices, Maximum Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Range of Exercise Prices, Maximum Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Weighted Average Exercise Prices Share Based Compensation Arrangement By Share Based Payment Award Awards Outstanding Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Awards Outstanding Weighted Average Exercise Price Grants Outstanding Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Awards Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Awards Intrinsic Value-Grants Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Awards, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Awards, Outstanding, Intrinsic Value Grants Exercisable Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Awards Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Awards Intrinsic Value- Grants Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Awards, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Awards, Exercisable, Intrinsic Value Per common share – basic and diluted Earnings Per Share, Basic and Diluted [Abstract] Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders: Income Amounts Attributable to Parent, Disclosures [Abstract] Income (loss) from continuing operations Income (Loss) from Continuing Operations Attributable to Parent Less: (income) loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest PREFERRED STOCK DIVIDENDS Dividends, Preferred Stock Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders Income (Loss) from Continuing Operations Attributable to parent Shareholders income loss from continuing operations attributable to parent shareholders. Income (loss) from discontinued operations, net of income taxes Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS Net Income (Loss) Available to Common Stockholders, Basic Per common share – basic Earnings Per Share, Basic [Abstract] Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Income (loss) from discontinued operations, Operating income (loss), net of taxes (in dollars per share) Income Loss from Discontinued Operations Operating Income Loss Net of Taxes Basic Income (loss) from discontinued operations Operating income (loss), net of taxes, basic. Gain on disposal, net of taxes (in dollars per share) Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Per Basic Share Discontinued operations, net of taxes (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Net income (loss) (in dollars per share) Earnings Per Share, Basic Per common share – diluted Earnings Per Share, Diluted [Abstract] Income (loss) from continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Income (loss) from discontinued operations, Operating income (loss), net of taxes (in dollars per share) Income Loss from Discontinued Operations Operating Income Loss Net of Taxes Diluted Income (loss) from discontinued operations Operating income (loss), net of taxes, diluted. Discontinued operations, net of taxes (in dollars per share) Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Per Diluted Share Discontinued operations, net of taxes (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Net income (loss) (in dollars per share) Earnings Per Share, Diluted Denominator: Weighted Average Common Shares Outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic ( in shares) Weighted Average Number of Shares Outstanding, Basic Diluted (shares) Weighted Average Number of Shares Outstanding, Diluted BUSINESS DEVELOPMENT Nature of Operations [Text Block] Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Equity Method Investments and Joint Ventures [Abstract] EQUITY METHOD INVESTMENT Equity Method Investments and Joint Ventures Disclosure [Text Block] Business Combinations [Abstract] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Entity by Location [Axis] Entity by Location [Axis] Location [Domain] Location [Domain] Culloden, WV Culloden West Virginia [Member] Culloden West Virginia [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Rose Terrace Nursing Center Rose Terrace Nursing Center [Member] Rose Terrace Nursing Center [Member] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Variable Interest Entity, Not Primary Beneficiary [Abstract] Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract] Number of variable interest entity Number of Variable Interest Entities Number of variable interest entities. Number of licensed nursing beds Number of Licensed Nursing Beds Number of licensed nursing beds. Agreement provides company right to purchase Lease Agreement Provides Company Right to Purchase Lease agreement provides company right to purchase. Purchase Price Business Combination, Consideration Transferred Number of states in which entity operates Number of States in which Entity Operates Number of nursing centers Number Of Nursing Center Facilities Number Of Nursing Center Facilities Number of nursing center facilities owned Number Of Nursing Center Facilities Owned Number Of Nursing Center Facilities Owned Number of nursing center facilities leased Number Of Nursing Center Facilities Leased Number Of Nursing Center Facilities Leased Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Discontinued operations Income (loss) from continuing operations Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Provision for doubtful accounts Provision for Doubtful Accounts Deferred income tax benefit Deferred Income Tax Expense (Benefit) Provision for self-insured professional liability, net of cash payments Increase (Decrease) in Self Insurance Reserve Stock-based compensation Share-based Compensation Equity in net losses of unconsolidated affiliate, net of investment Income (Loss) from Equity Method Investments, Net of Contributions Paid Income (Loss) from Equity Method Investments, Net of Contributions Paid Debt retirement costs Gains (Losses) on Extinguishment of Debt Other Other Noncash Income (Expense) Changes in assets and liabilities affecting operating activities: Increase (Decrease) in Operating Capital [Abstract] Receivables, net Increase (Decrease) in Receivables Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Trade accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Net cash provided by (used in) continuing operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations Discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Acquisition of property and equipment through business combination Payments to Acquire Businesses, Net of Cash Acquired Change in restricted cash Increase (Decrease) in Restricted Cash Proceeds from sale of discontinued operations Proceeds from Divestiture of Businesses Deposits and other deferred balances Payments for (Proceeds from) Other Investing Activities Net cash provided by (used in) continuing operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Discontinued operations Cash Provided by (Used in) Investing Activities, Discontinued Operations Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Repayment of debt obligations Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities Proceeds from issuance of debt Proceeds from Issuance of Long-term Debt and Capital Securities, Net Financing costs Payments of Financing Costs Issuance and redemption of employee equity awards Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Redemption of preferred stock Payments for Repurchase of Redeemable Preferred Stock Payment of common stock dividends Payments of Ordinary Dividends, Common Stock Payment of preferred stock dividends Payments of Ordinary Dividends, Preferred Stock and Preference Stock Distributions to noncontrolling interest Payments to Noncontrolling Interests Payment for preferred stock restructuring Payments of Stock Issuance Costs Net cash provided by (used in) continuing operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Discontinued operations Cash Provided by (Used in) Financing Activities, Discontinued Operations Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Financing Activities NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) CASH AND CASH EQUIVALENTS, beginning of period Cash and Cash Equivalents, at Carrying Value CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL INFORMATION: Supplemental Cash Flow Information [Abstract] Cash payments of interest, net of amounts capitalized Interest Paid, Net Cash payments of income taxes Income Taxes Paid, Net STOCK-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] VARIABLE INTEREST ENTITY Business Combination Disclosure [Text Block] Discontinued Operations and Disposal Groups [Abstract] DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Entity Location [Table] Entity Location [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Kansas KANSAS Ohio OHIO Missouri MISSOURI Nicholasville, Kentucky Nicholasville, Kentucky [Member] Nicholasville, Kentucky [Member] Indiana INDIANA Louisville, KY Louisville Kentucky [Member] Louisville Kentucky [Member] Skilled Nursing Facility Name [Axis] Skilled Nursing Facility Name [Axis] Skilled Nursing Facility Name [Axis] Skilled Nursing Facility Name [Domain] Skilled Nursing Facility Name [Domain] [Domain] for Skilled Nursing Facility Name [Axis] Chanute HealthCare Center Chanute HealthCare Center [Member] Chanute HealthCare Center [Member] Haysville HealthCare Center Haysville HealthCare Center [Member] Haysville HealthCare Center [Member] Larned HealthCare Center Larned HealthCare Center [Member] Larned HealthCare Center [Member] Sedgwick HealthCare Center Sedgwick HealthCare Center [Member] Sedgwick HealthCare Center [Member] Council Grove HealthCare Center Council Grove HealthCare Center [Member] Council Grove HealthCare Center [Member] Skilled Nursing Center Skilled Nursing Center [Member] Skilled Nursing Center [Member] Avon Place Avon Place [Member] Avon Place [Member] Ontario Commons Ontario Commons [Member] Ontario Commons [Member] Huntsville, Alabama Huntsville, Alabama [Member] Huntsville, Alabama [Member] Entity Location [Line Items] Entity Location [Line Items] Acquisition-related expenses Business Combination, Acquisition Related Costs Less: Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Total cash outlay Payments to Acquire Businesses, Gross Lease agreement term Lessee Leasing Arrangements, Operating Leases, Term of Contract Lease renewal period Lessee Leasing Arrangements, Operating Leases, Renewal Term Maximum number of capital lease renewal periods Maximum Number Of Lease Renewal Periods Maximum Number Of Lease Renewal Periods Consolidation and Basis of Presentation of Financial Statements (Textual) [Abstract] Consolidation and Basis of Presentation of Financial Statements (Textual) [Abstract] Consolidation and basis of presentation of financial statements. Percentage of owned joint venture Investment in nonconsolidated affiliate Equity Method Investment, Ownership Percentage Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding, December 31, 2013 Share Based Compensation Arrangement By Share Based Payment Award Awards Outstanding Number Share Based Compensation Arrangement By Share Based Payment Award Awards Outstanding Number Granted Share-based Compensation Arrangement by Share-based Payment Award, Awards, Grants in Period, Gross Share-based Compensation Arrangement by Share-based Payment Award, Awards, Grants in Period, Gross Exercised Share-based Compensation Arrangement By Share Based Payment Award Awards Exercises In Period Share-based Compensation Arrangement By Share Based Payment Award Awards Exercises In Period Expired or cancelled Share Based Compensation Arrangement By Share Based Payment Award Awards Forfeitures And Expirations In Period Share Based Compensation Arrangement By Share Based Payment Award Awards Forfeitures And Expirations In Period Outstanding, September 30, 2014 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding, December 31, 2013 Granted Share Based Compensation Arrangements By Share Based Payment Award Awards Grants In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Awards Grants In Period Weighted Average Exercise Price Exercised Share Based Compensation Arrangements By Share Based Payment Award Awards Exercises In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Awards Exercises In Period Weighted Average Exercise Price Expired or cancelled Share Based Compensation Arrangement By Share Based Payment Award Awards Forfeitures And Expirations In Period Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Awards Forfeitures And Expirations In Period Weighted Average Exercise Price Outstanding, September 30, 2014 Exercisable, shares Share Based Compensation Arrangement By Share Based Payment Award Awards Exercisable Number Share Based Compensation Arrangement By Share Based Payment Award Awards Exercisable Number Exercisable, Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Awards Exercisable Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Awards Exercisable Weighted Average Exercise Price INSURANCE MATTERS Insurance Disclosure [Text Block] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Employee Stock Employee Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Outstanding, December 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Dividend Equivalents Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Outstanding September 30, 2014 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Outstanding, December 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted-Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted-Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Dividend Equivalents Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Dividend Equivalents, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Dividend Equivalents, Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Outstanding September 30, 2014 Basic and diluted net income (loss) per common share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Debt Disclosure [Abstract] LONG-TERM DEBT AND INTEREST RATE SWAP Long Term Debt And Derivative Instruments [Text Block] Long Term Debt And Derivative Instruments [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Business Acquisition [Line Items] Land Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Buildings Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings Furniture, fixtures, and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Total cash paid Income Statement [Abstract] PATIENT REVENUES, net Health Care Organization, Revenue Net of Patient Service Revenue Provisions EXPENSES: Costs and Expenses [Abstract] Operating Cost of Services Lease and rent expense Operating Leases, Rent Expense, Net Professional liability Malpractice Loss Contingency, Premium Costs General and administrative General and Administrative Expense Restructuring Restructuring Charges Total expenses Costs and Expenses OPERATING INCOME (LOSS) Operating Income (Loss) OTHER INCOME (EXPENSE): Nonoperating Income (Expense) [Abstract] Equity in net income (loss) of unconsolidated affiliate Income (Loss) from Equity Method Investments Interest expense, net Interest Expense Debt retirement costs Write off of Deferred Debt Issuance Cost Total other expense Nonoperating Income (Expense) INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest BENEFIT (PROVISION) FOR INCOME TAXES Income Tax Expense (Benefit) INCOME (LOSS) FROM DISCONTINUED OPERATIONS: Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent [Abstract] Operating loss, net of tax Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Gain on disposal, net of tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Income (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest NET INCOME (LOSS) NET INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC. Net Income (Loss) Attributable to Parent Discontinued operations (in dollars per share) Continuing operations (in dollars per share) Discontinued operations (in dollars per share) COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK Common Stock, Dividends, Per Share, Declared WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: CURRENT ASSETS: Assets, Current [Abstract] Cash and cash equivalents Receivables, less allowance for doubtful accounts of $5,333 and $3,879, respectively Accounts Receivable, Net, Current Other receivables Receivables, Net, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Income tax refundable Income Taxes Receivable, Current Current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Current Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Current Total current assets Assets, Current PROPERTY AND EQUIPMENT, at cost Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Discontinued operations, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Property and equipment, net Property, Plant and Equipment, Net OTHER ASSETS: Other Assets, Noncurrent [Abstract] Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred financing and other costs, net Deferred Costs Investment in unconsolidated affiliate Equity Method Investments Other noncurrent assets Other Noncurrent Assets Other assets. Acquired leasehold interest, net Acquired Leasehold Interest, Net Noncurrent Acquired leasehold interest, net. Noncurrent assets of discontinued operations Disposal Group, Including Discontinued Operation, Long Lived Assets, Noncurrent Total other assets Other Assets, Noncurrent Total assets Assets CURRENT LIABILITIES: Liabilities, Current [Abstract] Current portion of long-term debt and capitalized lease obligations Long-term Debt and Capital Lease Obligations, Current Trade accounts payable Accounts Payable, Trade, Current Current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Accrued expenses: Accrued Liabilities, Current [Abstract] Payroll and employee benefits Employee-related Liabilities, Current Self-insurance reserves, current portion Self Insurance Reserve, Current Other current liabilities Other Liabilities, Current Total current liabilities Liabilities, Current NONCURRENT LIABILITIES: Liabilities, Noncurrent [Abstract] Long-term debt and capitalized lease obligations, less current portion Long-term Debt and Capital Lease Obligations Self-insurance reserves, noncurrent portion Self Insurance Reserve, Noncurrent Noncurrent liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent Other noncurrent liabilities Other Liabilities, Noncurrent Total noncurrent liabilities Liabilities, Noncurrent COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Series C redeemable preferred stock, $.10 par value, 5,000 shares authorized and issued, and 0 shares outstanding Temporary Equity, Carrying Amount, Attributable to Parent SHAREHOLDERS’ EQUITY: Stockholders' Equity Attributable to Parent [Abstract] Series A preferred stock, authorized 200,000 shares, $.10 par value, none issued and outstanding Preferred Stock, Value, Issued Common stock, authorized 20,000,000 shares, $.01 par value, 6,388,000 and 6,307,000 shares issued, and 6,156,000 and 6,075,000 shares outstanding, respectively Common Stock, Value, Issued Treasury stock at cost, 232,000 shares of common stock Treasury Stock, Value Paid-in capital Additional Paid in Capital, Common Stock Accumulated deficit Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total shareholders’ equity of Diversicare Healthcare Services, Inc. Stockholders' Equity Attributable to Parent Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Total shareholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholder's equity Liabilities and Equity Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2005 Long Term Incentive Plan Two Thousand And Five Long Term Incentive Plan [Member] Two Thousand And Five Long Term Incentive Plan [Member] 2008 Stock Purchase Plan Two Thousand And Eight Stock Purchase Plan [Member] Two Thousand And Eight Stock Purchase Plan [Member] 2010 Long Term Incentive Plan Two Thousand And Ten Long Term Incentive Plan [Member] Two Thousand And Ten Long Term Incentive Plan [Member] Stock Only Stock Appreciation Rights (SOSARS) Stock Appreciation Rights (SARs) [Member] Restricted Stock Restricted Stock [Member] Stock Compensation Plan Stock Compensation Plan [Member] Number of shares reserved for future issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Expiration period Share Based Compensation Arrangements By Share Based Payment Award Option Expiration Period Share Based Compensation Arrangements By Share Based Payment Award Option Expiration Period Percentage of quoted market price offering rate Share Based Compensation Arrangement By Share Based Payment Award Market Price Offering Date Share Based Compensation Arrangement By Share Based Payment Award Market Price Offering Date Restriction period Stock Based Compensation Arrangement By Share Based Payment Award Restriction Period Stock Based Compensation Arrangement By Share Based Payment Award Restriction Period Grant of restricted common stock (shares) Vest of restricted stock on each year (percentage) Share-based Compensation Arrangement by Share-based Payment Award, Vesting Percentage Share-based Compensation Arrangement by Share-based Payment Award, Vesting Percentage Line of Credit Facility [Table] Line of Credit Facility [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Revolving credit facility Revolving Credit Facility [Member] Loans Payable Loans Payable [Member] Letter of Credit Letter of Credit [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Credit Agreement Credit Agreement [Member] Credit Agreement [Member] Revolving Credit Facility Interest at 4.5% Percent Above LIBOR Revolving Credit Facility Interest At Four Point Five Percent Above LIBOR [Member] Revolving Credit Facility Interest At Four Point Five Percent Above LIBOR [Member] Rose Terrace Note Rose Terrace Note [Member] Rose Terrace Note [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] LIBOR London Interbank Offered Rate [Member] London interbank offered rate. Interest rate swap Interest Rate Swap [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Groups, Including Discontinued Operations, Name [Domain] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Long-Term Debt and Interest Rate Swap (Textual) [Abstract] Long-Term Debt and Interest Rate Swap (Textual) [Abstract] Long-term debt and interest rate swap. Revolving credit facility and the maximum loan Line of Credit Facility, Maximum Borrowing Capacity Long-term debt for syndicate of banks mortgage debt Long-Term Debt for Syndicate of Banks Mortgage Debt Long-term debt for syndicate of banks mortgage debt . Long-term debt revolving credit facility Long-term Line of Credit Loan acquisition costs Debt Issuance Cost Term of debt agreement Debt Instrument, Term of Debt Agreement Debt Instrument, Term of Debt Agreement Long-term debt five year maturity Long Term Debt Five Year Maturity Long-term debt five year maturity. Mortgage loan with principal and interest payable monthly based Mortgage Loan With Principal and Interest Payable Monthly Based Mortgage loan with principal and interest payable monthly based. Long-term debt interest based on LIBOR Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate Long-term debt fixed based on the interest rate swap Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate Notional Amount of interest rate derivatives Derivative, Notional Amount Debt interest rate at period end Debt Instrument, Interest Rate, Effective Percentage Number of owned nursing centers secured Debt Instrument Collateral Number Of Owned Nursing Centers Debt Instrument Collateral Number Of Owned Nursing Centers Borrowings outstanding Long-term Debt Letters of credit issued under Revolver outstanding Letters of Credit Issued Under Revolver Outstanding Letters of credit issued under this revolver outstanding. Number of letters of credit Number of Letters of Credit Number of Letters of Credit Borrowing under the revolving credit facility Debt Instrument, Unused Borrowing Capacity, Amount Mortgage loan outstanding Extinguishment of Debt, Amount Liability at fair value Derivative Liability, Fair Value, Gross Liability Accumulated other comprehensive loss Net income tax benefit Net Income Tax Benefit Net income tax benefit. Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Greenville, Kentucky Greenville, Kentucky [Member] Greenville, Kentucky [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Expected annual revenues of operations assumed Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table] West Virginia WEST VIRGINIA Danville and Ivydale, West Virginia Danville and Ivydale, West Virginia [Member] Danville and Ivydale, West Virginia [Member] Omega Healthcare Investors, Inc. Omega Healthcare Investors, Inc. [Member] Omega Healthcare Investors, Inc. [Member] Arkansas ARKANSAS Leased Skilled Nursing Centers Leased Skilled Nursing Centers [Member] Leased Skilled Nursing Centers [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Sales price Disposal Group, Including Discontinued Operation, Consideration Payment of balance of mortgage loan outstanding Pretax gain on the transaction Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Gain on disposal, tax benefit (provision) Discontinued Operation, Tax Effect of Income (Loss) from Disposal of Discontinued Operation Revenue from discontinued operations Disposal Group, Including Discontinued Operation, Revenue Income (loss) from discontinued operations Number of nursing centers under lease terminated Lease Termination, Number of Nursing Centers under Lease Terminated Lease Termination, Number of Nursing Centers under Lease Terminated Annual decrease in rent payable, amount Lease Termination, Annual Decrease in Rent Payable, Amount Lease Termination, Annual Decrease in Rent Payable, Amount BUSINESS Operating income (loss), tax benefit (provision) Discontinued Operation, Tax Effect of Discontinued Operation Statement of Comprehensive Income [Abstract] NET INCOME (LOSS) OTHER COMPREHENSIVE INCOME (LOSS): Other Comprehensive Income (Loss), Net of Tax [Abstract] Change in fair value of cash flow hedge, net of tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Less: reclassification adjustment for amounts recognized in net income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Total other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax COMPREHENSIVE INCOME (LOSS) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: comprehensive (income) loss attributable to noncontrolling interest COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document and Entity Information [Abstract] Document and entity information. Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding EX-101.PRE 10 avca-20140930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#FQ),IZ@$``%48```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=%.VS`8A>^1]@Z1;Z?& MM3T8FYIRL;%+0((]@!?_;:(FMF4;:-\>)P6$4%=4K=+.3:,V]G^^^.*3\+SO.A]-:`T5-SJD*]UG#+[N^*,+JS_.KOOH`&]G[^/(Y>]-<#[F&CS0X:?PTG,/NR<^#Z*06GIMNGP"3N'[6-HR1`]_:$`X)*8]O1 M]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL M7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&7 M4"T\U<%J"`=[!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++ M28,5\YS3$$X4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A`.>YA;+V`0``6!<` M`!H`"`%X;"]?FE!^1 MLD%(;+GW[]M-\>I# M7'=M:6@R-85OJZY>MZO2_'VZ/[LT14RNK=VF:WUI=CZ:V\7IR:Q!1/NSZ_^N?#N^5R7?F[KGK9^C9]\0[[UH7GV'B?\J$NK'PJ MS;`5[?X)R20S&_L-3JZ'+LXEPN&Y,@[/$8YI<*--<(!A6AF$$0]I:(J@ESE:LZC0\1=7A4:4] M2"C_QF]\F*\0SFQ4D!W\YG.-5'VN;,#G"(:T:0CBL/98 MSG`L9^VQG.%8+MH>+-B$1Q72;_()CA*D/4H0'"5$.Z($1I1V0L&`TKXI>%&D M71J"M6'M\&88WJP=W@S#6[0]1Z#GB'9\"HQ/[;C"::4\Y\`D)VU5$505::N* MH*I8NXT9MK%H3X$">T>T926#KNS1_^&+#P```/__`P!02P,$%``&``@````A M`/M5*+B5`P``&0P```\```!X;"]W;W)K8F]O:RYX;6R4EE%3VD`4A=\[T_^0 MR7L-28"J(SA5:5KGCEK*A43?.3Z)SW7H3P6">.KD?MG_OW+J>LH37A",L'IR'VCRKT2'$LP,"7(W<5.OBW/-4G-*KVAEQ/&W5KA7!ZB(99+%M,;$97UB/!&;ZJ-@[5MS"J&`C;GTQ!*=PO5> MK]>\]Y.R5:JW;X*\A_2-@_`]YM7AIKVM(Q%,*IIPS?1;-.6U^TS`""O7I]"9 M[SKRG,$_%89:J5(Q3I=#G^WBTI]T;WD<*23&47!'%5"26T;VD6`9::5PXZ\H\T!BL MC[[%L2B!,KZ*?I3`"?"!):"-1L+O=35N!5_-JB"ML?:Q MS@Y:52D-FG=$`[@M,_`L?8O0F1;Q,Q@`>%^+'%:5,AL$]X"GZ%MH3HCDT+V* M;H52T3V5E4X.SLY2TK83C]&WX'PDDI%%1B<$%E01U>7`ELX'K)`-'=$#!$\R MK-/JZV!X9W%*DQ+I#'$`PR/AQ3],(0XB'(Y*`23(3*5ZB`AQ+.'0$=JWU.K9 M(YUAJR`+YWVKS=()<2KAT*D'!:I9<#LX'+:ZLE#>J5(/"_8WZBK$(85#IYH] M"_-?04AGB)=6://"Y=Z5=:75U=_>Y MTR$)FNZF!60R^^^O31GL*AR8/,RDJ>.BCNOCN`GW/W^_G'??ZJYOVNN#Q_:! MMZNOI_:YN;X^>'_^[XN?>;M^.%Z?C^?V6C]X_]2]]_/C3_^Z_VB[K_U;70\[ MZ>':/WAOPW"[.QSZTUM].?;[]E9?I>6E[2['07[L7@_]K:N/S^.BR_G`@R`Y M7([-U0,/=]V/^&A?7II37;6G]TM]'3M&K.S?#/Z-3;74YWO[Y>V^[X=):\O[/H>)I\CQ\6[B_-J6O[]F78 M2W<'"'3).3_D!^GI\?ZYD0S4MN^Z^N7!^X7=B8A[A\?[<8/^:NJ/WOI]U[^U M'__NFN??FFLM=UOF267@J6V_*NBOS^J27'Q8K/XR9N"/;O=`F'8%3KAV(E=H)XSO>1:S.-GVU0P'40`DLB"$:[F)J#818@V!>,A` MK,Q,/-35!T_NAJF.G/``2`;5%80A*872MB=10NV5;>=Q$$4AOH&P`2R+XMCL M)&(@^\'!0%W%F6!!@.]0`$;>9V9)4[&)J#818@V!B"1.(NHJ3@4+R%X7@$G& M7*2AE!=,M+3M<<0R8J]LNU2GF)'.$3:`Q3Q@9IP@"G*>.'*AKE(*I/,*P`"% M)$M)A*5MCC(:7V6;61[0:2>0/0KS3TI)2;X9LU,SJ*LT?%*L!6`@?);26B[! M'.E13':WLA?'84+*5-CFB#.S1N'.L%8"!VV67&_V@ND7E1 M6Y5M9DF0$G("V>,T,7,$A<^DKCOV?KQ,"9`N+31([WYF[1`PP/8D)!M0(7O, M8[(#`MFC.#5V3$&IW[)\&(BB/4P9[=!"@Z!"2`&4R)A'B_#A!LZUXM.U.'0E M?([000]QZ"3!!0,0['Z6!\QD6&^_#4C2>+G_-H!+K:"36J![L%RU^#SB,!$E M?`XBH(>8B!D"T`<,0+J,Y*EOOH7F8=M]G@=D"%3(0<3H%!#([J=A;.8X)J&D MST$"%%%&,>L5L_9!DP#0FJBQ34BU#1&K$$Q'*:"A,YY>K=.?/(LO9A0C+5!H M$-2X'Q)SB^8AA)!0V-2!P;:B$J+F<3J MK`!(AY\S*F_:B;9G,9EPE;9#:?H\C4D3"@)@D=DA3$(IH8,$""0F8?9!DP#0 M:FEM0BHV050R3)0Z%;;1#[FQ8Q9*$ATL0"DQ"U(,!0/0E(IHD0ID3W.R"Y5> M/Z4BHPX$`236',$DE#(:$HNV`.'$9,CH+QB`@$R8++C8XNN'2;ZH*QO`N/5E M1^?#MOMY;K46XL*Q>E,NHYFH.".Q%!JD$\,B4N*EMD_C.25[4>'U<4C&NT#K MP]SRCZE@%5]0<:@Y;>>"VXK,%X*HS5,)A9R,BPJM3V,ZL/#Z)+#NCZG(XEFI M,*[,Y#L2/5D7&K36]-N0:ALB5B&8EM)ATSC3(.8@S[AA2!$4&J2++,Y($9;: M/J4F6ARV,$`>Y!;)0:<$EJ7F%IB%4F$'"Q!GS(+*06Z@9]FN9D5."-*.4TY M+<86""LJ*TZDK>"V^I*R*9'1IW.B0F9.6`ID]3\[]W(LZR.'*#:/"1WRSDGI M%Z./!^_SA("3.2'TZVZ%'7!:E@+9_32/S"[BA"CI-`F9IQ0H*DX$D;*"`TA/ MJ6C1&)J#5W/:>(+8/WNN)H_H-@&:C=%,-)WFO=`@>$H8!3D99"6R^U&6 M$*H5`D1!0.P"V?U,/KQR']Y#K.I3-L;+1`(Y.445&K0F@=N0:ALB5B&HN$)9 M/U9QT6X?S30WY#Q5:%`^/I0*]G3RE,CN!_O(3!X870@@'9#D"F3WY5_83`28 M#-;S!1F'KM.N+$(`363HF"V179$Q7:O)8`=QDJ,?.M"HO]#XP]S<*A\Z5)Z3 M_2LT:.9$:K]$=LDI([.P0H!@3[\>"&27"0I-!)@$5ONY>4!_Y<:9YQ'TFWD1 M`FBU>38AU;87L0K!=+#>+^K-I?NF=.'P$@)HRLVR>6R[LWEL@*MY;/M:\ZSK M?NC2?5)(A09-9*PO>2/9$MF=S0-WF1S$28!^%LUCPZ6_3YL'GP?FNG.=`TSI MZ@0!:`J)UGX9VG9G\]@`V3P+$K9]K7GP.6!1;8[S`/U;61$"",C$^UCX9MSH M%&TA*N0CV+,D1CDBPUW\,!RU5N0X,TB)GC(WFHG<6LF'S&G0VL38AE3;$+$* MP;3+LMKO@JOE!3LKAQ?RR#7*_FJR7C],!OD"R"WXVO]^[%[;:[][ER_ M2)?!/I6:U,&[(O!A:&_C*PI/[2!?_1A_?9/O]-3RO8A@+\$O;3M,']3;#_-; M0H__!P``__\#`%!+`P04``8`"````"$`PX``8&(#``"R"P``&0```'AL+W=O M2,4I*U8V M&KFV18J8'6AQ7-F_?D9W<]OB`A<'G+&"K.P7PNW[]<`K M.Q6B7#@.CU.28SYB)2E@)&%5C@4\5D>'EQ7!AWI2GCF>ZTZ='-/"5@J+ZBT: M+$EH3$(6GW)2""52D0P+R)^GM.2M6AZ_12['U>.IO(M97H+$GF94O-2BMI7' MBR_'@E5XGX'O9S3!<:M=/_3DGF@X$"6W:I( MLK(?T"(*;&>]K.OSFY(SO_IN\92=/U7T\)46!(H-;9(-V#/V*-$O!QF"R4YO M=E0WX'ME'4B"3YGXPA#IRAY/ M1_[,'2//MZT]X2*B(P*?C0CR1M[<1_[T'2KC1@4^ M&Q7O_:E,&A%(_C]2F38J\-FHO+TJCJIPW9D0"[Q>5NQLP6J'&O(2R[V#%B`L M6S)V867$V?6;B370F[#,^,IWWF8EG M="'J,SZZO$OS#DOYRGO;:AF5GN5NE+W?M`&KZ_W$G>G9;UNFG12:@9T9B-K` M119V9">K)0K;YI5$951+U`QLS4!H!G9F(&H#EZRNVZEE!9OX*BMSQ\A1V$+V M1JJQBX)5=92\%J(GM(!$.$KM!(KI%:);A8+BRW*X8&5W9L/`Z&Q,W M,*PJ9E(?'<:6W[9CE_E&&<)!8C=(1+<(S>3L59,R:IJ\G"FJGXJ9UB:GGF?4 M8*N&;[0['"1V@T34$O*0#BZG@V91WJ/^?=C+4=VJCXP-OU',#2_;02)41#!7 MBV*$7.W/6"4[@S;.QNC6ZS3O@>:]7<,RJGOV7+.]BKGE61'*T&P:&`+AH,!N MD(!KF4ST]2243W7M4C_N)3Z2;[@ZTH);&4E@@[JC&6SW2EVZU(-@9?TCMV<" M[E#UUQ3NQ@0.?W<$<,*8:!_DM:Z[;:__`@``__\#`%!+`P04``8`"````"$` MWLOMCT`"```_!0``&0```'AL+W=O\)"/\)092D8?U5L)WEK/43SAEKP;VK1F2--LD=PDNKMKGMB2G:` MV(A&V(\!BI%DB[>J59IN&LC[/1I3=F0/BQN\%$PKHTH;`(YXH[NA`3\T*GA)=XW]J?JO7%2UA6XG;@M3#9P$OT@*-P*0.7T?_GM1 MV#K#HTF03,-1%"<8;;BQ:^'V8L1VQBKYUXNB`\I#X@-D!#8/\208Q\ET]@"% M>$=#)J_4TCS5JD1XQXV+7KJ)DQ-G,+R\EX,`.0:S/CY-0H%\TPI'9F9GYYU-)KQD,; MX_C**MP31_#14?R_@]Z$OP-^]45Z(UJ.$EG!@&4YAC[6^`7UC5#:W: M*`L#/3S6\*'B,%5A`.)2*7M&ULC%A9 MCZ,X$'Y?:?\#XCT!FR.'.CT:CMX=:59:K?9XI@E)4`>(@#[FWV^9XG`5Z63R MT)WP?2[7YRI7&3]\^2C.QEM6-WE5[DRQM$TC*]-JGY?'G?G/WT^+M6DT;5+N MDW-59COS1]:87QY__>7AO:I?FE.6M098*)N=>6K;R]:RFO24%4FSK"Y9"['S'R1IW755(=V">8L='2N>6-M++#T^+#/08%:=J/.#COSJ]C&TC.M MQX=N@?[-L_=&^VXTI^K]MSK??\_+#%8;XJ0B\%Q5+XKZ;:\>P6!K-OJIB\"? MM;'/#LGKN?VK>O\]RX^G%L+=S9=69Y@)_AI%KG(`I"=J;C+[V5 M[0APSWC.FO8I5V--(WUMVJKX#TE"S3X:D;T1&-$;$7(IUY[P_/M6+/2H4Q(E M;?+X4%?O!J0'S-E<$I5L8@N6>PF]'Z,H6-M4L;\J>C<(W&W@Z=NC9\L'ZPU6 M*>TY`7)6IC%R-CZEA`-%Z5-VH^'!-$;0(?'`4`$!WT3,%;G>J$BAD#_:ZCK"I=X$R'$U#A,= MWF5$=QGQ+081!([<")%"=R8LSY@N0K!\"9"S[A).B@V5&^KH0CJ2I4ZDXRN/ MC8YU=.';VMQ$!&R.&R(4RD1(E@$!O@PINT$^_] MN?=:3BF4>N](YF&`'/1^'@)$_4X;A,!94WV1/GJU9OD:D]&^[4_ZB0@H*5H( MAI*DGE+GA603!,A!YQF(SV'2W%B(C-7(16:A7*1#C, MS0`YZ*:SX1I#'5Y(UV5^1CKNS.!8AQ=BO9IV"I$AH-'S8&B;H8.I$&C3-)^# MGH05R;4WK*B$!(>,\UDX(T)P;9OA,<$7:SC9C1Y0,:HO3IDU;`J![1)*]%15 M)`L\S7DN,NZ3L0)8I9I;`9GLD#5J$;)U.BAP3Y*U;`-'`@D#:'1=F@?&L1Q M6TT9WX'1G<%QC_/!5(3JEC=$8#.E(MB>"."(KRK=(,)G>$APE5_3@O9"J`'/ MWY`/LQ=S>Y\&2+712=M8"K"[ZIJ$9"D=""2-FEB2A`0'36NVJ2)"L)<^JS4Q MP6'/.),'-$"JGUX1@6T64G4L5<)A"1*(H1=/)+:6X7U*=)\2WZ10.:JU3G)F M]0P[KQX;SV9+%P@D#;'A)2(D^-5ZQ@Q,2]_E8TP-W*AGJL$R,7H]P_Y+Q;`\ M"0224,RU>L;P^>9A!'Y8COD,GVT7>>48H-6S#J;'`,]FZ13TI"$T*Z8V['%> MDK`,W!DD[9_G5P??%8%GA4&$/Q.AX]?J63_+8,#S;?)ABQ83.MC[ M-$"025JZ#?5,JL=4T[R>]:3!)5Z.0H*##[-Z1@A0SV8BT`NJ48]R1IC@_U;+P'"8?D4 M2"3A6X!O\S>JD.#>>L/;)\$AU]ARQ03WUJNIEU$)]"@P2I@?`83#I@C4A1OD M8"]!SMXH"7Y-`AD_>YU3MY:3_2L2\$H2+_**K#YF878^-T9:O9:0(A).ON-3 MO`H-Q!8NW>#NC#V/X(JT>VZ-`%Q<7I)C]D=2'_.R,<[9`4S:RQ6X5.,=)_YH MJTMWL_9ENTB+W`=7!?T2.KSVOW^]\NG MA>MPD=?'O*0U7KL_,'<_;W[]976C[)5?,!8.,-1\[5Z$:):^SXL+KG+NT0;7 MD#E15N4";MG9YPW#^5$MJDH_#(+$KW)2NYIAR3["04\G4N",%M<*UT*3,%SF M`O3S"VEXQU85'Z&KIBN77\^IG_K`M%D="3B097<8/JW=+VBY1X'K;U:J0/\0 M?..C_PZ_T-MOC!R_D1I#M:%/L@,'2E\E].M1AF"Q?[?Z177@3^8<\2F_EN(O M>OL=D_-%0+MCN:2@)>P$OTY%Y`R`]?Q=76_D*"YK=Y9X\3R8H3!VG0/FXH7( MM:Y37+F@U;\:A%HJ31*V)#.0V>9#+US$*$[^!TO4LL"U8_FX!$`J'W#M%H?> M(HZC9#%_RN+KHJAB9KG(-RM&;PY,*-CF32[G'2V!1581V*!\,OE%9A4&PARB M;YLHC5?^&_2E:#%;C9F[3H\)3<1N`I&8D.Q^(XMD_PCA@YG>$;3*=C0+>D#9C1FG0V\V[TMI6(!G8<*"C#ZSH#&/+#Q%9!K16D!>G/8B53?WXWSB MA:A/&QZ220\R:GL8BJ#XMQJC]T^\Q!XF*VU5.!NG$?+0($^K'^=C+QK,&>KA MC3+1`1FUU2]Z^UJ]QD1J`,*Y+;[+#F-H(;(.(=]WL56:_3@9HF%K0[L\9`QO MU>X!D%%;^V!>:]>81]/S%)%IQ$(_`&9M]D8.18-U0W\ZJ5]&3?UQ8+^)-*:M M?61-QJ[+_KSV'6*R]N,D6@R=,;3#H6.J^"ILJ[&PO=V]R:W-H965TJW-^+NKKP?_G[Y>GK>]U?5:?LY+7[.#_9)W_^?C;I_V= MMZ_=C;'>`X:Z._BWOF]V8=CE-U9E7<`;5L.3"V^KK(>/[37LFI9E9_E2589T MM5J'55;4/C+LVD3]0>(L'[CEAQE]5>0M[_BE#X`NQ(/. MRO[O_C]#U9<;SVT.Q&OY+P$ M)?CI5868`4@]^Y"_[\6YOQW\:!TDFU5$:.)[)];U+X5XU_?RMZ[GU7\((HH* M2:@B@=^*A"1!3)/-]@&6$$\D,_F:]=EQW_*[!^,!FEV3B6$C.V`6*<0)E#(7 M#[^(IQ(#X0ZB[\W#=RA*KC#/T,2I/BM* M(>8!*1B1B=20C8B:V="-W1K$Q+)QA&S=Q5H[Z474IK>+A1BD7R^P;YSL(FJQ M;Z/Q>%@?Q""[?F8T02Q2/;Q#9434)H\MP;Q^EEV.;7Q45^!4(!$NF^FPH.SL;7_3V**&'SNR%V]]D;O`XG15J<+C>]@N;G)@VEU^!DU4N'__? M+E>@!UQ"W:Z78:ML,Y@: M8HWP%H5WCR:[LA]9>RWJSBO9!:9T%<#*]5J\0^&'GC?R/G#B/5R)Y)\WN.LR MN)>L`@!?..^'#^*6-MZ>C[\```#__P,`4$L#!!0`!@`(````(0!93L=7-0,` M`+X)```9````>&PO=V]R:W-H965T[@02A52MJFZ5-FF:=GEVP`2K@!%VFN[?[[--N)ADRTL2[.-SOO-=<+;W M[W5EO9&.4]:DR+-=9)$F8SEM#BGZ^>/Y+D$6%[C)<<4:DJ(_A*/[W<$I*H5H-X[#LY+4F-NL)0WL%*RKL8#'[N#PMB,X5X?JRO%==^74 MF#9(,VRZ6SA84=",/+'L6)-&:)*.5%A`_+RD+3^SU=DM=#7N7H_M7<;J%BCV MM*+BCR)%5IUM7@X-Z_"^`M_O7HBS,[=Z6-#7-.L89X6P@<[1@2X]KYVU`TR[ M;4[!@4R[U9$B10_>YM&+D;/;J@3]HN3$)[\M7K+3IX[F7VA#(-M0)UF!/6.O M$OJ2RR4X["Q./ZL*?.NLG!3X6(GO[/29T$,IH-R1/)*Q"I3@TZJI[`&PCM_5 M]XGFHDQ1L+*CV`T\/T+6GG#Q3.599&5'+EC]6X.\GDJ3^#T)?/X`F;[%L-F\#S,J"&T$N,[G[(+<5",+CL/JV"Y-P MZ[Q!5K(>\[C$>`/"`9E!"_A-K<`=I.3N7&H=#3PJFLY?TTR8K,W>U:"SF=C,E[Z!];W5X@/YBKL#;;A5D0)>X:X- MLV)U^O[5#X*UZBK9,P'7J?I9PO\D`E>::P.X8$R<'^0-/_SSVOT%``#__P,` M4$L#!!0`!@`(````(0`KUG*-300``.&PO=V]R:W-H965T M=^[W?UX^I:[#^J(]%C5MR<[]29C[>?_K+]L[[5[9A9#>@0PMV[F7OK]N/(^5 M%](4;$&OI(7(B79-T<-C=_;8M2/%40QJ:B_T_977%%7K8H9-]TP.>CI5)?E* MRUM#VAZ3=*0N>N#/+M65/;(UY3/IFJ)[O5T_E;2Y0HI#55?]3Y'4=9IR\^W< MTJXXU+#N]R`JRD=N\3!)WU1E1QD]]0M(YR'1Z9K7WMJ#3/OML8(5\+(['3GM MW"_!)@^7KK??B@+]J,B=*?\[[$+OOW75\8^J)5!MZ!/OP('25P[]=N2O8+`W M&?TB.O!7YQS)J;C5_=_T_CNISI<>VAWS(26M82;X=9J*:P"67KR+O_?JV%]V M[G*UB!-_&82QZQP(ZU\J/M9URAOK:?,O@@*9"I.$,LD2:,IXN`C3.(A7'V?Q MD)%8R=>B+_;;CMX=D`?,R:X%%UNP@NN]095*BACH6CA)3*Q*$8HEC M50Q8'@FP,];II,@M19(O.LS"V@L>,Z%=U[!]&@7>JB&8\0267.4V6/YB`Z$8OO MJKL;3?,#T2!(K=,A8([UMX2VE(=R8YJ6OFE/36PF$0P"?3 M\!;O>1G<\\1=R1L"%'#AYY>Q97B0'NX M=XE_+W"A)G#7\1<`/E':/Q[X;66XHN__`P``__\#`%!+`P04``8`"````"$` M@A$019<%```B&0``&0```'AL+W=OKND?9(J]5^7%-"$M0`$=#FG'^_8\8AC'&' MWK2-_3"\'H_].N[VZX_B8KUG=9-7Y<[V9JYM965:'?+RM+/_^?OYR\JVFC8I M#\FE*K.=_3-K[*_[7W_9WJKZM3EG66M!A++9V>>VO6X%C?7*::YTEA^ZAXN+XKALZ19*7-D;8U)^)41V/>9J)*GTKLK+%('5V M25K0WYSS:W./5J2?"5O;]4M:%5<(\9)?\O9G%]2VBG3S[516=?)R@7'_ M\((DO!OJSE7M]_J_/!'7F:0;9@G.0,O5?4JT6\'V00/.Z.GG[L9 M^+.V#MDQ>;NT?U6WW[/\=&YANA?RD;2ZP)O@IU7DL@9@Z,F/[O_/_-7"6X3341Q4 MU(U$)&VRW];5S8+R@'!R&H(2D<_*,AM*NDGB>_LI6V!W`9:W_=! ML-HZ[Y"E5#'1F/$H$=\)F2D95F!#-UX'A/7J8,P#=7<1LE6*N#\>80,$Z57Y MVAOOCSR(]9(B8HSX88\057.C*ME*5&'#4%40K/N(W7*(7%AR3&)EKRYW3FY,"N$DLPC5+#?XCRO"P_V?;@S:_API M2&E>CA=3K`A6,K[)C%#)T@\TR<,THUU0R=IV%7D(H>35>FW(,A)F/;CH5!`S M0B5+\]`D#]:=A]Y")6N&%"G(_#95&1B'000;A6J&,`/-=XOW9+.^23QV&U7% M"#%"8A6'002+4*W27)C\HO?0_.KV!N=#.3#T-ZW$X[[S8W]C$:I6>@NC%JV' MJ`U'&>;\257#)"(\#J&:I<,\-/?5@,;#GW.\2?^*IQ'!(E2K])>'5OVLXZ'] MT/R.J@&ANW',EP9;5H'8$OZTU7G29AZB^P2C^U"Q^GFG>U:6[H?5&4\C@D5( M@GUJ='>M7?/4UJ`@3NLT(EB$:N4-SC<87*@?T!2$Q2#M;7"\PK6F"&94@D6H M9)CM02GH]>O+;CW-^C%-08R@>!H1+$(U\P[G&QPN'&E&"-,L#SZ&/"/"#$NH M5YD1JAD8+L^R6SNOA?KYTD?(_#95&Y.(8*-0S=3I^J6'Y@79&7R!TSU#7D9T M#O>`M.'$TXA@$:I5NLMC2QO5,9H/W=I&2P\A;NEQ'M;-@/`YA$HVVYR/#D:E MZD=W!:%4^4W#4+Z33BA4%'-!4:W4YOI2,-F;=IZ)_*&]X8ZF54NL$+,0E==/ MNYM/W6U4"B:7T\_L70S>Y:81P2(DOW!`'Y;O/;]=L[[]:LF+%,0D+YY&!(M0 MK;S+S3_C<@KBZE(QK32&L5HQB1E`K M7C'CQ6R1U:5&'L&`P``S`@``!D```!X;"]W;W)K&ULC%;; MCILP$'VOU']`?D^X!7)1DM4FA+92*U55+\\.F&`M8&0[F]V_[Q@'%L,JV1<2 M>\XB9<4%9MD#MUD$6JA*6T.FW0G]_Q9($L(7&5XH)59(-> MB4`/V\^?UA?>1.B+2`H1(;E$M9KVQ;)#DIL9BRFE1@R1@OL80E/]FBY@2G MC5-9V)[CA':):84TPXI_A(-E&4U(Q))S22JI23@IL(3X14YKT;*5R4?H2LR? MSO4D864-%$=:4/G:D"*K3%;?3A7C^%B`[A=WAI.6NUF,Z$N:<"98)J=`9^M` MQYJ7]M(&INTZI:!`I=WB)-N@1W<5A\C>KIO\_*7D(GK_+9&SRQ=.T^^T(I!L M*),JP)&Q)P7]EJHM<+9'WG%3@)_<2DF&SX7\Q2Y?"3WE$JH=*)>$%7`2/*V2 MJA8`Y?BE^;W05.8;Y(?38.[XKA<@ZTB$C*GR159R%I*5_S3(O5)I$N]*$D*8 M5[LW]1:!&X3W66P=4:,DPA)OUYQ=+.@..%/46/6:NP+FJX1K')TH2&VBT(\* MWCA!N`)VG[>!NUC;SY"EY(K9:J/)D0UB.D60IZ$BW^D$**LIP`O,DW;O0$S$?HQ8SDU(-(9X)N(P1@Q)XC'$ M>\ND(=J_*5I9H>=Z%?'#0<`[C9GU,(.\[.\BHKN(PUU$?`MA2(90AW6>!5V= ME76#((%=$\YE0KS;#LZ,8(*+;!(>[!/$MA"$6QD1/;/LV MJMV!R$&7[31$2_272S,#>VV])?&F_^&N?]SWGRW>FLY0!X.GIZX90KU75EE- ME>ZHE!JC94[\0:'W?6OHFSF(^L;)8I"A@V%U@T%ZX791L;V?0"U1WQYZYI:$ MG\B>%(6P$G:NH*\\Z+UN5U]:.W<%\Q'&W&`_&PO=V]R:W-H M965T.\;0\?S^GII/;70SIU.J\/;^N=<["?T__:I_3?+__]S].W<_SG]&G; MYY3(<#@]IS_/YZ_';/:T^;3WZU/&^;(/8LJ[<]ROS^+/XT?V]'6TUV_N3/M= M5L_E"MG]>GM(>QD>CTER.._OVXU=<38_]_;A["4YVKOU6:S_Z7/[=:)L^TV2 M=/OU\9^?7W]MG/V72/%CN]N>_W63IE/[S6/SX^`,2)?U5C2^S:5L*2LRO3R];<46R-V>.MKOSVE+>[0LK9#.OCRY M>VBVM;]/H?>ITZ?S73]NWSK;@RUVMQ@H.00_'.>1\-^SMQ^=9C+SLY][2/-3>4ET/XEX]9-H9L;0S>+#/5GR M?A;Q2EGTC/Y@:F;ACG4Q_"QB[2E+*?&&%/R9Q:L_LRZV/.%>*/HSBU=_YM+] MJR\ZT!L/.>3>OKYC%;1@.,4;FMW,%+5<*5],/IX:#:A\0VD*]V^,1D,JWU`> M(Z,9N7M&5*,AE6\HR_U%*LK?W[67TLCG,@^F:10>[MDY5"2B?VEU_J3<-:H7 M^<;?+$V_OVVTH&3$&]H]R:M6$]WA59QX\W^LABX*ULTCWU">XOTU(ZO=RW,I MX3_9O3K5L'Q#ZZ/=OWMUJF$]5'TB9<*#@CQR>9MSJ;H[&EJG8I-O:"O^X-BJ M4[')-Y1'3WI@R'HG#?=D4UF?UR]/1^<[)4[A8HA.7VMY0:`]RLS^:<8_5P0G M'G$"W$AN2>_.)4XI)Q']]6)JI:?L+W$FV_BF'#>&ID?-*QEY/I.)*Q1(!8EC M,U7)T$PU'JCS0,,+B`V[GK9)AM*V>*#-`QT>Z/)`CP?Z/##P`N+?ZZLV)$.K M-N*!L1I:U%03F)K* ML+6I>Z94LVBC2U.!>'FYI.*S(LFYD.)64O<#FLO9*X#'B^]!#=Z$KDD,-T$II?`]!.8@<+D64,,$YA1`C-.8"8)S%1E MV+C/$IBYRA2C-;9(8)8JP_IBI3`&.V]8UFT4:6)Q':UJ8AF.-+$7"#4QB7`3 MLZ-))6Y,/1_=,=6XB1T,:BK#EE5/8!IQ8^KL8-!,8%H)3%MEV)&]HS*L<+HJ MPXJBIS)L__05)L\*9T"&#MU#"MP8Y%'DE M,/T$9D"&]LR0!T8\,.:!"0],>6#&`W,>6/#`D@=6/&!9H4BDML0=OJJV9%A\ M&Q*^1S38/6+9,^(0?+F/C%YKO$)1@:(*10V*.A0-*)I0M*!H0]&!H@M%#XH^ M%`,HAE",H!A#,8%B"L4,BCD4"RB64*R@L*Q;)-*V\KOJT&?/]%F`##^GQ6<* M04L:.7976/;,K;8EX7U$'>WI"DV\+(+=PE5)R-G9U74M/(U=;-;#TUC.!DV[ MNM0F%"THVE!TH.A"T8.B#\4`BB$).0JL!$;A:>RV8$S3KN[I"113*&90S*%8 M0+$D(?++0U4WRG"T&_4D@4DS M(/)XFL^SV[56,/GJ(;6-20>3+B8]3/J8##`98C+"9(S)!),I)C-,YI@L,%EB MLL)$?,$MF_0YK>ZS:#O+[\(5E\3R5V'L+&S$SL(^4B_&_43OU2<%]]Q5T'7V M\5,%IZ@&Q+T>R;-KW%HP^6K_U#%I8-+$I(5).R!R:XKL0K\3F:KQW[ET(Y,? MV&5`+S*UP(Z]_T M9?4V#R9?S;`(B#M"[,IS&4R]FF"%B>A0K[\,[YHN=ZF#:'?*[[E5W>E]_QV^ M8]5S;%/+\H>85P\"?G="4L%9JIC4,*ECTL"DB4DK(.[XFNQ\W`XF7QW@#B9= M3'J8]#$98#+$9(3)&),))E-,9IC,,5E@LL1DA8EHY5M-%&UG^8VWJIV];\+# M[6P:[,!3EK^'1NT,205GJ6)2PZ2.2<,G_GVM4>2'^R8"+;R0-B8=3+J8]##I M8S+`9(C)"),Q)A-,IIC,,)ECLL!DB#7=N^JA#[8%E!C"([IU45B"VJADD=DP8F34Q:F+0QZ6#2Q:2'21^3 M@8+$1FFH0&R41IB,,9E@,E417IXS%8J6YUQ%>)Z%"D7S+#%9J0A?E&AO1=\% MRXJVM_QA@>IL[?W@('JV9K^9*LLGAUA[&_R7AJ\*Q`:\HB"Q/%4%8GEJF-0Q M:6#2Q*2%21N3#B9=3'J8]#$98#+$9(3)&),))E,%B1753(%842#>K%S^.4NW;U]+OM('%&" M+XXOB_/OL+T\-T@ER"+O1]FG-M5@XM5%U#"I8]+`I(E)"Y,V)AU,NICT,.EC M,L!DB,D(DS$F$TRFF,PPF6.RP&2)R0H3T=2W6LAK:N^9=N\QP[U]_+!?[=WN ME-HX/P^B,^6';$'4>YB^H3V*A_#$+])8O*4]BL?FXO&Q]B@>@_5>W^&PO=V]R:W-H965T;SY_6AT9?Q$%(=(!AUJLW4+*9NEY(BU(A<6$-:2&-SGC%9;PR/>> M:#C!F1Y4E5[@^S.OPK1VC<.2?\2#Y3E-2<+20T5J:4PX*;$$?E'01K1N5?H1 MNPKSET-SE[*J`8L=+:E\UZ:N4Z7+YWW-.-Z5D/<;"G':>NN'*_N*IIP)ELL) MV'D&]#KGV(L]<-JL,@H9J+([G.1K]P$M$X1<;[/2!?I#R5%<_'9$P8Y?.,V^ MT9I`M6&=U`KL&'M1TN=,A6"P=S7Z2:_`#^YD),>'4OYDQZ^$[@L)RQVI(2DK M82;XZU14[0%(';_I_T>:R6+M3F>3:.Y/41"YSHX(^4356-=)#T*RZJ\1:?3. M)#B9A(!IWL>38!&A:#9NXAD@G4B")=ZL.#LZL#M@2M%@M=?0$HQ/&9PPNIR@ MM*E2/RBY'@2T`J*OFRA#?3!L36:(3%=K`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`!+H"IQ(=*(L3;3+6YD9 M89+_]K(%1BZ33]50/=QW[?O&CH>-V9^K<=C$G?4\IJ!B6\K]:/PX6AW&+O=V M]>N#U/?;K[8F>X04`$FCC8=01+F"2&;(UO*8R=@4KY`9K8R,F?TXO@5`4E>W M,8$R6""1;*I!I"G=<=7F'^:2L@@`T0&$<2BO(0@'ZV2%P[BZBRQO7\^,<0!( MYOJA,L,)$'.:B?EJ$MT.7A#=-5Z;N?&CE;'(9S]0:X`DCH66<<(J589V)1/C MLR`\$L)CZL2X2N.KF,4'B';QLYRQ*\$*[(00%X+;L>5%"*9_M#(2OIA0!(!` M&*D49T',6LLY!5*"\7[@]^!4@G&51??70W2`0`FL#LS>G;4,K6FB9BN)G9/8 M?/^/5L;!^P$.``$.*F=-*L&*]E0JX919^(3_CI;L((J2IX5.( M/L">F-1WB#*@.CCU0(!VA;M1L3(7B($()LTDZU))`;$4?H@HAU&LEG,@0,,( M!Z^?T`3$`(<\36)&LJ0`95)/DG(8UPGP^E,VZ1(JE1BH6HT`,S&42^\%#"N`"2&9YYI.@!*A*SF.QE$>^]0O[ M(.`'4^M<^!!((008'6N_LRB'=844H'"V(?.-0K,L"\387&?,8C`F&5V#4!Y4 M+.=:K*CD8I.&.BBDX%I>"@(PN;@TGNM2*99:J?TFPRT"&.BXR'B_2O2!]ESX M'&@5J&#.55@J9:#VR(!*I5ETBTS!KZ&R`#D%!BD.9_7$GV`W0KI)094*+E(R:5@:C;V!6)` M'AC-$HTX"M+X4:*%H%HYC8)<:J3V^H:%``Q$D)G._;S#,*`3`"BE@QLKY;"N MD'*ID)KI3X$8S-*^BBB?)Y((15*H--6^4I3%NDR.KR7VWDPDRK<4*P&8:Q*% M;M8AE`>5RL5@@-:%=R_-=F$A`0-5267,^);$KDUP/66R+I9R*9:&;<,",<@@ M"Q[/-M-V=GQ3HTJZ!\V9P8@CN$V-6SV"G?I%$&G)M!'K`(X`8I: MBN#UE'9DU+@5#N,RE2[^:E$HP%R;SJL0RH-*Z&(R0"9)39@T%0HP4\KVL7I^ MY<.:$(`RP7ZC7*[+J%K**!_"`C$XA$:EC&Q)`8E*_1V:L1"B4-](L[O?H!(:#`B@7JJ23;.BE@@:?QI`#8""$R+.< MZ4J)3B:`/4Z8Y9YRH`HZOKQ>J045TP00>)T/92/V<(1/`8.&%O;G-H1R@ MU"$@$_("%;.NI6Z9;I.4Z62!&$C6]QW"HQ'YZ8`>Z8FA`CK-A5MFX9DL%8BY M7`$"R$T@?90"%4_>#'MVQ[=JRD44,7`8(M;>8AEBY2T6#OC@6.Q8=R]U61\. M_6;?OIWL=S-I3QCF53A8+,1=X8L6W%OS&PO=V]R M:W-H965T&ULC%==CYLP$'ROU/^`>&^`<`DA2G(ZJ*ZMU$I5 MU8]GASB)=8"1[5RN_[YK+T>Q";0O2?`,Z]GU,FPV]R]5Z3U3(1FOMWXT"WV/ MU@4_L/JT]7]\?WRW\CVI2'T@):_IUO]-I7^_>_MF<^7B29XI51Y$J.76/RO5 MK(-`%F=:$3GC#:T!.7)1$067XA3(1E!R,#=593`/PV50$5;[&&$M_B<&/QY9 M0=_SXE+16F$004NB0+\\LT:^1JN*_PE7$?%T:=X5O&H@Q)Z53/TV07VO*M:? M3C479%]"WB_1'2E>8YN+0?B*%8)+?E0S"!>@T&'.:9`&$&FW.3#(0)?=$_2X M]1^B=1XE?K#;F`+]9/0J>[\]>>;7#X(=/K.:0K7AG/0)[#E_TM1/![T$-P># MNQ_-"7P5WH$>R:54W_CU(V6GLX+C7NA;"E["3O#I54SW`*1.7LSWE1W4>>O' MR]DB">-HOO"]/97JD>E[?:^X2,6K7TB*VE`89-X&B4%FB\]G\]4B6BS_'25` M12:3]T21W4;PJP?M`7O*ANAFB]806:<0AU#*0H,/&C4<6):P^KQ+DDWP##4I M6DJ&E,3W.LK<9N0W&,N.$H".3@RD."%&HXZ851?'Z,V08H[<+.2]!6LG2'5B M)XU"'7HY):FS$U+N>I2%S=A8CM@- MA9:$=%*"1AT)SB.0(66L)<902T,$KCQ1!P,[*OZ:"YI"R\%LX14Y[(LIAJW& MMLO.)M'BK(=TX)/(N7T>T6W0WEM[V7A'1&AUE@;7'EO.B`8,X(*V!FUJ$QK0 M\RP-KG%&R'EMBM`UBG'<5C+MFM'0-E/'#;*6T^^+@6-,_=9G'^MEUC&R*@2IP>L.9IZ+B1'-:EM(K^*6&-^H< M[+%;Q:DQB]8P1\`0YZSG,$V:]:`#8,9KR(E^(>+$:NF5]`@APUD"9R5P',0+ MQ1LSN.RY@NG._#S#V$YAQ`IG0#YRKEXO],#9_1'8_0$``/__`P!02P,$%``& M``@````A`/&5/P)96@``6G$!`!0```!X;"]S:&%R9613=')I;F=S+GAM;.R= MVVY;67KG[P>8=]@PG"D;D%22Y6.G6H$LRU5*V9(BRM4)@EQ0Y);$+HI4\V!9 MN6H,YA'F)D`&*.1ZGJ+F3>I)YO?_OK76/G!3ILJFJMOHH)"V-O=>AV]]Y]/Z MYA\^7/2S]_EHW!L.?G]O8VW]7I8/.L-N;W#V^WOOCE^O/K^7C2?M0;?='P[R MW]^[SL?W_F'KO_^W;\;C2<:W@_'O[YU/)I>_^_KK<><\OVB/UX:7^8!?3H>C MB_:$/T=G7X\O1WF[.S[/\\E%_^M'Z^M/O[YH]P;WLLYP.IC\_MZCQX\>WI/K;&_@$[#N;[Z> M;'WSM5[UUU]D;X>#R?F85[MYM_YK*[]=";\N-'\XT>6 MD?WK]LEX,FIW)O]6'_:K^H.PB:/\K*=/V-I^^R*OO_75JYX=3:<]RK/O\G9_ M:6;?\B^SZ_K[WVUSO^]V'CQXLG3 M^D]II\?7E[.KVEA?_:>Y7QSFH]Y0I]3-7K4G,Q]O^,.._J7O#W*7H,3XYGOF\ZT_GE88?,`_[19'W-G.AH!RJP\^;S= M?;6ZNO%H=7.C/D8XDM>]?C[*=@#+V7`T>QZMBW9?+QSEE\/1!`K,=H87E^W! MS)OQA(<7%\-!UIH,.S^N9*USL&2<'4PG1J]\7E_%WF#"X5PPZF`\[/>ZK*.; MO6SWVX-.SN<0YSA[\*[U*KO_]<9Z- M+_-.[[0W2VRO\DZBIUG(OCLZVMT_SK9;K=WCUN_J<^ZTQ^=&\1W](__3M/>^ MW>?K&QN M;MKX]S=7GC][L9(!/O8Q@>;Z,R`_T%YY(\U47^WA*+]L][I9_@'V-^8@Q*L, M0EDG8%![/`;$]0\AX>%%GDW:'QC^=`JG92/UER(2^A!:?Q=:@,OU!E,.$98[ M:D]@A3.CO\I/<_"WF_72-/G,2\?#"61U\S(/CPX.=X^._R7;WG^5[?[3N[W# MMYS=2M:>P,3'D_J"WPA!@/?T8MHW/.OFET"O9ZLTV+0OA.3_;@_J7[]JWMQ* M-LAG9CH<:?=(!`%<6'(I]M+XZL'Q=[M'\]`M0>JT-P!U1'ZE(V2+(%?#]'N# M]_EX8ARM-X`R.)2"N-JGI[T^>YXY3T>GP7!P,]"W.^Q'I]?/V^/\?-C7.4+$ MS-BXF/WZ@+?`%$<"Q]AF3/4WFG_;";3\9F_[Y=Z;O>.]W0:"#G1@W`W&!1:C M5)RMLJ&+K)N?N'SOM"][H&/OW^.VL^%)OW?6C-['HW8W+^CZLGU]$_5P%">< MQZ0'>2Y.0MN=SDA$%BE[AE$=MJ]'PS[L10AX<=D?7N=Y=I(/\M/>++FW\O[I M:F\PGB+U8;L<)<)X6!SI#?*5AFJ%96M0-[^XYW M!V]>[1ZU_M]__?(__^\O_^N_C-L?_\L,VH?%;L^NL+0(=/W2\E:R^N*!;!Y6 MZ>QV_MI0AJ3N!"A4YM`4M6G6-\HP>KJR^?RYO2%(\-?ZL]+[%3`]7=EX\K3T MZOJS"H!+P+M98SC&Y('*KWW!44YB66P^*D\-'T+^IXW5,>(0G0)VD06N6/\9 MWE22L*>]3F]&/I9?<>[.?"#5.6H*J@XL>#Q'(3"4DM#!/$S((`F+L&79O\HX M$?&BMHA?2L)&:5;?ES.Q&Q;0_$&).`V;2@-\-3;E8#*CV2VD%1^B6V-2YI,> M!LC#Q;3D_$,GOYRX7IZA;+=OHSBW)F@-IE4`Z=>ND:"C'0['B"^H8+ZMN?T1 MW;?08>LP/+J!Z21^DSWH9XOLM+[[+QNX]LL?&;1?97 MYV/WGP]W]UL-JGX`RJP/XHT,&>/-YE0).G5]G=AT MIQB0,#IX7F3J,YS[6U1L>;@DTMO=B][`?&FRW^OCO;J-\7F$=36:=B;348,/ MQ053-`7J\\A$!F[[WV9[^VB#N]F#-P>MU@QGN'DK^+VIJ&P^PI&C"-)_E*YM<(^39RJ2.;?HY:X$K$G).+F[)]9Z^/ M#MYFK@:_$U0"?`[V6]G+W=<'1[L13L?;_SRK(K_:^]@ M_V'&1S=^$S`\0.ET-+Q`O3(WB=2-^7Z2AG6_VFN%I>^^*JU\YI@2KILJ9=#5 M\>#0J:/'M_B\,X0WOIO+X;C=O^G=AHTLZ/+9WSV.(&I&/_EF?I<]<(_00ULU MZNEDU#N93LSDF`PS63P->MH,2LQ,EFT?'Q_MO7QWO/WRS6YV?)"]VOL!8V)O M!\,B^VYW^\WQ=_;/UN[1#WL[XBN`?L:'?7BT^WH7[^"KK'5\L/.]!ME[M;O_ MJE4'Z>S\PI"%Y@0QW[X]V,_*-D]]>''I3E#/C5F['OSG_\Q.VN->I_[Z3A.J M"=+X(#^F-,WQ>2WX]?X,AUALUOD;[/;Z4QS$,UL,0*L>2_9J=^<-)_PJ@P,Z M1+.#UPG">KD^T!]V][[][I@OML&/[6]WT\LR05O9P;OCUC&^1MC&#,6]%.RS M![#$(+]G..PK7_QZ6Y!3>($/%]@-"M-E8?-%YO+&9,D M-'.F.^?MP1FN@$%VVNX%WX;8J#G_3W'G9^=Y]PQWAV1A,WMUOH9]T\='23BB M$YS-W3].@X=6T0#\SE.""`B[SO!L8)X2)BTD;!U/7>(W6ZZ_Z MNF$SI1/Z5=RY/O`-:_@\;'H1Q%/PYC7G-S>VM+/=^BY[_>;@#RW7%PHE:GOG M&+[?Z$N>X7?UO<]AI_77MA-RC#/$GI`"WS]NM\KA9O,5"7TEY#$\-=HFYIR= M7&9PM98\BJONX4K0CK+'&*^JO5D*_3`FT_DJ`CVV9KJ$Q[.C_@U MQTB:@Q5NOM1B#/6YA.XW8-A"*NY'QFC"TOHRZJ2ZM__#;LOLG1M(]7`ZZIR# M)F8M@W%00SU:5Y_'XE[!TP6O;_XHFYR/AM.S\^QD.NX-%&\$#4]PE[A9_J%0_0_;;W#EM.J3SWUQ!:7SK#<8 M&*N$_"REYQ9?`U4A5?-WK7>'AV]V%27;?L-R,=?>XC(YV)^1B#O2'`*.&N_H ME4/?FB"JXVEZ^:^WM[[9JYS,B\TT9=K\;7[8[9-Z!'A8JOK>U M4.`E>S`9GN66M7+5FYQGXDKCZ9"0>/A1'%O6,<1[$`+YEIFF%RDPSK6A*5J%X`*#!C+X$/-(C)*`=P.Q0 M_QWR_\;_KF@F"8CK][[>^J8S[#/MZ.SD]_=>OU:6VKH]'KW&O/;W]@:DX_0F M>OEK&V"R!;8&O]]'QF4[%\!S0Q_?.&0S])4..1'\+LFE`I3]:^U(,&KA@#[' MOTENQMM>]PHYXX%7>ZX_UTBBRF-2UR]__@\DEL&&6(K#,VMG5X`U(S<`6PA, M8CB2_A!4^(G+L&4>C*0$4F>DG*T!>').4@YZ87_*4`,_!99+%,_\J1K,%S8> MDI#33P.OD2N(([7K$2;T6FVJ^7M#^]KGV12IT`<<83-2?NOX$?:+25P#1)@F M`80\P"$`@+$#D_?"6`\Z0KP00HQ=\B_/Z'#2BQ!B=^/L*E=*QI@-P)E%F=KI M]%))!:4=EPZ$"&&C'I5`&0^+;6WWVR?M"R)Z6#8C,NF4B0EA#?C']VT48=#C M>\YBVOGQ6L@P'@_Q)J]D!^>]X4IVG`^DKN3A%([S#V3-EE&#E13:&&0_[4NE M$$3BJ0I\\0?0I(-*)=_B'#4%:(,1YVVBO2=Y/N#+:"*C!,&R--HI3$889_]. M\4;#=5/_W3HZ[:-!VSN5J?3:U'@TG^/?#ZM'%JX5M)XR=*'/.9QMV\98!G<@ MZY=XZDD^^OFG:N[OKCQZ]`(3C8>R(D]0NRMTD`VOT*:6`9"-S85&!9L_2528!:J( MUW)VL?G\3G8!4DI[J+'HX+,'I1)A3[:B*H,_^(?=-P>6(^IK+-+S2\9=3?>> MSQ@.!MG;-F8DJ3O*V]^LT!45"\J)E+Q!:+6#_9]=!KLS:Y^-2*;BI>S!/;&W M[?CWO8>(6\3KSE2<@3SH;O8_VA>7?V]\&CF])GHT]FP2!;9)GC$2*;#)X&;@ MKU8^Z`U'QR/\C/JQ)!0Z:V*<;<_C3'Q:4ZUD/439\+VM#'EQ.AT->@0=D0JG MO0_ZAYN1LH1"2JL6F,0XW_)OEXH+H<$M]:G3%$==,M=`\H2D3*",S.X/<=S: M:299:GY;SO6,DR,3E*2X>+8H82ZWE@&"^QM/5IYX9ME"PW\BNW#>E[86L,SU M"0]+!&5Z+-_)<.#`66BI?_G$$IE*ET0` M,O1,*4N''.-X*=JP<"A`S&:#EL*^-$JM?%%_S(1M=%'&V M^#IB0I^79JJ?!I8T'TTOF+T<($+B+H3[MQ0.]Y\]N3L9>77>0TUVWP#;$RR\ MNDN.4!Q4?72%9>USX_'*L\>6W;X0&#FDQ:RK+1?<@8I*Y%:C)"E&792B$;F` M[#WH`(:.&-=U$Q56#A]G_9& M%S.KD%HJ3"OPLQ#*:!ZLQD7ON%'PPE(XB)+NYD"+O&BR=1B5W$,IN?5?[]WU5)Z-0(WCFGNIKNF4F5:6<;CQ_= M++AT!NTLO,4R0%SC4N\+5[I/:B6!T=\76"P/ZK2$$KIV#HFJ+I MX%V)R[W":,;B4FD^/,%!JS@C*YCPT"+ER<4?X#>L.I+#2Z$1,I#'WN/]QBO_YMH?MR]/* MG.I%E<%ERWH]QJQ?#2D2+A8^3L.-Q1_ M/0*\[)UE+71XQ&OU^#;C%@$*,F`#6Z7`X$6PF4D'#AN4* M'>>H$5&,%IS+=A<>ZPL-5H`L(]#Z8Q[BIRX4OCALI/7,$"]T=.15595FAG1* M5+%@.E4F`DHBNY!)05,QL6[%MH,8JVS"/[0NQ'F)^TC$N$J0\`W>Q_$@KJ,B M,1R$D^ M$2D%JHPQM\*AL\WDG&Q*2?,ADU&U1;5;Z^#-WBM+Q[,.%B^W6WN4XKS.#BG) M4<:>$O7T=\@P)8./(IUCR^9K58>;SX>.8<_P8O*WK#:OZ)9SVI1V4LYX*:OC M,I-+[9P^DLEFP)E-@5.X\0HEOG^]:B+/Y<"X1UV(RD=,>6&A;^']\EB4$A>^8C3"3$Z@RB9R:KL#`8XFF0>8U&C03T@R^Z'O=VQ MI=CQM?OR),Z"I&.>(`A9E3Z5L"[FD,^+U*BR)I993IAZI.7BZ]L!R=%32VN0:O$' M0?:'WH@4V)Y\@T#-/(OR"?3?`V3>T:'@$^3%/TUQ&Z*WH3BH^YR\?O5(`=H; M'NSDK`PJQM$0%>J8[ES*O*I)&08A'X!)Z%Z6CSN49OJT^T.\DL]=XG",N%R4 M7\-;%20P34E!P.[!C]:U[)1O:@O13'^1/ZW$!]T,?GQ972.^[LFCO:*CJ@%:%OQ`_$:IGM1M02/B.'1U59)OV@B;:!3< M:3_B'4CJ4=<",.YQ=,DMBI*/H-,CEV65K)D[[#J\V?[44E+&] MT4:4F$B[!#X8(-G/%D^$%U_T)OJ@#*OQ5'&Q)F!94%'0&E["\=&D8(87Y/*> M66I6M`C3>>A-;M1"*_TVB?4(US%V=7L5B,&X4ZASIS$!#8<0$Q!ER9-"C M%Q*RMQ3>]!B.F?WNR[\C4>[9!B/29-$0U6C&"C\EI'E0T<<+!FT!1J^G0,6' MBWTY`(EQ%U3B/I9FB7E%$M#BE"ES"L77W"3TQ$IE5TD?#;J@\;OMP8"RMXQR:E66H3V^ MAN&1<;'Z?4QL0#^VOO7F15V>4;9L/KC58,].MM0E`=5TN]#HOYU2$$=O8V=M MA7NQ](I7X\N5A4TR&H$`.T-2U.W$;JJ4/=K=P0M)5?O.P3OKK9M]^PY_Y?[. M;G6R^7QGC_/)3T;X;*Y+A22OMULOL>+5*[>\$^P-VK%3@)Z]NU2V"QD7VZUW M5(V(TE;7'ZW,LN\>1:5-Q:PH-(MYX`&H]3W&'H",MD.S&J`LX[L#!H#HOT_.CFZ.#[@2P`46?K6#E?A:[OW4P3:2RP26 MH10)O[W#C!HK(:YJ""WM"5!RM:)AJ^Q@%Q8XX] MAK)E3,1EX+@):R/E*=E9*UE.59!<>L'/)P==X&D8JRH?3W)<]=$P'--7Q3+H M*%GR'L<"=5#[5^_"AC9-RF:F;2Z\D5K&`/2N)^OX^MC/6:`^K';C8FXBMS%H M<5(J,XRJ(ZHAXMX")_/:UYM=\?,$_!;`W<:,[YO_TX.*%8)JO;-?5M>?K\26 MUR5\_'2*.73S^,981_;@&.N^PT*>/#2V+A.=/@_(%G)\Q"D.2ME!,#+]%MTD8`M_6I,_4_,$9D-%^PL$W#4Z^+S$ MN?7S3^;>T4*%-;B-[*R)V3]E!8T8Y/\+=0X,X0*.S#@3DSO/^]U5Y/FJ^J8\A+8N_6C,N\&X)&_26**#;=`[%9TS M@3G`VA6JR:U/CS"T6)T=3Z%'1X7BB@H,%_S:'6N#%C^Z/ZN*2G3O"0)\JN_B M^;6-$(N+RG0==IB-WSIOC5ZA$@,"3VDP.$+3RBBW15G"T0X(:LZ+\ZH`71J M@I"_[W')#$,&6:S]O&_W*+:GSD;3Z+ETBS6"-(XZY.#A&Q/W1G?4>L40F9ZU M"I=%U8YBV@>G[.STJB`.84S(&8^$@XA1CSC[4XFP5COJNZQ':CC?#V;P=?&S M0G=H!H_OB#,'&FC0RJ3^B"LKMUP+:N;)^\.UGW_2SZOK+Y;#F(^4ZS7EY&0= M[\!S=#D6G1F\YI9&_GAQ(03GS$_7GX:.B"7A\&FJ%+[S4`UA^H?TS2CYP1>$ MLC<`-)QP42TQ"A;:JGG%/R=DJA)#+9UG,EW$O%7H'G'"LJ+5JX+/28;"M61QJ6$I9I!DP0\B/MNK;66 M?;N]?>AQ7Q9ZPJ8NL%P2U_%Y0LJ3:;,*5Z6?TQ:"(B"N^X^4X*$?__R3NU.> MS6$%(NS$#GP:^*!/X<\]SCR%,0"7H%.)_K"I1L-XUY(@%#0Z,_55$GPW-"EZ M<[#_[>KQ[M%;2OM?8H+17VIOG[_I_Y8=D0*2M?ZP?5@=7FRHV6`X9K_Q*"VE M(=8"!.:`/G!-TIY*YH0Z)^W!CR&;'0(93I3; MM_'7-_R`H28H"+AA,C/8(2K"^`(MF:MXZRK]`=)(\"X%^T?W'JYE!Y42ZVK: M7/Z!^(V=/5JP+""A`;,>D43`\KO9CD^2ZEIHS,2"[M4?JQ>!,:L++E_456JV M;FW25$9]D]96V67:8_HY+KUH=$!\VM92F+[D$$`A&P&GZTO$RFE,ZCW!2K=* M8OSU6!&Z"`2>=O^IW9#B=Z:D2L=8#]C.[C\N?J\N'7LZ@*SR/!P<7SZR:UUL MY+2KXJ/X2&>D`RGD1"F:ZG%6%3_ M"HEQ?V-E\_%&NC-&WK$3@KM$]"ZD<^LF*XI/O5;,2>0C(NZ6'O#/WZHAI,T9 MC07^E.IUQ@WL9SZIOTO%Z15<;D=2293O9-5`]R&[V`DBGDX%7URCX/R'D0_$ M(`1K7P;`2QB]T/!0[V+>GV9V&?:WE*U\?MQIWH/G8>*%0$\6VPAU5>XX""V9 M0F+3KSVY._N`NW)<WM-R%CN>6FL']1QLKSQ_;77<+ M#?^)@HK3-VUUH;ENN97?*.?0U9+J04;C$-UW/H(K/>#QVM,G?W<3AX<*QLK_ M`O<)6"P#;"JLF^!^6VCL3SS^4#=6S64>*\6M;^9'ZBU@C+]-[PT\=YB[`F+P MN=F]#.$V9Q$%/^$^4(@15]%-D(R67N0V2>Q*&^_@;ABO=G0'"^/XY;(^6-DP MG/G4Y&^=BEG4%\*K7?Q6,+#I%$Q(\];TY(]X.63PJ<0!3THXN8OVA][%]*+$ MR625!QJQU6R>$G%%X@OV37 M>_WC4/(JW\W&,E]#*V@/\G92)E^6/%(765@HMMLRB5@Q6 MUY^CS!$L&<6VP6YE5RV;-&HRL!DQ0UZ46D[N'43D=\,J4S0H$HUEG9MC2OLMT^7?B.9+(!HHPR(*;25M M1-0-)UU(AL07_U+(*+&K!>32%ZH?%\[\+NY@>4+-&YH.#67A!@V@Y(M/+5,Z MJJ^07LSYW]],(Y:'X?Q1QHI0=Y#QFRYZRV^6U^'J)LS%W/MR1E`%J03&6)PA MOA+V0UH,\>_1L$WI".LHIQZ])730H8N5*5'^!XIFF75CS.K/P411Z=B;KL3` M63Y3H>64GAEKUJ9+;8=N8.%N3>Z\;6%X>5K`:0[[5%B2YK!2F04A)(O"'"&F M'M4O3(_$-:4C)RS^C,K%YMKZ^MT8WFXJ)!VT0+:*FF^!N`E&QRQTO"Z)4YY@ ME"NT:)&G^\]67KQPSWX9GQSSE@&QI"[<;9]ZJL!0L:D5MB0&44#)@TY)\UE/ M&1@-UH&;QP[.`M?\J;LV;D_ZT92+AH4%^9;M)[E3[=#A$T%<37%)O&K&4"JQ M23>(Y4"\O_%HY=DCZR^Y+/?9TG&R,;.XV9]:J*QNUSUZYNE-#M$HAE)05F9J M47?MO=N,D8>$5'(#K#A;J5>S@<*;*K31J'=(61]2=+A2JQ@W>^UMKS_!0/YN MZ/T75S):388(KSQ#RD(0N<'K_7Z3AI8`W"%XCW8`1$/Q#96DDHD<#>"=!1@" M(0;+#YJ292H;/P0]+(\B=K]NT0YH7Q6=STU$Q`KS#6QOH"O)S(X0&L'8B[O8&BW"Y?*JB60W3?T-8T!F96B^A7P:]V*D2MW MR+)9/8X4-UO!AB?.]/$=3'6-MW%RP6]FP"CS3>*6I;[\?6[]D]O1-^`CFLEJ M(71E[$GM(BWAAV<.(%,0YC7L\D1&SHBCCV`/J27,#2[9L7@\OGIJF7(2>8># MJ1IIJ!>A/T1/]UDU;D^89DT8F4$%%M&'$I/RYX=MCQDO4),E3>B:MR)1PO#7 M;IQ1-PM2]DI9*AU"W0,R:O'[:5&6T)3\.%X<$K.R^O**@[6ZNET>)"L"[(8[ M]%:*FD`#N:T@I%*!F\33E05BP,>4+:U77)']2H&DN2_)@@%I.$>K`4X+_++X M)0E_$(_"2BG;)SLNNIJZLO+Q@]\6QJB0Q8FY?NX5=P!0#G1'*LEB!*\#"Y&0 ME%"0B-K*^.+,2OHII0&!R4(G2\S,1UIBK5M)-U?FO?F9Q?6K'GL+O3!$NX14 M=I^P4S,#DSVJ^^Z$V2&=.2YDYMYA9?F#8\%>@#9]X/)W-Q0F^*70\]EI6YD1 M9=]C4-^C952%,ZET;6MV+.!<%BX3`RY7`US"-QI`(3;++L3*$$$%Y#1*P^M- MD'.::WHYIG0P=,B[U+!1-HO>$S,22$8TC$]I"H`0AB=/J5;?;Y?+]W%Q>%XW-J.D0[6Z@G7#;*Z4:$ MJ&-!1)A:B#QH*&/HI(X&R($$I@5\,<7$;'D=G;)M=:H-;$"Z1P+D7&91=%@G[S&G M.BFD?4HM5EOUV)Y_>4WKGSVQ[,2$.#?1%UO]I#RN+PLM_%!/V_5[&QJ0P50R MNY#2M%WZG+F$U#6YNIP(73N>-)W*[-Y1]],%)F`ZJ(U;;QH7C6AK-^`KBH\@ MW++'KDDFHUNC%"PGZ^0W(E9S"CQ^&CP")N"MZ8RSM@CE2A.T9@I.%['[S^A% ML^VL^JIZ@TL5Q$ MRGMRX94[,>G07JOZ.965J%4=#F3,;%[?;NUDSTG"+N1J9(^?7K;Y6HSC!_.T MOJ6#-':ZM-[/RX<;/4M82LQFEN';MGG)?=)H'*EV*K[PK]LG*EOL3/YMYIW] MUKLCE9YG;[>/*82H];_D^H[1\!2=PM.\WH3K,=Q]<`#81UGQ+,U7G018+UA` M@7.BF*N@\5[:1S*8%1N0.E-+TC%13DT?61=&F-`*=WT0X>@+T7H4(:@$BFMX ML:?-^NGW?LS1>5#>3K#GN%B:TA_=/,$S>GF)K-!DA5WAKN@?T`YGU8/92$,JM.W$7E#UB7!U,6PBFLUP5WL9+I>I5D#H> M;;H-&\IH?;>3'?7&/V;B2G7H0VKATD@X5#<[+FX(KG-5SH^J M.:#L+B5VMCWZ49U(Q=NZ=4]DNC30;3TU7Q]QI-7UF'!M6%&ZY#BV1(X7&/L2 M/\1;BP6\``GPT.\%3_@6X#@J@V0;4(\NYW>+WY% M7#JODG;(?^G*5T036H_$5UQ=S`KU1NWP]K22N(;ZW%\&$AM52M(8Q[?:UDBQ M%N]?"+5N2Z4&R MD2ZJRI54&S)6L`\TB"5"Q(6+O+5T+T'F9ZUIQI@)2UH6E3UZNK+Y[,YJ&>35 M7]).ENX9L`L39>UV.K2ZDE?-?"\H\8$&;&OQ<+V#1U3$K:_'`"L]G;4?*UV1 MYG^20(*4..>Y( M<*ECA&JO,HXY&!2')B.(79S1($S+TP4!EP2IS0HJT9HH"@G(EIDY=+72M/2C M,C(SGA$/RMA#&%CR@V<.`4I(Q@,M%)'V,*FIO(4U/LMLG-OD9J M_45OU;6X/A:BH!BGJY'2Q9Z&@]8"2Y=YVI'9]8JQ5\U7T_:5Z'D-,=L#AIC M4V4J&9XXE3C8[`@5!3,(A@,72O3;5^.I!\`,Q_#4<+*PT_!=;+(36*G,?RMF M*TT5O/?2M\A(-69:H)(-8E;#@R?XZEF)33DQ`:D&E1EQ/DBGQ*]'Y/ MEYE&='>#UEBBS2&9?J6$'OY7ZZNPA_+LMN(RYNGM,B]V]4B")A*G31"\S.4E M@_,*R^=7,V`IA0X#[3GP$"8VG71'VE2.RXQN35?\,!+:2GW()1$)0D)%A+6IV3@#N]O))09^E=JF;\WPWDA#Q'YH-K7I(2%A`E:C?W MY]J8*GV,P$H-[2+7-U'M1,%H6"1(:(F`VG!QFGG#!<$LT#GOC['PCQLOV[:T MQ%FBA_\S^+26KN@V\[ZJ-B"A,U#+(`L]+F.;CY\O-"IG\VDNNV;S,#+H>.`Z MO\^7(])2-[0[V5[#Q&/W62`)-3#S$ZA]*L0WDLD9/5TU:YM5SU-&S$8QWDK@0AU%Q?E*_,':#BT$ M^-N[7J M>"DR^E3IGD'N9LK;?;((.C(,Y!4A=3YTZA_@75)RE[%(FZUPDA1Q4^#4O\DM M:CJ@<_>4AU94"4D1LC=*1F-Q44`II21ZB\/Y6[+RF/ M;;;`]O/NYN,<<;*U#2<93L^HPH6LHYO/[TM39U4H+7BZ):8K&I=.=F[P!#-K M)H'7B'8A#V+);O9,&'?N84VFN^,PXH*!&^W:!A\>T<^R9G_CBL5,>P-='FAU MQ11C^>U]D0\JX:5]TNN+V[*<2N_+LK4<#&AL(WS3UZ3.G7(%K/I1X'R()OE: M-396#(S6"QL+G=MU`6G6N>ZH0[?Z/.N$8E46/DSL5L\M"%X-^\G*,-B(&;,6 M*?#UJRUX/^7[)4Y<.G33NFO1!(]?Q!V%?"+9SW+)GRF-.]KY3(CY[^TO7&I- MK-^$;F:1>UX_N[5>,2&;)A4CE]M`@:+D&G142A*=6SHJ&6NS.5IV MY/3JZ0^O55%_0GR7]->8>>`U]*&CM2%Y-[_@CLJ0"F8J#?V\B1C@_4*[RE>Y M.H%Z3<6;0;^S49N$.F`DE_G&BQ?/*H:ER$++IJA:&7858U)@GK<[S-!P267_AF'?EUEF1=AE@)N=BK`HO=-IRJ28_S#[P^;\[Q]9CF+(:]*GW@M*F* M8IORWL[?080K(/@CB7/`U\HZ2RO;Q)LG'#S M2.4A)<%U/)ZW_H01Q;%P/NZ&C4%RSSEQ=;CJ6+X$>#UUOBI=W$GY(N:5V?+& M_"RYD=06A1O9`>>GM04R,4ZALL[0:WW].;^.3-`M)&/_.JRSRG$X=B-T(`5C M:P#Q5/3$!1SN^U1]ER=WK&7O0J\P2,(?S8PU0QX"K]_,O0P0WK_+3$.PQ&T8 MXU>Q^QILI"1M@LE0'J6CLFA]A M8V7CN=']W9S]TAPB2S]^2[-2%6KCV<([E"01VF7`'%*!J\5)(7SQAF#,FKY9 M:",XS52&(!U127W44_"]7H^V&7'Y&L^9QU'2(::,@?F*-`;0D@3)TL]BP4C@ MC+H0O)0%Z$-Y6T@U=NLZBQJK&VJNXV&!^TMN8(T)&XN;)WA_QB#<_8UG=Q?I MD-:A,ERT8'DN8XI5E:L%+=D,>.5".22$H46T7[A4[II5@7WT#@E[8A&2K8PG:Y-P0YTS6:1"%LF?S%R_N MK)#CKU5V!N8ISY.\63`Y%"$BMWAK@G^GP"0G.\4J#-7<"5:4$T>M#6XI#(S& ME9Q)NGRE(<8RV6I-AIT?5SV91CPX.@F(B.PKE4D-V MSKI"Y>=A^]K266^X4*EU?+#S_>K+[=;NJVSGX.WA[GYK^WCO8+^^@`-L):4/ MB9IT5>6X_L+>((LN6N[T(22:Y$KJQ^3'N<#F8V(74MP(KB[`W]I:Q&I\WT2"5OPRO/L`KB38S1 M^@_B#@'NQ+D5N/=C]?J4L:!GC@2+J7NJ85NY-YC-T0P,*].\*]FST&32ODP" M,DQ(C5V'3>/@]0G-61FN(30L\G2">)^@-TJA;1C%+>21`6JU+I$/U5:0X;&Q MM%^`,\K-.,!;2+*`/8?SE\P%00B$U'VW&^M!4TL>0?-^"L+A0PORMZF?G"%&0 M(S416^@T^<`]EX:X<'W*/7MXPAVA-IYX]]&%ADK.L,!=ZG@13I96WK,[=[QO M^"%2@&>:4=TA58%%VSUQ^L<4IQ4'CH*H4+#?]U7*,A;V9]RABF]9SF.[8-S) M8CB8PFH`9=R_.=H2H9/[D[T0%.K`_3Z[E1\0 M'\1*=CZ\0B4A)]7>K(-0(1B.4+?5A1RB`0%NK'H:FL`TY>GB7/2IS7Q.2T!4 M+"DKZ1G)G`SZULPXW[[*U4J[3+/C6Z",764OHO&^UR#=# MU:^,#5G@>D\D*00AO":^L;]`00$O7F2?4XX];RAC8XT=D#&]$&;." M=T=B!8C(;7@IOH)V&AAF@7TE$)N+/?##C?4HI,*8D43C/A0KXI3*0DJ30)P> M.W#\P!'WJ?(KS+^2;3Z_%9M"^GZR_*I+D:U=EW+?2KPY\U1#!MMQ3<^8;S2^ MPH6/<\+5$AD]GR_Y4)=X+C0NI_AI#BB(<:&);NEQ__SY0\V"_]?2HY$1)!74 M$H?4YTS+$2Z>BF'B@BA^.@<34$_F03J6PEO M7+:T!WC.Q#Z-"H+>-62L:@CL-LP\N;Y4SP*P$J?#YZT86K$*P M^-4SKA;HB@T4`FD/8]+J@!/'D&!CZI2L(H&@`(WR!P:%#B'-@0QIZU.+#K*6 M!4:M8?2AZ-RUKI5"U_'T`!0\7UL)VQS^7D"FXSL0E+:T(9 M9JQ$LBHK4=A5S7+25DLH,[.,>=BAAF%)_"&7V9]W?27%\VVX'64Z]<E!<`+%2>,?B!2'UM[]U[T[]\2]__M_U1W'6F;4_>/2H\/@6 M6WHX.X`\0V;58:!UJ$6U90 M%V^AJK]^E*S:^B\&G>P5JF#]EZ*#6_V75\%VSF1@8*^>B$T>2I>%7*;48F9:`-A>[[=:N)8RQS0X7+V"W1J/5J*`*N\9`,138;6G? M8E]@GV6?;+__G(C(R,C,JG+;N'MV6YI+=Y$9&9<3Y_*?VX,LB+G:R*W.S6K= M]VROYEC[%$JOML7Q782N\)((9K5A/_+[Z0D#07\JUV?4[*.4?UJD66V7W@O MHM*NDY:(E_CI%BP/J*"$EX.Z9/PZ:&?'/.U?,:CG((PM/>A.9/\_A]8J.!,G M71<^/L<&FF"$I=S"1346$(U7K$>@E986A"L.EVYQ_+LOI,+;18PP3\(]'4 M6&]BFFJ\UI53*OFD-'2=(.K(9O(=1%PO_7`E`>4*:Z">Y*1T!-!SR;6.MY@U4S>?I>1\?UM$IB.)PLDR="74<";+9=U+[Y/B5E5=N]82A MR&I\(&D49`V;&7\R$P0"X.*8Q#^W?K7X4(5'.*XV?H_**Q.UEF2CC]6WJ5`P M;!&.2S7WWPVBZD+Z$8:;&/4>&Z&^^;=*\78G#:XO_OG#^)P]LI!Y2R1B!_OG M;M%F93"SI[P"C0A"^?^<$^(M`MCVC,0'-;L6-NOC:?VK5*3YY= MTYZE7O454>*.L+"JURM'*]AT5BWU4^_3:'@."G"K`E<0OQ?;C@8UYV9?[-H` MWWN<#]J!"'6'(0N;W(802F!UA",9I/B3W#\1!P+/3@F\)T.]$@O*2'I";LDS M5T"2W>+N9RLA?SF.3!79%WEJ35<.`+D+US_@R)OO?GCR+S]8M]B;)U]?JI.\ M@[YO46G(7*,4Z*E%[GF<>2T>1%;X6:6>Q:#NU0V_%*Y!&;E9:>5)M$>$Z\.I MX4MR'%5E(P(#B$)<8EU2/H*;>2A*YZ>#O@;=5.:1.JL`<4]&IZ7&=MB_I`?- M^*S\/>C>#87YA>'LY=-O),R6V_\61R(5!RG2T*';?\VTW_);83QM:/FG!7PD M&_?%NA9H1/3@<>/O:ROK/]J?'ZZLK=;_VGUM3;,*41$U,9:"-E03G`"Z_H3& M3IP9/(^HG?/;@;@TO-^$T]@Z@D(M,95+3_:KBBV*38@#PAA"T@!L)_[H;#29 MQ<3_X%\SGYUHB('M^[4)YE%Z,14UQ8'514K205R4&R%.6S/?\_W[NOQI8>/_ M0E[_H_O?#EH/ZH=*G>CBW,6"$H90,>JY/H.F\?_$-XZ2$_2]PFLL/`LN9-"`;VFT_K/G]:"#!]TUZ;P?[5#C?/-PN!]_)Y&B9@@7'')T:1QZ,SF^E)2IE M/^4!>ALKD5U2YX33M0"`TDV5O3N!9Q-+H7CF*U.7'>IL("3'[Z0([U$4Y=VD MMRUR+J>=*%'@5_G'?8II3'U[_Y8:QGUBWGY2!)2Z6H2UQ`A4>@)6]]**&M@_'BDN#YD<2OU%I5:[X"$>D\;2%M>6UDO1>?-D$;AO M]6&YCEVBOG^2*,QG6,P,P:F$T6NP)NE)T7AHJ`F+JS^6PR\^*$2XNA[DW[*8 M-8W>+$WSJS:H,0'V8CT43JK(77OQL#'95]@>0W4)"'9Z,C,:@\923-F(CQI; M"UA[O_'FVH/&9.YV0VKW)E!,M^*>>34\ZM(9*X=V5AZ]+!Q4HN/E@AD M+'>D.:V2735NJ+AL?I,IDO)?LL&;NO\BVG+C"BVNKMQO4.\!7\56L0N:[5$Z MA?;MO[^RVEB0OKE6KI(?5YL;,$5:3RF(J<8`;$_C2.:8YC+;9'*O'/#9\'),H4J7 M(-&7U0O.JYHLG_0R2ZQ!:D_;J.I9VS>[K:MC(6B6NF^VM$_UZQH5:]Y<>JZA MOU35RW"#&"&>6^V&\Z`_N'&8@JJY4Z"7C@9@645U):DJY:5/WAMRK8?#92N* M98J.5/;PK[Q#!>6H3B>%(ZF^ZP1"5#7?Y;8=@GB-;BR9?7P++E=%G*ONQK+- M2F;J@,[R*!7"WRYAF\IN=6/R8W"+]OKN!ZWQ(73^>"BI6 MRMK6^.)$]\2\U=U*ZYO-PYW-I[O;O9U]VBAM'QWWMO>/=X[_4A^W^PYLME2^ MRCJ/`F9.Z["-+XAFUQ;V?''+FDY4Y2%KK1T"3`'Q0?]5)53-SP@*Y9_9-241 ME^VT+.+=(UE"(4'OI?5<;;:LH9;B9QOWZ;/CC?';RGE^X7U5E#)- M9*`"\!D+:ME7=_&U7O\$B-RING7C'%Q7=+SR'3@AB\(G),?H]8HH7W-L>HP[ MFXP]Y5>+Z]WOJ3FYO67PN\*D#A7$-R1MA`%D[%"Q9"I&>%^^M"5PF#L?R-?]GG M2,8ZS"`5A@P*)6Z-X4Y\C\D-1OQ](:Y(X8B;_QL=2_C@FD`+S> MZ(S;;G4SM:2V+8\;5\>MWO7O!BJ`'+X%_:GXCK.D:/EX\%>MN2%]1&^QWMA' MN6D@+*[MS^)>;T;7;ZDWK2+Q4*#:E:(7A;X%SA!#'0GVGZ+8H(IG"HW?<%02 M!JAR2?RF+0=-A)>GM(/P:ZW??'T6[IH$Z\2AH0I*IG9F;(<%N8RPE95-+ZL" M/%9=QE/-PD?ANEWZEOO,=6.^GS4=3U)1#[=C;,'^Z5!, MFWX1.)2L,G6MX&#'63OY/[Z_?,)L)N^I]\K_UT]&",:Y\J.E):QO+("$4 M!2H_+6S!^W#S68[^8@@]:7"#&BYIZV(*WHEXI!K;(=0855-8AC0OTAIH)$./ MOIN@4M3VMUAF2$$2PKY5);#H5/:+)C+P2,45^W[$_++'JOM.KJ;F&$A.^DTW--)R),5N7>`XFPUW.S0DM%%M^NPL M!47PGW)E4YMR0[XT8QRKY_+-<_83&96"'M(E*NBZ:GS@9^M/.Y75XR? M;[=36O413&U76^U#"D31,2>.H5\#S9IK@]!3-BJ6;PM[=C*$8:&D$I\?19PH MR\[`2]Y(M8N_A/5;0]/X6U@ZI,."(K(32PYI#F>C,RC,AI%&2;6TF!2(5$%L MXL!B#F^]QMET7P/'E/+5][:Y3"DLBJAV/$D`L8C16XB2?L)IWH?,#1.\TK-MI#J*O[K&?S*Y"84B#L9+"UWS/1FX809:KC*EH/VI+=H!#0 MZB3(PA=^7'KXV$J4M%HJKV)DG(:+JXU7(!&T+[>^-5*(DEJ%1NMZ@8;I4*KT M)^FC6&;L%IQ./]`T`&;_;G05O]G"8/V[9Z-?>,W754Q,XL!*L>'HE#I=FZA7 M)`QU'J'DH"GKXYFV/(^2S&XW=.-`6JS+#UO#-M3>7*7-]=FF.FRJK:PTZ^Z@ MNKGH6AJS94]KJS2N2^TD&:I.BK&UMW7[-DIU/D)DIKQC'=\]E>Q3(_3@8>^Z.TQ MY6%0>T-\0P,\,0J,E"+K3'GVB4)^$L0J`4OP5^T*K#UTG9 M*8%K(07E"BWR0KVP_FZKTTZS.NCH^B8R%KY?)31'_0MZNYMB8`^^C4QSG:F^ M:-EEE287*@76LWZ-FF4&A`VR?T=7D@G-S0\`5(@+0QRNZ3L69A)I;NIQ\F2H M%<>)BIM4H9#2_"#\"Z?AP-7B:8A7,*F<-Q*W1*@/\(.G40W&D.PE&5LF\L9( M5)0W7?"/*D*149?=9+]EOD=S4F*D,=1%IW/H6_]YQ?^TX4&?J>LT8='@+YKQ M&9;X):H;E@=;?1<+6EC_EH5[+!`2FH6L[D@97=AXE&53W.VIR":YBS.)M6V` MWL$5N+[!172WJT'J#09FNTH+K6DE((H3"W4(:I)0?/3O,W$@-\I5ZS6J()U2 M0A9_*F`%.P^\A'_2@`G7AR4(HO]SGA'XD@!19UN\ M)*TD>B%F?"*JYW*2>&N=H%9]K9"C8R*6)X`/'S$BB-]7W.I9GQ[2JK%]_J_? MK>:!K+\IYUEX9`%JTF*%>,0+O+#ZP'*1DGOISG9J1P7@1S?3-^0K7Y,GK996 M\O4\<[BD38&K^9$/DD!V7E'I>1V/V97B;^:P[KV@./+5-#7OV<[1U@'NH_W7 ME-4Z(/[):FH=E1^K`\`^O-WVXL%VS'/;/*Z"X[TB"L[`%BO;O&32T*73X2JJ M0\05,F0:=TU-WSS]Q\I2;W=WRR#/5\$^OS8G%8-11X^6OE(M"O@LJNQ29SIP M2V<%5)L"Q0'LZIX4Q)U5L16(;NF#\!7T$N>,,5#7`"D6R.$/C/DP1S&6O3[9 MZ=>]78/;;)4'%VAE(88JJ/Q4<(J]4K^S/W_WO1EH@)KR';H'TV&KL=*Z;!Q4 M?479V8-4`7(@HF,WY)%E/VHGKC(N&OL<2,O:@!N5$4E.4T`"PZKZ,C7.J957 M:0UP6;-NXOE6[#9EW9<88SYM]D<%C&9./8.BG_4O/PBQMLGN?/@T(*^R@*5+ MI+0CM;29TS/V?J\#&<3[#"&O^PZ@_L]-]1R*HKH><%RX@?ACT1U=:4QPH,BK99>'+AD7)_]5^4 MJ^L;]:M$\9,)6Z6R1SPAOUQDZYU:[EKCZC\Y+NXM[`>7)10..^SWWH9@,,UZ M8/(UN6IJ:W6<@2,W?Y<=K5[QP4K<+2B)6*_1VQ2F!Q?&59<7!]!(3*1+[`?H M9$1377/E^I%,X)KM2\YY?:^FK<"\D&?OS`$_;]%3T?,T40B='M MDA9K>R6C*NTZB`;(PJ)M<.E=?V*GO+2D MH>)2W@!4!&LZ\TY1AQY7K8#!MO&ESQ3V!-V'9\\4); MC(%O9207Z0ZAYWM^]FZ\5A91+1(CZH_.D>!!HC:BS?GW3)E*(%F`5=DU]#.< M\KCHHVMY?'TU!N>C=!3A6=?2:Z'![O2P:2,85HOTC_R@KETP0VL2R!2A6RY* M+`'$-^5[0Z;4V62X2/=`]!W#O1Z;ZAH3>RTCK>(/GF^,EBO7>G1$29[8'8^7 M,1-W7>(+QB$+H=K'*!ZX4ED\R.;U>ZJVP-A<23\.6C6_4:?C*!LCEQ6UJNG" M:C!(H"[B4VIA*.F@]"Q4V&&'I/-NL4',N6`B@5`4(ZCTM/'TH5J'F3:B&!O? MCB0(),\BG`XDA0GJF>,@\79RH7:6DZD9#AF19G*H3A._3B4^17HQ'-$J#*,4 MVY#C(%D;'J6-/LI[U&)0R5]W@HK>;?\;'ZM=!OW5'YV064\;'/GB[13#295$ MA6X5]T?ZNF:I*3L5O&L>L3^43Q-@^I;\)OM(2/*G4#M@9_^3Q0$SAT!(M3V" M)+[X?GZ.]%XPW4*JQUR?92/G2F<%?"1T,2L@N3 MC%?[`+D>QO-=\E$JMURYE8^;%]&:3!1-SJ3A9! M2MMZ5B]LAGDQ-Z?HH*\_#)R[.LC?WL`Q0QX1*]P_Q#')4Y6%<<@E2!8,^@BV M0=6W)L(,6,>JD$.X&6E#09)[#*=E)2GH7T'GIAGH(VZ'_&%;O75T48+M=VU; M=6L*QTR])LP#UJ/+$NE$RJ&IXA&;@U"Z3+U,T3.15D?OJC2TFL*ACPG9G0PQ MP]YB.B=UH55#B&"EQ=VAZ>@_X%#\7W/2M;55)H83<+!;_/78\TFAY".,#TW( M8P)UEZ2U6(P;&R&Z#T$XICG%_GG\B9@-ATTUE84UTI/#OWZ%<(3/44.3^9MR M!+]),,S7T6(^9Z&_34!&@359E?)(3/FMZ:8AC+^!@NC,>''*5?X0A2E$6M>" MG0)SMKNWL.IE6&V#%U:7UA\$K_\?=$4PQGT%'YR.SS$^IBGWOR>Z>M)&0EMN M&MG)G\+/L+E9E<`-,WLCWPN\N(T%B>U`5/:X%SDS<=XDM@:1P;@EQBPL6M@! MJ8+76%Q\ZR2DT#K/C',)6Y#!')/.", M6?V3PMHJ1PUMJCW.&(\-.%V1XAIG$SZLQ>:MF?$+J4F;0;X=*I!V+#3DOF=< M/O60L5*=H5)MC(^+3V(!8!]:)> MH<>V=C\LAZBH,$R06"S+2H*=J959:^Q+%9W=VU:([L1-EBJBI?'`E/#DH]=/ MCPA1)B"YM_V&_VU$K%0XZ\'IS?@$X&6&UYZ\1I)U)L%G+_QN0@4]R"M%X&BG M^KV':ZW)<-&M*!)X09J\AQXLT1*,8.33]^07&L!5/8;G)NMI+"C?'4<:H.IA MNK"Q\@#/%?5J`,U$7=[<*OF6#.F-F4L._B:`#$U;B4GQ-+*-5O'6EEY^O<5C M`563[\N3>>;Q\PJJ9@^LJE(HUR9R2.2X29HAJ9F*:0&OIZ2PPO[J'?YZF_+B ME>-3DA7LC$B-*:,O]11D@*]=NI=5R3-)T_C1"TYO@FRJ`ON\7PH-"'UZU/^V M\K:A7N923Q4'W7NR*:+PBHGET-)3?\L:C-7Y;L^HF=5YSE9BP[8U%H7(#*B. M"E;E-K2%N'5^,#_XPZI^[PX)I&H1QDFSX=*;"?'R!"LQP]V,6=N!-$M>Z3`R MIU<*QI1>'#3Q.*)@Y^[ZXVDYB\]PDX_.FY?C:?/K6TQ_>%WNC.'PY8]4UQ)S M@O`M=,("*5R[UQ:HA8#QGV:]H>K%`LGN_H*';[&I\0UY3;H?CT^YW1@#)\S4 M(F&K<8F[)I2_:!RJ\>96DEGB2CY?$+^@O;-)S@MPN*2=QSA7% M"G-6TWDTV[:%Y0J_^'/'PU^4;??]%/E4;497SGTYJU?#:VVTXEA8IQ2/09'/ M4N7\2!)X+;-*UJ=\FG+@W=27])ERJ+2]%B4BI^VAG,!''_M7O;2'O<771\]Z M"PT9<']JD;C=X0T4_[>#L[]M`=*,;LI)I"^:VWG"%\LG#H=4C/X@]>C41HAD MTV#AI&JN='9QV"4$:-*#FTN0E9_8W7EZ<%C^Z//M;4;W:OGWO3Y]O6XORI^K MZ88!GL=Y.+D^QT99$3I%F\,VFWK(75VHQ;J;U@?S`":]@A;K2 M!D/I2@>#G;TA?!-8R#)MR^_?6YMO8FG4E*_;2KZ-Y2A+-[VBLTX#==[_?3I. M&?:[:8W-M;?UEP8$MGU`$)"$5B['&%O]:2X?@I.:5$JW*)^ON+/SV;JD(Y); MQ:F:$NXI)2K&'V%1B*8JRK` M40BY^M,0*^"KFRE\=OL?)Z0.EB/M]<^OE/JN(.=JU+_N*N5F!^U@\A_E&]7. M=AC;Y_ZE!HEM*6#0\"ZD&\3A!<:(ZSA;IM2YJ,62FEH\&*WL8U\EO.700"YX M822SO(S1M=OZ#AJ4ZSG@O*^SM>]<#FZQDCY9G"A.%YMI=RVQZES%8<.'ZQ@# M7O?116,[?A[3W1BZ/,WM/]L('2R%$E'7FNNSY07C]@K<8G1+*(<@AG)9(9@Z M&S`*B]J.!VO8"]'JOL,R!FJEA'96#EE?:LHD\^49"X5[AN8=VHSD<"*:T[J+ M$#(GT[-]/Z(AXQFOF*FP90;I7Y^,@!5<>]6EOT1U[*VN.7=N[.JKW`=VD1'W M>;!X5$2-,]4>S[D^R8:X,";GT$_[&M"U0[[P0)$L-R-4J(!5E1_;B;,(?X<. M6)W%8!-CB[VFL["OE&_6EMBR+(75>/_NVH@V8`1/RC&/7F[U#M42A.![FC^& M#)G>?]($(/,I?N9^;OHT""<^UY)\1:TZ5=`0RXF7LWQ]F53T@9<"E"GU99,T MG*(5R8G6:IIRTENTE-&F ML?V&YXOW)H;5P&\L(,^TJ$7(+QA3#3O&H9W:DM4SNYPAY7$?6+MM:=X7<%B- M)S6M[>%*JOBTM2RANLX-PJ6++93*+VVKN9.S"-=8R@?NT0+;@+SR#\SQ48"J M8M);Z_1>I=W0UK5WG27&4;:7U+/R,_$P98)WS'"M:X),7C21*/\^MZC#.O-.*T:TK=W6U&B-.FWM5OCGCU2>YM?U&&1WRAB:LCCVB,SOM38YTZ0 M/=XGR,J/4\35^+&.8]?(J9TT.D98/#QZW>2C7^$\0D$:5`%*%#H0Y]HH990N MJPN$IHO%QAU:ZE5LTCY/7O)=T\SGS[%QRBZJG@EW>"[#1[Z`X13D;YMH[O$G M.C+8V4;'MH]37LCC)G=V5ECXJBCUC1-,WR5;9#A;%?*+$4+S6%< M]0R)S<=: MBM?/.8@+.?W)E;KY2X,D4XWH8!XTBS2RKJ4?(/*8U'#?-JQ1#A? MJ`R``):6SD&9;*DR7TS`+N<1A$:CTEK:=X1QNPA.SL*LO,?LMPA02.#_>CD9 M.\(NSX`JZ4ZLQL%2;_.\?]*_Z)?ONP^[_/4H5,+8G^HL^+/ENI7O;B'>27`- M">^6[][N:WC9_^23F_WH+AYKU"&'?:8,>30FZ&L\Z!I648X#^C2@]4/Z<+ZY!8+MC'!V!AO[\E_+5;7="[\;L MT6E&O_GHW6>R'"LU&F)*-:9RW./Q#0B910P!.Y.%73[@"9;)L6*Y7.4S]U:[ MO!A60@5P=?B1K[3;K!&UN4P.^-/^%67C"3YO>;NQ@/:KGBMQ1>1"38-OOW]$ M"]F-ZS3^6F\M=G3[14U3S`YF*FI3D_9!%X&"9W,P.RRLF=;Y-;:.W#\D3$C\ M*\_4LPK]OI+X+UQ?YD,J>U,^3QAQNC8-VHX)?>5+T5=;_EX+!2__2.TBOK3N MM8O*/\Y1:Z9\)>A#*8YAB:@'@"A<&4?O5,U/JG(QY3QC:!1V21;>F5RO9=&-QNM3RTN43^,=4]$$KY<]:-<^ MRW\S*I3G23><#0'I'0QQUZG2.7JS^66")Q5$VCR2Y6>;X8HS MW5@[%)KV6+[)$CX%0NWP[,F#8P4LE>AN04_EEW(%H2&&PO=V1YPO08Y%RW0%`5%439S?*@D=;%3]'_O M[/(U*XK<);G27H#&R%FDQ9EOOGGL[O!U^^U+X&N?W3CQHG"ICR]'NN:&3K3Q MPJ>E_M='ZV*N:TEJAQO;CT)WJ;^ZB?[MW:]_=9NDK[[[\=EU4PU$A,E2?T[3 MW8UA),ZS&]C)9;1S0_C+-HH#.X7-^,E(=K%K;Q)R4.`;D]'HR@AL+]0S"3>! M(R(DL.-/^]V%$P4[._76GN^EKU26K@7.S;NG,(KMM0]07\:F[12RZ49-?.`Y M<91$V_02Q!G1=NLY;AWEPE@8(.GN-MP'5I`FFA/MPW2I3\I=6O:7=YNE?J5K MFN]OD9^VS[4,DC`D2)_*C6$O!H6`* MW1/:@9M]8V7[WCKVR->V=N#YK]GN"=E!8R#_7N"!1\A.(]-P7CUK@J:P:4Y@ M,#9-R1YL4P`FV61GNTWVCT=L8G3-^+J&\,?HHE:TVR5-5STN:AP.T57Z"NF) MG]9+W;*@7(Q'(T(K=MB)E"U6(]!W-F57L[-9-K6FUK54RYA8K/N-*)Q:,JGD M*+3>7+\]&YWRE359EY?A%"CWV;&Y#WV#U?\N_#9C;V4B&6DE!Z6*J$< M`^I!V02$"3>I8(['SQN8.?B'+-/I$,//6BK+"Z*P+0J:V"G<5)\3'8013\`8 M4=OBI0[12.E*(%H]WR\GVU.3S%%AS]TMS/M3-PXMV-#RSX^O.YBAAK!$R>*1 M?H_S[:?8?AU/Z#S-R+[*.2")?&]#4#RMZ+PXMW9U]6"M'JA>A(QDA0B*!J&6 MM;H^@="'^\5*/M+5@H:A(='\B04_DI&^F9$?R4(M^&\EC=.\LIBR0);RM-0C M2];1Y?5BL9B/K^;S^<*JSHI@"@"N9[/Y;+R8F/`_K7BG1R";TYFNVJL(@2*O(@2*O$J74C)*7YXI MT$!2G*L(@2*O(@2*O'HMN0)?*_14A M4.15:9//O`(OE'L5(5#D583@W%XMEE6KAP>+MH/J,[/F^3%==,':<1W%&SBK M59RJ&<]@W9;MN[OUW6T*J^;8>WHFO]-H!_^NHS2%/1G%$ M\;OE2#A+!B?$EGKZ[#F?0!FS)L_P9BI.I:&L1":9X9O7YNC:G$VNLD64)-6! MN_'V0=VZ4O?16`$:";=\PQ&'8:DD#X>J.V@0+^3N$SR"NIIZ6O``B(DB)`2/ MD&%CU2D7M1$=(68C.D#01G2$J(V0.L>2JV!R$^WA!.VA@RUK/AIE34E1/>T" M$?`C$7,7*QY9 M#1(&#E<'?,DVABM^B#'"#D%*A(]I"Y9\7@#3#,?U_8]DX/_[MIQK0$OM[O9E MBZ[?@(MJR%4/Y/(0\A':POG';%Z1;8`OFPZ:-!ZDV;N=__IA'ZS=V*)7VE`5 M=*\%>JJM>SHAJK;?^-Y3&+BT*:AG8KZ+H]1U4GHE$&WJ-^&9-N`9YX)$\`S1 M;S;H!YZ$^1BB'YI.1YT(O"C5#\$EK%]F/)!KGO*@!A?@H&[#(Q,!M!8*!.`$ M%0C(-5HY!Q">*A#`DJU```%:(0`X+5$Q)`_@U%^I$F*@4@GZ3Z42:DQA):/R MA%8VE5_0WV*EQ93?032C>@N!7M$,&RT`!JEL*K&J2@QR.V1:10%LM%!@P:@K M9\B#!D(9=\!!!4`9(:CH,H"@#+0Q(B\J4MMQ.ZKAIU02RBL.SY5.V=`1GT,446DL3<';1/-6>H]C[&5:9Y)XY![JI M;JR3VRE3S\%[?HKMW:/[`FO1[`37RW:0@1Q,E7YH?.M:%^72^1F`1<#3'"*X MEM-5/;;&R%<$*2[HQH#X3K'(#T$)*4(R5S5-,$HJ1P#=A6,F+QB MV*F:<6,5*2?+"77*8812IIRL)Y4IGZ!F,'B`F3@.'L'(U0-X_*J-'QJY0R"[ M]QW.5QIMXQA<52^7I0%#B?18Q35-*FFRDVH(:2WG``9'6C%7ZE1QF@"1YF\; MHJ*_QAVKL5M[(43NFQXN\ML06K0MWPE?%G:=^#LQNKY8`-8IRE@7.&I+^O_C M&JVB9,8U/,6DM3"P:=>K3`C"19-\/!AQBL3QI88%TV"RDLRG=MU+![WD3V!A M*`2ZSG%WU+V8%[6"5+U\X="!^EXD=RDYS5CJC+:!$>:N+S@IY;FO&7LVEIC9!+>;9 M:M"8`8,!H21DAWH.(G:D%\(W<)K&PN.-]BR^7F/K0+Q`X)I>*)O?*,36M![^ ME8F'-Y%33MA)``K.YAJF'0H3XL>5:P@=D3;YC9' M.0RQ@YL07QFZ`2O!YM%.`=B>?7*69-Y,C66Y5Q[WB(DO-T29'![#@K`MB87I MZC0(-]T(*0T-+GJ]ULE`TC;O0#-\<9)$3@Y+20L.4C8KE.+N0K!P/.((D#EK MY=`JC*]3OH#2/M$H#`:3)5CKQ-:H-;9$>N-L:/8RXHP>EYPZ]$TH[1=%HFA@ M1\(:VVW+5EK/>>#X^_ MIU?Z0=0XT*".@OML9WZG$RH<78%1<\R-I*2-_@$^*(S')%.,JD5%YC MHWPJ&.69E,I?;'R;@O&=2:D\!?*012;\0=RBTD=3EEU3D-U[>U-4739@R#@C M`@/>DNWL?7A1>41>01A5W$P-$9&C;^R&6A7<3`T9D8MJB2^9.(F'?A;E]ZB*VE9.@6 M$?'>"S^Y&S9R6(8G`%)$T@=WG\;PCM/<(C:E)H+$?""/*2]EL"4B>Y5H\4SU M?/[Y`9Y*7J@D,VV4.V3=(@+\+_L4T4B.0D+(@PI$A#QZ*;RU(K>=S6$"2TA$ M!`\**D4<5!1!&7^SXY!D"Y.Z!S':8%'UW"68_6]>JD?64]Y3&][*01]F7ZX' M@*B-N[7W?OI8_G&I5Y__3-\'`\&4?^L[[W.44A%+O?K\GKQH![(86N!0;MXG M\/(6^*WM8V^I_^?A_GKQ]L&:7,Q']_,+<^K.+A:S^[<7,W-U__:MM1A-1JO_ M`F6!'R8W+V-SJ3^GZ>[&,!+GV0WLY#+PG#A*HFUZZ<#[>Z+MUG-<(]G%4%22 M9]=-`]^8C$8+8V$$-GUU!@BY27SX5IP;FX/_6.U;ZF@C@T\;^``;GGI1&&$D MY,G_'XF2N_\!``#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3```` M>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU- M&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA* MLAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;] M2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA M,S*A/D%#3=+;RHCW&+S& M2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5 M"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/ MCA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\ M>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMA MY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X M8NXS'"LY1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^ MF9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P M1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H> MSHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O! MY+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH M9IR4Q>Q,O91&\\!)0.YF. M+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM M3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8 MV@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1J MZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD M%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG M60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A M-]0A/X#:BN#[A28&80-1?F#R`Y+<&ULE%;;CMHP$'VOU'^P_+ZYD0M!P&HA;%NIE:JJEV<3#%B;Q)%MEMV_[S@F M`8<(VA>")\J5",E[-L.]X&-$JYQM6[6;XU\_GAS%&4I%J M0PI>T1E^IQ(_SC]^F!ZY>)%[2A4"ADK.\%ZI>N*Z,M_3DDB'U[2".ULN2J)@ M*7:NK`4EFV936;B!Y\5N25B%#<-$_`L'WVY93C.>'TI:*4,B:$$4Z)=[5LN6 MKW[\ M)-CF*ZLH)!O*I`NPYOQ%0[]L=`@VNU>[GYL"?!=H0[?D4*@?_/B9LMU>0;4C MO27G!3P)?E')=`N`<_+67(]LH_8S/(J=*/%&?A!AM*92/3.]%Z/\(!4O_QB0 M?Z(R),&)!*XG$C]RPB!*QO_#,CJQP+5E"9Q@'/E1_!]:PA,+J&]94F<<16$\ M3NXZ;>Y`A"='7>12/I^XK M%"8_81;7F-`/;,RRQ>CR:.*L#:".^&K3JL7H-@"5G50HPH!4'>U+36T9"X-) M\/FI4>#9F.4U3\],=HV`=K)95KZ^HBL'UBU@;/0RR1;(N)!$3H*1\YERR4CNP(+@P&_W=Z;IN[:1*`GM?"\,YI:1NXC,(-+&:NCT*KJZM=\RDUIFVH-9 M1WLFPKX)@[%,A#T9RP&,G8IL`)'T6&#.:S76DSH68\;,<3-Q2BIV=$F+0J*< M'RJHC@])ZJ+F\V$13!;-.'>[&S#5:[*CWXC8L4JB@FYAJ^?HH2?,!X!9*%YK M2K3F"N9Y\WK9T7W[SOP```/__`P!02P,$%``&``@` M```A``<,Z1MP"```H3(``!D```!X;"]W;W)K&UL ME)M+<^*Z%H7GM^K^!XIY`C:8`)7D5(/?V&"[[F-,B)-0#9@"TNGS[X]D68"V M'"^Z!]W-]J=E27M9EH1X_.OW=M/ZE1^.ZV+WU#;NN^U6OEL5K^O=^U/[O_]Q M[X;MUO&TW+TN-\4N?VK_G1_;?SW_^U^/7\7AY_$CST\MIK`[/K4_3J?]N-,Y MKC[R[?)X7^SS';OR5ARVRQ/[>'CO'/>'?/E:%MIN.F:W.^ALE^M=6RB,#[=H M%&]OZU5N%ZO/;;X["9%#OEF>6/V/'^O]4:IM5[?(;9>'GY_[NU6QW3.)E_5F M??J[%&VWMJMQ\+XK#LN7#6OW;Z._7$GM\H,FOUVO#L6Q>#O=,[F.J*C>YE%G MU&%*SX^O:]8"WNVM0_[VU/YAC#-CU.X\/Y8=]+]U_G6\^G_K^%%\>8?U:[3> MY:RW69YX!EZ*XB='@U<>8H4[6FFWS$!R:+WF;\O/S2DKOOQ\_?YQ8NFV>)%5 ML6%W8G^WMFON`=;TY>_RWZ_UZ^GCJ=T;W%L/W9YA6NW62WX\N6M>MMU:?1Y/ MQ?;_`C(J*2%B5B(#5LWJNGEO#BW#&OR!RD.EPCQ8J9C#^P>C.^H]W%Z5D6P/ MJ[%L4/>/50S9(H-52E;FS_O%8$T1O7MI4\^\M7L[(E5EBNWE:?G\>"B^6NRY M84T[[I?\*33&_!95$U`BH1D@#,QJ(9.!R ME[YAJLV+!7/=2Z0U)BG3MYA M(@),Y9Q+THZI+'(A1@]J4VTHXF`15T=,XA@/WL?7"5K90$`,SNX&)=*9OD&)@.HL8OHI+63? M4,BAA5P:\*2*'&M]&@AH()2!RUAK6600G-W`1#K3-\G8%-P&3-C&(0-L6K>P'RL&(0$;C,(*:4L"GA4,*E`8\6\6D@H(%0!JY33Y[I MV0U,I#-]DZ0UEHQTYIP&%C+04)M$9WHC\FBE=0P9A3*=L:Q+RY6DL@5!75)Y M6$FJ"%PEE1(V)1Q*N#3@T2(^#00T$,K`I1NU]]I,,C(9$0W$-#"G@04-)#20 MTD!V%5"ZF$U8K[NX7`P,NN>Y/[_,UG17\T5K0.:U$\&P9_4\IR0#_102-B0< M2+B0\"#A0R*`1`B)&20B2,20F$-B`8D$$BDDLB9"\2);BUY[42YB>/BIS::A M9W_UNV3*-A%,7ZQ.B4&G\N)%@!C4ED2YN"7%'7GQV^(N)#Q(^)`((!%"8@:) M"!(Q).:06$B"=SC)9=)P+977OLU%)@E56?$9V^2I\QD/4Y^16=1$,(/29P/3 M).^_J;C<,!3:S0(.%'`AX4'"AT0`B5`0HB<,8T@>FAD4B"`10V(.B04D$DBD MDN"6&ET6*.4N5B8OUCE2<9W!=F'K;%?&5=^Q?<_S,JB\RZ2"&IPUQ8B-$0XIT M/[AWF0(:_#KU)QT7*ZC1GT*G`;&QBH,1%R,>1GR,!!@),3+#2%0A8K`=ENDF M^8ZQRAPC"XPD&$DQDC4BJCWY_N.5/>6LD'_'HMF2K'PG%=3@N2E&;(PX&'$Q MXF'$QTB`D1`C,XQ$&(DK1#CWP3+9][C$N7.LLL!(@I$4(UDCHMJ2;UY>V;)< M.%^/FF)S\WK58O0NVQS56UU`HG?N>MWN2.N>J2$8L;0A?6=7%YL$G"8!]WRQ M;OI25M+#B(^1`",A1F88B3`25TA3K\VQS`(C"492C&2-B.I*-M)=N_(\6/(X M?8>31?#$$%#C8`D1&ZLX&'$QXIT1/BTG#X9?710I[G>-@:$]6<%9X%OOAQB9 M823"2%PAHK[LS,*0O^75*=U<9:Q1OZ\Q"WRK!",I1K)&1/4DW_!M&BG%AK`R M4IJD[1-V^(0;6/1/;V3JW3-5D#NS7],]ML+TZA!'0>Z,X0.?7JN9<"NFX4GQ M5)E13U?Q5<3L]_278X#O%&)DAI$((W&%5!XMEQUJO\P58E!.5%5B@6^38"3% M2-:(J/[D6^--_A1;Y]?^M`;D6[J)(:`&1TPQ8F/$P8B+$0\C/D8"C(1GA`_2 M!MTD:KP:G:]^.S['&)EC9(&1!",I1K)&1#4EWS1O,J785%=-J4TOFW;>R\G= ME!]08^-J@V]MC#@8<3'B8<3'2%`A8I026R-D^`ZQR@PC$49BC,PQLL!(@I$4 M(UDCHMJ3[[(WV5/LPE_;LZ=M&0E&OM+96Y;D:H,:;3?O^Y=AJLP/:W+[?BS@5T3#ZND3$TG<(/*SB8R3`2(B1&48BC,08 MF6-D@9$$(RE&^$G\[\\:8'8'6X[$Q9@>2]7C*?UE0$Y^:XVE= M?1QSS,[2Z#JN.69':EB\Q\O#^WIW;&WR-]9T=KB>+>T.XB<& MXL.IV)>'U%^*$_O%0/G?#_93D)R=]^[>,_BM*$[R`[_!^<&PO=V]R:W-H965T&ULC%9=;YLP%'V?M/^`_-X0AWPT44C54'6KM$G3/I\=,(E5P,QV MFN[?[UY,"!A2]26!R_&YQ]?'OE[?O>:9]\*5%K(("1V-B<>+6":BV(?DU\_' MFUOB:<.*A&6RX"'YQS6YVWS\L#Y)]:P/G!L/&`H=DH,QY^ARIIZ/Y4TL\Q(H=B(3YE]%2KP\7CWM"ZG8+H-YO](IB\_< MU4N//A>QDEJF9@1TOA7:G_/27_K`M%DG`F:`9?<43T-R3U<1#8B_65<%^BWX M2;>>/7V0IT]*)%]$P:':L$Z&[7[PC,>&)[!RQ,,5V4GYC$.?(#2&)+H"8!+] M]YSF?H)9_"9-^_F<\K%:MF_*2WC*CIGY+D^?N=@?#&2:X?!89H"%7R\7:!RH M%WNU,D1B#B$)YJ/98AS0R8QX.Z[-H\"QQ(N/VLC\CP71FLJ23&H2^#_5)--W M#P[JP?!?#Z;`\W9FW\ZBJL0#,VRS5O+D@0]!IRX9NIJN`BACC,%[C(9D`94/ MB8;HRV:\]E^@?'&-V%H$_#8(VD5$9P2N`"1K,H+6@8P8Q8Q8<)2PM8%V@HF3 MH(\(&D0G(Q2JE='#I0W0,G:N^!4"K9E,&QHKQ2)@@9JYSKJ(Z"U$1PJ0M*2< M)6`T)#"?)L&\FV!K$6T)BRXBZB,N(CL2P*4#$C#:E7#;3;"UB+:$91<1]1%7 M),P')6"T*X&ZKK.0M@;JVJX/N2("W#U0!XPZ(AS?;2UD5FV+*5U2YWMDO[=% M7E&`#:>_]S#J*+CXVAK20MH9J./9J`^Y(F(Y*`*CCHC+>"O"0CHB'-=&?&PO=V]R:W-H965T'4,2:U12ZDQF?_O=38.A%TS_S5^^-__V%]NAH/3>7UX6N_* M0W$__+LX#?]Z^/>_[M[+X_?3:U&7\:GMV.Q?JH6VN_&^F0R'^_7V\-09+@]7I.C?'[>;@JSW/S8 M%X>S2'(L=NLSV_[3Z_;MU&3;;ZY)MU\?O_]X^[(I]V\LQ;?M;GO^NTHZ'.PW MM][+H3RNO^W8^_ZE&>M-D[OZHY-^O]T9NW$ M6^!;67[GU'OB(;;PN+.T7;5`>AP\%<_K'[MS7KZ[Q?;E]\87V90[MB;V M_V"_Y37`WOKZ5_7S??MT?KT?3N>CV6(RU?39)V$_ZR3:;&3HL\7-9[),ZRSL9Y-E?O4F&/7"[&>SL#[2;V;:;/Z) M-\+>[8_D^8%TBV]&GMS7O8+5;M@IVH/+H M5QZ^'[(-9H?BB45_/AB:=C?^R7J`36U6PK#_6T:7S6/7D"QF(WA/P5=MB<"B M.MYYP*8!AR[BTH!'%_%I(&@646Q\V#5DXZ-&-!L?T_4D-)#21;(FH-B2O#&\ M!V8-=VD]UO_UM1X/\]9K-FLE`MID4C?E=#DC#56+5F.2IC2;I!_;J<_E)!9, M8D/A=(6AD?6XPBR7OWLW7C<)>3<^%`%:20A31"A%#%,D4*0]@NROK$L,G>R0 MO&L^A%1SK$?NJSD>EFI.!'C--67X6(=:139=+N4:,FD>J[N0H1GR0G:?(17N M7&'<*XS79Q;R]OA]YD8V09\A.R.\PD17F+C'Z!-Y>Y(>HY%]F%YALCY#]D_> M8_2/=4GEQL[@[7(;\`O+*>_'Q(F*ORR5G0A(95>'6F5G:%/YW9LTC]4LU!2O M30,.#;@TX-&`3P,!#80T$-%`W`0^^F&#ME/28W1R[DJO,%F?(7LN[S,?ZY+: MDEU0M=NR:4,>EMI0!*0VK$.7OL2D"UE4V#3@T(!+`QX-^#00T$!(`Q$-Q#20 MT$!*`UD3:+6Q3OJ\O#'TFH!=K+9W,CU@^,OL"&H?#/0\OA*&->SERN[CX*P. MNT^<0`[1^G'W>;UQ,+$Q<3!Q,?$P\3$),`DQB3"),4DP23'),,F51"Y05C+*`N6OTRM. M,I.UXA/Z#+6KC]3>8TV68O#"&!E+Z=^-]86/MJMZ5S$:+_>N="B3?Z`$%:\@=J]/:N,M=3!Q,?$P\3$),`DQB3"),4DP23'),,F51"Y>/EZO M*EXQGB\7+QWZU%2#_F)2"!,3$ZLF]2"*=F,L.K?&-D[C8.)BXF'B8Q)@$F(2 M81)CDF"28I)ADBN)7)]\"+]5GY>;?3&T+]&S;9U/IN`$%B8V)@XF+B8>)CXF`28A)A$F,28))BDF&2:Y MDLB5RW^`:Y&U_5 M2'6+7Y/Z]#<93*26#%-2J1LJB;*:4JK,XN0PP<0(+$QL3!Q,7$P\3'Y,`DQ"3"),8 MDP23%),,DUQ)Y(IDY^GV6;S37?+7:7=)A^QU@925"8F)LUB8V#6I)[7UA7[3 MN75W,Y5DD&'X58V4 M==F=2B)93)S%PL3&Q,'$Q<3#Q,2/@MDXBX.)BXF' MB8])@$F(281)C$F"28I)ADFN)')9\HF8UCUYYVPN)FK8N?CR:?=%Y]X'3N8\ M\B^7LRH7=67,NV=84Q*S^;)3>)8DOO0EL6NB.$X<3%Q,/$Q\3`),0DPB3&), M$DQ23#),#\"^`4?BGG;+OO+?C^TF]7 M??E-_99]T9!_P^ZR`O8LD[?U2Q&MCR_;PVFP*Y[9)D]&"]8M'\5C3\0?Y_*M M>KK"M_+,GF)2_?K*'D]3L"<:3$8,/Y?EN?F#KX`_;J5Z/,/#/P```/__`P!0 M2P,$%``&``@````A`%,RJ[W``@```P<``!D```!X;"]W;W)K&ULC)7);MLP$(;O!?H.!.^Q=F^P'"0-TA9H@:+HF=)3]$J6$GMCNX0HO.%52 MR]+,`!?X0*]S7@6K`$C;3<$A`UMVI%B9X[MH?1^%.-AN7('^<';0@]](U_+P M6?'B&V\95!OZ9#NPD_+)NGXMK`DN!U>W'UT'?BA4L)+L&_-3'KXP7M4&VIW9 M*U0VH`2?2'`[`Y`Z>7'?!UZ8.L?)?)8MPB2*,XQV3)M';N]B1/?:2/'7.T5' ME(?$1PA\'R%1/(N7693-_T\)?$0NDP=BR':CY`'!>("F[H@=MF@=0PFI-=Y9 M:XX7&$%4&JS/VV2UV`3/4`QZ]+GW/O#9^\2]1P#T7@("GI"P5BMAJV4U[[UA MR$M6RVEB,DFTU@NB-UP25]/$=))HK1=$;Q@2TS"<)D)C!UDC.QMIUA?8GL(4 M#(H7+<_)^H)X'Y#L"YQ-2\VOI9*PE[*G.8;J]I@TC'J0E_(^J>OT&Q6"81CD MIVV+]`6RFCE3L.U$5;S5J6`E7P]D"YDWY)>8? MC.S[)KL_[ZV_P```/__`P!02P,$%``& M``@````A`),$.;5/`P``MPD``!D```!X;"]W;W)K&ULC%9=;YLP%'V?M/]@^;V`"9`F"JG:5=TF;=(T[>/9(4YB%3"RG:;]][NV M"<$$M+XDX7!]SOWTS>KNM2K1"Y.*BSK')(@P8G4AMKS>Y_CWKZ>;6XR4IO66 MEJ)F.7YC"M^M/WY8G81\5@?&-`*&6N7XH'6S#$-5'%A%52`:5L.;G9`5U?`H M]Z%J)*-;>Z@JPSB*LK"BO,:.82G?PR%V.UZP1U$<*U9K1R)9237XKPZ\46>V MJG@/747E\[&Y*435`,6&EUR_65*,JF+Y=5\+23W#%7W%"RF4 MV.D`Z$+GZ'7,BW`1`M-ZM>40@4D[DFR7XWNR?"!S'*Y7-D%_.#NIWF^D#N+T M6?+M-UXSR#;4R51@(\2S,?VZ-1`<#J]./]D*_)!HRW;T6.J?XO2%\?U!0[E3 M&_0 M',\Q`J<4H"_K."&K\`524;0V#\X&/CN;BT4([)T$^#LB85`C87)E-!\+ M.T6/;S;*9]`_1)UU0 M'CTTQ)`^B6Z#^87?6/C\#B%>79.)E)AK\=*,(^X;`Y_>(0/WLW'W%R/TBZ3+ MC7GMDSMDX/M\G-P4Z,IY,@\NN;$6OD`+Q7[V;R<4S,0-TC.;Q?WR&E<',;30 M((C%A(09PH$$26?]"IM4#R4IZ:7*\2;!+CD^XDZCY>%!R5NY]]XE/`ZD:FH\YC^^?UTMZ1$&U:G MK)0UC^D[U_1^^_G3YBC5BRXX-P04:AW3PIAF[;HZ*7C%M",;7L,OF505,_"H M,@/QZT(T^JQ6 M)1^1JYAZ.31WB:P:D-B+4ICW5I22*ED_Y[54;%]"WF]^Q)*S=OMP)5^)1$DM M,^.`G&L#O@3=F`OY0M2GU.$X+![=?JI[L4-I?LGC-R[RPD"[9W@D MD24XP2>I!,X`I,[>8AJ`@TA-$=-P[LP67N@',TKV7)LG@6(QG1!">AI0%^W0;#:N*^01G+B M/%@.?'8:)G@\6Z.L%TWKAI!ZB4)%>.$'H=0+6PG*B M'F?6,08A`V4B9$1C&LU[YX/PDK3U.)%ZG!L>T+.>!\&V!W,'6GEN`A):NZY$ M%O%AQ+J:]P,8I`!17LDO_;X^,H;Z%O$'/0AO=`&&8ZP?+L.^/C*&^A89Z8?3 M+<#U=AG,MCRAOW(NY4'"4-XB(_EH6GXU(>_-G<5%'QE#?8N,]&]T%YLTCC^8 M+WOQMXRAP0D:.W*%% M=-D@UL)N<;M!*ZYR_H67I2:)/-1X?Z'Z'=J]/78!UFJ,1^N=?:NXW2^P[!N6 M\Q],Y:+6I.09:'H8-U'VO6`?C&S:Q;V7!M9\^[6`]S>'+>K!@)%,2G-^`&>W M^X]@^Q\``/__`P!02P,$%``&``@````A`"X#$Q6-`@``%`8``!D```!X;"]W M;W)K&ULC)1-;^,@$(;O*^U_0-QK;/+9*$Z5;M7= M2KO2:K4?9X*QC6K``M*T_WX'TSAVDD,OEOWZY9EAAF%]]ZH:]"*LDT;G.$M2 MC(3FII"ZRO&?WX\W2XR<9[I@C=$BQV_"X;O-YT_K@['/KA;"(R!HE^/:^W9% MB..U4,PEIA4:_I3&*N;ATU;$M5:PHEND&D+3=$X4DQI'PLI^A&'*4G+Q8/A> M">TCQ(J&>)NM[I>8;-9= M??Y*<7"#=^1J<_AJ9?%=:@'%AC:%!NR,>0[6IR)(L)A/)/)DMTDE&9QCMA/./ M,JS%B.^=-^I?-&5=],CJ_H(P2(O2:0^*H:)G.O#,>L'G>":654 M:4>`(R'1RYJ79$F`M%D7`BIP;4>:ESG>IJN[!2:;M>_/7\$/IO>/3*T.7[4H MOHN60[-AF]P&[)1Z`WX*=&!2_IOK&_U.$;%U5M8;>G;@E3 M#3C!%TGAC@!43E]RG(&#*&R=X_%L-)TGXS2;8K3CQCX(MQ8CMC=6R7]!E'KW MP/(YW%-+-VNM#@CV%=2FH^Z4I"L`'\V/A)@.-(4Y]=;)HCQTU=T$#WZA)HX*`;?0&OY[WR<)%G85K@/.\"X$^+[O.&P]XOI;)-*;N M9J%E_;06YZD'S:2GF5ZW`LF5U%TTQY-9;WV6+B,AE',4]33O>,"F]CQ\.>-E M+,?->J_8IQ!)X0#&QO?=!ZV'%"_8R6PT?VN74PSY(9(.-B)+8G4#/IR0"_X\ M&;WAG6"(#Y$S_#LGQSU]YZ=VDL;>N.DA/$3.X.?'*%S1<#TDUQ7_PIO&(*;V M+70T`WR,QI=AF[F#>AZ?K+;^Q2!Q`BYR1RO^@^I*M`8UO`1DXAJ.=+CS86!5 MYR_E3EFXPOZWAJ>9PT5P[4.E4O8T`&,2'_O-?P```/__`P!02P,$%``&``@` M```A`%)N[M(C"0``6R8``!@```!X;"]W;W)KS?YQ3O MQ>+8._NP&I\J%@^KBH?LENY^_7X\3+YUEV'?G^ZGQ=5\.NE.V_YY?WJ]G_[G M]R^_W$PGP[@Y/6\._:F[G_[1#=-?'_[ZE[OW_O)UV'7=.$&$TW`_W8WC>36; M#=M==]P,5_VY.\'RTE^.FQ%_7EYGP_G2;9[UH.-A5L[GU[/C9G^:F@BKRY^) MT;^\[+==VV_?CMUI-$$NW6$S@O^PVY\'%^VX_3/ACIO+U[?S+]O^>$:(I_UA M/_ZA@TXGQ^WJM]=3?]D\';#N[T6]V;K8^@\1_KC?7OJA?QFO$&YFB,HUW\YN M9XCT\QPHH[9-+]W(_?2Q6:E%.9P]W.D'_W7?O0_3OR;#KW_]VV3__8W_J MD&W4B2KPU/=?R?6W9X(P>"9&?]$5^-=E\MR];-X.X[_[][]W^]?=B'(O:,BV M/V`F_']RW%,/8.F;[_KS??\\[NZGU?758CFOBG(QG3QUP_AE3V.GD^W;,/;' M_QFGPH8R04H;!)\N"/[YP8#*#L"G&_#SL]8V"#YMD&)^5=3S:V(N)Y^9E>N, MM9MQ\W!WZ=\G:$.L;3AOJ*F+%4;:5-D(/GFHX9:\'\G]?KJ<3I"6`>BWA^)F M>3?[AFILK<\ZX\,]&N=!%:&P;0JH")B!J:>+S/X,77(GNFZBM0,"_S+AYCS< MD#8%5`0P;JAGRJU>^,R1%?W%,G?#YUX;'PP*]!;[WT_HZHE/(CDC2`DS1(0K)(2'HG3U(@*D8823II@^JXHA+*F5@$<:)TI3O6 M.WDF`E$QPIC<9ID0RIE8!'$B)E62$^_DF0A$Q0AC4N"$TR`A M##3\Y%8?X]0:B*TNAGA84K40-K,Z84[`:=!LA5H M^-49-6.U,Q!;70SQL"0T(6QF=4:)V`0&^FQUUHNO+IS;G`:I3*#A5V?%)ZZ= M@=CJ8HB'):UZ=2ZI.%%OI935_S&PFU$E(,XI.3 MUH2=X%N0X*1(!L(ZW#(;>C""5P2U$E(,XI/GM:N4VF4AUO^Q=IEG'NFE&,0G M)QT**]>[I%A<+;&F<;???EWW:/'"/VR41K9BO;,0SM60$>-%^8XV2'*]:NU` M>+F!BD&<9UX"2RF!%J)\1Y.G-RKGA?1%7LE]IG5>-^:)=+&8TW]^H^M\*^M4 MF7<'[*&2"ZQO*RFKI8%`VN6BD5#KH/#TQ:**V@A M['G'IY608A"?G(NOGUQ*+LD*=D\%\8L*D5X&K%=2U+13 ML+Q2$[-$!"R$#Y>=QD)1`5L'1=5R4&9RKM0^85*.*P/11Y2P<.LSBNB\:M.Y M95$N1>>VPZ^*$>BH'98K' MM?NS,Z:2FFXAUE'&"Q4).1.0<@/U#987+*_-E=1F"^'6YV9J+`3]71>IJS+Q8VHJW(NLHAU7M$UG%"VBAZZ MN;%>6(7/EX.B#G)09G(NS9]U4"TEVT)Q$2V$%@FDS,`(4LR+%Y&$6&I2;?0Y MUB0+\2(6R9YJG!RG'0"LQ)>E*\Y)D=*&3`I2O_?G^!)*[[&3$]E!00T:";424@SB MI/**CKJ*R2T$^0F%*](')#@279PLE5-,+=_#R M5"6D&,2I\N-"I_7C#EB88R/N``LE5-.K;O`*5,41I)@7IYHY7#[I`'S)G(J` MA1*NZ;TS>`6N]LP)9R-]ATWA$0M>AJOY3MI\PWKL+J]=TQT.PV3;OYV@.0LZ MTCULO@Q?U\L5;5&$$)8;6+0."6.A;=WUF"TOIOH]/ M+07&F.?-U%)B#%YH95B7%2SZ1!-C:ECTL9):Z@76HP\%8;F&15\+4PN&9$=@ M0-8?:!R@)7G MQN#G$X_9S%.Q,G.LJ50Y'!/DZO18KQ[1VI+L&O7+$<(]&Y&RR:KG2$F.5`,+ MW3?E+"TL;=:":R\(Y,8T-=:(*Z",MJX6JS4>R:2E@86>WZ0%SX]83\ZRKI:( MEFN7!I8V:\$3%Z+EQV`]YN$D;>ZJP#RY]32PT%L,R;J%A5YF2(N"164MZPHM MB\=Y.::!A9[]I07O'A`M9UF7R)MYM9*LIRF1`_/2W$M@Q) MFTW_OJ1F)')&M)N79,TYFCF[CTV^`X#-?' MS:;?'>MSU3^TU_JB+8>V.U>#_MF];OIK5U?[\:+S:2/#,-F]O0E6[R??X8^'^W.RZMF\/PX-VMP&BRSWGFWRC M/3T_[1N]`Y/V55[?:UX?J[33\T;[_7#>OQT&7.S:7[-J3 MCJ3_79T;TP-ZZ]6W\?_W9C\Z/73,_EJ99A./VC-N M`7G,F]*YW1GT1P,?+])T>[WZ]5FH]&GS56=IAY@",&FPLAB**">$2:[F,9/1 M6^1DHG".;:PTMHRIX\(#H8ARB<@M?T)&9^,.&6/5970WJ3(:JP",'-*@O/_1>`@?!*1HQ=Z9IEFEDS M"2^T7'NV/RYS`JSI"P1!,ZQ58A4`2H!V;`$*!VE`"+4"`((BC%&K8DYBRT@T,)&"6S M!/B`"A`Z2H1/*((P$TQ,2V)=Y[=X&#VS/*:A$"!S)+ZP?8V5`!#$MXG&.KC& M2%HS38-?)_5#P7(J6-,5"(+PNBD7"0`G:!>9I4\IW)=*`4JGZS$+D(A9J`)! M>LLSB'5->1=""5'1G$L".D=*PF6Y$`#"0111ZMP?L"X$$<>.X%(6?K44'KET MA@P;`T"8^4@R.2G1R<122#OCE`.5S,60>+0S8>-8"%<=E8B8O21V&2>V;H2* MI.K)J8QFIJ*);3A("X(@+4G&FJA$,V8E5D[I*!4JHE-_2)]XVK%#"JXZKI.0 MV4MT`AQB(>S,40JZ"QW56&3#F'DV6!,4$D"0C64R7.LZ\.+?OP02LC(WE)/I5GF&;&MAD0`A`V@I%QT"`6(6S<7\WKCD%B4 MQZ.N";^YC#ZV`91GT2;@81I@E2K;ZS0=5%SG7@51U36>]5+PAXI"`@@81*Q] M2K0BA2C+;5DI`ZJFBUQX5)7?20KI:J9(XN78`(`GBQ+Q"ZKT":J]66-G$$'E M'5RBC_OA[VNI]&FI+2K2<+542+EX]D$O6!0I4V5[G"1#/_2Y'3KUQ;C,QF3Q M@H0@V.V:"WZ)9N`@LM`.$65`593W1>11TY2-08$@#"5U,/9B0`!K&>;1#4&- MC-Q9V5BP`34D.I:R.UDQ^C`3:X?*9G\L8'D70M-C1-$2F@L$6DD&UWG?@3:) M`(1=(%3&2UA2A-1OL;?R8A3/0P.$D-)@"E%$KEJ*Q.T$S(8+B$-WK&DNJ)S. MN?#(:&I5"',!(&Q63X=0)8V]"%-`[;>>>Y1?/\=EG@5^,T'0/)Z""4F) M@*EG;W*XKZ#*HZ!<(`L$82C%OPB6S![9\2(54??ESA&$:4FD\T@# MI2$`D>7.(PDEXY=.Y9%.+HP%@I!$G/-/024"YMK8(:8WE%11)5TDQ:.H3GZ1BJNH41;S^_T88QL@ M577K*ZWR:^JXS+[/9G8"D<*DJ;>?.M"/;I;Y:=\2I>6ARKK(B4=AG<^=2`A` ML&>I=@OB>/<9E)2<9"%`B",P3^9F5.V,R[(%B=3H;P M<'@&1T[GNGNMR_ITZE>[]NVBLR?TY_AY%0[M"GUH-QY\;6:#/DJ[5J_U;U7W MVESZU:D^Z$O#AU2/4`>G;O!C:*_C^=!+.^A#M/'/HSX=K?7!5?B@P8>V':8? MYNAI/F]]_@\``/__`P!02P,$%``&``@````A`&X-%I_$`P``\`L``!@```!X M;"]W;W)K5C MVRNU4E7UXYD0)T$+&&%GL_??=VP3L$V5W)?=P#D^GC,S-K/[\MDVU@<>:$VZ MO8U6GFWAKB*GNKOL[;__>G/6MD59V9W*AG1X;W_'U/YR^/FGW9T,[_2*,;-` MH:-[^\I8OW5=6EUQ6](5Z7$'R)D,;1*+VL;U/2]VV[+N;*FP M'7Y$@YS/=85S4MU:W#$I,N"F9!`_O=8]?:BUU8_(M>7P?NN=BK0]2!SKIF;? MA:AMM=7VVZ4C0WELP/%O)M70V$DC-;@9PK`UUZWK@;%Y0.NU,- M#GC:K0&?]_97M"T0LMW#3B3HGQK?J?+;HE=R_V6H3[_5'89L0YUX!8Z$O'/J MMQ-_!8O=Q>HW48$_!NN$S^6M87^2^Z^XOEP9E#OB2RK2P$[PUVIKW@-@O?P4 M_^_UB5WW=A"OHL0+D!_9UA%3]E;SM;95W2@C[;^2)$*?1/Q1!%:,(LA?^>L( M1?%K%5=&))SD)2L/NX'<+6@/V)/V)6\VM`7ET<(8QV0*#FJQ^M'NG#Z/Q2=D2T9FT2GY$N*KS.*)4,1T1P%3QUQ%/I'R2X*-OI> MJ>2$"LX&>ID*%G62]F7?7PH=CH80OCHC281PUZA%Z^D:IY,!VDU4C MTNPE(W_)*)XQ-$/Q4T,<->H2SID1QS65G%#4Q8]"W6ZFHL@SDI&K:)@8ET>A MH?'5(2CI@'C-*:2(PTXR#>BR'0X,*J5:W"0&+=;H<&^/\.:"3X% M&#>OTE8<-4T8_9M*CC2!E&U$C3(5=1865!1Y1GH*%?7#>5_-P$8S\#C6_*T9 MN-$@J>3$\EC[R:PO(U=A)UPO.DC%P\`SJE.HL)/$X5Q<+7P$W_LG!1"P:<38 M*AU)L@1&HV<:Z"#C\LHUV/PJ%1KJ1/,!U#WPKZ+11&$T??U@^%D68VY'>99' MTGC)+JNAX5".I1&YRR@0!$8>^`C&HY`X%&1CGFHY8,FQI,7#!6>X::A5D5L' M%Z8/=J:W#WP$F6;UPW\```#__P,`4$L# M!!0`!@`(````(0!Q!5==OP(``$,'```8````>&PO=V]R:W-H965T&ULC%7;;J,P$'U?:?_!\GL#AMP54C4AW5UI5UJM]O+L&`-6`2/;:=J_ MWS$.%$C5]B6!F3/'<^9B-K=/98$>N=)"5A$F$Q\C7C&9B"J+\)_?]S=+C+2A M54(+6?$(/W.-;[>?/VW.4CWHG'.#@*'2$>IUG.2ZHGLN85>%*I2FK@ M566>KA6G21-4%E[@^W.OI*+"CF&M/L(ATU0P'DMV*GEE'(GB!360O\Y%K5NV MDGV$KJ3JX53?,%G60'$4A3#/#2E&)5M_RRJIZ+$`W4]D2EG+W;Q"*:EE M:B9`Y[E$KS6OO)4'3-M-(D"!+3M2/(WP'5D?9MC;;IKZ_!7\K'O/2.?R_$6) MY+NH.!0;VF0;<)3RP4*_)=8$P=Y5]'W3@)\*)3REI\+\DN>O7&2Y@6XWYS%9 MP$GPBTIA1P"4TZ?F_RP2DT!$&Z&JR/6Q+.-MXC5(E=,#N'66#485;S(63?0JP^RQNWAI<8,@PY MM`C;$,B]$P!E&0L(_2Y?ZQWF&XS3?04R/'I_C5@MAI#X&A(,$8=K1(]DH"@< M*&HK;ZTP-_VJ+H='[!QDVH.,M.[?1<3O(@YO(08Z()$W.F.]$8:J=%-"PM&8 M[!QFV[[7C(=CV'<=R_"<3OZ7D+\EVD;2("->$."]8XEC`9CYS!. MPDWH^ZN1B+[?'_KBON^56+C:[/F.^R76"7"7EEOUDJN,[WE1:,3DJ8*"!U#2 MSNKNRAU9PUK"=HWL,=RAC=WK''"UU33C/ZC*1*51P5.@]"<+R$>Y6]"]&%DW MNW>4!BZUYC&'CQ6'A?ON\[?]#P``__\#`%!+`P04``8`"``` M`"$`+WM,)64"``!*!0``&0```'AL+W=O9!@Q257'Y=#@W[_N+E88&4MD1R8E68-? MF,%7[>=/]5[I1S,R9A$0I&GP:.V\25-#1R:(2=3,)*ST2@MB8:B'U,R:DSWE)Z)'M!V_P@E.MC.IM`K@T!/HVYW6Z M3H'4UAV'#%S9D69]@Z_SS4V%T[;V]?G#V=ZM^Y*=BS&B.V.5^!M$N7./D.(`@?66V?)]X M>4;TV915#-ZM0NE/`BNS500%LZ`I3S155)P%#Y)W@G>S#8:(8^YEMHZ`8!$T MI:]>'M?.X-`5)_#7>;C55R9Y%D'!)&C6*^^2):^3"#T=.D$P/;`O;)H,HFHG M?2.V=9R-5^FZ\+S[;*LL]+;_ M'.&?Q>!L(3",>J7L<>"N6_P+MO\```#__P,`4$L#!!0`!@`(````(0!RS*-. M&QH``.B!```9````>&PO=V]R:W-H965TZ)91Y[)C=G=:[4LVXJV1(>D;O>\_?P@D`02?]+MOFFU MOSQ4XE!``E4%OOOGGT]?+_YX>'E]/#R_O^Q=W5Q>/#S?'SX^/G]^?_F__VK^ M,;V\>'V[>_YX]_7P_/#^\M\/KY?__/#?__7N^^'EM]';PS,DGPXO3W=O^.?+Y^O7;R\/=Q^/1D]?K_LW-^/K MI[O'YTOOH7CY&1^'3Y\>[Q^JP_WO3P_/;][)R\/7NS?$__KE\=NK>'NZ_QEW M3W/-T7\\_/AY>[7[^BW'_VAG?WXOOX M#W+_]'C_/KS[^(@2N&J_>'GX]/[REUZQO^U= M7G]X=ZR@_WM\^/Z:_/_%ZY?#]_;E\>/J\?D!M8UVWC\_.4-S3UR)O>'K[@2_GOQ].CZ`(I^]^?Q M[_?'CV]?WE\.QE>CRU?#_F@R/5[^!Y;#8(F_P;(W^6&,*,VQH/@KEQI=34>C MX7@Z`?O!I<;!$G^#Y2C6T`_L$,_QBO@K5_S)PN$N](T2*[3_D\'VI$K=__S- MR_:D4M%33K8_>UVII5ZLII]M2]=ROKQ)5?WXNM>^&Q^[?W7W=O?AWZ?^B]-_?PE%=/)7T#\^]$?C=]=_X-ZZ M#SHSUNEIC5(TW/WEW%8YJ'/0Y*#-09>#>0X6.5CF8)6#=0XV.=CF8)>#?0*N M4>VGND=O_5MU[_1=W4NMS00DC9%5M&B(296#.@=-#MH<=#F8YV"1@V4.5CE8 MYV"3@VT.=CG8)T!5-&YMJNCAZ-2GG1CCN.K3$UV1,Z\#HUC7(ZU2GE1.E4VD M)M(0:8ET1.9$%D261%9$UD0V1+9$=D3V*5%5CR&2JMX-EWX>X/'%Z;^_'&)0 M3`:8J:[I65#Z46.<5$Z-0:0FTA!IB71$YD061)9$5D361#9$MD1V1/8I48V! M"DL;0\9TAX]U+G4U"T0/\UDKE"R([%.BJMBM8?,4$.DSNOBY0=I9Z-KW9(QKQ-H?WV2U?U(ZU3Z1 MFDA#I"72$9D361!9$ED161/9$-D2V1'9IT35_JU1^X/IE5M-GJM^9Z*KWY.L M^O.D^Z1TJGXB-9&&2$ND(S(GLB"R)+(BLB:R(;(ELB.R3XFJ_AZV"OYF[S^: MZ/H/*&N`?M;_H]:I!1C5C!I&+:..T9S1@M&2T8K1FM&&T9;1CM%>(=T>;K&4 MC$:2H_3\(@J)H=3=3%`RA3*J&-6,&D8MHX[1G-&"T9+1BM&:T8;1EM&.T5XA M7<-NE635L%\]J1KV2$^JXT'>K4]:TC15CU#-J&'4,NH8S1DM&"T9K1BM&6T8 M;1GM&.T5TI7N%DA)I1_W6?YBF'<[4MDX']``-T,RSP[S!O&&T(H-0JB.OD2K M8=0RZAC-&2T8+1FM&*T9;1AM&>T8[172#>(624F#G,:9L'A*QQF/LDK/5_]N M,Q"MI2J=4,U:#:.64<=HSFC!:,EHQ6C-:,-HRVC':*^0KG2W;+(J/2RGTDKW MJ#\X]>'2;1N@AA-4,:H9-8Q:1IU".FRW.K'"#JN6-&R/T._DIBK=!B_"3E#% MJ&;4,&H9=0KIL%W&+V%/3[M=;IC(#ZG5A.61TD\9<\C51!"==!*#)N`LH)D^X)MU(H%\>YA M"*0+XM+06)"PV7[EGJ>\?7F\_VUVP*C>BRWELU950(^2.,N>1WT,-LF^$1ZR0Z(+?RB069Y(M(T7*N M_O@P&`QN;C*5*J@,CH_\CL\7:K&Z/?7P1A!NSWBYFVPN;8/6:'"\W/AJG"ET MZF*ZY&DJFY2<,]F^1RBY5&@I*.[V5X)B&6I&C:#HJPUHU#^Y[T3KZ$M'[5*W MV$=E7NS[C"[MBP$-,"S$"ISDJ\Z@-5+=@FE'S4[[:J"6UV2E? MNKAI8I8T$N=>F'>.$WQLD3(@E$VN5(E66A#*O1HV;!EURI>.VF461B/YA$,U MDD?9396G\&[PP)R`'I(V9=;5JZ"5^(W5?>93<"Y4KC\LKXAU3"TK+0(9MT$I\=1JFGENHT)LLM2- M+KQ+'6+A_VKBZ_M,0U5*2#[2N\^C46RW*AB.8D96!Y3,_XUH1<.642>&1U^Z M-&Z"CZ4Y#9%^WE=1>^1Z13)$9G-SV0]:?DKK3T;&E.95U)06K-(^&A#:(5Z. MIS2O%:>TK#MT(1Y_,5WROY?`]#F!"0@U(MVF#&@4F[82-#UIU6*8%M>['T74 M!JUQG/H[Y4N5!@5,VY%ZY;\.W])T[*BN4Y:`DA2J#&@<[Z6*4&0>Z6HQ`:H&36"U$U`O3)H83!U`\[X M:I(-.)VX.5Y,EURG+-2.65H]X%0FH+17!I3V2D%)KQ3#6`.-:$74!I3V2M$Z M^M*E23,2MRCRK^3$54+>+3E5&7@TBG=!R:AB5#-J&+6,.D9S1@M&2T8K1FM& M&T9;1CM&>X5TS:=9%6I>!O8!IU4!(4,[#6.,*D8UHX91RZA32(?M,A.9CM*P M?<:2SD<#CY*]B))1Q:AFU#!J&74*Z;!=MF"%[;,(%;9':ICU"(."-$`U(%0' ME!@V`67+^BR[:J.6N.\4TB5QB8A5$I^@J))XE`14NMP,Z:O;%!,7"I@542GS*HDGB4!%0>K;&*P(P3TX]IOCJ/6A)0'5#B MJXE:J:]L<=E&+?'5*:2;*4U>K($UGRQEXE`1:!N26*['0XRS%JZ*6!%JS MKR9J);ZFV5JYC5KBJU-(%7J8YCC)X'#D.ID)*$L+LN8K1E-."H()4 M10*LQ2I.BHT@W+6QXB@M"%HA61U=#;,NT*F+Z:*G"5%:=,Z(AAZE\[^@)"L5 M%`M1,VH$Q0RW#2A=*(K6T9<..\UFTK`Y;1EZY&[Q6(6T`R-:0Y]960T6_,3! MM!:CB)J`L.)T&1I>$,F:HHT*TNZ=,FH"2^Z1E MU"E#';;+`(SI"_,6A1V2!77K3+-]J3(8ZDV6:;9>KH)6=AMF6K5HQ?[91/?^ MCAK3'>6C3'IKI]SHTKMIW2J]G^YA*,TQ&WJD[BB/DDM5K%4+2@M!AFW02GQU MRE"'?2;G&'+.$5!V1V6Y6QFTT(N243'?OZI,7Q-J-!^$NM,\"G<:9J0\XXK7 ME_KNY&+&:/\WDY(A)R4!J3O0:XWCCG\5M,9QQ5*+8;PI&]&*ABVC+B"D6BBA M:DPL..0ZW0A(WS73+'$JQ=`]%?OC0\^-CUE&4HE*4C+QG7130:B9.%=2 MNA&TQC+'#;/ANE,7TT7/T@U:MV?II4N3L[$TH/2V%*W8()6@./?58IB6-[B/ M25@;M,8Q,^F4+UTZ3?.YSF.WG!$%HR(%6,:D8-HY91 MQVC.:,%HR6C%:,UHPVC+:,=HKY"N]#-YG9OZ\VX=LJ\XWI1!*]D.JAC5C!I& M+:-.(1WVF40-#T4H;(_2O9^@E:"*40;J:_F6;AF1(UGT>JT![IO9];RD].6A)H'=PGOIJ`M"_: M^XE:XJM32!4:SQO,OGGD.AD+2&?6].Z-:/F]GV&/<[&@D6[]B%&290K"K1WO M0\K%@A;&;+\Z&F3)>:Y6)R5^*I7-ZL`:79LZ!DOA04"U$S:@3%[*8- M"+/]J<%$BQ<#R-?M!N/M'M'PZVS<>+(M&S!QK1DU`F(?. M;/U$A5A,'[0?R'3KG$EPL#:AUO$HS8B#%IZ'R*4J06DA@F%$3=!"(<2P9=0I M7SKL,RD"%@L4=D@1,.7&UJ&MGV"(?9+CVL:XFX*;M-<1:H(;=#'G9GPUS2>T MJ"`%[^321A\\DU%@U4"E]$C=.@&EMTY`:2$(-<%]V?H*62[UB$]YFDU!E^J)=!-%*.Z./ZW1'Y5-WO'QL,V]BW5!N M4C>2$+\ MHY=!RRVM8IOE.Z&5^$H[I+]BNLWS4[[:J!6;*?6ER^L2@:29:$F=[1",?>*0 M;MP%I&XYKX416$*H@I;?G_$OP(IA+'034&+8,NJ4+U6A%0=LOE M>SUBZ/=ZAF,>$$4C+KUJ<9WT2T&HF-@-*+T(6A@)0WJAOZ+IU+5TP;/LXJ_: M<<)91T#)#5:*5M*.@N*,58MA6MS@/MGI"5H8+J5/=,J7+DZ6=5!QLIV>"6CSGR!./LAZ?/0PIHU;L\2=#035K-8Q:1AVC.:,%HR6C%:,U MHPVC+:,=H[U"NCU)\\JV$FH+3'$ZHFA&I&#:.64<=HSFC!:,EHQ6C- M:,-HRVC':*^0KN$SRX@)+R,"RKIU_M0_:DD?KAC5C!I&+:..T9S1@M&2T8K1 MFM&&T9;1CM%>(5WIV5KF-)#SFF7B4?)PI&14,:H9-8Q:1AVC.:,%HR6C%:,U MHPVC+:,=H[U"JH:G9Y971ZZ75P$ESW%*1A6CFE'#J&74,9HS6C!:,EHQ6C/: M,-HRVC':*Z1K.%O'21^>\GHMH&3#OF14!:0?@N3/E^JH)<-+P[[:@)+G0!VC M.1LN6&O):,6&:];:,-JRX8ZU]@KI2L]6FZ=*YU7EU"-5Z82JH)55>K:?5D>M M6.GDJPU:JM*]5H+F'-7HE)>C`;FOWY,54;;Q7(I6W*RH`LIBI-;R5X265%3#OEK;5[:K MU$4M\35G7XNHE18H>Y-B&;7$UXI]K:-6ZBN+:Q.UQ->6?>VB5NHKBVL?M>!+ MMZFU`.Z-XM=$V9[CE%>_`;E/_$]MC?>P]'99*5JQR:J`U"/-P4VVA5Y'+:F' MAGVU42L-(EN"=U%+?,W9UR)J_<#7,FJ)KQ7[6D>MU%>V4-I$+?&U95^[J/4# M7_NH!5^ZK<\LKJ>\N`[(?<2;M&F>"(M6W#2N`@H/97N]JQZUI[]:\@BX83^M M(/\H&0>HYQVJ"QJ)G[D8Q7@6@L+G".1FR6Y68A/=K`6=#6?#?K9B%/WL!)T+ M9Z_4>]WI#?`5B*3O2T M8K06%#Q-^9;=B$ITM&6T$^0=W=[RA\5[43DZTFV8+?;I844^G_$FP-2C]-F+ MH!AX%5#R)+-FK891*RCNXG2"8@>;"XI77`B*3WN6@J+6BM%:4+SB1E"\XE90 M]+43%*^X%W34TC5_9L4_Y15_0,GCU))1Q:AFU#!J!?E!UCHOH0LJ:O((VQ!Q M0%F(HXB6C%:,UH)"!,:W\9N@DD2P%:MXN1VCO4*J!6ZS'8&_ZOM'?;U3$%#: M,HPJ1C6CAE$;$-X[E#RG$Q0_FI^SX8+1DM&*T3J@Y(H;0?&*6S;<,=HKI&L^ MVRF@FL\>D>*G:O+'&0%A59=F7/F**6I)!5:,:D8-HY91QVC.:,%HR6C%:,UH MPVC+:,?(_=J/JT*_"O:-X7^]Q_]\R=/#R^>'\N'KU]>+^\/OSTAB^_C4_,.[ M$_>_&S2;C`NW.8_:),D$DF-')%.FS2NTQM"\#3#Q4U]5_&& M_B_#XA?T.PYIAC8TFW"$UK#TT>NL3H=YJ7`C(E]A#HD;&%F"6:IP@R%+,#,5 M;DQD"2:HP@V-+,&\5+@1DB5(\`J72K`$>5WA,@J6(+TK7&+!$F1YAE#49H29!&%FYSX.L@<"C='L00)1.&F*DLR*5P"QQ*DVX7+ MXUB"K+MPZ1Q+D'P7+JMC"5+NPB5W+$'F7;@$ZE@0;2VA32X)M(K2/)9DAMID96PE):4JPH8/VL..K`DV`E''5@2;'6C#BP)-I@1@36X8[L8$5@2 M;/XB`DN"K5Q$8$FP,8L(+`E>'"S?&2;!I+&E+20M*9D-IX6,[S5RM[P_G!1FA*\,URX MMVK9IH:D-B4-).Z%6K;I(''OU;)D-AXC-BM9*R$I30G>04=LEDT-B7MOFZ_3 M0.+>U69)!XE[99LEL_$0L5FM74)2FI(*DLJ4U)#4I@3?,R`VZSKX:@&QV1+< M<_BNQHJZCZBM?EV.^XC:DE20N&]*V!N^C4'4E@2?R"!J2])!XKXJ86_X:*ZH M\,T:2_`)7.&^9F-).;J%C=5W\`49;"S);(R[T:R=$I+2E%205*:DAL1]_,2Q M-9"X;Z!8TD+B/H5B"3ZH1]269#9":_OMMVQ148[0X_%))GO#%YZPL23XU!(V M5K_&MY2PL20SQ#8S8\.Q!$5I2G`:`:YCE:>&Q'VH;T6->C,E+6S<9_ML,QMB M%,,Y#"S!^1=%:4IPYD7ASH%@FQH2=QP$2QI(W!$0+,&A%H4["8(ELR%&,1SX MP1(6I(W$$V+,&!/(C-DN#8'<1F269#C%4X>HB]E9"X,X]84D%2F1(6%>X`,I;,AKA_<-`52W"*&,IC22I( M*E.",\10'LL&1XD5[M@MODX+B3M]BR4X-PPEM22S`=K'?UV8CSL#]%$<`\C> M<*H@;"P)CO>#C=43<7X?;"P)#M*#C37ZXU@\V%@2'-I;N*-N.3:<2`MOUFH7 M1\["FR69#7K%#$>46MYZ16E**MA4I@2'PA:U*<'9L(4[,)6OTT+BSDUE"0Z" M1=269(8ZF-EU`(D[9YB]59"XXX994D/B3AUF20-)8TI:2-P9Q&PSZV-,]"=B MY;T*DM*4X/1NQ&;UD!H2=[(U7P<'=R,"2])!X@ZU9IM9'V.B?YA,L6%,-"4X M#!ZQ6:,8#H!';)8$Y\`C-DN"T]X1FRU!'\6O%5A1]Q&U.5;U,5J:$OS.`**V M;/!S`XC:DN!7!Q"U)<'/"B`V2S+K8^0SHRXA<3_NP.7!SU8@-DN"7Z]`;)8$ M/V*!GFA)\,,5B-J2S'K8*<&/W7`$90]C%4X<9`E^U04VE@2_KP(;:T3"#ZC` MQI+@)TM@8]TE^`$2V!PEUZ>N^/KAW;>[SP_KNY?/C\^O%U\?/F&W_^;X!M/+ MXV=W.K+_QYL_KOOBU\/;V^')G=Q]\>7A[N,#?EOUQOV:Y:?#X4W^@2)>?S^\ M_';\0?0/_Q$```#__P,`4$L#!!0`!@`(````(0"R2?)VQ0(``!,'```9```` M>&PO=V]R:W-H965T18N>F-)< M=@6.@P@CUE%9\JXN\)_?]U=SC+0A74E:V;$"OS"-;]:?/ZWV4CWJAC&#@-#I M`C?&],LPU+1A@NA`]JR#-Y54@AAX5'6H>\5(.2P2;9A$41X*PCOL"$OU$8:L M*D[9G:0[P3KC((JUQ$#^NN&]/M($_0A.$/6XZZ^H%#T@MKSEYF6`8B3H\J'N MI"+;%O;]',\(/;*'AS.\X%1)+2L3`"YTB9[O>1$N0B"M5R6''=BR(\6J`F_B MY6TX$,XS&WDR[YBD#)8+ M*5NUP+-\M#[-(T]P,0ZFD>>-&-#X"S&L.L3P=7$*S/%KH<=1)WE#:B,FL@.9 M1GEPG?G.6L>4[Y0$RN\;F>9OM!(FXI2?Y`&,WW%PK&&*=\IB,DOY&YVU!^/K M,`[I)]%LG+YU3/E.B<=SD^:I;\JD/(MW^=8QY3OEA#^[S+=-.MO`8N:K,[R? MX@_2"?]T9-P1Y#YU.P'437O-&I9!&ULE%A=CZ,V%'VOU/^`>-\0`YE,4)+5 M`)YVI5:JJFW[S!"2H`DA`F9G]]_W^`ML[,Y,YV&2'%_?>WSO];%A^_E[<_&^ M55U?M]>=3Q9+WZNN97NHKZ>=_]?7QT_WOM?_S3]O7 MMGONSU4U>/!P[7?^>1AN21#TY;EJBG[1WJHK1HYMUQ0#?G:GH+]U57'@DYI+ M$"Z7=T%3U%=?>$BZC_AHC\>ZK/*V?&FJZR"<=-6E&,"_/]>W7GEKRH^X:XKN M^>7VJ6R;&UP\U9=Z^,&=^EY3)E].U[8KGBY8]W<2%Z7RS7]8[INZ[-J^/0X+ MN`L$47O-FV`3P--^>ZBQ`I9VKZN.._^!)#1<^\%^RQ/T=UV]]MIWKS^WK[]T M]>&W^EHAVZ@3J\!3VSXSTR\'!F%R8,U^Y!7XH_,.U;%XN0Q_MJ^_5O7I/*#< M*S:E;"^(A/]>4[,>P-*+[_SSM3X,YYT?W2U6ZV5$PI7O/57]\%BSN;Y7OO1# MV_PCC(AT)9R$T@D^E1-\_>#D2$[&IYR,N6\$BZ4]/J4]62Y(O+Q[GW`@%L^3 MEA=#L=]V[:N'3L3R^EO!^IHD6+;,EF0QY@]E+)GU`S/?^6O?0V9ZH-_VT2;> M!M]0D%+:I+8-,2TR9<&*PMSF:,K@J4*F#B'\ZX*0LU M)9\#5`,,;BCCG%N\&C/'1M%B6N;(_;T9.Q4VF#316YDFV6@R\K,0JB,&0S3. MG"&VQG\6FYGO_/A.HQ-M9H12:?06Y]%DY&PA5$<,SG"L<59]R%!.3;E,!1*A M<;36O)ME;S12TW(+H3IB,$$>'$P8:C(1R(K+%&_OS$)R"Z$Z8H3%9G.$9:@9 M5B!A-#9[9B&YA5`=,<*R\W`2!I5WAIIA!4*TL!:26PC5$2/LQ@@K]6BQ1E&& M0(SA33 M$5P(J1%<0+-^6IM[-B-2@46G$#PM.+(SVJAE4#7-43^FK0Z"0G(-@@(RFD=` MXH(N[V861(F$',&9;#J""S4U@@MHUCRS&U%&I)5HGIAM(S-_^60QY49.LHL7 MFMK]WO'"S4U-EY#>40J:%#.W(:H@OGF-=@[=VLSA67`AUQA1:\VDE9!\43`; MH@9D!F?R:A8$40,RB^B6;'9&S:Y'$C*+2&9[*E-6V$=:J:TB2O=$"'N\CIEXF?U`%0>N MP"9I4\7?S:2M[J&4K^V-/3.C4<0+ M"/$LW53=JKI(45.T1 M%"C)G",Y1MB*[3FH!%Z\N$;P1N:!)V?."V]J^%+G>`A'C@AIE.#1TX[\$,._ M*W`:)WCNLR=`U!#!'3I$2EQ!(#Q(B6LDQPC;XW8<:`SBN$:R$-2PW^PY*5DG M*P0G>9([1W!8(Y.N.2G98#V\66=)QLD'UJX1BA%VFK@88#VX"=LC*8G` MVK4>W&<3=F6TY^0883='>X1BA#I'4H*6Q=W)GI-AA%VT[!%<].#--9(B;7QO MSW.#!/"KQPQ/R1+177V3880]QMC1\6`%7JX1/$V!%Q\)QD!X@7@K3M7O17>J MK[UWJ8[8[$O^?-J)=XWBQR!TPGMJ![PZY*_9SG@G7.&!=+F`;A[;=E`_0"H8 MWS+O_P4``/__`P!02P,$%``&``@````A`!<^*+D0'```%88``!D```!X;"]W M;W)K&ULE)W90:'[L<1-2X7M$TVR M]GWBS,RU6J9M15NF0U)WG_/V\X.%9`+X(?V7_=G)\]O]Q]_W3W;?]]]^'\ MW[OG\W]\_,__>/_W_NF/YZ^[W7E1W)Q\7S_=?=X]_QN_V/W M'9+/^Z?'NQ?\\^G+Q?./I]W=IT.@QV\7\\O+JXO'NX?OYY.%Y.EG;.P_?WZX MWVWW]W\^[KZ_3$:>=M_N7I#^YZ\//Y[%VN/]SYA[O'OZX\\?_W6_?_P!$[\_ M?'MX^??!Z/G9XWU2?OF^?[K[_1OR_:_9\NY>;!_^0>8?'^Z?]L_[SR_O8.YB M2BCG^?;B]@*6/K[_](`<&+>?/>T^?SC_;9:,5[/SBX_O#P[ZWX?=W\_.WV?/ M7_=_YT\/GYJ'[SMX&^5D2N#W_?X/HUI^,@B!+RAT=BB!X>GLT^[SW9_?7OY[ M_W>Q>_CR]07%O3)![O??$!/^?_;X8.H`LG[WKP_G<\3P\.GEZX?SQ=6[U?7E M8C9?G9_]OGM^R1Y,V/.S^S^?7_:/_S[G[^/YI__<9NDV4SO./.],)SQ)CS+9M MV]*.K1V=SKU1_\WH?SB'(MKQ,^A?'Q>W\_<7?Z'[N+0B*$)0AJ$)0AZ`)01N"+@1]"(80C`ZX@-N/OD<%_R7?&WWC>_': M6H`61E`4&]&0(-L0I"'(0I"'H`A!&8(J!'4(FA"T(>A"T(=@",'H`,_1Z`Y^ MR=%&'V.76\DO;_PJO)YTEFCSQY:P\E4V1Y6C]XFD1#(B.9&"2$FD(E(3:8BT M1#HB/9&!R.@2KRS0P?Y261C]#^=+=)%'/R]N%[ZGUU;I5&$<58Z%020EDA') MB11$2B(5D9I(0Z0ETA'IB0Q$1I=XA0&'46',5^^`IYD6]_\FQ*$XQ(WKB2S0 MR6D!S2[]`MH=/K+]B M_C38]^=$KN?JSXFL_$XVF%5OCTI2#"F1C$A.I"!2$JDF@EY?XJJ/.NXX$`S4 MS5%)@K5$.B(]D8'(Z!+/ZV;QZKK=+G'>F47SR]>'^S_6>PQ<,UWA&'V_/`XF M,/-V"L2B.8969]@+IM];U9+\IHPR1CFC@E')J++(+1C5.I'41K4DJ2VCCE'/ M:&`T>L@O'[,\]ZLEW[%\]/ZRO/\A*YNCJG:F`T< M%,;U\K`[,+^<+?VYX%85)"I="%<1RR:ABR[5J6B$4$VD^6_, M/O)4)P1M+4(%$)2*EKH@8Y0+TDW#@FV5K%4)4O.U(+75L*U6M#1@QZ@7I+8& MMC5Z6KZ'S2(PYN%I<>AY>$+7^#DVL<7LVF]"&[,'#Z>O,'@=M>;7-)\[:FDY M3&A^>RR:S-IR4!XSOY@%>XJ%:HGY4FRA3CCIHH9&B:C5UF'@"4(T*I:H6HE* M<](QZC6@)F@1]DB#:HGY46R]EA._?-%FW?)]G91T\/U^8*<:KFX*S:J%SB M:BU::E8Z-MQK0#HFM8.@X&BWFP"MI8+?1RKE90'[>J)14F%?/N+A/5_7&&`PYA6I)C.5/Q5AQC+7:2:3WG4][*>[`:I';^UKD]KZ,4HN<4F2Q"`;\0K7$?"FV M7IMA3W,7T=)$U()L7I9+:CZ32Y!9B:R5,&JF8]1;%.0E&+$&U1+SH]AZ+2]^ M\PFV9=Y:+9A=^V!28Y&[6K#HQMD08Y1:Y,S*,XO:#SU\?EY6TP[*2BH$[.Q++V7;F@DY$55@LCJ#LZ!!.? M,FJ+UA2BI8FH!9U,1&.UEI+C\*A2*PJ:XTXL:V2]H).1#58KR'$P\1JCMIP< M^W7(;%XX@]^;K7?:[/`&Q0EY@Z+5_^?^A_MH%/T_ M-=T)N6=3K):#MHQ21AFCG%'!J&14,:H9-8Q:1AVCGM'`:/20[_E@E^4X'>&= ME/F$,"#*X+AAM&64,LH8Y8P*1B6CBE'-J&'4,NH8]8P&1J.'?`^C'W/K]M'# MA@?+Z@GAL8]ZF-`6P[D)Z&BEC#)&.:."4@AS\-X M+!CU\('['K;(/4!AT1M'6E1+BB9EE#'*&16,2D:514[W7ZN6,\J'#Y\;U9*D MMHPZ1CVC@='H(;\<8GL&L]6K!UR0M;`%6.25SZ1EIG['I3C>X_$?FVQM0&A) MIE-&&:.<4<&H9%19A!^)L5:M$TEM5$L"MHPZ1CVC@='H(;]\@L7]6_.;!2_Z M+7*/65CT^C$+59#\IHPRB]QC%JIU>'+$QRQ402R7C"JV7*N6M1Q,\1M5$,LM MHXXM]ZH53_.@"F)Y])!?8J]L%BQXL\`B_VS%(M@6W%@MM&&)?6UB2H1CJ^"`):.*;=6LU3!J&75LJV>M@='H(=_IP?K] MZ'1>I"\F=(/IZ-'I?*#%:ID%X%&+#[18+6P+F>9Z^>XRV!%*Q8SN+F6,H%W0RLD$C MI>*PH=@&M3]G7BPFAHDB[VUB$6B%H:Q&J@*!4 MM-0%&:-K02>ZDT<9[0C3=+7H;/"FQ`?Q=\27/I MR9;7(B9D'B$>BY>>AV76O#=).-K2@(MET,L6FBYI@Z78.AEC)5HZM-9JRXV1 M)GC'=$F,K=@Z&6,G6AIC'X\QV'P=5$MB',76:S'Z]<(L^V,=W[0=X.Y"FIUI MTQCQE-HS3Z#)&N5K6^.D,6Z%:XI"2 M;56,:@TX#6%APAM5$,LMF^D8]1KP1,('U1+SHV?+*[8E"MQ:*5]_)91:A&Z>@F8"=+JFW/`@E$I`=56)4AMU1RP8=1*0+75"5); M/0<<&(T2\&#+]WRP'2&C%YY/A+VG1=Z4TG5DH"EV,),Y]C2J5^N1$MCK-76U(965[?>?T'6&M67 MN%N+G*QU'%&O`36%BV5@?E`M,3^*K=>RYI?U+VYM+'EKPR)WMFB1\U!RRRBU M")VYI#VSR"OB*4;'5L&V2D&Z`URQK5JT=,K:,&HM`PZ,1D&'=/F> M?V6+`L=9J)5-Z-8=[A;+<+5L`YH>5:LT/5VU6O;(T.6[J\!,*O&K)S.QK'U, M+NAD9(5&IDE:+(.%4QFU%8Y-E6AI(FI!)Q/1:"*F%GL5C.>M5<"/U,-.+&MD MO:"3D0U6RW^ZN@H7;E%;3H[]BA)LJ[PY$/)VRW)"J$"2PXU%&`4$;2URGCRF MHJ6[PYE%SDPF%RVU5;"MDK4JME6S5L.V6M'2='5LJQZ+(!S8+R5'\YV3I.]FFC2\QH MV66,FJ!9U,1*.)>&6C2\RHY8Y1+^AD M9(-&YN28-KJBMIP<^Q4%,48KBN'!`F%"7K\X(=0*[13N@&T[EC<^.-+JOE3`"WC%)&F2#->2Y(9^\%HY)1)4AMU8+4 M5L.H9=0)4EN](+4U,!H]Y+L?4Q!VO[?1M30J05V?T(V[\;R@C2X;T.^!:*-+ MM:1X4XO,^=UC\=*"*K-:[G:DVM*`D27 M6XM.Q]AQC+W:#`:/1L^9XW6PO..'9L,(8'#69"WI22-[K,\P$$ MU,5U4.^VJB`%E5J$):&@S")WB:4!M=YQ+ZE:8JL46^A;7N^7*]'24:I66[+1 M=>G]%_1>C>I+W*U%3M8ZCJC7@)I"WNA2+3$_BJW7LN:7=;#=\F8KXVT8[%^: MTG5GBQ:YV\F,4HO<[61!ZO"<`Q:,2D$ZLZK85BU:NLW=,&HEH-KJ!&FZ>@XX M,!H%\7:RF4M$6QGO4QQ4\?P%4\5C95VL@D:TL5KF5/11BT\H6"VD*[[MDUH% M9QLV$\LZ,\L%G8RLT,@T2;S1%;7E+&.FA9MH:2)J02<3T6@B;(Z#)MI:!2?' MG5C6R'I!)R,;-#(GQ[31%;7EY-AOHF]MMP3W?*'543<](7M09&HX?\PC!["[%9R;3GX*ZI5Q.ZQ<#D M.#UH]ANKA7<93+]P=1F>+MFJ@HRMJ2"M41FC7-!D>7437B1>J()8+@6IY8I1 M+4C2'#[':%1!++>"U'+'J!_JRV^R^?7L^N]__^1VCSASKH8_OC_SX09O?#BD+^!H?NCDL+4(^ M3\:H_B(9#_UBH/_;,OD->4/B`L%ZF8R'S(9\E8R'Q5#(K_#EG9B=^352=.B; M@A!H;HDI7(X;K2XQ!(K3KD-";!#AQR&I-@(PZU*B;!?ASJ3DR"#3>4:4RRAF0= ME6P@V48EV/B$=V+6L/\)[\0D.21F4XQ]C7U.U)V8!,\'X+?8H(/'!/!;3(*' M`?!;3()G`O!;3()'`_!;3(*]?_@M)MDLT2OC&0_G)X>DB$KP^"HQ#Z#+`U/,E!^<0D>*"#\HE)\%P'Y1.3X,$-RB'+,$#XH3\QB8)7CLFYB'NBS! M0US$$Y/@$`=*+I:"$A+SM)^M59"8A_XLP9F-Q#S[9PG.::`>Q"0M).8D`(=9 M0[*.2C:0;**2+23;J"2%)(U*<`(F,08!.]ZP&\Q"5[F@-]BDLWB M)ME.#YF#U50.B7F+B?V&]Y&2)BK!>T.)>2N(PZR1@O4K*3`C;2QM>#4'Y1.3 MX`T=E$],@A=U4#XQ"=[$0?G$)'@9-#%O'7*J\4YH8EX^9`G>`T5.8Q*\^XF5 M<4RR66!=,AU?(U]CC1&5X#V^Q+REQRG`6WF()R;!6[DHN5@*\"8NXHE)*DC, M6YP<#U["3H!S$)WKA%JF,2O#D.'\1ZEQP2\Y8WQX.WNF$M)L$[ MVO!!3+)&"LS;LFQM`XEY:98E6TC,N[,LP3O32'5,@E>G$_,F+8?!&]2)>:&6 M);A4`ZF.S;@V"\R\<7<"A\DA,3=!L`0W/\`[,0EN;D`\,0DN34`\L3DYKD!` M/#$)+C1`/#$)KB=`/#$)[D)+S.5:G&I@-6Y0/N9Z%+:&&VS02F(27&0#'\1Z%UQD MEY@KS=@:+J]+S,UF+*D@,1>86\]8LH9D M'97@1L!D$Y5L(=E&);C^+S&WOG$\N`4P,9>_L027`2;F#CB65'/,N*;+;X+R MP9V:R&FLU>/F3.0T)L$%FJB),0GNT41]BTEP429J54RRAF0=E>#N4G@G%@8W ME,([,0DN*H5W8A+<5XJZ$Y/@0E+4G9@$5_C";[%67T-B;HEE7^/"7O@M)ND@ MZ:(27-\+O\7"X'Y>^"TFP?W9\$ZLE>20F%NL.6VXCQJICDEP;S12$).LD8+U M*RG`;#`JP?W+*)]8JG$-,\HG)L%MS$AU3(+KEE$^,0DNN$_,?>J1G$)B[E!G M":ZS3\Q5ZBS!K?:)N5&=);CF&2-%*RC*43D^#K M1@@32W4)21F5X"M&*--8&'S,*#%?Q>%4XP-&*.V8!)\N0FG')/@`%WP0FZ'@ M)V&_X;!]R&IV[0&(^B\=A\!D\Y#0FP:?HD+98_X9/R2&>F`2? M@D,\,0D^Y89X8I(U%CFQVK;&0D;[#*BW4?FQFF>]$0%5;G44&-17/, M5`U3YJ.+B/SB.#5Y_OC^Q]V777OW].7A^_/9M]UG/($U-U"_[EY?]H[D!]NSK[N[3[LEH0_GS?O\B_S`1_+U_^N/YZV[W\O'_!0`` M`/__`P!02P,$%``&``@````A``!-`?_$'```-HD``!D```!X;"]W;W)K&ULE)W;?SQNSN MM5J6;45;ED-2MWO>?GZPD$P`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`Q!%8(Z!$T(VA!T(>A#,(1@#,'D@#.X_>![=.A?\KW1 M-[X7KVT$:&,L`T>+AB39A2`+01Z"(@1E"*H0U"%H0M"&H`M!'X(A!&,()@=X MCL9@^B5'&WU?]H!6V M!R5)MB.2$F)#$1&(I-+/!>CX\9<;+#OXIDDN%AH M1U^<^QU]>U`ZN)A(1B0G4A`IB51$:B(-D99(1Z0G,A`9B4PN\5R,7AESL<&^ MBV=R?7&X@FZ)[(AD1'(B!9&22$6D)M(0:8ET1'HB`Y&1R.02SY]F=^^L"656 M,-CWYTR6B?J3R(Y(1B0G4A`IB51$:B(-D99(1Z0G,A`9B4PN\?R)?5;,GP;[ M_IP)=BTRNK=$=D0R(CF1@DA)I")2$VF(M$0Z(CV1@\CUOMC^_XGF[77)'QHPNKAS/S^ARM8^[+,\7 M*W\FV)EXEVD:=U`0RJV6X[M"$YJ(#BP'5"M>)E'51#+DX?\%C-[I+#%DJLW"$S+^L?$!(,+MD47N%0Y!OOFFTY*&.MW"($JJ4&!6N5C"I&-=MJ6*MEU#'JV=;`6B.CR4.^_\T& MRO'_P>EV8^6.C!GMKS(2A%PL+ORQL#516+16@E7NH6F6YT'3[*S6V@ZI1;"E MS<2*MD#.J!!T-*]2\](2)8L@:%1%;5T&6K5H:;D:04<+T6HAS*BY7`<5[L2* M&NX9#8*.YC5J7FZ%@X::HK:<"OO=Q&P"8]UDWAQZEZX9H9O(X-F:`/O<)P3M M+$('$)2)EKH@9U0(TG!LR;8JUJH%J?E&D-IJV58G6IJP9S0(4ELCVYH\+=_# M:-.HAPT/%MA-=MJ1$OW?RVCSB*G7#W;&CCAR&@2M"^7[WFSH0T] MOTS,$N/UVVWS)MCS_HR\RU^R#`.%BUGKXI4+VT[ETH:912OU:&Z1L^"FSZ!)M=>BK\.KCL9**@3L[%LLY=A:"CF956"U=0M^#!PJ>*V@K75;5H:2$:04<+T5JM ME=3X/)B).E'0&O=B63,;!!W-;+1:08V#A=<4M>74V!^])G@1]J%C"^,YV.&M M=V;D;4FLECMZ+=)M=H;I>S\3:&`MM\BY^!2BI;9*BR[T,ERQ5LVV&M9J!6FY M.D%:KIYM#:*EY1HM5J^YTT,XYCG__7XS;TUNIQC'I[G9^2>5K%:#MHQ MRACEC`I&):.*4MHA[><]_#%N&V MV\'#C':,,D8YHX)1R:AB5#-J&+6,.D8]HX'1R&CRD._A(*`A?1@S9]B'+7(/ M4%CT@P,NJB5-DS'*&16,2D85H]HB_$B.C6HY5_GPYG.K6I*P8]0S&AB-C"8/ M^>T0BQD\MO'[&:/766#`TC)O/MUK[(6N<)C%JH@EBM&-5MN5,M:#I;XK2J(Y8Y1SY8'U8J7 M>50%L3QYR&\QL]UU6NPPL\W;8*]E9N2?K4B"L.`VF;4PETKN.T89H]PB)Q!9 ML%;)J&)4LZV&M5I&':.>;0VL-3*:/.0[/=C$'YS.F_5D1E=NV#A)@FW/UFHY M,\6.4<8HM\@;$W..CJV2$U:,:K;5L%;+J&/4LZV!M49&DX=\IP?[]X/3YQVY MU]-G=(4%_^&"P`=:DEG+1`P.6GR@Q6HA+&2&Z_F;\R`BE(D9C2[EC`I!1S,K M-3,M4I($88$J:LO9LL[!,]'2,!D%',QLU,Z?& MJR!H/45M.37V.XK9*,>F1+N!UKOL&W.8";L3=!29[+86H5<(VEF$+B`H$RUU M0CFW&EVN$T@Z# MDK??"._M?8TEPV&X+>@VN]5R9J\=HXQ1;I$W$\XY.K9*3E@QJME6PUHMHXY1 MS[8&UAH931[RW1_LR.=(IN=^WIN;6*3IZKB\']R?K,);!5;+#X*O:"D]V_(& MQ(S,/>6#>;XA:\U[:X2#+4V8K())MM1RR1"LQ-;1'&O1QU5"W)<1);K^7H=8L5M&+SWI[[802+KE#'0VLEJR`T MNK5:N#,W7PB<"7=_B=FI@I0XL\@9![&+"Q"#Z(1 M0RM+ZZ]_X*JM:HO>7<6.57K.:-!$VH)DU5@ M?E0M,3^)K=>JYK?U+T8V<-:"1MF,W,6BU7+N2>X891;A@BYESRWRFG@V[]@J MV58E2`/`-=MJ1$M7K"VCSB*G7#W;&CCAR&@2M"^7[WD34(@LQU=SH,'=MUET M[5[NDE6X6;9:YMJH79INKEHM>V+H_,U%8":3_-63N5C6.:80=#2S4C/3(B6K M8-]416V%%]5:M+00C:"CA6BU$/.(O0BNYYU50%-)/^S%LF8V"#J:V:B9.35> MA_NVJ"VGQGY'P4[1[2@_O!`:_6!=,R-T(*GAUKQ0Q&@IVEGDW'C,1$N#P[E% MSDJF$"VU5;*MBK5JMM6P5LNV.M'2\B80X0Y0\']Q< MQ9@ES\_HRIV,DW6XO;`)K[6[[1AEC'*+W(T#:Y6,*D8UVVI8JV74,>K9UL!: M(Z/)0WYCO!*^6''XPB)OON0XE]4RV_EC\^5L_K#8ISB7F-&VRQD5@HYF5EHM M9*9%XCA7U)8S>\QQ+M'2:,"D%JJV1;%6O5 M@M3#C2"UU;*M3K0T8<]H$*2V1K8U>5J^AW$-I'G1BW.MC$9P#9K1%381A^'& M<2Z;T%D`[AAEC')!6O-"D*[>2T85HUJ0VFH$J:V64<>H%Z2V!D%J:V0T>F#>=I/Y5;+#4:J M+4W(.SC5DARKG\JQYAP;M>7DN`YB>:UJ28[=3^78<^*L*8KEC,SVC01,>*?BH6F)^\FSYS6:B*L<6F<'9`A,M M#9MS1FA.R6]KM9Q=\XY19I&ST\TMF`6-C&;IMR6P:9_.96^0L+@JU MK/TN,DN2^4IL>;M69^4TKQ5%2R]2C>8XCZ'UQ;GW7Q"(:E5?^F!GD5.UGC,: M-*%;M<#\J%IB?A);KU7-;^L@VD);N7"4<13&7!3G/B!%V%KD1I,991:YT61! MZO""$Y:,*D$:`:[95B-:&N5N&7624&WU@K1<`R<<&4V".)H,YWCSVV&4V0"$ MYK[9J^YO.SM=81T,HJW5,@?4=:E!<2ZKA4XR]]\PZI-9!2<*FXME79@5@HYF M5FIF6B2.),P$TT85CC5@MA:QR,H!!TM,:C9N;4 MF.)<45M.C?TABAQ_Z4)H](-%[HS<4/1Z1FNMX\B7&$2Y`EWKMO-@OFN>8@ MSK4V^H'G9W3E[O:3=7#S>&L37NCTLF.4,"5\L>;PA477N.P?9L)D'0S[K=7",R1F7K@X#\^6[%1! M+FR9(.U1.:-"T&QY?74=;*)*51#+E2"U7#-J!$F9>;*;O8%*B>5.TJCEGM$@ M2,I\&=S_&%5!+$^"]I;]QC)!C7#D'#FXC6F(1LZ,T(B2W]9JH8\(VC'*!.G< MD%ODS5FS><=6*0G5?"5(;=5LJQ$M3=@RZ@2IK9YM#:*EMD9&DZ"]+<_SF+V/ M>SZ8L_;Z_IQET;47;5T'=X>VHF4.<6'X+,/[;CM5D-;*+'+FIMPB=U&O"8WE MR/!1!;%6:+3>:<%]F>B]`JPIBN6/+/5L>-.%<9AH^JB"6)\^RWXA!R.)' MJW(X-!P^%J$1);^M:.EV>,SX6==B'<.FIW^@2`($%:HD9P7ONU2@\"V(3.C[> M,_?ER_/)[>.?7W&!7R+`\_[M@<]?;MI<+.7338$$WW3Z;=\]`K[!MY[V"["0 MPU!4/TFG_<4IT/]ME?Z&.F#8!8+-*IWV/2[DZW3:[TA#?H$:Q.Q8U,Q0;`T7DM1,5"S!]20U\Q5+"DC,',427#Q2,U6Q!$NPU%SP M68*56&HN\BS!>BLUUWJ68-F5FDL^2[#Z2LUEGB588Z%SQ"0;2#91"5:VJ5D8 ML36L7U.S/F()EK&I62:Q!*O9U"R-6((U:VI62"S!_ADUC?5=;*-3LR_C--@Z MPPQ$E20F)TM MYU-#8C:X+$'<(C7[7)8@5H%>%9,@2(%2QR2(#J$?Q"2("*7;J&0'B=GN"=F#<%I>"X`H04RR00DVKY1@@1+$RH;;;&B?F`1WV]`^,0ENNJ'4,0GN MJJ%]8A*#)(M*<#HI-8=5.`T.*:7F MS`I+>.9'/@M)L&3-_!;3(('<."W MF`3/XM('?8I)MUTW- M9T>I M8Q(\U9Z:AYPY#1YN3\VSSBS!^TY0ZMB*:YM@Y8W76G":`A+SD@Z6X*4<\$Y, M@I=J()^8!.^S0#ZQ-3G>3H%\8A*\:P+YQ"1X,2XVWU:7F M]6,9B:M\VQ-;Q7,#4OG6,)WB68FG?/L02O%$S- M*^A8@M<(IN9-="S!^P-3\T(ZEFP@V40E>%ECNHU*=I#LHA*\F3$U+^3C?/"" MQM2\EX\E>$]C:E[/QY)ZB177_,*!H'WPNE/4-#;J\5)3U#0FP;M-T1-C$KSB M%/TM)L$[3-&K8I(-))NH!*^5A7=B:?#R6'@G)L$[9.&=F`2ODD7?B4GPKECT MG9@$;U>&WV*C'B]9AM]B$KQ+&7Z+27I(^J@$;U:&WV)I\.ID^"TFP:O-X9W8 M*,$KR%'3F`2O"D>I8Q*\TALEB$DV*,'FE1)@-1B5X-78:)]8J7-(S*N6N8_B M1=DH=4R"-V&C?6*2>G&-]HG%`O`)`M0T)L&7!M`^,0D^.(#VB4GPW0%X)R;! MAP70/C')!I)-5+*%Q'P2@'V`#SK`;S$)ONL`O\4D^+P#_!:3X/L-\%M,4B^P M$\=G+[@$^%1*:KZWP1)\$B4UG]U@";Z,DIJO;[`$'TA)S124R" MCQ?!6FROB6\8I>9C.6P-WRU"/C$)OE6$?&*2#4JPB98`W[])=U%)!HGY)`J7 M`-^Y21?VP&V2ZPXHNFP5=1T0]C5Q)\'!4EBUEK8,U\%1-> M.SL4X?G]VV\WG^ZZFZ=/]U^?3[[[C]]/OSC97XO[\GOCR\O MCP_F%;TGG^]N/MP]&6V&ULE)U=4QRYDH;O-V+_`\']`?H;*FR?<'TW=$/WQMG=:P:W;6(, M[0!F/.??GUOAV].?NZ?E^__C^>'1R M=GRT>[S;?[I__/+^^'__U?[C_/CH^>7V\=/MM_WC[OWQOW?/Q__\\-__]>[' M_NGWYZ^[W>PO%T]^QL?_\^?YN5^_O_GC8/;YX(T^[ M;[]H_[S^_G,#48[XXO3B%I0_O/MTC M`E?M1T^[S^^//XZ*[6)^?/KAW5!!_W>_^_&<_/_1\]?]C^[I_M/J_G&'VD8[ MN1;X;;__W:DN/SF$PJ=4NAU:8/-T]&GW^?:/;R__L__1[^Z_?'U!<\]/^T\O7]\>3^U?V^.CN MC^>7_Z51,.6-C(,1_!F,C"].IN/9XOQ7K$R"%?P9K"RB)V\\?1K*X<]0 M;OZFMY`.(>-/\?9-_470QY^_Y-=(`G+_\VLEQ<51]/'-NCCUK3KTAOKVY?;# MNZ?]CR,,,;3;\_=;-V!'Q0@!A'X0&O/0,]!![YSZ1Z?__AB*:/-GT#\_3,X7 M[T[_1%>["SHEZXRT1B4:KKLYLW4.FART.>ART.=@F8/+'%SE8)6#=0ZNR)+()9$K(BLB:R+71&Z(;(AL4Z*J'G,N53W6F5?G M%Z?__GB*:2V98,YU39=!Z:W&.*@<&H-(0Z0ETA'IB2R)7!*Y(K(BLB9R3>2& MR(;(-B6J,5!A:6/(G.[P4.=25Z4G$TQ$:F)-$1:(AV1/B7* M6ZSCEK<.:V\]09XB;5T1J8DT1%HB'9$^)5 M)^C0XG]-I*%2K2C+J#DIBND^)"N#"#L!A'8`G:0">I`$0::A4ZTD6 M0+:T=0>E0P`I40&,L,](FR"DBR<+C(>7K_=WOY?[82\@33/HZ]`"2F,+:(QY M*YENLDF_CEKB9\.VVJB5VKK(VBQJB:U>(1VTR]^,?H<0\G8+R.V,8B2+,_WT M2K3.??X\F9R=92IU4)D,F[@A16ZDU,6A#[>",+[CX\ZF^G%=T)I-AL?-3^:9 M0J\>ID-W&945NL^TL$Q+_94CCQ"ZH$I0S%AK03&(AE$K*-KJ`IJ-#^9[T1IL M:;==.F*Y'=*4U&V/)IAT8A4N:+_BM6:JARZR9+MVVS@,Y&20-HS:@-ZVU44M MJV=+QNA7?BC=D`FF\'B%>L5N-/()#@NJ`5"2A8)Q"6R[8,>J5+>VV6T4M MM_WJJGJ71]G`FNB>7KG$$@V`3I(V9M;=ZZ"5VS#++ M7520FNR5&1V]6Y6MZ/UJK:(/"W@<#Y7;^/M0Y5%U0,D(;`2E05#!CFWUJJ!V MVRW/EMM^V59N>Y2-K6S]K-RI@XL$_2L9@=DB50>MS!8U6GABVDD/YEVC+4[R MTXHN/E]JLI>'#69T]&YM3Z+_Z0+H+2EG6(/OCC'Z9"'_]B*C/HZU0FH&3`50'-XO1:"SH_3*^- M%$SB%:V(NH#F,0?H16NPIG?=+"8TY>`D(V(`.A"F@>4H5T.*\D'F-./`+*.F:6\56BM1B2H/%TRAU35&(3-(Q:05AJWNB8 M00LKD9MUYB>+;#[KQ78V$*Z^3,=JP&ICADRF+1C!I1V M3(_&L0K:8&L641>0ZIBI+1V.RQO>"B?OF#[/0#BQ?B?G67.6;J_@@DY;(1O[ M5=21_EPS:ABUC#I&/:,EHTM&5XQ6C-:,KAG=,-HPVBJD6\=E3$GK'*8'GTFI M3N41&E^JLW)C#JV0H)I1PZAEU#'J%=)NNR3&H5TB[[7(1RVV?HRBW/5*3L4?)^E^/"34!)07;@+)C@"P/ZZ*65%2OD([$ MI2=6)#YM49%XE#A4C3U2D1!J@E92L`THBR2;6[NH%2/QYE$02$?B4@@K$I]: MJ$@\2ARJ,%,.R2M6T[@:G.>[^:@E#C4!);;:J)7:RK:B7=026[U"*CCD/2JX MGZTE@[Y>2P)*'*T"I8)UU!)'&[;51JW$UGFVL^ZBEMCJ%=)!9ZF0 MS&GH;OE"&9";:&(D=%XC6CZI'8W..7<(*G!*'&RD5%PX6T&8;.+C**D-6B&I MG9U,LR[0JX?IT%])FR:<-@6$T,7C2E"2(PB*032,6D'15A=0>EXC6H,M[;;+ M'HPQ./%913H&`\KV@5D-5:(U]>F7U6#>-*I2PF^D4$1M0-B;NC1N=C++'M1% M!3'3*S,ZS"P5.G3,0\HC1LJ)1^DF45!R3",H>MPP:@-*SG5P7%:1>>V59 M1^DR`"M*GQFH*#U20R>@=.@$%#UN)H3:@))QTC'J54'MMLL`++=]9J#<#LD" M_HBSSWEVAE6YD47',>=9;ET'K6P89EJ-:,7^V4;S?D3-:40=GA\;+3@^F-'1 MNV7=BMXO]RKZD&#$%JHF(2E(1Q1I-4$KF2E:+M@QZE5![?8K.<>$9]HTTSRUU4D#*]/&PPHZ*?_F)2 M,NCKI"2@=`0&-(\_$-2"8NK?2,$D.-&*!3M&?4!H4T2HPWDEW9ARNA&0'C7G M6>)424%W6//GAY&;'_.$4E32R/SCTFXJCT.#Q@%/Z4;0FLL:-\VFZUX]3(>> MI1L_2R^GG(8$A"J1GE.)5FR06E`(>VVRTPLMWW&DBZD^'\72;HA#"B9>VI=L`\KV\]GJUD4M&2Z] M0CH2ERQ8D?@D`@7%2#GU2$7BD8J$4,,%VX"R2/)U,FJ)$[U".A*7BUB1^!Q% M1>*1BL0C[1"=3$P/6N)0$U!BJXU:R4)RGF=N44ML]0KIX+(4B.;:[)1[RJE1 M0(FC54#Z9.*"5L^0X:2KB4>)K=:T12<342L&G9I70<^RS$K8JX?IR%])DESWS*;% M@-+<3E!,$FI!,8B&42LH+O]=0,F&JQ9S&YW;T8LDH2`V MVRZW&QL_CXI&S&L:1FU`KQ],1(5#OU1F=.MDB<^A7W*"@\9W#9;F:X+B<*H% MI4&$@A&U02L]F*UO:[5=2!!BD3N61'DYT,!$*XMA[R+R-T13,I+V.4!O, MH+Z=F?E)OEWKHD)LG-2,CO*5C&+&&45`:NAX+80DCZI%*PTB:$74!BT$(04[ M1KVRI=U^):.8<481D!XZ=#`1M%S=Q3GJ(EN$:M,6[7%%*^V,WB^8=XTV.\F7 M[OAXJ8]>6='!NYS!6+KQ7@#US)!>Q`:J@A9V&;Y.5TMMF+O:QBU?\M6%[6D[GIE M2\?K5NHDWI\E(?@1G)HO+/9QA:F"5GH2$9`_/?"OI0//LHN?M2/>9\G;,:!D@%6B%6?`6E`]9:BA:G^T`A9`E=%'1D]-:.&4B:T0VC#:.M0KIU7DF6YIPL!:1.@R;YDE5%K5CIWA8*"FI8JV74,>H9 M+1E=,KIBM&*T9G3-Z(;1AM%6(5WI+CU*9NK#U.;3IG1EPOSA1D-Z&L2H9M0P M:AEUC'I&2T:7C*X8K1BM&5TSNF&T8;152->P2P&M&O:IH:IAC]*#*TQLKM(3 M5#-J&+6,.D8]HR6C2T97C%:,UHRN&=TPVC#:*J1K^)6,>,X9<4#)<43%J`[( M;5\/,_IXGN5@3=22N:1E6UU`R<%7SVC)!2]9ZXK1B@NN6>N:T0T7W+#65B%= MZ:]DXFY.S@X>`E*5[K425`>MK-*SW4(3M6*EDZTN:*E*]UH)6K)?E]%\TO(7 MV6I^%;7$B17;6@>4//&:T0T7W`2D:R)W8ANUX(1NFE=V&W/>;03D7F2//?TB MZ^F5:,54K`XH\Y%:RS\16E)1+=OJ;%M9SMQ'+;&U9%N742L-*/N=Z"IJB:T5 MVUI'K=16YM=UU!);-VQK$[526YE?VZ@%6[I-?W%'-><=54#NS?U#6^,WT.Q3 M']&*358'I`Y_)V?9`4$3M:0>6K;51:W4B>RUM#YJB:TEV[J,6F_8NHI:8FO% MMM91*[65[92NHY;8NF%;FZCUAJUMU((MU=:+5[:;`]?;S8#H`\(9X'`B-SH9Y>T9-)(#[I;M=(+\03FNK\D[5,]VEE(H^G,I*+P*2&:N MV,Q*RD0S:T&ONG/-=FZD4+2S$?2:.UME1K=>MF>6C'K!>^.`TF-%0=&7.J#D MP+!AK991)RAN=GI!T?R2T:6@6/!*4"RX8K06%`M>"XH%;QAM!,6"6T%#05W# MV3;^4,.'[;J,SG+AD3J.F9QEZWDE6LF<%]#AU'*:3=4-EVD9=8+"SQ+&&ZZ] MJ,2'+QE="O*&1J,I_\)Q)3K1THK16E"P=,Y#]EI4HJ$;1AM!WM#%!7_YLQ65 MP9!NPVRS3T95T)BEHK1FM!\8G7@N(3;P1%6QM!\8E;08.6KOE7=OP+WO$'E!RE5HQJ M1@VCEE$GR$^RUC>-?5!)%J&EE(H3RB6C*T8K1FM!P0/CX[7KH))X<".EH@<; M1EN%=`MD)P(_[?M\4N#NA7!G,=&%BE'-J&'4,NH"P@\:,I/V@N)';4LN>,GH MBM&*T3J@Y(G7@N(3;[C@AM%6(5WSV4D!U7PX`'8967*EV\/NZ6A)*LX3"G12P!"<#A=OWLP3[_,+M MXEF"73LF54M2PK?2]*V"I#(EV%^C?:QX&DC<_HT]P/8:[6-)<#:*.A@6XVPR MQDDGZL"2X"@3=6!)<#").K`D.'E$'5@2G/?!@V$E)@_.X8$EP5DEZ;7%23NEW#+:_0=4]*@C/M=G,NTD+2FI(.D,R7E[+PH\=(# M6\/K)85[VX(E>*6DJ$T)WBPI&E."%TP*][X%6\,;)(5[[8(EY6P.WZR>6$'B M7N3A,GA%";Y9D@82]UH/EVDA<:_RL`0O(<$W2U+.L)[B_2PN4T%2F9(:$O=^ M&)=I(&E,"5YW@V]6F1X2]X886\.;HI!8/:2<897!<1^7J2"I3$D-B7OED,O@ MU4EX;4GP!B6\MB0]).ZE0[963=&K\$HS2_"&=.%>=F8)7DE&&:OOX`5CE+$D M)6JG-&NG@J0R)34D[J58]J"!Q+T;RY(6$O>*+$LZ2-R;LBS!UT#PVDRLIVAM M?!C!9:HI>KS_`3F;W_`!`,I8,U(U7:",U:_QJCW*6)(2OI6F;_BFJG#?%;%O M-23N\R*6-)"XKXQ8TD+2FI(.$O?-$9+HO3OII%OB\)])LG/P1>@16U*\-5GX3Z: MY#+X^+-P'TJRI(?$?2_)DG(R@V]F#X&D,B4U)+4I:2!Q7^'R<_`U,7RS)/AF M&+Y9DG(R@6]FCX>D,B4U)+4IP??G\,VRAL_0X9LEP6I!RC??QO$WGO':./^C>?,PFN1$$9:P[!W20H8_5$7#Z",I8$MX"@C#63 MXTX/E+$DN)D,$JL5<.D6K%ES+V[50AE+4HZQ:IJG%[CXJJA,20U);4IP[571 MF!++N6>,RY0AS(MXW8`DN+"PJ4X)+"@MW<1^7:2!Q]_>QI(7$W=G' M$MQ"6+BK^UA2CC`GXH9&EN`&3/AF27#K)7RS)+CI$KY9$EQX"=\L":ZUA&^V M!'T4-[.R;^4(LR4N`V5)!8F[A90EN%(57EL2W*P*KRT)+EB%UY8$-ZC"-TM2 MCC#SF5[CLE[X9L6#.WKAFR7!5;WPS9+@QM["W6[+D>*67GAM24JW!31*5)BH MK-[18IJR>(6!8\U$+28BBU3:)0ZPF<62;TG[[G1.#24*0^H+(/\>_<_7) M^OZM*LDK5UK(.J'!Q*>$UZG,1+U/Z)_?3W<+2K1A=<9*6?.$OG--[S>?/ZV/ M4KWH@G-#@%#KA!;&-"O/TVG!*Z8GLN$UO,FEJIB!1[7W=*,XR]I#5>F%OC_W M*B9J:@DK]1&&S'.1\D>9'BI>&PM1O&0&XM>%:/295J4?P55,O1R:NU16#2!V MHA3FO8524J6KYWTM%=N5D/=;,&7IF=T^7.$KD2JI96XF@/-LH-1F2*AT7PRB_TH"&>4[+@V3P+/4I(>M)'5/VL4M-XMJXWAD1FV62MY)-!8 ML-8-PS$)5B$DGZ*X136A,27`TZ"^;J(X6'NOD$9ZLGFP-O#K;"X6'M"="XAW MQ`6JZ`+S1)\/5NCR0N>QQXMZ/(+UBGP7.KX%H1-6%%]`UI6UF79L9N.NP&0D M=%03.IUWSD=QY`C6Q\FH8W/#!_1NQ`>JK0]7'ZL$,%^NX%VOO1)!:"-,5/M, MJP10^@YSZC+I,6$:.LRV[&$03V:N\FC0QULE[.-OE`'7V640;5>C<`*C?1Y* MM.CSK3+@S\?#7U[S@WC9Y:-%GV^5`3\>YV-CA@D$R\Z5PO=]?'L$[G._/HL; M?+QOEP*=BQ+8:PC#Z`;E)`VZNKR!Q6MWP=JV+J>NZ$@9AFVE?M@+_P9_Y+:& M7?[I+G;CMQ*F<9G*Q8WE`IOY*OYH$77[VIH,*F]OYR"%RYJP@V]7MEV7%5=[ M_H67I2:I/-00&+;6J>Y3L0VQ$4-]NMK:3XCGWL!F;]B>_V!J+VI-2IX#TY_$ M<,V5_0C8!R.;=DOOI(&=WOXMX&/-867Z&PO=V]R:W-H965TZUXA5^YQ7>;CQ_61VWVMN/<(5!0ML*=<\.*$,LZ+JE-],`5W#3: M2.K@:%IB!\-I/0;)GN1I6A))A<)!867>HZ&;1C#^H-E!0LM$] M:(TY/%!'-VNCCPCF"FP[4+\EV2J'VID'MQZM\`(CT+.`/F^*LER39RB#O7'N M`P>>D9-%!@'U:`'Y7K'PJ+?P=7K/^P!,]?+K>L69'O+]*M*8NK\%8))642ZB M4+`*G-F$,X^,L]2!4-J$\W0HB)/8$].$_:,<_V`Y#"&B?XR5A7TPQ:'#9+'<6]WVL&6CZ\=_+TX+%&:`+G1VIT.8$SB_W#S%P``__\#`%!+`P04``8` M"````"$`8J5JC"@)``!;)@``&0```'AL+W=OS? MYQ3OQ>+8._NP&I\J%@^KBH?LENY^_7X\3+YUEV'?G^ZGQ=5\.NE.V_YY?WJ] MG_[G]R^_W$PGP[@Y/6\._:F[G_[1#=-?'_[ZE[OW_O)UV'7=.$&$TW`_W8WC M>36;#=M==]P,5_VY.\'RTE^.FQ%_7EYGP_G2;9[UH.-A5L[GU[/C9G^:F@BK MRY^)T;^\[+==VV_?CMUI-$$NW6$S@O^PVY\'%^VX_3/ACIO+U[?S+]O^>$:( MI_UA/_ZA@TXGQ^WJM]=3?]D\';#N[T6]V;K8^@\1_KC?7OJA?QFO$&YFB,HU MW\YN9XCT\QPHH[9-+]W(_?2Q6:E%.9P]W.D'_W7?O0_3OR;#KW_]VV3__ M8W_JD&W4B2KPU/=?R?6W9X(P>"9&?]$5^-=E\MR];-X.X[_[][]W^]?=B'(O M:,BV/V`F_']RW%,/8.F;[_KS??\\[NZGU?758CFOBG(QG3QUP_AE3V.GD^W; M,/;'_QFGPH8R04H;!)\N"/[YP8#*#L"G&_#SL]8V"#YMD&)^5=3S:V(N)Y^9 ME>N,M9MQ\W!WZ=\G:$.L;3AOJ*F+%4;:5-D(/GFHX9:\'\G]?KJ<3I"6`>BW MAVHYOYM]0S6VUF.K.BO*'/%S0V?>VU\,"C06W"7QKMX?@)1,<(8 MHEE2AM@7/RPVN=]/Z^N(3G&;Y&MMG3[B[%T\9X&H&&&<$3CB[/J04$W-A5Q; M)&[-XN8VR9YW?'7AW.8T2&4" M#;\Z*SYQ[0S$5A=#/"Q)1@B;69W5E'@"`WVV.NO%5Q<.34:CY/KD5J=AWC@6 MBE?'(!Z6:XE<72E5Q4*?K,YYH82^,_$DEN_,,J\J&DY69X7&/%#0];5Q7@%J M):08Q'.0T9Z/I;^48F0A)OWE/#VV@Y?3Z%9"BD&<:EZ?2JE/%EKH9S5]S6\D MU$I(,8A/3EH3=H)O08*3(AD(ZW#+;.C!"%X1U$I(,8A/GM>N4FJ7A5C_Q]IE MGGFDEV(0GYQT**Q<[Y)B<;7$FL;=?OMUW:/%"_^P41K9BO7.0CA70T:,%^4[ MVB#)]:JU`^'E!BH&<9YY"2RE!%J(\AU-GMZHG!?2%WDE]YG6>=WH)])BL9C3 M?WZCZWPKZU29=P?LH9(+K&\K*:NE@4#:Y:*14.N@\-RI'*3O02QCX!-7UDVN M8=[3%HHK:"'L><>GE9!B$)^IGFJ6D;<DU<&QUGK6BEG>E)D5S-&SLPJG$K(<4@SI64..'Z\7-G;;2;4;5RSJFF%WD[ MD%'U`T-:8XA3Y>>`[KW/TBK/B-I`R0Y/]FX3O!RQ5D**08PK'GE_,JUZ!)=G M"R54TPMW\/)4):08Q*GRXT*G]>,.6)AC(^X`"R54TZMN\`I4Q1&DF!>GFCE< M/ND`?,F$1"UZ&J_E.VGS#>NPNKUW3'0[# M9-N_G:`Y"SK2/6R^#%_7RQ5M4800EAM8M`X)RRTL^H*96A9S?+>N!5Y8Z%MW M?68+2^F^CT\M!<:8Y\W44F(,7FAE6)<5+/I$$V-J6/2QDEKJ!=:C#P5AN89% M7PM3"X9D1V!`UA]ISF892<[F&"G.9KA`AO'52&;E=;5:X_24%MP95G3Z2DL+ M2YNUX'*`E>?&X.<3C]G,4[$R\>$"UG69?(FWFUDJRG*9$#\]R<6-;ES6IM M'M032P,+O5V3#/"^;T4OV:0%+_DPC[;,?#C\XN>\>>W^N;F\[D_#Y-"]0(KG M^D9V,3\.,G^,YOHZ>>I'_-9'_S1FAQ]Q=7C#/Z>O85_Z?G1_8.J9_UG8P_\! M``#__P,`4$L#!!0`!@`(````(0"8M^&PO=V]R:W-H M965TU` M-US!3J&-I`Z6IB2V,9SFK9.L21)%8R*I4#@0YN8>ABX*P?B39GO)E0L0PVOJ M('];B<:>:9+=@Y/4[/;-`].R`<16U,*]M5",))L_ETH;NJVA[M=X2-F9W2ZN M\%(PHZTNW`!P)"1Z7?.,S`B0EHM<0`6^[+X>8[)2NRG`R&8PF41HG(XRVW+J-\+X8L;UU6OX- MHOB$"I#D!('W"9*.[X60D%!;R!-U=+DP^HA@.""D;:@?M7B>0`.9-ZZ\-<,3 MC"`I"];#,IVF"W*`7K"39ATT\.PT<:<@0.]"0+XW0GBK#^&;Y6.N@Z'/2V[S MTIL\;\TP/+MTTNFP`X0003/L:4:=XB)ED-Q(V5LS/!SW_-/I.R'$.(EZFG?% M10PX^!LQO+6-T?4E6&(8SEYE_V%":CTF\O,XB[I3];N7[&!)H/4]]OA#3\+X MAZF1W)3\"Z]KBYC>*_#R0]-9NUNW2OS!?K0/YZOV-I)N`RY)0TO^0DTIE$4U M+P`9#290M`GW*2R<;MI9W6H'UZ/]K."WQV%PH@&("ZW=>0&!2?0C2`62(YY,K79!>CYY2BVH&56*2&2^&F#5;&=`Q;ZJ5ZDUN@ MD[*<4PM1:ADE/0)S/Q+)@-1J1/KWT/0`K2@T8,%%I*Q@]+L;(5C\\T*?G#6M MB0>?9AITS]E:?85C>X]F+'9=5W337B/Y,_J\NGOH1\V-.^Y*`1''_302XRJM M*NHK^S2JO>CJL`,H+.TGO\R^Z4/$UO;M=+(B8EF^6,Y>5\ M/6&ZGHJ37<%R/0#@+_)IX`HO?^^>?B$P``__\#`%!+`P04``8`"``` M`"$`A.P$G_D"```+"@``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````"<5EU/XS`0?#_I_D.5=TBA MZ(10&@1M[T`"4='"/5JNLVTM$CMXG0CNU[-.KFT*3G37E\BQ=];CG?%'=/F6 MI;T2#$JMAL')<3_H@1(ZD6HU#)[F/X_.@QY:KA*>:@7#X!TPN(R_?XNF1N=@ MK`3L40J%PV!M;7X1ABC6D'$\IF%%(TMM,F[IUZQ"O5Q*`6,MB@R4#4_[_1\A MO%E0"21'^39A4&>\*.VA21,M'#]\GK_G1#B.KO(\E8);6F5\+X71J)>V-WD3 MD$9AY'8?,WF@F>PH@2QTN>(D3AKB.Z`>Z*-N728!R5]J($ M8;7IH?Q#93L->@N.X.@,@Y(;R94E6BZL_JG::8[6Q+^U><$U@,4HI("ZLVHV M8YMM>18/SJL(:NU'N@PU$QK8YSB7-@5\6$ZYL1[*`U)^Q[EB43.N"6U49.0- M-E&6ZL5N5:VVU$WFVS7<*@M&9FRD%>I4)MQ"PJYYRI4`-CL`LFFA@RZ#716JX5[!$%E M8%="Z()D4ROVJR`M2`-O^)U6JSF8C(UA8:L9*AD!+7OD;=7$PE2BWG-+DONI MSZP6+\26/##2&1T66&U/+XD)-XJ8(KO3B&P*QD$R6O%LS5N6^>SVU2(%,B51 M<'1KD_KSOQ;.O_=@USHA1$GQK6;9"$(5*2'5>6O@6*+0KL0%K?&!3LMJ@2W5 M*!8(KX539E+2MR7*7S,V=ROU0[I+Y[>V;X5=IGTBW5?U$NLWGQ]RJ M3^XCG=I9M;CP+\9KELIS7XU;>W'AA[3H]D@^,_*_(#.Z7I/""^F6VG\B=6,& MWGG:ME9=-"]DTK+!.B`-4VVW6:>47D!=+CH&O+1:=FBG^I\WJH_3WJW[Z9Z] MD^H%G_*Y'M.-M'E(['=&E<42NF(WX[N.Z(;>$"9U249KKE:0;&*^#KAGSW/] MMHM/SH[[@SZ]:!I]4;A[Q<4?````__\#`%!+`0(M`!0`!@`(````(0#FQ),I MZ@$``%48```3``````````````````````!;0V]N=&5N=%]4>7!E&UL M4$L!`BT`%``&``@````A`+55,"/U````3`(```L`````````````````(P0` M`%]R96QS+RYR96QS4$L!`BT`%``&``@````A`.>YA;+V`0``6!<``!H````` M````````````20<``'AL+U]R96QS+W=O&PO=V]R:W-H M965TR^V/0`(``#\%```9 M`````````````````'T:``!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`/XOE;7X!0``(A<``!D`````````````````]!P``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`%E.QU&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(>5&'L&`P``S`@` M`!D`````````````````%#D``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,Z$Z;:@!P``&POLLNIT-``!)@P``#0````````````````!,L```>&PO&UL4$L!`BT`%``&``@````A`.H-GY=*`P`` M/@H``!D`````````````````V<0``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`),$.;5/`P``MPD``!D` M````````````````K>$``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)72&%N1`@``,08``!@````````````````` M,>L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`&X-%I_$`P``\`L``!@`````````````````\/X``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`+))\G;%`@``$P<``!D`````````````````S2(! M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A``!-`?_$'```-HD``!D`````````````````CD@!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,^8"*DQ`0``0`(``!$````````` M````````^XT!`&1O8U!R;W!S+V-O&UL4$L!`BT`%``&``@````A`(3L M!)_Y`@``"PH``!``````````````````8Y`!`&1O8U!R;W!S+V%P<"YX;6Q0 52P4&`````"\`+P"[#```DI0!```` ` end XML 12 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Variable Interest Entity (Details Textual) (USD $)
In Thousands, unless otherwise specified
 0 Months Ended 9 Months Ended
Sep. 30, 2014
Bed
Entity
Mar. 27, 2014
Rose Terrace Nursing Center
Sep. 30, 2014
Minimum
Sep. 30, 2014
Maximum
Dec. 28, 2011
Variable Interest Entity, Not Primary Beneficiary
Culloden, WV
Bed
Variable Interest Entity, Not Primary Beneficiary [Abstract]          
Number of variable interest entity 1        
Number of licensed nursing beds 6,229       90
Agreement provides company right to purchase     110.00% 120.00%  
Purchase Price   $ 7,693      
XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt and Interest Rate Swap (Details) (USD $)
 0 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended 0 Months Ended
May 01, 2013
Sep. 30, 2014
Center
Letter_Of_Credit
Dec. 31, 2013
Sep. 30, 2014
Interest rate swap
Sep. 30, 2014
Revolving credit facility
Mar. 30, 2014
Revolving credit facility
May 01, 2013
Revolving credit facility
Sep. 30, 2014
Loans Payable
Sep. 30, 2014
LIBOR
May 01, 2013
Credit Agreement
Sep. 30, 2014
Credit Agreement
May 01, 2013
Credit Agreement
Sep. 30, 2014
Maximum
Revolving credit facility
Sep. 30, 2014
Revolving credit facility
Revolving Credit Facility Interest at 4.5% Percent Above LIBOR
Dec. 31, 2013
Revolving credit facility
Revolving Credit Facility Interest at 4.5% Percent Above LIBOR
Jul. 01, 2014
Loans Payable
Rose Terrace Note
Rose Terrace Nursing Center
Sep. 30, 2014
Letter of Credit
Revolving Credit Facility Interest at 4.5% Percent Above LIBOR
Long-Term Debt and Interest Rate Swap (Textual) [Abstract]                                  
Revolving credit facility and the maximum loan                       $ 65,000,000          
Long-term debt for syndicate of banks mortgage debt 45,000,000 45,000,000                              
Long-term debt revolving credit facility           20,000,000 20,000,000           27,500,000        
Loan acquisition costs                   1,341,000              
Term of debt agreement                     5 years            
Long-term debt five year maturity   5 years                              
Mortgage loan with principal and interest payable monthly based   25 years                              
Long-term debt interest based on LIBOR   4.50%             4.50%                
Long-term debt fixed based on the interest rate swap   6.87%   6.87%                          
Notional Amount of interest rate derivatives       21,847,000                          
Debt interest rate at period end               4.65%                  
Number of owned nursing centers secured   13                              
Borrowings outstanding                           6,000,000 3,000,000   7,991,000
Letters of credit issued under Revolver outstanding   3.00%                              
Number of letters of credit   10                              
Borrowing under the revolving credit facility         12,728,000                        
Mortgage loan outstanding                               8,000,000  
Liability at fair value       (755,000)                          
Accumulated other comprehensive loss   468,000 569,000 (468,000)                          
Net income tax benefit       $ 287,000                          
XML 15 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations (Details) (USD $)
 3 Months Ended 9 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended
Sep. 30, 2014
Bed
Center
Sep. 30, 2013
Sep. 30, 2014
Bed
Center
Sep. 30, 2013
Dec. 31, 2013
Sep. 30, 2014
Leased Skilled Nursing Centers
Sep. 30, 2013
Leased Skilled Nursing Centers
Jan. 22, 2013
Omega Healthcare Investors, Inc.
Sep. 01, 2013
Omega Healthcare Investors, Inc.
Arkansas
Facility
Bed
Jan. 22, 2013
Omega Healthcare Investors, Inc.
Arkansas
Facility
Jul. 01, 2014
Loans Payable
Rose Terrace Note
Rose Terrace Nursing Center
Sep. 30, 2014
West Virginia
Rose Terrace Nursing Center
Sep. 30, 2013
West Virginia
Rose Terrace Nursing Center
Jul. 01, 2014
West Virginia
Rose Terrace Nursing Center
Facility
Apr. 03, 2014
West Virginia
Rose Terrace Nursing Center
Center
Jul. 01, 2014
Culloden, WV
Rose Terrace Nursing Center
Bed
Jul. 01, 2014
Danville and Ivydale, West Virginia
Rose Terrace Nursing Center
Facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                                  
Number of nursing centers 51   51                     2 2   2
Number of licensed nursing beds 6,229   6,229           1,181             90  
Sales price                               $ 16,500,000  
Payment of balance of mortgage loan outstanding                     8,000,000            
Pretax gain on the transaction                       7,522,000          
Gain on disposal, tax benefit (provision) (3,009,000) 0 (3,009,000) 0               (3,009,000)          
Revenue from discontinued operations           0 40,161,000         10,988,000 15,944,000        
Income (loss) from discontinued operations 3,928,000 (2,444,000) 3,444,000 (1,875,000)   (935,000) (2,432,000)         165,000 680,000        
Number of nursing centers under lease terminated                 11 11              
Annual decrease in rent payable, amount               5,000,000                  
Current assets of discontinued operations 390,000   390,000   2,870,000                        
Current liabilities of discontinued operations $ 136,000   $ 136,000   $ 1,359,000                        
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidation and Basis of Presentation of Financial Statements
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
CONSOLIDATION AND BASIS OF PRESENTATION OF FINANCIAL STATEMENTS
CONSOLIDATION AND BASIS OF PRESENTATION OF FINANCIAL STATEMENTS
The interim consolidated financial statements include the operations and accounts of Diversicare Healthcare Services and its subsidiaries, all wholly-owned. All significant intercompany accounts and transactions have been eliminated in consolidation. Any variable interest entities (“VIEs”) in which the Company has an interest are consolidated when the Company identifies that it is the primary beneficiary. The Company had one variable interest entity related to a nursing center in West Virginia that was dissolved in the first quarter of 2014 as a result of the asset purchase of the Rose Terrace nursing center as further described in Note 8, and is no longer consolidated into the interim consolidated financial statements of the Company. The investment in an unconsolidated affiliate (a 50 percent-owned joint venture partnership) is accounted for using the equity method and is described in Note 9.
The interim consolidated financial statements for the three and nine month periods ended September 30, 2014 and 2013, included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management of the Company, the accompanying interim consolidated financial statements reflect all normal, recurring adjustments necessary to present fairly the Company’s financial position at September 30, 2014, and the results of operations for the three month and nine month periods ended September 30, 2014 and 2013, and cash flows for the nine month periods ended September 30, 2014 and 2013. The Company’s balance sheet information at December 31, 2013, was derived from its audited consolidated financial statements as of December 31, 2013.
The results of operations for the periods ended September 30, 2014 and 2013, are not necessarily indicative of the operating results that may be expected for a full year. These interim consolidated financial statements should be read in connection with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013.
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Q-#EE-S!A85\X8V8R7S1E96-?86-B8U]C-#$Q M-C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=&5R:6U?0V]N#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D)U#I%>&-E M;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G1S/"]X.DYA;64^#0H@("`@/'@Z M5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D)U#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D)U#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E9A5]$971A:3PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D5Q=6ET>5]-971H;V1?26YV97-T M;65N=%]$971A:3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D)U#I7;W)K#I7;W)K#I7;W)K#I%>&-E M;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I% M>&-E;%=O7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO2!296=I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U$S/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^ M)RTM,3(M,S$\'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q-#EE-S!A85\X M8V8R7S1E96-?86-B8U]C-#$Q-C'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO"!R969U M;F1A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,34\&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XW+#F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@U,RPR.#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPQ,S`\'0^)SQS<&%N/CPO'!E;G-E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPOF5D M("AS:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P M,#QS<&%N/CPOF5D("AS:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!I;B!N970@:6YC;VUE("AL;W-S*2!O9B!U M;F-O;G-O;&ED871E9"!A9F9I;&EA=&4\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO#PO=&0^#0H@("`@("`@(#QT9"!C M;&%S#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2`H=7-E9"!I;BD@;W!E'0^)SQS<&%N/CPO2P@;F5T(&]F(&-A2!I;B!N970@;&]S'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT('1H2`H=7-E9"!I;BD@8V]N M=&EN=6EN9R!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ,BPR-#$\2`H=7-E9"!I;BD@:6YV97-T:6YG(&%C=&EV:71I M97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO2`H=7-E M9"!I;BD@8V]N=&EN=6EN9R!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@V+#(T,BD\'0^)SQS M<&%N/CPO6UE;G1S(&]F(&EN8V]M92!T87AE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQD:78@F4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD M97)L:6YE.SY"55-)3D534SPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HV<'@[9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^1&EV97)S:6-A6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SYN:6YE/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^('-T871E2=S(&-O M;G1I;G5I;F<@;W!E2P@36ES&%S+B`@5&AE($-O;7!A;GDG M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HV<'@[9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^07,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`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`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!I;B!A8W%U:7-I=&EO;BUR96QA M=&5D(&5X<&5N6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3I!F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CQT86)L92!C96QL<&%D9&EN9STS1#`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`P M+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[/B!B971W965N('1H92!A2!A;'-O(&%S6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-S4X+#`P M,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/B!W:&EC:"!R97-U;'1E9"!I;B!T;W1A;"!C87-H(&]U M=&QA>2!O9B`\+V9O;G0^/&9O;G0@3II;FAE M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B`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`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`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`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,30L-S0R+#`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^='=O/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&-E;G1E3II;FAE3II;FAE2!A;F0@82`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^('EE87)S+B`@5&AE(&-E;G1E6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HX<'@[=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+7EE87(@;&5A6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[/BUY96%R(')E;F5W86P@;W!T:6]N+B`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`@5&AE(&YU3II;FAE'!A;F1I;F<@:6YT;R!O;F4@;F5W('-T871E M+"!);F1I86YA+B`@06QL(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/F9O=7(\+V9O;G0^/&9O;G0@ M3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXQ,#<\ M+V9O;G0^/&9O;G0@3II;FAE3II;FAE65A3II;FAE3II;FAE65A2!O<&5R871I;F<@86YD('1R96%T:6YG('!A=&EE;G1S(&]N('1H M92!T'1087)T7S$T M.64W,&%A7SAC9C)?-&5E8U]A8V)C7V,T,3$V-SDX.3`V,0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\Q-#EE-S!A85\X8V8R7S1E96-?86-B8U]C M-#$Q-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N+"!#;VYS;VQI9&%T:6]N(&%N9"!0'0^)SQS<&%N/CPO3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M9&5C;W)A=&EO;CIU;F1E6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HV<'@[9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^5&AE(&EN=&5R:6T@8V]N2!I9&5N=&EF:65S('1H870@:70@:7,@=&AE M('!R:6UA3II;FAE2X@5&AE(&EN=F5S=&UE;G0@:6X@86X@=6YC;VYS;VQI9&%T M960@869F:6QI871E("AA(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT M+61E8V]R871I;VXZ;F]N93L^-3`@<&5R8V5N=#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BUO=VYE M9"!J;VEN="!V96YT=7)E('!AF4Z,3!P M=#L^5&AE(&EN=&5R:6T@8V]N3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2!T;R!P2!T:&4@0V]M M<&%N>28C.#(Q-SMS(&9I;F%N8VEA;"!P;W-I=&EO;B!A="`\+V9O;G0^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!A;F0@=&AE(')E6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`Q-#PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M M9&5C;W)A=&EO;CIN;VYE.SXR,#$S/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!A;F0@8V%S:"!F M;&]W3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O M;G0@3II;FAE3II;FAE3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^5&AE(')E6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`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`@("`\=&%B;&4@8VQA6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M9&5C;W)A=&EO;CIU;F1E#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE2`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`[8VAA;F=I;F<@=&AE(&-R:71E M2!T:&]S92!D:7-P;W-E9"!C;VUP;VYE M;G1S("AO2!I&ET960@9'5R:6YG(#(P,30N("!4:&4@861O<'1I M;VX@;V8@=&AI3II;FAE2!T;R!R96-O M9VYI>F4@=&AE(&%M;W5N="!O9B!R979E;G5E('1O('=H:6-H(&ET(&5X<&5C M=',@=&\@8F4@96YT:71L960@9F]R('1H92!T2!A<'!L:6-A=&EO M;B!I65T M('-E;&5C=&5D(&$@=')A;G-I=&EO;B!M971H;V0@;F]R(&AA7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^5&AE($-O;7!A;GD@:&%S(&%G6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#8U+#`P,"PP M,#`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#(P+#`P M,"PP,#`\+V9O;G0^/&9O;G0@3II;FAEF5D(&EN('1H92!A;6]U;G0@;V8@/"]F;VYT M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#$L,S0Q+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0@87)E(&)E:6YG(&%M M;W)T:7IE9"!O=F5R('1H92`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^56YD97(@=&AE('1E6YD:6-A=&4@;V8@8F%N:W,@<')O=FED960@=&AE($%M M96YD960@36]R=&=A9V4@3&]A;B!W:71H(&%N(&]R:6=I;F%L(&)A;&%N8V4@ M;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN M;VYE.SXD-#4L,#`P+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!W:71H(&$@/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SYF:79E/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^+7EE87(@;6%T=7)I='D@=&AR;W5G:"!!<')I;"`S,"P@,C`Q M."P@86YD(&$@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A M=&EO;CIN;VYE.SXD,C`L,#`P+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!!;65N9&5D(%)E M=F]L=F5R('1H3II;FAE3II;FAE65A3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+7EE87(@86UOF%T:6]N+B!);G1E&5D(&%T(#PO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^-BXX-R4\+V9O M;G0^/&9O;G0@3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,C$L.#0W+#`P,#PO9F]N=#X\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P M<'0[/BX@($%S(&]F(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E M8V]R871I;VXZ;F]N93L^4V5P=&5M8F5R)B,Q-C`[,S`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`Q+"`R,#$T M+"!T:&4@0V]M<&%N>2!E;G1E3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXD,C3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&)O6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^)#,L,#`P+#`P,#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!O=71S M=&%N9&EN9R!A3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+B!4:&4@;W5T6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&]F('1H92!A;6]U;G0@ M;W5T3II;FAE3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`Q-#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[/BX@0V]N6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!T:&4@8F%L86YC92!A=F%I;&%B M;&4@9F]R(&)O6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#$R+#3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN M;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`Q-#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BX\+V9O M;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN M9RUT;W`Z-G!X.V9O;G0M2`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`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#(Q+#@T M-RPP,#`\+V9O;G0^/&9O;G0@3II;FAE&5D(')A=&4@;V8@ M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXV+C@W)3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.C$P<'0[/B!W:&EL92!T:&4@8F%N:R!I2!B87-E9"!O;B!, M24)/4B!O;B!T:&4@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!A6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V M,#LS,"P@,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[/BP@=&AE($-O;7!A;GD@9&5T97)M:6YE M9"!T:&%T('1H92!I;G1E2!O9B`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M(&%T(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ M;F]N93L^4V5P=&5M8F5R)B,Q-C`[,S`L(#(P,30\+V9O;G0^/&9O;G0@3II;FAE3II M;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#0V."PP M,#`\+V9O;G0^/&9O;G0@3II;FAE7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`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`P+#`P M,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/B!O3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN M;VYE.SXD,2PP,#`L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"!T;W1A;"!A;FYU86P@ M86=G2!L:6UI=',@;V8@/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-2PP,#`L,#`P/"]F;VYT M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^+B`@06QL(&]T:&5R(&-E;G1E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,2PP,#`L,#`P/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M('!E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,RPP,#`L,#`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`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BX@5&AI#MT97AT+6%L:6=N M.FQE9G0[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE($-O;7!A;GD@979A;'5A M=&5S('1H92!A9&5Q=6%C>2!O9B!T:&ES(&QI86)I;&ET>2!O;B!A('%U87)T M97)L>2!B87-I2P@=&AE($-O;7!A;GD@2!C;&%I;7,@87,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`Q-#PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/BX\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I M9VAT.C$R,"4[<&%D9&EN9RUT;W`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`P/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&9O6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SYN:6YE/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&UO;G1H3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2X\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[ M<&%D9&EN9RUT;W`Z-G!X.V9O;G0M2!S:&]U;&0@8F4@9&5T97)M:6YE9"!W:71H;W5T(&-O;G-I9&5R871I M;VX@;V8@:6YS=7)A;F-E(')E8V]V97)I97,N("!!8V-O2P@=&AE M($-O;7!A;GD@:&%S(')E8V]R9&5D(&%S6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A M=&EO;CIN;VYE.SXD,C$W+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!A="`\+V9O;G0^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@ M3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^(&%T(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E M8V]R871I;VXZ;F]N93L^1&5C96UB97(F(S$V,#LS,2P@,C`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`R,#`S('5N=&EL($IU;F4F(S$V,#LS,"P@,C`P-RP@=&AE M($-O;7!A;GDF(S@R,3<[28C,38P.S$L(#(P,#@@=&AR;W5G:"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+"!T:&4@0V]M<&%N>2!I2P@=&AE($-O;7!A;GD@:7,@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXD-3`P+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[/B!P97(@8VQA:6TL('-U8FIE8W0@=&\@ M86X@86=G&EM=6T@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,RPP,#`L,#`P/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^+B!4:&4@0V]M<&%N>2!F=6YD3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V M,#LS,"P@,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[/BX@5&AE($-O;7!A;GD@:&%S(&$@;F]N M+6-U6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B!4:&4@;F]N+6-U6UE;G1S('!A:60@=&\@=&AE($-O M;7!A;GDF(S@R,3<[&-E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M07,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@,C`Q-#PO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BP@ M=&AE($-O;7!A;GD@:7,@65E3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M('!E2!P2!F;W(@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%T(#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^4V5P M=&5M8F5R)B,Q-C`[,S`L(#(P,30\+V9O;G0^/&9O;G0@3II;FAE7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('-H87)E2=S(&-O;6UO;B!S=&]C:R!H879E(&)E96X@'!I6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,3`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`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE65A6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+71O<#HQ,G!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3II;FAE&5R8VES92!O9B!E<75I='D@87=A'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE3II;FAE M2`\+V9O;G0^/&9O;G0@3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXV.2PP,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMGF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY796EG M:'1E9#PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZF4Z,3!P=#L^*#(L,#`P/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M3W5T6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z M,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-2XT,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-#$L,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-2XS,#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`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`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B!4 M:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA3II M;FAE'0M:6YD96YT.C!P M>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N M=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY'6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ8V5N M=&5R.V9O;G0M6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF M;VYT+7=E:6=H=#IB;VQD.SY686QU92U'#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O M;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ M8V5N=&5R.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT M+7=E:6=H=#IB;VQD.SY/=71S=&%N9&EN9SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.3DT+#`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE65E6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-#0Q+#`P,#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0@ M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXD.#`Y+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[/B!I;B!T:&4@/"]F;VYT/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SYN:6YE/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&UO;G1H('!E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T96UB97(F(S$V,#LS,"P@ M,C`Q-#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXR,#$S/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!R97-P M96-T:79E;'DN/"]F;VYT/CPO9&EV/CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^ M)SQD:78@F4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE M.SY%05).24Y'4R`H3$]34RD@4$52($-/34U/3B!32$%213PO9F]N=#X\+V1I M=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HV M<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26YF;W)M871I;VX@=VET:"!R97-P M96-T('1O(&)A&-E<'0@<&5R('-H87)E.CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^)B,Q-C`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`L/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`Q M,SPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@ M'0M86QI9VXZF4Z,3!P=#L^-S@T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R M/CQT9"!S='EL93TS1'9E#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-"PP,#@\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#@L,C`P/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+7)I M9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M3I4:6UE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF M(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@8V]L#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`Q M,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.7!T.SXR,#$T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.CEP=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M;W9E6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XP.3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3W!E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D M:6YG+7)I9VAT.C)P>#L@#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1&ES M8V]N=&EN=65D(&]P97)A=&EO;G,L(&YE="!O9B!T87AE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#`N-#(\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI9VXZF4Z,3!P=#L^*#`N,S(\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^ M/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#`N.#,\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XV-CPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`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`C,#`P,#`P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`N-#(\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD M:78@6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^3F5T(&EN8V]M92`H;&]S#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P M86X],T0Q/CQD:78@6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[)R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#LG M(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#LG M(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(%-/4T%2 M3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+6UO;G1H('!E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^4V5P=&5M8F5R)B,Q-C`[,S`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`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`V,0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\Q-#EE-S!A85\X8V8R7S1E96-?86-B8U]C M-#$Q-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE3II;FAE'0M9&5C;W)A=&EO;CIU;F1E6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HX<'@[=&5X="UA;&EG M;CIL969T.V9O;G0M2X@(%1H92!I;G9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M(&%S(&-O;7!A6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY$ M96-E;6)E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B`@061D:71I;VYA M;&QY+"!T:&4@0V]M<&%N>2=S('-H87)E(&]F('1H92!N970@<')O9FET2!I;B!N970@96%R;FEN9W,@;W(@;&]S2=S(&5Q=6ET>2!I;B!T:&4@ M;F5T(&QO3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&UO;G1H('!E6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#$U,BPP,#`\+V9O;G0^/&9O M;G0@3II;FAE3II M;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&UO;G1H M('!E3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^+CPO9F]N=#X\+V1I=CX\+V1I=CX\'0O:F%V87-C M3X-"B`@("`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`@5&AE($-O;7!A;GDG6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+71O<#HV<'@[9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^07,@;V8@/"]F;VYT M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SY397!T M96UB97(F(S$V,#LS,"P@,C`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`P,#PO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!I M;B!A8W%U:7-I=&EO;BUR96QA=&5D(&5X<&5N6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3I!F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CQT86)L92!C96QL<&%D9&EN9STS1#`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`P+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!B971W965N('1H M92!A2!A;'-O(&%S6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A M=&EO;CIN;VYE.SXD-S4X+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!W:&EC:"!R97-U;'1E M9"!I;B!T;W1A;"!C87-H(&]U=&QA>2!O9B`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^+B`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`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`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`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,30L-S0R+#`P,#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('EE87)S+B`@5&AE M(&-E;G1E6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP M861D:6YG+71O<#HX<'@[=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+7EE87(@;&5A6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BUY96%R(')E;F5W M86P@;W!T:6]N+B`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`@5&AE(&YU3II;FAE3II;FAE M65A'!A;F1I;F<@ M:6YT;R!O;F4@;F5W('-T871E+"!);F1I86YA+B`@06QL(#PO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M/F9O=7(\+V9O;G0^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C M;W)A=&EO;CIN;VYE.SXQ,#<\+V9O;G0^/&9O;G0@3II;FAE3II;FAE65A2!O<&5R871I;F<@86YD('1R96%T M:6YG('!A=&EE;G1S(&]N('1H92!T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3I4:6UE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^5V5S="!6:7)G:6YI M82!$:7-P;W-I=&EO;CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HX<'@[<&%D9&EN9RUT;W`Z-G!X M.W1E>'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!E;G1E3II;FAE3II;FAE#MT97AT+6%L:6=N.FQE9G0[9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^169F96-T:79E($IU;'D@,2P@,C`Q-"P@=&AE($-O;7!A;GD@8V]M<&QE M=&5D('1H92!T6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.3`\+V9O M;G0^/&9O;G0@3II;FAE2!I;B!#=6QL M;V1E;BP@5V5S="!6:7)G:6YI82!F;W(@82!S86QE3II;FAE3II;FAE3II;FAE2!E;G1E3II;FAE3II;FAE2!P86ED('1H92!B86QA;F-E(&]F('1H92`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&UO2X@(#PO9F]N=#X\+V1I=CX\9&EV M('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HX<'@[=&5X M="UA;&EG;CIL969T.V9O;G0M3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B`@5&AE('1A M>"!E>'!E;G-E(&%S6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)"@S+#`P.2PP,#`I/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&9O2!P;&%N2!N970@;W!E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#$P+#DX."PP,#`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"!N970@:6YC;VUE(&]F M(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/B0Q-C4L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^ M/&9O;G0@3II;FAE3II;FAE M3I4:6UE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O M;G0^/&9O;G0@3II;FAE3II;FAE2XF(S$V,#L@5&AE(&YE="!I M;F-O;64@;W(@;&]S2!A;&QO8V%T:6]N(&]F(&-O2!W:&5N(&1E=&5R;6EN:6YG('1H92!C;VYT6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE M.FET86QI8SL^07)K86YS87,@3&5A#MT97AT+6%L:6=N.FQE9G0[9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^169F96-T:79E(%-E<'1E;6)E2!E;G1E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SYE M;&5V96X\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2!E;G1E3II;FAE3II;FAE2!/;65G82X@57!O;B!T:&4@8V]M<&QE=&EO;B!O9B!T:&4@=')A;G-A8W1I M;VXL('1H92!#;VUP86YY(&YO(&QO;F=E2`R,BP@,C`Q,RX@5&AI6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^96QE=F5N M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&YU6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^96QE=F5N/"]F;VYT/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&-E;G1E2!R961U8V5S('1H92!A;FYU M86P@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.R<^)#4L,#`P+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BX\+V9O;G0^/"]D:78^ M/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUT;W`Z-G!X M.V9O;G0M3II;FAE3II;FAE3II;FAE M3I4:6UE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O M;G0^/&9O;G0@3II;FAE3II;FAE2XF(S$V,#L@5&AE(&YE="!L M;W-S(&EN(#(P,30@<')I;6%R:6QY(')E;&%T97,@=&\@<')O9F5S2!E>'!E;G-E(&EN8W5R6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+71O<#HV M<'@[=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%T M(#PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&%N9"`\+V9O;G0^/&9O;G0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^+"!R97-P96-T:79E;'DN("!4:&4@8W5R6%B;&5S M(&%N9"!V87)I;W5S(&%C8W)U960@97AP96YS97,@;V8@/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#$S-BPP,#`\+V9O;G0^/&9O;G0@3II;FAE M6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.R<^4V5P=&5M8F5R)B,Q-C`[ M,S`L(#(P,30\+V9O;G0^/&9O;G0@3II;FAE M3I4:6UE3II;FAE2X@(%1H M92!#;VUP86YY(&5X<&5C=',@=&\@8V]L;&5C="!T:&4@8F%L86YC92!O9B!T M:&4@86-C;W5N=',@6UE;G0@;V8@=&AE7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA3I4:6UE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M M9&5C;W)A=&EO;CIU;F1E#MT97AT+6%L:6=N.FQE9G0[9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M169F96-T:79E($]C=&]B97(@,2P@,C`Q-"P@=&AE($-O;7!A;GD@8V]M<&QE M=&5D(&$@=')A;G-A8W1I;VX@=&\@87-S=6UE(&]P97)A=&EO;G,@;V8@82`\ M+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^('EE87)S+CPO9F]N=#X\+V1I=CX\+V1I=CX\ M'0O:F%V87-C3X-"B`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI M9VXZ8V5N=&5R.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)A8VMGF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ M8V5N=&5R.V9O;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^5F5S=&5D/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^*#(Q+#`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`C,#`P,#`P.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-#8L,#`P/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M86QI9VXZ8V5N=&5R M.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M86QI9VXZ8V5N=&5R M.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C$X M+#`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`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,C6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M;W9E6QE M/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,C0T+#`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQD:78@#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.'!T.SXF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M8V]L#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q/CQD:78@F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CEP=#L^,C`Q-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z.7!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP M=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`C M,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMGF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q M/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M86QI9VXZF4Z,3!P=#L^*#8L,#8W/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^4')E9F5R#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#0X/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#LG(')O=W-P86X],T0Q/CQD:78@#MP861D M:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-38T/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!S;VQI9"`C M,#`P,#`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`C,#`P M,#`P.V)A8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.7!T.SXF(S$V,#L\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI M;F4M:&5I9VAT.C$R,"4[=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P M<'0[/CQD:78@'0M:6YD96YT M.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`Q-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ M8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXR,#$S/"]F;VYT/CPO9&EV/CPO M=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3F5T(&EN8V]M92`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N M,3`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`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`C M,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XV-3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,"XU-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U M8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^*#$N,SD\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO M9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M;W9E6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,"XP,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#`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`C,#`P,#`P.V)O6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,"XV-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M'0O:F%V87-C3X-"B`@("`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`P M+#`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPQ,S`L,#`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`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Q-#EE-S!A85\X8V8R7S1E96-?86-B8U]C-#$Q-C'0O:'1M;#L@8VAA2!O<&5R871E'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA3QB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`P,2P@,C`Q,SQB'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6YD:6-A=&4@;V8@8F%N:W,@;6]R=&=A9V4@9&5B=#PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A3PO=&0^#0H@("`@("`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`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS M<&%N/CPO2!L87=S=6ET'0^)SQS<&%N/CPO'!E M;F1I='5R97,@9F]R('-E;&8M:6YS=7)E9"!P'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!L87=S=6ET'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C;W9E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO2!C;W9E'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&-E<'0@4VAA6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(@>65A'0^)SQS<&%N/CPO6UE;G0@07=A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI M(%M!8G-T7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2`H1&5T M86EL2P@ M3F]T(%!R:6UA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!-971H;V0@26YV97-T;65N=',@86YD($IO:6YT(%9E;G1U'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Q-#EE-S!A85\X8V8R7S1E96-?86-B8U]C-#$Q-C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2`P,2P@,C`Q,SQB2`P,2P@,C`Q-#QB2`P,2P@,C`Q,SQB7-V:6QL92!(96%L=&A# M87)E($-E;G1E2`P,2P@,C`Q,SQB3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO65A'0^)S$U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO65A'0^)S4@>65A'0^ M)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)S4@>65A'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Q-#EE-S!A85\X8V8R7S1E96-?86-B8U]C M-#$Q-C'0O:'1M;#L@8VAA2`P,2P@,C`Q,SQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@;V8@8F%L86YC92!O9B!M;W)T9V%G92!L;V%N(&]U='-T M86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!B96YE M9FET("AP'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4L M(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)S$T('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC'1087)T7S$T.64W,&%A7SAC9C)? :-&5E8U]A8V)C7V,T,3$V-SDX.3`V,2TM#0H` ` end XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Restricted Stock and Restricted Stock Units Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Restricted Stock Units (RSUs)
  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding, December 31, 2013 118
Granted 68
Dividend Equivalents 3
Vested (57)
Cancelled (2)
Outstanding September 30, 2014 130
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding, December 31, 2013 $ 5.41
Granted $ 5.51
Dividend Equivalents $ 7.72
Vested $ 5.61
Cancelled $ 5.47
Outstanding September 30, 2014 $ 5.43
Employee Stock
  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding, December 31, 2013 41
Granted 25
Dividend Equivalents 1
Vested (21)
Cancelled 0
Outstanding September 30, 2014 46
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding, December 31, 2013 $ 5.35
Granted $ 5.51
Dividend Equivalents $ 6.86
Vested $ 5.70
Cancelled $ 0.00
Outstanding September 30, 2014 $ 5.30
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable) (Details) (Stock Options and Stock Appreciation Rights (SARs), USD $)
In Thousands, except Per Share data, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Stock Options and Stock Appreciation Rights (SARs)
  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, December 31, 2013 333
Granted 0
Exercised (22)
Expired or cancelled (36)
Outstanding, September 30, 2014 275
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding, December 31, 2013 $ 6.64
Granted $ 0.00
Exercised $ 4.54
Expired or cancelled $ 7.87
Outstanding, September 30, 2014 $ 6.65
Exercisable, shares 244
Exercisable, Weighted Average Exercise Price $ 6.77
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Schedule of Stock Options Outstanding and Exercisable) (Details) (Stock Options and Stock Appreciation Rights (SARs), USD $)
In Thousands, except Per Share data, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2014
$10.40 to $11.59
Sep. 30, 2014
$2.37 to $6.21
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Range of Exercise Prices, Maximum     $ 10.4 $ 2.37
Range of Exercise Prices, Maximum     $ 11.59 $ 6.21
Weighted Average Exercise Prices $ 6.65 $ 6.64 $ 11.11 $ 5.49
Grants Outstanding 275   57 218
Intrinsic Value-Grants Outstanding     $ 1 $ 1,145
Grants Exercisable 244   57 187
Intrinsic Value- Grants Exercisable     $ 1 $ 994
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Common Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:        
Income (loss) from continuing operations $ 219 $ (2,321) $ 759 $ (6,016)
Less: (income) loss attributable to noncontrolling interests 0 (17) 25 (51)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. 219 (2,338) 784 (6,067)
PREFERRED STOCK DIVIDENDS (48) (86) (220) (258)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders 171 (2,424) 564 (6,325)
Income (loss) from discontinued operations, net of income taxes 3,928 (2,444) 3,444 (1,875)
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS $ 4,099 $ (4,868) $ 4,008 $ (8,200)
Per common share – basic        
Continuing operations (in dollars per share) $ 0.03 $ (0.41) $ 0.09 $ (1.07)
Income (loss) from discontinued operations, Operating income (loss), net of taxes (in dollars per share) $ (0.10) $ (0.42) $ (0.18) $ (0.32)
Gain on disposal, net of taxes (in dollars per share) $ 0.75 $ 0.00 $ 0.75 $ 0.00
Discontinued operations, net of taxes (in dollars per share) $ 0.65 $ (0.42) $ 0.57 $ (0.32)
Net income (loss) (in dollars per share) $ 0.68 $ (0.83) $ 0.66 $ (1.39)
Per common share – diluted        
Income (loss) from continuing operations (in dollars per share) $ 0.03 $ (0.41) $ 0.09 $ (1.07)
Income (loss) from discontinued operations, Operating income (loss), net of taxes (in dollars per share) $ (0.10) $ (0.42) $ (0.17) $ (0.32)
Discontinued operations, net of taxes (in dollars per share) $ 0.73 $ 0.00 $ 0.73 $ 0.00
Discontinued operations, net of taxes (in dollars per share) $ 0.63 $ (0.42) $ 0.56 $ (0.32)
Net income (loss) (in dollars per share) $ 0.66 $ (0.83) $ 0.65 $ (1.39)
Denominator: Weighted Average Common Shares Outstanding:        
Basic ( in shares) 6,020 5,892 6,004 5,878
Diluted (shares) 6,248 5,892 6,171 5,878
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BUSINESS
BUSINESS
Diversicare Healthcare Services, Inc. (together with its subsidiaries, “Diversicare Healthcare Services” or the “Company”) provides long-term care services to nursing center patients in nine states, primarily in the Southeast, Midwest, and Southwest. The Company’s centers provide a wide range of health care services to their patients and residents that include nursing, personal care, and social services. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company’s nursing centers also offer a variety of comprehensive rehabilitation services, as well as nutritional support services. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Missouri, Ohio, Tennessee, and Texas. The Company's operating results also include the results of certain discontinued operations that have been reclassified on the face of the financial statements to reflect the discontinued status of these operations.
As of September 30, 2014, the Company’s continuing operations consist of 51 skilled nursing and long-term care centers with 6,229 licensed beds. The Company owns 13 and leases 38 of its nursing centers.
BUSINESS DEVELOPMENT
Acquisitions
On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities was completed on May 1, 2013. The Company also incurred $338,000 in acquisition-related expenses associated with this transaction. The five facilities acquired under the Agreement include the following:

•
77-bed skilled nursing facility known as Chanute HealthCare Center
•
119-bed skilled nursing facility known as Haysville HealthCare Center
•
80-bed skilled nursing facility known as Larned HealthCare Center
•
62-bed skilled nursing facility known as Sedgwick HealthCare Center
•
80-bed skilled nursing facility known as Council Grove HealthCare Center

As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:

 
As of May 1, 2013
Purchase Price
$
15,500,000

 
 
Land
$
2,130,000

Buildings
12,127,000

Furniture, fixtures, and equipment
1,200,000

Inventory
43,000

 
 
Less: Liabilities assumed
$
758,000

 
 
Total cash paid
$
14,742,000



Lease Agreements and Assumption of Operations
On August 1, 2014, the Company completed a transaction to assume operations of two centers in Ohio. The centers included in this transaction are a 142-bed skilled nursing facility and a 42-bed assisted living center. The lease provides for an initial lease term of 10 years. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On July 1, 2014, the Company completed a transaction to enter the state of Missouri through the assumption of operations of three facilities totaling 339 skilled nursing beds. The nursing centers are owned by a real estate investment trust ("REIT"), and the lease provides for an initial 15-year lease term with a 5-year renewal option. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On June 1, 2014, the Company assumed operations at Diversicare of Nicholasville, an existing 73-bed facility in Nicholasville, Kentucky. The nursing center is owned by a real estate investment trust ("REIT"), and the lease provides for an initial 15-year lease term with a 5-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
On March 1, 2014, the Company assumed operations at Diversicare of Big Springs, an existing 135-bed facility in Huntsville, Alabama. The nursing center is owned by an unrelated third-party and the lease provides for an initial 10-year lease term with two additional 5-year renewal options. The additional skilled nursing center increases the Company's footprint in Alabama to seven centers, and the third center in the Huntsville market. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
On October 1, 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On August 1, 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT, and the lease provides for an initial 15-year lease term with a 5-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Common Share (Details Textual)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Earnings (Loss) Per Common Share (Textual) [Abstract]    
Antidilutive shares excluded from computation of diluted earnings per share 228 326
XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 3,855 $ 3,781
Receivables, less allowance for doubtful accounts of $5,333 and $3,879, respectively 42,067 32,658
Other receivables 899 1,118
Prepaid expenses and other current assets 2,339 2,442
Income tax refundable 515 763
Current assets of discontinued operations 390 2,870
Deferred income taxes 7,757 6,579
Total current assets 57,822 50,211
PROPERTY AND EQUIPMENT, at cost 97,605 93,572
Less accumulated depreciation and amortization (53,288) (48,516)
Discontinued operations, net 600 8,987
Property and equipment, net 44,917 54,043
OTHER ASSETS:    
Deferred income taxes 12,130 15,912
Deferred financing and other costs, net 1,839 1,914
Investment in unconsolidated affiliate 399 487
Other noncurrent assets 6,180 5,698
Acquired leasehold interest, net 7,940 8,228
Noncurrent assets of discontinued operations 4 1,251
Total other assets 28,492 33,490
Total assets 131,231 137,744
CURRENT LIABILITIES:    
Current portion of long-term debt and capitalized lease obligations 7,208 4,549
Trade accounts payable 7,863 7,177
Current liabilities of discontinued operations 136 1,359
Accrued expenses:    
Payroll and employee benefits 14,200 12,255
Self-insurance reserves, current portion 12,159 11,711
Other current liabilities 6,024 5,116
Total current liabilities 47,590 42,167
NONCURRENT LIABILITIES:    
Long-term debt and capitalized lease obligations, less current portion 42,851 43,552
Self-insurance reserves, noncurrent portion 15,378 16,375
Noncurrent liabilities of discontinued operations 0 5,952
Other noncurrent liabilities 13,875 15,214
Total noncurrent liabilities 72,104 81,093
COMMITMENTS AND CONTINGENCIES      
Series C redeemable preferred stock, $.10 par value, 5,000 shares authorized and issued, and 0 shares outstanding 0 4,918
SHAREHOLDERS’ EQUITY:    
Series A preferred stock, authorized 200,000 shares, $.10 par value, none issued and outstanding 0 0
Common stock, authorized 20,000,000 shares, $.01 par value, 6,388,000 and 6,307,000 shares issued, and 6,156,000 and 6,075,000 shares outstanding, respectively 64 63
Treasury stock at cost, 232,000 shares of common stock (2,500) (2,500)
Paid-in capital 19,891 19,570
Accumulated deficit (5,450) (8,435)
Accumulated other comprehensive loss (468) (569)
Total shareholders’ equity of Diversicare Healthcare Services, Inc. 11,537 8,129
Noncontrolling interest 0 1,437
Total shareholders’ equity 11,537 9,566
Total liabilities and shareholder's equity $ 131,231 $ 137,744
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements of Comprehensive Income (Loss) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Statement of Comprehensive Income [Abstract]        
NET INCOME (LOSS) $ 4,147 $ (4,765) $ 4,203 $ (7,891)
OTHER COMPREHENSIVE INCOME (LOSS):        
Change in fair value of cash flow hedge, net of tax 254 100 478 469
Less: reclassification adjustment for amounts recognized in net income (128) (135) (376) (226)
Total other comprehensive income (loss) 126 (35) 102 243
COMPREHENSIVE INCOME (LOSS) 4,273 (4,800) 4,305 (7,648)
Less: comprehensive (income) loss attributable to noncontrolling interest 0 (17) 25 (51)
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC. $ 4,273 $ (4,817) $ 4,330 $ (7,699)
XML 26 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Development (Details) (USD $)
In Thousands, unless otherwise specified
 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
Oct. 01, 2013
Sep. 30, 2014
Bed
Center
Mar. 01, 2014
Huntsville, Alabama
Option
Bed
Center
Mar. 01, 2014
Huntsville, Alabama
Bed
Center
Oct. 01, 2013
Skilled Nursing Center
Center
May 01, 2013
Kansas
Center
May 01, 2014
Kansas
Skilled Nursing Center
May 01, 2013
Kansas
Skilled Nursing Center
May 01, 2013
Kansas
Skilled Nursing Center
May 01, 2013
Kansas
Chanute HealthCare Center
Skilled Nursing Center
Bed
May 01, 2013
Kansas
Haysville HealthCare Center
Skilled Nursing Center
Bed
May 01, 2013
Kansas
Larned HealthCare Center
Skilled Nursing Center
Bed
May 01, 2013
Kansas
Sedgwick HealthCare Center
Skilled Nursing Center
Bed
May 01, 2013
Kansas
Council Grove HealthCare Center
Skilled Nursing Center
Bed
Aug. 01, 2014
Ohio
Aug. 01, 2014
Ohio
Center
Oct. 01, 2013
Ohio
Skilled Nursing Center
Center
Aug. 01, 2014
Ohio
Avon Place
Bed
Aug. 01, 2014
Ohio
Ontario Commons
Bed
Jul. 01, 2014
Missouri
Jul. 01, 2014
Missouri
Bed
Jun. 01, 2014
Nicholasville, Kentucky
Jun. 01, 2014
Nicholasville, Kentucky
Bed
Oct. 01, 2013
Indiana
Skilled Nursing Center
Center
Aug. 01, 2013
Louisville, KY
Aug. 01, 2013
Louisville, KY
Bed
Entity Location [Line Items]                                                    
Number of nursing centers   51   7 4 5                   2 3             1    
Purchase Price               $ 15,500                                    
Acquisition-related expenses               338                                    
Number of licensed nursing beds   6,229   135           77 119 80 62 80       142 42   339   73     107
Less: Liabilities assumed                 758                                  
Total cash outlay             $ 14,742 $ 14,742                                    
Lease agreement term 15 years   10 years                       10 years         15 years   15 years     15 years  
Lease renewal period 5 years   5 years                                 5 years   5 years     5 years  
Maximum number of capital lease renewal periods     2                                              
XML 27 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Development (Tables)
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The allocation for the net assets acquired is as follows:

 
As of May 1, 2013
Purchase Price
$
15,500,000

 
 
Land
$
2,130,000

Buildings
12,127,000

Furniture, fixtures, and equipment
1,200,000

Inventory
43,000

 
 
Less: Liabilities assumed
$
758,000

 
 
Total cash paid
$
14,742,000
XML 28 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Development (Schedule of Assets Acquired) (Details) (Skilled Nursing Center, Kansas, USD $)
In Thousands, unless otherwise specified
 0 Months Ended
May 01, 2014
May 01, 2013
May 01, 2013
Skilled Nursing Center | Kansas
      
Business Acquisition [Line Items]      
Purchase Price   $ 15,500  
Land     2,130
Buildings     12,127
Furniture, fixtures, and equipment     1,200
Inventory     43
Less: Liabilities assumed     758
Total cash paid $ 14,742 $ 14,742  
XML 29 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidation and Basis of Presentation of Financial Statements (Details)
Sep. 30, 2014
Entity
Consolidation and Basis of Presentation of Financial Statements (Textual) [Abstract]  
Number of variable interest entity 1
Percentage of owned joint venture Investment in nonconsolidated affiliate 50.00%
XML 30 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 31 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 4,203 $ (7,891)
Discontinued operations (3,444) 1,875
Income (loss) from continuing operations 759 (6,016)
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities:    
Depreciation and amortization 5,252 4,572
Provision for doubtful accounts 4,235 2,785
Deferred income tax benefit (467) (4,214)
Provision for self-insured professional liability, net of cash payments 815 660
Stock-based compensation 441 809
Equity in net losses of unconsolidated affiliate, net of investment 88 (99)
Debt retirement costs 0 320
Other (468) (182)
Changes in assets and liabilities affecting operating activities:    
Receivables, net (13,775) (5,551)
Prepaid expenses and other assets (323) (1,124)
Trade accounts payable and accrued expenses 4,131 2,565
Net cash provided by (used in) continuing operations 688 (5,475)
Discontinued operations (600) 5,117
Net cash provided by (used in) operating activities 88 (358)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (4,228) (4,109)
Acquisition of property and equipment through business combination 0 (14,742)
Change in restricted cash 33 (3,894)
Proceeds from sale of discontinued operations 16,500 0
Deposits and other deferred balances (64) 0
Net cash provided by (used in) continuing operations 12,241 (22,745)
Discontinued operations (61) 1,808
Net cash provided by (used in) investing activities 12,180 (20,937)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment of debt obligations (14,850) (28,757)
Proceeds from issuance of debt 16,808 50,500
Financing costs (180) (1,341)
Issuance and redemption of employee equity awards (30) 28
Redemption of preferred stock (4,918) 0
Payment of common stock dividends (993) (647)
Payment of preferred stock dividends (220) (258)
Distributions to noncontrolling interest (1,411) (158)
Payment for preferred stock restructuring (448) (434)
Net cash provided by (used in) continuing operations (6,242) 18,933
Discontinued operations (5,952) (150)
Net cash provided by (used in) investing activities (12,194) 18,783
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 74 (2,512)
CASH AND CASH EQUIVALENTS, beginning of period 3,781 5,928
CASH AND CASH EQUIVALENTS, end of period 3,855 3,416
SUPPLEMENTAL INFORMATION:    
Cash payments of interest, net of amounts capitalized 2,496 1,854
Cash payments of income taxes $ 66 $ 74
XML 32 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts receivable $ 5,333 $ 3,879
Redeemable preferred stock, par value (dollars per share) $ 0.1 $ 0.10
Redeemable preferred stock, shares authorized (shares) 5,000 5,000
Redeemable preferred stock, shares issued (shares) 5,000 5,000
Redeemable preferred stock, shares outstanding (shares) 0 5,000
Preferred stock, par value (dollars per share) $ 0.1 $ 0.10
Preferred stock, shares authorized (shares) 200,000 200,000
Preferred stock, shares issued (shares) 0 0
Preferred stock, shares outstanding (shares) 0 0
Common stock, par value (dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (shares) 20,000,000 20,000,000
Common stock, shares issued (shares) 6,388,000 6,307,000
Common stock, shares outstanding (shares) 6,156,000 6,075,000
Treasury stock, shares (shares) 232,000 232,000
XML 33 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Development
 9 Months Ended
Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BUSINESS DEVELOPMENT
BUSINESS
Diversicare Healthcare Services, Inc. (together with its subsidiaries, “Diversicare Healthcare Services” or the “Company”) provides long-term care services to nursing center patients in nine states, primarily in the Southeast, Midwest, and Southwest. The Company’s centers provide a wide range of health care services to their patients and residents that include nursing, personal care, and social services. In addition to the nursing, personal care and social services usually provided in long-term care centers, the Company’s nursing centers also offer a variety of comprehensive rehabilitation services, as well as nutritional support services. The Company's continuing operations include centers in Alabama, Florida, Indiana, Kansas, Kentucky, Missouri, Ohio, Tennessee, and Texas. The Company's operating results also include the results of certain discontinued operations that have been reclassified on the face of the financial statements to reflect the discontinued status of these operations.
As of September 30, 2014, the Company’s continuing operations consist of 51 skilled nursing and long-term care centers with 6,229 licensed beds. The Company owns 13 and leases 38 of its nursing centers.
BUSINESS DEVELOPMENT
Acquisitions
On March 6, 2013, the Company entered into an asset purchase agreement ("the Agreement") with Cumberland & Ohio Co. of Texas, as receiver of the assets of SeniorTrust of Florida, Inc. to acquire certain land, improvements, furniture, fixtures and equipment, and personal property of five facilities, all located in Kansas, for an aggregate purchase price of $15,500,000. The purchase of the Kansas facilities was completed on May 1, 2013. The Company also incurred $338,000 in acquisition-related expenses associated with this transaction. The five facilities acquired under the Agreement include the following:

•
77-bed skilled nursing facility known as Chanute HealthCare Center
•
119-bed skilled nursing facility known as Haysville HealthCare Center
•
80-bed skilled nursing facility known as Larned HealthCare Center
•
62-bed skilled nursing facility known as Sedgwick HealthCare Center
•
80-bed skilled nursing facility known as Council Grove HealthCare Center

As a result of the consummation of the Agreement, the Company allocated the purchase price of $15,500,000 between the assets associated with the transaction based on the fair value of the acquired net assets. In addition to the assets acquired in the transaction, the Company also assumed liabilities of $758,000 which resulted in total cash outlay of $14,742,000. The allocation of the purchase price was determined with the assistance of HealthTrust LLC, a third-party real estate valuation firm. The allocation for the net assets acquired is as follows:

 
As of May 1, 2013
Purchase Price
$
15,500,000

 
 
Land
$
2,130,000

Buildings
12,127,000

Furniture, fixtures, and equipment
1,200,000

Inventory
43,000

 
 
Less: Liabilities assumed
$
758,000

 
 
Total cash paid
$
14,742,000



Lease Agreements and Assumption of Operations
On August 1, 2014, the Company completed a transaction to assume operations of two centers in Ohio. The centers included in this transaction are a 142-bed skilled nursing facility and a 42-bed assisted living center. The lease provides for an initial lease term of 10 years. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On July 1, 2014, the Company completed a transaction to enter the state of Missouri through the assumption of operations of three facilities totaling 339 skilled nursing beds. The nursing centers are owned by a real estate investment trust ("REIT"), and the lease provides for an initial 15-year lease term with a 5-year renewal option. The centers were already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On June 1, 2014, the Company assumed operations at Diversicare of Nicholasville, an existing 73-bed facility in Nicholasville, Kentucky. The nursing center is owned by a real estate investment trust ("REIT"), and the lease provides for an initial 15-year lease term with a 5-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
On March 1, 2014, the Company assumed operations at Diversicare of Big Springs, an existing 135-bed facility in Huntsville, Alabama. The nursing center is owned by an unrelated third-party and the lease provides for an initial 10-year lease term with two additional 5-year renewal options. The additional skilled nursing center increases the Company's footprint in Alabama to seven centers, and the third center in the Huntsville market. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
On October 1, 2013, the Company assumed operations at four existing nursing centers, three in Ohio and one in Indiana. The nursing centers are owned by a REIT and the lease of these centers provides for an initial 15-year lease term with a 5-year renewal option. This transaction represents an increase in the Company's footprint in the Midwest, expanding into one new state, Indiana. All four of the centers were operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for these skilled nursing centers.
On August 1, 2013, the Company assumed operations at Seneca Place, an existing 107-bed facility in Louisville, Kentucky.  The nursing center is owned by a REIT, and the lease provides for an initial 15-year lease term with a 5-year renewal option. The center was already operating and treating patients on the transition date. There was no purchase price paid to enter into the lease agreement for this skilled nursing center.
XML 34 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
 9 Months Ended
Sep. 30, 2014
Oct. 31, 2014
Document and Entity Information [Abstract]    
Entity Registrant Name Diversicare Healthcare Services, Inc.  
Entity Central Index Key 0000919956  
Document Type 10-Q  
Document Period End Date Sep. 30, 2014  
Amendment Flag false  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   6,156,332
XML 35 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations
 9 Months Ended
Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS
DISCONTINUED OPERATIONS
West Virginia Disposition
Effective April 3, 2014, the Company entered into an asset purchase agreement with Rose Terrace Acq., LLC (“Purchaser”) to sell its skilled nursing facility in Culloden, West Virginia. The original asset purchase agreement was subject to a number of conditions including an amendment to the Master Lease with Omega Health Investors, Inc. ("Omega") to terminate the lease only with respect to two other skilled nursing facilities in West Virginia, state licensure and regulatory approval. The Company concurrently entered into an operations transfer agreement with respect to the two other skilled nursing facilities located in Danville and Ivydale, West Virginia.
Effective July 1, 2014, the Company completed the transaction with Rose Terrace Acq., LLC to sell Rose Terrace, a 90-bed skilled nursing facility in Culloden, West Virginia for a sales price of $16,500,000. The Company also entered into the Fifteenth Amendment to Consolidated Amended and Restated Master Lease ("Master Lease") with Omega Health Investors, Inc. ("Omega") to terminate the lease only with respect to two other skilled nursing facilities in West Virginia, and concurrently entered into an operations transfer agreement with American Health Care Management, LLC, an affiliate of the purchaser with respect to two other skilled nursing facilities located in Danville and Ivydale, West Virginia. Upon completion of the transaction, Diversicare no longer operates any skilled nursing centers in the state of West Virginia. In conjunction with the closing of the sale, the Company paid the balance of the $8,000,000 mortgage loan outstanding on the Rose Terrace facility.
The transaction resulted in a gain on the disposition of West Virginia which, along with the results of operations for these nursing facilities, is presented within Discontinued Operations on the Interim Consolidated Statements of Operations. The pretax gain on the transaction was $7,522,000. The tax expense associated with the gain was $(3,009,000) for which the Company plans to apply net operating loss carryforwards from our deferred tax assets to substantially offset and minimize the cash outlay for this transaction.
These centers contributed revenues of $10,988,000 and $15,944,000 and net income of $165,000 and $680,000 during the nine months ended September 30, 2014 and 2013, respectively.  The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations.
Arkansas Lease Termination
Effective September 1, 2013, the Company entered into an agreement with Omega to terminate its lease with respect to eleven nursing centers and 1,181 licensed beds located in Arkansas and concurrently entered into operation transfer agreements to transfer the operations of each of those eleven centers to an operator selected by Omega. Upon the completion of the transaction, the Company no longer operates any skilled nursing centers in the State of Arkansas. In connection with the closing of this transaction, the Company and Omega entered into the Master Lease most recently amended on January 22, 2013. This amendment effectively modifies the terms of the Master Lease to terminate the terms surrounding the eleven nursing centers in Arkansas, and only as to those eleven centers, and effectively reduces the annual rent payable under the Master Lease by $5,000,000.
As a result of this transaction, the Company has reclassified the operations of these centers as discontinued operations for all periods presented in the accompanying interim consolidated financial statements. These centers contributed revenues of $0 and $40,161,000 and net loss of $935,000 and $2,432,000 during the nine months ended September 30, 2014 and 2013, respectively.  The net loss in 2014 primarily relates to professional liability expense incurred during the first three quarters of 2014. The net income or loss for the nursing centers included in discontinued operations does not reflect any allocation of corporate general and administrative expense or any allocation of corporate interest expense. The Company considered these additional costs along with the centers' future prospects based upon operating history when determining the contribution of the skilled nursing centers to its operations.
The discontinued assets and liabilities of the disposed skilled nursing centers in Arkansas and West Virginia have been reclassified and are segregated in the interim consolidated balance sheets as assets and liabilities of discontinued operations. The current asset amounts, which are primarily composed of net accounts receivable of $390,000 and $2,870,000 at September 30, 2014 and December 31, 2013, respectively. The current liabilities are primarily composed of trade payables and various accrued expenses of $136,000 and $1,359,000 at September 30, 2014 and December 31, 2013, respectively. The Company expects to collect the balance of the accounts receivable and pay the remaining trade payables and accrued expenses in the ordinary course of business. The Company did not transfer the accounts receivable or liabilities to the new owners or operators of the facilities. Further, in accordance with Company accounting policy, the reserve for professional liability and workers' compensation will remain in the consolidated liability accounts as future payment of these liabilities will be paid through the Company's future operating cash flows.
XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
PATIENT REVENUES, net $ 90,331 $ 64,631 $ 250,443 $ 184,558
EXPENSES:        
Operating 73,006 54,186 200,517 152,014
Lease and rent expense 6,876 4,817 19,094 14,398
Professional liability 1,743 947 5,360 4,212
General and administrative 5,582 5,006 16,077 15,769
Depreciation and amortization 1,812 1,634 5,252 4,572
Restructuring 0 944 0 944
Total expenses 89,019 67,534 246,300 191,909
OPERATING INCOME (LOSS) 1,312 (2,903) 4,143 (7,351)
OTHER INCOME (EXPENSE):        
Equity in net income (loss) of unconsolidated affiliate (30) 63 (89) (152)
Interest expense, net (916) (855) (2,757) (2,140)
Debt retirement costs     0 (320)
Total other expense (946) (792) (2,846) (2,612)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 366 (3,695) 1,297 (9,963)
BENEFIT (PROVISION) FOR INCOME TAXES (147) 1,374 (538) 3,947
Income (loss) from continuing operations 219 (2,321) 759 (6,016)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:        
Operating loss, net of tax (585) (2,444) (1,069) (1,875)
Gain on disposal, net of tax 4,513 0 4,513 0
Income (loss) from discontinued operations 3,928 (2,444) 3,444 (1,875)
NET INCOME (LOSS) 4,147 (4,765) 4,203 (7,891)
Less: (income) loss attributable to noncontrolling interests 0 (17) 25 (51)
NET INCOME (LOSS) ATTRIBUTABLE TO DIVERSICARE HEALTHCARE SERVICES, INC. 4,147 (4,782) 4,228 (7,942)
PREFERRED STOCK DIVIDENDS (48) (86) (220) (258)
NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS $ 4,099 $ (4,868) $ 4,008 $ (8,200)
Per common share – basic        
Continuing operations (in dollars per share) $ 0.03 $ (0.41) $ 0.09 $ (1.07)
Discontinued operations (in dollars per share) $ 0.65 $ (0.42) $ 0.57 $ (0.32)
Net income (loss) (in dollars per share) $ 0.68 $ (0.83) $ 0.66 $ (1.39)
Per common share – diluted        
Continuing operations (in dollars per share) $ 0.03 $ (0.41) $ 0.09 $ (1.07)
Discontinued operations (in dollars per share) $ 0.63 $ (0.42) $ 0.56 $ (0.32)
Net income (loss) (in dollars per share) $ 0.66 $ (0.83) $ 0.65 $ (1.39)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK $ 0.055 $ 0.055 $ 0.165 $ 0.165
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic ( in shares) 6,020 5,892 6,004 5,878
Diluted (shares) 6,248 5,892 6,171 5,878
XML 37 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Insurance Matters
 9 Months Ended
Sep. 30, 2014
Insurance [Abstract]  
INSURANCE MATTERS
INSURANCE MATTERS
Professional Liability and Other Liability Insurance
The Company has professional liability insurance coverage for its nursing centers that, based on historical claims experience, is likely to be substantially less than the claims that are expected to be incurred. Effective July 1, 2013, the Company established a wholly-owned, consolidated offshore limited purpose insurance subsidiary, SHC Risk Carriers, Inc. (“SHC”) which has issued a policy insuring claims made against all of the Company's nursing centers in Florida and Tennessee, the Company’s formerly operated Arkansas and West Virginia facilities, and several of the Company’s nursing centers in Alabama, Kentucky, Ohio, and Texas. The SHC policy provides coverage limits of either $500,000 or $1,000,000 per medical incident with a sublimit per center of $1,000,000 and total annual aggregate policy limits of $5,000,000. All other centers within the Company’s portfolio are covered through various commercial insurance policies which provide similar coverage limits per medical incident, per location, and on an aggregate basis for covered centers.  These policies provide coverage limits of $1,000,000 per claim and have sublimits of $3,000,000 per center, with varying aggregate policy limits. 
Reserve for Estimated Self-Insured Professional Liability Claims
Because the Company’s actual liability for existing and anticipated professional liability and general liability claims will likely exceed the Company’s limited insurance coverage, the Company has recorded total liabilities for reported and estimated future claims of $26,377,000 as of September 30, 2014. This accrual includes estimates of liability for incurred but not reported claims, estimates of liability for reported but unresolved claims, actual liabilities related to settlements, including settlements to be paid over time, and estimates of legal costs related to these claims. All losses are projected on an undiscounted basis and are presented without regard to any potential insurance recoveries. Amounts are added to the accrual for estimates of anticipated liability for claims incurred during each period, and amounts are deducted from the accrual for settlements paid on existing claims during each period.
The Company evaluates the adequacy of this liability on a quarterly basis. Semi-annually, the Company retains a third-party actuarial firm to assist in the evaluation of the current portion of this reserve. Merlinos & Associates, Inc. (“Merlinos”) assisted management in the preparation of an estimate of the appropriate accrual for the current claims period and for incurred, but not reported, general and professional liability claims based on data furnished as of May 31, 2014.  The Company used this estimate from Merlinos in the preparation of its estimate of liability for incurred, but unreported professional liability claims as of September 30, 2014.
On a quarterly basis, the Company obtains reports of asserted claims and lawsuits incurred. These reports, which are provided by the Company’s insurers and a third-party claims administrator, contain information relevant to the actual expense already incurred with each claim as well as the third-party administrator’s estimate of the anticipated total cost of the claim. This information is reviewed by the Company quarterly and provided to the actuary semi-annually. Based on the Company’s evaluation of the actual claim information obtained, the semi-annual estimates received from the third-party actuary, the amounts paid and committed for settlements of claims and on estimates regarding the number and cost of additional claims anticipated in the future, the reserve estimate for a particular period may be revised upward or downward on a quarterly basis. Any increase in the accrual decreases results of operations in the period and any reduction in the accrual increases results of operations during the period.
As of September 30, 2014, the Company is engaged in 48 professional liability lawsuits. Seven lawsuits are currently scheduled for trial or arbitration during the next twelve months, and it is expected that additional cases will be set for trial or hearing. The Company’s cash expenditures for self-insured professional liability costs from continuing operations were $3,641,000 and $3,005,000 for the nine months ended September 30, 2014 and 2013, respectively.
The Company follows current accounting guidance set forth in FASB ASU 2010-24, “Presentation of Insurance Claims and Related Insurance Recoveries,” that clarifies that a health care entity should not net insurance recoveries against a related professional liability claim, and that the amount of the claim liability should be determined without consideration of insurance recoveries. Accordingly, the Company has recorded assets and equal liabilities of $217,000 at September 30, 2014 and $440,000 at December 31, 2013, respectively.
Although the Company adjusts its accrual for professional and general liability claims on a quarterly basis and retains a third-party actuarial firm semi-annually to assist management in estimating the appropriate accrual, professional and general liability claims are inherently uncertain, and the liability associated with anticipated claims is very difficult to estimate. Professional liability cases have a long cycle from the date of an incident to the date a case is resolved, and final determination of the Company’s actual liability for claims incurred in any given period is a process that takes years. As a result, the Company’s actual liabilities may vary significantly from the accrual, and the amount of the accrual has and may continue to fluctuate by a material amount in any given period. Each change in the amount of this accrual will directly affect the Company’s reported earnings and financial position for the period in which the change in accrual is made.
Other Insurance
With respect to workers’ compensation insurance, substantially all of the Company’s employees became covered under either an indemnity insurance plan or state-sponsored programs in May 1997. The Company is completely self-insured for workers’ compensation exposures prior to May 1997. The Company has been and remains a non-subscriber to the Texas workers’ compensation system and is, therefore, completely self-insured for employee injuries with respect to its Texas operations. From June 30, 2003 until June 30, 2007, the Company’s workers’ compensation insurance programs provided coverage for claims incurred with premium adjustments depending on incurred losses. For the period from July 1, 2008 through September 30, 2014, the Company is covered by a prefunded deductible policy. Under this policy, the Company is self-insured for the first $500,000 per claim, subject to an aggregate maximum of $3,000,000. The Company funds a loss fund account with the insurer to pay for claims below the deductible. The Company accounts for premium expense under this policy based on its estimate of the level of claims subject to the policy deductibles expected to be incurred. The liability for workers’ compensation claims is $261,000 at September 30, 2014. The Company has a non-current receivable for workers’ compensation policies covering previous years of $1,183,000 as of September 30, 2014. The non-current receivable is a function of payments paid to the Company’s insurance carrier in excess of the estimated level of claims expected to be incurred.
As of September 30, 2014, the Company is self-insured for health insurance benefits for certain employees and dependents for amounts up to $175,000 per individual annually. The Company provides reserves for the settlement of outstanding self-insured health claims at amounts believed to be adequate. The liability for reported claims and estimates for incurred but unreported claims is $899,000 at September 30, 2014. The differences between actual settlements and reserves are included in expense in the period finalized.
XML 38 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-Term Debt and Interest Rate Swap
 9 Months Ended
Sep. 30, 2014
Debt Disclosure [Abstract]  
LONG-TERM DEBT AND INTEREST RATE SWAP
LONG-TERM DEBT AND INTEREST RATE SWAP
The Company has agreements with a syndicate of banks for a mortgage term loan ("Original Mortgage Loan") and the Company’s revolving credit agreement ("Original Revolver"). On May 1, 2013, the Company executed an Amended and Restated Credit Agreement (the "Credit Agreement") which modified the terms of the Original Mortgage Loan and the Original Revolver Agreements dated February 28, 2011. The Credit Agreement increases the Company's borrowing capacity to $65,000,000 allocated between a $45,000,000 Mortgage Loan ("Amended Mortgage Loan") and a $20,000,000 Revolver ("Amended Revolver"). Loan acquisition costs associated with the Amended Mortgage Loan and the Amended Revolver were capitalized in the amount of $1,341,000 and are being amortized over the five-year term of the agreements.
Under the terms of the amended agreements, the syndicate of banks provided the Amended Mortgage Loan with an original balance of $45,000,000 with a five-year maturity through April 30, 2018, and a $20,000,000 Amended Revolver through April 30, 2018. The Amended Mortgage Loan has a term of five years, with principal and interest payable monthly based on a 25-year amortization. Interest is based on LIBOR plus 4.5%. A portion of the Amended Mortgage Loan is effectively fixed at 6.87% pursuant to an interest rate swap with a notional amount of $21,847,000. As of September 30, 2014, the interest rate related to the Amended Mortgage Loan was 4.65%. The Amended Mortgage Loan is secured by thirteen owned nursing centers, related equipment and a lien on the accounts receivable of these centers. The Amended Mortgage Loan and the Amended Revolver are cross-collateralized. The Company’s Amended Revolver has an interest rate of LIBOR plus 4.5% and is secured by accounts receivable and is subject to limits on the maximum amount of loans that can be outstanding under the revolver based on borrowing base restrictions.
Effective March 31, 2014, the Company entered into the Second Amendment to the Amended and Restated Revolver ("Second Amendment"). The Second Amendment temporarily increased the Amended Revolver capacity from the $20,000,000 in the original Amended Revolver to $27,500,000 through September 30, 2014, as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process. Effective July 1, 2014, the Company entered into the Third Amendment to the Amended and Restated Revolver ("Third Amendment"). The Third Amendment makes the previously temporary increase to the Amended Revolver capacity from the $20,000,000 in the original Amended Revolver to $27,500,000, a permanent change to the borrowing capacity as a result of the increase in receivables related to new facilities that continue to progress through the change in ownership process.
As of September 30, 2014, the Company had $6,000,000 borrowings outstanding under the revolving credit facility compared to $3,000,000 outstanding as of December 31, 2013. The outstanding borrowings on the revolver primarily reflect the Company's approach to accumulated Medicaid and Medicare receivables at recently acquired facilities as these facilities proceed through the change in ownership process with CMS. Annual fees for letters of credit issued under this Revolver are 3.00% of the amount outstanding. The Company has ten letters of credit with a total value of $7,991,000 outstanding as of September 30, 2014. Considering the balance of eligible accounts receivable, the letter of credit, the amounts outstanding under the revolving credit facility and the maximum loan amount of $27,500,000, the balance available for borrowing under the revolving credit center is $12,728,000 at September 30, 2014.
Effective March 27, 2014, the Company executed its purchase option to acquire all assets associated with the Rose Terrace nursing center in Culloden, West Virginia from Milton Holdings, LLC which was considered a variable interest entity ("VIE") by the Company and consolidated prior to the date of this transaction. See Note 8 for further information on the VIE considerations. In conjunction with the purchase of the assets, the Company entered into an interest-only $8,000,000 term loan ("Rose Terrace Note") with a maturity date of March 27, 2015. The structure of the Rose Terrace Note reflected the Company's intent to sell the property and transfer operations to an unrelated third-party operator as further disclosed in Note 11. This transaction closed on July 1, 2014, at which time the Rose Terrace Note was paid in full.
The Company’s debt agreements contain various financial covenants, the most restrictive of which relate to minimum cash deposits, cash flow and debt service coverage ratios. The Company is in compliance with all such covenants at September 30, 2014.
Interest Rate Swap Transaction
As part of the debt agreements entered into in March 2011, the Company entered into an interest rate swap agreement with a member of the bank syndicate as the counterparty. The Company designated its interest rate swap as a cash flow hedge and the earnings component of the hedge, net of taxes, is reflected as a component of other comprehensive income (loss). In conjunction with the amendment to the credit facility, the Company retained the previously agreed upon interest rate swap terms, and redesignated the interest rate swap as a cash flow hedge. The interest rate swap agreement requires the Company to make fixed rate payments to the bank calculated on the applicable notional amount of $21,847,000 at an annual fixed rate of 6.87% while the bank is obligated to make payments to the Company based on LIBOR on the same notional amounts.
The Company assesses the effectiveness of its interest rate swap on a quarterly basis, and at September 30, 2014, the Company determined that the interest rate swap was effective. The interest rate swap valuation model indicated a net liability of $755,000 at September 30, 2014. The fair value of the interest rate swap is included in “other noncurrent liabilities” on the Company’s interim consolidated balance sheet. The balance of accumulated other comprehensive loss at September 30, 2014 is $468,000 and reflects the liability related to the interest rate swap, net of the income tax benefit of $287,000. As the Company’s interest rate swap is not traded on a market exchange, the fair value is determined using a valuation based on a discounted cash flow analysis. This analysis reflects the contractual terms of the interest rate swap agreement and uses observable market-based inputs, including estimated future LIBOR interest rates. The interest rate swap valuation is classified in Level 2 of the fair value hierarchy, in accordance with the FASB guidance set forth in ASC 820, Fair Value Measurement.
XML 39 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business (Details)
Sep. 30, 2014
Bed
Center
State
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of states in which entity operates 9
Number of nursing centers 51
Number of licensed nursing beds 6,229
Number of nursing center facilities owned 13
Number of nursing center facilities leased 38
XML 40 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
 9 Months Ended
Sep. 30, 2014
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS
Effective October 1, 2014, the Company completed a transaction to assume operations of a 62-bed skilled nursing facility in Greenville, Kentucky. This facility is expected to contribute in excess of $4.5 million in annual revenues with initial lease terms of 14 years.
XML 41 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Variable Interest Entity
 9 Months Ended
Sep. 30, 2014
Business Combinations [Abstract]  
VARIABLE INTEREST ENTITY
VARIABLE INTEREST ENTITY
Accounting guidance requires that a variable interest entity (“VIE”) must be consolidated by the primary beneficiary in accordance with the provisions set forth in FASB ASC 810, Consolidation, as mentioned in Note 2 above. The primary beneficiary is the party that has both the power to direct activities of a VIE that most significantly impact the entity's economic performance and the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. We perform an ongoing qualitative analysis to determine if we are the primary beneficiary of a VIE. The Company had one variable interest entity related to a nursing center in West Virginia that was dissolved in the first quarter of 2014 as a result of the asset purchase of the Rose Terrace nursing center, and is no longer consolidated into the interim consolidated financial statements of the Company.
Rose Terrace Health and Rehabilitation Center
On December 28, 2011, the Company completed construction of Rose Terrace Health and Rehabilitation Center (“Rose Terrace”), its third health care center in West Virginia. The 90-bed skilled nursing center is located in Culloden, West Virginia, along the Huntington-Charleston corridor, and offers 24-hour skilled nursing care designed to meet the care needs of both short and long-term nursing patients. The Rose Terrace nursing center utilizes a Certificate of Need the Company obtained in June 2009, when the Company completed the acquisition of certain assets of a skilled nursing center in West Virginia.
The Company initially entered into a lease agreement with the real estate developer that constructed, furnished, and equipped Rose Terrace. The agreement included the right to purchase the center and all associated assets beginning at the end of the first year of the initial term of the lease and continuing through the fifth year for a purchase price ranging from 110% to 120% of the total project cost. On March 27, 2014, the Company exercised this purchase option and acquired the land, building, and all other assets of the Rose Terrace nursing center from the real estate developer for the contractually agreed upon price of $7,693,000.
Prior to the exercise of the purchase option, the Company had determined it was the primary beneficiary of the VIE based on the ownership of the Certificate of Need, the fixed price purchase option described above, the Company’s ability to direct the activities that most significantly impact the economic performance of the VIE, and the right to receive potentially significant benefits from the VIE. Accordingly, as the primary beneficiary, the Company consolidated the balance sheet and results of operations of the VIE for periods prior to the exercise of the purchase option. However, after the exercise of the purchase option, the previous owners paid the outstanding debt related to the entity in full. Subsequently, as further disclosed in Note 11, the Company sold the Rose Terrace facility and all assets associated with the facility. As a result of these events, the entity is no longer considered a VIE.
ZIP 42 0000919956-14-000036-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000919956-14-000036-xbrl.zip M4$L#!!0````(`/*`9D56+=L@,]<``+V6"@`1`!P`879C82TR,#$T,#DS,"YX M;6Q55`D``Q?C6U07XUM4=7@+``$$)0X```0Y`0``[%W9;MO*EGUOH/^![8L^ MW0U$,2>1HC-<<-*)3VS+L9WDWJ>@1):L0BA2*9*R=;Z^=Q5)C=3D2)8E,P@, MFS7NM=<>JHK#^W\^]@)A@&E,HO##B?16/!%PZ$4^">\_G'R]K9FW]OGYR3\_ M_N=_O/^O6NU?ULV%X$1>VL-A(M@4HP3[P@-)NL)W'\<_A0Z->L+WB/XD`_1& MZ$2TAVDP%+[C=I,$T&=SKNMQ0D(%4744-0T:JK.B*)W<,S4=O M'L]TV>M@7:^WL::H<*G=]I"'/0VAMJ;[G7;6VV.;!N2,_11`FC`^0P,/?3CI M)DG_[/3TX>'A+?('D8<2$GIOO:AW*HN2*AH*R)K5]Z(T3.APU(1U]3;&WMO[ M:'":%[)&2DV4:HHT:I92"F`M:I>7\M&F&_J8E+>!@I+J^-'KEM=G)24-2#C` M<5+>)"LKD8;$D2I+^A1NO&5$[Z&ZJ)SF-8H&H,^?2VJSXC:*<5$]1,2+R^?$ MB]B4I.DIA5$8IKWR,?R$GB;#/CZ%2C6HA2GQ1NU6-YIN0'%GH23:*906%6/B ME8L`!24"Q$F?+J@/)24-TKAVCU!_U*:#XC:?2%Y0HFPHH5&`X](VO*2\$<.A MO!$O*6N44'R_$"?C%,J+JJS`GR'Y",^L<*IJ4EJUGE5-)JN2900-XP2%WHAR MCW,4?5!X;.JH:^V45H5OI]%^7%[=>%_?0N#)97;DVF@WX*$%XST8[ MBWG1#>X(?/2S+F<>\U>UPBF]A:FG\XV+H8Z+1DK'ZD/5A;YL^,#+C1Q('9\S-Q0'7A6]#(NFVF$0W]!DZ)D M>CH30Q>7HE[;4Q'[6\3F!F+EG_BZ)ZB?I=X*.`],`_PX_/M'A0VU@.^9U,; M7GY8.\:0Y+`3WY"-# M]^SS[:K11JR;0N*H&>W@=G(.KHGR)&Y,9LCF?)*8]Q1S2#.@#I6=\T+FQ"R5 MLF()L$0QTWMI#;_%R7(1@=$/F(U_ACJI]W-XV'Q9XDDX;1;)NR_F-#9G3F-G MS%%;7G*0B8P]4>$^AN MV,>\@W$A"N-K-$3M`!]V>%^X^5.JL&UZV^?1^58RW4W$*N/-R<=QZ2QQ]N5$ M],V=B/Y<3F1%3+EL':JUK8HIEZV*#D`'ODFV8G?G3XIQ6++H&),H;!=3W:9J]JP/` M%VAEA1&9#XCZ$'!*Q'%64"ICQ9`YACRGF[W` M*`9]E&RVQH?-P6=U@BM1K%C.U_P'F?L^;:F\2Q@/,O=5-V?C[F&L M,6H7C!IO#W<1Q1;+Y.RHUP<%\NK\:FRF23>BY&_L?PU]3"?&N`8/`S[$?<34 M(S&^AA4.OD'A_8(9S==KA0=^H/@WK[>BR1:HDB*SL]1CN]>X@J.ST& M.QTILK+3%79:7'5[_2`:8GR\>Y,E$E;L6),=U=YUQ9"-&/(U)$E\<_OU-3!E M6M:*,6LRAF,WF1:PL'^4?%DB:<66.;;8['4SF/9A4L,KU)M,WC_9-R3^:2-* M07%L%V]VV0`\\-,`MSJ7*.A3Y"60$)Z'<4K9%B%73.C?0=OSD?JG*'E-HPZ. M8[Y].-'#!4%M$@#2A\W.,F"+;'H!LEM="SQ-.6,S6D\[E45M8%%?0]3I`'@P MLL\W\`F>6XI7-O4TFUJ,;655QV!5U6M$7L9K1%XV2ZH[?:H[?8Z?Y6Q!,YU9 MW#U$=]THC1'H)_1=ML?,ET'7*?6Z`/#A+_8F9&IVQ@\$%U3W$E#'_L.]`$MVP&^C@#8`]^\>/+>`8]2*T!Y[1P\ MA[[E+^I!W,6=O:@Y87#(-?BOC!`L2K8"A_)%.30X9IZ6V#(^DU:;FZQ^29[S'9@^87OFH,#Z)@P+9B^<%#$WG\=.J<[\'F*H'#8_D`:9G?]"PLK?J@<%7 M;&_/_L#@WNVMVCI[35JNML[VMW6V7\TOU,#%UU`]8=#H_P_JMESVPM M@VV;46_E/6#+H3]B3D_O\DU^?C'THY!O4K91^+/5Z6"H>8.2`U__S,L[^O[B M.[Y,=98K?__ M>/D"#JOD>?,`J2KH67[Q?%CW"[[F3<6KY3$9/H;PV5O]MF,Z)]O#XWHV1U02_$MWNNU M#.!M4GV!CHJ[M18JZ3G-[?/M?LRM/O$,^W[-#1PC7/^31H/*YG9G)S2,^2?>*ZO;E=6M@+@RN5=F(AMBO[&U7]K8,W\K87IFQW6+__H%X M/RMSVY6Y+4>X,KCC,+C*4"IROGAR5K?TOMR;8YZ1!M4'$_;VP83]*/QH@\KK M<^B*F=ZOH]C\X2P(M7QKY3/42;V?!^[/EZ@[?S:K7-[]D*"Q.Q+DY"@&6Y^ M0Y2P1^Z*VU=Y9X1]6L8.4!P#9;).6YULF*G$MK3Q\"I*KBGI(3JT<(BA`P*_ M'J9S!'C/RN`MTIV%^&Z3W$]1T3@7WUA'>[`4B;U?4&[LR%):7O+;>PB'1MQ= M[PSLQ%U*XN[>8G6`9D:T,S0&W40X<9-%=D>PNDW(/"U9JH[%3ABECM:Q_`OC;GP6X> MME"_R&9_F>'S8/+]VUZ^`7L3Q?@.4XH\?`2Y^F*WPT/*]V_;#&#/^I79Y7K: MC\$PF]F1P?R5AGCM_>,KXG4C6+^_HBWD)2+OAPO:SH+H]%'"TI3>'/!WNWJX MRN,926;@./KD7=W=8<9&-&R%"8)![*C7`R=><9$?8I1@4A%R>X0\6EJ]0L7^ ME0;#5?L$:YQ'5U>/,]9U:M?7NC[M3`'A3R[1J%_/ACZ*,"5K3V_K:VC MABNN3/;-N2KO- MHMJRGK,:3^H\X\NRSK,:3^J\.,E=UGU1YTD#7*"'."7)LO[S*D_KGK^<^T>K MDQ_7+QUGINZ3!LR^,;=LF*S&DSKGD759W[S"D[H.TQ)_6?20VQ+\^J2^8QX= ME_:=57E2[VF\R&9)'*FRI)]]O76>VO,UICRVSXS@DP$X_EGGQ!I>I3V6Z$9S MSG?M:4VZK_(>)X9S#BA-SYWN#.Q%?.!1][I(>"^,-)#?[*_4Y2LUS=5EW#J1L-U5$LRX:KNPVG86IF MLZYHBF8J^90=U:@[$)N6ZUB646\J MDIG-N:$T&V9]=LZJ+&KEDRZ;R^_,>AG20`E3TIN.6A=%S:X#S'HSG[4(UXW9 M62NR!C(^>=9I+PW`M_H.'G\4#GX/,$_18&743\7&LM8"GIU M=-%4'+MNN9)DN[IA%I;5U.TY-.J*W)C3]V[1:"5=3-F7:RGNLK2:O1>?[:9< M1'$,U&IU[M#C9A2P[8:K29(I6W79,41+UL7&R#0E69D5NE;7C$4RKS.[+8NV M3)^&8S::MJEI#=%R;=MBK5,1XXE:I8N2B8X$K.N&HJCJ86SM%73GV3(&5.X!9[*>4/(KJ/;"<<^TT:]9@!IDGQ/"*B(0GOXV)Y`7$G MG177R9ZZ_G+G+)2X[EB0&)L6*-%R'!?$M=U<8AGX.JG(8@TFRS-^8AL3?RXL M_KT$"U,V&TI#R==&2S*9J.X4IRG5Q+D#415DJ`VK)O%J=J7.VY<=L M3Q)"LG7#%>LJP`O+6$5U=$4NQ&WI*[+6_P`$/#&]R')0GVK2$OH]C/=G,A1%V@ M&-8E80H9!=_EGA+=V??)RR3D]0G(%5YOM>S%\)GOG:;0=Q3/NT]G+J_@6+JALVS+DAF6J(N0#INL8 MME2DJ([6F$]_E$8IKJM!6`F>'<$RP\\)?T=1&'J@2G:S46^` M`Y*:EFO"HG24+3NZ)IU\_"-(WOED(,3),,`?3CK09:V#>B08GMV1'HZ%*_P@ MW$0]%+[C93'Y&Y])8C]Y=_+'??)NIGD`TZYU,?OPW9DDB_^]L`V[7C8F"6'A M3I+9=DS,&B@JRI`[2T,`D0V6]?C-O#DWK0M7.+^ZPIS76?:?>2S:%9+HOZ9UG_,QD+M\N46#"??3MW1W])[_Y/ MZ*50KXT93>(H@)[!F0GM(?2)A7[VPAK?L;V"(B7@6./Y@X3^-TQ M>(]O!!0+S"-`AX`'"'(5)5B0!<2^'_M6N%N$3IRAP=YOE:FE"QVUHP*EZ`%3 M(8D$'_3F@L(D@*Y[?:C.N\G4^C^Q M`%QG)U*>`$D40-[C.D&ASVM%;:`BAX2-B-IQ1-L">(!7[;"NL463+,L@RM2"+-0)G@\EC%RLIN% MA>)NX4P[#\`[G\1@%X.,P`R_#J%0$5"GK"$@Q\(!HSJ"$>(T2`IB():_"_W\ MBZ3%599F"'F>,3.+-YQVH+TP`HZ%]]#]E$ MBD<R1WDPJ";3:8X=&F*^YV):_QX4#56X$PU3$FFPY&;K>",PU M)5U"?:&;='+C(+#*GO14[-<2M=%-K`TYQEI[.&74,9N3EIB,4C^*\F18) MC([9&M?`IRP[2**P9G<1#=C+$T/0`J7$CW+SC#J02,:"K-:Z44KGAV;H^9BY M\,S5]##.`@XO"3'VN57R0+_$:0IJ`ZO_& MS`'9F";9F^FXO[G"V)^B5M1.$,F#,7MN'M@G&F^$ARX.%U"0.[+QDH#UZL$@ MB*4PV9X?CQV+-##'GZT8IR1OV3HG@Q[,,P_%7(;"[R(AP,R-H^(UR^.\C8+A M")A[75#]``?L;+>([[D%8_^-T$EI2.(N^Y7IG&6>_3[T/ZG-G:).KJ(T!?;:=+*`B^?&+T)"%LR%&M+B2`R!P M.N;7&*I=@2`95!@8;ULGCSOMI_3ZGTR3-,XU\Y_/=6MOZNIA@@E#D&6`H M53N^+<+7IQLXR*_,=/J;V>%TFP>F.TBF& M`S*_K!&:ASR$_POVI+%$K!/`UL]^R'SZ$=ZN1Y"5O`#_<*UN6D'`@=$(TJ92%:F327%[JKI#J&KJ M@/L"OW!G`0';\M^0H3_(=&:RC-/=I>H^C1^FR6J1"02$0-,L"R_OOL`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`B6_-K4HUA/RU&KJ#P&!BX7/GJ/:[@!KYNJ=L)H MA/)3>)BO$,+#;S)+D&L3=\#C451A'^@KN'59T@8?=#==X@>JO%JL('!H9=:Y M=I%5P>_!TZD.*\3$T8UJ_]5=PEE6JLX"(ES"[B8CC26`*0BS%R3.L2J_2 M5'8&QW^ME)\!/L<0LBTP%L%6H\H0M$DT36B\96" M?FOAO&Z.E>W#3Z`]'4QA#TVA+/1$BUMM,DN^E?LW[%:#%\'1MF-_$%-IZ9*S4V*;+7^TZ*(CWA-N]/D,T6;G M,%B4_EB4,UFJ@0BS"':F,JX09*VJO%/OG!+^6)U_RTA60)DU9T5K>0^4Q^$B6LLH$P3[$<=68 M^;$@3MUBT]1=-SR>$>)AE*4;V_XEFJWB_&Z>68Q.;>[KO4(^'ED>Y%Q:(+KIA M-T$*Y%6J+FO07BF8UKV)3;Y)F686Q8 M1BA8X#"+P[_`]D*'FZ2XWQZ:=N/^+W/6X!-.N1N/"Q7^V0(6FX%MBM!R'9$C M>''/"$GSZJ>Y!A35V3+4[=J+^2C%TZA@#N3_CS>K'H5;"?P@-%PBA"Z$21QF MYN+E!V;SEC\W=UA..VU=KFH+1(5O"<-GKJ#4H:XE*!$L;T5Z-A,-8(?W!B-& MAPO[C)?7QG@_^NL">_6A\DKS&U$Z:>=-5 MV$:CZ?J>,+VQT(/)/>K*MTBN;87,=QWNN9ZP7-\*W1R?PB:!:.)`O&<.:^[Q M$9=^(9L51UEZR(GNVB:W3,,);SD#!B1YXPN>Y%T%`ML:A*%MO>I$CKOPR#Y`[7WE(;-/R7&'`>FT>AH$5 MYJ==?#L(&M$,(X1O7?G.Y!YUY5N$70^($1#F@`TW(7`+11@ZN9Z'7C-R>&_I MVRWQ(\A#Y4;:'!J@:_EAFU8E/J$AFY^L3]PR+I+ MTKXOIA_FT]EO[Y;I*GZG_?H$0F247,*"Z*'+"=7M0+NZ[-\,;HE M=.\4B_DI;*B-9?2??W!KGE@7,M>DC`DF#-L)`MV`N-XN?*.IKT,_UH2, MM*[D,;HZ6,A:WEY?"'<#RPL]B.!#Q_.)10*=%@8_6#=0QUB(&C(B5LO;),7# MAWLN`,)P[C$A0MLF;HB`<86ZAU805H\)%V"!JN"CM]*_3LX3Z-XH0:'E<]9Z=20T7<\,?<_E#@FIZ1DBQR*D MU+3:2+:HSC=3K`@YD-I-)2E*=(-"[`J6Q>>4!I:5)]LV(<03K=2N82L?1FUE M8,Y^#*:<6;H9.MPQ/&ZY''[)HX70%#6(Q()DG;/-)%>H>0K=&X%P0Q;ZCFY: MKJ?[PO12.'7\/> M7__R?4G;B%CO$)L3+*98)J>^$(53X2$QFGC"EKD?:>M(R>TPT.TA8QVM4N<0 MD(##P&(BY]SQ@]QIZ-1R6Z#U>8.+CQ'S!*JWP,J&IA>Z.G$]1^B<>A8%SYU1 M;1I&2YT*03E/0/:VHJ'O,UMWJ`_!N&5:B(M;(,#J>@NS*6TXB>,P>Q/5+H+- M609PT"<,LDK(NPJJ(;=N5DVXY3B=DUU@5GY&`/QD+I;+='J]6LH9%,FG9"ZO MS&;PE1S+?6QL"KL,:(;.P39MSV^)$+W#XO%!?S_'VTH9#%G!B[FS1NL`U M?1+:06`2X3FA9[JD@/WU($MOT;IFD/.RV;-)3Z@`DQ^:1LC!A.J6:_F%ZS0H M:5X'!3TQ&S'*"V;/%N/G4.;HF/V:GF`N?AL>&$+(K5)[$Z)V]B(8;J@NL%<;.KS1EGM MOPC#W>B,NBU"ZT-&YU'&?%TXH,S,=3Q>F+S`;[`.\CK6B#0V4X>%R.#[/9[\ MW5_NB!%2B"U=YMN6X_HFY/G%^!6;60VELD$%UWUSG81]"=PB>UQGKC"%:3,S M\"T/4DN23W(PB$L;^.P69[2YNT\A<,L.&RPTP&AS-Q06]WT"24]17[8@5FOL ML"G3B(Y9N-%PALSW/%L/A:D3'#Q3E!=XZ%M-]24.;/$^F^S'U\MR+DQU#$PP MF>#IH0!%G>BF/0\J;L&JN83YO,4:"/?'))KG0\.:<,C5DC\1$(95:K5CDT&1;ENP[H)!@VG!^&MA?QPEYX1T,09H0 M&]0DS157"5]?ET)TEG_*@.]!3S!B.&0\@>>&(5ZO=RA0:^FN*,<3!,)FS3ZK ML^;*MM+S9/(W%W^XX3K<\7S7$`X#>^WG$2P%=6P.T["ITP7Y*IB#."ZS3ZZ" M,=K;EGL>=7C`(#VE-D29%-M$N>%P;=X<1F:NC0G<0M`3J=_6JO:HYSLV#X@/ M-)M"%RS(A8<:?H/[[TWC$>G9BWQXFP(&.'0ZH^?K.`>,>X3SP'(91"0YN@>$ MF[0Y!).S=JZW4/($DC?IJ1-:GFX+R[9=+P0N&F&0ATTF!'#-J(3Q=D$_B.1# MU=.@+AA#@YFZ0W0_U"W3SYMNI@>I9`O>T%K]:#,U3Z-\8S5<=TS##4+.J16& M(")6V6.#GQJ56CRV8#R!\G)VXMK(Q+T#;#NT`Q\2)F*Z+@NH#>%A<2+.=7G3 MY]H-PA\EY@E4;XFZ;5,(QPU=QZ$.M<$2VF$1=0=ARS@[BZY;DB-1OMX*YZ'G\X;Y M8P8[F.I\BF,835/9&+BEQY@%*02S/<-UA4XX$USW#+UP7<", M1A+/UXZ,[[JR-7X4MWHO)U@<`E<7K4^"D0TH%X$B(?60YW[V`:BQ7.(X/C$@ M?'`88Z9PG`),S#`\[Y4`U%S]>>G]_MX55X&O>9=_?`X^74E$FH/O2%6`W?%" M\'3RH]-;4OBYZU0;S>(HA1PPF]ZM<&%OWE`]:#0#22B8;C>Q?= M74<[,N\O2@QZ!/YF)?!EKG[J:OYR&1?WG]PD2L<*X`>A4I-TH47CY#X'%L7' M:!\1O/Q/1(N&Z!7171YBR9D:GHY\)[Y:!=51]SJ+/^'5=+R-6\7+P9M+V.Z' MQ:+B*[Q0=;])@0O+7G9YGU-RWNNP'.+"V. MFKLP'<79+]T()3N]!B\V*G!AK%K8G`T&:-N`S&HB8-)T-+V7J@#\BR7:!_R0 M#8C`,0WW$`1.I@A.HKIM4 M9`CRV5/QJO(NV9]#I`L1LIAE,7G.VX5$OR6]EQ.LX MM*Z#0)/HNP::\,YU[W4&EA:MI`H*HGOT66#FZFA7/R^JTK"H#,DA>F9^BX?O M$*KBM^3%@4R6SPZ+8FMA;$9`1V$LM5]F&'MX!#PS]\G]Z!J^X@EMF5 M'9;=G=D[Y39:SC',=25^6L_"\FEO\=W]+/D19P"&=[**M'A\OQ%:$+,-]-&S M#,H6$02U!WDBO_Z=&2%J=%XQ32B;=O-(W(U_4K70'^JFA"([>]*R%GL62>EY M/=PNOWKYXQY!WT$`\6+TR7:3TJYRE`H8,@09.)YHG(6S.-H1`EF)SRUAMVL< MD3S".AFNN^0'XAM58E\YW;8 MF$+,EH-^$*D3?`1R"*&,"MFL":0,#K)O/$,P\;^R'+=&23E'N2DH#3+.'Q$) M)$Q"5<\JR4)T!U^3*#PHE9T@MIJ,X&H2"!RM48J8FY7<0#T]C>_0(H)07I1K MK^4E&Y4S+^@!X]Z,$YDMDH8GP23\67P(8]W9XM6\I8(RV6Z-E44KJVJR!)I+ M1@[>6Y<\->(D'S&%F&7*ZN4C]-HM9R\COZO5'?@%6>O-YK<54^:RK*%6L,*Z M]@)K)QFF+6:#,:1Q'XXR%UFAR._2.\P?@I.4/^CY4Z:(*:Q^KWZM@NZM)_3X MGN+!\N@\2,ILEKWGMW?Z._G[`D\)9K_OW_4$3M],YXK(:+5,\A>D(52O?)N. ME[BWQL MHS)1?,":'01AF6Q<)\MEOFFY@X:HJ^-7?U?MK+RG)Q%>VDEG11O`M*:(" M?[B=CD$#NZT.%-B%F]$&:]PNR#7>G9Q7+X$_@_SL*#^T%_*SNXL\I)[U37G) M:\A:U(/^1[X0CW=EV&"E!BLU6*G!2IW62@E8:W33G+TS&*GG,5)9]I)Q@MQ_ MUR3@MI97!5ZE$"K(E\&FG=ZFO4EQ"_(F[V]7T4)O]`Q>Z4F0>R3O*^4]Y12EO+N5TSJ2^R M@I_;^Z#"DS>YDEX9\[E=6:' MOQC&2;+#IJ`RE#;]6#'4\13ZU\YCD;TJ4A7=K#I^'5=7EJ>81W MBF:S#MW;$2KU_?%RU.K4R^W(J[?M[`:?]KQMV6=U;?SNT/_DB9+6[YN63S>:+MY+6N<6>GYTO0NS>2"5@W3SFU^OL M^VXO"_:O7_3T4^V]XM4@5P?(53].N_>75T.RM[5WA_=]7T^RUYM(Q3#-?N1S M?1&W(67KJ6\];39L^%^5EF>G3^#_+RH:LJ`O=7\:#F8KKZ8KC>)EC.`,PW@3"<4-YSF*P>_ M#,!,71_+'H"9]N(=(>VS6H8+@#V0DE?F$SKWF;V7M@&8J?HY=FZ2P="\KCQG M`&8ZT0&33MUT7W;XV-YX<+JO&).)G;/.W,EK48@A3=PPR32;G:?A#-:':`9Y M?F<5G]>9'`Z8O4-JV#,O]7IPE_@Y-P;=&K*A75GX'SE%?BV'5R/5/?E M>K[7DW^Q<[.[*YM#_M6+B/)$ITR>$P[BH#[YBP"O(L#+DT)"O`68JO[I:.]\ MW^O0QQZ?7=F5A2_>@D%(T=UQP\%\U>..QY$@3D;8)B2'"A?_6BV6T\F/YV?D M,])[M;J[BU)X;:Q%H^7T8;K\H243;7D;:^4U(DT>N]>^SJ?+A39)4OGGJV4R M^EO[O$I'MQ&.KYU%M=Z-BS^Z"]X\\@/SO*SYN\_#E`:PQ6J@_\ M&>3G_]F[UM_&C23__8#['XA!#ID`&AW?CV0W`%_:\V(R]HXG&^33@)9:-G5&!^7;<>7;6\2=*O$[5.4\NP:2 M"U,)K:O,SJ.-I]>HGSY0VBO^U_6E?ZV@.1-?AZ?7.%(YJE:K"W=EA0^MC;G2 MO>@K8SR]!O<2>7J-`QYXYZXA=PV[I:4NYWJ7WC=USEO<&]J5A#R]1N76SSD#! MG8Y=.8N>/XMR;XTGXSCXN16=Y^+@VVE'UZ"7P8X=/NCRAG)Q*%Q\O=%<'%40 MZX#8DU.1)P[9>;PW:8B)0!*A,<`7ME;8_@43LE&/R#!)@RQ,XI^1$,71GW5G MF/<9>8^E+W&3R93$E/6"'R9AEA%2YCYQDB`=X0%_Z5[+XR^WUK?V9+KZ0?OE) M``NY;&>*KT%O&1O')$B_D4R8IN%P,38<>1#/?Z0@HR83Z(.R-^$/_)4-3!@% M&>D+PA?,T\*Z8UV4C3\2FAUMW13E?UI9MG*"XS"E64^@T!=,":>5/80I_A6' MH!9HD(:$EK1:4J/''B7?I["@KYY[?BR@J;?VFM<<.)X*XS29[+R`3P0F\8CW M)G(*I$CX$7P(IR&8;OFC36B5_%Y=>+J`X78I6A.?)919"W7`SBB# M)M!*@-;U2>)$7QE&H1L&IAZK*KO.!NW--X_ M'D+PD.*DU#,@_FMJYCX_?BZ,9BFNQQ'-O69\<"_]BE+@#(U4,"(?PV1&H_EB M"=98`BF9!,##227.&C#KIY51+$*VRR#1QMCM/NWG\B7/%\CD`\NZ1\N/$#U,,]$SV7L]K8X?3YXVGOWII)D@.J',#5.?H MP_'#\.IW/#4^?HP_%S5O@YLCRZ MBK,TC&DXY(BZ5$1UCCX%GZY+I#-Q5(Y=[2&([_$D$^=+SI>M`,HO#BUR M0'%`M0(HEAN6UVO@<&H'3JP4PP<.*@XJ+J,XG+H)IWUDU'XYKHY?D:=;[D]I MK0HW>'&&<_`)./A-5H7B<.-P.R+<*CF*..8XYCCF..8N$G.%.<#EI#AW<>[BM=HX-:*EV`2/!G8A&GAAA-O]=-H1 MB7@.A.L,L>M;TE)'2;A&.UDC_D)2YK=6&Q,F5,60%,F,,' M5EL2Z\.%6$IN&,VP1FY`A8"]!9.$KK%0)8E)&D3LR6`T">.09EC:[Y$L&DQ2 M(9FR^J/Q_>++?`"S:5%ELHGFO!SY10+*L+4B>:;Z]N6_[]M_^= MT0_W03#]V0OI,$KH+"77XVIE^\^YB'$3FM';AR`E#LJ/FV`^`=%'O\"TG`C$ MRJ___5^"\+=UC2U?JC9KIRFFQF2-./-&P_93D(X6C6/Q9B3@9S+^^[N!A^O\ M+^7/+]X[(1S!%\$P^^"HMBF[NB))BNBHLF-KGJ)JDNPIAFM+CO+NUQ5U4Z7J M,Q4DURGUK=I*;UM9E>5,0;G@\K)*T+62SG4-$04Q184U!4`05O?UCJ`!TL3T M/KH89\?KA3[\K!KJTJL;OK96J/'*4J&R"M39LRZB:.[[JKKOB];Q7]S[S1=. M\DS.%7?++>E>4KK.T8?C9T?\*)W`3\<+:W(IQ:44EU)<2G6Z\!874CRE5/L@ M9-$&GAWT!#+M3<*MG@3YH**O0]N%A]QUK>2^[`D>&;)8L*!(+`3<#*9V8>^U M,_O[BJ+P6^+E/+N&D@O3"ZWKSCP>H<9(W>UYL;P+OIB5"YP35F26Y.X75GF0ZMDKGD/&Z5\@7_%^:+K&J1#]NLA:5LZX:TI ME\OT#M_+\E&\PR90#D>EUK'T4R(U'='RRGZX>XX;:;5VU9V7*>==EOVI*K-Z)O&L=BM*YS# MW;DC[0`NKH,(&V^!\`O"/-O$60J!,^+WSJG;U^&NU?W)L\!J>YN7KQ:;9R\E M];ZNG9Z<9P&[-Q()6!6/Y?4Z<]KN9<'N[1>]_E1[IVC%<;4'KKIQVKV[M.+. MWK-[=WC?]W*!Y>66?$F=XW#A1I?HNR M;*=L8;LF$3G]Q+9FO6DA44TS"PZ,)(QG9'2=I_Y*XG\$8?PQH720)A-X8)K0 M(+H>KWW4(>,D)5?Q,)F0+\'W35EPOHY(^-6'E[.Y,_^8Y+G#[.\A_4JS:?KU MCW]_+0;T-6_J-@LR-A\GB'#;^/:!D,R.1S8P-;X:1$NJP)3+0?X#<#ZE5RP' M&C#_VA%3UFWP.`R^?DXH^4*`>$/R:992>,-E=ZU^8\;;.V%$AN$DB.C?WWU0 M*GE\=-67)=DQ1%=435/7/'D@YGE\3%5V17AT%HLZ'7\3-.?2'8]WK20_\)T1AN(HNBV.?`51Y8MTU"T@:&83D$4R=4D:Y4H M\)NR.U%V'O=Q:*%LIX5J&9KE.YKN&I8F>[[K`C)R6HBJ[3NKM#A?*ORYA0J> MYJJN;DJJI3BBK\NF9,B:)]FJ:CBBY.H70@5U.Q5LT_%LR_`,31(M6=4=7V%4 MD)6!8NA2@PIGQ!0*75S3565)TB00F-9`4W1+T4IYX3?D M!73%>@&4]-LG3FTBIZ'4GYLIIMZQY?K)J;6=#PW9E473T@U1E$W; MU0:Z[2^PI2O&&\36-JGE^KKIR*YK6^)`EFW9]+12$_J>(78;6[F_5G'QFH]X MLQ2*=+/*0!97+<\/FJD] M;WF^65!*ECL[T&39V%$>3/!OF.7`ER[0U799+ M>2>Z6F.FAK)#F+?=B39$PC;3Y<7<*\FVZ>BZ!E)>-\'B\N6!H7F2!GH2](`G MO32"M^_`CTJ39_A\8.O:P%4UT5-]%Q2@Z&AB3A-9TWS#:\AV111WD.WG0IIM M_**)OC8P-=$9H#3=<]Q;5D4]0UV1FX MMBXB:0S7,QQW-3)U.9QT:5M_KF^+OJRKBF75*N& M]Q1)D15?-!7+`[$U\!V[--Q$4U4;`EW2-7:PHK:D>]%][]7[F,3W'\-',K(I M)1G]E,3#69IBF:\:#UXQN:1NMN14`V;LF;*HBYHNF@-)LLK@$_S';L/,U?>'_\81'X,&VUC! MA$D-7%E1O,'`50:BXAERR0HZ$&>5!J9E&MTAPF?R2."+35;)2:3Q1X(GD&Z_ MA9CQH2:/Z3,ZUO3!T1`U96`8MJ?[DF)X3KD6ABTU=*PJ2OK>&[]G;_X>0T5RZ/&41?-0S?\L%<&(B."]I#,7"EH[CKE:VG,5@@V-G M>8O>U:U[_>G+U:???4^XOO$_VU^NKC_=;CVG>XJJP/E'?/SG,`NB<%B65:*9 M4#I@0@X+QB"OGD!QJMQDL'>+NAQ#:26XAS.2&,@V$886G+,!9*9[@G MU)8C+W:.$X<41 M>[FHM/Q;0($D`M,R^:RO)^0^$/Z/!!%\N(H?861)2GOPY[`OO'_'?G['Y@@O M3F"$&6$M1:R))([F>3M%T59\L(&I?18X>TI::4=(8+3IIG4)"5*LOAX]Z`)G M"$8)5PNRI-,4R'>2@8 MZMDO6-88$/^9,/$QJLO:]^^J'T&@C<]=\*^5"`+OT]9F)]),Q1?!4$J$JT'AN,C M.*)`62!GG$`?\3T:(&Q!H$]DHM4AY:6IV$)C<[EJA;97N[]B>PS_F<45X8DO MH$N"[13#H6SL50$\#<)<]M[E+F#Y9#L"QT19TYJ\$29)FMT#"H%TB.1E^C=@ M9C;JFKXHA2V0YRSTY9<5#0C<,XL*$`;"?0#_*Z8Y6GH@#3`(3P_A\`'8$^&U M!$+>&,7'*Q(`=0W\"D1K\D"O7CP>6T)NJ#B_PM+[+4=VA7`-)W7YO@@SL.Z7 M+\'"X)RACRSX7IM@S1``P[T=-!H];4-F\_VT'QL]#IU\QYNB!)V/9!@&);G8 M5-BTVIO#>RS<9>$DFCE9]^(IA`"#3%TL@#"@S$^:3D&)Q.!3%;`!C(!,H0)( ML70.+^/55P!2FDR`(5-A1$"AH+Y!NC!GC#4#GA?R:A8&$327C,?HI:%`!;4< M3F!(N;0*Z`.R=13,"VB&M(J%_KGZVU\8CY7"'!DH#>_P:#/P)0L\T1:-/+%G MF69[0A=7J:61:3UK0YZ1O4>&R`Q9,+--,WE])A9:)2S9F&#H9'':=S-HZ MF/N,NE=:\F#`1O/^DC9,`U99,,V50V%7K#%C,;R6FS2CJB51L4E&"2QDG&30 MYSA"[R%W+J-B.R,/V*53G"YH5Q+#BQ$C:S!"94(S;.B1+)0RNM-;6@B9?P0& M5/%\H=8K<2EVGB2/4*".7^R-P&\4M-N*H55,]4=A/,LP^C5-$T8Z"A8VA59F MZ"@L=2EH.!85>WH@0!*2.ZHE9RX41<6CV.0A@)+%"&I2M:[.);YNI]]0Q]/" MV_]2>.LM!MCUDP78EZG*BLJTSP39ZZYX'N*H13!PE:-E!+I%'WM7N4(B-%K: MD8>K,&Y-74H]R93:&6,>RH9%NB.C6FA@@=OM49<%3ZZ)N##&77R-R*B(0F!Y M$H!ESE@?7=M6YM/F\E6DSR*V!`*7$I3<2+%Y#N%^'B#)A=K6($F5.?8+DMR6 M09)R>1;QD9AL"X_4?8WZ2'"!82"DQX+U),@K'&(9BU`'.IR6I:ITU`IOYHQ10B-FH6K7O M#LGS%4[*`Y@L-!ODK-%IW.?#K2X=0&,V+%8NB&'-(X$=F9P&<\R<);"-\>92 M`I\ MWV3%LEV<*!*F[(9@-9!62*E@.,R[14X(B[#9L!HV&P-CQ\,0$$07`;3<.CU" M+&%G%'7(3=YYS*K8DW2I_4`$\WV.27Q+Z5BD8N>1RSU5:2\6R\,9/)S19CB# M,3((:B04;L)/@C1DRCUB1BC8)>#6CPGH"18(B,+@+M_7+X,.8>X+C*K`'(=9:.>6^,\6SQ\RDVCSH M#3@O<%;>3LJ/``83\($RL-#SS:V`X:=D9#2]V,RA4>0Y-,;P:>:ZA8_,4F]M M.T&Q6HS;M[>=(/=,H\V!96]B2D3_>VZC@!4!PV5F MUYKS5>LT#E(*V*HXKS,)"NNER6X--BL4;)*"J8%11F@[I:RONQEH=#!45P8Y M"D?,,*Q%GM=JP;0F%8J89PP+E#S%S(!-%V'?A6&Q/$0$W0YF*9ZVZ[%C3-!# M.F)T8%;>(KR:]XS3G8)E,)SWRD-+)`4C`VW@#08WDN,I2;\Q.W%82=D.'411 M0<:2/C7#H])&.6\P/DI3,T_LO@SY5(G`6KXCY=FY-)G=UT[/_+AH9FF9-,,3W3 M:-P]U@\XUF=2O`P&ONXJBFL8IN+ZFJO_/WO7^MLVDN2_'W#_`V'L[&4!V],O M=C+_130$AWK1@^O*,7Q_?57I$19,JTW*5%2#8*!)/-1 M7?VK9W=7$:KR>EZV<0KG$+/"]U4R=G&].L5"Q7G`*-62&E?0O%(5\5W%"L3: M&Z#`1/U4#R9YM9V9^84NIG^E]E92- MJ%U2NCL(&:"4,<^5@1T$/M$Z%RX:^L$\:B_(I>95D+NXQBI,NJ>!4)L9I8SO M^XKY8W*-\OP%54.EK(BYBZI]0U@N;1EZ#N@PSK5M[,GI=ZHY])([6Y$[ M+F>Z=M%MJ1T-H_*-F_I>N;J=O=@0+YMM7:U"TB9BJO.TJ?KH+5 MF5YU),\.MP!9W='WZ==TTZEJS^[-2Z^9/#CKS64UXG9[?,V[,["]Z??D`2*R M\??UI:P3I1G?$9'1<-#+?QBU&\Q^>6PU!_=P-3!BW"\MC7VCAR1^FW\H9+Z? MZ9[N=?K<)DV^VLAUA7:I&3'OSH3ST](.;+-]X,8WTDWO([M^(0X0!UC'`1Y( M-_;Y:W%Z,X.BUS0H<_IDJR5]LF=;4M*''U:6UMJJ!>JRKMFKV[T!9D:_CMV2A8.$5"$H$)8*R M-$8?B)&N:TQ3#VQNXU=NFV1\=4O-P6I`U'JU0E9Q8Q,BZTB0M94]186&L#L^ MV*VL[=9SVF"LO]Q&C3^_9>>G+\:[31N-.+Z[JY4KMSU"KX:=T:;-M]:H%GR^ MH#L^-V%%@]%YF6Q-<=";*5XXJ@N9?;R.^]];C3BONCF]%'S?:P.`DL7KNYN* MP`YGZ1!T1VV8=;Q*%Q&'B$/$(>(0<:>!N/5=QUDND5U@[<4#1<4'C&==Q:SH MZ_@02BNMHC0YAK+/J+`N'O9?RF9"^6/.,%?JH!EURAIV7>8QO>^UE7[,?-1W ML:\NV#E)'?"&G7-6++VXY+&*!4LX*P?7:[59>=C5. M!NOD*R8#9%NNTI::;%MC/;9\.?[KN)TK9>6EQ?-TS#0*+@HN&4FU.V]RVU=1!!-*DIFC23SC5U:CAM-:LDQ[Y&%MJLNNV^V M:;,*-7!PTHP+UYB/KM`L'IP\I(NX7&-NMLS0#P6F6H$IZ\1*!:N=NK2#4JL/ M$DT/2M+125*Z9BA+RV5N9)<.0@)Q07%K%DZ*DL.-::G;9EZM'/,F6TFP*,VM MQ+P))CSW;5Y/2'!U:7MU4'!1<%%P=Y?+8<7^9"BY*+DHN;677!N=Y;K&P4<6 M[E:[R/A:99BZ9+OV*N)4E;:-H"Y(PNQO?6SEP$33@Y)4RL(C+V\S-BX\XL+C.I%8!]&/ M&)>7^!BH:5#2S)R#.M:PHQ[B`- MJJ$>.H@5JUHIJ2HX5HFK1':GP`X"1>A'H?Y"_74@^NN-/F>DHC,Q97E@!X&] M37)>/V=9GE>OG_H\-8!VJQM?W,<9\R@C/TU1LFTOV17UT")B%K6ZG67PU%-F ME%&:S\N>TNJ"GAU]GWY-M]?O1.T9S-#TFLF#1VFS1MQNCZ]Y=T;.LN\`BT;^ M_17.W+0Z<6)=Q8_6EUXG*JCX3M3_UNJ.B(R&@U[^PPC'V2^/K>;@'JX&1HP! M"V!L1P])_#;_4.A(]DSW=/;S&<3RU53X"@G4C)AW9\+Y::E\S(KW^$:ZZ7UD MUR_$`>(`ZSC`]98V]N;:SC>)>C.#HK=R;"?$JCUT?M^FE?M6#D3V]7%DXFY[ M[>;H03?W_3BV/L+?[A/+@$%LSHNLKN.'0=RYC?L6)^<89I6_/(YH_.4*W+`9 M,%JEHA'59;7]C"L`:)&399U9*.!YV^"&$5KZ03K4BPB[Y;#C"#N$'6H[A-U) MP&YE;5?9D;?CVQ#X`([T]/:^MY5`=X?\6S#]Q;J-DE:C"@R>(M0PJ$7\('X0/XB?VO('\;.' M[)@6A^Y#K5J:=Y^26ON*"^5MDUZ&ND,X@T8N26F+=+6?^O0^++9Q)"Y![=&& MBF;FJ`6Y%.4U2C_MPB&HAU`/H1[:V.$IK[A'W:<>'1Y4-*AH]N3PT$M26H/B M$W=XMEP]VTWFY\4#TW?6HSHX)B;KJ]2/S.@A?A`_B!_$#^*GAORI:F&-DH/? MG?1IY"QUO\UN/Y_T5:FNH]@WJ4$$W!2HB<8BAZ*'HK> M/JQ>>14P4?10]%#T5A<]CE:O%@GV(X@`?XM:7:O737/H#[TD:N\@]-MOV:0J MEM9WUSJH+K!)[\-RSS4Q;<[`(JF_+B/)^VW;O-6Y?[6`"XV_*R2 MA0??\)-<[K#A^D&`"-<%*O=K4'VA^BK-X]/EE>O"=L6HW5"[H7:KBW8#YTRB M:7%T#G;7QNU@S_,L+#91K/5'@Y&[;2QY0LV&:HE MXQ!QB#A$W$$PKC;,0L2=`N).?JWU$)J`U(57I46QU8VYWBT]ZC*1F`C;KQU' M)7!@2J#4=AL;Y9KJ,OVXUHAM'QU7282'054`J@$UENU*J]-Q6DX M"H=]9/O%`X^[306FSC!9B\E:1!PB#A&'B$/$U6]!Z@A*I^ZM><;6P>8>LK+E M]<@XC6`+$S*G+2_E%:M!>4%Y.7YYH9C,0WE!>5E97LJKH'(:\H)-!`^HA<3Q M-'LAEZJB@^]K<*TN0$OOPR)E-3>&IR.;>ZC^C2**(HHBBN8391-E\]!E$\UG M^2)Z\J?$:ML\8Q/QK&\)7G(I=V=7#Z%X1]6V%4WH";>9VFGOBM-(YZ*\H;PM M:AM144$^-&`H4"@(%522JR&-I$8%=P5"#H@;=/RA1@Y;J9%;4]QR= M3%21J")111Z\BMQMJPMT,LM*?W9`=[7C/6C/2K>ZQ-U>I]6-!H`,ZY]Q2E_< MM%P8>O0MMOQ1OO,ZS7VGD2@>*)XHGC643S!>BJ-XEF34ZN''W`& MF[>FWEHJ#T[XY#D3NQ.^ND"D:A.(ENZ496JWX2#*%,K4\JM%:4*%,H M4RA3.PZ\CD6FIN*KGP<1C/"UZW=&V!33VJUN?'&?;5UZ2QGY:09_-$5;F6R\ MN8\M")OCQB!)2P$5B%SSF>-8?(R5;/Z;<:,WJCCT-F7&Z+6,Z7.X8MO79<^R MKC]=NU\2*^JFU8VRTD96[WEOE_48]V&,/QKM83-NCKK.#6#4C5[G83C("$M' M/C[\:L&L=>&NI'A`]J[7SVXW9DS%Y[B?;5>\`5'RVKW&G[_^YW]8UM\GEW4> MVKVG./X2M^'5S0^MZ+;5SGCF#_O]&"8AK?P%]WZ)[]Z=A>_3R?I#G%D@E*U. MU$[>G5WP,ZO5A+]%C<$%ET%@TY"Y'C5.P!3GOB]LR@*N`JD\?68-NZW1LX9) M\^Q7RIAM@QQ/T;V,H*WI%W_PN?3[A'B&NVX@;>5(GRC!3$Z__Q\F@`]=\>NS&_>2^]0"SUX#O(^@M'@>;&H9A=B"4 MXTJA/<%TX+*0C(=AB.%B:AC=82J19[^22WMZ%*N2MYOOEHKFY*\K>I]6I-T)):DV$7X)$=4(@RBW9W M!WHI-3?]^*X-[EM:VC&S.7#Q`)[;L6:NOXW:4;ZSY_O@.$7=)ZOW"([6KAQ& MF_Q4BI-Q:66>P>Q0'Z/48(.6C]KM)^MNF/E,MT\SHTU=A!9HF#%;LN^W\;>H M.U51$UR"?NIQ@NBR[$6M9-59A"NC1J,W[*8_IY[',$F?E%(09QK$ZF0JQ`)2 MI\F*?T`8EU@)H+!U!^%<]IJ[]C"&R0:':CB`^`TFNML;6=)^KVW!PWOPB/YC M*XFG03)Z&7A6@Z,?ART._=Y`DH`'!?W[@ M?$T$&FW8AU'"ETSTX>)G%3?6#,_T/[]K.OY:\HX\E*Y7Z&Q-A\[K1LY+O*OC M4FPC@=?U55HC`JG-RJ/P"#%;F1$N27.NFS-9.=1Z$:+]2!L6#UO)?18EWP7Q M[<#MI+[83$@VCLC^>]A^HE_']WY-KWW?30;]87JO^Z.5?(V^-Z*O7WH)O*[? MCQKQ56\0?\SX-+GK?5:*[SI7L=[(@;I.?7.WVWPV%\^D)]Y3,&XE]EN_-WQ( MX!'M81J/3%=W_S31TZ]3,NRG7J4?IQ'""Y(^]+K?X-=..J";IX\#S'Z-N M\CEZ2O/DH_OF!M4J\&P9N+ZO'4:89"Y1X]R%YHKZSLN@6I.7&9BYLS$[:VF' MM>1#9FL^=5^[:7X\/8=T(NW`*->7-M"IA'2-;X])I[8T_"7I4T0O)69KVOEB MVKGRM.2NE#;\LP5CCL[9S@2G_DO:+SB;9?NZ(X@A"(K:&5H[$#N!!$1I,M;\ M>(B[2?PJ_7\LH%^'KA.ZBGA*ZY"X7)J0Y[!Q/$Y?TF\3(F?I7TS0EM2+)=1[ M'O%!T_E M4Q_"_];_90KW2_P]!@U\%8.T?(9?0&RNX_[W5B,>_^5SO_>]E619@G7116S; MN"YES!-"\(!ZCJ_R^;&%+`S0(9S3F0%N37/E+%BB'H0@F@HC32"H3UT0*=_) M$_L^I?9+%D@A#XX%2V!.B4^(;WNNKX4![<(I<&2<^Q4J**S-,)L`6@Z,!TLT ME;$]SR$,[(2QA0![8?382B@?_(ZBIM("5&V5/!AYR8T)-\)A!5/..)O%^G*BMA_$$IU%F99*@=OD&$FE M$PKJTEPIN]HOS!2CSCZ&L`ALH>-(%=A^R%/0N:YBKLC5+B5.P:@K>_=#6"(O MC"@P&8[B@08L::U-&(Z'`.+C%#S:"TFHK'@07@R1=#RZ[B;M//6QU>U!"/CT M/HU*(&@#,SS[E)46^U80+`Y^/%,FM$%7:%">H1]ZN0;UA/N*CRP=>TUNE#:Z M&K%UB:@K&C+?=VRF`VT;"2Z78R9L55[!=>=R78@=(U.722ZWB><[O@3][RJ7 M*\)S(T`(-VX!JZ"L.+)UF4X/F!\&@@N/&0KA,A5"Y6$FTT(6'0CFJ$/AZB0C M]+G73W]P!X-^ZW:8;6Z\Z5WUNN,%P#90#CHO;$1\0BXPJ]X*G)=R3P<9BU+"$!$X'K*4*7\,"3& M4"XGZ2;A%SS3]9WK7;#J<]S/B@IE^QM7D:[I+7*A;3P8.P#%E[YG4\^1.L_5 M*MM^L7'2&6H M_'0?K="^[_HA%8'*]QB";S%WB#")SBY'.#YMO1%0#&/L]U M=Q!XGETB4*?)+'V4BS4.YP)L$H2.2C'J"^+XSD3IPN3.%<=--$ZEPUP,6`DP M#1RJN)(AI9ZGM*TFV2?.%VF==0%;]60N&*7OA-KU1.`Z8>@QSZ>^G2^7$;"@ MK$S-L^HP7U_(S5*2$$>L'Y9K`5&Y,2+TI.\P[8,GGD^D-D$A]\/AF@5>PF+J MRAS7LBR.;X@(07/O0:V5W9]HAD\-#_^L]_U'!;Q_R5:B&U9HJJT-&. MIP(AY,3E"A@K2`^5]8#82';VPND/<92`^OZSU6['S1E>)TN8+2`6<4$+4PD. M`]6!(/XD,\H8*RS<@JKBK!;L%H?(;L=UB)!&*2%M""O@GS/)F;I&%!6HPVL% M[F/2,[:C&03F(;/!7^9:^XXS.5NE`E)(M$I-]C`5LVF-+]D6:ACA:!+6MG,@ MX#ZAKK%=[?E:NJ'MJLF:YRO)Y:WLW$+2=\:1)2Z-KUS?%J$!(^/I('2D?':S M/2D*'-G.I:D'2Y9N%0.EPVC`2>AJ5]M:3O9'0DQI"DIJ*[>\'AQ9XM#[+@D] M8QSI@E/2$H;'0 M]J5G>.`$MC`BR.%.21#,'[4]-_-0AU$O3K@83W$?'`&/N;YQ.'6)ZT\6PXA< ME#WC>X?X-FE#9FN08JH"'?P_>U?;VS:2I/^*L+@/=X!CL$DVN_L&6(!DDSNY MF\2Y)+.+^TA+M,V)+&I)R8[__57U&TE1+[8L>YS<`KN3Q);(JNKJ>NOJIR#? M@NS7"ZB[LIV%.Y7\>7O[-#6G9]:%:<#`[4>#%+LCC,A1_3D`<0^+C6,<'SG7O\>=K^>HN^AW46)!Z'T)<)*3,O MYEG>=>KZ<;SG,(!&+\[YR3K)0IH(YH$59YDD+/*YGS@F`S*JK>YMS3FB_>-4 MK5LIF"2?BS"$.)1!7"IE9'N*TSB(MG3$[B&3BSF,E&Q?2MC77/HK"S^6TK.XP+WX:C%*8!!#8!20'-R(%$^!.W-5# M*OFHRDW)MA+/!@E'4;D/EHHR+Z:$"2+3C$)ZS7H7)"$^&QE6MM5G'Z*RP>*U M+/6?[Q>QAG2Q5V>Q.#N=-NL!KMB3=3;W!3*`4&>00<0B]WP;7(99EHR.TWPZ M/L,Y@LZ7X?70'0P2L1@7+:%A0@,_BZCK@4JS<-1N&I)@=!7F!7C]U)1+V$VR MO"J;IIP9(P6/ND!@G;AMRV-:OJ.$BC3DOB^P;X:(*/%M,.9[ MSD28$$,V^4$E!*#VEJCYQG47Y@+;(HIEZ2IXR'>9:'L4\S"_J8>6$\ MCH/`(QTR*$\BO5TU%0*8I45[\_2+[W[N93F!=`7"YCB)_-2F8ARR3SJR$`&D M.P>)[U/T7/H/29^D/"*P!L2+,L^C1$K;/)?CI==Q8'=H)SR-_"_E_.K]HETW M>(0(7RV;NZ=?P0:M$8R&#'*NC,N4^DG@*CTRBD=W4_DX!'@$6:=AY8`^45_X ML#43T'Q0((^%J;0I<9;(;.1=5;SU;%;,;X]#A<1[[H',4YE'$"+&DG*G0I`+ M1_)'084\`.CX_N.7WS_'']-L\B'^^C7[_.4D2([1Z0"U]3_QX_]9K8IY-=5/ M^M345V7;JA/YB0TR-*"@\DV]GSE%>&NL.5!*`_PUN2E:A53F&)L[)BK+!*BN MP5U&["3$-%OH#H+)5/=S3%8WQ>H,,9@U>N5-U:[J!D'I)]-Y4=VVDQ+<>%-I M,,.JA9=\*^.&[^GY1SLZ&*)OU MU55[4\/[YM5MA3]8KIMEW98]F2#5U:PJFH>SR9=?T\GGJOTV28L&N&S:,]"` MZ?GDWS6@$D2"WB_P&?/S5R5]+5S-\6LW)27".N M"PAA/K>P`+-":>?7FS2-7C^%@KC>7%9 MW!9GD_]&],[I-Y#CQ4U5GQF2OQ<6HPZE:T2SQ-O[,Q4;&8U4"Z1`ZLI*;<)7 M@TD$SW%F=R6,[7;83_"\L!#[BL$U<=-HA9(@_"KM7_- MZ02G9A4UY67$T# M#+EM-*-MODW7SM1/YZ;/3IN/&D<+]%8'IP/800":.L/:>0=YA[:F M[5%D:=EB:GY4_56[$)V*$I(:PV!WZ.OR%;P`7VI!S[3E`9U[0'>S8W_V5_W- MC7/9$7W:/`B5.&M7D/*@E\:Q026UFHJ#;$;7=+;E>W;-]7W:?Q2^O M%TT)F\(ZZP15>`*4E&<# M9=14@>V$%*YN5X,7Z($XFIAS%2X8J&AT_[`)_W!C#`I$FY]AUX<&Q-=^6.U; M]5%XCOHY&NUZC4*Z+AKU#MQ(RWI5JK2PM^5P8]UA*HEO5FBB^K5@I!QQ;J&4 MM>@SU+<60Y&;/>>6S4P`*(NI!>75\BEZ[X0WKA6G;A95_\5]>6M)+SK395XW M?LM^K-RGV.F7'FOADNJ[8K[64RA0`K/RGVL<0J&2097J6S&C/DS@EZ#9F&DJ M73@'#W9;O=/A]`:H.JSU"I->^!8\J9F]PY$-#UKY&]2*JZJY5;H"-K]=6>AR M0T^EQX&I(H(90;34&`B.M$:[U//)!U6>JMO>Q$+\&_Y_$K=M/46P\VU)_?"+ M)K/7Y(!:W!8+<`YV[`)2LL3#C<81!]O#JJ>EM5C"!EHV&@Z^ITU]/HSR:(51 M6MFW.&7-`]U-9Q9L8),?]TL3+E$[9\/QQ95L/]W%]J?>Q M7C1MB,%?]+RA'I)0W+=K5(.NJJ=3,O.],Y,D&B^#R=GF=)=!O*:J!(B$XN"5NKG5F@EN#PP*2,6Y%N5Z2X-Q6\R;LI@]='Y#I1_* MGIM$"Z?-@8.%TCUU0F4)L&YC9DZNE*-;SS7OO2%'U@YW;D0[70QJE/X, M'V=?L^MQ)I;I'GD^.4UR?6J#%?]43F%H:M'K+JXAZE#J^%H\AN.QQ[*Q6EX&P.U4O$LVH;FLEJ9H*BWH19` MZ60%C@1LB1H48DY>JI5:<7D9*;5=5XL!SMG(U?-E-6>`;AJ.`!A9] MBIT0RM?!,]=VUFJ+1:?*%)UV!6`J:526V[3\(R\]E5_5\7M^W M+H4V,QK1)EVOJYD^T=?V$>)W/#^/OR23^,OON-#>.S\\F_32_D^Z<.5"7=?N M86KM:DW-Y.'>+S^[VM59KV"@K3;$DTUU596VUP&-\QQ(F:JN!WTAN[U1X[,Q MMT?N&>?TE%KYPPA#&[ZYRA^T3D$/T M\OFM);L)=NVJ&'NSV#.HFA>Z&U45)/^Y6>I\U;HX^3%G(?Y45NO?PO"4A_@_ MS43*'\$(QW.T#]?#BF:N^QW;9L6'WC437C06&C5T$> M%FQ-TFYC\"V5V;,G4(QV7`E*Q_]KL(P-DFI-<-D_L;0U9U-/ZE<9[$%%.P&; M^C"955=76$I0!2I;9C@?'@7W:%$)@3KX+R;S&@\B'J;SLJNPS$S5J5ATO3RF M*J1^5:A'Z-*2/I32]%]5"U5QT'YA4`-Z]+GNYA%,M5`%B6O0[H6M4N`JH]"G MIDL0J"N^`4L/D,I@.:15C@_+$[M[W;:N-T M.GQCVN7P9JB'>%(OKKK#3>VGO M.%+E=[,*G"?27*@^R)W,N\*YFR9KEV^A6G.6=:NR1Y.EW**9I4V&9UQ@YU7=Z\-WM0PO1E:[`Z+..1@V+.-O+ MD94SB.2/M0K6[S=6&/VAIJ`_J!GO?T_^:PU9]$8LYP43S&'FVW_)=EO`1VM2 MMXSNC�"[YILA5#2Q!RM;XU7EY7W6>EJB%A"6C1?5RW#0"'0UMSI1F>/W0\ MJ;#)XZZI\&>)HT?56[OWE*,`25ZM5;5#MQI4>%M6=[*=3WY7NU-Y`OVCT;-& M&JB.)ZJF?;T(^+1=TJY_45FX/\RN&71ZWA;?JUM0OA^WFW%HO7#]6Q6L0<"# M_["E"[W7<$7-.2>*8ED,0JG+9AK0F_]<:UAYOK30WKN@,V M3^M5_%I"&M([7^LMD=K<^A$=)>WNVQQ?!^'P8]Q!%Q:_8L_<*2O*/T]M8.Q^ MM;>UM;>FN_G_F)5U#=FZB@0N9(G'I-A2KJ+^5V[()CSX5YODOH7?L=0J"2W5#H-6E?- MUNYR$;;<]`VIN_MFFDI:%])U[2VJ)6.]PMS/]/SV!&Y/%$P]:N5$!V%"5=ZY M/:);.%?E-C>\T<6\T3(\:GSN->K]"0Z:"_$O![W33F/E$*N14Y7XK^Y5BJQ+ M8_U^*9TU&XW314S5_3[35EA'BL-6(E4,A%<>L++V[_T[][OOS^^X:=\!5$`2 M^:&8+QO@H9H^$?J(I&GJ^V&6AH$?Y$DNXM3B`"9!*L,1%`_9Q.0Z0,ZSJ=\' MB90P(H6?)C[!.5Q,^IFTH'FAE\H1\+)"77X.]7I.G(%F>3*\'/7"C(2IG^99 M)KD'_PVXQ0+*O&PT`Y[339")P?N?2-P!,#D_B[C'HBCUTB3*B9?SQ((R!22) M1L2)T9SEYQ!W`-,BHH+'4J1^S!"8#^*CQ*IIQHDW(LXGHY5^INCV40?2$2EG M1(@XH7%(!1%N3J8(QB#Q.&WLZ=0=BQ`G?)H123T:4LX9""_-/:MUN<_'`U,X MW<27&1#P1.H.R"[R(I(FTH=5S%FHAG4YY/!0\O$DR%!LU[NMU/VF;O_C0`X( M"N*FP>J]LNX&A'5QK89UM)\A^KHOYE_+YG;`@19O>#%=D;Y$J20LR5A$4R(\ M!'[RW7Q[C_G!7_[ZB?YO1^$11)R>"U@&+"P2-X+##=_X6XF5SN4-WBWNAG5\ MN!@`3&+V`Q!;HB?FY>(N\@VV,U]>/5H+?ZG5U0`,HV,PH8C3P M)959&D05!B#R@$"E$+`X2/X6_9$G@`%V] M)`%!D&,D,63DA82Q:=(]R>,(P@LO#7.1>4DH/`O3F,6Q9&^8F?#1*ZL,^\6O M`^RV+(PRDO`\S#,FO!3'.5CX;"_"+4V\-\OV\0Z-9^"TP69%81AQZK,\ZM!] M$YI[;WJY7\*OH3.+*`UQX$$6B5Q$H46^]ED0\C\?O M1Q*,TBS'H1%!G)*`T#S.J!N1$J9>AA(,3RW!KIDI7LR^K.KI-U#W6=FT&CG^ M:>40R"L)%](+"83XX`;\T(]@T%3Z=PGT8$J?)).%IFKC1<0GU1T"]S"?>3O5\!)T75X.9D?M'1AZE'G[`$X^R+`UPKH$' M.4&5`BK> M'NO'[C@FLCBA-&,\]&,:Y5G,N,L7DC'\-Q4;4TZ>3_#+"V"O74R$1S,?LE^? M2T:C*(D<_CF/LI%=?`76'_*ZR=4=]$^JXR:Q1ZI/8HR1()!BNUKOHF:3]D4)H4U3SC9GE!@Z7?"E/Y-K!-*'05SVN;RKYW>^400(:*HFTI,,SG"QO85 MN/I0)AV7C^3_O8OL`^_9,MC#&X_RE'*PX%Q&20KNTW=!/]8$1KSI,\SG\Q;\ MC_^AZ&6OIVEVZ'LGQS>-WQK#EZM#8E==/4]TAML83? M;(2PVUB7Y>7J_:)=-6L,_KM\13\^OH:TY;:7;NSB-TV$])E`^TL$3Z-8]>(:LQ1D9?\VWL7LCD6VIQOQ*J_7S:>Z6JSRZJ[\ M5#8(^QA?UG?E;]5EW6SL=:1G9>@9I7&/UJ=W43]4]R,"]C[S!`D98W[.F?7W M(5B'46H4C:3;D]$/++W?RA7\SJK)@2'B:10(2"19QD(\*2"9<"=%89BEXX!7 M"'(2H4'L\I:$=J3*"1`7A)(<(FF?DX3'@0NNA<='T@N.4SG(OA@G1Z5I6<@RX0DF$PD./HE($.2. MH2P9G=`SW^-'\+,]-7D>6WM'@OE9+"4)"<-A8(3E/'!'^V!X1GE_2$/Q$FP9 MVU! M>PF%W1=E%`254N9"N]CK.RR->(4C7+V(L^WB.6SA[=0!C3A2>"'F81T MFU$2N5IU%-`_D[>_XWWCRWGY^.7?$ON:0\C%K%ZHYUP6BV\7JFUOAL\[M/8T M)%&24"93/^5Y3F/?[G>P92(EV^43TD>*9QN++R&AW0R"9F<\%S0-?!93&1&9 M1Y;!A`7>BS/8:Y)S772Q:M]-S3VYW]3\@QW]0-W:*X#<1MU6_UC%LGVG3]9P@BZ>_IU MNJ?[:YY<70$Y\(R'3.UE:?7"UH$10@GQ(,@FPC*#.`+=VP8YW.H-'".;R,$S M+<2NM)1K]4F?6@W;HWYJ[V^MN2(03@L6XT:4S1V'N,)M:XIXV`MT]L3).',[ MD-NNUVD^>A2JQ<'7;A_SE7;\\(PX7\MN"H[)"%^$L_N1@#5[3EQ63@<'5SH6U':C&*M% M/`*^N-X2IS[M93]LYCPIL7O'94U]>&`Y<10'063%U*11Z#LFU_NF$#/UE(]% M"?UQ7+*\*#N;35MFWYCO1S::^P@B'^K;9NRW^6[+Z0\:MMB"6"R\?EO@5NTU MN%'@8GFTXP61%X:.'X4Z*`\@#%V5&5L-UEF"V:3SJS8AMH)O.[.V?2(8\TV' M"9N9-!:FIU>7DM#Z@XS6]+]>G)Y%%R]NHJ;JAI:!#:XRV='P-WD647Z\2,M[ MD)EVO$)=7*>RXXQL<(")RW;4HIPXV.G#N.:)W2:+NNGI[,<+1XWEZ(;VC"7V MQCJI92DU/K%JGH@G).='&1IWL!#RH-P!^RT/UU)5MNVIL(\9R'`)M^NC?!?% M%/XD57UL_)Z-'U+\@$9NJHK^SUU1P]U$L@)[]53:?CLAE@(SNG3=H'OP>N:ELBZU/FRW^_ M[.?&M%)-XMK^-T"?!>9H\'VZW<[B\$M0E@6.&,6N2G(\7EK+>2G8]J!,;]*\ MPC&F\$DY?$W/H59,.B,%\FE=ZF;/U?0.C]IV,.\LT-^J)]HP:Y(N&\S9S!!% MP03IRW%4IQP)VAW9^7M65<6TS/3PSLZLT<4YGC-0"EW8V+:2ER31L#2=\W6/ M>7T,?-RIANBB(%E#]K23;9[*=#3!?G[@5[?3"JZ24=NF9-;KK-(EPY+](&J9 MZ,YINMP?^`V`O.:9BE+RU:T:F##H4A@DX'4\3>L2QZW M&D..15FJ;91U'.2MSC&EWC#P0Y2/)S>Q2?!X7@$9Q4-^N*/_`S585?170R\. M!3H;:)9",U)IP?9L=B+_#^4+&V'T[^CC^:??H[,O/ZRM+XNZ+FX_8(/*K@+? M?\-*,?J_::9:<^X^RG-(&W..?1W+T8WA+)VT+D,W])::!FW8T!NGJ(]NL']L MHJN9C)^.\&=M==/1.Z78`IFMF<@NT^TH-O0PX`WOD;>E8R%]H69,4-DV8U6] MP^';19IG1?FEG"ICT'%G(,Y`N)"F4J4J!P-?=VQDM^CKZ?F)<@*:&NASE7U7 M,S":MN39'=ZC_)S6D<0>P6FI_+E#J8PK0'\8I3$WV5W.=1SIT4;:]9,]=[H= M]]I%A1A">5F':\)C'P_97U`9K!:?AI\4XAW2&`_)K'6I=#%EXU$E!@OM]1JW M5G7$.5Q#0N8.U_A&=OEME<^)'BO0M'ZI>LVJ9;_`ND2JR5Y?C??_FH5!:PK= M$G=.9=!VQ^\\^=%R\!`4Q(C6=&FYFI8-;70K+%,FIO`4>Q?J`6XOD# M"ZOWK)S5:SE/J2?Q7$_R`S@5F\HWYX-(]\DE1O8+X58C\8_&MQS"%70N@ILD MG]9Z=S'``"R0OLVF=.\PW<]2M-[D[*7)V2HV^3-+&B'#[`IL*&J_)8_J9/J; ML+T)VY].V-QAO/4-9>UC4N+PKC=!>Q.T/YN@.?20@G:1CJ\?LM&W-U%[$[4_ MC*A)X9([/#C0_<,XO4JFD_HY[!@6#,,UXU?WLY->6NWP^;S`,E$;R'7-W^DK>*V8W8GX]#?"$V[^Z"SX2FJ(B$KC?MD M,DUG0^2:/4:<[:H>^=Y85KVB7Z?O;RIV.J]:7(-*3CBD MU20ZQ90-`8I:S3N_P?[WD^2@^9>_$.N86W3`/(3<,6]DIR-D"_*#>8B%4;R: M03(<`:!$3&E%E07[^#$X7AB-6<*_L84_IG*0']4+<4QF'PP]<&#&H1TN1`'0 MD'_:%+)GS>$PYEZ[M85#)T+ZFUIINX]AW^QI,U5R#T'VZR,?#TL!+<5I1MX3RWX+*C MU;1J&+BA!+G[;E3%)!L;6N/O@99+Z+>Y4MF2@O+K@](KE\5DW*T-[&2L=W"2 M-V?'RV3T[;H$+WU\TEC3T2A-KZZ>@4\7M=*0?/I)&^9/:)A_.-#[`5E^DN`O MA51_&8HZ:UEK!95V)(9DO$&IL2(L&9HL+X4!=O+*7K]9U'ZD.7"M]WY-Y&%, MX,NEU3Z-GOG:K=[')!^_V;HW6[@Q86^F[L"F[M4K&7^:31"TU57O3Y@W MN@?SMD4\MP=_$82(\B&%Z*6L\[/(RI_%4L?]4PS'\\<8]B%=@P;_SRMVQ_0M M2GLS75O2\#3'^3!%^;@7X=K#YN6SRIC%!A6P->1Y*3SRDLW>VS;)QIF$`Q+T M51'QE6S6[767)*VJ#T9GVH>NQ7C.K9.70IS!=DA>TT;(4[4P;Q'\?:X+D!Q),JNU5ZUH M!(83=[I.>-86=6<<%CL;[9-MSW-#3*^Q-EF5HUGSM>NS-BO)7"U]K2O:NXW? M!BCYEC#5#\4@S^DV5<3>1:HWS.RB;!O2U._/]TPQ9#O*8;`AUB%.O"$C#@3P MD/"J4GAY[N%^U@:MJ6R7G=UF/5^;SD99#E$ZN#GJO[+QWE",108Z__`(VDIW MU6S[`:;(,I,R3<:/G0:;N"XU7)1?VMZJ1>?(B#I;,D[J5#VQ5`<+\F+QN`&Z M?"AXJN^M[.Q5MU2<=?1J#@G`M45FT3WHAFF:>0#-],_IY'%KO:3(@S>K0Q58 M;=LT286K$%E=MZXN,*SMH^]GK?` M5L4#'E.Y?)0'RF:G3K+\'CY)WJGE*96?CCY'IU^.WJD49;U64H>137L8K8.R MV=4=\E3.0)IQ2!#+-$\?@'C%7:=)UYLRV:OH@*0VNLW-026< M9:.;8I*H%BDH&4;Z'4S;8#J!#],R55K=UBL`UV8!;MTYNF&XA6;JX`6]*8G7 MH22D7/^HBAA,0P#C+%<0KT<_J&ZJNRL(/[LV+NYP;%VU!_5`V$!\M:@??IL" M@S3*H>D\OX%NR(UIKCM1=D^S'E(7#-3I8*DN>%EQK#Z!/A3I]J>B=%34@7BY M7L#PNU2=O3N2]C=DE:)&*:H[HQ!0#0T"I_F@>PLS\R?%8(:=O#83+N,V M*;^E]9L*WZ<*/Q_5Q25@2I:UQ%ZNQ`=AABL(+H?AJM9H++C9QP-I)(QKAX&T MV5.3W#K($XNA9NH`9,W`E*6&K!<+HQ^[8+C:62,+LW3>O-I]>+5?%G=?R_2N M!.JK#?;64FBE^H2MP'^UHY+2[W`+JAZE]8"W#'BGVA$Z[K"'F`RTAL.I`-WD MI[L5\.S&8>4.P*NQ#W.9CHW,PP6PZB@Q/DV2TM>UK\S]7JA?]>3:^LC^@HILZ$3](;_GA!* M/.O`6*EQKSB*;-5&A[$;5"E_M4#W0-0[YD^3RVZ_(M`WB_ MR*]9YMBRA>4P5\06XT%H>@0^-2-:&>L/$SYQJ$4/C?RIW(;^,2'EPK)YS3U?B"CT[9"'.-I:8R5< MRGN\2XEK'ABI0824$-/S0\%\/V9$^!YGHAULS%D0])>/$=,A&740*664 M$D9A?=THH"RB=N0(/;Z`-\58363PF?3QMBV\DGQL"O%_DU[`MJ%HS--TP)(21`/P'P%]; MT8A$O9GPSLY\NQ'JI_FHN$T_%M7R9?S7"DQ,2D.!*I8RVW.]F`FB?5EF\["_ MC!9W>_[`[/U;@6:M`\V+?O[!"??Z[MU&H(FZ+K/+J2QB_E*<%3F"6A83K)\ZE7,IJWIK;N0>-:,X M!OH*"#]"&OJ!W7`C#7C@].S>B@7?!,#!\5O#TL3S7!K9L6N+R/%#+@AS-4LS M,Q*+^+TTW%:QGN.9)(P!+8@A(6**.2"I/3;*">M[;#US\,P(KI$MUP*&A`@1 MI#VR`PB?P/AIR\[ATR*"=L\C&PZ_^R2;J-\&Q>UMD5_4Q>C;33$9IV7E)U4V MVIHU&>#YI*]M3<];@=]:``?&;HUB<:W`(584>8[C M14P(CUEZ=X/Z$/?US9SKK%#9SX'>RGC!BBS`S00K#D&\"ZZGJ=5^[!*WCYZT MX2\'O36J)8`((8S].`9S%M@V#5RGW9NB'NNY6Y9I#KIX#V(T*J;HB%V#RY;C M.`QU,D3D8YQ=>)U6IWGWGBP?97>3M/H"6/H3>/K3*,]\RMB-!0>S9]MVQ`4C MD7"TZ0X]QSKZQT*>I;M!_'H&AG\&S^WLBP%![/G7LR^G9[\:OWX]#<59$`V2 M7W(&/L%ZFAMQ>EE.D_*QDTZ*Q85O9%4U3ROB'WJAY",EE`<#+8OX&L[*+V559W!I)!Z]"XC6:PRN3 M>&%&"Z\7.;SQ?7?JQW$'C*S2L(T52#))?6RDF7QP.UIDU`X5:9XN\\XRUU&T MM4%Y46,7L"J[S@'<40+_'`(+/1^BN8(B863P\H;HXZ(]\B!)?CW-QG)2Q3@; M(TC&37*/1Y^`PBD.S,%Q[*"#-&ZSW#L.H<&#F!*D*[7%B]5>&M,A*\,'%EMQ M5V:33IGGG,Q>?)7_.3'=XQ5GU(<1SD^*@=H9(W%+QHN6C,9/7XH[L(S4M-_) MU-RG9L+],6:ED?OP8J3[R.G;F6.^^V#,I#_,JI':,$#Y[N2XX"Z]*KX&HU4UV5:L7-&+2E=[TZBI5DE+,TWDHA/O$DK7B6"*M21K-7@6)0V*!NP648MSPA2==H MIY%&LD="M0B@M$J9.L<9]GD^A5<"-%D!9O`2")KGTB[EJ!23*TP1ARFX3Y=I M.>,,8JN";$G(#..?[+9]2/-HM<[S+WAO1$D)/)#NH;=\; M_TG5XT?X8G5N3<&+"EJI9KGF@+5B-<2C&>.%E4RMD"#G-#.(M``E,[]#YO&[ M=3R]8KCT>X9(C:=8N2Y)W9;P[ME4-,*P.KW_C&8"9W0\;23.BDZQC+(8WOXM MQF`2**X$P0BF50TFOVQ-AF,Z[P91U,?MQ"^I?*IYSPR\E0*T MX/_2CB>&3%,VL,(MZN=9C5HK18#A&J@_^0PL^-#,J88:HBMUA0[?;89Z^[I` M68<[JK2\ST;R-*8QTLC.E)94JB"E6*MEW!95/2O6TJ`TH$JV;MD9).CK^XOW MQJ]"?`)(01HS%'ETGSIJL#E6J8H(I2_?UY+=>C)XPS^3'*.#CC*3NHP_H9M0 MI%K]I%[7ODI=5[7R4U6@VCB=>*5,Z[*H[AI(4$$K9Q&_-5:I4[=SFX*V:UZ@ MH454FNECC1+1OT-%.'.*/$5E*?D(=;V!(RB5F#XLTK%6\Q#<)(H"C^"[5ND$ MWCT[W-N%&VXJY[I5T#9Y%?%_+(?$E9W$V-"$9CRMV0>YQYED>IWG]V+>(& M7=#E2X_^X76@7@_.//SG\SCNEI^T(VH+V_("VW=#$KN^Z;>E5,3KR2!A"[1> M`L0.4*Z1.Y]ZP@*E8,:QYX>CZP)^^'^#RMU5EH.*6Y*1W):;L M0E1]!G/32.!9NGW"T3,YI9;C10XQ8V:!"H[:K`ZU68^LCLN=Y?`N`^>'(%]G M+V+?]2AGIATS#Y-NO@BU=%'>+[*UW(5D\%XA7YFM79,:CDV/?U M1G[$HUXE+;"(YQX(]'5U9\2WJ>D*RW,C#]P*%CAMBC-VW5Y^FGCF0@WP-J"C M9ROD@%M,@$[+$B/8=59COA+;CBPG]#S!B0OJ-S0=*EI[YUH]<00+O>!5+`5B M)SC9OZRGJV[-,+0#XA-0Q$QX(77"MBP#+%Y/"3-F>>9.<,YMY\]T#!#__.I+ M\GUK,62@ZQAS@!<<)P8WTQ6<:[-,R1*/@ME]N-<`-00::_0@C6R/^K;GN<`A MU,1*T;!-D(:\E[LGU'D6--:H%ML$)\X5`;="+V`A*'-7*T4:>Z0GGW31^AQN M-597,0L!B,0BB,*(,-OA1!?WAG'@^;W5,)<([6!HS/)D*DH7X_].51.4N"QN MQ7EP>IZ':9G=RU![=U&R:,1"TR3^&X0N#WR3MY7/H-Y[^H8L5-;],8BT1@W$$/:'PC.CR(W1KX-X M22ME*HCHU>K0+;39ZR'26E<]0AV#I2(04(#0A?"3QC=P:-QS(-FBY_M<1/J: M8TNF['_I^-/++CL`_`7?5U77, M%#R3GK11V]J(1KNC<'@2K=':C@L>KL=9[,6F90G7<73M$02F5MPK:R3F$L?M ME9-HC:1%C`8VN+0!NN,09-)(=$BTI!R:;Z:S7Q.)UL6$U/8#<-`X\8,`PH"8 MQVUALV.9O0``0O;#DZ@S/278)1J+7<^C-"0V"`GAX.PP%NDR/8\[O>IMQZ1+ MU$D?BAU!7160^828/G4\WX&@S(D<+N+9V8*0]?;N;$*66(=M0=TU?/3!:_3" M_V?OVIH35Y+T^T;L?U!XIS=Z(VB?NNKBGIX(7<]VS.EV;]L[&_MT0@;9U@X& MCP3MT_/KMTH@&1`&)$H@0;XX`".1E?KR6EF9S-(M*JL\+8/A/"Q'4L1*.H@3 MO)FS&V/('2G>!`4A_X1@[+LR`>;X(MPU:)YWE<7P"@?9%X31FTG^%OX,]OT"L;)MV34]/$&ZB(J=*L-`@&PY%5"1-\;JVX,FP38>)^,4U&74]0ZA^[A6Y5[^\1Z,WI:F9A\ZW5[4*@XM5M/WPL(G0'!5@W3-]P;4*<^>I\AY;3=:K7 M=7WOQ;(,=C1(%RK4JV=S=4^H`1\+0RP,!W,X=XKL*&*HY-V+A[KV&:TG9S_2 MMSP!YL@#P!Y'IF-X%N;(,\RC?(!RY6C?WN2OOR0[-%@]D$TZD?UUN.Y MS/$0%\ZQ8;K4]KCI!D4"V"^G-0A?+RX5:&Q@D5OP1FQ*+>X(<^2;KNF9NO!9 MBMT#A$JG4`A!32VRZ$;ACM-)=9/D. MW[]%25UZMQZ0\6P1P5LV\PWB"T>1DH)>S[#*^S;F6YS?C=R,]Y_G98[U6&R9 M'O$\GYN$NMS%(MZAKQ$1]AZ\[B.F'W(WE84(EQNX81[C)@!([KO(K\@ MFXBXMD0V>TN0=R7[=FSWLX(\9RIBN2A-H_379'7O>L9P\B7\B7^?W^#W_/O9 MY;/J*ON/./T]_-$/?[^9-6'Z.JL3=;,RT2]956YQ?5&=_FLT?DC"YTILI@2>2H7MNW`O^<(6>>(!*;M,ELXA*CPI#P1DN_@$"I8 M47XF)#L1(FSAZW&0RI;:1`YR?5?GID5$>&(;%LX?%#=9*>0J-3#8G39U:]K6 M\,DW=4RM(+!]ZHO`2^=YZP-3-I%84YJ#+,5K^A*/QDD\^7GS&";1_$!IY6AM?['NOIV8_V;>TG,,:R+9Y'=6R1+/3- M0WE*++>\L?N&F[L3Z4NNX;'M"ZP:Z M0YA@JQ]0PRB8;YO>2DHE_Q$A\)=X<1D[D:9F.1N+*I'M>S86B_$Q)CYBGA$4 M3=!DD>*&Y:A<3?:%U)Y.'L4S_>>J_MWZ4&QF^+HC]Q8X"GPD7-K"5<3"\UW< M@DFS7Q*AQR;!Z#]\^PX2S6> M^]3SN.=RP>O`$O;<;(O9Y.LC,(V6FK2C033NS`M0)==VS/LX/`=0LC;%I+NF9'FA=H MV9/PS=CP.:)Z'`,4LQ<$7B9&/> M>49?>"\+%82U=O>PXP2V,"'$98&++)U@5'#2]DF)DX12:U6/;:-(P1(V@<'C M%O8LYNF&M/!F0(E9%#,ZPL:4R^=6PY/J2WC-W,M)0NDDGK4M?HT"*CN(R$94 M=RVB<\NG-!#>H5U$UWI@EZ-KG9^^&S_(0YDW4GR:S+<<:Q=\!=:@78,<7 M"'-TL2AQ19Z)\RU2BD(XVO1P*M':V)*W!9.$V8'T";AOHIKO(3U.,NX\GM0Z/Z91S/:`VH98?&)1Y2"\" M389P*556:F[Y^MN[T[2EU,UV`HXY98%MB%>682":.Z1NL*8%W`=FZ%P%41O% MR,&!P:GG8U]V%]1UG,/!"(1_4;)V'PS3PGL3M:UM,<>!/+A!N>ZZIN%PP\R? MGFL0MW2<0+@1=%>:UJ>W18"4>SNVC4NG&?[]HZEA4PMF[KON^PH(C[N.Q+N-JB?:4OZ%H2:E&Y M"<0ZLZAO6UP$=ZXI=#-Q"RS(GMSESL%XI2!I)S*?B]W;;$)TDR!=@]O/)E-;I'K(.&$VJY814`P84)Z<>&0&F8I MOEFBO/S[=2C<=D8!46;I\F0_)Z;.N2M>%L2@;[P+!969,TP\C-HX&H806(N[9+.#?L@)I<4LB8>*V7_;HZ MC)R$LI6-'R:RDU>ZT)#3B^[C?EQ1[_F!B"1$]"W<3M,T7!UYG!32)71AN?,O M6S$FVRG:?P4;3PUX;A8'81P0UQ)T!UX>)_LZQ:4]PP^L>]18N\OZ.LL64(,9Z[+NI-&-I*NZ5R@F?_>@Y:Y@UN^*J=ANYUQ59 M]1AAE1M:UB9F80+FK$/?+@\[?[9R9N85RN=HQJ.!N$/V?O%G1O)1#9?P@.5W MBAMGK>>U?C0 M3![%MP4C[L;)($H^],?#8?B<1E?YB]*,T%>ZD^*5W"24U(X^76#AX"7CE_F; MXLN_3`:O+Y.UM\B(^73!K'=+=UBX];J[O5Z(ZUZ'#OV#L$!88!L7^)9DSG7/ MCRB9R'+*N3:X&T\FXZ>/2\J0",6VJ.D6W\^^O_313!7)3[:2N:!^WYY:;-8S M*&9%@[+,ZH)8XV(SI^8J=LX'_/R'EC5RU/+YM'4XN5;9KN?5%OM6IV'JR\S$ MW8V'@]F-;N7`>^V+^-]CJOFR7[*\]9UL82QA6XW3(LC@4A]\);NGJ,!\+\*W7S`(U[HO&K;,:_"$9-*1H[HBY7(9J[OX;B MJ.3TX-IJS@'*:J",'@%E9;[.?R4+!4L_`:`$4`(HE3&Z(T:ZK3%-.["YCU^Y M;Y)19I=/1P."UFL5LB@@ZU21M9<]!84&L#L]V.VL[:HY;6*M'^_"_M\?DO%T M-)!;6./DZM_Z_2BZOV^5*[<_0K].GV17=[&^^8#0?$,W'V49+HRSEMO!\E!& MD@IF)9'VGU$XG#QF+V_FHYUZ\C:72UO!\R.^F_=WZXK``9]2%W1':YAUNDH7 M$`>(`\0!X@!QYX&XZJ[C,I?0(;"VH=>O[E*=Z@)$!)@)*8?#0X.`J@`T`'G+,.>*_W$-;!4:CB*#2VH760 M=$63+/PM2M,K+5[>S%K9Q!)*6>8KDO%P*!,6L=R9C-))E7Q%L4"RYRZMTF1; MA?U8]7(\4^4FP41=.K!!L$%P5694.=' ME]NVB""85)#,%DGF>ZXLQPTF57',>V*A[:[;[O6*-IM0`YV39MBXAGQT@V:Q M<_(@-W&I";E9E:$?"$RS`J/JQ$H#NYVFLH-2NR\23`](TLE)DMPSU)7E,FO9 MI4Y((&PH[LW"8AZ7N%#VBAWD$\PA;[*7!#-E;B7D32#A>6SS>D:":RJKU0'! M!<$%P3U<+H<@D%R07)#<[DDN!V>YK7'PB86[S6XRKNL,TY9LUU%%'!O*R@C: M@B3(_K;'5G9.'MZ3'B/*V\J=MNT"@3FNP+1WNX3KL/$(I@W(OYM&>1X^=Z9QO&/&I^'83W[ MK<:O(FC=W*CG$'N*%2!,!80'XZDD3MF8T%/H-K8SE[K0CHSUD*7L$.A6SK0% M"Y`Q;]S?`$4#BF;Y!$3/U!O*,6Y@S6D[5:"'6JB'.K%CU2HEU03'&G&5T.$4 M6"=0!'X4Z"_07QW17^_-'D$-G8E1Y8%U`GMUM=]?>+VP@&$\BCX\ M1AGS,$'O%BC9=Y;LCGIH$S&;1MTN,WCA+DO*2.;SLKO$(Z%G9^\7?V8T3I[" MX1)FL/Q.<>-9VJP?#8?S[WRZ0!?9>P&+?OY^#6=NXZ[%[.1$]W4:)1U(,P2_WV.*#QXU?AABV!45.*1E"7S=]5 M(]`]('>[(/.M8=;I*DM`'"`.$`>(`\2=!^+V/>MA=MVU^[;BR&G_GD\+QA^U MNS"-^TU@\!RA!D$MX`?P`_@!_+26/X"?(V3'3-9U'VK7UKS'E-36=UQ05R:] M#75=.(.&+I&R3;K6/WIY'33;.!&7H/5H`T6S=-0"73)U@]+/NW$(Z"'00Z"' M:CL\ZII[M/W1@\,#B@84S9$<'GR)E`TH/G.'9\_=L\-D?E9N*'^S'=W!(3'9 M7J5^8D8/\`/X`?P`?@`_+>1/4QMK&'6^.NEZYBR-'I;+SXNY*LT-5#F=UM'H M$JMKI7/>\0[D7128@+,2/49`]$#T0/2.8?74=<`$T0/1`]';7?0H6+U6)-A/ M(`+\-8Q'VG@D<^C/XS0<'B#T.V[;I":VU@\W.J@ML)'70;OGEIBV4Q.HXH@< M488GD"N0J[.7*S!4(%`@4&"HVB!7<-KM+X4$'/'="%\!N!PA]ZX0>77)U1Q'`E(-4@U2W0*K5 M;H""*3_MXTG'[=N\5[N_"L"%@9]-LK#S`S_1Y0$'KG<"1+`OT+A?`^H+U)&/4 M.G^88>.PC4$\G$YFX[1AY`L,&6HEXP!Q@#A`7"<8UQIF`>+.`7%GO]?:A2$@ M;>&5LBBVN36W>Z1'6QXD),*.:\=!"71,"2@=MU$KU]26QP][?:`C0$>\X2@H MRU>WY4&"HP!*`)1`M5TK=6,JSL-1Z/:1[94;GO:8"DB=0;(6DK6`.$`<(`X0 M!XAKWX;4";1./=KPC+V#S2-D9=7-R#B/8`L2,N\P!#!#HV0.)UA+^C2:.C@>P6NM05H\CIH4M9R8W@^LGF$ M[M\@HB"B(*)@/D$V03:[+IM@/M6+Z-F?$FOM\(PZXMG>%KSH4C^<7>U"\XZF M;2N8T#,>,W70V17GD0-YVS0VHJ&&?&#`0*#.4*`..K'A/`Q8MP_C''DH MPX<:S>`J8%)5P\Q.3Q0Z7"?-K<#N?(O-PW8([C3L(,G=UA,HH")!19[*B`B8 M"@8:%#3H\4$)&E2ID]G0W'-P,D%%@HH$%=EY%7G841?@9*I*?SX)W36,CJ`] M&RUUB4;CIW@43@0RM/^))'W10+/%TL.'2'-G^],M>OI))V$([F2JSH[ M%MLZ(S3`V<[;(K#5@!_`#^`'\`/X:2-_FMI!YIWWK)PPC?MU8%:ML*..R]^9 MD@^]AXBREC_U^=862$'&J`56`,2SN([W3*NABBP03Q!/$,^]K2=B()X@GB"> M;11/83T-$\2S):=6NQ]P>O5'4^\ME9T3/KU'V.&$KRT0:=H$@J4[9YDZ;#@( M,@4R=?HRI?>PH6P4)<@4R!3(U($#KU.1J87XZI=)*%:X]OMK7O_YEVGZX2$, MGZ]N^H_18#J,KN_],!D)2*3?HB0K+LHVR^S18![#W,K[WPIF.,-Q_^]_^==_ MT;0_EV_R/>J/'T9BE8//0J0F\7T<#>PTC2:IW?_'-$[$N]'@MSB\BX?Q)(Y2 M\;_IT^K-L_GOXLWWZ/[31>`1A-E_T?^]]2ZT>"`^"/N3#]36&;I^(;X]DNZN>+K M4-37`O$FXA8DKB\P%"6[/*`EC8>>YS,`XY%$8?9^\6=&X^0I'"XI12R_4]PX M$R:M'PV'\^]\ND`7V7NA*?KY^^K0>@J3AW@T(S*<3L;Y!S,#EGWR$@\FCU>< M7%)&#?XN5V9"20W#YS2ZRE^4AAR^$I^LLRELK7[?(5F3$?3I0J?OMJK-91T] MOQ#7O([R@_Q@M1P5."LE8&T=KM5`TXOJ)3J[*Y6*',S>OLSTRMUX.)C=R$YE M4[HOX4\-]S1AP'8^P5@+CBW:YFC27?HV3?J/81IIWY*X'QTS\&A]YE[=X9`] MSGZTYG@'YCV.4$]HF\;9TA8`*`PMNF06G/=,9''J5)M#Z^:-'JHZU;O MMW"DK)T1V+J3MW6DARF8N@.;NLXK&6<:#R5I,-8V\Q>%$!%#I1"UY3D?15;. MQ5('TV043Z9)U-/NXS_DB[2G">NM1?^8QL]/D>!N`])U.M5WN$<@2@/359&' MGT<_A&2-DY^-"->I=>QE5*F`G4D3[*YG9=L;^E?:23@@0SO%Q(XDZQK-DD1I M>J4M5!;(K7-96G#,U$E;F*,L0]*E1(C!38C@P)2!*>L4$\&4?;P=3\*AU@_3 M1^TYC%L^RJ`+S><.URGQ2!QK(!7#>@8CS86*ZTY#=@%*"JWO_A6[2HIMWZKD MS6N`H\&W\*?,7=HO83*XF8A+KI^SV9M_"X?3K&(UN^_LL\J%O+Z.'.Q;EJ7; MG%D$49]XLT)>PW=,/6B\D'ILCZG#AZ&$([$B>UKFP=^+-C!J.)HH[6E^WGW;8!4*<* MJ-;Q!_`#^`'\`'X`/^WD#^!GMW0F1"$@=*?`^NCS:)+$HVJC,P!1G4)4Z_@#^.D4?MJND3H2J!R8C=_#T4.DC>]!+D$N ME0#*_R-*^G$*H0L`2@V@?LTJG@!.`"EP$,`>8`\P!YDX2(?:T3\,,QKCW=#?`E M5C?![]2;3()P@7!5X!-7VC@9I`NDJP6,:XUT81`N$"X0+C!=(%T@7=V2+C!= M582K>Q7+ZK-!Y)(:63)(OR3*XG50/NKYTQH=PR__G[TG;6[;R/+[5NU_0*DR MM4E5K.W[R,ZXJL^,=VW+L979FD\I6((L;BA2`Y"R]>^W&R0H'A`O030DX4MB M\0#???5[KTEC1<.VJ,%CN^E.(9ZQ0B#8;4'O=*+3B<5`%!+::46G%9U6S&N% MZ&X\['2BTXGY[TE).IUHJ#;150/;4`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`;/DK.L[/>5=HO_G;T*OS5.P_OI6>C M5Y(Y8ZUS@$*#$/$00T0H1!9SSS751\DXP%0^:UR<'[V&"%(9V#Z']/V@/`!F M_!NY%V:'O`E`".`"R$90"KF=PNP\MG`%9L@A;`[F]\/!V3ZDYAY[`0GS&F%! MO$7`Z@IL:8U9`9MB+C:"?0?-PR!?1W!%M*>,&F6@--@)9T1%<(^5IRN0,\SI M_I!'W='+NK,(L2TAQO\\M?<"C:$"U@4:>F"PAI8ARB9`"R08$ MQI?4US0_C_T.H]O`O%$^CB\6)Z-@A$\OT\')=7Q$X8?Y1=8+)NS-X$.PSL/S M^_#_8PK+'^5S3V^O,_6M5\Q>K;.%'S_]_JY,?NZ73>\0`9P19"UWF!ECR91V MT#$HYVA7E'?('KU&6Q#O40CSU#CBKJ[[P]LL*_FQ@0^"<^:0DQA;2;S3@&$U MY0.!Q-D:/KP()HP#JM4FB.FL==F9&B<7XQQ/.<;SV!J#YKVG5IQ18C@36`E) M)<6X4AAM!5DT-H%F)?Y'K^,ZU@,R;"NZ/2->;M"U!0X:;YB0P;UQY;6#*NC= MU!T;326[CX/@^*!VKU4<+'^Y^"X>"FIC*5(A!N$N1%$,6C!3.*6QK[&,3!S( M12V2Y4DQ8Q?G!`46'EIMJ,9*:JXL,5.-T9HC51LKC-<`,K MC(TI$$$4$X<`XL9*7F5!VFI0PPK:L6)7T[0I6$.$2:E#0F="-JIS84*KHF9LA)-"$DL5 MY<099[VMJ@E$(WM_U$SAX1G6TK"K!;&SQ8PQS[W"S'`E08P'JC25<-_QL1ZL M]\/!3=E!_'Y<'D77E0\?)7C&!`,@/2..>21ER%"5FI5W<*V1A/!0KFJ)*JUA M1E":1V&&0\@J09U2$#%@$0SA<\6,\!:M8P8&'3,:S&20T@J[6"W&(?T/N>1= M^&R@Y*Z&!82]<`YLMDV[<(!#`*40TF*%`9("$U957S0,WJ2.`]N4ZY\P!R;. MZLW@+,_"=VTV^?]!BRP$60>AUA0I"ZRPD!HVJVH"3&JX@@_$E'KJ/$G>[*(G M,:XBBCC/K1#!.4AA*XX0"12L56G!$ZAPX.I1>M($%K+["#9XHZD>UX(?BXR1(G#:K%6H\NAQ.KC1:F\/$&O_[]&K"B_3F+/WC M].OP]'(X+M+!N1J'[TKF-2?U,=/$PIOS:;3;/!V./ARFN57 M(1`*L/9NMF*4(LA+Y:1&(8HP5'!AJX9!:P&L.[_!XCDS:A.A?2#L7I36&"C! M)7%`$:8YD<'_5*D^X9+74)J#%E!Z^3N_#\Z#08V".[%V$??"?56^THU,H"3_W(T6@_'W*DN;%DK(\`!%]NXI*/42KGPN" MLE'=,(C]HH823H0"REHX*[D9>_^Y`SK&&[MUFF%4)Q)-BL3)(-LD$I9``H'% M'D&H,7;!'E>'MR:\)^X3"0B.R9,7B=^OKSN16!$)@0$5(9G'&`O'H1:*FNIT MTB"%[A4)>$SE(\G$$JNC MB$3\^N6P'YY43!*FW884C`4"!)-(`0,:*$X41W?M%&ZEB5Y`M-1-L0+`[@"N MF__0ED%%D952&L&-TP3/DM``(%J9HH@#(`^$,`2<_7&<Y_' MY7S3Z3!.8`0,\F&_'S[R)EY<$!+1W;!"1E$'!'70&245LDA44RW>,LWVP6H? MJ`]#B74"B`73DD&KE97!&&/*:26`C@*[,B4C*6./3XCQYR+[USC$]>XF5AYF M\V3W#ZGDU&`Y=1B8 M-LQ+X_7+.%JK^&/3&UQ^UY_<;[^[]Z>)^T?X[Z>U$X/KX)V?+A77WU;N&6YR MW-%=7&1Q4#!+3LY&PWCN.;FP@OQ<7C,=K74ZB!;JZKJ?Q(-UFFR@OU>ZPE1(X]Y]3D`7OS9B[N$DL$X+^)" MA(OTK->/UKQ%@W;:79U'10Z MOYU82I/F^6V0#G4U'`]&BW;R0[K[L*8AQC`0S+E0@AK`B%.SN5AOJ5LVYG-F M?&?(&D=LG9>RTAA-B"762F*$88+ARDLY`>TR8D0NM5,UB]Y6M;;[@]P`.1<` M2P@-@,`I(*2OL&$.U4V=T778K*]W[0S[$B,689>$>QJ2,PB4DIP@0&9#"8Y( M5'L8VS#L;X(+V!ENY[@VTE++A3)(&"CLK&_9>U/7:K$%W!-0'@#S6CG!BE.O MD<*(>Z(%HDI4H0PD$MO4$V@`:DE!%M9+">B#F1I],G8CO#WILXACGMV44/?GLCM`RPJ5` ML;,1:R)6Z MWN0]#,J:,]I-3D8:)&D03PI"7$Q0L!5"5";">+3B/Z= M:<*U<)J*X.2#1FF!*R("8M%*UKHS@$MGN-5YBNWUQ[$%8;U>3;.QW]:L#/!4 M>P2"8"+F,2(A]1159T(L:]1)`0L?6\!A1Q@;1A"O1Q#X@`Q0&@*NI&'04`AF M0Z[(U;6/42%1NQ!^I=.B=[:S@'+J@-=&0VR991!1-`O?C'`> M/T!`ZR%L%+D-Y@5Y[DU@GG#`!DMC@@:JV=DS8[6S:0"!]B"W3C!#)@>`MEQ9 MP;SFT"!-*N\DO*E'#I"6(+?!K$@LF"0*4QV,9S";!OE9&5RA^OG:+4D-#[D(YPY)6S MT-+9F8"S;GD9Q]%KO*QC&T%Z.`H;M`D&NPXF$6FPAD[1P*/*5`1-6]D@M@?T M\4#L%W46LH#PD;>QX!6KY%7!^WTVVE>>?-02QX()M\PXK:"&M`H#'78K)7LN MR83^.T#4``IK=W-)1#F43&(;X]F0J521+#=&X!4)"@F.>``*)8-FC8QFV.^G MX0MIO[(1)U\'J!3S.C[Y@3AD M-D5G#^CNQ2WV:PTOXFOJ2YZ5W5(;3Y87GW!WF&L"B7MWSZF.;N>FNDB(_ZRV MP:8I@VE0HEE+!PYO'+W^0/]9BV,-E',852VR?\_2_NARMH#M7?JM=S6^^I#> MQCK=ARQ_$\SY3>]\G/9566ON;S[:7&*:L\1*B[$,%@UK$`*BF1%P8KD!(7!L MNA_N@5#.H?IF<#:\RMX.B\+GPRL3H.\-QH'-)[/CC;K:9.G2ID=NNP>XC#&D MN'=`A?@6`0JJ+%=@[_"*-Z*,W"']<'@?&?D-X:_V-.2=G@`M0GH//9?"S1)0 MB_PR\J\004\)_0T!,F6*AX!*Q(8\KST+$E_-D0/*:(W`PR>$_*;5BH`X;(&$ M<0UG($#P0;,*,'5H9;7B*X81/0CZME><39Z7G=\];OJO>$9>?3CXMY.+T_1; M5FR=_,Q@&Y3BKJ[40;2#&M.^VJ M(L`**"31Q+.XGX\I@ZJ0UAO`UZH(;XH84]@/18XUL@&8-HII+2%&2`7!\+PZ M9_':D77&LSG9."0YUOL2B*GC@!`/C19>,NQ`U:@9`DK.#^)+#DR.-,PA MC"$A(X<:$$E0U2X"(^36=*L[+/7NK+W.T2ATVG& MC46`NT;NZI5I)KNI8QL(Z+Q6Q&".XZ$0(%58+8A`=)[M@[*@$=**8U118A<< M#HAZ;[`5ZG'-$\',PK@&G7),;!4Y$:,6!JWO4(=-H!X+*+W!9"ZNK"I4ZR!Z M@X_Q89/JPZ2[:0'_26$._G,LV*N) M=`[S(@CP\::-,T([B51+ M);2RGW;AHTM6?T(J_"F[AHU0:FX<-OQ6Y/FOV?!+GEY?QLM-RB<5H^O\#_5Q MS72E!181J+U5WANA)9+5&A^G!)T_0/?33M+8O'X/4;P.0\IIA#3WU0&B(X:Y@Y!W%#]U9B"<\X8GD(Q"7!U?%'<,9>/9,&_[H^ODNLTZ>)>F^3-^_# MW^[3:?)1G;KDT_^J#XTT_;/K;XTV^9_.=?('YY6DE8^;-H&G27$;A.0L2'YL M_OZ<#OXLDHMA'MZX&N:C+^F726MXTA^F@^3'HY.\]R7H23]Y5[W[-KQQ]%,2 M1&U^;&!VK27_KR+VG0>9+'6D%-<[*.:?6$GNT4_'27(R2-ZEM].)!+PXD9!] MR\[*O"!`I,)3SLM_GB=Q04MIVR9*D=R=NOP8OWZT_'*`^FLP2)12^; M(#!KA(]_U*,[0W8%]KN'%\EY"8O//N?C-+]-D"AQ@0&YDBG+,/:FRZ2*>5S_ MHT@^#_-\^+4D7GH=#-WH-LX@-#-KP&B\Q+#V(L.]VO73?K`;)=J?L]'7+!LT M-0WR`VD8TD5^_GA4R5&=6#>%`P+-XC`3NCOP%W1H(JKQ?+;X?_:N=;=M)%F_ MBK#``78!3]!--MG-L\`"?2%GLB<99^/L#/;7@);HF#NRJ"6E9/SVIZJ;-TG4 MQ3'EV-E@@&`D2V)W7;^JKJ[*[96=:5&!7*955>"E5/BX-0$H;H/;;\5\^]["T`N?T1'%$YD)*[_.4)U2-'!V]3CET:[_ ML8^IQ^G6<^VVG0I.E',KN0&/.\[U)KP@XPQT;;$Z`W_XVLS73VLE#,?3POU.`Q2O@G"XQ)CK_LG8M[K-RQ7$=^-H7(%%E>WM_*G+S5VT M_,H@@EG:&-EAA'D.@6511QS3*>H>YABF6?[).A=GJ/"PP?W2(9^[-\3!.&%: M%E7UP[0M`L5@P?W84)9CYR>L/]\V(+"XE^P1G#O?D+DA%C2?6E__&WP":MP< M^_54#=ONW'E6SW)B?@E3'^`SID"T:Z!4+[>Z;J.&LJ%NZV"[!`F^-2GK-KUX M2/=JE\#/(0;J.F^\37_E[G8I=@<_)B7<'*&@7IU&/[L=\5Y&4I"&C!9`DA=[JP MUS.9:.[5N,(;K3L]E8IR[C:F>RH#:KHE./5)XT@!&SJ4_MK[/%ILXMAEF=\YQ%5F-W.+ MEC?._](E*'T**!'3$=/I^F[MS,K;#!/CN7-T[D69;1@@,#+X:203 M`H2-<.NI[(;_BI"1HJ'V],*%,1W'-\)$&PF.\L#56"'W+G/JI-:J6`$3/]F& M**.=X_&+*!KQ'&]\J_!<7,XK$)E%E8-^X-XL!NE.KK(YX"\;7>]&W,Y7.:YV M3+WH2>?#O4.3&VF"=5L"\C5RG6,COCY=TT]I/K([0""75L+\QDBG MW-X%]\2(Q]Q/EW8_NSX\2YB[G;\!`1T*6)LR)O-%US1/FN:>UK;&]73\!"+%ZT.8K<=`(F($__^F7U_&?_H*I MOO[VT#K@#Q3SW%4Z`9`IRB9TFM6Y3NOE>VUC`2=<9=GDYP+^+*S*W:Q+G&4$ MCX57=ZD[:G(8"9[;KC&M$WJ3UUC'LOCW>N':T+9TZBA<^V1+T@,YA%YJ]H=B M,7]\\MQILQ@7`?>+[S9$`4F(%6S.;;?'ZPWA-R0SJ',<6.,YA0^V1-KYQ0:$ M9K,M&(JDM%&PIAB^<%6%-!X7/"OOVYVR[PN\/:EB;JC2=.[B5^_']MN=[4_5); MJ_`>F7^%Q]H?.A5[ECHA47/+-N^VK0H;QCU?-!:04'J:$^@=\'?UR8UY=:GS M^LE8A]:K3'-Q]&3:NS"QJ0BSK,H_NFL7B`6&'HAIQ4[/;K/9QZS%WUE:+FSJ M`%6IL'G*>B'V31>;>P7N'%ZAVG1%W/]S_7F%-+;Y59K<9.-=/-H59@,7\ M,]C5ZB\'?&RZG6S?"ADV"5UF:)IJ3])+HEOJSB9K6-,0+6Q=H*L'@U_O2+=[ MH+^7=([\!QE;9A9];51;6QN8_I[5Y2OV:TLWTZQJ<\+(^VDZG]9IF.8<>@E& M;FKQTS=4%H*6.6W;Q_>H\H1[&K&R!_S=/.NX"(I27$-,W63I+>NW^=V(QE8] M5\WV"C1BF^%CG3J/Z01V[H(@.JZ:RP9MY=:BGF2PQTK9.KW_K,'`9:4KWLMK M1?V&//BF#9ME*WLSS-J?=+7/""&J;*FXU_I@5LT%.'<0LLWA(\Z#8/B%-GS> M=!)\4IO!@^![[F$P%X=LO$GSLDN'[F&_1;HX:,>%+@UB]\A?G;===*WY&A[G M6=5^C/ZUL2=#D-\^+[_;#+:;]%5UFV4KM])>IK!_3C#D[]'/?TNL&B\7Q\(Q M$W$6PE@HY@QMI^!;M8B[,M6ANML6GP'`FUR#D;[)1[QCXXDQRTAE=5B.=_0& MG"?&]K.F#/PN+7^'C6=_N%,G9XU[2IA7?9N\MMFPM&=9>Q7EF$ZPF'RV$<*F M\WOP6_6,G^;E)I_LA!^(A!#U;%Q3.0@ID=UK]*G%-<;'KM#=;N<'MZI\L5QC M0)TW0[DF\%/YG16$F[7-RSATL?&8Z@1_`AN8SL&GNVN,8(+>9)_`P7C-NGL$ MO,TA8H?(Z/["3@::@KK.NN@^]4XMOE?$+N];5)SQZ]3AU&L M@U@&6@721$Q27S73+CP6)*S?Q?/0H_:MJ"BOFJCU\D;A;:JF&A;_O+%`UW7% M>YO>TP,3(HT((FH\8TP4IO.EVAN\FG6]BYUI^FZSJ_9:9?OLC+I M*C<.]U&YFD(@O)[#@X=^W(XN7EI[]!O(>3X20:7JVOY_7W M7-N'H\3;W_KBZB?]/J]^QY%50#'L>+'=\.(+Z=[.@B^+&PC";#S9^X6VQ_@Q M#FCI>9Z?&!F0R"A)9,0:^55Q$NWTTJ8GKE>U59=984@"_ MD!!3X)"=%,RG:.IQ?O#+N!C06'-W9LB:/O\$C#M(1K`,(A MX;[F@2>Y+TBK-R+9:.;C=A@R.N(.;8%%TV/<-J1Y#SC_7J=WJ7')%@%7A`'G@KA7\.$ MPK%R[6@H&?09[>8T_^EO7DN#8YOH[[AVA'@'YU?`G>^:ZZ*@H,W)1-U2ZFUA MKXK:"=(G0"@OYH$(A5(J2IC/`X[]:>I65SQ4'""4UV*H+UQ&;R,_9RO70.Y# M^H>J0[.A1D"]!N^[4!)=RH8A:IZ-9S-X-'.DO9>(`L;#4&@1Q4;KF.BVC3CQ MF-AI(_X#B'HGO`-;Z&^PX2?(]J)J>]^K;/;0MOS2Q#@0DP2:A3ARP(BV17U" M->NK&/PZ3IORHF:)^Q?Q!4NM!R*8;.J)(PK45%=@;4536K'E='ZIZR8:GC6^ M2=WK.B)S/WIYXQZSP>C!+]__7*S>V:K0>\>/:0[_>Q1[@:#[/&2)T$G(L)L^ M:0>!>&QC6KLE;T3.1MPS&2!R9D*M`Z())R9IN^53;Z-EEMTA]8,SRH\- MC6I4Z.8+UY]OP.DF?'F3EHMLUG5-VX\9?#[1]JM M_=_5@5FBU#<19:'/E.!&:M,.$P-/*(R_35QQ3O'QY?HC/8TJ\E.Q>#=/I]G# M2''YTX$ICCHAL8DBED0QX)PDI*8Q5+$()=V1L[:)[CGD;),6^[?EI*P`"EF= M:F99'U,JQB-/"L\/N9+8L@VG"#5667KL59H0JD4( MY/04C0&4"-KUB`QW3!9_3L2%4`S>_[&$X/OY4C@$Q!,P32#N#;74DM!`M=A' M1^0)[=:#*?Q3>N^4]?F2UQ=>(G@40>QGT"J*I,DG",9]MD->2L^'V<`O8+W? M*<;0[NOMY0$LX0=)K`&*$JIB%80L4DU#?6-$)+?WY?OGQ*(/E)NK;/;QW]>+[&07^G,^O2T`N3_( MBT9&Z<3X$G!WI""$CAAOQ@K&='.DLK/S_O-`3Y>+%1:.ZN+NKECLI-.^'$(I M)7E((Y%(%6L11US0QFR01`N]38_S(JAGU39::#`Y`@.U2,LP,,JT%I7$_@"Z MI(*>WZ0^.@QV*826+LH5(UQA>8)-JO-<2Q;H MED":,Y&,9+8WF)9TET\?ED\24O$DX:&,XB"$L(PQ'K:Y2K,QI[89\QAL:]*> ME7SAFNO$DF7L(YWP@<;AH:^E%U,F%#-AS*EF+>!-&&,#VV9GW_6VTWF$ZT@` M:DK)`R69`6R6Q#)HE51Y?C"POVTI/,?^SI+1"@TX1DHBGRHBO(#XG#=[39@* MAT1X.T`\AP0[.#H"#%0!)'/E^-XE'A&)(15^*AIY*G]<_'QAZ MJJ4,I`=P0`!PA.`U#)I1VSBU-1F@SXNQ8&/8`@E8"=RU3YC'9)CX012UF3@F MO2'Z;`/K<]@"3RX/V0*[K5]_>5'0B&@E0T_Z"6$1Y1X14=AX%1ISY7\EJWL, MG;Y$4D,XI!,513XSGN$T,J%H8L5$1[IO%+O!)L^!V';7)G6`-%W,7G^ZGZ7S M[(4'!5)J$T:1IEXH(H"\BH?M:$4IWD>'!O8Y"FP,V+F&P?C]*.*`; MQ847JF8N$`M4J(;6S[9%\Z$;V'<2_]"U\U"%1L*G2`A>T",D#MIC9HB#>VMW M9G(7E.U;R=Q/ M6I'FNY6)01CU9E(.+N#A"]PBYL8"&8/0T_<2)94OHB20BOFMS!*U4[T74D%. M7^#[;)9E=R@46%T+?BJ;7:V*Z>_OTO*RM!YR9NO>FW&D1XF[Y<4BQBF6:@F9 M1'X4D:`]QHTI3>3FXKN9I[V!N`]=X:B;.ZR1AC+.O)!R+@0QQA-A4WY(,=-^ M8'./WYM];5.'G]P M!_;=2JY7MT6)C:WM8);>,]X!5@,T5J\?Z)9/LVXZY\Z*=C]WN1APBRO?&?]XQG_X7!QAO!&4RP@<;>S%)B:Q M\+L)S;%2_C;CHXB]4-8[UWIVEN^E=,"(`I#-$\634,0>4TD+)",6]IU:9>4" M8AMV%F([2IR%R+_:&_393+I;(AL2^:2D[T\AEY[@D0YB0&&!TH8EFC<>607& MV^N1PU=M$=#34&ATEF00M!\NPW\2T5=AZ"542V(\GY$HC&/"6M0@-HQ,*_K> MV)+?T6(\,B=%>9/E>%T4"13_L!G[8E$`%+SDH!%34BB/:9_Z(TUZ^KL526E,\Y)2!'\.3`Z+;NRM@L_B`ZHRD-@.4 M&(_,O5'4_V5(^'@(Y`FM(@F.27"?^9$G2'??6)+DC"'07JY\9_Q3A$"$>#'G MA!@1*"H%]:/VO@6+0A+L,)ZRX(7R_FO'0(0:7R81"SCQO=`PKKC7F%4IJ1D" M@OPLQ!X[!CJ!R/X_V),0V6>>XI1J)K7G\5#K1$;M`7+$A]"V[_LOC,@/"S3/ M2/H^G.,)8Y*`)`-:49A+\UES7@$F1AP(-$,V.O&?!KA],4N>*/:/N%0L$K&B M+/&)CQ4^3?F[TD;[!U@2?&?)M^?Y^[)AC)&,>9[$A@J&<(^$;7PL8K-778-7 M+/HN&R]:-@;#@;YL:,,\RGPAN2*<>4DHHS8O'G&SUVY0^HK2%R<<\7_6^>J^ MUU'+GJ%^N$T7-07WK\7&JR9=9=@P;$](L=_]-N^^K]NAUX>!_P3:5N^O_GF8 M1X$B@""E%W(J`L(CS74#W*DG97A`?Q_-HE$I]@)8N%__'\7"Q".!Y@HB;5`Q MPB(6=9GA(-X^=]Q@H?^=A6.S,+Y;SHO[++,,/'*FHGT1:>UA:9[OJR!04=M@ M*92$[6><_^@XX[^-<(HQ!WU^PJZIMLX5C MDG`ZR<.2^GM\RQ'H%F/ORT0'3,8BH=17NKG*8PB+A\GH/]J=[.SU(02L'GB$ M^5P/M(2.N<2RS403P74$WJ`YT")AR,4^Z\)>!2=G0,:DU8@\VCRX>:X,XGX< M2R[C,"**`O+2OF[[@F*#O?T%?*?G!TWNA;^:Z:E1I/"0A).%8Q1X8E7I-F,`DV-/S;.TK^]6CB#N_S*`E/"K5W M`^BFOKI7V>*X^_4.%W@84>9%OB=5$((%`I_90E*BO2\LL!J;/M\>0YYE+F>S MGER$,J):<2IYS(T"]6N;8_M"J0')"/AWP7CI@G'\Z%?%(E1&FL3$*N%$`0(G M708XD`."0<4W)QF]J.MKV_!8,$^$1LJ$!IP2&9#F"J!@BI'DRPZ(QZ;/M\>0 MKZVJ)Y3G1,8D7"@128B&(P%1-&(@_%<0SR7K8WVA%,GK0ZI:54WRT&=" M-G05PD8+3>B_[W@W>Q".+%%417U!L!C/9QN/Q^/Q-T=,_.L_;9'7W6?KUGUF ML\?L)EV6!1^GBU#D1'?C6STR_;S]B12:Q1QVGAPC+CR\;;S]!`MQ.-Q5D.YH M?9C.^]]&]00_,IA!$@6KF@E!$2%6M8X$'Q\^/.=GDG_XL0S-?XL/L)X5[^=F M..Y);F>6T2)FE#/LD`H',*A)FN"HD#)P[3IK,T M*W-O^;QPFUFZ6OTHTOOL]WV9@>&T*\$)CBW!CB#CE%76:]$&:6)AW6Z0INR$ MM)V.KFK:39J-]?USIEV_F,Y[I#TP(?8.&6RM4SA16#)GZHO@#E,SG-Q"\]+S M:*?R5J:IKB[[;#6;+D(Z*;>\.78PL<4>+@QAC"`:>]"Q8#3C.G`!@U&=#">C M$28CBBL`AR2U6&P^*R=95:0:>`_/#@;H=_N",,^Q=BYQVF%GD'?-I7B*'/3% M!:UP')1R"$C`VA<&,;!'D*"7/#$TUC0$?C4TX@1[L`C@5_N`-%)V8508^P\, MP?`?9B)VDDFKN,?8-6QQR%-1@1@A-0HGI`6 M-`QGVG$<(MI'%]N20]6M0%=R+`2"CV*Z^`(&T>9KVB>7FB,>MFY<.6QC;2F\ M2>J;C[!\2#>"5_KZ0=("55:JG-*FNM8W3MX]39*72$](-I2SR3 M6#C%B())1&HZ%Z0IWW=SBF/&*25;^(\`?-D8GRW2PL#XSO.B5WXZ+@&'2IP( MQ*Z"A'M$-4(I3#R<7$'#H,[!9?J0%^%DJDX%V86X)?8EILMTGH'&AX4RK%"] M!EI;%K+3P$A*[1/J>,W;@$%IH^$$%F;0PUD@=1VT_*Z#J[1X!!-Z]6D0&%Z[ M`+=873TE,,>PZ`EVB(J!>7!W63@TGYN7B M!/N/N-J;OM*4JKV+;'DWOLWS]3)?I]_@PV!3/BKRD'7QUWK],(ZBIZ>GL\UU ML3C+BWE$$*)1^#H*!8?/Y=Q;LIJ_N,S\AU^=A+GO@KE_../SWY[CYZ_?_GZ M];.__\]__LW/RJO++BSA?G+RLHUW$_NEL$T\^-^7WC3^/ M%_9-Y>VB%>=\L;C\_O3TTZ=/WWUV]>R[JOYX2C%FIU]J/5HB_Q^Z+8;R(T0H M8N2[STUX=@*#GC<=VE^5_/YS?G"O_"?6EB;&F-/VMU^*-N6Z@M`L.?WGKV_> MMT-$Y;Q9V+F/SP"#DY,?ZFH6W\5TDO_^[=WK>PW8<-4",O??^>KB-!1W3C\_LE;_8XE@#^F#=+/:1^W[%0<1[6C@.C)KH.8'&>JKLO'5')XM8SB[C'7; M^]81;*XUHF`=$>Y4>1@Q5VX#3.-/T.'B^O4\^P=MAUNE[%!W$"%_LO4\NREO MJJ9Y&^N7U<5%-7]_;NNX3<3M-4<6L..$=VY@&G$_Q,^+I9WM+?6#=D86OIM] MZ5I_&&'!P"ZN?XV+\RJ\GE_%9M'%&]I<:T3!NK*U2^5!Q'P];Y9U=LE_M8L% MQ$/;)'NL_"C"=$1K2[6!1(.6RXL[RQS!*L]RI^_/8]SNMG2M/XFP;^%=G"_. MXZ+TVW50K\;&&L:=KW.67MKF_.=9]:D/]AO;F43XZN*RCN=QWI17\?419<=QE8B,!SO0(KW MG^SEMA%TK#Z%J!W5_FZM#"+XN^BS.^Y]M3UKBZC;Z@TB7.MB M0:@80U8#H`-:QJU_^KP&@_FQI>>+Z[LB;^UU&V]\LC6$12UA?P=(8\@1R.?+ MZ.''#U5^=+9]=Q\HY2V&&F85'Y/[\9PU8\-M8:4;"N M\]6E\HABOH-IK$O?ZE7X/4SC@R>_SW4U(@1WBXOM[U>4 MW_M%'*&O$4'H%H)VJ3N,D$O7Q'\M00W]=-5E]?*Q\J,(TY4!FZL-(MKOMBXS M^K=&^F8Y:YMDFVN-*-ANJS2[M+%6:'`%_7+6ARRRV%V;HY!HM%GI\OVR?C]C3_, MSOL;0_;:=B\V_HYS6G">:\.C36@L8%OP[R#VP<&)6;+''.] MK>IVDN\-]!_5/*MNF#40[>.M"[KA51VGPT)0(8(R&,$,`\09YV2H0RQI+IR5 M5'%QC$P^"+NJ(YV2XR#\7N0MF&/&">M0L,8@+WE$V%&)K-8D>*\-<>X8B7A, M9-B9GSU0GX)K]\W3?GISY[8*#J;.&`"!,>$1F#V!;`)@B)-41TR9T3V-.[UC M(OKWHN(4LS`%,U^55V4`'[^!8#/%NEXM+6_@WR,U"NLL53API%G4"&L5D-0N M(9%XPHHJ0H4_2I8=@^4=#M3I3>?ZH!U>D+/TP7Z^#]N[>)E?T/G'^TNH6RWL M'GT4P?%@*88WS<-H`LP"8MYQQ+`R'A0`,V9KC+>5F$\\MCD&U(^-N6]CW0)Z M;TEF3Z;>:[,@@)#2SH"SHBG2B0;$8B3(6R>85%I91[8QL]?JPWHA5S]EFW5; M^%;N^.C*RX"M@XF4`G,`@#CMD?/1(B-`E[8:%'2?Q+ZG"3F$RSP:$QY?CY@0 M^6F)*.VI)"=UJ MIY^07>K/AT$M4W_TGY1MZOA.C])?D:+R3`F*E,N[DAP`8#L*UJ8:-)042%M`)5%I(+B'(2 M$>$21R^]TC+NZKD-/NJ7R[K^ZD7:/,Y5X8)PI2*&",+)H!$+2:*HB$":29YB M\%$&<\S^U[!35XV`UQ0>TX-S,B_M9;FPLS?1-O',S<3!R\1@"7[[Y`^'9(,"]44E/CIXG)67H.05AJZM0IXZ@@SET0$<3HF>.H0]17J,`=@4)'D? M9^F+&_HN-K&^ZJ`W-M0J3#(2:V]1,O`R1($U\MXGQ+PQTD5-J>FYO,N?(C&& MA6H*2IPMSF.]D[9XI$:A<7*2,!A02A9Q[#BBQ&($,3LG7#N=^J8_B*=(A>%@ MFL0UO1.T7;)I%V]^J:OEY9?$HK4+.3M%,WU:+KA@7!KGD!?4(.JT04Q'BDBT MA$*\*ISJJ6'D4Z35]'!.3+^[*%TDGCXGP*!J1-6R(2#G-$!.8$JV8 M)XD^$2=VU"AY+\B.)U#>.T(NC!:2,>J1U4(AFHA'P1.%%!:1,,*--CT),WEH MW'=.>T7'/8`[E'O;29ULKECPJ.`%"QC!N#CR&*PUEMX@37E026-#CSN'87B: M#`[8(5S=3M1XO%*15/)1>-#!03!X$QS\P;5`,N`$(9X`5V[KG9>$$,M8Y[@HA-#OQ#FQ>M2[SV"FR)\Z3P'G)/[1-[`,?*)UF`X*3)EF.*>D&$>1%#XBJPQ! MQA/))82K2=@GHO6&)^/!,#X,0W=B6T%E%`"?!3BM0U%+T.K86(0%-MX[>'#< M^^2'F-RM_.J!ZA1@PH@3^>]D$@FB35)80RPV-G;VT97L]7*Y)?T793QLO6R@7S0FB,`34; M-5+$*Q1)/CH:N1;&0T3*CSK"'I@7HR`V!4_>Y6S:>0RW"=//O5]>+-OTC%"<:W;,N]L#\V04Q"9*G;L5 MM%VM?.2B_ML#"IO3Z79IJ>!!8F>$0Y9:@X0(%JEH`7UO%=%6:*[Y,6]D#ZUI M1H=O"CK]6LZKN@W3MBZ./"Q:@&?MK&`B7SCM'HE";[WQ?R MUPY6!\!TJGBE;,^SY`6AF[M5/L:Y+^.F3>P-M0JKG#-$!!0E%]`M1&C*T8@D M98H1+GCJ>\G;Y,E6PR^1#0O<)%:IO7-XD[%I"Q1.$&5Y(H@+,*<.&R"ZQ#K' M:DE*S*B..]^7,>0(.B2A?UVND"IQ$S4T*%)`W&%0[U%8%(TAS!GEHSWJ!(P^ MT_+0#NX)R"3ZRS;G;39(U.R-9%F"[U"P/_2)Q`62M,45+@ M.FH=$DK>:4R)$L0]`3+TFLF'"FPDO*8\FY*_M`.2@^4'%Z[[X91UU8K@&2;@ M]R&5\P;R76)(T>PL@(7P1"?#Z%&?3AF.&0/#-$UD?BMJTXD):\L7Q!+%\UD* M9\$IL(9YI/.2-'/>,L$#]:*GPS/-!O5P%!@*GXGV:"YMV7X$:MY$4&EMJ-?5 M5^A0NV"4*J"W0=Z9@%*P"D717GR:G#9.1*R.>J]X.%Z,@]9T=P"U5Y[?/<&`JWVZTOPDFST21ZO5E@2K4TV`<"@6".G#&D1$^*<\N1H3#SV MI,N4<RQD#XW-0)@#'FTV+#C$J($681,%9CYS)1_`8PU3W MW%J>9CUCN*GLRI&^N$V\KO!$WSL8C7H'A'@2;[J[=>Y# MT"&:+W@RWA+`RV,+-B5?Z\\(C"-W)CMZM8I#. MI^X>EB_`'3&>,HL(21AQJA2*EE%DM):!RJ15W^.Z4ZX![N5>#07,H4+[3K._ MN6*AN:""1XNT;:]/`8H;)B3R,F"'E?3,]CR..XU?-<`<=@CT]P)L2GJ\K)HO M(2JHLIT8\FC=PBK0@E0KE#\1DU>[/,(J2F0EC8:R$&TXZKL@QB/)D)A-P9/U M%\-NBLL>J5'0B'WRPB,!<"&7J$#>)XZD3T83+@E8QV.V'\-S8CBD-C/AD?OO MVP'=#>71+)C'"Q?@T^`$XB*+"0B93+ZE$;/5-Z<2!CUWU/L_P\WIH"#UFL[; M;Z:WUX7D=*[;M+QMAG^'VH4*,0^``32@+CC18-;R5^1NQ@+J*J2>$S[--L_` M$SX::D<6KN:+:=Z45S'L$$4,T7SAE&ZS&F;&VGS3)_$04`6!K11$6MTS M7)UF.VD$1^(PL'Y%R.%O^M]V5_K-N?[SN"C]F-?]KQ'C_0+^;*WR6;=7VXZ"1]U)A"&_K*G^X,KRX_JV)(/^7#[H\]XORJDUPWH!%]T8* M)YWPH*L1M4XA2R7/=^=(>(%-"%90)?51?QINO&G_]L.TXV$ZA57L/H`=O]F] M7\,%`WR$-R%/"D?&,(-D5`F11!ASU$J/CWK=92QB].;?0"A/EZ+U_]^*WY]; M^T_Z7^6;\%]OP#W8=]NX]/=HK4()1:UE$24G%2+&0Z@3"49!>^8CS`N//7WU MR3YT?"@6#0OK1&D;5V4#\OUPV/7YSTL:CU0HLI1>,9I7O`B)1 M"I1X=CZ\H"E$9LC#3]0?UPKA`0DT,*Y3[D!\R9==Y4Z_B/.8-EX8L*5FX0B/ MW.:/Q<`L(L("A_`Z7WXIM3$V>>U,S]L"IEF5/*@B&AK:B?RC>Q',Z_FZ*W(W M^T@=&BAXA(`HLH"85@KDR-?KYDP#)XWD24MK=,]MK6E6/P_K)XV#\!3\:C_Y M^`*D#OF>!'@?MKE)ZRL4UBJ+G1=(2P_A#+,:,:DDRB<)G0T:8Y6.>37S@/P9 M#-')$F[RO2#YIZN`G&8QS)'`9=,_H M3$V33WA`V@R)ZF$LV5<'#G::UP_UX9_X->3<2Y(U$R"X-%C;IX!/52+C\$::H M"(3#@2).('[A5'C?5Q$2_%?WP":#O%?VR]TZ;`;MD8/`X0B@ZWW>NW78 MI^!U=#UC2C+1<:,#ZK0QX)WJ2J@.>*W-"MIXZ=T^[1:>.RPMN!V4R("2Y@I% ME>_"D=::Y*46[*B_U#71%O74(!\P:^)&9>^9C[.FD0+>/L*"2$A%[!&Q'"-A M.7@5U.5],4N"V'H5WR&I=NA\G&$P/2YF#9./T['A(G$5B#'YAE,5$)-9%^C_ M:^]*>^2XC>@O(L+[`/)%LF+'@(,55G+RD>!1E"98S6[FD*/\^A1[9^_9.7JZ MV2/;@"%8HR:[^?A8K"+K2)*HS*FRL;C(>]YV3^HS<3(Q>O-O()2;7'Z';YT: M^O%ZXP#>)YSW\$Z\,,RR4`L5*\W1ABJ)E)H]QDJ'ICY/`FC/S!;3&A.CL.#Y MS?B8,$]U)+Q$PR>MH-L_CCP5?MS4QY!E2(Z2$K0B6AG<7BROCNA2"19YT>+T M)-B_4V*-`&Y+V?7C]0)12VC0=)YKW1GB<>K:D3WY:#.N,)>(,"(35%TPP$5Y M&,IN=\5]K;T`#5II2AQ%FRQJB=@*%/B,<\U"H#FIG@2;U"FH";]&@7>J`[@M MB`UR`'=POUY9"8H[("RE3"`R0V@,`;78Q#,D7(#Q>_3`'MHF;0WRA,**%[CL1;UGELR48$NRT#U-TL0@]2:90PE3"Q2]X)BD$(VD4/(CO\0#N9&+TYM]`*+?@Y"7< M;%33BU*CW#_"XDN]KNM6=%GJ!E`D,B5&8\*)JPJA`MS8D?EXNU]5K??]@]J8S[M>G!\IM%%7_ M<"7@9E0B*0K0XBJL2%D*SWVC@2?5]%IPL27H+0]5+LH]>EV2L0,.4)XW\2*9 M(*@M1$'A1$3J2'8YU5+$D04MA`L]+QJF/:)KPJOA0)U.GG5A%LM?Y[D>*R8< M#EKEM43@UNB+>H.RO$]!TY41O+C9I_6-^E[/,\-)PKDS12#,G`I2-*NG[XH5 MFWG0H:=9,FGHWW1R<;J):2L[W\TJX/.\/*RV^>Z&'H).Q3):\Z<'X@P(8EPH MQ#I7($@953F]7O7O7HX.!.U$1'J_V#CJ=]^-:^;V!ZA9K8YGU[[><(&A;J)P M;Q$)O]`"2)*C,KC5@%,\91%3SV-H_4>DW`AXM[UANRO.W$GJ377?@^[4MC7T MRMI$K;0D1FI)D0Z77I:)6*N8D%;95%P_=DT;@]B278-!VU:@=72_4P@.MRQ> M-O,Q"7-;%Y-F0:)S%O\O*,)S,#HK@2NJIP/`M&&(;474(,`V]C2YA)OU(GU& M??&B7$(&^%(#AI[*V,,\30[IR5,5E114UR)7%'4$&HE*!O^0):'^H)V3T(]H MT\8=MB3:>%A/=3^[!;U![F\APW?V-,38LCL#])42L,V>!& M793D('"0?<-#IV;+^+/Z\H2T/ZS-\@Z]LJ,<(,D/:>YC5$9&)PE`B<0D(XBB MRI%4C(XL*(CAK'68=%4<,R M9H-2YT!N-L5\:J%Y">DJ+)>S,DNWTYS_O;Y-05%OR=Y<_/#SD\&?*&-[OLVS M$+B.-M?L*A*'J2(B#)(4$S@51>;$>A;E:13%-1F9VZ+>R%OS86@G6BY']^6E MX.`7C6].3B;V$Q M1_"J_W9WM_)N=K5>[8PA>Z6%5Y)!"I!)+;I((L-5[7@&HC+-'`50+FJO>CM: M'/">2@,XELTPNB'M&/W1?7D:74BUE'%"L48TX/=%*P)1*=O('55:G;6W]2#S M?73MA]-1;!1A_F@.61NW)CVR>XC>_)<9S2`,NY3H=0@(+2X"C,&/S"Y*+)B M>7^IA`:8'#IB7P*D)"G:C1&JYL<$L2)F8EB4B>= MPXT\_\?-R?=VB_9GM<7=5.@[@;^7RHG[/_PME.L%W-?0@N6=X^_=Z=Z;>7[: MRRMYKD\BVF!?X1D-)5%PA)6`1F,$04H2G#"5&;<@=1%G+;R&IMK13)YR*IK< MH=VE+SY(,]KRM#<\\N2LKIM)(#'G>D9F4!.N!2MR49K'L_9J.EL./+\)&P3[ M%ISZ.X2KU>_P%`?D`BZ^S6D*N^Y?[2IB[ M&'ARW[YHKJ%$--!2`51M.5J)&2@Q"DP0B3JF>]ZY-O(?.)4'U],CVL21O`98 MU"RQM]5V=OJ&/WO4HPYD37:&,)L2B3@,DAF:1)"T!1II<'VC0%O=RP],D@$0 M:C7G%V5#U'TS_O"@#]HI#C62*SE-2M&,6(Z$MF"M*-0(!3W#3EKY6IXR/5OF M^B1LFNHMO]0\7\M+E$^;P>].W+*SG4>P4(YQ7!U2%0*.UV-$EXF@AEJE&./N MK).S#,J#H:%J08M_A*N;14@K9&Z5>;?:W">8IV_O%_!EMOZR+PSRL`Y\UA1L MM$`0PEJ(,G-B=$)KNN*9(\ZM:`BU_F7S\UJ_;O$:^V\=8QQZ*@N!$F M5_,04R)D=R7#@[,IYMBWID(;5?-[.38;<@;:WU&<>KOP&J)2JFALS2X0Z^6? ML)(([6JR`UX M@\);M,O*;!=)7FGA1;`"G*4D.1>)TLH0XTH]`*):BFA*8*?[$([)C"9WRT/@ M=F[^J0.YI'K!E+'9,&*=Q67'T"8-3DG MV?;1!XQK$VS<):I:KPZ.*A_C=5Z)'&10EC@+EAAPA4B*RS0Z84HJ0;O0,PWG M%'X,0]+H^:G->:`_&:\?1<_/EC?7RW!5LX]N>;`ODX]^@>=%1QELW:=DQMU) MHSY3).)8F$F*9UIBS_O+*0X36G.W!=Y_1I"??03Y<([2C6/&1Q1_6W,J[Y1G M6UOX$`,W-$O$$,4[M0:7JXV%J"(+-=PPOC\X^WS(,7(4Q7`@GD=B@?=A@3]] MAM4,W_;T`^^S#-Q]Y0G?\ZP0S-W:NL1/^O!;N)GLQ>]@A71Y+;W"`.^_A%K> MX4U*U^ONYOVG-<[&/,%X;]Q>1&+[KV\6BS#_U+'B[;>'1S;9:M_\%A9Y4VKB MGP@:Y,W-4BW&_?&Z_H3*XG(5YC6]5_=OL$BS95U]HP/;+;L7`VK]OHF&^5`3 M_2Z1_K-??IW/5LM-4M=O$WWDA_09\OH*-LFU-T0Z-\9\K.\>\ZWKN(3_K*N# MUM?'UT/COVET0/\9%K.*WOUI/$JXU;?6[]L,\R.^:;U["_OK7^H_160`_N7_ M4$L#!!0````(`/*`9D7(O,6EX38``.FS`@`5`!P`879C82TR,#$T,#DS,%]D M968N>&UL550)``,7XUM4%^-;5'5X"P`!!"4.```$.0$``.Q=6W/;.)9^WZK] M#][,ZSK&C2#0U=DI7+M=D\0I)]V9-Q8MP38K$NDA)2>>7[^@;,IVH@M%D325 MGJJN:H?"Y9SO.P0.@,.#7__^;3HYNG5YD63IFU?P-7AUY-)1-D[2JS>O_OAX M+#ZJT]-7?_^___ZO7__G^/B?\OSMDO7U]\N\LGK++\Z00#@DV6MM27*?QU7 MQ8[+1\<0'6/X^ELQ?G7DE4Z+&NT_E/RE_'4\6U9X6C@XN?]Q6;2L^ZSIKWA1 M%G+.3Q:_+HL6R:J"OE%X\L]W;S\NT#A.TF(6IR/WRL-U=/1KGDWT"NW3T>I1-3\HB)W)>)*DK"M]IV?@ MQ.1OWY>;W=VX-Z^*9'HS\3"<[->Y=K,XF=26X;OB+8MRZR;936G`]<7YH4I7 M(NT,U+J:70E8&N5X/G%GEZ(HW*P0HW_-D]R-FPM>L\6N%/H47TQ<$[F?5VQ% M/)6E139)QHOA3Z1C&1=)<7;Y(7>%[W#Q].S2)JD?#I)X\M$_<:4D6Z7?M]T7 M5:ZF9;74?"NJZJ089:E_-G?CLQN7+WK?JL'F6AT*5A/A6I7;$?/!P_`T&M_A M[.XT+5V)18=;I:Q1MQ4A39RGI4?S-BN*#RY7V72:I1^OX]QM$W%[S8X%K$EX M[0;Z$?>3^S:;QY.]I?ZNG8Z%KS>_U*W?CK!^@IW=O7.SZVQ\FMZZ8E;'&]I< MJT/!ZEIKG9;3J:/,[/S ML_*D[/3CM7/;W9:Z]7L1]H-_%]/9M9LEH^UC4*/&NE+CT=DP+B3R$\>YE^+CU_AFFP8UJ_CQ;CJ?__](G;05X<@U%N"UJG;CI#SB\+] M:^Z'(7-;9_=R7?E.A*EK`9NKM2+:GW&>E.A7D_3]=M8VR3;7ZE"PW79I=FEC MI=!Q/JKD?OCSJ>C+$[HDG9V,D^G)0YF3>/*=:&O.`*MCO?+H,%A(_*1FFP+Y MO\NE1Y8>C]UE/)_,&HJWMIV.A,VF<9+N+^NS9EH5=='R\=1-+US>5,Y5;;0I MY+5O*Q_-+]SQ$I*&HFYH::7`WD@2/R7[8F]]F8>2I4P['RC?-^_?6)>.W;C% M#E:.J9WTL^9XM]N^-JNWZ-!W.?=369%]>1[ M`WAX'"TWB7YSV54>WUR7VT+B6[+*H+?6B4)%.1((8<4"!C55C+$*E%!HTI-1 M;!B_-QG)CL1FW:"R,)6N6;^WKJ>2ZF?.PRK6U]6);$BU%B$0G`+AE4-*+1&C M0N6^1L^^MH&64?CYKZ-\*GNDR;"-H2GXUYQ>SF[PD'B[^ M*@F'3P@OGT7_^+B"UH=?HA!BKR:FFGNM"2`!@:B2#]@P[(N\56N%%M=/WD<4PT$:``'H77[F679CI0A(K*#%E&@42NJ%IQ!64DLI>B-V\U3;,@-9 M1_`T(O7W^.Y^NM^-UBW5HI`'@%D58N+-'%$:H.6,15D@F_F[K2_].R2V78": M.<1QGKKQ;KQNJA,QPSF"0`:*"64(%I;R2F8(F1[&?D&'I+:(3K,)UHVOOB:C M+[MQNKE69``WQ"B`M`RQ"`R3DB[E]K\,8T^A0U9;Q:?9S)K-4Z_+;WEVN^OT MNK5F!"WU:T#,()60`R:05,LS9&-(LV/.UK<>NIQCV\:HCV.N*FQD\4U\<0__ MYH/N-34B`"4A0G-).?0+>.J!6\XTB,MFL0^[C]HORBUW+NU M-2()3("TTB`07#/(N9_<*GD5,`,[(&\1__5;)WO@TXA/<9NE'R;QR&TF\;MB M40AD*(Q?(5J)"8-(>($JR80)!K)^[IBY_4!I1-=9.HOS)+O/PE!LYFQ5V0@& MVGJK`HSH,`30>,F6JT!)PF8Q#YV=J7=$7`O(['Y$6R^"6"X]RS7N]+JB4:BX MU`HI&Q+OB_H1`S!3R4\HQ8V8W7V=W*L?W1(8[9-9";/6[_FQD%=>26NM@EH: M8T*H#1/+19Z&>GA.\/[P9RVC<1A,#L95?4D"VS@S^UULX0F)I_&60X'5 MQ:-`$V2Q('[XEW[H`=XW7[I9.)!L&&[H/A!GK:/0+-IL7O9T=OG,UWW81DO< MV@B*+=4B`Z`E0`AIE!+*4F5)%;P3AM@V\VDZX:^M[V@Z@*7/#0+O>%TDZ0*# M,L=*,G[(I_(IC]/BTN6Y&\,5QM"DF4A!PC"@4'J/0I&06A56(UE(;-`L@K[U ME4J;QM$#3"]D+$^6`>=N4J;E45DQJ[/IO+V1B$N#`;*$,.G_\RIS50VF80!% M7_O0PS"4=D#::Y)XFXR\][+<&)%NO'6"6%$E\M8+N1_]_""(+<`<4E+%*(1& MV6:TMGY\V-GDL#\D+_2NG[M1=I4F_W;CT[&?V9++15*&YXF813I^ZQ\_3'C^ MM_G4/7VRV\#01H^1"+P7IC@00/@IEA(>2K"<=!EJYOJW?IK9TRCR`HCV8:T/ MJ:J*3]F#$I7JKO@M?Y*@;X79;:L:*2:5!!H01D%(<(!16.TAAC+$S79Q6@_N M[L)^6H:F#T-X6TKGWKJX'%J?Y#4K'C($IE?E;ZXH\]J5Z1S361Z/9AO,HUF# MD6$!D<2OT21B?D4H<,"7LS(DIEF(3'@(1M,+8$,RI7.7NJ_QI-2G!3MZTEH$ ML#68ZT!"3+V;IQ6FRW%6^S>ND1&QG\F(FJ/5R!%^%W]+IO/ITI,K97@0X8/+ MDVR]/[R]9L2TQP1:5!Y">[2@)7*YWC/$-(NZXD-FNQMDGC#[Z\GS+#P=9.;9 MZ4:2G3+VM!KUL21IMX"/1VX5A$$82LZ15H%%G/M_WW/`@Q#+8)MU=J/I(_HK MA"_DW9-_K4L`U+2IB`"F;6#]6LT0QBQC`(85(OXGU.A];2E#4+N4?I_^H5ND MXJ'F$FHOP%(%FFG#B4!&A&6$40AD!0A4N*_D4K4.AKMGO68$YFZ@'7YT71`* M"3672H=:!R$'`5^^GC!$;'B'SZTQN'.873.L?GX;&4F6A`0M)PV MJ>WK='28OD%;L/5B%JVFG?/N.<6,4(RUYEPI/SR:2C]F@H-,0EB;L]KYYYJA M]/-9P^#F_2$9P;[QB?LF(:28:")#HJW@V*^TH5^#5_+YN7%@WUBT@'.VC_X_ M:Q24=WY"&UJ)_`1(B*(4!TOTC,&]O<*-_;S]-Y(ZQ.O@0B3B=-Q7;(3O*BH3 MO2*+`2>6,*BXUO3)J*NV;N>^^-="G5A?GY@>FH7*>3(I+R;J*X1GV5]$,%>$ M(H4EMMR&`(4&+E>01@\DB1'.1B#;0KLH1EL>1%UZBWAKB>#7?87*0P8Q%`#P#6T7`!5 M)3/A5!C=S!?M+-?LX`VV*;"'9K`O&]<+"+%2>6>H`OH1PA!K60E)7IV"0%9CFKF(9)[5N/U>S4D%K&J-\0K%77 MCK9X'=OCG>,EP^E8QD52G%U^R%WA.U\\/;NT_O5+1TD\>;R5?'`"=7U'GDZ* M,C0G2>=NO.YR^\FXN]/4"^>6@,MX4MY!_O':N?+^=#$>+_2,)Z7DDZR8 M>\+DG?_'35;$9;*Y^4WAFYC,R]79:NV6;_J&\:Y'*2(DC;*AD"'2-E`AA"(T M%$FB<`@-$EM7.H?*P[9@PIXDB(@T&A/.*86!]2.]U'XL7N!??BZ*^TIKL#$& M<9#VF!T"7QU'0O:5!@<;J)D!C!)LE""0`H(KI(27)+"'N(// M?ZZ+._C\9^17A5(SK1#D&&&!`\A-)1_#0;-U;A])=6H#F^VC<*/03S6?3+*Q M2S^[8O9GDE]Y@+:D/%I?(R)(&VL0%!2I0%HD)0\>O!=@.;+#.)1M@:!V@6A$ MG([31<:E.!V?WMZ-XXFK3V&=NA%F@/@^0V4UUC*P2#"\U`&Q9D-B)\E+VB"S M`TAZ^<8W2Z]F+I]J=S'[Y'O=$K6[JG@48D2!8)9KP:W20:`4K[1B`C3+#]!Q MP.Y0W=L6@7X)\]D:T;FZ0A2B@!%II;8(8F`"80)=:8:TQL-SA-LA:@OK>Z'S M,_$_&/=Y2+2_!-UQ6GR([\JA;:V'L+YP5";F`L(P+:55,*`AQK32**"\MR2D M]0Z:]J7E!Y;WQ*,/ADM=3]-BEL_+:7&+-_!CX4B$C./0(,4AA%PI*X+E*T#" ML%GD3TC]S[;+;E"HZ5A2-DF9\CB0+2AAQA M(IYL7FBB![+-UA[86\>=_F)LXWWA:^J7BDI*6D_&0]T#*T%C,, MPJ6[:V&S?$T=W>YP*'-]"T#W83[G[F:>CZ[CPHFKW"V@_%[RK4-_[38B&Y3; MV$+[%96V5@HE[-)-5H21X?H#^]&9]0O87\]P!N=$#-1>6O`KSJ;N*GZ\2K2, M$"\\V.5H^GK+G5%;:T9$:&@4]9.J+C^@58""I?Q6Z8'!U>"A&" M0^]T6Z`"22T(E"RW4RK'6S3,&[K[YQP_E6?2%MJ'EVO"#[H:4"4-IY";D&IJ M1*5?J`0=KOO1`F>UDTXT0^GGLX;!^11#,H(>(H#$^;H(('$>680T0$AAC(+` M+\,-%ZB2#]"AW>[:`L[9/OKW\7)V/^UM\2+Z$2!"E`F!F!08$``5"A6M=I.@ M%$&S?!.[?ZSW4[DD@Z2NEXWV772HMP_?K,6("BJ`U(IX4"@"W`9`5=@P9`=X M0>A0C>?[,X!>"?F/T3[%:'`NW%_45EL^SJJ?G79SKW!"N,@*X633"@L+?@Q'JT M#_EKTP[@WLM06KK/DU,>A`0A8_R:FI77E'.Y?&.@'3U6%97N,BM/ITM:/L7?-@^';?84!4(! M;;0)RPM\)65*(U)A":%L-EUWENSO$`SW91EZ,6OWHIK+2S?RK^J][#75W=76 MF_83A9@)3@7W<&)1,HO(^!F8-WON;ETZWY0$:O?& M(HX%!*%E2AHF%"5^M@-+1'@XL%2$!V*QW9+0WRGQD]=JU1:6\^_?9D]BEV:B MT$(`#,(D\'@`"`&78KD/@:5L9(JM7SY]2*;8(?S-MXK+J[,?4L?>;SQDSW>F MBGGJF7M6U*VZJ6+/%B.%=6"E$M186[Y]5G/XN.U*FJ7+:/WVZT,PMWZ9:,7R M1)K./5ANE)<_)'XD3F+K1Z&[T M,KZ>-GWKZ7-?D?3>+$B@)J`^C1=+>>_O0.6OJ?QC=_JQ&X\5T M7#33>G]`%?R=[P6I'.:,IW*&D"#(N)(ZM.Z2A3IVFCO6GV^VK. M'_!V0(;I%(6$,8:0)$V\6;>(.H[I*99G9[WXEBCW,FFG=71&W59G/V]Q"V)4 MTA20D,QJ1"3EW-906&OR8OTZKMG>*HD/*4QQ'$AOL+Z`ET/_M;P0.`<6,6BF88T!CX1FNY\NESZ-J9_ZI2_:# M8Q\\MG&N>_6$'6\%0SF@%&#JG/"<(PQ$LX\$)6JX*F7G5"V[1O%M2J*J^+^7QU[?($G_H6Y'YOW?7#!@A2`(Z))IHK:@`5T'I7K]PIT%MM MO,,4FU9H^++G;Q=`96FL5_&7*11E8N/&B).(A^M5>3L=;R?V(:\%IA6P6HN( MB*<<<@"5;\YGGBD9.M-=VR1Q!_!D$?9+-1W=?JQ4]76Z>+B5K(7?ER@NKZOM MSLEC7@\2FI08XH'%44!R!95IC"I$>%Y!@XZK[G>A8'8(6IYO8?WAB2^KU]/Z M>%=4?Q:_%U]^%;=WQ8=RMKB9;]4$3AHO(!&-,.0(U4`I82RQQ-27!L;0`99I MZ8:4Y?G`?-L,-!@E\X+YII_S9K=*K?%G+-O0-,<:D`->IQ-;XW%_9N MY:(GBAUY_F1!V(?QL>DH_C#Z/?VQ_&'*B-/H6W$5U;/9>#K9'4=WW$#!0F\D M5])H295$P@M9;T3)#.O-ACU,4^WF@KY3R+*DR:89/80W?UY^O9W^F"Y2C-,J MDGZ;/#EBB(`EHS2:^!P`XGD4R83!>D46JH&5UVF7"3H&ZURRXV'V-?N^3TLX M4FAL&"$`!Y5SS/!5&1#+)::X87V@\H)X.BMST9^T.!VKGODDA4F:5>#NMV(V MOE?C<147\-=LDN)YT[75ID2KK'&"U8Y2P1".""#/;,1"-OL%P+P[F,ZJ573. M,ZTC=E(=IJ>>N,;]]G[T:[Z<+O969-KYB6`=TPBZ>(Z%*YC%"32LJ]6 M`.<[5+J`J35MXG-Q>[WZ1S$QY7PQOQI-)W991:Z,)]VTW)IGF3-6$$AJ90#G MD%L6U7E.B6_62%B>Q[NS:@@]Z1SR7*^ MJ.Z?)"ZIK_$'&\N:72&XSZL)V5EQ@&ZXI"NT M6K95G^G#5TVIR?OC3=9M(P40>9\2*0A!0AFGO`.-J@08S1V7[JBI^3)<_5DK5 M-G%S_$@AHH4)D5X*J2.>E`%&ZO4Y;?,<99WY/SH6-YWCE\4?[L?/V_*^*![Z M\+WTYZ[K0:S.#B+S=>BSECQ@,P4)Z#)S'B#%#N<,-KH1D"I3. M?!\=\TMO./99".$^,KI?+B(Z#Q$NNIA%FFWTG1SZ:K".**8-5L011Q6FRM:> M0V6YRE-J.O.<='\,M0Q8AX4&WJ4;@NF/5)`XSG"2HO6?5G;H,F]Z]X>O1NE\ MOBD6J959G[-H*ES,/UZ;T?S&WY:_>H7AV03B4545-RF0X:YXK(EVKND\UNHX M_PSZ89#WY>Q;JMBTJJ\\FZQF5\P7G^*,/O\:_3S7=\]992!Y`R)G5L5DNJC- MLO<'5!G8^5Z0A`I,052J%(I_E'7>$PJQ,@P!`O=>U/6WUGVU!;:^$U0T*:!# M#B!$.;4R_E'K-0)H;%^143LK"K1$I5<'8CN8#+:.0-JOB_5^744G[TX/V_1X MH$81SC"%40?`2$`,,:JA(%KV%29U5&AN"X1]R2JG0].+.OUBFGOS,.D>%]Z!>6=Q<I M&NPS4;P%")#3RT924U!"JE;6^@.O8L[PZ1+4*UUU)$%*10Y-L[8&$CK^1N"\N[O.R[)T+Y:GHM';_3O>Y^?KA MH+A#$&"HH-%>4$2U;+@;<9!W@':<"=)#%K5ZJ!55 M'AC-E6GT/N_I@#U;IY!J)]5/1N>M\<#@SN0AD+Z%F*('P=44]MN=R+WQX:"9 MT%HF[;!F1++IM\8G5U[]JX MC1.7?BWOBO?3KV6UF\ZM#!Z,I-YYH:QS@&I,9$2QT4^0S7-P=.;&:I\D-I`K0T!0`%F.*M7Q)7HJR_[F37SDX'IG]1[-;)- MC\>]X!5FE-O474EH+T$#$+12N.%JY*>0:">U3T+FK=!]<%KXN]UX`WFD( MJ8/,,X6XM)PU&BO$K"]W:9^4[`*8?LH+/`_+WKMQ-[\0$(9$$&\H9DI)A(EC MC<]?L,RKJ\ZRKEK=O*T@T@^MN^Y_NL=^ZV<"04-B!,<8,B*U%D930>H0;\U) MGO@Y/I?KS#;A(,'NQ?M_S!H.NQS(&S$@+11CTBE$E:-1$#BF:VP$MG2XUNK0 MF.?EQ42O!/F7:9]B-#A3^Q_*JRW[V)?5/)F:JWJ;ASO;7[\5L&>>&VP=8L)K MK0RQS;PUS?2Z=W?KUC5UMCGE3T:NGXOT:GH7UYXR=^N;B=3I;F\$S?;7@J?1 MU"$,2Y`*NC)F@:[U&>21R+,4CB],=_98FM8@ZI<14AW-5%G@H(RA7:\%")PF M49HB[P0B.@+&1+U*`X8D2#J'!A M*#"`KL[<0!;IWIIO''IKWP:1#O0H'85,KDMX5]&&+\7O1:H1M+VX9,8HP1'A M!-6,6A.U:X:8D;6G#$'"AI9#V&IY@>[QZN7J9P,FZYAP7595^2NINJ.?\3<; M*U'F#!.4**B)?A.%B:^K#[?SR;3 M2(4X1SV:?9]_**O%M]&W(OWZ$$FR9XA4L,Q%:2N0%!0K"H!3CP:Z%'EBI/7[ MPSX8HF/H^I8H!TJ,@`V6&@J`/5>&>D$X>3P?H1A(IDM3G\^7R9_ MW:H>^TZ#X<6S04>!%8587)4"3!&H?)-FA`#0>3%!K5\Y]DGN4S'*DO+/XU;3 M*LOKU3KKV/-MLGWOBP%ZYWBTE83W&B/F%/)U#`3"7N6U,6F]*&-O$KUMP$X_ MU*/9\S_%J/HP6BRK'47&=[T3M*#.6,DX(T8AI1UOH,#"J[[\@4,AD3MD4E-4?/"25OO9-&KBM@QAF?G*3_]74S:8*A7 M`P6--3%"6XDM)=)C@[BLD:#(Y0DI^6:YZ50`#V>E>3'^KV_E743J+GXJ,1)> M_SVQ$'["0@\_?>+&_;-\B!90/U)GN`V\LN>-@#E/\?T(1?,JGM6`>=.L27J> M&;$.+I$KVH6J_\SQIWBXZ^MBO'C,B8QLO<]:/72<()66GG+LK7,B]>PP5#6G MM#&9]UT7[Q;<3E0+4FW@`@`X[TGZ=H/.&CJ'%Z,!\GH]L7+[W<6NQT/J<2XM M2YU:-%0:<(L:#X_)O<.`E^OS;`>G_E7'OV;+>3%Y=>VZU:K(&"4(H*4P3D+- M-;<&2@CXHW-'9IX$%^DZ[1Z^/EC(_4XMRI?3^4V:_<<'Y_X^CMG^4I!&,BJ4 ME,A2905Q4M0US:.JC$$>@URD%[5UM/J-K?2C:?7WZ'99I!G7/VQZ=!T49[E[ MB&"Y,D9Z1#AU`L:-(3AH5N]SPVDNVC7:$79]<(X:CY<_ELDFFJQZQ6WIPO5G M$;?`E]'O'0QTY$B!.F0A-BQ=1`)F&!--K3G"M<[K.P\OVBG:+81YVFJQ>/AP M_-ZZI=]63?7UHY'A/?%(2TT(E-Q(C4@=Y4B4])FE&B[2Q]D21D^HV':#Q-0@ M=K:(3)A.N7CX_;&<3E*$R/,)M-CY[?/-J"I6]X]/^]1N_JFJJE1_>)6X=__X MR-7H?E6]\M>HFGS\N4J^^CL2K9A$"KK?/XMQ_.N7,OWHB9FW^EU1C:?S=&=U MS@9SV6M]?T`7NM,'#U##R.22.4J,9I8Z@CRU,)Y=E$,)]@;6=(3:^*:8+&_C M(;MWB?-M:]S7VJZU;P0H#:;6<\QLW,Y<&FW1&D-F`>PK265G*[P^6:4UC1_=[&>L^>"Q!1J00`5"(?M0#E*&@6CPWA/7'94=F29R#]2XWK!`S[ M4,_S<7E5?/=!2N.'2"N:VQ,(=VBE#P#]/ M/.;.?/6_IQ-_N&3=*CY;_DZ@AAK%@'/<`"H,AE`TN]XH/)#,W:$P2#D<4IR# M3?^(SRWF[V97134M)W]4Y7QK7%W[7PJ&:&,4,!P1[0S7!L`&'\E=WFU&9S6) MWQ"KGDZ,U\5TD2HA/MRG3-<%[CIFV[W?#A;46_JJVHZ+A)IKONTXPZ<3,!$1!ZQ M/AKF2E-`+)2FI@B2X*TH)X.R\;JAS9GMOUV+ZMXJW/7U``6`0CAM`8$NP4=\ M(W6DR3P0+L%6;)W1NK$C6R1>-YM@M_/SA9W1R49H;09!J)2XY"UEVG"9^L/P M6K,4EF6F_@Q/X`]M,YR+@&?9$*_LF7/LB:,F$1Q#6*8T8@F,TUA@3G6#JK0# MJ?OU3]L67=)PD$;S&;2HD^84M%'"J\L#6.!&860QR>M!X,^[9(C`Z3.U8Q-J_6VUUJQ\;/ M_9MJL9V+K4>IHR1PEB16<4SI=8TC:8"1>]L9_)MJ401@B%8">J&8@U$18U*L M,[6E%E+W%;?9=:K%P:S26:K%<4`/-M6BCF7;(:LYOP[GTW4+"M)I9BC6"G"GK`#1 M5&K6"!3,\\J=+T"C=TG3"JR#4*FV(5=W=UC]=JZ6BYNRFO[?QNYSG7TK0)L* M8D#IB,+61N%-0$,C3V6>;!M>2D(+]Y)GAK[G^.F'.,/'B+T34RF/_$XP3F"! MI-7`,`NA]9"Z&AO-U-Y`@X$=N>VSY1!@[S>\[<.H^EXL5A%+'Z^OB]2#S6YN M@-?)=X(P3D,NF$$L'FO82@15C0T3;R8IO6N6[!;V_-)<.7.NM=O]\K&U+P1. M+-;; MT6R=5O`\^ZL+1?3(*82(MW5`Z_]O[\J:V\B-\#]*`#3.JKS@3&U%6;L[=C[R/7 MK%14YQ6$IFR?]LO(L#9"F4,]*8Z#52T[;B$&#H(JIJAFC"+JN9%;PCA#S4S5 MSNL6C;X@CP7X>`ORR<5CK)=[$[$;_!` MAF>'H7IQ]>PWGU)K:UW6@TTK\EL?3I"1U=&>5S6;@P[\^G>JT\O2] MR%@(/&`>M#".:1S*".^'<7)NAU+`8_HA'$WU8>>55L`.(4#^^X_KY5U1'.?K M],K3,5CAK)5&:H*-#0$0D*VQ;*"9T\JT/)V:"DM[.+/0@HU/B7]?+GYNBEKV M7"FD44$TI`5DPX21L6\LWX9*WQMC=G7LYDANQ-%35X'Z*7 MCI&@E"4X`!".&!=;,0G\7-R_>A;.X>=0(_JF/7WRNYM&0@:2C`2*,-;&@".T MRNF4P(%S25E^+I.G%7O3GCOW0_YM<;DJTKNNN/]WE#GT>E=B8((+Q\!9+975 MU@M,MV:WEID%0O_RQ,TZ6%8&2U%0<:`+-\C3D MYVUX+C.H+8'3GD1;DIXE=]W8N:7O?)C-5Y]GU[=%-D=RI_0TELNA,%I1+[%` M6C*[+>>))$;-O.'RVUY-XLRN1^*&]1"N'?+^S/HO!]VY=W&GO8M:$)^,<"JU M#CJ@X$%M+0H9ZK/UGMWA7C]2W(F;\YC,3UL-'JQ8=-2OSO5U_*ZP]H%SRHDDBE6#Q^[D)+6+T_,=,S]U8%]N]-EJ?;A8T*G?B=C20*R7`G&+!,.8:W@#-CG`F4P:IJ<4X/A.92_?+,3;4X:U:B\AQ`*4(3F!J#1X$ MH"VF+OA\K^8F3>I[P+;[`S77UW8.[9^7_;CW:(XWN@]\'JDFB(J M`B982NV4H8C1:B2>PR3\%P?B?EBF1ML/#*ZSN-P3FH]<@'*4\PE,4HBS(C`C_I1D'/Q M"FXNS?F2T:%0-YR457FX76>AS8!/$^JN6X\^F90&B2"UD5Y*;Y*%6>'H@FJV M1.?G*-N+4(],QL@K]6^+F]5\L9Y?]A,C6=->Y-P!0DFU*<,2F8)9^5`$P@K% M&L9HY.DD%%IB"5'*SN2`55@3+9I>\.13Y(".L]:1_Y?%HH$S7SKQPB""*D515N6UMF!VL M$LUAI_C6M#P_/VJ/1+9>Z\_'5N^_ON>-B(BQ1+D`9=XHC1,DAE7H8E#-5%;? MGNRMF*T1DV;`#'(:_K*G]6X/^]Z)*EEO2$*PGAG)A$1)=5;C$\SG[++3EK%Z M"6B%T?G)0GZ.+-F(P.C4UQ8[>?7Y*#!SSB/&@'C*#$&DN@`IK64W6#VE([UU<_N7;\F?:9LSOB4X_/.AS3M"I'M&J\[L79U?/A0#%P*0 M1%8RB13S(0A3]5D*R%`UMX=_V3$:TV`R&\4Z)H$=G"#^?544BY_SZ^OB'VD) MN;W\[]UA[[I]S\?42^R8H"X8RREH1A79&A`ZEZ(P;4!>=@]#(\JJ$^>+^662 MS;*LRVH]7WPSQ?[KAP.O1*8QU\GN0])8!U0%X^RVQ\0-%D38R)YI?MC1,2Y# MV*_F-G6N6*_UY1^W\_4&\@]%0N&V^%#\6*YNBBMSM_G;JKBZ7Y+")V=EV;-+V3[T=+DU69K#^P:=L@19GVS%6X<8*;V<[]K?Q;L?Y8K+Z_^VJ7BYO5[/*0KV"S#\9`D,&! M*4\=A63H*BQ1A4SZ2S/#H#^_J:[%:Q#4>KS@^3Q;S1\NH(I5L;ZYGP*]W;B\ MWMS#OL6-N86K>C`R$DE(8AQ431"DOPP/5GJ1_:L^E>SI[ MV4;$OMK_>9+8HS,='?Q"=%('R9AD@1K)$=,HZ(?Q8\$'JW=]\,JF,P[W)BGJ M$J-L+W/V#=+O9>CW_.K^W]-]]O0>XYJ:GR>>B9L9B7T;].\`J,,Z\K*`T MX,1`XM8P/+TC,5D.#N00)L_SSNY1)G6W!Z=\)@(V`7-'N5>>"66TE+A"05.@ M^9U@#4/Z?JQ]OKK MY&]%!^`E(]AC;YQFL@REJ/`@+F1VE-0/U<>HP@Y!S.\FC8%ADB)*$5'8<$2- MX)7MB@0:ZOPG"X.H(Y#RN))A3"")J`!KD=1:67"AZC/Q4N9GFK2'?__=3#,T MIL%D-B;`F`1V<%-C;Z^OEU?%XM]I(?D\7WU+H,T.7Z_M?R,:1:T62&DOD>9! M:J^KM8=09S,)]6\#]+(/((:PNHY)C?>8]P=`"6@"=##D5<&!5[A-/(`&1GZ9LP<-K3+;"89J< M9J,SQZ%R>`K_F>#\?ON]EL0GST4.P1A`EEK*03A'G-^.P^B&M].];5$;,;#L M;OR#\#C[WW$\[CX7)?6(.@P0D`I)T3CEH1J'!JOR\C+HA,<6XQ_).Z7&)-KS M1@3.?)F.`XC#`1$FC%+5V#BK#R?K*(M$5@92-UB-)0?W_B[U@1:U[T:B-#-< M!(YEV@-:9:256^,_H`P]?#MC\`B)Z`*K\Y>1[$RU_$2C@\./#\MU\;%8K6:7 MQ8-;I2W*)?'P`&VAKV'-MPYY6/:%46:W M4FZ^+EU,R@)_^LNZSH>PW8)N4W/GX_+][>KR/^FQ?0)PRC>B%-("4DAXY"E)^EB(:DL.1O%F$M&; M3_D8$M$CG$/N-U*'O\P7F\LINTRV^=7&9WZY^+B:+=9?DTE57.$#YL8IGXF6 M@?1(.`@LH""3-6`L``00E#@``!#D!``#,76MOW#B6_;[`_@=N MYL-V`W%;[T>C>P84)74;<&RORYD,,%@4Y!(="ZF2W)(JL??7+_6L\J/*)$5* MF@\]L5.I>^ZYY+F\EQ3UVS\>-VOP'>=%DJ6_?U!_43X`G*ZR.$F__O[A\^($ M+M#9V8=__/T__^.W_SHY^9=W?0[\;+7=X+0$*,=1B6/P(RGOP9<8%]_`79YM MP)_9/G74TU1]-/^7QW\1/732?>Q MD^I7)ZIVHJN_/!;Q!T`\3XO:-H61[N./KS[_0Z\_K;JN>UK_;?_1(GGK@^1K MU=-_?3I?U'Z>)&E11ND*?R!L`-#PD6=K?(WO0/7_GZ_/#L)S3ZM/G*;X:Q6' M*YPG6;PHH[P\CV[QFN"HO^T^QW=O?\4ZSY]]0T616U&D6A5%?WOGB\NG!_S[ MAR+9/*P)/Z=#'.!`7+Y&*PU>3<,%#\ICO+[\0M&`;\BTQF(AO_Y*T:";P1:D ML8PQ_/)K18,7BUGNX,C*:"UX<+SZRL.@U]7'SLF?VD]67W]$AFOKK;CN?3-^ M+'$:X[@1SV??#9+X]P_D3\MM1H*>%N4>;0JEZ[OAG:@VIJG^885&III^X:I MZA"9FFT@?5D;7^+TY/.BPUK_:@HP'UC(?1TW@B/;YJLF]Q$OJB5!X]C?]_%_ M!,\\`%$:@WT?0'8'>B_`S@WP[\Z1__WM=$?4\U!FJ[=&9XW_+BIN:R=:4HDS MJG&*UV71_>:D^LV)HK8I_V]"V7\9W6PU472;8*VK!5.6=[/LV5R`^0ID>8QS MLL+K_E64K]X9%NTG3E<969X\E"?/1DBUT)O4Z6S*"=503@AZD^Y7TE,M]>+M M&E_>7>-5]I7@Q/%93"PG=PF.85%@@F'UUS;)R4\D1271+5DMEPDNR-^1M79\ M$]VN\0U1.X\P_FUI&T&HN9J.PL#V;%,G6-T6IAYZ.EJ6?9I^5XG&QL:B2>6! MU<818>K00:ET#G4RU7>UZ!UJW#DC2/$-/EF3E'ERWC"`LL^'?M M$ZB<`K578Z:F1@CVHTZUI68@\HAA2XC$3.9#C6S;"@&:_+\ MW(%:I3O%3M+G'^R\("O"R=:"(L@_(N>CQG8F,C^NS]F$DXFU#=$U//::(%=9 MD=1MDBXE&8&#D&?[@4D,.4%EO&V!&*$>V`%MX2G"EL1JLH/WO#G9(9QN&4?# MV[&"3R3M,YG/8GUZ69J))XR^WEJOLQ_5WF^8Y7ZVO2WOMNM6&`I2*.+D>U7V MH2U9-Z;ETM8#%6J^&M@ALG1/`0=0B M!GD/F7$A)C@&E$7O9.0S5KW/6.^0=HNH`NRP?@0MVK&K7A8FCY6]4B(R$P&5 MY-S+PE]*:O1]%2VO<8SQIK)R1888)H;B14G64U=1?IG70A__,UIO\17. M%_=1CI>ZK?F.A[30AZ%AZ@[4=+4#H6FF02>I>@J)#_3*FPDD)R7&&GCP6;PNX%H<<*:K"`H"72T.R7 MQZ`&#`AB4$.>-@9Q>P*PWE&=<2R>X10[,7ZA3G05#77Z4EQ=J9,7%S%O)"^Y M!$^(B>L[QQ^4.CS+#30VOA(*Z\4-I9E'_J3R.U#VIF[$'6>*6N*X*9ZEM/%[1+#(9#WP/,#29A`WKNPVAEE^Z)'`J1K8F:;H= M9HA1KAAIG;%4L7I"(5-+6@)314Q-".)V^CDRQ^@N@/R^8X*K;YTY[5 MI05MSW0\:&B&J_NN;VA!=UN=$C@JZV-+'!:DJU0'ZH5.\1Y]Y2&13I)DL\>F M1#UMS[1H[".MKRDY=HIU`($S$9M!+KP\JSJ8#FII":(\K=X@TG6K^MM90@1# MS3&@`@W?=@Q5U]SVW+_E>E"AO9*=^_OES8\.TJY#.]W%1(?H.3)7!C,ZDPDS MW(],\%`;.'5V-XV9KH-L0]%-RX2N[>D6@EIGT`A-ERTW\]N1GJ$#>'UQ=O'' M`OQT?KE8_`RN@FN`+C]]NKP`BS_A->O]C0,8Y5,C.50.EZ/I;DX\R!"#(K&S M.E-)XG#D'4WBI89:E+QMD:2X*'QBJ>]SZ5:D=A@IR MH!H$AN%YT"7";]N>ZYJ6[01^8%+.:?8OEC=E>RS3%52OZ#@RU?BIF\E,&N!` M)FH4<;^TZ5.T?J@L)2O<6Z_?R+'4D.59KF+HNJZJAA_`P/4ZTTJH<;Z(B=\> MRX09^'*E/9!@;S;5.(],)7E4TXG0V"RSR9(`@B6_L>@@:T?42R3G,]$SH2X= M?%N0*+H8MIVW*=&%AR@OGRZB#8:/2;$T$%2@Y6J.:_F>9KBF;?N=+=]'&HO( M<1F0K&K[F$`%BJP)""Q6$>/CCG8G63)MK#O(K(Q)VCA^S,!),Y$=X;Y M\&J#>#`AU,IRC1_(8+J/"@R_YKB^3_;1$FZ#'W70DK@0L\-5!3ZAEEM M*#4`#,?V6.1&G-7Q-:@!QJI"`GFFDZ9I*!ZL5^^R*T6QJ,DZ(F/B"9^)MDEP M+),]5EFNIU_\B:Z3XAN*\CPA"G&6KC[AS2W.EV0)9]NNCZ!OZ@@BZ"'+ZHQY MEF+3*-XP"[+KQC\1J("!#ME'4M&L6.XPY^?NN(J-1QMC(?@F8^#?#3#:I#"0 M.H9KWD>AD.\Z=VXJZ>YQ/^3Y&PHNAJDYW,L^W(E,Y.!A4>'/:71WEZR3ZNFW M("WKM^RVYFQ5,77+]%W'"BS%TYW0TCMSMAO2Z_``&Y*5>!\9Z*"QJ,D0^BBD M>"3FV,3X3=*XM'@(>PQJ/!*+?'K,RR:='!]V_9`@"R!K#I(LPHU,[!@2N^%" MO@RF\0W)$/VKT_.Z8Z$&MA;X4`TLT_9T'_F>I75P-,U5!6["<&.0+.N[_8$* M8GWVH`()=BCY>IK20B)DLV:4:/#N*W,'8HH-G$-,\F_J#([-3)H2TMUDV_P1 M1"O]\SQO&6Q[),BT%=-4=#,(G-"V-5UQ^C3@F`9DT=TA=B1KZ^&)S->A'40I MG6Z.Q2:;-@X@4LZ#/X=9.J)[(KB=B;8)<>7E`T'"Z&&X+S"[PT5!:I!HO2>: MYTET2]:OY5.[:G4=Q=8-S_!L:"+%=%0_#/IC0E!AO&E&D%&6V<9Y>^`.)]CL M'2E9=TA!TF47YML#Q?!.IVD3$,XF;\^8WC^\TT/O;IR4`)I=-W.ZK;#;1KCV">K2F*U>L=EMDY6G4W+@XKO>0[1XM"T M55M18=B?([(-RBL'A9@:00I;@"#N$8*'&B)+#V\PI11MT#&Y9%6YCL0=--!@ MX^J(#F:3H2TZ)JM\O=$C0W3P"X??\?Y0>U04:7/HD0KS)9,PJEAD_29/HO5E M#O/;I,SK(=;U#6Z2#;[+N\-2H4*2A602$+2_UD`'! M#-Y4RPHWJ("#!CEHH,\L/"Q'[^80)LZC>=SA&GQJCY.T@Z?Z9`=A#LE/OI/9 MF.-:<,'5EGL^\GW5]NPP4"QHNU`Q$=Q9#ZD>7Q%L4G("W,WB.S*+RRX=1GNS M.*MF<5K-8E4#FW=FL%3VQ91?$HB75(!QM.0$LBVV")/`NN0R3-"A1FIN!I1B MC.3.(1])\(JQ'.,BC7IC^ZT30.=)BL]*O"%5(`QTV[)5Z#NJH:F6#?M'P%U% M\Y@>RQYF27)^.7`10H4/U`!93^`,Y)5NOWH\2MDRQQ`VI>Q)'R7JR%:T&()G ML@,MR)E,QA@4H%J?HL=DL]V@:AT8?:U>.'66KI+J?-#25T/D$M/(JUZWISFA MXW;-+-="%N-+[P0;E[XGO9N!S2X?6+4HP3K9)&7S_KO5.DHV`C1N2!3X16\D M^@6HX$?08@4=V/JFTP[N#'3Q,)>,0BD@*#-63A'>44BI,!+I>A!O08!INHW6 MB^UM+1<$`<+5X^Q+W;5,T]8"6U&,T/;UP+#4SKZO0JK%H7"CDM>)#2Q0M+@: MZ:R1L52_0EFFZ#9,1;"(56/+>`>T5DLT+>,,'8>IF.?K.8B+`%W/@8&=0UT' M&03/H>\@Q:],\L@4L(IO('3I[KS"L50"%0:!A0B"P#1\V]5-O4]T"F2\DEN4 M5>GK]FZASKUNU"UBDH'O?#19ELZML>[K;E M-L=-/X-V`U!2')@5<^00\.MF!13L(27RV6#]"/;13B>?[S-))Z("(S(_*17I MW&%!%4XA72?C8EMMFU7O-=@]&-4+R'GTH]@F9;&T-#>$CA(&EJNY`;$-]>XF M4E?S7/KKF,28DRR@#A9C$\S7[="`-UT;0HJ0@XU*,2R.8?6A&"/,FE#;VCC>X'7 M=_4/.$99419741+[VYPDLBN<)UF\=#37@TBQ;=7V+>@@VS3"'HAA43[N+\^^ M]!8%BHI[@!\?,,GFU;*[J%?F!<%]DC3`#V6:5>70T`[N\`!Q-L]'C8R(+GH% M&+2(00T95)A!`QHTJ*_F[[>XRQM-V%L3^')"?7P?<: M\8*I9'\OVS5>X>1[]1J8,,OW$"X]W=$<,PA]#8;(56U5"?>.(9HA6R]^N#WI M*>XB2T]6VSPG,QWD/!#)/UVX:EW*V MW+43Q!VXFN@]>%.]0>\074?Z2.*HGDGO2*!#A]ZX)X@J:L6[+.^K(S6M];,T MWA9E_N0GQ6J=5?I;[-Z;[EK$KJD8K@ZA'WK(MWK)=>Q09U,^<7:E*V`-=6^Q MTH$%>VBI7G$I.P!T`C@-\VQ"*(QR*9I(S>`1;10?A9EHI`3',MD#6,P)P6=; MI62=&D:KNM9?*D2H3<-U#$-S(`I@&"A]>U^QS$#`04%NVY([[E=O=S_ZZQ`_ MOCS=`7;G"N]:'\2<<^./#F>/9,3`B.B0O'G^HS[K%LXD#D*.'8X2#PFG#[GB M,O04XB&RV`\C#J9]KCT14>[1'4T41"-U=?"E*?#17GG?;T>@IBD`T_B"<-?\ ML-3)T'*0XRF*HBI>Z*M(Z<_DZYINL14)PLU+KQ6>']%I^R//VR-<)W/$!X*N M6)@T`FQI[4O7C-H'N]L-';E&8"7N2*D@+08SJ1CD^9>--)A9ZHNX'JEF3$NQC`Y&X/GT#QI)L"VY?OCREH+N M50]I):BONM.U^.+:&?#0>@,>B#LL2U@9@:(H)2:.$9?F/I?54`QAT MB.N-O:GCP%!*3!P/OE)"?%SH2@EVL@Z5$A)IGT,I(=.];)S1RY+T@LW#.GO" M^$\_A M&09M12$;A?3"HL&\G_HV[>-1STX;M=VT:%.=+*Z[:$GO#(OHR@P811*<2:38 MDF$'&K2QVO5PNB?96N#MC0<==-!AGTN`&++C3`+%ER4E!HPN7?*S=RAMCA"/ M.:3/,=S,QAWFC)VYOG`E23RL'_EJ7HC@X13?58>$_<"`EH=T:`1&8$+=A'[W MJ![T;1BP=>(&FQNY\]8_'-=TVYX](]><74J:*C\&M]L2;-,7_X"Q/3<\&G3M MN%'#P);]GO/?@.M>6M/!&[D']QY;1WINPHB>28]-G#^9I!')^B+K[6V!_]J2 MG!]\)__9[?G[BN$%KN.%T$,NTBS-,UW#5'6(')/4+R[M:Y%YOU_>#-M!`@VF MZ4[`'&+GR(P:3.A,9M)P/UZ^C5@,,=PSYP8_EA[Q\-M2]V&(`M4BT]*R`T5% MT%4[@\B&!M-+WKFM2.XH+SY[B^!_/@<7-R#X)_GO@O5U[?ST\2F/'.8&2T\% M"]2XIA:?GB`&]6$G=:;RP^'(._K#2PUE)S#*TR3]6E1/Q5<7+&6;398N[J,< M5W:KPJF3/T7W0P=YEF)I;A#XT'`MI;%N.9;BV"R-/V%&I9-JO8UQ'!(RJEVQ;3-6+^\ZO`1KC1+66RA+S;;4_V?O6GOC-I;L7VE@ M+Q8.H'C9;#Z:V4_]XHWNVI)74APL\D$82[0]N-+0F1DYT?[ZY7,>LF;4;[9S M%P@218_I4Z>:IZJKBB2B'&,B>)**6$1C$I[AJ-EK:F4T/YBGN1=W^HF'U[-]4"WYX;MP8` ML>=*MN_*C5BW@;*SXP3TEG@^!EAA_\B1P:]W`SE>>#:ZGO*"4HPGVQN,SC_N MSU/Z^Y3[V!\F*VJVW>SQ_N]:@Z.&4TSEB0<\R0OLX2798^*967QXBOK M/:%P)S9;X*V*/!E,ZK#W#WXXZ47EQPX_&`V8KM1I1O@1??'DR4"$Q9>U]227 MBVH)=GC'U?G';FW:KKV+CBR7S:53=5CHX_9W!GSDC]GR]JIM.3<`$>0)XEF9 MY1'CB)9<;`#FF=(+JORA##XW.J`SJ3P&^=4:KW M=7OTL61=.4CW*M:A/7O63?W:EB..U;N].SN0.#.!X4_KZ1-1+U\8Z59H_J9[ MT3TL&8<9AT24699D,8Z+=%P$'#>']UT>CAW"M?@*1(LTP3\]%!M0()^1:DO5%M[B]EVSQ\YF]]7P MDO`B92E#24I22"$F.4FS8H,UB5.EY'0*@!X5JD>DG&1.XC;)?#-TCREV"7]_ M:(<;A\3Q17>YR1P=4'HLB9S2@X%H^+0(W)3'Y;J^^>?YEQ;=JEFQ M^U_RY5LN1K>[@U94L9,X#S*6)2G$&8$;4%P*GV+L_65 M7=M#@U26Y6/V@,GM@WP\2,Q^3ND"QGJ#,/OBM!ZTT M`F+?#0J3().Z0V\@Q(E;Y(9%5-DZ-#/BC/401D?<&5?[V+A6SD;==U?D8?VY M7L[_M[K]9=$PO@.YC;)-.!9_5LN;^:IZMYS?5!=MG.Z.<9QG"8TX$@6)N4C: M!XVP$6J19\S\:.06G^.H.*("'2S0X=*KXDSB/),#4CA^4SP?Z;C,XRG)B%?E M0Y(?+P9]1O)$@=01R:<[?,25;X$.A[F(9P@510RC]I&W2*`<11NHO)1ZU.R4 M^%R?M@[T#(>ADQ78V@4>6L/`;BH*.MM.P/-29[."YW@3.(]/7ORO>-2;TO6A MQ;E#_G$3YXQWP_F7N"#$R!3D;O(96A[-BTZ'RFSW";$2-JS_J86U> M%#S%`O$"49'C##+*Q[69H-A2U)!?T'74B%^CO`L:V>L8VI,R!4:-8X8;,JW' MC`:F@YBA0+2UF.&&<&S%#G-?R8H6&3?,S0)%-NA\8@W M\T5UNJ[N5]=0B%P@&&.2TH+@@N:9-YDOLV>6X.N8+FQ6'5VS3;9T_1AWM1_ M5,O^J_8=34VDHX3R$B6B$&UE31"XF==.+2GZ%T6DY`9^5P4.CL#"(>V7&9K^:+[DX).H;YYL)E.\;, M0=/$O5^^?-G#+`02A*"<)R@3K(S*G&RFR@M.X61Q3Q7HOW+<4W;J!''/I3_# MB7N=E7^5N/?$9;[BGNY.^2O&/6TN7,8],P=)=I9TCZ'=OU;G#^O5>K:XG2\^ M_5JU\^?5+>E?R;MGSG66HT(D,,,Q+7`$TSB'VP)G'DL]2CLDO(ZCX(@-#."> M1D.E!DP8C$DURL*`ZC@D`GJ\]DB'VN/P>_NUQ]Y2L&,J>&&S?(][1:77%P9D M#ZW"H/:.9+_1BW,.MBO#VAI!=#L#HZ0.]THVSZ(TT[ZSA[8G?/YQQZ#>PFL1 M\8Q&>8D)Q0)C07FVN:&/EX54$2$DO(ZSJ+\W.V>]IW?FL="_3[7SIJ#=&4XI MH;>W+3GM!L;>Y.]QOQCG3D'O&X/<*:C]8Y(_V7:06OXTV?8(-W^:CI*7\Z>) MW>6["G6Z6"_GB]7\YOWL[J%)]C*.HD@@4=`TQB1/&<8#V+Q(\11U)T6$CG.D M#1K0P?G11<[DPX]>JTL.7>AYENUD"%0GNQX_`4]VQ?>Q!28I&CG<"G93'6]; MPG=E:-\#[FM!FAX/-WOQ28*;>H^12R:L\`P_:1]N/217O(A%G)./Q6>'5R3G]@U?#I5A<>M.T.L\.Q8'$J%1V._3%WA<;MO M0J[PJ.R?"2L\WSC(:X5'?WN$FR--1XGS"H^IN[Q4>'9`/DGV>")PDL,<)@@7 MN)N-BD>P,<123XZ<%J'G"@]PD33Y<*3[$H\?'TY6XMDQ;\H2C\$6\%?B\;,5 M)B_QZ&T)+R6>@QYP5.(Q]WBXZ8M/$BR6>&RY1/H6H*=OT&UPS6_(XI;W[^O> MO`>S69(1@4LB;*]ZE8XWWXSG"E(2K1?WGWBI.-R0/.*=[";`D M@4?N9+'M@D!N2K%N5NUVYRKJX^FBN?R']XJOR+J1Y`\/ZU:>K^J+ZDN]7#?8 MQ&(]7S]N7S2\?7LP@24L2D+S2*"H2$F4$]J(XR8B::KK%XEQ+F^-WM6PW MZT^@MP2\:C"N?@"SWB(PVS&I?<09GS?K--YN=??G:G:W_MQ]>5DMO_8W2#8? M\WI/GC_7=\UV7_VD*,:.G2PGT>%X5TVX!U\.P`%YXL1WC5L6ZQ.P`WHZ%3?B M^(BV^_%=((KOR=AZBLM#*SJ\:52L;&AB=;/^XJ$!`>H_)%5;7BAZ"DTXY%S^JC1;*D1?"L6F\7WU?FLX:6 M!DE#T5T_M%(U.WM]S1@E>9Q&:9IA#M,2QPR/0#*8Q=>+ZM.L2>[E--'^^E)7 M;]%?O;M0I2_B-]5J]1-X->]@_P!:I?PF^UWL80?S`;RJ;#KPCIR*3N06+5%M ML()]87VJGON0P8C9LYPJV@G"-^U*7.] MD$(K"I01D<6$DY(0E*`XVJ!-23NC5Z]G=[8R6"<0E5K.&VNLY[QZ-0[KF;*; M76`KNYY\`[C)R#M?]H:!P;)`PXP;%QEE^D[W1"`!:VH6E$\4'IPB'?H:(9W? M5HO;U;OF0JB6RZI_7?!UR?*4,%H4)4W2G$9IDD6;RD\1)VIG#=U5G)\HWEV( M4EQ<"`XNK\[9?P%^^OZ4BS-^J1@[M&F4$W^G_&FI]P;1"=A@ZB=E/8ON`6J. MJ*8IF8'(GK$9M=T]IC+D^;)&[FMB7X2[W.E57<%2B%(RR8 MYIE,=13_7*509`O3AZ^,J&J*;/56OOW16@,N`?:<@^NNMUB M.ZO6YQ^O9G\>;4M?1T4A2IQ`AC'!I$11D6UZT*)@2@]$]X?*^;T:WX3\VQUK M=H3D!"RJ=7M+VJ`[Z]F?TH^%G<"9.L6P4/QH'--W#=FK@)WU+FRL.0FQ06W@ M`.GJE@\G!W*RF\#PHS4L?]1K-L^_SN9W_?*L.ZMT!]V_'I\$Q<@=,S=OY6-%IS?GGY`RC/+]I"E[BX/&7D M0H"?!7ES]7/WY:6X>'_*Q.5)^R>O0?-7;\_/P.7/S<]^/G_#FS\QZJ-;<)1. M%]VOCXQ[Z"/<5MU[P&`7\3#@/VD/_45&I3OH]GP3B'H[,^]H]]PVC89W0FT& M2$64D8@E"<]@E,`\@Y2,B[(2Y3;N?Y)=R_D$Y_&[GJSL'6,(T[ M![B:DFFELM?(#G-PLR][C!H-M>CY)A`)=6:>\AB*"8TZ;=[GRPC#5^VDR_C+ M8V6A&C+7`J;HG!7 M#3:35F[T!N%D++&LR]4"J9SI';7-PB'ZG5^ MY2]OVI#]86FX#ZQ(LUPIV[K[PVL'N33[<$O9$M\*XZ3-X_CZ;+UH,YXOF MQU_JU>SN_..SOSB"W,]<4!01G#3_+DJ1EHQ%L>`IC[,B:WO96*E!/`4^Q^E" MBQ[4BU9J.NPV8_^D;I4[ZH7N4;7\K1G M1PBC&KD(*,MD3F0 M@.'!4(,))!-JS?K8"WBM! MV!%H338-NMI6B;34S0ZAA:W:NI;F,1#I,C1"IE6M2(FVY#Q]=J=`45F@"*,, MLC+*BSQ*QI8-Q"*7ZHO86LMQ$>/@:(V=QP@K,ZLG1"Y)-9>DX!X6K/^08%VB M`]4L;7->4"\SFNR.V@Q8^AQ.1"RG"6,4Q5$*!H^8YG$& MA->$)JC(N"`P+[.$$ MB9RRHBPXQ@F$+&K[LFF><0KS>)))'26$CM,(CRW2B3SL>6C'F7.#&=N9\K#I MQ$T^1G>TMD4@A]:)27`UOF/@$E<#//N0(M1@HI3F"/(H1VG;8AX";0YCYG"$ M1PG'O^P0CYJWG(SQ.'-4>(,\X=0XE;QB;YA'R]>!A!`OIIH-]!C0:]I?O\Y$ M)%B24@IA3C#)XR39MO.1V5"/[!I_C;$>:4:-^NE6R;361P^C>:[>-)=F,Q`Q M,S9#KDFN2(NT"/U:S3]];IOP7QL5_%2=/=Q_J);G'[NE5^ M[6JJ?8J="NH4\^-*5%H04#67?&?JJ6BH"1(I2I/0S2]NHJE[;6XR'''.B55?749]M(/[W0[",E#4-##]&I MKJ+&C@E;1\W-DU-22S3*/]!\MGY85N_755_K@%MKII_^CY.?TO.$:4R8#(0,3*QX.ECNTW)4)KANJM7W6KC MS8K5+:OOOU2+5;SQ_9[Y(_9\K;=8]T6NRYP1&!) MRC++"L9)U-=#6Y@XSO-4Z0FXOK%YF-OJS=ED&S]^:-&"79/`KDW@P^/>+PYV M@"A^D$W+)O7AC:FF(7!!(Z)C/_F4&M MZ=P@';0N;SY7MP]W(\@/3T%>5*OU2YVP/3!S^7+CL2"8/8*8&$Q3"XJ`.\E,T" MYC<1N\-U_J4[:;Z?W3WTH7ZU>KCOO_<$I4`B2:#(XSQN8(H8ELDVK$=8ZL[> MB:!-%!3W$ON30?$&JT[`QBZP8YA9%'3N8JVX%Y)W[40Z#<<&%]H,O2(?S'RY M/\SPY>S(,X&(@S/SGDXJ.Z71]/+>%IQVDT)T]:->G#:KZH5BM6WW]H[VAHT[&-4N=) MDK#V+0:PR")[3KH:]GRWG[>GF=-%$[.;Z%HOU?#VO^B//-<>DQ&F*TS*A.(M2$I6; MY?.,:G:"S-;T6+\:@8(1*1BA#A6,(]>@6]Y5:T_^*-J/ M'0<$HH/6S3I8K[%)F[0Z'EJ4/K*[V6HU_SB_Z63Z_&/WDT?RYWQU35+*H"AC M)CB"19EFJ<`C%HJXTOU.3@`XULUC5V^+3U4JW3A!3C`WWK,022UQTA5 MS6BM."@0R75HH$PN:Y'*%\7WMII?]XO2QS=U+_]=PIPBFN(D2I(H+B#-HH3F M0QM9Q%$>2=5.M3_<=:NVP]3>NS.B4CODZY-V7`&]\*78=U6GZHA^K:J;UY_J MK__1&-I+5_/%4\4Z1,(S@F3,U\1Z8XZ_MK1Q%-1B_/PA&4S3/,)1DB/&(DQ( MP1`OQQ5B(3=*K/&QCA5BN]G5CJ0Z!+VL"0ZY45,#!5HLJ,"^V0>N?TUN`KCR M=9'7QAM#Y6UB[.'NKKZM%K\VV18J'LHKV!NTOO$"IRSG!2 M4H(1BQ,4P6A<`#=!0*4`)O^ICC6W`Z+7=55@1JX6Y884-5V5X\-)U6AC_I%J MD#I%@51Y-(#7IKM#YTH?Q(1A*B`3"!&^*O3GKGTM\Z6O_K=-*G'_<#\LDJ&2 M4A2QA"49RCF/N=@L0@E4&F95^V3'"C"`4;ST%\*`I!CV,R(=BEX9@0:-$5BA#H@7\J!`84*-].1FY^?YBO MYILV#\I248@$HIC#,HK3G!;%N%R6QIF*).BNX5@<-K>3[>#2*Q)HDR@G'3[X M4Q,1+>J>*;#`G*1II116L0Y M0TD6;R2UR$KI+K?A.J[KL`TZ,,`#`S[0`U3IW)J2>5S!?/.H6+0]3*%6%]R4 M2X5.N$=.];KA9MS*M<2/DW"H+6Z)NA!:X[9,J>WO+"OWDKQIHLOINKIOYR+S M`N.<5P4`I>;?EWS'V9^YXC\6HZ%_=`M"N"W%B+H,%JYNUF%7KE$U2>S M:E)O2*K'6SPV;!U)46WQ'$B":LT"=AQG;\KA. MG@1.);(RLXZ3K8XS>((0`18NNS$D<>Q"$++@N45%,$KD+ABS#$;FC56ZC$RA M84M@8M4@?M/1T$$<9D9B/_34SD1+JW2QCTY:A$W;ZUZ0YX^R6+Y MB?:RRH_F7LPPBYM#MNM$)`O2)"8>BZ7;1>,P!&(*;V8MZP)^O.[U6RL0ZU8@ M\LI9,I_8^MP*)"QZ)55.9(]L?CR%IU\^)9(6O?*JEK:X^K0RF/^FF[>XQL-' MF0MC_(TA=V'.F-+&(Z8B^'?K15[L\F63-T'YDG]C>,1+?.I[H9\!&"7@N!Z? M7RN?2&,*?L;Z:^*M0]B8=%O+CG.2K4^,F%K?Y?-=#K]L\^I.S8=M^6V] MS/DXY-=Y\>.17SL_+1_8<_7"_MHLB1/L@Q3$%-#`0U$H\ MMJP_#,ZZQ#8Q&/MJ^T;MA;G$LZ^]E<@P]-'>8H7E,6PV=@PK;3^@^I=.X++8 M,2#;ZC?3[;S8K?+M-E^Z,QSZ"04Q\;,P`UD29`"W%8,^H)%46Z'1A2U_9+1. MX)GDA:CXV6%8+)$_&+ER&\^Y:S]NG#=(G1.HP]\"\B&)`C5]1GTQDL2['=NN MWQIBBD!AF6P_%)[8II[O;HN_OZP7+W6^?_+*<>2[&?*@1S"$('0I\4/?=1/: M+$W2R`OE#D]-K-AC@GU7P736A?,7!]JDUYVR@2JIF4;H%I/*OGE6S\15[,>0#C-ER+@%MAB`CLC[YJ\B7,Q>S MZ!EAZ++_RG",81RTS3.$9)E0E["YU082>&?5X71*#M2@1@G2K*_ZYADV+OW. M9!ARS>T"YDFVMA5<(]O(AE"MH;@KR''Y"VP-D@9)[`\J5!G9)*K4]7)&(0S3 M-/5\PK8F`&F2M/?'4YJ1T#>U2P@N-X)M8E,A-2AEHDSK;Q062#:_4]P-Q:^Y MO<("S_8VBVM\&]DMZD44MPM).G^!_4+6(HD-0XDL\;NV>8**/X>3%9[O7K)- M^=>QW-TC?I1X*$X\W_=<&F0Q\OG(D3!*LPQ`T2F[6FO8TZX.%M\>.#"G0C9< M:\DEGBZD9HW0.Y*@/6S*0R?_L/)[B9_?W*R MQ\GOSN2!/L+I[?W?'(BGMW_>3F_IT[_+GDM9<(3@,=6P'I`,Y/)]K8$M7'XG MU">.V%D7GYT.M'-$/9Q0RC-[Z63+GIM&(JHV+7Q_[F6;3&$!9A!6Z_U=N=O- M@MB/4]\+,79)A#WDI;!;(0N`5`V4Q#]K^].6O;'K8E%^S9U/&X;GLZ0PRA`D M)GB6N)$7LMN&%@[E\PW_[>:PY.+U4&ZK"B6XWV_7SX=]U;&U+YU[]B*5Q9XM MM^%_K6T#ZEG6COQ=D"L%DD'KY`Q`W@/,'LNUL4A7S8: M5A8[]HA-5M/Y]].G:%H^YJ_\Z2J^U,?\,PH(24$,_!@3$"0LS@1A"S"$R)L5 M^1<6ER[%=*<_7$*O9EJ_FJ7S1BA%][5_ITVDE=]`,/+ MH=\7+:'!-3JVZA'>#$64@`2D)*)I&@<@1,1K5V9HPMF^W,\W*OJAM)Q4/-,A M$Y:%V]-8QN'/E+/H8(Y%)\X1)RP`6JR/\LW6L^CB*VN`+.%W$2[_][#;\PS1 MCK__G(KU)F?R<(0T+66_:WP8QA#X81)F/H!Q$N`PJ;%"$/J^)Y?.&02B]83/ MB54\#-^V=KW]L+D@!OS_5;"(?\%3%Z^GJ8M#F[HHN]3%O&-`-HDTS`,B]M4U M^B=#[OOMW2/1&>3\]&''?_S+I*QL>.G"QC/H0S&2K6I8#LH1O:62VR')7YD2 MK^MKYHLE_,KCX7_5I^@I^X^;\0E8<82S,*&09.V2&`:2NYK.2M8WIU-PSKQ8 M.O,3>)(;B!:E8OM`7US*R?DIJAN'_6Z3=WR>0N1C_PJV@2\/B\OT6E'G"]Q= M$%D3C(]$*XV84II_(.63_M_6.[9`5FY)>7C>KPX;N%B4!R:[LR0"689P&JAS.Q*E,F/+S^<*I@B2B++J!N@Z`)S.O]/OKWRB M43V"=#]STR#RW`QEQ(6AY[LI1FZ[K)=2*!MIZ:W60[15`VP__??S[\YS#4XZ MUM(D5C3>ZH]1V9BKH;+Y7&;8G`:<\ZF!=^&TV%*$=9&MBU&6&9Y'HE_&S/DI MVC))D\PQQI87J)*\_M_;XBG?K&Z+W6$[9WP\YKM\^RV?A3`DF+B(Q-##'DUA M<%P]#8"DF!E:M.BD::M^OF@R3QIXA7W+_-MCGA-/Q\;QB2Z^2+V",$9"M,`92@.0Q]Y72XO M@5XLIY"*BUA7Q*=]N?C';\\<6#4DKT4F*7&J'(I)6@_DR4E8!:AA#0NQ9J<_ MX2PO%]1)D\B1J)&N%>^[$4R0(M81>CQ;X%;1?QY8B/%[OG\I693X+6^.(^[S M?;GBI^U5#0P_5'V8KY*`U1A$/(L'5G"RF)V_*UJ6"[J$TL"B5K M4_F"VQHSCQUXD,9/IOF,@95SX+6CNW*S7O)_V)FO5BR68[_L@KEU9Z!,$Z15 MYUT6PG$X3#7:.SDAK@H'&K_5V)T3\#?5F3)O_CHUP.$6C,91$CVL8W&86F>K M=<>)M;UJD'AF(^S-+V-HD>W%SK+G!UXRN/_;G'W@WU5;PZ2@W_FY_6&]>ZF; M#TG^O)\%V,-N0C)($@12ZF$2=@M'D%*)?=7ZEUMXFQSP+@C2")(PID]448I1&67144Y3*];JHKZ.@ M8W(25D&3E"P-VL2DRC)?2A)587(:4%W=9H.K[\.G#PFZ($CZI(Y$B`P84II^ MWK0/F;JJ2#Q_7>_GFZXD$I`@)%D24Q)2F@`71"GJ"HMPXNL>-"DO;#VUBE_8 M[^IQTW.V-^QW58U=>[3$BY_GJU6^V)\4T&O5Q)MTBNI14R_>,'+<=*Q&;Z`. M5XHN3J/4P9.V+T:BES8LNWH`98@\#45]S!?Y^AMO@=S-^#P<#Z6)Z[,E`A!3 M'Z2=C,.42+4S3J%)L3L!-[BVG6"1DC,5@D>K M8$K&7!4M=8HT=.IAF[_.U\NVW*F)/&&QK*)26$4^,Q0B+_`"#+'OHH0&O%^T M1>/Z"=`5,",@K"M;@]+):WAU0%A6'V9UA*@M=6:,4I/2FF"*U24FK43Z/56+-67A5?"Z1JJ');+/\P_\'W`][NLUAL#TRQ MCM^?,S?U,A"XA+I^%H(H29.D34NZ(4Z%+C>W#$% F=DVW\V7>=>'P`L]J M`E757%B#[<1:6YO-N$15FWOWAA%M;E$[#R>>:8`[)\@'UV@1>J4TVJB_1JO1 M9JV\JM$62+4P@/;LI!7?I2C(DLA/6/">$A>S#:-%A3P*9&8/688BI=GR7#D2G>_+6N59 MMP9(%M9]04CG)^+-$ABD?A;X(("^#V+L!5';E^\&P"4R(;I=))8C=>DAE4,X M0TS7Q^,'.5F7EO0W/AM,U+7HOJ#I_;AQ))+>D['E$&^*M4!^YGD!H7'F^1%( M`"))F/AQBX#@T+43M%]==M@`_5RM@[7X_+H+3,?B1MFW'G>/-L`V$DP+^V(D M*FO#,N4@69(\7?VL6P3.S]5#+O5]G``*,7)]&A,2H@X)P(&1FWAT`-@O)GMW M$\_M_9_TRU@L>>?6*_\K,^AY$00P]H,XILAWB>OZ M'0(:!G)U&P87ME^KP?[\9=YT%+\V.*OCI[P%*3NTSR#M8C+;-]]J`_T:D'QZ M=`/3:7'>.!72FXIW>IUW.S/^A%F\(*467#$2";5AV?MI@+;(4Y=,=-BMBYRW M?%67EG!E;WZRG(4N\-PD"?T`$C>-PRR,CG$S2GQ-T=19VKIL5DAVZVJD\(?" MZ>Q?MN7ARXOSW)C"1\\\KPN5R3-F/:.HJ]9=8DQ9CTB//?L\MFWA#JVM%YB4 M45<3#AFKOAJQ[9K"FB-0JP6"!<+K!1,AOOXL00$F*$Y=BI(04`^@J#N@H[&K M740LN9QU+:T;R'@9U+9#5B56#71$R!&K6G1F@U&S?1$=K_@BK[WU1ISR)=D> MH43U2$3.G#T"31(:1,D,OE_D^;*Y[*[ZQ-\?MOED=136&2'83:@+88"S-/$0 M1EFW-,.32%Z#J[V>Y1/\%F(]2V@WW^0\^E@:.=XJBZH`XD^B<81=[[#L= M0Q3`%"5N"-RNU#8&,5;[4C:UNO4`C^2O)?M6/NT#6[:CXI_G&S[[5EH(37M` M[HNX5^KU/HKY!/!/;^3R<]/V=>Y$9Z#O8D$^!3Z-37MF+$)JR[P//I#MT&CA M[/QLB2O%.(I!$`,O!4D`LB"*VO8S%P?0,U"/9`K*_]LF`F.^,GW4;MU-UH_= M1]U$(,BXD>-X+5>.1-G[LE;YF-X`R5I-!&<@?5`(2Z.`0I@"SP6`D#A*LK!+ MV(8ICG6;",PA^66;"`PZ0TS7Q^,'.5F7EO3Q-A$(TRW91&#>C2.1])Z,%6@B ML$6QA4!^EF8!\-G7A(\R[((8H3@%71M#F`5V@O:KRPX;H*\[K3#=1*#D`M.Q MN%'VKH&D.+8 MAVX<=Z5A`H!.!#H#>FPBRVWMXCZTT$6@Y0DM-^_*`457M0(^YB>`"L_)" M:\)-XQ9<(Q:*":\Y,H4%^#%O;T.=K.[*XLLTWW[E=QW`8MF,S'W*%X=MO0ED M`0Y'GN-(K+;W>[`"P*NHV%[Q"SP21Q';ACA@&#/!VZ2PA80 M"('DK0OV<%@/>=_60ZT;\*T4:U29&?:'?.W9<([0J4B[/?'`6Y'^0'ZK-H4! MR]6D:!8L8K/CNI&H\G`<)P2[ ML$TF>S&BKEJ]F_0RUF/>X^>LRI6"ZO3)%:O9X4VO*HW)XI$\?)D\JY5G[\D1 M*#%3YG,LRJ5MQP=%8YK$:,:+U?WFNS^*):]46S`\ZV]\\NWY:\]Y1^V._;7- M85[UP_+6V+_FVZ5.P\,`KM8)5\?H8U,A;6V;<^#&.9UU MU4-0_>BW9VZ@*`A;F=D4YEI=.8.8K0UY#+I,/COA^5L6Q$XR!#*,P> MQD4J'2F/^6LSTV6R>F2*G'_E,^`?MDW'185F!C$.$?1IEL4)30,7$DA;&)AM MUPJW@9N&H!"]*]P-_OAFSWIM(3H[CE&]*<6,$^3B_%Z)UV]*.6+ES!_1.AW< M>H<8KB5%A$VQEA2C?AF+>MLR[^.6%`LT*B0[R)H?2A;+'9/\KV51KXH1I1$B M./-PY*8$04#;&69>EF2*+7Z*BUE/?#P;$`$DZ4O960UE@ M6_]!SLBIH2`OA"$):1K&J1\E,`-)VL6M01!JZYLV@CY%[UV<:%+W]#VA+(;] MN,"*0KZ+&:M,Q!']6)3S&L%R/56',F7A=>PW0JS%S\?5V4V_7^1Y54 M>"DWC._=#(:`EQ.GP(T"'"0N0;@M+/82&*>J4Q:5%K.NL63-IQ8]'ZID"1_H M5[!GIRSV[%_<\)SANMCG?$J8\O1$-8[E)-4FN=H3$N_?$GK;$#K4^=MYK@2$ M4)/DD6F>KC4?SCDT0))"7%D)9IL\K<\"041=3#`)?1IE04I`C2C219F*<`X\3LQ)2F(#?2MFH(B M\WK^4L-FC/E*3"-'Y"8Y%55HSQKUL!E!QB\H/U+X1)U/A-:_^LS^S*GFSL![4O^"_MP#/^[BX0`$[NRU`OVTGV_W.HHJ MNZ[,>_P>HO@K_9%JWCC/^9=U450)XY53+V!$2J7YU]%0FZ0;$\\YCT]KE$X% M!&Z=^"&.841)!&&51&':B3#M=I(5@ MU8"95>55L05H0A-S?H?.=37\A=]24?Y_J;=4V"BEMU2.,N&W].GP^KK)^8'\ M?,,19)ORK]MB56Z_5HF\;O8>8&L$F%+/]8/831(,47=`@P`$4^5 MFM^?_GAXN*._L_<2WK'OOVSR^#N+&J-9+$P9@E^Y0.4481VL<(S. M"QE;ZVN2Z4?9BOEWRF$@4A!<#S7!"Z64`R M&,)6N-,QDVW5]8U3U'>IS[^6!_ZS13UM:OVO2S>J MFZ%33-ML,BFG82T2AT,98KK;.RHN")(J:2,1'F7X/]VAK$.#S/WOY==\.O^> M[]J5`,&N[Q.$<930R*4Q]MJ/+#]%/I#3$NE_OG\YX1"=/<[-'FBRF&5 M-UGQJ!BJT`PH(.\9N:@ARO2-1D;4+?CY-G8],H3%A!=8;,I==>_QZ02:QWS# MVQ:JNNGCC)JN+23_OD<;WM,6^V[LTS2C$85A1,+(3<(@='V((QAX`,E]N=E& M8_^+;CK!__D;@D^4.'CR^P.]?ZJ^Z"15RKI7Q"1M3.Z0T[\C/>S"V'>6DDA;Z]U)Y!>EX7 M%:(CTN/J&8))&J<$(NI"1#*,(*I6)P`BCTIFX@PM:EVV_X2/MQ#=4>?V?DH? MZ=/4H??3V^E_2\JV*8[%U'D`UF[0=*:HOSKQ;\$Z-=KATN>2=%Z)A_Z/O6M;;AM'VJ^"RYDJSRYX M!O\[G#CCFL1.Q9[=BURH%)FVN2.+&5'V)/OT/TB1DNQ8,D`"(*1LU=9NXGB) M[J\;7S<:#<"$81R9R\;4>R7?,0>CRNS>&6US=^KKTKW&.B$A,,-!DJ9!'(;8 M2SC..KG\,%$ZCV5<&,,5-W9^12]%!G3QAUC'7G[@'YM%K&H;JGF32#.P.]90 MIN1=VMV]_7H/6Y\YDF$-!?TP<=NQISM,;DG?[ZG=)M!O4QAT`X3^3R4HNZ^WS;,Q&N10">3F-&U5`%(9I@.<5^6S?]R53_\46J[I3OSA)`5TAJ*U<@<-%C\ M4H_+J#:>K::KIM7CU[R\6TZ_W!>SZ1Q_+:I)0N/4Q[X?4!0AC\44(=0-F&`6 MJJ1Y_4P5BZPCW#%7G)/9J@>9-[JM67Y>3W MJTGB!8+'@IBE@M9"&$:AYW>?A5F2R#",[+<,\\COTT4UE6WMDM;_,#V84%V- M!'['%U?X0)%-8LU2*U'/>*_Y4SW3O9V9WJKXRGQ657[D6:LL;MG/QBHS\/*W M21#[*62!%_H)HCCA6<"3S6<]1J1GH,2W#,_`R_NB5)E_,MI+S#_-BJO-O\O? MSB]-S[[+W_;-/@7579A]*N*6_2RL,OO>7]:?K8N*&?50@#%&//%9]]D(Q['T M[)/XEN'9][ZHZG\K5&:@#`(2,U"S\FHS\/WYU=7E'Q_/3<_"]Y?[9J&"^B[, M0A5QRWY6EIR%TZ?9=')1S.[+^;1Z*N;S_'>1_3[._OSV/G_XG"\G89S&E*1> MYG$?(0HCE&S&\WPB=49A\""&Y^TST'Y;14]M8F_!SCP:2V9 M;`UA.((WY>RQ.2)8EZC=0/*92!80?4&QM:Y-R0"F`6PH]"WM7^%6;8"-3+KZ M]"@U>Y)*LG1^,CS/,+=HXOL.E4Z?QB7ZJDH+T+J9**N&4_(ZND2N_*Q^+5"1^$ M-*1^BM(T1)Q!6C^MLQDL@O)Y4N\1#,_7K5PB+,FVV`_$3"(QL@*7VA3?BC0L M(^J/FT(Z9`6_?KE0/QSE\J!]:N]+@@;#Y$(&-%R)4J?GJ/#NU9_U0#<7C\NJ M6-QETUDQ+U;?+J8/>;,O+(:)",24,<1\XF<9PMM^E(QR:?8=.(YA#FZE`ZUX MH),/U`*J=8QH056"GRT"JL;2KF&IP-D6,>W'W,.PE6/PPR#LXW%-T+G`YKI4 M*?5[EAYF;_?=12SA!-+8IQYF"$,_#+J>GQC25#ZS'CS2N.RNUI>C"=M!#&\` M5JT`++]F+[#L'GS=%S:W]OUI!=+MZE?51DY\N\%D1S]T_OIXG&5 M_Y9/YZO[V729T[R^CZM=2D`24"\+XI#Y"8G%P+'G=2,2@N6Y?]@PAHF_%0ZL MI:-".K`63X69!@(I0?3V,%1C^;WP]:JZ#,11@=[MX=F/VX?@*D?F!Q'8Q^1Z M8'.!QC5I4FKW*14"_VWZ;5T%VC-FDD80930)0K%J\.,X\C='A6(4$:DM*RT# M&2;QC7C#:'PPG!)$;A-)-2H_`&(O,A^,I@*=VT2U'Z$/0U>.TM]`81^IZP+/ M!5K7IDMIP+N4-CNGRT5^LV=`Q-/4]R")*,*4AP'.XK0;T/,0D]_P'#**Z4W/ M1K9AC#X,19DM4%L`*FZ#[L&NWU[H(!!5]D-M@=ES3[0_J)(;HP?TW[LYJ@,S M%YA;CR*E;G=2*J?G-W=_%[,_]PS)8I3FG&V_IWR#P;CD`>^8PR&.&4(2]-Q:#=SO"O"0Y)@#E&6D2!$GH_%I[LQ,(_D]SI5/VR8 M@VMQ0"./"G$HHR-!MB:!46/8+2:]6%49'`4J-0E2/_Y4`DN.,U\HN8\H^V+A M`COVEKW4X`PJ/'@I_&%9E+1\>"@759<*1RP3G`M1R)($>EQ\?E/=)F$B=:U2 M_Z\;9L16)M`*I3+S^X$EP8W&<5(CR!<0]6+)?E@I4*5QS/KQI3IVHM1,5S^OW;1Y8/&SZ<.T'2MBH9\%.!0#DI#%$+-M\AI$ M!,DWT?4UWIO\]M`D%P@V\$ZE!J]IO?#).^*17Z^RA^J21"F*(Q2Q"#B,0]] MY*6;0B[+Y"X%'?)]PX3+7[Z\44L&&M'ZOU*B@-YAXK4%G!KO]L-,^Y,E&RA> MH1,=P#GW=$D/%?8^7](7CB$/]N+97X]%5;Q\37B2$AY`/PM#1,1_LBA-*6XE M2"(/*SU=IW%8T[7$K5B_+-M'O?.O]7O+N>PRV@36APEI9)C5>.JU!WQ%CK.5 M\_ECZN._X;L'PE?XS:`=''G1P(1F;[_GJP>\(23Y,9^5=XOBO_G-^8W(Y8O; MHGYH"E=5OJH:Z9;Y#5[#(8YRF$$,<9"0.TX1T M^6&2(%_J3,+8,AJFWW="I?\#.P*!Z5K&X=QKQX2]B=HYZ^E@]:U28%`GW0Y;0I(@F#SER\^E;!P:/)P*)>U* M)LU,U^5J.@>S:74/RL?5?"I[<;H^0.5B@E4DU7"Q:A^&7MS5_Y97 MU_GRX?*6EHO5`]0J6%[.4*PIK4LK4X"0V3\,5_D?T_GM5`3&&0\2%E$O"!."6Y+1.A MP@03JXQOA8:7:X&`$+,H50L81E#7R\&F`#=*P*W0#1$[2KX[N&I@WCY6.C+: M[:5B3\[M#Z=XK&7 MA81WP_*0RQ^IU3"682)M)02+1L0Z<9I-OQ3U>G[^"L4J];GJ`/HPGXZ!L1IW M=O"NI0.7MVN:W)#DAW%@56C@L@QOOUZNP3#+M76]C<6^#B^-*+K0[*53G=*, MLZG=LK"HRGEQL]X*7=P0$:.JR]L/PN,Z5[R\S8K%=#$KIO,K\9-UY+K.OZX> MIW/\N5JO#Q@*(BBB5.Q'C+*4I'ZZ[@AFD,1QR.4*OU9%,EX(IKU;UZ)=_+\0RZK[X(C*.62WF73XA+$+8BPE&L0]QC#&CG0`4 M^4&D4FW3-ZKAI>%6DGK"EW_7]T[^IRP6*_`D?ORXS,%6?%`LP$*XX\;@=YUU^A#WZURH-&N+N`W^HD_;#4$GVH=0:ND;((^ MMC?(D?T1.():9!C;!XQ$%#-6.A!^1G8+1V+5V"B43LU5I3OZ^HK:_->NI.OB MYR2B4?VJ&N<)A1&B@>>AI!.2XL"?K'=DQ*)IN9*H)UJ73X7P7JHBS7T[8IT! MEL^:4\(@\,Z`X)5`Z9([Z_:3J!40J0PU&*M%&J_;UG46K]W]6S$+76 MRFTSJ]R`Z+*Y>]Z;.(;9)>]$T(11Z&S'31*&/9039#*^<&Y&D#SV.9B#S28)IVUA? MS*[5JH_,U(K5A>FU:F\>HG'#XO;R!=.6'Y`QC.0!5A*'5V`WE#H,,?`))`^# MU->8/@PW@Y4$@G_-E[.BRC>23F"`?`Q1P*@74L_WD0-(P0'F-*<-0$UA)&+)R>9L7=2-0A1<@EF4^'Q M]8LF%F..!KN:SS4LV7+W-V+%05^RI?3N[Q;(WY8%K.\;F^[;=O;@A#YC+$LC1@F$0R9E]).$S^% M4KN^#HM_G"W59Z#3'[0`;"I,H(%`_4"DPS:RWXL]AGMQ[%<;^*6-*^= M!F_=OG9ZS=_:$3+7&&[&F+87((>TF'@(>@AQPF#H\5KB,-NLG5)*TM%:R0=) M[72#N>WURB$DS:]BM-CQM-8V>B`QL^+1:"Y-/%>I=-`<%!]ASL7JC44QH4D: M"JY.NGTRQ&(/ZVMYM2?S$;;"6C2HCKTF-VVI?]>IDMI,:/LF-_L&;ZTPCM5S M=.Y%N>E!YG:E;'N2IH1*FYEZ)U7V'>4H$JL18%%*KL8RFYT$Z[M^HX,:\-@/ M4@A]L>REG`0H2"*RT2!EOK4<2Z_8AM,L,VW"=@UK(=<:SZ9CI5NO=)JZE'%I M=B&+2==XKC1VWJ75I>RD7DK&,I5]F?&84TC`#"&C,PMSW\0<)# M/Z(PPH@RCP6$H\W6"H%>:FL)K"Z9G;V'6J`S4-62V[P'JX>AS*]4S=IHI-7G MCE+V+T?M86;K=Y48,O?(2SX5L]N\JF2+MJ%DH[]53R"M&*"\_JM*>IO`=JIP M,,N)8?V@.^/8CTGLXXAGB&VR'`][(R00@^2UF5:X4]/49FVK68@U0SN0FYR@ MKXR2RECS&8<2'+()_&%`'LXRK".HEAYLQ`);N<"G6C+0B&;[S/DA MF`Z<#M>"KB/GN/7H4AIP/T5^^IA7*\%_@A6O5F*8/Q;%JOIX];%&4X(B["7UD0ROLK;"@48ZT(@'?A("5C\K,M5`2.6H MRAZ::EQU$$CP:2V?;<(Z"-8!QM(#LB.4I4F9TH0?JCXJ_O!E7G[+\V;(=BC! MAXQ21!#V/4*S+(!!MWD&0Q)D2L^']_B^Z3)0*])Z5JF^]MT'+SD>,@V5&OL\ M1VDLNGD%DP,D,P1!1ZAED`HO']H>#(?Y>^/6CX&+=&VU;"HVU>7J/E]>WT\7 M[=TW%V7S1'A^L_LDJLC?B!\$$&8>XURDD-ER!/QH/<^LF MN5ZV/A`0'74Z1V*MJ^CHNCW.AA%=RA#:#7V.6.1G:4I]+PL"/X91G&Q2G"Q& M\O?'N2>[>K?P6,^4NX>=.X':@+&/)D:?7BC>VS+FKD?].`%8%1C[L;>7Z1P( MN\_O$)K`!&5^"H,0>AXF)&!^F'7R>V'@R))<46C#BW&UJPR=0V?T@&K0FJ[& MTY>/1)],.'UNRU&B:4]W.OE@VA<7:[%TD.$<"*5KN<\7LV4N_K]BQ=7\[R2+ MDCAA4<`H1BG%E"=>V.DA?A2X$5)["F\XM++BJ;C)Z_L$A/Q/TWDMN3-QMJ^] MQXZW%DSM:MQM[Z'H=`<_==H?:&DYL@C\NG5'B<0#'>WD(_)0?*Q%9BV&="!" M_ZM9JF\RC+1N8TXARP(4!X0@%L9LDV$PAA1>BG9.=BFV'OQH]%HH9R*RJGW' MCL0F;.IX!%ZK?((KW^>V'"7>]G2GDX^S?7&Q%E\'&9;6C`HM\DB6, M>HPP5#^:[(>;.CCV`^A4:%47WTYTI8J7@;J(U.@QUI!Q'0^S&ZU/,-)^9]%1 M@FU_OSKY>#L`&FLA=ZCY'(BZ+_>><1@R'&+*/.*'G'AQ3+HK(6%$,9.]5]$] MR=7[I8;ZV.XB:_V3Y\W>P(S6[J)F.I(Q-Y>C8M MEO^:SA_SW6;:>CF6$)R&''D)Q"BB:!,:D`>Y&UMX9G0[Q9,LW]WFTD`$:HQ` M#1)H4))ZP_XT_'?L1=KXKNOJ0LZ,UQYKUJ+B'N/F-D8<^8Y)J^,YYW-,J!J] M(=-=!W$U0WGF?QTDOQS,44[1*6UFN-1W@HX$F98[0\WE8Q@Q02!&G&"4/$AT'`NO,87L*1 MU.']8]3+W4.(QXBF='GM>%0ZA7SD-2\JUMV.1[53JK^9\5Z%0IPS M9C]8D'-&2FGG=*8P=X30?5>@.T(=7"G4/3]"];:"<]`YM&>)'L4;"B15Z5I0BF."4O2,&4DBW!W8,*+$D[=2#NTJF0X MYW#VD+0FAQ@[YQC-%UQ-.'8`^>%R#15G&/-4MEYO/?DLPPQJML]RFS#Z4379 M)SR,?!+$*"+(3S(8,!AUJN&0>[('P(])I^,Y&OZ_-E'S7N!,-?J(('.P353- MW/)KP-E]?O,XSR]O^72Y$)+4%UMV^A0SO+AAQ?RQOJMI^GF^\](T3JB71)X? M4,08Q5PL1.GZI6GD01H1M5?I34FAPH2]'JQOQ`/"AN!F+2!8Y"M0+&;E0PY^ MFI=5]3,0%`O$WQ]$XEW5*JDNRDQ92'(5Y8!I%)<]K<3UFWF=S'4A=+W..0-; MF[62@T^-[*`6'C326S\FW`_D0\L)PV9S)?\WK>;+A-T*K-+LS?+/*U94,T$T M(M/O#KE/PB#$D*]VZ#GU\W-[%H@L)5HO&/]KR-S M8#H.A-*1V394BU*K?ZFL1M^5B[OK?/E0#UE/4K'J>1)YW%.^DYYM9ZOO9Q%" M&!.4,#_$G,?"#5H)P@0QN>3&P,#&\YEWEQ>__G+-/[X'C)-K@"\8.+\0?^=7 MU^`CON;@ZM_X@TKKG&;@)?HPQT-*!H8T*XW[:>\E.'FLBD5>57CVUV-1 M%4V1@'S;^5N354["_V?OVIK;QI7T7^'#>9BITMD"[\2^X<9$M8[EE96&Q'_?4'\NM&HP&@B,=^C.U` M>%$41Q&RPQ,.M664.Z`%4]W]M7D[N2L36)>2)6M&Z^$8QN0,?5Z9]4*#3 M[0'&H_T\6]-0&)Y<-Z.TT:Q:\^B,),$WY]^;\V@C1#;6WBO6;^0WIH?D:;]D MMNV'(<78X:W_5O"L'!]4.[N1VDPG>^,3 MIHD=J#2B?74TU>B<%G9'HFEZ?,D,/'XMM8IE3U_3;3[!F2RGJYE MKIH^IDHLR7Z?'$[0=LE:YK4W\MOI1J),]O)G,JU=WZRVZV44>;X3NPA[L1?9 M#',>.)6F!JR5OO4&SK`F*@PM9:^_\8%)Y2B'IJ6\7O@RL<[>6)?N6"=_K-*A M?,GGPB6K\&EBU0^V46'6-2@-Q+SW\1]9`.C?_S>"QD`#,4B@H<=THQH<]DO/ MQJ"[3(9!:#@TQ")8+CH6)6YJA=BAL1/%Q,6^C02B/')P$#)$;/G?ADE!VX\W%]9/ MB*P*TG`[-=[@IN9MZLKF2%ZBSFYD>A\RX"OS,5EM#M_9:I?,=M]6,G@6D50& MQ&-RFQQFCW?R.Q+(?;+[D3XDQ4_N=MF/=*]ZR)9A&/MA%`=VR&V)T.,V*X$Q M+!P;MD/5/![(V]AJ;\<=64S%[<*:BR_B]K.XGZB]JL#)40_#TDSSQC4>,'4\ M8;<4>.L2O9KXY"@MZ8#JJBUA933NS7J.[_8WH2!2Z1X>SH5X> MH.JS;"^G1-NU^$,=M"#G0664"1'QA@+K9T9&H6'<_,LV/ M6@O-F3T62K=?^G$4R$GA?A$#F!5QH-?81@*M'-EG'1R%'ED7:G9B/)"1I0 M03KRV4Q0^B,2IB\5+NL$3,WT)),%MHF:[_4L.;5,U2B0'H9'(DB:G,E,/(1` MN?JTVCRK+$E*XDVF5I^V"D&R??AYMTN>TN-3GE:I;914VK=%B*@Z2!S[."BM M8]L)8+JER:CYRMTSV:N:ZVEB;8ID-VA>@B^%F2C8`M3!)NP!H*836!<2) M58"T9UZ;J5V? MA,)D[I+)E]C*[*UG=7N'JAI9TT7R2/1,FSN9F6<1J&#S1)TX]'`X[J1LLN^K MW3G$X$@4IIL/F<9'JN,RVC((7(1LAR$G#C"GC$HSI1V& M,%D>5.];N\6S=S\_SN+8$`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`U+0L4YT:,(_2>%'^5_?J)(_9+CG]WF+U M1[+_E&ZS77Y)^2D1)-MULTDE\C%C,EF4>:($;SM^Q$7I0N10"M&T,>$VK)(O M5ARM>#[[9+'9[6)Z^UFM1Q8KD[/;>XN*>#87Y:K!@OQ3W'>JFPW\-+2IOOWK M/`B=:WAG5ZVSK];7W-FW"WR3,F#D3$SDI/NP6TFA3+>KW<_3=4,32ZJ05,"# MQ+DYA9@33X,6!XV.;.,2XSB>KY&$OU%24UON'`G&-B%:0BM2`9ILD\?TL!04 M,XPI]WR7.@P[;H3=TAR*77#QM)T5XT54*FY%/%U8O]W-9U^F]S+2R2`XFW1<`FQL6=SVX\BO\2*$8I@ MP6D0B.:;5*LBM.K?RIL;E(@=5G\`P]$P(]@L(HU^Z&!!Z7H$FEB-@Y5U[SZBQ6Z"'L.=SSF^#)NNL2..!-G="*&]`WW!,EP8[$";$EY6A=P=8T;#IQ?$7.TCRO'5]*1Y9A=A@ MB>Q]]O57O[02WT]A2_ZYS7&=3QY4?4!J_NM2UQ@7GNN'05,MJ_%HCD2XS?C6 MH0(%)+#Y96>[[#$]Y+N?8T(#9`>1RQ$GS`UQ+,HSG$3D(5#[$N!C#0OHK5@T M/=/`S!5F%1,UKU(+ND;RHK1!_OH"LK;.-V]#3@X7N_PY";@;QM2+2$#D)P>X M.FQ6Q,SU0*W'H$_N^U&WR&(QG]+/"T)OA+6867SZ1S'_,F7J\B/YQ_\-VJ(,([=9IF".5U@JH,+[RW3@^NI5WUW)E_34=2*WHG$D MTM(2_.N.XPX4&)G*W"4[NMJG#_??Y9.S#+R`4,(C%CKR;X&8Z]L%H-CSF##7 M)`##87RQA5^?U5B_I5MK+?/EU6YOR>]:>P5WF*:>%KQJ2I_;C=5(WN,>'.V0 M6'>A5N,N!`F#IYOC(5F?@/A^'$:^BT+J.TY,&'51>21TC,`7->JW;UP/+MJ_ MQZT&#=CLU'[==F1&^?9K=1#<"MV-2E/9P`M()`X#P9@M:."X-E6-UF6"$ON< M\/V/,B'/%DO?>;YKN_XGNTZ'N9>;'OE`DP<>-"+&K28-!__9Y\^S6ZM M^\6,_8>J6TRYN.7W%A?LALP%M^[$W+K_J*H7L]BZ_&7P8<4@Y7<+F+T?E_P^X2J1NK;\GM\>EKLIL]YK;WL^-A?UAMU2I;U7S7R*A$]C M4DW:N(B!]PYJ-V]<*O\AIA\^+J0FDB]B3CZ(2@Z5/-Y;L\^+^P6YY=/;#S7[ M*,R<\0+DLN85-C8L(WF=S?GW^C08LT0V?LW)?I\<]NRX4_7SLS&"`]\E3-B1 M(#%S*`_D]`QCUXFCP/&!\Y]V-LSG-I_GU)*Y9BF*>,5A. M4MR^KS3%9AD'H$NXR!U'A$^+'(G`+X]BV"07.K+38-"\_$E]^]\F# M^B(Y(^T[J6]"5UU6KY7ND;QRFIUZG=<;H*QYQ']XR([2W#QY2*3IKQMU]V\A M!TO$/,^+0J4$R*68V)Z#"YN$8DZ`@;^+*>,OX!F5C&SR7WMKM=ED_YN?Q/B8 M[:QU=OQZ>#QNK%7AAFHQ_)L_<5TW?V__YDZB$$\L:>(Y>5#W\&V@%_=V&XN& MN41?@P!,*4I2S[CR/LXJR>@[LZBAJ2[!T,'N2$1/CR^OTPU]!`$NK*S>[`MC M(?=BQ`+JNXB(('`=AWNE,=O&P":/=C:,B]HL/^9R=P8'OKJR%77-I,@\9S`- M>A$!!M2>J[S4B$XW'D>B-AV=^.4.R^Z4`-JUD^=56MZ`)S.Y_*U[,;%:1H0X M;L"\B,5,!#RR(Q26ICEW@)F4#HO&M:<`65UXF6=)IW-W'XK"P2I'#-0D+70W M4ZB^>8;I54EP>;J6XO1\)-JFU:5?&O5UTP4_(S"Y M2.>6#F7*%,7(BR(G#&B$JB0N]KR@3;,,U(9Q;2O:SP^K/V1R]7C8-IU>4!L"_F>,-(U%5ZWNT!:DOG2&2HHQ-O'078@1+@NE2^)SK? M'?UAEQV?JZV=5YN&*O%S?-MC/F9>'-LA]CP4!"6BP!$4]*`L!'U6%2:=(+0!9Y\U\&2 M^0[J\K*GM,HAP66Y3E0VD]6^.`3J9DF>.E6ZE,3BN`>U3'8Z+8Z4"S=#R64- M>35ZJ(/RD0B>%E=>'YRCC9YV[5!+SQ8RJ;6%BSP<.L@+(LR56IZ(").#BY`ARKZ;I%)2MD0A&2_!US4Q`"B"GL\B,Z?#S M3CXCZIX.U;/QK"[CD"G6?K_T8QQ[B/J.SZ5M'.&05,4VS.(86NGO9,Q\D7^N M#H1?_)=%;KDE_O/S].Z3N%U,K-7I=E!P:;\;M4VK^KUQ"BWHGX!-K!Q:7M"O MP$VL'%[_)^74<%5;QM="\DCD29FX4;?B\.1YESRDIY-I MD^=-HKZ00,B3.BSMS_S[;X)<.CR*(D^B8784T2"VW5!4ZPJQ'\(N`^H-5J,7 MN,OM03=Y]]C9'6M]X4_^5J\N'($WB?4T>@V3M%$-6]OFLVJH+GU0.^L*+_)1 MN_1#:O1+M9Z\E.O^^]6TC$)];UN_`ST2[>_?[U][YH8@'G*\>-,2X]O8(LR0 M(X@KH3F>S,]#+JH9/&'8!QXN;AZ0X06;-PY:R$\8AQ\MWL/X-"PKCFUH3*_; MU.;T_1\HWIG\NOIEGV,[DN#0K\^_'B7>-^'=JR2WB;09,(8CQ#`*A2/LT`\0 MKQJ][1!TVF!*RBC%)4KX=3W`N!. MU&ZVC)=R9XN/8MYR^WM'&IOI4W_\P03J9<_U&=IP^^)KF:J1*#T,CT2C-#F3 MF7@(-;3.G*TO24@\S(E-(_F/S:@=N[2T&G.BH7L&8.Q?MH$&0FC['AI#3!IN MHSFC'D$GS1D,L)FF!?&O.]$PH>N'X99:EX,; M2+[>)*:!@G4G=60BIL&A-W1,%U6-I4Q-40\_/R6'[]EZNOV1[`]JOKI?"D2P M[WA.',5!;#N<.W:Y-A=9J+7LQ"\Q1N*0+,F(T(B@-"/55JT/1=: M0"W+7:BKEYF>.&M3G;JH2I&^R%IG#T?U\.>SR:%)>P$&2-[I\:JY@^V5)"N7 MI6T6G/<*Y7HK0V)4R9\YUP0N:E6AEN(,4# MD`O3YHK7"F%U_?"I'M>D[F:.8H"`#T!U.T5_[U'NK/+-F'A+]C7S.(8XH-NE MS-QC9Z[Q\2;;?KM)?R3KUTM'2Y='P@Y=#P61CQCV>,#+IDPJ40:&&A_;`S(< M:VY?I_7Z#JOH9[P:EDS'-E3`JBJX$5)Y8>5N7%DJ'V\CY)ODZVF$[#ZV(ZFC M].MS^T9(781WZS"26NFON8I:U.D&5P7K]("[1=J3.-(E*NC$TWZ@X"4`,^G6&(?.5@@ MAR'$(S=V?5Z=[T@I=5L<3/'N1_:B'AU.HGB?DV9"88`.8(G@'0X,'CE1\^(# M:1G)FPY%??5T":#3C=_EFW3U-=VDAS3Y]3:>V$81!6Y"X\-M.$G@B$Z<0%J!%MH,#'_DL MHD)$$0\(D:;]$H0M;`]2QM)KV7"]JGS7GM4.[&RKJE4;B?_O\J.>K+7TH+C5 M*_R:I!"\!UL=ZN?ZA#MQ6ZU3DJ3+'(#W^<1<3BU8Q'9<53N>Z.1 MQ\-V5["UL60\^SYA;'F'6BLN&\X)>R(1NI9<\%;`FE@YL*$O4+M" M4MV\4@.U(]$O+:Z\<7M:=WK:3$M;'28=DIC8`?=9(!P>40G*K9IT.(EA>:%A M+#UEBINS&_K6-HV/$WAN//@0&5_1O#+E'FZ>K?EP_KX&Z`9 MDI'NI+F:H@,5;DQB%-BN8R,:Q2P.RQO"*<->!,Y+.]HSGIT6$*OK[*!U20V4 M-DY/>^02G*3F)(ZK6ODN8_49JR:V1Z*$&AWZ-7O52E7S77I/SYOL9Y+,D_P0 MQ5\!+*GO1B['$4-V9(VOU_U%UK;^,XLOTK!.YC>X#,0-2# MDG`_D1(U&Z`[Z=O)W8O%?##4CM(Q)K&RDIV9_/LE];"5Q);YE#6#76`FG78= MGI)/%8O%DKX]ZVK&=A#L+S^V@ZDZN.![L2[N5](GK@;H%5.V:7F54[8>V\]5 M"VX.V>%)OD9TS1S7,]$U@PMZ?^7/,%7"NG93/-Y?KNMMQ8=T?"OJHGK9E0/B M-'69K2"DU,G2@:N&Q;UW?1]P=S4C* MFA:[8H(V%:UR4L91@1TLT.$ZEXB-<#0B7R:8G8EP&5E*:?[!4^F#/:"-8930 MB/@Q<=S`I7X4!+M;?$F`$BA3(%2U8;GP=_WFI>>#\I]*2ZP*A6)J-`5[#3.H(-:=:8S7(G(GX:"_C4'NL-BT:374++X.N[Z8TR&#D9JGG.:AOQ4VR M+(YDFF45/GZ2QEE]J5$A3OJ$P`9GDMTBYY<6*571(&\F@J*S@I,M<9)DJ,C( M@:&?89*FB4>@ZSJI[R1.D#D[HRFF4+D]5\&6]-&EY(_99LC'W@OVHKC7K2*:\(2AZTSM"4OTD&G1GV9>KW9`K3/Y5R;)>JON<`:&AV$<4)JY M?L+^GWK(ZQLP6'8:2Q7C)X!C.5T<[,UFU;,KXS#IK?(UT?5'+-XU<9+M5.8"W1J'T(>]X!10<)DCB*56!U)A)G8B4G#F25R=$[ M3.$'P(X716D6AQ`1]NEP=Y$A"3.,%(]E)2Q,C0BS.!.YT5R$R%&()"7"(I.43T^K]M4;O*;89%X_BO62&5_`$$*'8`B3 M.'1@1-+0Z6_Q)Y[C2HY3TK%DO:"77'_YI5< MTAM)U=&B5$Q[IN)23H$&J-KCBB&NB75HA*$1-3+!ZTPTRF5'\Q._WX\VF6GW?;IH[_N77O!'*-$+8S6B*'9CY+LG@ MH+4%)H[DNZC-VY_@<*+BU;<$5,5=43QQ<."YZM_N5V_*Y>\7X#]_@0YXSBOP MDC]NBPL07#B.`^H'M@;VY=UN'LJJ.>KEW^-57;/-^$7S[[O?*;>;>L-^PLB0 MU$<++A53S?/Z4DY+=UA!"_8"]'!!B_<"#!E:S!/KK#2G(^IKSS\ST62+ M"RRG>M1ECXVYW/`73A15W6+97V*%+H\,<1J'_#7@D/JFGI!*II<:ANPK M\M_Q-_KWZ\\I_7;SW_\1N3#\'T#_]_\N;_\IVP^H0Z?@T?`T/$H>"P]`_:U3 MQ"/Z=[[NP./,C1T3Z],]$W$SL9+WQ\.FR!&6JZ]]GM28YJ]X+Q89\6(*?<]S ML8,1P=A)^CG&2H&1$N'2)GHEA:2RC-/5<*);MR M/;"3)`[.0L2R-A^Y2>9Z*-S9H6&`Y.MT4A]OOSC7(#JH2%R0WHF2`X>BA"Z\ M*&I^@TL2^R\G'.YTAUM;=`$#-/A5)WRS*1[(V07O^'LNEIO52_'XJE`>E'.? M>$W0FM_D"X',83/0M/>DG*C]*?$W$S53QW^@RJ=!A'AIKRKR>EN]#BP13#$E MR`UAX%(W"0*(^Y/4-`S<:+$N?C2C0\3J/?(&A+X37Z^[FQ$#G%M2#<>;X*<$.2G#@HY"@ MWG(<85=R2J.^0>M)%4?V\VK=W^N2'=)H@%(QQ9F82SD%VH,#'!U@?';X+L`P M"9IZ3N-)SD9$RB#A,Q$MDRMZ/ZK1-%G"HO:MV.2K=7%'\VK-MB0U7BZW3]MF ML%I:W*^6J\W"X25]1#%T2$(]SX$$)3O+)'#D1,V`0>NB-L`$[EI0DL)F@E8Q M89N83SEAZ\&!'AWX-.2V`_C3Q+IVFK(173/(]TQTS>2*2FL/I_Q$[=Y2TW++ MI/2Y*AZ*=;UZ*2[7;%=4?"[K^JK87-_?YG\NP@31)/5HXOM!%F(/[T<#I%D8 M2LYO-&U]4L5K7R*\'$(&CPRM_`!NLQX03/3.2+UDUC?@O&WZ?X,5M&#!)P[W MIPO`$//]/,,\_;AN&4;'6C^]::H7E9+?K+`_/.+=K?&::)5NS2,>3R,U&%32#,21W&<.;O[MZF;Q*'BO7LU8Y.(^W"4$^^( M&XC]WVHUF==G64S`)R583IH_OV.5GN#1]BW]@_R,:*BBN;6<_P:OPFB MQ*\PL,?M*G\J\)^K>D$A4\@$9BZ.L9_@P$UI[`?0PTE,/!QAF;VTU`=;WD=S M+("#`;]Q."-7?0QP)*8YUNB1TQ=Q9NQ<(ABP,*(B2F3-1#'4L+^_+Z!.@+02 MI.53OEHO:.`3@@GT4Y1AGR2ADV2]E2P+,Q4M$/SHZ=2@!:2J!Z),R2F"!9*4 M->$D/U95H;4NH`N2E,U,&631']$&)1).JD/^LLP7MW^4MP_EMF89*$M.LM5+ MT4\79YNR8LTOMG`47XJG[T6U@)F'W,2-W"R*`R<-7>3Y'8(D<7TJHAP6S%I6 M%?:7`\#Q`0X0[!`"#E%08&R0/2X^9^993I@83M`#!0PIX%"/<@Y^:P&+JKL- M\N_*Y98/P&G&DL[5"6]`GL\9[T())Z4)$$[L.4UXD*?I0.BPR/69PXK-E976 M'U3U<$17/QXVS8;Y*WM4'_)Z:-ZG?HP\Z!$_22*8.,@/TYUY'WJ*L4C+IOU` M%+7W"$`/3C,&Z3$L'8`F(U'Z1QLRRCH<9@[2IQ)C;8CT6Y)#OPA!&J><&R',B+_7C>`<@):I11M.J M]3@#'0L;'EVJIQX`#)*G5Q#&GY^KHKEJGEDO_$X6-_@;S>=X8`VE3WB9)%'H@@%Q`E[ MP]2+8YDRO;XURR&G3?2NUX_=$`E.MEIMN(%J?UT/D M0]?WHR3S_,2%[-_AQT[$R2-@VQR>S1C1`ID1I-P*%*4O2!OK/F0H=).I4%:5([$S$RLI1# MF8\1>L2%B3=(D[PN[H9V<56Q9Z_@-0KRNO^5K_DK_Q'^(Z_NKK8ZWFVW5SJ/F+Y>6E<;I72DHJ+/VHJ0,SS@N0$D MDB3O>+;R(.:-<$!F[^^A=PL\1!WJS=K7;8 M=Q:WBYT(FF;[V*GAV;PZAY/%\RV^G,,7RVBB<`SCE[SZO=A\K5;+XOK^G@%< M_TCS3;&($DI@&*'$Y2]`\=+8A;@'B2)?Z#3S/,@L)PK,B?S0.?]1\-W+O[8E MKX,_-5C!,P?+?MRB!;];BB1D*1;.9&PY=:_1")A;?%2B81=%P@F$KS\K@*R/TK!\FB9^&/7P(@>ZXBG$=)@F:C-0+#-,Z!N1S&">;E$Y4M2)#4.? M*M04)O2I3!8P3]\JQO])?2P8]XT1?#3B3^_"6<3Z,RR[/.\W9ZKC[G[Z&\/9 M?`OK9ACZ[4.^;BL=]:_L(S;U98^?(4ZI0PB*J1^T&[Y5$'QJ#\ZG?HW+5!ZP<8)JZR'XJQ^L6N/%U'FK7<=9 MKJ[^@WV!^9S,704^/>\@BUXJF=Q_-DNJ=ATW>1-0MQRP7\]R_R4 M%M\WM^RO-E-I@P3[(?("&.+4*)LZB,6I#JE5)5-,9"_R94)KSS*\^3(Z$VDBR M.5.]D5W%"<51(D5B`L5+^?C"MG-O\ZA^BBET(^)F49C%0>('!*=IMA.Z%&=R M9TIZMJQ717?PP++=+MQW`*7'4VA1*B9$TW$IIT=[$C_LNQ9TE*1P6O-X@PBEOY`@@.<.0D)<;)3K2P+I(J_ MRD:F590+K9<4JC.IHB^62-12&6'^)E`;H=<9:E,Z2^516<>H_B@3(]9VVR9+ M^$=5--T_7=9$4$1(S"O,D+#]&/L?W5F*_5#HU<@:'V]9>;HT?X=*IB-2D:]Q ME9F(*CE]><^2TCLW%.F2Z`6U3YM:6Z<"?6*MF0<7?$!G#;`SAX9)S164QAX5 M&54]4B._7#.U*NH-WF3LL?E:KM8;_D;!KJ<2?R]?BL^K[V75[UWC(*-9A%-* MG8!X?LQ$OD?FN*E0B6I".)95^_@94[\.D&^`_TOP7WT?-&B6`#Y?DNMO,J(U MD?<$8L+\'&?J7'#G,\Q^R/XZ:%;1OE;U@/N4@L]$?I0(5O/SIUIPF]*O8E'1 M"+/'HNBT;IM#U)UXQ>79OB-24;VLB]NBJO)E<55N^D,KCSBQXWEAXH1NYJ8D M0M3K+7F1)W0.K?'QMJ,N`P4Z5(##DA)@-<)$`J-UKB0#W7N:U`*6&E\R`<@Z M;XH!18$_P.G*4+M&^54#M146!,K>%LF3*D4)88]%(0I3;(P(EGL[.Z%P32.J+J."!J86DG4CM#4N%-1 M$PNT:>K)>0[-#K$BK"F2),Y25637,*HK2H2(;?P^E^N[Q,09;5LR7QNE&Q/2]51]^@1VA)/R M)B8TL:S)9DH]M5$;NGFC_RYL^9ZT(_\+`D\A''L>CY%:6\M0BF2 MN_FF:,2Z@.]J]/S;`6J&3#)55&5/+%F<@#8Y_=[QU>@UAW2N%O'#U(SDC)I< MSB1KU%U%:?0!DY::9?E4W+"(ULY7RA_Y.S=O'HIB@]=W^(ZEL"S4Y8_IJEX^ MEO66(2.O[#^>RSI__+4JM\\U^XC'[1T?2<]^IUQO5NMM<7?]7+2OO*F;'36! M?A*%G@>1'Q,2)22(_`Z]2T)?JOU\)I!M-Z!V@$&#N&N?5*G"S80N87F=!5J+ MC;$*?K6DUE,P/:K^LW+U;*+)O%CY$)WF!4_R2H,,D$%OLTLBC%!,L1M@&K`0 M3!'IX41>*G6;VQ:&2>-1?0%VR,$0.MACU[PS8?=4A55!2I^)34CYK9O1R/5)@AP4]383 M)U64*05#T\E4#TYKD*(>J;(R99E/99G:47FVZ[3'&1*2*0UB9R=3.FLY*E/: M!&G-L^<_NV3[^WH1^T'D!4Y,"7;9/SBE63\OS75\F.C.M!>W9%FH/A\;RM[\ M00/1Q'!["6;%Q&HZ4B6;"K3XG&S2_8ZJ$=DR0_%,=,O08@2FWJM2)-SS]..V M&TB+UW?OS\QNBS\WV_P1?Z\;&5U0/Z)10%"0)AY$R$5)W!^>N=!'@C-C;5BV MWP_%AS'?]L.80;Z^`P=.C#]UN']B&Y\.NFS+CU%_C*O?N1TAJ85_20_(M6"= MRQ/*#5G=@/*[WB.K#UTG)AJS)&@9:=.R0>Y,FK:L+*VT_VP:R+*_Y'^NGK9/ MI*RJ\@]^H31_9G^R>5W0&/IN$"4D96'3SXCO.#L,L4M@PPIV8$&/=@:I^S$B)3-Y;7_, M.+'77YM`GF^(0/FT/RNKF]?UW8H1ST"1?/U[_:6L-C_R'P7_XT7B>]2'*'+C M*/!PX#@4[UL(XD@UY].HP-[^DFF=JNT`R MS9^2>ZTV/K.I;(D7$Q@Y7A;B),@B/_3[]R&Y*8QU^0.ER>,&2)78ETY+KMIN5)MDL?WG22J. M[3K-<3B'O:;!U916'C3E,N?JI?AGD5=?\LVVXG55$@4T26,4(C_!+B8TW!U1 M>5&&A7I']:U8SQS?EG)XV^,KPP>>.H#*U3-I.F5KE#:9E-^`@GU1LIERS*&! M+Y.3J%ISM$FFF2+CAR?3;$7Q'0%")415TN:@XV86-F'KW94>^^_W_ MU>;AW^5=VW+DJ);]%1[[1#C.Z"YQW@"A;D?[V!6VJSHF^B%#E2G;.9V6/)+2 M79ZO']`E+[8S$Q`H53,O%2Y?DK77AK4WL($OY3*?+U_2U4[]0?^R:)'73ZLW MG%;98A8D%".21+:'PB0(:>BR>42')0X])+%A90J"\57&S0X)W^('?S/HX*7' MOE^G\]*]K/O`(&AR]%)D[%-A,.V(*,<^XC<6(/5MV_VPG.G>O)3!P MF,7H9?[XC?W+@>Q6[0QMBSHOX@C$MC1"0WV;2W/_9.W&8\ M-^,7%+G4DT(&_2"X67=6!ZCNZ'&T%V"+%W2`08]X$P_W?HOC'WO[3Y;?8WN$ MQGPUD8T!@P:^WVTT3*4>`4Z6/[*]FND9=K%'(AQ#-_8]F+C$"6&/PG>HX"3% M4..CU]9QA%O=Y27*'\\1Z!1B!7]H4&&SCM`NP0W` M=3*R.Y3$DYJ[S%_9)^^<\[XNVMO2T'.QSNN9&X;\P0G'"3V+Q-`*$K)I#B:A MT''KH6T87MCOT8`6#M\/VY?,Q0:X:*'(8%:/2^28A,INX_:0+L`[7I5$KLKF M_WPL7O^CM9A+G-M]S<7-W1&W$YQ\HF*Z6#RS7&DSH]#;N53JT#;;FKN21Q\> MLGF]?;J0J>,,(@P3/W23F-+(==R`^&@S]2=$\K8:G2T;%JMX;W[=R%-:@Q?F MK&(!LEQT5=,0ZV*9W?D('UB3LG=&^@)LT.[D<^>HD1.E\E3]G':73"21,V3< M9W5WABA4J8L.S%MX@"4?ZU)NH\B("P1V M[\[-_B!A!5N\H//)S0-H((,.,^A`G]T7RA6!X_M$2XV@%M^HE`T*\2562*B7 M^BELSQFU[W"QH0DBE5:%9TX8,=)(DB1>X,2.16W2/ZKKNI&-I"ZDD/E@PR%I M<=U4<%54F*J)I,IJV(^L:$H2 M(%B,G-5\;/5'X_AIEVSQ-6?V,&7:#IX922+?"2P7VHF+8I9>(X=L=JD< M2W!WWD##YO>&6K@\P^V.Q"X;Q&#-(8,>LX+4F'"#0)I[/OXE96I+?'>%30L5 M?-TG_F82Q,M40I_-`8JET<='0/VTK+ISX_O#8'C%M`Q1!TNHC;`]A036D&6% M\:XJ$Z;:)+EXZ)`4_4ENAX86C(,XP03;"%MA[&PJO`F_4T!TS46U@='655;O MAY^,RBG3)Q!(QF!.+F1L2?L0/$8A32((C$&>FMPKD2@FZ`>,/B3=0SF:@D@/ MMJ'0V&D&;2=^S==5MOAP(5RWHQE9&$:$0AN'.(R)#6VK/R_IQB&4+"#3V;+Q M&<+V'L4^(I5%X3U&/,R:R M3&+$M*/[B3KI$Q91^J-F;:V7U1.'<-,>,V];A`0&?H0@=&(?Q9%'8>3T+2:Q M:\EIYH"&C$OD_NDE]579(62*J=](+,J)W3ZH_K*),PG;88:.Z)@&6B57S))T67Y+5^N,-]M_\VJ9?F^RE5D<(D)@XGBA3R.;Z6,46IOV$^S, M\NPQK;.%:%JGJ5FAH0;;H;:+4'S-JX?"*\,>&%CPRM$JOVLVE&;1U&U,?H>^ M=[:!#OW%;5]H=G>P3M.(5'7\KL*N;UQG3Z/OTQ\RG3FR[).`W!5D! M"8((^AT,+\38DQ-'W:T;U\@=P*#@B,%\%S++]2KQ>A8]HU>2PR.#V)0W)C*6 MC9E7C-.II;80LKIMB36`LSQ[6-9,01(O<3#$GF?#D$#L>/WC91Z"B2\V=)4_ MWOC89*#`LD$%ZO0'^-[BDEH$5V%-9-?`%%UJ.P897T5J>&)X`!Z))YF-`L-\ M*6X2?-J_!N_X?F+LP13)#NUM^K[+_7K+?05WYO(C_, M/L-N$B2V3\/8XN\^6A&T@K8MA'T22Y41*C5@>"=VBPDTH,"?#2S9=V/5N!.; M]QFG34Y4Y1DSD@Q^QLJ1C&\0B1-)ZX;94&CL50.5A?TU^K&L9I:#B0/CQ"5V MC)'-&L1=/HB([4*IEZI5VQA;7S@P\">'-E1CA%E4DQD3!`Y4&B'N1E&;CAP) MP9&E,'7++3].*:6[[L.]7SL6`Z"?6,DC*6>#E9K8605&J8[HJPI:8X!PH;.KEI( M9Y::%H2XS$CR.$V)D37BN+PH42*V!OYKF67YZW*URGYG#:WG?[UUC4462Z?\ MT..UHX'G(M^#SB:K0D$D7$>OW()A:=GBN@`],IGU777F!!;#1R%-3EX^XTM` M8G02)[$Z/@J!:DODBD2*+90?LOO0:OE@GJ:P9#[^LDS.LWL3\&.XPF@*C'"&H37%6NBJM#V\=;;C+6\SFZSEZ*L MLP5^:WY69@N:U\OZ+2G*J[2J49ZOT]67YHJ\&?'8S)WQ@QT#+D!G`NAM`-_?0&\%:,T`#T4)N"&@M02TIHRLO5KH/R+4 MX[IW(JH^LM'%.4>49+QH"TONV,RG>143IRO^(O+=4Y:QYA=HL5BVU]K&RVJ^ M*JHU&WGXC?WGI:C2U:]EL7ZIV$>LUORH#_^=@AG`+%O<;$2QW57V,(U=#\(@ ML/W$]WP)I^T",XNIEZ]OBW25\3[==^ENN=F- M+,^S8,@R=C?&?N*@R&T;#JW$B<1WX+2T9GA,]QC;MV5;E!=`9:1K)%A@HVYT M;N740H!6I3T\/?S*W/<]-L^*%WQKX5OP2F\!2@YM^VFEFJ?IJG97;9/!U4E#R+_&?7K(=BFY(`^D'L0]\C5F`%FV9);`F' M"`UM&0X0#4*PA0@V&)NYYI$39F:8%8@-(Y,J%QE.\:D4%G00*Q$41B98+21H M(%HL'IQFXU`TT,CC%&*!3G,*,]U-9O*.;F>)X\26XQ#7=7S?0YA"Y/0?:P4T M%)Z\"WR681U'Y5]I7J6BC\T(,R`P;]=LO)S>HMO?T?4=NC,]94>WAZ;L$N9/ M8>[OW@J^.Y1EF[L)Q%Q`VAYD06=T/8]B,.P:]6.42)^ M\_3PI@R/X18@Z!`.>49*`ZL"B=BXA,KIPG$NE;(P#:1*O5HP)KFJ+Q4,)%GT M78(35!Q*P/1Q.(7\2Z,UA9&.-KEBAZM-?9^#*4E"A$,G3GP2VC8*:6\"=9#4 MV=(IX?X_5_1PI5RF/"6W3*;ZP4Q/FGH%A%`G^DG+(*X$ZK^GV*_^WY1#*%`S M>DF$JOO$+SS>17,<#&%XEHON/S.7>+$?19%+XX1"&F*68"["'?.PKDQ4)/A(P MC/ML(NIOWL[W5RR/0ZR.US$\A#S7ML/`IS9D;;MAF/0M)A:&,E.D`#U,V\:)S+@<&YOIP5QF M_#;<1V8`*/+F(;"ZY-M@\^-A>1I^$TZG)NLRZ2SKTUR*&P-^X>;\`W!-V$[Y M^<,[!_[H>V/6SEW2XR=A.MUR/#<[2P>82$PXF_D?,[DSNF%8]&'MT8>';,[B MW_8-``',L]"-$`P09%A=Q-<)'(_T(+&'A`HDSH/,<.3YM0LYBP[FQ>ZU[."7 ME[)X758,YS]T!"%S[AL0@B;A.3T!B+]$T-K"(TX74N0"TA2BCZI'9&./<<]/ M.?*8-UXD[HSD`A/+O=UA^QETD6V%240PC?@S"6P.9FV0P%#J%B8#S1N.'_T- M&(V\+'8E97M_B;EU7V$?:%_Q-4&_Z;7>#O-T5WD[@'K6=V4]-!VQ-F:A^IJN M&IF2%30[VO_)5M_FJ:\PL2V+.J[G,S26;5L0HQZ#[V(L7P*CJ>%Q:EA^66WS M.6G!-5@K($;BR9E=\7#?C'> M.F=D[_UJMI@1-_833%!`DX0K3!)#NX<3.9[X86:#&`R/[Q8IGYKE7?WIO*L_ M;=""%8<+Z@U>Z9)?0YXYGEM-R2ER"5:#!.R@O@!;%[TO$6Y=M/\GTW&1;+GV M^5TUH([;E,LD:KR5^#M:_&W6(Y.I"C=LYH=R\3%H58N=[2U]<38O^0^6+`// MZR_I&[\"J-OVC2FBV$;8]U@.#J%-_603P1-D"96"&VK:<*3L;M)<=`C!,@@+2!.41]-="O$!?'97YP..S\$._X@2,&7WH_H"GX84#P&] M8+^HA;J3;(E&.'VT3S&P:;3N6#S33:+P8LYU6J_+[.9A.^FJ=V=%M]V>4C$4<65P:P-I$EE"$6 M%-JZD.8JA@.;6\1Q/"^QL)_8B,;$=>TDQ!#Z`4)AXGG29P<,8#!^<*"#PB9L MR]V%S[$*%!0]HZ<0P;Q+3!0<_!05!;HK!X:Y:B+::MA(R4H`'92*OZ[4GT[K M*Q!0OB#%\TN9/65YM7SM*MW0]ZHNTWG-`@6A3D"H&_N60R,/^:'5!HHH"F(( M1=\*TMRLN;&_0='U_0>7%Z3FW]3 M\,O5S=W=D03(R.#;[X86<2VG1^9YB,H-D!$`F9]XW/]&;P$;6%]N MZ6_T^N[R&]T?:/^2G&J,X26QK&-B[I%+1!KPGV<@;8WS!6`V\"R%3TO.EI0, MY_B(GH[HP(GH\)@6%V<;+9IT_VO.FE\M_R=;]`=Z;O*8(7QE4ZC7K$+EDF]M MQNN2_=LBW]0#L6F40SV/!"X):!`$EH_=#=(H\?7$`8,`C<<%\L3^UVRF/*3+ M$KRFJW5SYGJ>5D_@857\#9ZRQ6-V`?)6A>IC9_DFX]9A@6,B_M0>2+9V[9WJ M+'*P8QWHS`.M?=W+CKM1:"*A1]U+"J%HA"XQ\=`T!@."H6HT9VB9LMQF\U5: M5X- M$P]KHU`@,04;QQU:U^)F+L*!A;%C)S3&B`57%,&^;82A,ZN+.EWI6VL[V:!4 M:PH':::GU+9EI9-K@H-B'E'BC%TLS_!-HJ M;Y/">I4D8<+J]TFS?9.;DZ5?BK+1Z;HNE]_7-:]$O"^N&7%%7C,2V:<_7O*B M^ZRJ9[9K^TR-71);(2%1;`4)[6'&B2\EE&-C,ZRI1W8F)'5T=*>)2>Z4_26G MSH*ZO'MXOS,,[%H&Z@+LVP9ZXT:6=,VN.:+^Y^H$$PD49S._F,98E*TYS^IM MK!,"$D''"S%A8*($1MB",-HL;^'$MA76C/2#&'-%:#\]_Z7-S_\!>'X.TG=B ME.^+T?(\8B3-]['Z>&.^FXB@P?76]82IUY*0SQW$=BZ7";NA2&_HX@1[I MFH200E=3?GFRG?/EB@#=W]]>XJ_W"%]1<'\#8O8KMW>7!-U2\!M%5_>_-5_> MT=MOEX3>7?`_%WU&5XL+!F>+6MDWE/F]S_.^I/PHZW32.K4439CYB:BC%E/$ M4R=)>L1.D,?=\5&4+VA>+^NWR_RA*)_;M=&^(,4.8>Q2+PJM.$KX/>&!';8- M!Y1&Y-1-:?H:,GA8I8/7O,?4`@0["(4JPTRQ*W$6>726U8X?[[&=M6POMTB/ M!`RQ0\8B-'RB4?HIG,)18KT&%:9ZFZ!J+;+EK&WL-GM<\C;R^CI]SF8TCBP$ M(8&)9WFQ!Z$3V7T[/H26R'%AY0^7RLCD)UN=(&U!`8Y*4(G4&3LNZZ.0):?B MLCP)O([-K&Q3(O;%^TSH$`.?2,M@LLZL),/Q%YIZC;1.\$MYRG1UF2^R'[]G M;S/L4R=R8Q0[(:(Q\BF*8=\0=GVA6^/4/WTA0@0868+BDM4*:-5&Q,$F8 MDEI(<*5-+]Z1<%0P5`F;C&(H&_!!,H91(:09?4YSS_YD%N$HD*O#TE_J&&%V.3>'(R$+,@1&D;]K\($!K\3) M!,:Y&NYB8&=0&-5MN3+-%W%:9S,,_1`F)`YI$CG42Z`;;>3#"SQ'=GC+??I8 MX[Q%!1@LP'$I#'E)UL3'OCG"%$5`F"N->K!'P@EA4"-L0@JA:,`G4C&$"B'- M0*R515,9NDH?9S3R>9;A>(X?8#=Q*`F]30-Q*#QKD/M4PQJQ`0,X&@EED.3F MM"*8HT5."409T3#^]TP^,.[5:)G`>%<$7@SM$0HY0;*LYNGJ/[.T3-AWJEG@ M(P?QZT4\#P=6;'EN1#;I1P");%8@^_ECY04M+L"!@0:90F8@S9UX;F"2-L7L M0((QC?G!.R).9`BJM$U`,P:;\$F6,(P.!1UITY*V,1]&"%$_]G%,0BNR?:95 M?6,60HI*(M/"R%K2I<_#U$2*05D],47>,$41XTV[INR0(:0J*N1-3E>4C#BH M+.J4"&D+69?EGHKU\QT8V"[A+VHA'+O(CCS/V^@8LD-;5%J4&S"L+!VNO9"K ML(*ASM]I81F%.CE=46--@ZXB M?)M!`JW$1\A&@8.B$#N6&_7-1##VY?9$Y3Y[G!W1!A/H04EOATK2);H9:HXI MI:U049*T[8/NV7]T%U2-J0GHQ"#X'W9`A]`@4S-1/#\7^5U=S/^Z>TI9Q[E9 MUU6=YOSDS@Q2/R$NM2FB(21N&,"@UZ0DB:BD6`QJ:J1JB@8B:#!>@!8EV($I M7UPQB%Y1<1F-626M42=57Q7&$8*.EV3H8'8RVJ3'FH_%&OI(VE&NW6YQQ;YB MW^R_Q?[YGE89^\[_`E!+`P04````"`#R@&9%$'<>ASQE``!Z#@4`%0`<`&%V M8V$M,C`Q-#`Y,S!?<')E+GAM;%54"0`#%^-;5!?C6U1U>`L``00E#@``!#D! M``#L75MSVSBR?C]5YS_X9%^/8]R(R]3.V<)UQK5.G'(RR;ZQ:`FQ69%)+RDY M\?[Z`\JFXMB215&D+*E7!EZ$OOQU\+?*K@R]Y\2V]2?[WX&M>7/EB='OPQ9^[=!3&+`\/ M[X9_E8.+OU5C-[F MQ<41`@`?S7HM;%']Z[!N=EA=.H3H$,.W/\KAFX.@=%8V&/^^Y6\_J@N_M/^. MIZVA$.)H^NNL:9G.:QB&A4?_>G?R<:KB89J5XR0;^#C]6YN_#A)1XUE>-2\8U%N_"B_KEC97)PG M7?H2:66@%O7L2\"*E,/)R)]^E67IQZ4<_'N2%G[87O"&(_:ET*?D?.3;R/UK MQT[$TWE6YJ-T./5I,ANJI$S+TZ\?"E^&&TZOGGYU:1;<09J,/H8KOI)DJ?3K MCONBRC5D5D?#=Z*J2=NQ+P/&X(9 M;;CA^/8XJ^*#Z0V72MF@;R="VJ3(JC#E)"_+#[[0^=55GGV\3`J_3,3E/7L6 ML*'!&P^P&7$_^1_C23):6^I'X_0L?+/YI6G_;H0-$^SX]IT?7^;#X^S&E^,F MT=#SO7H4K"E;FW3N1,SCK)P454C^+AF/0SZT3+)%[7L1IB%:2[IU)%H8.;WZ M.3/[,"N/JIM^O/1^>=C2M/]&A/T0GL5L?.G'Z6"Y#VHU6%]J_(QU3K_JI+QT MH_Q[&^R?'67;QR1=7QI]7`>-4HC!QG`4I/GY/KI=IT+#[)D1MZ/97&Z43P<_\ MH`K'!X-\4B4/%W],@JVK>M8249?UZT2X:8@54D4_K-Q`\`%3QLV_*HLP85Y, MZ:EN?S;YD-Q.\XWO21'2HBEA/P=(_;#*0'Y<^T'X\U->73J=C*M27E4PG?[F MBT%:5N%=0^-MI;#=F&&<#[X]T6$I'L_VZE&PIO9JTKE',<^"&8MT,/6KX?=@ MQD=7_LK2JMXV3F]"Y+R64FO=JD<(?A87I[_?4W[M![&'>_4(0K,4M$G?;H2< MG)?^WY/@ANQ-D^KEHO:]"-.4`<]WZT2TSTF15NC7D_1=.6N99,_WZE&PU:HT MJXRQLM`/W]").YDS?U$%F"?)N7\DV[Q^HZ+XI5OU5E!4;P4AG4H_;[0.I7SO MQ]T*^GC`#F7]$&+X?&BSCJ&=/VSG$H^@8ZT4#=RA[B.!+WZW43X?L4MY\ MG(PZEO?)D-W(VX(,XZAU7W;:LR5W^G?W2`X39\-_?!NH4"X MQ2@?S--CJL/7I#R?*C(I#R^2Y/JH\LY'?C0NZRM3?WT(X/U*B+_=7XY/BXLD M2_\S%?SQ2[>E;]OD>8@*D\&L;#RJ+P4%>#'WQ^QOXYB#\\M47Q?V<]LQZERD!QT^\15(,GE#WUX[W M+8ZNI]6\HYY]U#,M[ MQPI)%(@O002MP1&&D-M:;T%1M"E/<>.+\WPG?$5CICSV%9U;XX'SF,/`I[E4 M=64FQOM)$7S#A?958N6203I*Q^E<.C7I%J,($L.XXY93%C'-*&*UY(0ZV9)' M:%]GG%59U(,1UJ+/23KP61DRQCM1E!\NI*V#<:XMB<@KB?JU M1!]L.O%59;HEG>XZQU;*2`B!L`DN%$C+.:'W6EAGHK;94_3*IYY-L;%L:L$Z M_]>,Z@$K(*`6(4T<)AI2C!B#^LYT440CNJ.5%8Z`E8&(2N.0S%M%5&1KK<+S M)U[SI=8\6%Y;60W\S7N#US++,C*@2,,0%U!$D*)"3.EP7QV+E#%V':=0^L'; MB_SF:.C3.]C"'X_1"I?BNYR[_B1P^N)ZCMX+6L981R'("7D6C;2%U%(-<*T! MLD2_EE9;6CSO$O?G0\MNGKB9LG_X_*)(KB^K98?R1_KM@UXMM3_]<9-O3/V-,D0`& M0X(8UY+9$-W.9DD`C=J?\GG'MET9NUYL^^YTD6W?G5;R&428TY!C*26W#)E: MODC2/:IQ=VS;E;%K5U!,!Y?Y*"EOTM'(_S.(/QE\NWWGJ^K4PC+BXBXQH8)J M):"#%G&N0<393&*(U-*RQ^X4H[NS=L>@]O*('[]?](@?OX\=AI&QT]>V04Y5 MN:"9?!PYN#\5XXX?\96Q:_6(G^23=)7G>U'[&!---!)<",*M`5II,)MJ>`3: M/MQTG^W<):*MK/_Q6W7?^JWG_2N&V_?)E5^0K#?H%0=9(Q7T-X8;I)!S7/Y, M6IU>6LC:_H"MJW2]>S0[9L'"1+Q1OSC0URJ@*=)0&BX!(KA.1"G0HJU/V**T MK%,+-F-%*VQ;\4)?)MED[/_TR6A\.0@XW+V)?'Z">+93#!36T&%*#&**!N$I MA+742LG]9\2JULM[@K85(?Y,;N]FJM4HL:1;S$0$N-,,D_"(($HC-'.;E$>J M;8BX11-&CZ3H%MQV,6129'ZX&B>>ZQ-S*P2"0$6:2VT)EH[6:\X#J;G9_;)` MCX3H$-EVT80?7GQ/!]]6X\/SO6(+A"56`V04PS*R7"DZDSO\LONE@QX9T2FV M[2*)?)(%7?XH\IM5PXFE/6/H:$BY,(=400&X1$J36GYK2=O7@UM48>@SIN@: MWTV\,JS7ETSW.2W3J>&>?[F\H$<,H")$&J&H@"'7I@&XV>R(A&J[9&&+9IJN M7RUW@^1+L>1N8]S%>6WCOC&VDD,322FD@D0(`N7LJ8!T'W+;SBS>@$'K8-M! MS:-1A+*P1ZR`C9#1(<^7PG`H1/"3M;P:V#UZ_=RA[197.];`MA47Y$V>?1@E M`_\\`1XUBQE03-J07#F%"8=(!H%JR:2-]B!M[=GJZP':RM2G`>\BS>\VARV? MM_>\MC&,C`N,!)P8Q@"T0;)9`J4(:[L:88L"AIZ-W@&JJ[_$;+;N5NT*UI-L?%<=E<&2R56RI%`] MOWD<&8(^ZOG M??R3UC$F@I-(VVRKX,JT&ZR;)1B%#/TVSVB4\ZO/_6[E.19.6= ML>`<(K49)M:0<`PH5.'ITH11IUD]FS+BHK9?+6Q1*MDEL38`\0L1[4&N=>9' MU29].B_'30K;RP>)A;(8($<(5^%_066AZPF=15#N9:V[%Y)U`_`V[#$3F`]% M\+K!^6('L("4U&M&F-6N+26V.F_M:$);'\X7\C%G?I!?9.E__/!X&(!+OTXW M$?[UX$"9#4_"Y?M).OPVN?(/KZSFD+JX8RRCD(%H`220(2R@1#`%9H$"1VUS M[:V.O7OQ7B]@C4TP_?Y8AO)3?J]$K;HO_R@>'$8SA[++NL::*ZV``813P`B. M,&)U89HIAMN6]U9>V][GSA9]L*]C8#=!HY-*.E]ML5.=-O#S!)#R?J^-[&*Z M_4Y9G0!3'7R4+=L4142127"&NE9,X$K-8`A+;=L$3VV]WMQ&PMXF& M9S[SWY-1I4\'''PP6@RPLUB82$%,0V!K-*8S#V_"T]J2@/R5@.LAW2IM>)?\ M2*\F5[/8M9+A7H2[O?879@_+>\;>D'NY_V MG//BOU2W#_ZU:%^HMD/%!'#C(A?R94LX=YP#R&:(<(-VOZ[^0@QZO,%+OX;9 MK:6_.C+<6$$DLI)5"Q89F($(-=ZCW?9K2@8WR=;![H;!U5HE:+6+]6<#2$$;A81#5LQ&Y@%7X M=ZTEPZKM,5=;M"QD&_*@MGCOZXJW$.\QQYQ"`5A"-*4XFCV3UF[NL(`7"8M; MD&&=I6^K8;USRU*2;-ZA-GW=*J[V4D8.`T$NL5M-@HE"WKNI)5>S^\4$"TTHTEAA)QP#B%DX2]:MV8-->':&YVV-LFMD MM^&W7\Z.ZIGLL_O%.J(6.!K)""FJ).=:U9$>!7@?]A?:&;*W-T$=0:4W;V'N+EM+N#-G;&F77R/ZR:\P%!G5!MUQ=LX=[46T_X]F;9]47DA`J$.#1245YMP:@H ML+/9S+8^ZV*+5O3V2L*.\=W\@KEI2?%U7=SB54W"A(S&0H84JHYD)RBJ3[*( M$"-ZZ5<6?:^+>^KS@H];[O&F=O\4+*V"@-\:+9OKY$XQ(S8\7PAK9YEB$0Z@ MWKO7"#NU3PN<-LR_A:OJ7L)N/3NRQW"JI$S+TZ]+47WU!B@N\,KG MTB_<#;R=`2L^3I+1,W!T.7QL.(Z`-9JBR&@CE`C)2HT&I:UKPGOLD1KS)W]Q MP:ZOV@ MVLL8>][6'1V981,%J>IER/CVG1]?YM-:<3FNX#C]GH6(U8FXA)6KUI"7"&IE$;7J&J.\!XL;7A1$O9MD)[C+I.6@SP\*MG$#^\_ M9PY`OD@X-5^48,KPPW5>)M5Y%I/K)H'3BB/%""'.(XJY5$@'0U!EZL]]#8^B MI9ZZ-SP>"'N<#4:3:KW`?.6JJZ.\G!2-JE+K#AT3I8"3F`D1G"F1D%GI:L00 M87M4ANJ-2_F+FN1%W,I+)FLOYUT4%@8+J`T24"B@E*M6^RBB,77(N!& MY5=^-@^J9!1F1O_QTOMQ4$4.A]-7/,GH)]5*=;L229=]4;XA"<*#80TF(6^A M,'(1B92QM,9?,[P'&WKWSLQ\%RRW^GGP^T^G=8WU^*3 M"59#KY>/^KY\7O11WY?/L1!(&6XT@@(C+'$$A:WE"SEIVZ4D6V;=MD;)UP&K M55U03T:C?.BS+R&5_YP6%VF6+CEI8G&/F"!CG4504J0CY9!2(KJ3EP$GD-O] M(DP'QNT6Q%9&-TDV/>@BR8;'-[?#9.2;F[])WQAS0,(]F78&&Q4Y)#F>Z1`R MQ]W_`*,K(O0`YT8V>FW2)OL>UQ8X?F>0G2+=U18GZ'F*&($^64<0AB8"-I(U-KAHQI2[PM MBD&Z,>P2EK1"/JZ`,@+3=5J0!&E&%,:XTB*O:H ME+*N29\P9$TL-\&.2M?CK!P7D\H7+YFXGC:.)>,",XNT@!`*K9V,9H\/8:SM M"^\MBFUV9=I:VSB;I]O/,^\;D^YGEQA#P0EWDFD4$-,BH`5K[01S;8_MW4+' MM(YIGV5):S1;)5IG>>D_!5R3@7^?CY<.:R4ZO_$7RIT]&X\M!@.)N[5=>5$_3 MVR5GT2_M&1-IH-4TN&)3[4ZG`04S^4.&NG3Q]NX0I`>;YGUBO7L;SQ+,0HCH M@(X4=2#2JLHSZS!1MC[\90MWB-CVN;`K&^W>?K7!S1M`M;*"0F$9-=3*6C^F MY1[%[!W8N/%^M:NAVLNK;7FVZ-6V/(L=0@8@I#%&410R"RLDJN4#U.[1.I@. M;)2O@]TF/$+_WG7)%+<9`6+T_^Q=67,;.9+^2[B/1YPSWO6AL#TSL4\(ME22 M*IHBO3S<]O[Z!4@6+=D\BF`56&([8B+:]A1`Y)>)1&8BD1$<,I:TK/HCWNUJ!#,_+#!'!P8OXHDB`1%`(@XID9HW<25HE<\M#3?` M_)FB,M,U\-=AK+YMT:NAX"H"TLYXKC1'UE/#(53<-3QP2%U!D^G?9NNY7#^K M4,*+G>]'M_M+@+89%CS6B&K$TL4CP08C8!L'%U(&KRCG;)#RL*N60C>L.DO( MWM:WU62^/69TM;^;]8$A03)).4'(.4J4,%);J;?G'/17D'?_ZH3K?#85][P/ M`_.B1TM;U_N$*0,VQ%(A!';6.^FXCL95@PX0/M<%.CFOKD3-HB&+<6%&%BE% M\RTN^&%9SQ]7U4KN4Z:1>DKWK@<$>?^@0)0B&$+.J(,RTAH]2-]0Z('.K4+_ MM\RW.5]0.V-4(8W[*PC_B,[JV^E\[B/^#7B1CEV?ZNI^FB[V$UL^C[X=5L1= M_E*@R@#KK.,21*>:"6,1:;"$4.<:&7_+B_5.M/,%N7NQG1*7ZN[OJ]NXS==K M;TGNJ?LD]W<"QT))IF0J(J@29Q'9AIPT4;F7P'_+Z[2>=DDAW@[,?O]8?:WB M/W1CN6\F"Q(K"+@71CNA#"/QE`5;1"2_HL80KT3:^V5@N5#VLRVY*\1?Q;U[ MV/HY99K`/03`(4QHQ`-`"*16VX@/UCI3C,5O,[>4$C>1,$ZY314FI)XF$@)'?7;/>D5 MR"X)#7X+Z=E"VC7W2I@$ZSXT*ZN\=41R.4OL.V`@Y$\:C!(0>.2:'2KI+KQ^JA3HM:OZ'? M0=2^3X.S`B@IC?0$$$ND1`(V-%`IK^`=9@_\_*4&ZUF@GOYLJ9U0)&]D-AJ_ MB7OGVW]7NQIW[_TV:.J0P%99Q)6SBCIE94.!QC37YQR0XB\A%N>AVKU<-.2F MND][Q.'Y)T%H(1#5C&O-##18.,>:]7I.6 MY<>CASWR\.*;X`1-&@P11)G&T9`<-/O3"SZZ#J/Q M_U2CF8__LJ\=P)ZO`Z,**>.P)40S8$%T,LQ6NT4_X_5?@I?1#>?AVK=TK#57 M>_EX]GV@4JA459)J:S@0D$;Q;B@!2N5*R(`NCDM*2#ZRW*I4*H^O!-<(8-&L7DB;6ZY@0/>?)7S16_?D."-\D@0 M!51R!0C$2&YZ'S*I6S1,*$-AF\Z<>\SFO(78G35O4-!# MZ97FP&$@J0(\^<<))P(08=GI.J]!&,^6G9VYN64X43[;W*RS)2(-OS:)/YIC MOFMP,-8K'X]=YX&VD%&-'&THEC([77>0LE=(-@YFBW?`A!)B][Y:_%CW2ZC> M3RJ3Q;[_?YTZ5T5)Z32C7 M@!(&ME!+U'^_EJM7P-T@G_7PYOA^>(G"S0K&E;7^.!U'1NXM`77^S`$93KR. MH%KG.+%QY10V]$.:_6#W]&R-*U.&E^'/T-[C'H2Y]!I0YLF0#OMRG"KOE'T=U>/URI_=?6VVZ2JJTMHE.SI34!@+ M@KVRQG#F,178;+&`(/M2^_1LF"O3RF7X4:2"V)Q;K.;DQ/YKB(QVB?0PW/M(R8J(%Y?G67[[BYF"`51R+15"U%., MO$^M@398:,^OX)51QS)QLL-]#MX=^#R[S8+-GY*+WWS<6`K5WA.UP]GCSJ8" M&$8EI!YHPA#C?!M10/"*JN1V*W>7X\'%"S)^F!RI"=;0UU97]O!K`0.@HKD" M@/0I$1Z_,,Z&%6O_KT\CP9FA^?=_*?,&>0R$@NHBEMD`&* M8JNI:7BEK"[7L;IWCZ>$#=`?\A?S;4[U:8($6G,5[78M)8J.FU/`;^B"2*/< M+(\!1C;[D:@N4+V$M.0GK_WL^3D,?+1J173RC`=<\%" M;9GCVD@OK1`$0@.2-T8YLQKRW(2W5W"R=Z5?A\"7`7K)61;!2;,&"W`$24<(51K"*.+IS@BY(=O MAZ_98^Y*LKI!MH34_*>J'QX3R5^CQ#]439>Z7][RMG"C3YTJ.*NY55@);'V$ MQ4OCMNC&_^56UQ]0I:A2?G7/T`])$(\%`4^:)UA.",8.6<(03E$ M;J+#`!WL_D0D4Q9S&'!!07Q^^A^I0)$Y4\#>:D.$E0AK#A4S,IX5&RQHW/[7 ME'5S:7'LB`F7?A"?'O(O1^.7BWJ%[^(AMSBBC;Q"D!K`#0=T4X9`*(2/IOZT M#+SMQW,#Y+&*SZTG""#*J3":`8:DURMJK#[KZE=T[5W3H$_?1EN6;KA_M?@#O6>[:3^0/B#$;W M50CE+*$.14W:%!,5(%)V#;+9ERC]W&/B`@RYV*'S.65'O_XB+$PK[27DJR1' M89S40*W1%@!P=]3O[(?"3[>/U=UR7/TJ)#]YBRLNM"FFE#EC4-Q`3B'"1E@; M_5$*[:9LEX#`T%R_?%#JH3LAF5X"]+Y5P/\NZ\7W=]7B<7KW9O*UFB]2";G+ M;/R=2YE''/]K6D\6_XY_:5DLYL29`K:01W<4.("CL1*5,R:;4NP4*DF/GI)% M\?CQ*J95F;76DP3K*/-<:,.Q<=$S,DRB!@7!R]D*!8)T?G%<$H\/?TWBWGFLO\2#Z#8Q_^'0 ME63K.8*1`F(JI2,&)R-9(]\4(^3"H.QNCJ]?,[26CE::X7SLBUP_[L;H]#T7 M+&!:0R(\IM`@K`C#C2O&;?ZCUR$F'5U4KDY%NGR:Q>DRU6I\2&47C<$48:`9 M-L`@V'3>XL2[W(>&0TS[*21A?>#>LSGS9A)MK=2^\=UHL7A67*6H!;-=1*MB MES]]&ZB*3BH6$F*GH"(&8K/Q46DT12\5R-BN\S2?Y-"P0!PB'"AH"$*4,^D- MWU)JJ2V6"%VF7&(VGW_9E9U!6G@S7M*K.&]/-]!?H.+KX;C;^DA=:WU7;QJU!4JT#BWM$!&::9!`1C')5ZZA4N=4,W\-GI MB`/T!L[@^=Y885>XEK#13+JRJ&81K,7WU,A4?:L/F62[/@_$J-18&`G)K$9$ M4LYM0Y6U)C?Q>H#2TBF/IYU#6T)@/E9?EK/;Q]&\4@^S:M4Y^^>5V^G3J)X< MD*+6"%[N]Z%^TSF/_M`S`60^D/OW3?*SG?YK1 M;%9'&*-W\:Y*>3O[TC+V?1_B?N)<6J,LC3:34=HPUJQ5,W!%^7T]\&_:/<)9 MTO"OR>C^OA[7J23IJ@987X62^7OEAIJU5_-YY.)H_`R?M_7HCZBV4WQVSQ%ZV@1!"L`QT41S M10V@`EKOMMZO`KDE>P89F^M$`J8%8,XRM%)-]&6*L-FXK>(BHH:^F8[KV_VB MTF982J4"5FL1$?&40PZ@\ELES[,5TB#?-70I(#V`FR46GV?U:/QAIF9_U(OU ML]A&\7ZNGZK[V?X8T"G#@X2&40=3"[2HG+F"*8S6:&7"R_7CN/2YE649]0AU MG@N_^>$[/YW]NJP/<2^^K[XM/O]5C;]6[Z:3Q>-\K]%SUGP!B>AS($>H!DH) M8XDE9D.K-(;FBM6`S*%^6#\M#WY?VNGP\=5Z@A`M10NYYCZ54N-2`6K4#VK\ M%806"W'[1)V5!7\)$WN7^GY;3ZHWB^KI4/#@X+@@E<.<<:BL@`1!QM56]4N` MCB<7OIYW\7V&"+K$^%*R]&[TK7Y:/IGI^O'J330J)[>I?]&A.^G3)@H6>B,C M^49+JB027LCF0)#,7%<7U(YDHH6D=09XUIFX:T5J,EF.QI^6?XSKIWJ1'G95 M*1:\[U0\88J`):.4(\J_;V0QA=6M`/4,]*6TUGKUC>B_ M322G31/L-I1*AC"$0'DF8U8R.UN`S#WJF:` M=ECO\M8YVEG'8E/\XWG$=1MF?3OZ:[ZL=V:7MQ\<&))>1;O4,8FDBW0HW*1? M2*1E[O7RZ;737IG,]`9Q9_;3IVI\O_I+=6>F\\7\9E3?V>4L=:^M9O5T;S'> MG+F"0%(K`SB'W++H2G-*_)9&PG+O5$YN5_CZ#KM2F)=Y#;-9^\?JMJJ_)G?8 M3V?/B&N3F;QO;-!8($&=MTA%AP1R"/RS<`K-+6M_:;1T<;4]$L9PEF-;E[/YWIODS!D.PD!X#YS%BS%#N\!970K)5 MVMRLIRH<3QNM7`<9OX92H2L,XZT]6DNM\=)6L[-%A'%-,&*^*(HPI3 M99OXLK)((.8D^C_:Z.9XP9K"!(7,/+1 MA#ZN:/NA7,WG$?3&RCI.ZL[O@U.241S]`BBB:V"0MJRA33!4+L6NQ(;NEMD_ M5Y/M`-XB3\!'\\=HDZ?_I%HO7T?C556917H>^+V>//Q[-%X>"DZV&A\XXSCJ M*H.`CGI+4>_6S\@BW1)"=55U2,_D_,\/PWO`MX1#\AY7^OEJ8HP[\ MH6$AM;PE@B<8`=9208+DADJEI;VJUP?=2E&'L)8I,]`L<]Y*:G9^'[@E'ABF M*0;*,881LJ2A"T*9:YP.,LVD6W'I`L\R[^*J+]'5=]]24"`]UEG9Z"^P."`U M+48'H13"S!!AO'',"B@`;VBV-KN!VB"=ZFYEJ'MTR]S3INIWJXZM/S;!P;O9 M'=\'I$VB2DM`A$"<:0&V&M43DAN*&:1;W*W4=(%G$?-F1?6J%^JJ*^H_9M/E ME[CX\3*U'MK9@+*%\9,]:1"(0F*H-,1[F")-8%V[(R'$T/'Z@5UEF?0?:.[8 M,"H%>0FAM!M.Q>VSIJN5\71@5'JGDQ0QH"12Y"#0Q(B&1A1]CFM*+.E6L+I# MM9PZ:ZNA&CH(=%$?0X+2ZL$V!AR\I4!:UX_S0?<'A@8%ZZ0G0-$(3Z95"PTN=HISH6C0\FDY3G<$MHK,BF@D(.*?Q]4*DIK.%O7_K?Y]+WV'(T>= M_$1(_3\$B5@9*(1F/K+(;9T23W/SOMN'#>1:2B?50R+F]4KIA3A2Q-)J;R[F MR'(7TP>E5BB_`BXN>\=%.S3GAX[`@ MF#%2`",!=\A!3AFPVT`RY+E/'4Y_,=.[/7B9T_UTC(NEH6]\G&UF7]O4\WWC M@@7>4P48E9QA%Q'4H/&N=?2;B@4T7KVMV"7,EPIBM,K]/3PP**Z(M/]/WK4M M-VXKVU_"_?*(ZSY3E6R[)I-GE&+38YUM2SZ2[)W)UQ]`$NF[1$(DR-&D*IE* M8L#LA85&=Z/1K:`6\6]H-/18UY)ZJW)#&9.\@NYIS5N$-+(!+DFE[2.QCIGD M1\<&@@@4U@$DE1/22H.IK^45OERIA)^?4'UA7()3_35'7!EF+ M8.VE:\QAL2H(A7+#>V=//[AFY7UO!7HARE:TSU*Z/_SAX)@T!@(%/%.:X*@L M=\\)TU=*F=UD99(7R_VN?V^@9BV]NHJT2^!6LW5UN[R[WJ;!1O(=,U,ZC`Z> M2HN)`AHH:BB7)MIXM1P`DUS7?8*E!P:@QB`83RRH]-MR\?VW^5-U_1:Z?H)* MGTX?L!71Z<0$,$&C$THLLZXQ\CC/S6R8X#WS0"9/^448+0;0U?>/ZIM(A+7F M3%H*,8VZ6S0G-X.YD??.M\W#QX^&(5LX@/G'FP)57D%EJ MF$-6Z(@4;@(H5OE6V=Z.C5BG,*@0ZC\WH%N,CMR;ZPQM=JFQ;V_ML/W:,<&QLTQ0);*0R`(K4R M54C4&\A(PW/S2R=YQ=OCZK^]5^D9YQ*\:BJ"[DHXKJO54PN#[,"H(*U%43C* MG2.*.V&!K)\<&>91;KK`)`VRX;C4'\+%HIB==-(G(P(7Q@E-I`:((D<$I\\&>;IA#Q/ MCG4&S8`F'%@K9=R+6GMLFR-:.)4;E9IVD/,4!F3%.3O"/)8]W>IB]_#`()VG MDFI#4=R>BENN8*WDC18\]Z2;I%4]#*5Z!7C*PBD;U1)L,6<5@)X@[>&+H`LT(+O$ZR1O7P9EW=#8%W$@-\NK_Z3D^VAP[,1H57W[LT$A MZO^TJV1TC%-6K$#)NZE/`>ZR==HD/<=!V=4;R&6J%.S79OO5QVI1?_#3P6LL M'208(P44TTH!4V>]&JFR.[].5"N=OK3OJWB>"&DI&VJY:,61MS\:C`'*M+/Y]9?%/E3_@MV'4MV.#@X. M0^D!L5H!9A0EC.OZ28^5(KM8P"1SW0;@4.\(E^#4UVHSFR^J:S=;+:+]OGY5 M#^UF?C4_7-+^V.``DM7/G(INJ'$8`ZB9:236%)2*$/VDG.H=X4(9N?5';F.B MJ2'>JKJM%NOY4[4KGOW;#8$0@2+Q'T3!44C.!7<-WCW)33;K7DBY0 MK;)W=IR(YCC:H[D>ODPU8..JO8ILICN;Y6(3<8V?\KT%H_KY!<$0AXD32EAJ M)!;2(DF>S4A4+*?N3+14@34H?*6K%M>=3L)C0P.QE@B=[CB]ED)&)Z:YDK3( MR.PDN^X9*#]WF8.>@7Y!JS&ZI^YN=FZKS?QJ=O?ZR\ZHE6KBP??7>8)'#NH MD(6.>\.P1L(37&/A%,AM-3;1FXH^R?'6U1H0]L.'S2[QB]46BNMM7/2R6OUQ&_'[@%)9\P3,TT-B$_6;\H1BH1"&M6P(T=SGW!.] MVQB`4B5@'R$U9/N9:_6XN8UNPS_5]0$==F1DB):A]HA%8Y$931&PF)%:5D7L M6379'%1K]0OT:*3ZLEX_=B?4;E2(BE=(YB12@A.N+)91&^]E%-CF=A^?Z"U) M:3)E@3P:D2X>-^O-;)%\QZYL>C$T```L2H42I>%0`6.90;6TULK:9U,*\. M#PR8>B2HL0H;[:6P4/%&4F=%KG4UR?Z;!9EU(LYC,>JH;?7YH&"BN2@,`D@H M@(UB2AI72QAU=6Y<^^>MC=DGD[(P'HM%[0RK(R.#=#1N$NB)`)(J"2W1C8\+ M/,A-F_QY:P_TR:=\H`MGVV;85"U&!RF-3PZNHPI"ZI664NUDI@#1_%#HS_N" M*9==_:-=F&$=;*D#HT*$CR`,-$8^[AG#HTN"&QDMRR[7^^M%U_M#>10F';6A M/AD1H&86>NFBC)IK#3#VK):-@&Q3_"=^@=0;@[(0'H4][6RG0\."I4P3391& M@!/)(%2FD=)3D6LX=;_N/S\>Y<-<_!G*[H,/!3;?_W1@BFLJM"*(2&RE)C6SX]I`%D?7%C9NM;?[?\[_KU1Y7/#&D^I%M&R+MA`44# M5"#-!<(804<\US@EYU`FHRVACCYF&$;2?U>;]*F7J^73/.*J?_RYKJZ_+/9% M;!;?U=5F_K1+.3HN?_?)@D16**N5D=IQ0"D4P-2H*$7/[/5J'_18%L:\3!1G M>3/?I.=]W9<_#MP1#GA^0 M^(C1A_6VFJ``\R-!43$O;TKG9+P MH]%B&SPMJ>"#VH(,'6N!RA-\5XGG,7[PLV2MF?O1X*"9LT``:9F3DA-`M46U MQ!&%W/HB$\S!'HV0/>!>YB7X_S[N6TFGC1'WT-7\KHJH/4OS;=F?43C$KPM8 M4:X`IH)Z#!07Q%"Q0U4!&@VH<\JC*LCG":Q5B1U@J[C*T=W>KO[B6MVGL^&? M[;\>(/*!44'&OZ`7D"O.C*?14;>^EM%$A_N"2ZD](!H32FHIHQ&?&S.;9-1^4M3K<57**+W=8NZ@ MBA:R^_NA6JPK72VJFX.5.HZ,#%`2AJ#7WD)%$8;2:%C+BJ3+O9+Q_4@SL M=V$*>3DI,%W9:O?GE\5'Y=X/>SHM)@A446LLU)8K9)"3BCQ++DEV?L4D[<-) M47*0]2GR?#_=D>CXQ=>I<$G<1;VV64]*G:`Q116=ZD",$V*I5"`ZG0UP?\ M.G7*X#R'0D6)F:2:&:JB]`V`,KO3C80`PR4%BOK-!`.F0L;>1ER@V?^?]+ MTG2H]2G!QVU9L511)6*TPVQO[Q[@X:=C`B&2*9N:?:\W[0<_+U` MP3N:25&OKR49QU]I$-E7Z&P1`6\_20"64.L%=Y8Z)P`$3.HF9&5$;@W"23XZ MF!0I!UNC<5CZ7`7DR+7AY^-"RD9!6@J(HU0$<(>!;*!4,O>M>ON8=D$%.<3R M'V58/MCCD.IR53U$2[6..NVUMEKLZGVJ:$LQ'VE3I.NA=[^Y._&PS88`2>4"@=1![ M"IB00M1V,J0FN_["!-LKCL+.`=:@!#O;7]IW3/4Y;>*`H=/$"X9%/%2DA29N MWQHIC5RQDNIGE094=$V*/`MJ)\W'&7B'W@V=,F\0BDCL"09$80RX0835]_F0 M`)AKD':N0G)66;\EEV1:BK<7)1L0(M;QU`4("*"MH`+S&@%KLA\P3+#H^R05 M:D?\1V3@[@:@IRAT._5P?[B^;_M)@D(HVO:*8\*YTQBF MQL,-`BZ[$NLDHT5#$N1MDME0*S`*!_7C>KZHTJ73]IE&`G'_?PX6?>HP3:`0 M(!C=/TR4A9)33]GS>:"S(^B3#!>-RL<@^G&"`H>`9HW[YCC,=:DGV3VQ(.-ZQKU0>O=555WO7Z=M(=D\KJJ+F^?- M8VCN<"#Z+;>@2]YN/KEZJ4` MVZ#]!RBU.%];SA0,-"B:&$9IHJ06D`+81%LYX&;P&.)Y*KQAEV%:GF\_0>^6 M$P=G#..`<(`D$`1XPEA]>04-R6[,USUP.%:,9@BZ%EV3L8+>'TC32]"[];S! M,>*4DM&@!L!:SH2GC2V="I$7BR^>TXE?@)P/'VP]B;U+HM6 M.&C"_M3G!GNZ][+\-15J1_Q'9."^L%D_0>\#DP7H('+:.$B4,QQ'"X@WP2\` M3.XUS"3?()8,>O>'>0D6?JT>]D;TQ*\>4,8!ZR.P>!>0BZ+]`X+L7DKQK7C_8&I0.!:7JK^GQXW%! M(KXM`T2=Y@P$6\X9I,P0:Q`&4$A5XP,H&#XH/GZYE"$X6FI!2H:3FF*DB^]F MN3Y\QU-_NSJT?RZN4T#K M*HHR?TH)G1^_W$T7G.NFN_:VCNW%PS%?>]#?&SC53ELB@9X%I&08 ME%8KX.J`"/+"Y]X7Y18D.#?"]8+Z2/QZO2>B>M_]ARHJ_`S2'9LM:)0*SU`G M*9>8">6!D,U90$AN$=3EZ)LMMKO\\5R5;>`O5W>Q45NXP=]/#`H M"E*(5@+(B"$"6FWJ8"T2BI]5H8$12-<+ZF75WW8'U)9N>R_[_;``F(/&&DNQ M8YY("\1SX`M3E%M$I7V]@//F5@^83^ORI9^\BY83!V2P=X)AR!GT449*_'B`VEZ2;QH/6^`C&/"X@E"!04(QY.$B<9` ML2+7:^G>4'&TS(LAR%MR3::E>GM1LR$UG8R>G2+,8&0PP;Y0]`23W%K%SJ8J'[;)$'JPVY\*TTZ`^'XH!R"6FBBOO+%.* M>=;4N$3*95.LI,* M/!_.[7KSD\$!Z@!`"`(*/;%>455O&`QM=D^-"3J?O:_NNW>DIR!;Z''RKGU' MM6Y#E+<_'(`U$&.KC6'",>BX:4K<8ZGQ\!42SX@K)X+[@BYC-,U>WL?9;ZO% M>OY4/5?1??V)Y5MH[[XD&0GOOZ];5^TV,P4<5QXQ$]US"I`3)&YOL&MS+@2S M\NA]VV`9<9U:'!LDJ8NTA4@H`12R7I-:"N3`N3;&[G>%/^]PW`W>$J?`]IWO M)SNX;FK[<82@Q1XZ??(@$$0.21X1(Q1S$+U$5"-&B#JK/G.E"%E\6<8D\I^+ M^.5W\W^JZ]1\(HEXL;!1N*=92NUS\7Q:VCT:B M^<"P88XQ!FCJWK='5/C<)*%):MZ2!&S)_6(K-[92_UI=W$R>2O)$:*\V`U@AZ9[6*&D$)64NMM,Q-=)]@M_LIF2H=82]RC_#^B^NO M;9Z+7*:>T7&=-[N.;"E7_]LR-2A*/=J6=_&;OM=!I$,W#OW^I@`QI'&'8F,! M-T98P+RKL;2>%FMQ?SX4'G>%"F6C/._*$_G<>:X@)")$K.744HGTQXV#O\\.+1KZWB'7?%"[#H$?C0A2(HNTCYM884DA<*G"/9*,&Z!@_'.< M4/;_1/]\+^3];K+]63]7B<4>8R_A?HAQ_5*NG>6KZO?T_V^RZ M]9&K-.A=)W?_6"@ M7G`;SUI,A(+,@7A&-I(HD%T?8I*JY_3E_(`?V5@6B5O5W6=^2\&^]=<(TE[X MPQD;!\<%P+CE&C./."%"7D%!1+WO@I.=,GM"4H]/OL[B$)'!F>7+G= M^ZSOU>+JQ^6JNI\_WA][#-IN@D"`T%%VZ#CX?_:NM+>-6VO_H_MR7SYR+0JT M=9#FMG@_$:H\MH7*4J`E;?[])67-6(ZU4C/42$D0%*D]PR&?\Y`\/#R+%M(* M226K1RXA.J@W7E,VQ-9)U0G&)=CU4S6)TV&<2F3>/X\FHX1#N@Q8([.'5@?> M#!*C5%2;"\.TX!1:JU`]5@M1,5OD5?*I77!+$,E642S#T8NX8K>?DU'TY2RP MAT1[W@I006-`W,V]\HH9R@3$]1BC)IF;)//D6(ZK)%![P)8@SZI*RW*X6%W0 MFZ?![/%`KM7WCP>7YV;D%LG2PMX7N)4?L)I M/#"&`8#(`.29M-KH.)AZ-`;(7)>$'I;<[.20=0:618]9[QV8]QVN7I].A:&B MTL\QPX9`2[W3&-1C5_VS::\]$L0VEAMBR"%YC>)`DESV]U'7;YD_;Z):+ODE43XY4*89Q\?77:O&4_+M2 MY875G=+!NYL#[PAZ&,_5(@>V1N>TBW3)*,## MY_!OG@R,$JREA8I1SAR.9T-=(^52.K/"SI=7RYMS4"W!D#]GHT5U]_!P]V#7 M8DG)XS?3CNTAS>&7`P!$$L`@X1YXH37DCMW,S*UCO9% M-:8<32E0#GP\3E)C/2.:0B9)?9IT!)O<*XL>>B9V1Z.VT"VO(6U+*J>KA^FL MVHB>K5-RUDMO/'*VJV=UVHL`J#0F;A)Q?XCH0Q1E[&H9"*1S]]V3S977=X+L MKY2*1O*O)[.N)M7#Z*AP_K=O!*>ED5);0K%&1B(L9&W7=<#C7`;V,F=Z-QP\ M%]-^K*QG+8@!2Y"R)0(K&>0(I]1.OAZQ%MDY+'MH*2V_CIT(;GDZ;<^A63OT MOG4C_UA]3I=*DT<77UA\/=IEM<5O!>4XE](QS:*6C+$4&(CF6(:RRXJ?7%3T M&@UOEY9&D5OI;:,Z8N#K4.%5.9;EXNC(\BX^%Q!GU`B'E8*20`NI$+1&50(@ M;LE#\(*<_/8"_?*BO-@$V0BB'\T_3^>#<:K2L>7!W"EQ\@>"D"2N)]1CN6*K4M=P%Z??L=0*5C&+N==$**9BYYEL MXBB<-SB[YL3IS@M7MQB=`V29(\/6>GU[SP!;WPB$(DPQ(,`1AK0@"H+FVLIQ ME:O4GU"8Y(K7EG9`+;^!?1F,QB]+H'FM/+JNP*<'\]'PZ.WK8$LACEI0Q1&) MZ[\/5L$]I^W+7%D:P&L1K.61=O;UJ*VW[< M[ZDU#DI-C48V*H4U%LC3;/VI?_:NECAQ\EW<.7CWS4B5Q\(3V@R,,*53N3R. MXE\'#*;-\I[2YI>ROY98]4HPLCOL+[:UGKJE!@V`Q8XY`)$E@EK*#6G&)5GW M'J;%E+-N&-4&JI=@BQV-E_&TE:&*??-F4$Q0AXFA#"&9CCE,JF;5YME16_!T MI[M"UT+=J6+G0=L;96P]C%;4L)_P0WW M](TVQ&T%0BZ]]=0C1)'%N`Y5\`+27`/:%:AH;3&K'63+I%=H+'NOMN6ZUZF2 MP&POA8YY/5!#**:($H@1D99X2&I?$,](=E(@>'*6CFNTGG6`<)%`Q6KT^)2F M4L1\\%C]MGS^JYK=/:RZ/;];+N:+P22E43_B/'!J4\'%R41$.E@9JH&CVJOF MZ&R=SPT[@[TLI-HVWSI&NT_<.V3`.*F=`.-8+4MI;+E@41]PTC5ST`J3JY'U MT'C;'44RN9@C@`L2<5.1W!S&Z53(W93^86A+!!R(MFPO^P`OVI6HR&@_';+EY=6GP'#(`($NL!YB`M$(:L:_(JR@^G M,RCH?I^B$!\>JN%BAV?UJ=[VA]H+W"!$B`>:>JB<-1A#7V/#/2EVV7A))>EH M?ASC)-\RXA<+!-D8QSL+R3[?_S,8>M)W`N0<&FD8())BHK0@#JYQU([QW*3% MO0T+*YPBXARCL5>K4=&N"AV:"JQ M"9TKW&DAE"\[46VU&(S&EZG'U-9\Y1K&;9[QJ.8[Q)GF4>-?XPV\X@>O#;L9 M7114=?=@XI08+?Q@.!J/%E\_)?_./0/<^4Y0$B/HD`,(Q1W'ROA'U6.,1_`; M,G><*^1I-Y"6T`_37%VLY^JG^%7U[VA?-,BVQP,UBG"&*>3*8B0@3C;J]:B( MEKD!:CTD2@N2_98KYP-Z"9K8Z?-@M.\\L/V%H"@C4E$(O6/4.2J\;Z:4\[Y8 M6:0"5#E+L`=8DH5F"9Y\K+Y,QU]2NODW<^37*AG2]M!E[WL!0B0T\H)[F>[! MM++6-[#9_("B/NJ0YXKZ70V`]H`ML]`,DH'R:UI4#[+F_<.!8^_BO#+>2*BU M1G$8O!X15LD#\%8L!RT3Y6PLB["C6BR20?Z%S(?YL>7Q8+Q43GD(+4Z6%$&, M79?J9I!`F!OI<[KOR]4QY'PTBVQ!@\GC(36V>28@CZV'7BD4V1Y[;`RD=?\- M0;F5H_NX7K2NN^:B6(P%A]6.UZ<"1(H)Z272CL?N8T.]JV,I/;`=O'\X*.X0!#C55-->4$2U;&8&XB!W7^BCEM#ZOG`V MG.4)\MO@^;!-8]+AWGB'8O2[+1W,^5 M'?=@+VQ7C[-J=>NZD>)?U_12$GY#57S.%]2T932S M9+[#$M*DFE_XZ7+V83J:+/SH2_6AF@U7]_'3+]4OH[^FL_T<::7Q8"3US@ME MG0-48R(CBLTVBFSNT;2'AY%V.74)]/,X.)U7GZ(4/A`XKK^X>#8UY(;:#6A@"@ M`#.R(PO)M_RXIFNI\P9?[%+J>C2@5@'M^/)FMS?A?4J>'\'Z:S#Y M^^XA`ES=)S>O_8K-H?<"\$Y#2!UDGBG$I>6LV>`A9L6,+UN M@0=-MMM?"`A#(H@W%#.E),+$L<;^*%BV[;Z7R?M:73A:P;-.;ZZ^U>_M/L^GR\SPV,5ZFL*WM>2`.J-IE.A`T M)$9PC"$C4FMA-!5DC3S2G.0N?3W,?-2^^MY+$14*\CE^#,>9NO-:#$@+Q9AT M"E'E:%P^'-,U-@+;7.M$#P\6?2/;^SB@`@(\VPBVG,W3,:!*V]#QUK#W;P7L MF><&6X>8\%HK0VS3;TVSS6(])%[GDMUE-3L;]3+7>N_C9#Z.YG\?O`'>_5KP M-*K'A&$).'*<,0MTO1\ACT2N=GER`D)(C&@Y^-@!.O"0`-"A+I[-2*_5FE.N7&$>M6 M2]"?O8SYZ>SWKY/[491@[*,>3/Z>_SJ=+1X'CU7Z]3%KV($F@B'814U!("DH M5A0`IUZM"5(4*[?;Y0)6@DX=`U]Z+3MRK0K88*FA`-AS9:@7A),Z<@A9*(H5 MN[UV^K0`;C$7Z?E\F0R;9CI?''2AWWPVZ+A8Q@4TCDH!I@A4OHD)B.+0N3XF M/7)$*DF5<_'-VIW>>N"E44X?5N.LO7=W[4D'7PS0IZJ%)`4?:HR84\C7[@D( M>Y5;=Z%']US%]J&VP3Y?D1E]J?Z_&LQ^'2R6L^VJ\,%W@A;4&2L99\0HI+3C M#118>'4#1M?+*"KGX9S%C5H32EY*?XX63Q]FH\EP]#D.ZW7`M?/2=+)X&G_5 M@_G6I/3G-!>8CZ=5XP4DBGO&'<>RSI&%+2>Y$1N]RAE>C%-EA%`FX\0K6NO0 M@#@N'>=(/`O^$?^;QK")X3YM^=2V`DB5O*AER$$KG8UG3%';;K&S*M<(*;XW M4I:2P,49Z4?_5O=MT/%=0T%C38S05F)+B?38("YK)"ARN0ND_,'%#N`_GHCS M:OB?Q^F7_QM-OL1/)1KB];\3`?$&`5]^NG'9]-OTQ8E%/4^76[7]`V\$S'ER MLD,A&_QN'%*7'(KG!L.T$J M+3WEV%OG!$:8&:H:[<*8[*OV[]1:WB7X+1@DS'0\CGV9#<9UH8:[?R;5_1M' MI6TVJ]RF`O!*.2XHC^=I:8$4VC3**P(^^_ZO1^$I%[):=(%_:57M2$4L("ZB M0(SWGC!D$7#0U#&G&`N8G3F@1R&\E]*R3L0VS]*U2H,VK^WVR2A;W?]W$F7P M$M86R;NWX,_IC023\FHP$(_*'BL;5U.%3'-$02!;B^I5?$LY,5H(`6@KC)-1<5H_I1Z?_=R]72(;[M?"M)(1H5*U2VILH(X*>HK6&=5D' M?#\8S?X8C)=5ZG']PU]&@[]63EM'.>/O;R)8KHR1'A%.G8!Q6@D.FM'[?->Z MXXWO\H5ID^HQ5>N[>J9UA'P)WJGA$-#G11 M/^MCM8/G42PNZJ9Q6D7:#%\B ME0_7T3JEF:")$MX"+#BCDDDD!5XKN0;$/P?S(':#Q&_5/Z^C^#";3N(_AR_5 M=>-@UL/Z>;+YS,HG8ESMK:G79O.!4V,1B*@92!%6G@L@:^0TE[EN=;V,4.F& M4M.+2Z7CU655Q7KEC),VQK@KKEK9_E,UFZ4!KA(IBKCG&BC$#;4P*LB4000O5%3P]^%3 M=;\<5^MZZ_LX,M]%DD-%"%O[1H#28&H]Q\S&?9M+HRVJ,;0`WE*P=2&R3?LA MJB*'P%7G#E=!?/-<@(A*)0"@$OEXME(1H]/<0L9S.;[,S.=VDYP!GG/G*2` MK*V[L/SEB%0AYS<>H(9.Q,.EH\1H9JDC MR#>(29"[;O;(.:P_>D!QGW?C`X#+F!#%FK MXWZ**2$*U,A:C&\HNWQ)&K8U`]J479[>D=OSU7\V._[BI;-3+VGY.X$::A0# MSG$#J#`80M%LB4;A8JE8/E>ST31NX8/9HI_L;HEBT_X(\Q)$_RD^MYC_//FP M$O=/L^E\IS-[^U\*AFAC%#`<$>T,UP;`!A_)7>ZU=!^UF=NA^?F"O`31U]<" M5=/QCFC^[CL!8($4$-@:2`Q$2,1EH,8&());+.EX3_RW]^J??G"]G#0OP?2( MUT,U6J1DX"]79:-UGN:.F7_PN\$YH'Q*2I720F.N.86LQHXKW7W9L!\SH3?2 M_;ZT>H6LIPIH:!2ATGJ$O6TD1E'N]45V;2^;-* M)MKJ7GVI9H/'JM[^/LQ&PRJ)XJ&DN>?(S@1,1.2$]9):I2D@%LKZEIDC"7Z< M(GIF"NI&KA?>4/8-JOMM9M_7`Q0`"N&T!02Z!!_QS<8L3;;:]3V8E%JG:C=; M4XOB[V8:[;^"_,:DT,E4:JT'0:B4&"!N^DP;+DD4.*]/@,*R[-#Z6]IN^C:1 M+B7\BTRF=S:+2\RGDSH1'$-8IM1"$ABGL<"Z`V:_.(Z-8&_^T[`W!%$#:!*&`LM MUDXTFK,&L/MKT/[O-_E6NCZ([,)TOL"><.37`P.IX)UU"C'-D*+."]LL"S"[ M#L4MJ5J]H7Z+@NPZQC:YU[\;\X]@UXWX0\R])!Q[CCE"BBL,>9UQ0;FH.5PF MV/7H06VR]:CP_C-;#CP"A)WTCCE%X]QC4-192A1!0-]29'\I:GV;OJBHB"ZR M!/T(NW]/%T4DB7N9B]N%Q0QQ)C1[$9O448@'LZO^"+NO`C!$*P&]4,S!>/1C M4O`:PWC6NJ&8T5)DZRSL_C11E7"2J>,;#T3=;SX6'!3_:^_*FMNXD?`_VN`^ MJO8%C6,KMM'36UNX?,1ZI/A3=HFE!]%WL`%U)'2&DR2>"D)!R\Q MQ]Z+O5PFPW,ZME0FFOJH(W4>$WJ!]H'20^;M;P?WVY/'1NXWL@\H*`I*"0Y5 M?PQM/=6]!=2/X#ZO4[@\Q6[+C.D#B&^+]2T9A/PY<*\\%(IVWR#M6AFMX86#OLR&KW81`/+BO MTSN[1@WPJK_LYJ]K;F:_Z_H)&_ZT+M< MH^$2K=06P=<6[EMB6\\99MNP[8?<@H8%9<[\3K1>446T`V2%P]@%S'U%&Q`F M5Z-?HAWI$X3;"K:"-5#9;!7.'?+LOR2Z3ESKMS5>KWB9(Z"]$F6$S68=Y9) M5=%#(?R:1=@+WIPOCN\VRQRRS[-J>_"\/[S"G$ M1&_G$8#0GNK$?^\>.?#(U8:`MI49V$=P]25:Y-WRLU_+IFR+5O:)*U;E5?;L M4_LVS;,OQ""H9)IK9CAGB'D!:L\PP5&N<3ZJCNV#;P9#L6NXS>!LU1V1HQ:3 M@"G5DF#*-0K[;4Y"=FN`4?5V'ZVB/9/Z@R2H/+G7,8N/3W[S^V)^LS;)=+I+ M.\)K.LOS#`.ON,3$8ZP@L=4(C<,N29,%Y>HCXU_368HHM74\&.$9*!XDXDD! M5S1T-N3NER,\G^T+;)VELYS'JO%&_RF:J"<]PYB"%T0+HZH*N@@%]YK0TH3W M1Z/_SJ/\*%SO"XC^H]Y0['1RPX)&5+BR.D5%59OG@.1--?43_G<>$`8*N M-M;8Z6->\)(U15G'"*Y0K.)9H7+<*VM\NA%G@Z$>DZ6%>R]SE$ MKQPG06M+<*"4",2%W,,DB-Y"($??^:)C>/&SN6:H1/L>SL5,6P$@,L6OUT;DH$E\-DL8G($($AGL0.GRL[$"345#PRA MN95O3@^_?17"GH6P*08N6P['>!YC&'.&&>LP$.8!"P%5DR'$;7;^WMDAPB-O MCC,5`6S&_HF(WY.&$AM'N4PE"[/YZOWL^K88S6W$.3.-I4$CP6CF%9;(*&[5 M7I4JC'*#K*=TMG,1UQ4=,KW?E)?:)1]NXO5\T:VGR[0ZNV@D\HQLY:"5W9TCL7/8F?+2Q\TE2/[HY1H2-YY38`%J+Y-!P MO.]!A0.VXG7C'8O47SIV\O?O#T<6^^'^6:K'D<7>/"S6S>_F'XO%YL&[V77Y M2+-]?#2SC`%9!`K9X,$I((A25QW/8^E5[D7I]WE!T]-.?JGHN>P=_=N#]7'N MZ&?.,0KA@Z(4L61_(:6=,@]:V0'*O9Z=4@V5D4C_I6/GLF7_48/[<0K^.1., M06MIK1'@I&;:0>"F.@S%7/K>RL&\2OWP4M\A<%X/X;HZ2)&><0)4*`Z*R("H M0[SB@V$^MQWE]WN9]=TM4,0" M%Y8QIQR303`7=DVIK`B:O=9(J?]&HB'%CE$G@I#(.@K!^3T-I9A0@G]?8.NL M1LIYK!IOC10.#$$P0132OUH%/*&UT.9`;@/=':Z2<1_E1^+(74"-% M<\LM9=QP#%@9:;C0>ZHR,MD.:2>CJ9<.:6K M+8F7J+QS/8I-@?:W)?EK]O@.OA:=$PR0HUX;DO8[FN315C354N2>X(WQ)GYP M2V%X_HU<)IZO,=/<:/2UB)R@5&N"$S&-H9Y*BO8T=6%"O>T'161[TM$2)QN; M+,_G\$$G5&AU4!P6ITQ2\5`);<-5*K(?)MV@='$R*4/A;4!! M&OVPET-N7,3%6$*7)R?-.-AOA-'F/T?"+;Y97>L11&=]/0I)M6=8*`):(9[/@\P2B[:]'G_P\0#(H`\HKY2&Y M?14=7="Y6\.4(MT[$8B!&3GP#O'CXF8U7ZSG5]U$E=9\+PKA*$)I2]7`$S,E MMVK7$,U*S;.3NZ84Z#V:7:`1Z\:C]Q]%9@Z@]Y]]/3E>Q!-II"V[3(J@B%>5 MNI`*1&]U?[XW$1B8D4/H_4=S[D7O'_Q>=,PK)K'$C"JM-LX4J6A%L,H-#SB[ M#>GW!OK>63=(@/[FT/DUX/YQ##0U8#`3F&.C&<58!['#4/+;@-=6QNB>6@WN M&!)O(4WPSQ/)U\*78G)U#0XF!"&T=09YY&U%3REY;L7,$1YX]P6\Y9@8ULOY M]K?7:\]J)IS7B7FC\TZ1A"X_&YT"8-@XC$7R@!U&V(:*RBP_)V6$Y]L#B<6( MN#>`C#R3[\=A#J5YL@7.>GW[9?N[7*EH^*&8W&+&L)=$DD1*3W!@#]H&J=R( MEQ&>;H]##OKE5]=&[>V'=?'7;1KN[TIB#6+(/IW$"2;JH2'1(09>*PBF;%). M!`&^NS-37'O0`V5[/IGN26KBT)A(G0G68^&D$=(GS6DTKM9HI9E2B[K&;'XJ MRRT1M6>Q'#*ONTWIM%CPY,;;\M1*H\`9E[M=WP#VI+;$4B\KK$VK?N'Q"+3L M?\R]=(@@AI'22%0KX_9I8_E)RN3)S#TNDSGT[,4^?#+-^H3F`R,B(F")=H&6 M#1"228(1[.*?C,54YYY(CA\K9[*V!B=YY!P(*O590(?&1"T5($73[L1!<:F0 M8K):G^1^2@&/33E<2"(5"%CY9FYFU"A MCA9X>QPM610]'2GKXNH?GY9W/WPLYEN0I!^>8B/]*OK%S?SF'N[?;(S$Q)67 M]YQ#CT9FL4ZVK`^&6&4I]5RQ:OX!0VY:^`B/R5K9;%JB8_LXJ"9S<"-Y_E`, M0DJ*%$HNC$*:^Q`D5'-6DDY@YVC.KF5+U,NZ9/_7JB@6=_/KZ^+?:9&W5W_> M'\^"._1\3+/$CDOF`EC!J.%,D_T.:?KKL-TMIW,9M&R?A`.8!&].23H[,"2F M!>BD"(T25D@4O/=RORE2(+GM"D9X2MRESY%+SRSE4(7_O)E?%8MUV;UKM9XO M/D%Q.([LR)#(#18FF=!(@764Z0#.[O%-W(0*$#5GVK(3FO:A,^`V3:Y8K\W5 M7[?S]7Q[/9*H<%N\+;XN5S?%1[C?_"VQ:[MQAN7JS6Q]8Q:+V]EU;:O05MX? M+4L&>C*DJ4W>FY)ET7Q7T4T0/*&[V]:P."0#^@#NF[2FHGA3S$KA>AQO\CW\J_U:LWQ6K+^7UWZ+N$#KOA3$0!#AP[9EC-&T9&BM442;])==F'O]& MV1R:O5"\XYN7][/5?!>)6*37W&Q%:)"+ETK2[?++A_EBLYI3+E^.#8M2*Q\2 M$P4@XI!0SJ+M:89#!ABJS?SI;:4/=_VGW)6>]H(8P"@MM3/@<9F!;,'`?O7$ M]Q9)=U>L/BP[ENYV8'!@\VF5SH-(].Y&M9QSVA6G(]^,,4L1,EB+Y.0H;;S9 MZE*/*96UH0%=AU:]R(QYL3Z]E/71-T2G3%"<*QX8*(&X06&_?BE@0N??[<#@ M8*A3FV3NPWP\-%^XM]>S]7K^QWQ[=/3+'UOYK[FZS7E=-!PL]F5]3T>Q#EQP MKRJJ`'5R.N!K'2?+WLG?!RB?3O;`5E1W-7S.:R+%$+!P3'CMN=1I)U:XHH)A M=$+!8=V"9-D;#P93C_<_+V]^7<8(\] M.,-56;NAH@=Q84)'C]W`Y!3MV"(#QG>)S2EPQ1!CB&@,`C&0N^-[3Y!$4SHO M[&AG;8FTX[C7YEPBA9BDUB)EC+;4A6K.Q&>G/(Q(GS1GU^%[[?.HEW5U96^O MKY?YHOY[/C-]N$1$32S1J+DPRAD1%#)EZF@3IBS$XEBR&72 ML@LB]F&2G-(NX*$D-Z5:.JM8>;1$+6$4853-7R4:3>A8OF/?*I>FO6&BU@!] M]%2T"CRVGE*3[!L=<.!546%/:"+$Y2N'!GQ[B?-9=.N#]S\E;?7E]DLM][]Y M+@H:`"BRS#)!I7/$^?TZP&3?)(^5_^=R;]D>[7K!P.R_IV'@\7-1,8^8PY0& MI$/2A$Y[6JW#4%N;\W)2K/KHI=%)\M2CDY[IH>'Q6%\MAYSL$":"(M9561 MJD01+7*;-%P()C)YN.R*OL,=IK\Y(3R[9F3D5&JE)#BLN21:>Q7VEGWZ)SX0E409- MM8::_!N;YBQHE&QP2!KK,@X.C8LVJ>SDF6#A`BMK.)*DQJNY2]Y?];KAX-,^ MFU]*3VB)`:/(5$G&)5'44\*36VJ$0@\S#E)-*&5U2,`TIWP65C8AX.93LAG+ MT/!?5\N[^<>BC&+[.EO<;_HEOUO^>KNZ^IP>.P2><]X1E526(HVD1YZ19)U* M69V34-`B%TUGWQQ,50%UR(P^#PP>Q5':Y6*=UK#:%OA=S1;K+9OQ$2/KG-=$ MRZGR2#H:>$!!)<_(5DXT15[D7EJ,\&"J9T#VP(VZ:/5__E`^7%8@3/_S?U!+ M`P04````"`#R@&9%G1E4GS<0``#!K```$0`<`&%V8V$M,C`Q-#`Y,S`N>'-D M550)``,7XUM4%^-;5'5X"P`!!"4.```$.0$``.U=W5,;.1)_OZK['W1^VJU: M8PA)=DF%O3(0LM0!=H&3[#UMR3,:6\58Y6 M_[JE5DOJ43[^^VGFH@41DG)VVCDZ..P@PBQN4S8Y[7RY[_;OSZ^N.O_^_9__ M^/BO;O?/L[MK=,$M;T:80N>"8$5L]$C5%'VSB7Q`CN`S](V+![K`OR"'BQD1 M[A)](^-+ZH),V>T&HI#_ZTG:'Z0U)3.,L%*"CCU%+H'M@CC8<]5IQV/?/>Q2 MAQ(;5'.);CE%D'BML)@0=8MG1,ZQ14X[4Z7F'WJ]Q\?'`VPON(459=:!Q6>] M-X=';P]/C@$N&(#)#WAAX3KT`.8A1?\T%NX!%Q.@/#SNZ==C+$E(SCACWBR; MP5:BIY9ST@.B+E`10:V(KYPIS:`);!7Q)+5ZU_-?)DEI`0;*I,+,BC`\K6%^ M/#;41RD MD)&UL4:Z0VQ+(R.KD49%/2E'GW46_5FJ$?%M1XZ2' MA:7=#9ZS5)<\S5W,L.)B>0E_5U/-%2(EY5,L1.MXHG4\>K^)CD8T(Q,=WZOK ME.3:KB(U#!-R;*Y`=F"NHD>2\]9GW*8ZS5390(_L::3B*`H9=,OO:K8IB74P MX8N>Q3VFQ%*'J.,JL2V++_RC&PMIJHTG!&1)R\JA-I,Q^JM1E$W)M0FMK4O( MHW]LK@%YLJ:U58B8S*_-E:!L0:2JW4D2;,'OS;L(P]0R4_%1'4UB+O]G-Q;0 M4`])K=I:A#SZQQ8T4'-17X60R?PJ4@(SQI619)Z%3^=SRAP>/(*'>@[_$$[D M=\1!)E_]$,RBQ5EM;R[XG`A%(;E*)/9&P%00Y[2C5P_=<(GPEX7=`\B#0Y*U M!M(IAIFO@,7R7`/C.E8RE*#C]VE'@KU=$H+_X:ALXM1%!2R4T3:#Q5MP!V0%'&N M#-'JC.E1D,T7/`W-6<7*%T1AZC8P=LA8:/.WND<=Y=D<_10(^7EWK;\@+I_K MW:@F'HB9BWL^=/W\GH\2\>%<3>AM_*9)?[\[B:/\.&$'>0WQ0*V_IY[^V$J49X[)+-G!J( M*/3=\='A<<$\E?*=+V_GG'/.F>0NM8TF?6:?84GEP!DF@`V<2\HPLRAV[^&) M.62IX;O&+92D?6\R)K]46P@S&YG6]'A,MJ?_CEI$<9-[YU=S3>V@O&E#)=GH MFXQL=,.NL+OA6EN1,_"?!Q)@>6DTJN'K'/Z25#9K$9>4A&)1>X=H*]0>@\5B M2G*@K/5>CGMV>.0$M0\0X#Z!7=3RBNDB!Z-8#3\522ERT^&A7@^:4106821^ MZ@CHRT,)@;OFHD]8,%UIP^%UJT=\05OV:LY,O\M;OAK]3<(_*D/.QNT8&AQ'(_ MKJW@*_L1!8WL_1E9O^[RO512\2K^\->,57RY_W9T1?_INP>3_`U14VY?F0/K M>OO0.?PE4]M)UM1F)"%?%(IE[3W2:$>Z6$Q)"#S)2.#S_+.[4]@5`]/HHL(; MK!01-9RSQEDR7MYEC)=(!@J$[+KY:P^1/`$E@^-=QN!8<\8NCPK`3V?QCAJQ MS["K;7,_):3.7G"II")''47KVVB;SOC)B$1)F2@0BGRI>W^EK3R$](BI*5'4 MJI.-UQ-;YLEW9LC5]"3Z*=7(?B02.]ZR'CCG6$XO7?ZXV8C,EECBS[<51V9B MAYT[2(M'1O[>DVF[\QE@G!(FZ8)<,7`7T3G9&/);"Y9M M>[>GW-+DO*6ZR!+GOFGDW-T]EZEL^.W-MU7DEWFYXL2;Y^5=GX*O.9N,B/[$ M=*R/:(SM8-U\!]:Z?\3SZNXM$U2R@'R;L8#4(KM:)M)"S9%/*!9IN4@+WCLL M9>?::\R*\DJ6G&\SEIR5W+>[R]`[8NEC4V:7\QV^QD&?IWH099G5,I^VA<"LXF95\Z6,J^X];#6AVKTS&S^DB#U/B-(&4D9763O$2VZ?L@H%%,^A->* M"?+\LQ\[:1/?0;01U#(K('@/(73ER1=00?8M11=4+;?DUV:-EO>"M]5[0=R@ M3V2"[-I#HP<*%=D'WM4I/?K\P[P/9K8M)A+;;+6\^[RKWGV2WZ/X72508S]Q MU^@_=:M="J645+J\SZATR??OCE:XW'MC2;Y[`.+3HMZW*&NX^H.%&L70Q;25I)^O!;QA#*\]9.%#!,\25\@8ZZ/">Z9 M-"[6%VS\%7[C>TU@CIYR-]H3OB7JEC/_)B?5,7?AG'8J4U/7U7XY[2CAZ6OI M(-2!7SRMS&?!O?EIQUS2^($J,NL@_RH._\F,,W"=6%[!&PVR@_SG8[^8XK1C MDS%5X=,Y$93;(\/O7ZJG4I?HA'@QM"^PI4*%8OP+SH8NML@-F8V)B("N/6Z" MR+\<\X/-9YBR54!)U6U/!/LL=70_GV+F*?('P:Z:6EB0C^0&UE@:^*:]VJ]ZF63YS"5!UJ[T/JBK!]4H6QC9X!P0U5_(H@A7`&5 M\[*-.#S7Y39AWR!:?J5B`L$>KX`IHF@AH@O,%J`6@37XU6)I8Y?D8ZM(^W(H M8U1DK*Y@)A'FT\-S#AK!",'NK:=U'#B#1T;L6T](&,_^Z)$1R$:LS8,*!1$3 M(HHP%\V).9#U(2YWS`EQ.*ZR`683-H<3^N<9>FK!9ZFKLT5%VO9-!04?*F7/ MBW487@QN#&\V=_F2!'-7HEC^BRZRPCO)A)> M34+[&8:B'VO_`W2>];!,1^*"]RV<8_[`2VF4+4YNRLG:B,V#)--HW0?=\&QE MRLQ_W8)9,BZ[O11U=OW@/SW0FHZX7W=G@HM>-B8FS:U(>L;1 M:9D4A`(-O8?MM=J`&4 M"^IZYA;W+9DFEM"3[ZTFM.G?TB#'#@YIJ6IIACR8BVC>B0Q MQ"Z>($IH6A!1S99:E$@/89E.;2+UF1EFRSLZF2J(?9ZPIN:BW`!5/9X-NK6N M%]P21KULH"S8C-'YU06!'@$O*+O3*/P\K#_3I8DIH#49VY:QY5K!7QYR)[TR M]!C,;2G2.-1M).'%UIOY`UCK:-\_Z%QG97V\,HHK$+9B*)N/;@>.OSUU)25, M0E^T-^[(@KL+(A(E##&V>DS/.)B;.9$S&];NVAECS!X&CD,`B"[]7O%A.5T; M7)@NE+\``0M@T]^;A=L?9G_XS.760P):+:8-<*I0S/:7)27?".1L)M3F>OD= MA:3*E^"E_Q(L;K#RA#EZ7H>50?."FUW9,+BX7T*$L,#L`^<,QI>\X4)-\(3H MUYFH2EE>4RK(/2H+-C\*WK<@Z-Q@=ZYA48M$NU-^IG/.(?Z#1Z[IC*HA$9?8 MHFZBFS;B?(D$:5-#W'MC-T#B3_SE%LAB>5W0[XGKF#]T59Y49HEVX>D@.#3R MBVQ0@;=]XSMA#;,W&QZ@F/P/:HTDS6,G4[8OB.W!*D-72W"76BMI3CE9"SQU1VQ"9J;@`]0EX!'_L\@A%@-A2D#M MK]CU=#E(<,.Z#ZX!WW,>)C;RH[^?K.=3$^'"'8$P:/?5)??$D$/PTCM>0W^_ MN#_F"W)-QWSE8&U;PEH8@^ZX.3F!=^26KVYCY[UL.8YD(I4/*).JAP:9^WK]]6T9R-SCHTBW)C1<^V\/TC>B:$F+W_3.%X`VD0M1ZAMY8 MTMI+Y55;MBLXF*6W\9]![G/VP1\2!&%*"#*]"]3G@F`-;B-+9PO]\4KTQMCTG>)^L4T6A'H"QM;*4MB^^TC M:RY*MA)"M]SH*\@I2Q"G4[\?8>-:+;YF`_N30+Q0J;GLK"^W#05;!?=,R[ZG MIES0_P5?*21NBAQ":BM3OK_39@BK!!);/'X?*C;B,[36TE1T0Z3)^SF?WZY9 MK;7#KN."83A>QB3ER9^*D[\+?24`889P@5U-4B\E;9-6+Q:'\T][,K[I6CGI M*:)HX_E52M_P7/P6L/2?J,Q&E4%5#9FM/MATIO^3*C_J_Y@;1_*57SF8+*=K MPS%=YM6W%1+V\$[K]:1@FQ+;>*].\G;H/@NN&I_/!;&HD68^09;W>/4[S@9\ M;1SA"13K\^2`D7S0Q>2O#NOHD=?!FB1O(=;UVHFPLF($,=81*R&\.GF;8WD% M%&D7UV%HHY,?^6C*/0D9K#Y_T@''+^0+KDO0V>\*X#HLJ_'"ST"OF-XD MTN5Y):#+F5J/>T18;=BE/"U$_85AQX$\2U>D?@K*\-,8"RE:D(]]X^*!")G^ M7TTL`NL<4.R2BT]/%I%R*,B,>K/4S3>-.%_\B,^_M%E"$)UA^//_4$L!`AX# M%`````@`\H!F158MVR`SUP``O98*`!$`&````````0```*2!`````&%V8V$M M,C`Q-#`Y,S`N>&UL550%``,7XUM4=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`\H!F10+.M?@-(```ID\!`!4`&````````0```*2!?M<``&%V8V$M,C`Q M-#`Y,S!?8V%L+GAM;%54!0`#%^-;5'5X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`/*`9D7(O,6EX38``.FS`@`5`!@```````$```"D@=KW``!A=F-A+3(P M,30P.3,P7V1E9BYX;6Q55`4``Q?C6U1U>`L``00E#@``!#D!``!02P$"'@,4 M````"`#R@&9%'H6/*D*J``"K$@D`%0`8```````!````I($*+P$`879C82TR M,#$T,#DS,%]L86(N>&UL550%``,7XUM4=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`\H!F11!W'H<\90``>@X%`!4`&````````0```*2!F]D!`&%V8V$M M,C`Q-#`Y,S!?<')E+GAM;%54!0`#%^-;5'5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`/*`9D6=&52?-Q```,&L```1`!@```````$```"D@28_`@!A=F-A M+3(P,30P.3,P+GAS9%54!0`#%^-;5'5X"P`!!"4.```$.0$``%!+!08````` ..!@`&`!H"``"H3P(````` ` end XML 43 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION

Overview of Plans
In December 2005, the Compensation Committee of the Board of Directors adopted the 2005 Long-Term Incentive Plan (“2005 Plan”). The 2005 Plan allows the Company to issue stock options and other share and cash based awards. Under the 2005 Plan, 700,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted thereunder. All grants under this plan expire 10 years from the date the grants were authorized by the Board of Directors.
In June 2008, the Company adopted the Advocat Inc. 2008 Stock Purchase Plan for Key Personnel (“Stock Purchase Plan”). The Stock Purchase Plan provides for the granting of rights to purchase shares of the Company's common stock to directors and officers and 150,000 shares of the Company's common stock has been reserved for issuance under the Stock Purchase Plan. The Stock Purchase Plan allows participants to elect to utilize a specified portion of base salary, annual cash bonus, or director compensation to purchase restricted shares or restricted share units (“RSU's”) at 85% of the quoted market price of a share of the Company's common stock on the date of purchase. The restriction period under the Stock Purchase Plan is generally two years from the date of purchase and during which the shares will have the rights to receive dividends, however, the restricted share certificates will not be delivered to the shareholder and the shares cannot be sold, assigned or disposed of during the restriction period. No grants can be made under the Stock Purchase Plan after April 25, 2018.
In April 2010, the Compensation Committee of the Board of Directors adopted the 2010 Long-Term Incentive Plan (“2010 Plan”), followed by approval by the Company's shareholders in June 2010. The 2010 Plan allows the Company to issue stock appreciation rights, stock options and other share and cash based awards. Under the 2010 Plan, 380,000 shares of the Company's common stock have been reserved for issuance upon exercise of equity awards granted.

Equity Grants and Valuations
During 2014 and 2013, the Compensation Committee of the Board of Directors approved grants totaling approximately 68,000 and 69,000 shares of restricted common stock to certain employees and members of the Board of Directors, respectively. The fair value of restricted shares are determined as the quoted market price of the underlying common shares at the date of the grant. The restricted shares typically vest 33% on the first, second and third anniversaries of the grant date. Unvested shares may not be sold or transferred. During the vesting period, dividends accrue on the restricted shares, but are paid in additional shares of common stock upon vesting, subject to the vesting provisions of the underlying restricted shares. The restricted shares are entitled to the same voting rights as other common shares. Upon vesting, all restrictions are removed. In addition to the shares of restricted common stock granted in 2013, the Compensation Committee of the Board of Directors also approved grants of approximately 55,000 unrestricted shares of common stock to certain employees. These shares were granted without restrictions and considered fully vested upon the date of the grant.
Summarized activity of the equity compensation plans is presented below:
 
 
 
Weighted
 
 
 
Average
 
Shares
 
Exercise Price
Outstanding, December 31, 2013
333,000

 
$
6.64

Granted
—

 
—

Exercised
(22,000
)
 
4.54

Expired or cancelled
(36,000
)
 
7.87

Outstanding, September 30, 2014
275,000

 
$
6.65

 
 
 
 
Exercisable, September 30, 2014
244,000

 
$
6.77


 
 
 
Weighted
 
 
 
Average
 
Restricted
 
Grant Date
 
Shares
 
Fair Value
Outstanding, December 31, 2013
118,000

 
$
5.41

Granted
68,000

 
5.51

Dividend Equivalents
3,000

 
7.72

Vested
(57,000
)
 
5.61

Cancelled
(2,000
)
 
5.47

Outstanding September 30, 2014
130,000

 
$
5.43



Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:
 
 
 
Weighted
 
 
 
Average
 
Restricted
 
Grant Date
 
Share Units
 
Fair Value
Outstanding, December 31, 2013
41,000

 
$
5.35

Granted
25,000

 
5.51

Dividend Equivalents
1,000

 
6.86

Vested
(21,000
)
 
5.70

Cancelled
—

 
—

Outstanding September 30, 2014
46,000

 
$
5.30




Prior to 2013, the Compensation Committee of the Board of Directors also approved grants of Stock Only Stock Appreciation Rights (“SOSARs”) and Stock Options at the market price of the Company's common stock on the grant date. The SOSARs and Options vest 33% on the first, second and third anniversaries of the grant date, and expire 10 years from the grant date. The SOSARs and Options were valued and recorded in the same manner, and will be settled with issuance of new stock for the difference between the market price on the date of exercise and the exercise price. The Company estimated the total recognized and unrecognized compensation using the Black-Scholes-Merton equity grant valuation model.

In computing the fair value estimates using the Black-Scholes-Merton valuation model, the Company took into consideration the exercise price of the equity grants and the market price of the Company's stock on the date of grant. The Company used an expected volatility that equals the historical volatility over the most recent period equal to the expected life of the equity grants. The risk free interest rate is based on the U.S. treasury yield curve in effect at the time of grant. The Company used the expected dividend yield at the date of grant, reflecting the level of annual cash dividends currently being paid on its common stock.

While no SOSARs or Options were granted during 2014 and 2013, previously granted SOSARs and Options remain outstanding as of September 30, 2014. The following table summarizes information regarding stock options and SOSAR grants outstanding as of September 30, 2014:
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
Intrinsic
 
 
 
Intrinsic
Range of
 
Exercise
 
Grants
 
Value-Grants
 
Grants
 
Value-Grants
Exercise Prices
 
Prices
 
Outstanding
 
Outstanding
 
Exercisable
 
Exercisable
$10.40 to $11.59
 
11.11

 
57,000

 
1,000

 
57,000

 
1,000

$2.37 to $6.21
 
5.49

 
218,000

 
1,145,000

 
187,000

 
994,000

 
 
 
 
275,000

 
 
 
244,000

 
 

Stock-based compensation expense is non-cash and is included as a component of general and administrative expense or operating expense based upon the classification of cash compensation paid to the related employees. The Company recorded total stock-based compensation expense of $441,000 and $809,000 in the nine month periods ended September 30, 2014 and 2013, respectively.
XML 44 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Common Share
 9 Months Ended
Sep. 30, 2014
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER COMMON SHARE
EARNINGS (LOSS) PER COMMON SHARE
Information with respect to basic and diluted net earnings (loss) per common share is presented below in thousands, except per share:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
 
 
 
 
 
2014
 
2013
 
2014
 
2013
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
219

 
$
(2,321
)
 
$
759

 
$
(6,016
)
Less: income (loss) attributable to noncontrolling interests
—

 
(17
)
 
25

 
(51
)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.
219

 
(2,338
)
 
784

 
(6,067
)
Preferred stock dividends
(48
)
 
(86
)
 
(220
)
 
(258
)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders
171

 
(2,424
)
 
564

 
(6,325
)
Income (loss) from discontinued operations, net of income taxes
3,928

 
(2,444
)
 
3,444

 
(1,875
)
Net income (loss) attributable to Diversicare Healthcare Services, Inc. common shareholders
$
4,099

 
$
(4,868
)
 
$
4,008

 
$
(8,200
)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Net income (loss) per common share:
 
 
 
 
 
 
 
Per common share – basic
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
0.03

 
$
(0.41
)
 
$
0.09

 
$
(1.07
)
Income (loss) from discontinued operations
 
 
 
 
 
 
 
Operating income (loss), net of taxes
(0.10
)
 
(0.42
)
 
(0.18
)
 
(0.32
)
Gain on disposal, net of taxes
0.75

 
—

 
0.75

 
—

Discontinued operations, net of taxes
0.65

 
(0.42
)
 
0.57

 
(0.32
)
Net income (loss) per common share – basic
$
0.68

 
$
(0.83
)
 
$
0.66

 
$
(1.39
)
Per common share – diluted
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
0.03

 
$
(0.41
)
 
$
0.09

 
$
(1.07
)
Income (loss) from discontinued operations
 
 
 
 
 
 
 
Operating income (loss), net of taxes
(0.10
)
 
(0.42
)
 
(0.17
)
 
(0.32
)
Gain on disposal, net of taxes
0.73

 
—

 
0.73

 
—

Discontinued operations, net of taxes
0.63

 
(0.42
)
 
0.56

 
(0.32
)
Net income (loss) per common share - diluted
$
0.66

 
$
(0.83
)
 
$
0.65

 
$
(1.39
)
Denominator: Weighted Average Common Shares Outstanding:
 
 
 
 
 
 
 
Basic
6,020

 
5,892

 
6,004

 
5,878

Diluted
6,248

 
5,892

 
6,171

 
5,878


The effects of 228,000 SOSARs and options outstanding were excluded from the computation of diluted earnings per common share for the three-month and nine-month periods ended September 30, 2013, because these securities would have been anti-dilutive due to the net loss. The weighted average common shares for basic and diluted earnings for common shares were the same due to the year-to-date loss in these periods.
XML 45 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity Method Investment
 9 Months Ended
Sep. 30, 2014
Equity Method Investments and Joint Ventures [Abstract]  
EQUITY METHOD INVESTMENT
EQUITY METHOD INVESTMENT
The investment in unconsolidated affiliate reflected on the interim consolidated balance sheet relates to a pharmacy joint venture partnership in which the Company owns 50%. The joint venture was initially funded by the Company and its partner and began operations during 2012. This investment in unconsolidated affiliate is accounted for using the equity method as the Company exerts significant influence, but does not control or otherwise consolidate the entity. The investment in unconsolidated affiliate balance at September 30, 2014, was $399,000 as compared to $487,000 at December 31, 2013. Additionally, the Company's share of the net profits and losses of the unconsolidated affiliate are reported in equity in net earnings or losses of unconsolidated affiliate in our statement of operations. The Company's equity in the net losses of unconsolidated affiliate for the nine month period ended September 30, 2014, was $89,000 as compared to $152,000 for the nine month period ended September 30, 2013.
XML 46 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity Method Investment (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Equity Method Investments and Joint Ventures [Abstract]          
Percentage of owned joint venture Investment in nonconsolidated affiliate 50.00%   50.00%    
Investment in unconsolidated affiliate $ 399   $ 399   $ 487
Equity in net income (loss) of unconsolidated affiliate $ (30) $ 63 $ (89) $ (152)  
XML 47 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings (Loss) Per Common Share (Tables)
 9 Months Ended
Sep. 30, 2014
Earnings Per Share [Abstract]  
Basic and diluted net income (loss) per common share
Information with respect to basic and diluted net earnings (loss) per common share is presented below in thousands, except per share:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
 
 
 
 
 
2014
 
2013
 
2014
 
2013
Numerator: Income (loss) amounts attributable to Diversicare Healthcare Services, Inc. common shareholders:
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
219

 
$
(2,321
)
 
$
759

 
$
(6,016
)
Less: income (loss) attributable to noncontrolling interests
—

 
(17
)
 
25

 
(51
)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc.
219

 
(2,338
)
 
784

 
(6,067
)
Preferred stock dividends
(48
)
 
(86
)
 
(220
)
 
(258
)
Income (loss) from continuing operations attributable to Diversicare Healthcare Services, Inc. common shareholders
171

 
(2,424
)
 
564

 
(6,325
)
Income (loss) from discontinued operations, net of income taxes
3,928

 
(2,444
)
 
3,444

 
(1,875
)
Net income (loss) attributable to Diversicare Healthcare Services, Inc. common shareholders
$
4,099

 
$
(4,868
)
 
$
4,008

 
$
(8,200
)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Net income (loss) per common share:
 
 
 
 
 
 
 
Per common share – basic
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
0.03

 
$
(0.41
)
 
$
0.09

 
$
(1.07
)
Income (loss) from discontinued operations
 
 
 
 
 
 
 
Operating income (loss), net of taxes
(0.10
)
 
(0.42
)
 
(0.18
)
 
(0.32
)
Gain on disposal, net of taxes
0.75

 
—

 
0.75

 
—

Discontinued operations, net of taxes
0.65

 
(0.42
)
 
0.57

 
(0.32
)
Net income (loss) per common share – basic
$
0.68

 
$
(0.83
)
 
$
0.66

 
$
(1.39
)
Per common share – diluted
 
 
 
 
 
 
 
Income (loss) from continuing operations
$
0.03

 
$
(0.41
)
 
$
0.09

 
$
(1.07
)
Income (loss) from discontinued operations
 
 
 
 
 
 
 
Operating income (loss), net of taxes
(0.10
)
 
(0.42
)
 
(0.17
)
 
(0.32
)
Gain on disposal, net of taxes
0.73

 
—

 
0.73

 
—

Discontinued operations, net of taxes
0.63

 
(0.42
)
 
0.56

 
(0.32
)
Net income (loss) per common share - diluted
$
0.66

 
$
(0.83
)
 
$
0.65

 
$
(1.39
)
Denominator: Weighted Average Common Shares Outstanding:
 
 
 
 
 
 
 
Basic
6,020

 
5,892

 
6,004

 
5,878

Diluted
6,248

 
5,892

 
6,171

 
5,878
XML 48 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Insurance Matters (Details) (USD $)
 9 Months Ended
Sep. 30, 2014
Lawsuit
Sep. 30, 2013
Dec. 31, 2013
Malpractice Insurance [Line Items]      
Number of professional liability lawsuits 48    
Cash expenditures for self-insured professional liability costs $ 3,641,000 $ 3,005,000  
Non-current receivables for workers' compensation policy 217,000   440,000
Other Insurance Industry Disclosures [Abstract]      
Liability for workers compensation claims 261,000    
Workers compensation insurance, non current receivable for excess premiums paid 1,183,000    
Health insurance, maximum self-insured annual amount per individual 175,000    
Liability for reported claims and estimates for incurred but unreported claims 899,000    
Scheduled for trial or arbitration over next 12 months
      
Malpractice Insurance [Line Items]      
Number of professional liability lawsuits 7    
Professional malpractice liability insurance
      
Malpractice Insurance [Line Items]      
Liability for reported and estimated future claims 26,377,000    
Prefunded deductible policy
      
Malpractice Insurance [Line Items]      
Insurance policy coverage limits per claim 500,000    
Other Insurance Industry Disclosures [Abstract]      
Professional liability insurance, annual coverage limit per facility 3,000,000    
SHC Risk Carriers, Inc | Professional malpractice liability insurance
      
Malpractice Insurance [Line Items]      
Insurance policy coverage limits per claim 500,000    
Annual sublimit per center 1,000,000    
Maximum annual coverage 5,000,000    
Unaffiliated Entities | Professional malpractice liability insurance
      
Malpractice Insurance [Line Items]      
Insurance policy coverage limits per claim 1,000,000    
Annual sublimit per center $ 3,000,000    
XML 49 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements of Operations (Parenthetical) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Operating income (loss), tax benefit (provision) $ 384 $ 1,435 $ 732 $ 1,101
Gain on disposal, tax benefit (provision) $ (3,009) $ 0 $ (3,009) $ 0
XML 50 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Recent Accounting Guidance
 9 Months Ended
Sep. 30, 2014
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING GUIDANCE
RECENT ACCOUNTING GUIDANCE
In February 2013, the FASB issued Accounting Standards Update ("ASU") 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes, significant amounts reclassified from accumulated other comprehensive income by the net income line item. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.
In April 2014, the FASB issued ASU 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity changing the criteria for reporting discontinued operations. The ASU states that only those disposed components (or components held-for-sale) representing a strategic shift that have a significant effect on operations and financial results will be reported in discontinued operations. The ASU also required expanded disclosures about discontinued operations in the financial statement notes. The ASU is effective for disposals (or classifications as held-for-sale) that occur within annual periods beginning on or after December 15, 2014 and interim periods within those annual periods. Early application is permitted, but only for those disposals that have not been reported in financial statements previously issued or available for issuance. We have chosen to early adopt this ASU and have applied the new criteria in determining the accounting treatment for the nursing centers exited during 2014. The adoption of this guidance did not have a material impact on the Company's consolidated financial results.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.
XML 51 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation $ 441 $ 809
Restricted Stock
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Grant of restricted common stock (shares) 68,000 69,000
Vest of restricted stock on each year (percentage) 33.00%  
Stock Compensation Plan
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Grant of restricted common stock (shares) 55,000  
2005 Long Term Incentive Plan
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares reserved for future issuance 700,000  
Expiration period 10 years  
2008 Stock Purchase Plan
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares reserved for future issuance 150,000  
Percentage of quoted market price offering rate 85.00%  
Restriction period 2 years  
2010 Long Term Incentive Plan | Stock Only Stock Appreciation Rights (SOSARS)
    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares reserved for future issuance 380,000  
XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 92 255 1 false 54 0 false 12 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.advocatinc.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 1001000 - Statement - Interim Consolidated Balance Sheets Sheet http://www.advocatinc.com/role/InterimConsolidatedBalanceSheets Interim Consolidated Balance Sheets false false R3.htm 1001501 - Statement - Interim Consolidated Balance Sheets (Parenthetical) Sheet http://www.advocatinc.com/role/InterimConsolidatedBalanceSheetsParenthetical Interim Consolidated Balance Sheets (Parenthetical) false false R4.htm 1002000 - Statement - Interim Consolidated Statements of Operations Sheet http://www.advocatinc.com/role/InterimConsolidatedStatementsOfOperations Interim Consolidated Statements of Operations false false R5.htm 1002501 - Statement - Interim Consolidated Statements of Operations (Parenthetical) Sheet http://www.advocatinc.com/role/InterimConsolidatedStatementsOfOperationsParenthetical Interim Consolidated Statements of Operations (Parenthetical) false false R6.htm 1003000 - Statement - Interim Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.advocatinc.com/role/InterimConsolidatedStatementsOfComprehensiveIncomeLoss Interim Consolidated Statements of Comprehensive Income (Loss) false false R7.htm 1004000 - Statement - Interim Consolidated Statements of Cash Flows Sheet http://www.advocatinc.com/role/InterimConsolidatedStatementsOfCashFlows Interim Consolidated Statements of Cash Flows false false R8.htm 2101100 - Disclosure - Business Sheet http://www.advocatinc.com/role/Business Business false false R9.htm 2102100 - Disclosure - Consolidation and Basis of Presentation of Financial Statements Sheet http://www.advocatinc.com/role/ConsolidationAndBasisOfPresentationOfFinancialStatements Consolidation and Basis of Presentation of Financial Statements false false R10.htm 2103100 - Disclosure - Recent Accounting Guidance Sheet http://www.advocatinc.com/role/RecentAccountingGuidance Recent Accounting Guidance false false R11.htm 2104100 - Disclosure - Long-Term Debt and Interest Rate Swap Sheet http://www.advocatinc.com/role/LongTermDebtAndInterestRateSwap Long-Term Debt and Interest Rate Swap false false R12.htm 2105100 - Disclosure - Insurance Matters Sheet http://www.advocatinc.com/role/InsuranceMatters Insurance Matters false false R13.htm 2106100 - Disclosure - Stock-Based Compensation Sheet http://www.advocatinc.com/role/StockBasedCompensation Stock-Based Compensation false false R14.htm 2107100 - Disclosure - Earnings (Loss) Per Common Share Sheet http://www.advocatinc.com/role/EarningsLossPerCommonShare Earnings (Loss) Per Common Share false false R15.htm 2108100 - Disclosure - Variable Interest Entity Sheet http://www.advocatinc.com/role/VariableInterestEntity Variable Interest Entity false false R16.htm 2109100 - Disclosure - Equity Method Investment Sheet http://www.advocatinc.com/role/EquityMethodInvestment Equity Method Investment false false R17.htm 2110100 - Disclosure - Business Development Sheet http://www.advocatinc.com/role/BusinessDevelopment Business Development false false R18.htm 2111100 - Disclosure - Discontinued Operations Sheet http://www.advocatinc.com/role/DiscontinuedOperations Discontinued Operations false false R19.htm 2112100 - Disclosure - Subsequent Events Sheet http://www.advocatinc.com/role/SubsequentEvents Subsequent Events false false R20.htm 2306301 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.advocatinc.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) false false R21.htm 2307301 - Disclosure - Earnings (Loss) Per Common Share (Tables) Sheet http://www.advocatinc.com/role/EarningsLossPerCommonShareTables Earnings (Loss) Per Common Share (Tables) false false R22.htm 2310301 - Disclosure - Business Development (Tables) Sheet http://www.advocatinc.com/role/BusinessDevelopmentTables Business Development (Tables) false false R23.htm 2401401 - Disclosure - Business (Details) Sheet http://www.advocatinc.com/role/BusinessDetails Business (Details) false false R24.htm 2402401 - Disclosure - Consolidation and Basis of Presentation of Financial Statements (Details) Sheet http://www.advocatinc.com/role/ConsolidationAndBasisOfPresentationOfFinancialStatementsDetails Consolidation and Basis of Presentation of Financial Statements (Details) false false R25.htm 2404401 - Disclosure - Long-Term Debt and Interest Rate Swap (Details) Sheet http://www.advocatinc.com/role/LongTermDebtAndInterestRateSwapDetails Long-Term Debt and Interest Rate Swap (Details) false false R26.htm 2405401 - Disclosure - Insurance Matters (Details) Sheet http://www.advocatinc.com/role/InsuranceMattersDetails Insurance Matters (Details) false false R27.htm 2406402 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.advocatinc.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) false false R28.htm 2406403 - Disclosure - Share-Based Compensation (Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable) (Details) Sheet http://www.advocatinc.com/role/ShareBasedCompensationShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableDetails Share-Based Compensation (Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable) (Details) false false R29.htm 2406404 - Disclosure - Stock-Based Compensation (Restricted Stock and Restricted Stock Units Activity) (Details) Sheet http://www.advocatinc.com/role/StockBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityDetails Stock-Based Compensation (Restricted Stock and Restricted Stock Units Activity) (Details) false false R30.htm 2406405 - Disclosure - Stock-Based Compensation (Schedule of Stock Options Outstanding and Exercisable) (Details) Sheet http://www.advocatinc.com/role/StockBasedCompensationScheduleOfStockOptionsOutstandingAndExercisableDetails Stock-Based Compensation (Schedule of Stock Options Outstanding and Exercisable) (Details) false false R31.htm 2407402 - Disclosure - Earnings (Loss) Per Common Share (Details) Sheet http://www.advocatinc.com/role/EarningsLossPerCommonShareDetails Earnings (Loss) Per Common Share (Details) false false R32.htm 2407403 - Disclosure - Earnings (Loss) Per Common Share (Details Textual) Sheet http://www.advocatinc.com/role/EarningsLossPerCommonShareDetailsTextual Earnings (Loss) Per Common Share (Details Textual) false false R33.htm 2408401 - Disclosure - Variable Interest Entity (Details Textual) Sheet http://www.advocatinc.com/role/VariableInterestEntityDetailsTextual Variable Interest Entity (Details Textual) false false R34.htm 2409401 - Disclosure - Equity Method Investment (Details) Sheet http://www.advocatinc.com/role/EquityMethodInvestmentDetails Equity Method Investment (Details) false false R35.htm 2410402 - Disclosure - Business Development (Details) Sheet http://www.advocatinc.com/role/BusinessDevelopmentDetails Business Development (Details) false false R36.htm 2410403 - Disclosure - Business Development (Schedule of Assets Acquired) (Details) Sheet http://www.advocatinc.com/role/BusinessDevelopmentScheduleOfAssetsAcquiredDetails Business Development (Schedule of Assets Acquired) (Details) false false R37.htm 2411401 - Disclosure - Discontinued Operations (Details) Sheet http://www.advocatinc.com/role/DiscontinuedOperationsDetails Discontinued Operations (Details) false false R38.htm 2412401 - Disclosure - Subsequent Events (Details) Sheet http://www.advocatinc.com/role/SubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Element us-gaap_LongTermDebt had a mix of decimals attribute values: -6 -3. 'Monetary' elements on report '2405401 - Disclosure - Insurance Matters (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '2406402 - Disclosure - Stock-Based Compensation (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2411401 - Disclosure - Discontinued Operations (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Interim Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 1001501 - Statement - Interim Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 1002000 - Statement - Interim Consolidated Statements of Operations Process Flow-Through: 1002501 - Statement - Interim Consolidated Statements of Operations (Parenthetical) Process Flow-Through: 1003000 - Statement - Interim Consolidated Statements of Comprehensive Income (Loss) Process Flow-Through: 1004000 - Statement - Interim Consolidated Statements of Cash Flows avca-20140930.xml avca-20140930.xsd avca-20140930_cal.xml avca-20140930_def.xml avca-20140930_lab.xml avca-20140930_pre.xml true true XML 53 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details) (USD $)
In Millions, unless otherwise specified
 0 Months Ended 0 Months Ended
Oct. 01, 2013
Sep. 30, 2014
Bed
Oct. 01, 2014
Subsequent Event
Greenville, Kentucky
Oct. 01, 2014
Subsequent Event
Greenville, Kentucky
Bed
Subsequent Event [Line Items]        
Number of licensed nursing beds   6,229   62
Expected annual revenues of operations assumed     $ 4.5  
Lease agreement term 15 years   14 years  
XML 54 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
Summarized activity of the equity compensation plans is presented below:
 
 
 
Weighted
 
 
 
Average
 
Shares
 
Exercise Price
Outstanding, December 31, 2013
333,000

 
$
6.64

Granted
—

 
—

Exercised
(22,000
)
 
4.54

Expired or cancelled
(36,000
)
 
7.87

Outstanding, September 30, 2014
275,000

 
$
6.65

 
 
 
 
Exercisable, September 30, 2014
244,000

 
$
6.77
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
 
 
 
Weighted
 
 
 
Average
 
Restricted
 
Grant Date
 
Shares
 
Fair Value
Outstanding, December 31, 2013
118,000

 
$
5.41

Granted
68,000

 
5.51

Dividend Equivalents
3,000

 
7.72

Vested
(57,000
)
 
5.61

Cancelled
(2,000
)
 
5.47

Outstanding September 30, 2014
130,000

 
$
5.43

Summarized activity of the Restricted Share Units for the Stock Purchase Plan is as follows:
 
 
 
Weighted
 
 
 
Average
 
Restricted
 
Grant Date
 
Share Units
 
Fair Value
Outstanding, December 31, 2013
41,000

 
$
5.35

Granted
25,000

 
5.51

Dividend Equivalents
1,000

 
6.86

Vested
(21,000
)
 
5.70

Cancelled
—

 
—

Outstanding September 30, 2014
46,000

 
$
5.30
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table summarizes information regarding stock options and SOSAR grants outstanding as of September 30, 2014:
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
Intrinsic
 
 
 
Intrinsic
Range of
 
Exercise
 
Grants
 
Value-Grants
 
Grants
 
Value-Grants
Exercise Prices
 
Prices
 
Outstanding
 
Outstanding
 
Exercisable
 
Exercisable
$10.40 to $11.59
 
11.11

 
57,000

 
1,000

 
57,000

 
1,000

$2.37 to $6.21
 
5.49

 
218,000

 
1,145,000

 
187,000

 
994,000

 
 
 
 
275,000

 
 
 
244,000